Citrus Sinensis ID: 014725
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 419 | 2.2.26 [Sep-21-2011] | |||||||
| Q7X8C5 | 748 | Wall-associated receptor | yes | no | 0.923 | 0.517 | 0.565 | 1e-135 | |
| Q9C9L5 | 792 | Wall-associated receptor | no | no | 0.842 | 0.445 | 0.612 | 1e-131 | |
| Q8RY17 | 751 | Wall-associated receptor | no | no | 0.821 | 0.458 | 0.630 | 1e-130 | |
| Q9S9M2 | 761 | Wall-associated receptor | no | no | 0.911 | 0.501 | 0.539 | 1e-130 | |
| Q9LN59 | 788 | Putative wall-associated | no | no | 0.825 | 0.439 | 0.636 | 1e-130 | |
| Q9S9M5 | 730 | Wall-associated receptor | no | no | 0.821 | 0.471 | 0.616 | 1e-129 | |
| Q9SA25 | 720 | Wall-associated receptor | no | no | 0.923 | 0.537 | 0.561 | 1e-127 | |
| Q9LMT9 | 764 | Putative wall-associated | no | no | 0.818 | 0.448 | 0.609 | 1e-127 | |
| Q9S9M3 | 730 | Wall-associated receptor | no | no | 0.804 | 0.461 | 0.610 | 1e-124 | |
| Q8VYA3 | 769 | Wall-associated receptor | no | no | 0.847 | 0.461 | 0.592 | 1e-123 |
| >sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 481 bits (1238), Expect = e-135, Method: Compositional matrix adjust.
Identities = 226/400 (56%), Positives = 312/400 (78%), Gaps = 13/400 (3%)
Query: 26 GLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMD 85
G L + G++GL KFV++RR++ R FF++NGG+LL+QQL+ EGN+E +++F+ +
Sbjct: 349 GSALLLFAFGIFGLYKFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHE 408
Query: 86 LEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN 145
LEKATDN+N NR+LGQGGQGTVYKGML DG IVAVK+SK VDE VE+FINEVV+L+QIN
Sbjct: 409 LEKATDNFNKNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQIN 468
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
HRN+VKLLGCCLE+EVP+LVYEF+PNG L LHD+++++ +TWE+RL IAIE++GA+SY
Sbjct: 469 HRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSY 528
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LHSA S PIYHRDIK++NILLD++ RAKVSDFG SR++ +DQTHLTT+V GTFGY+DPEY
Sbjct: 529 LHSAASFPIYHRDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEY 588
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
F+SS+FTEKSDVYSFGVVLVELLTG+KP +EE+R L F++A+ E+R+ ++++ R
Sbjct: 589 FQSSKFTEKSDVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDR 648
Query: 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQ--------H 377
+ E +++++VA L +RCLN GKKRP+M+EV+ ELE IR+S S +
Sbjct: 649 IKDECNMDQVMSVANLARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHIEDDDEEDD 708
Query: 378 NCEEIHFVGGDNTRHSGTDYSSTGSILNSVAYSTDADPLI 417
E++F ++T G ++ S+ N+ + ++DA+PL+
Sbjct: 709 QAMELNF---NDTWEVGA--TAPASMFNNASPTSDAEPLV 743
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q9C9L5|WAKLH_ARATH Wall-associated receptor kinase-like 9 OS=Arabidopsis thaliana GN=WAKL9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 468 bits (1204), Expect = e-131, Method: Compositional matrix adjust.
Identities = 217/354 (61%), Positives = 287/354 (81%), Gaps = 1/354 (0%)
Query: 24 GSGLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTK 83
G+ G I ++G++ L KF+K++R++ K+ FFK+NGGLLLQQQL S G +EKT +F+
Sbjct: 378 GASFGSLIFVVGIYLLYKFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSS 437
Query: 84 MDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQ 143
+LEKAT+N+++NRILGQGGQGTVYKGML DG IVAVKKSK+VDE +E+FINEVVILSQ
Sbjct: 438 RELEKATENFSSNRILGQGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQ 497
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEE-FPITWEMRLRIAIEVSGA 202
INHRN+VKLLGCCLE++VP+LVYEFIPNG L+ +LHD+ +E TW +RLRIAI+++GA
Sbjct: 498 INHRNIVKLLGCCLETKVPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGA 557
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
+SYLHS+ S PIYHRD+KS+NI+LD+KYRAKVSDFG SRT+ VD THLTT V GT GY+D
Sbjct: 558 LSYLHSSASSPIYHRDVKSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMD 617
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322
PEYF+SSQFT+KSDVYSFGVVLVEL+TG+K I ++E+R+L +F+ AM E++LF+++
Sbjct: 618 PEYFQSSQFTDKSDVYSFGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDII 677
Query: 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQ 376
+AR+ ++ A + ++CLN+ G+KRPSM+EV+ EL+ IR G LQ
Sbjct: 678 DARIRDGCMLSQVTATAKVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQ 731
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1198), Expect = e-130, Method: Compositional matrix adjust.
Identities = 217/344 (63%), Positives = 290/344 (84%)
Query: 26 GLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMD 85
G L L++G+WGL KFVK+RR+I KRMFFK+NGGLLL+QQL++ GN++ +K+F+ +
Sbjct: 354 GFPLLFLVLGIWGLIKFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKE 413
Query: 86 LEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN 145
LEKATDN+N NR+LGQGGQGTVYKGML DG IVAVK+SK++DE VE+FINEV +LSQIN
Sbjct: 414 LEKATDNFNMNRVLGQGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQIN 473
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
HRN+VKL+GCCLE+EVP+LVYE IPNG L+ LH ++++ +TW++RLRI++E++GA++Y
Sbjct: 474 HRNIVKLMGCCLETEVPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAY 533
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LHSA S P+YHRD+K++NILLD+KYRAKVSDFG SR+I VDQTHLTT V GTFGYLDPEY
Sbjct: 534 LHSAASTPVYHRDVKTTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEY 593
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
F++SQFT+KSDVYSFGVVLVEL+TG+KP EE+R LV F +AM ++R+ +++++R
Sbjct: 594 FQTSQFTDKSDVYSFGVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSR 653
Query: 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
+ + E+++ VA L +RCL++ GKKRP+M+EV+ ELE IR+S
Sbjct: 654 IKEGCTLEQVLAVAKLARRCLSLKGKKRPNMREVSVELERIRSS 697
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 465 bits (1197), Expect = e-130, Method: Compositional matrix adjust.
Identities = 221/410 (53%), Positives = 302/410 (73%), Gaps = 28/410 (6%)
Query: 26 GLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMD 85
G L + G++GL KF+K++R R+FF++NGG+LL+QQL+ EGN+E +K+F+ +
Sbjct: 357 GSALLLFAFGIFGLYKFIKKQRRSSRMRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNE 416
Query: 86 LEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN 145
LEKATDN+N NR+LGQGGQGTVYKGML DG IVAVK+SK +DE VE+FINEVV+L+QIN
Sbjct: 417 LEKATDNFNTNRVLGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQIN 476
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
HRN+VKLLGCCLE+EVP+LVYEF+PNG L L D+ +++ +TWE+RL IAIE++GA+SY
Sbjct: 477 HRNIVKLLGCCLETEVPVLVYEFVPNGDLCKRLRDECDDYIMTWEVRLHIAIEIAGALSY 536
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LHSA S PIYHRDIK++NILLD+KY+ KVSDFG SR++ +DQTHLTT+V GTFGY+DPEY
Sbjct: 537 LHSAASFPIYHRDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEY 596
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
F+SS+FT+KSDVYSFGVVLVEL+TG+ P +EE+R F+ A+ E+R ++++ R
Sbjct: 597 FQSSKFTDKSDVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKENRFLDIVDER 656
Query: 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS------------ 373
+ E ++++ VA L KRCLN GKKRP+M+EV+ ELE IR+S S
Sbjct: 657 IKDECNLDQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSSSYKSEIHNDDDDDDDD 716
Query: 374 ------SLQHNCEEIHFVGGDNTRHSGTDYSSTGSILNSVAYSTDADPLI 417
+++ N EE VG ++ S+ N+ + ++D +PL+
Sbjct: 717 DDEDDQAMELNIEETWDVG----------MTAPASMFNNGSPASDVEPLV 756
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LN59|WAKLK_ARATH Putative wall-associated receptor kinase-like 11 OS=Arabidopsis thaliana GN=WAKL11 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 464 bits (1195), Expect = e-130, Method: Compositional matrix adjust.
Identities = 221/347 (63%), Positives = 287/347 (82%), Gaps = 1/347 (0%)
Query: 24 GSGLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTK 83
GS G+ +L++G+W LRKF+K+RR K KR FFK+NGGLLLQQQL++N+GN+EKT++F+
Sbjct: 382 GSAFGILVLVVGIWWLRKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSS 441
Query: 84 MDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQ 143
+LEKATDN++ +RILGQGGQGTVYKGML DG VAVKKSK+VDE +E+FINEVVILSQ
Sbjct: 442 RELEKATDNFSESRILGQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQ 501
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
INHR+VVKLLGCCLE+EVP LVYEFIPNG L+ ++H++++++ TW MRLRIA++++GA+
Sbjct: 502 INHRHVVKLLGCCLETEVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGAL 561
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
SYLHSA S PIYHRDIKS+NILLD+KYR KVSDFG SR++ +D TH TT + GT GY+DP
Sbjct: 562 SYLHSAASSPIYHRDIKSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDP 621
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKP-IRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322
EY+ SSQ+T+KSDVYSFGVVLVEL+TG+KP I ++++E R L F AM E+R FE++
Sbjct: 622 EYYGSSQYTDKSDVYSFGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIM 681
Query: 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
+AR+ K E+++ VA L +RCLN GKKRP M++V +LE I AS
Sbjct: 682 DARIRDGCKPEQVMAVANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 463 bits (1192), Expect = e-129, Method: Compositional matrix adjust.
Identities = 212/344 (61%), Positives = 285/344 (82%)
Query: 26 GLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMD 85
GL + +G++ L K +K+RR I + FFK+NGGLLL+QQL++ +GN+E +K+F+ +
Sbjct: 362 GLSGLVFFVGLFWLFKLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKE 421
Query: 86 LEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN 145
L KATDN++ +R+LGQGGQGTVYKGML DG IVAVK+SK+VDE +E+FINE+V+LSQIN
Sbjct: 422 LRKATDNFSIDRVLGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQIN 481
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
HRN+VKLLGCCLE+EVP+LVYE+IPNG L+ LHD+++++ +TWE+RLRIAIE++GA++Y
Sbjct: 482 HRNIVKLLGCCLETEVPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTY 541
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
+HSA S PI+HRDIK++NILLD+KYRAKVSDFG SR++ +DQTHLTT V GTFGY+DPEY
Sbjct: 542 MHSAASFPIFHRDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEY 601
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
F SSQ+T KSDVYSFGVVLVEL+TG+KP+ +EE R L FL+AM E+R+ ++++ R
Sbjct: 602 FLSSQYTHKSDVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIR 661
Query: 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
+ E K E+++ VA L ++CLN GK RP+MKEV+ ELE IR+S
Sbjct: 662 IKDESKLEQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SA25|WAKLG_ARATH Wall-associated receptor kinase-like 8 OS=Arabidopsis thaliana GN=WAKL8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1169), Expect = e-127, Method: Compositional matrix adjust.
Identities = 218/388 (56%), Positives = 293/388 (75%), Gaps = 1/388 (0%)
Query: 33 LIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMDLEKATDN 92
+ GMW L K ++R+ K KR FF++NGGLLLQQQ S G++ +TK+F+ DLE ATD
Sbjct: 330 IFGMWLLCKANRKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDR 389
Query: 93 YNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
+NA+RILGQGGQGTVYKGML DG IVAVKKSK + E N+E+FINE+++LSQINHRNVVK+
Sbjct: 390 FNASRILGQGGQGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKI 449
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
LGCCLE+EVP+LVYEFIPN L+ +LH+ +E+FP++WE+RL IA EV+ A+SYLHSA SI
Sbjct: 450 LGCCLETEVPILVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSI 509
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT 272
PIYHRD+KS+NILLD+K+RAKVSDFG SR++ +D THLTT VQGT GY+DPEY +S+ FT
Sbjct: 510 PIYHRDVKSTNILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFT 569
Query: 273 EKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332
KSDVYSFGV+L+ELLTG+KP+ +E R L +FL+AM DRL E+L+AR+ +E
Sbjct: 570 GKSDVYSFGVLLIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDR 629
Query: 333 EEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS-IGSSSLQHNCEEIHFVGGDNTR 391
EE++ VA L +RCL++ + RP+M++V EL+ +++ G+ S N EE +
Sbjct: 630 EEVLAVAKLARRCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQNGEEHAHIQIAMPE 689
Query: 392 HSGTDYSSTGSILNSVAYSTDADPLISN 419
YSS ++ + ++S D PL+ +
Sbjct: 690 SMSLSYSSPNIVVENSSFSLDTKPLMPH 717
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 454 bits (1167), Expect = e-127, Method: Compositional matrix adjust.
Identities = 211/346 (60%), Positives = 275/346 (79%), Gaps = 3/346 (0%)
Query: 24 GSGLGLFILLIG--MWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLF 81
G G G F+L++G +W RK +++RR KR FFK+NGGLLLQQQL++ +G +EKTKLF
Sbjct: 383 GLGAGFFVLIVGGGIWWWRKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLF 442
Query: 82 TKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVIL 141
+ +LEKATDN+N NR++GQGGQGTVYKGML DG VAVKKS +VDE +++FINEV+IL
Sbjct: 443 SSRELEKATDNFNDNRVIGQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIIL 502
Query: 142 SQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201
SQINHR+VVKLLGCCLE+EVP+LVYEFIPNG L+ +LH++ +++ W +R+RIA+++SG
Sbjct: 503 SQINHRHVVKLLGCCLETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISG 562
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
A SYLH+A PIYHRDIKS+NILLD+KYRAKVSDFG SR++ +D TH TT + GT GY+
Sbjct: 563 AFSYLHTAACSPIYHRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYV 622
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS-TDAEEDRSLVGFFLQAMNEDRLFE 320
DPEY+ SS FTEKSDVYSFGVVLVEL+TG+KP+ + ++ +E L +F AM E+RLFE
Sbjct: 623 DPEYYGSSHFTEKSDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFE 682
Query: 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+++AR+ + K E++I VA L RCL GK RP M+EV+ LE I
Sbjct: 683 IIDARIRNDCKLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728
|
Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9S9M3|WAKLC_ARATH Wall-associated receptor kinase-like 3 OS=Arabidopsis thaliana GN=WAKL3 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 446 bits (1148), Expect = e-124, Method: Compositional matrix adjust.
Identities = 207/339 (61%), Positives = 280/339 (82%), Gaps = 2/339 (0%)
Query: 31 ILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMDLEKAT 90
+IG++GL KF+++RR I FFK+NGGLLL+QQL++ +G++E +K+F+ +LEKAT
Sbjct: 366 FFVIGIFGLYKFIRKRRRIIRSMKFFKRNGGLLLKQQLTTKDGSVEMSKIFSSRELEKAT 425
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
DN++ +R+LGQGGQGTVYK ML DG IVAVK+SK+VDE +E+FINE+V+LSQINHRN+V
Sbjct: 426 DNFSIDRVLGQGGQGTVYKRMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIV 485
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
KLLGCCLE+EVP+LVYE+IPNG L+ LHD+ +++ +TWE+RLRIA+E++GA+SY+HSA
Sbjct: 486 KLLGCCLETEVPILVYEYIPNGDLFKRLHDEYDDYMMTWEVRLRIAVEIAGALSYMHSAA 545
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
S PI+HRDIK++NILLD+KYRAK+SDFG SR++ DQTHLTT V GTFGY+DPEYF SSQ
Sbjct: 546 SFPIFHRDIKTTNILLDEKYRAKISDFGTSRSVATDQTHLTTLVAGTFGYMDPEYFLSSQ 605
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330
+T KSDVYSFGVVLVEL+TG+KP+ +EE L +FL+AM E+R ++++ R+ E
Sbjct: 606 YTHKSDVYSFGVVLVELITGEKPMSRVRSEEGIGLATYFLEAMKENRAVDIIDIRIKDES 665
Query: 331 KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
K +++ VA L +RCLN G KRP+M+EV+ +LE IR+S
Sbjct: 666 K--QVMAVAKLARRCLNRKGNKRPNMREVSIKLERIRSS 702
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8VYA3|WAKLJ_ARATH Wall-associated receptor kinase-like 10 OS=Arabidopsis thaliana GN=WAKL10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 441 bits (1134), Expect = e-123, Method: Compositional matrix adjust.
Identities = 212/358 (59%), Positives = 286/358 (79%), Gaps = 3/358 (0%)
Query: 14 EYNSHSISCCG--SGLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSN 71
EY +H G + + + G++ L KF++R+R + K+ FFK+NGGLLLQQQL++
Sbjct: 352 EYTNHRPLVIGLSTSFSTLVFIGGIYWLYKFIRRQRRLNQKKKFFKRNGGLLLQQQLTTT 411
Query: 72 EGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNV 131
EGN++ T++F +LEKAT+N++ RILG+GGQGTVYKGML DG IVAVKKSK+VDE +
Sbjct: 412 EGNVDSTRVFNSRELEKATENFSLTRILGEGGQGTVYKGMLVDGRIVAVKKSKVVDEDKL 471
Query: 132 EQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPIT-WE 190
E+FINEVVILSQINHRN+VKLLGCCLE++VP+LVYEFIPNG L+ +LHD ++++ +T WE
Sbjct: 472 EEFINEVVILSQINHRNIVKLLGCCLETDVPILVYEFIPNGNLFEHLHDDSDDYTMTTWE 531
Query: 191 MRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250
+RLRIA++++GA+SYLHSA S PIYHRDIKS+NI+LD+K+RAKVSDFG SRT+ VD THL
Sbjct: 532 VRLRIAVDIAGALSYLHSAASSPIYHRDIKSTNIMLDEKHRAKVSDFGTSRTVTVDHTHL 591
Query: 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL 310
TT V GT GY+DPEYF+SSQFT+KSDVYSFGVVL EL+TG+K + ++E R+L +F
Sbjct: 592 TTVVSGTVGYMDPEYFQSSQFTDKSDVYSFGVVLAELITGEKSVSFLRSQEYRTLATYFT 651
Query: 311 QAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368
AM E+RL ++++AR+ K ++ A + ++CLNM G+KRPSM++V+ ELE IR+
Sbjct: 652 LAMKENRLSDIIDARIRDGCKLNQVTAAAKIARKCLNMKGRKRPSMRQVSMELEKIRS 709
|
Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 419 | ||||||
| 255545828 | 694 | kinase, putative [Ricinus communis] gi|2 | 0.830 | 0.501 | 0.729 | 1e-152 | |
| 255545824 | 727 | kinase, putative [Ricinus communis] gi|2 | 0.897 | 0.517 | 0.697 | 1e-151 | |
| 147852023 | 413 | hypothetical protein VITISV_028337 [Viti | 0.918 | 0.932 | 0.665 | 1e-148 | |
| 359475620 | 822 | PREDICTED: wall-associated receptor kina | 0.825 | 0.420 | 0.721 | 1e-148 | |
| 255541802 | 743 | kinase, putative [Ricinus communis] gi|2 | 0.823 | 0.464 | 0.759 | 1e-147 | |
| 359475622 | 867 | PREDICTED: wall-associated receptor kina | 0.921 | 0.445 | 0.658 | 1e-146 | |
| 147765961 | 679 | hypothetical protein VITISV_007744 [Viti | 0.918 | 0.567 | 0.654 | 1e-144 | |
| 225455808 | 718 | PREDICTED: wall-associated receptor kina | 0.904 | 0.527 | 0.662 | 1e-143 | |
| 297734146 | 1029 | unnamed protein product [Vitis vinifera] | 0.885 | 0.360 | 0.667 | 1e-141 | |
| 224053054 | 722 | predicted protein [Populus trichocarpa] | 0.968 | 0.562 | 0.629 | 1e-140 |
| >gi|255545828|ref|XP_002513974.1| kinase, putative [Ricinus communis] gi|223547060|gb|EEF48557.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 544 bits (1401), Expect = e-152, Method: Compositional matrix adjust.
Identities = 256/351 (72%), Positives = 302/351 (86%), Gaps = 3/351 (0%)
Query: 29 LFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMDLEK 88
+LLIG+W L K +KRRR +KLK+ FFK+NGGLLL+QQLSS E +E+TK+FT +LEK
Sbjct: 336 FLLLLIGIWSLYKIIKRRRAMKLKQNFFKRNGGLLLEQQLSSTENYVEQTKVFTSKELEK 395
Query: 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN 148
ATD+Y+ NRILGQGGQGTVYKGML DG +VA+KKSK+VDE ++QFINEVVILSQINHRN
Sbjct: 396 ATDDYHTNRILGQGGQGTVYKGMLIDGRVVAIKKSKVVDEDKLDQFINEVVILSQINHRN 455
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
VVKL+GCCLE+EVPLLVYEFIPNGTLY Y+H+ EEFP+TWEMRLRIA EV+GA++YLH+
Sbjct: 456 VVKLIGCCLETEVPLLVYEFIPNGTLYQYIHNPNEEFPVTWEMRLRIATEVAGALAYLHA 515
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS 268
A S+PIYHRDIKSSNILLD+KYRAKV+DFG S++I +DQTH+TTRVQGTFGYLDPEYF+S
Sbjct: 516 AASMPIYHRDIKSSNILLDEKYRAKVADFGTSKSISIDQTHVTTRVQGTFGYLDPEYFQS 575
Query: 269 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328
SQFTEKSDVYSFGVVLVELLTGQKPI S + E+RSL +FL M E RLFE+L+ARVLK
Sbjct: 576 SQFTEKSDVYSFGVVLVELLTGQKPISSYRSVEERSLATYFLMTMEESRLFEILDARVLK 635
Query: 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNC 379
EG EEII +A L ++CLN+ GKKRP MK VA ELEGIR+S G + H C
Sbjct: 636 EGGREEIIAMAKLAEKCLNLNGKKRPKMKTVAIELEGIRSSQGHN---HTC 683
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255545824|ref|XP_002513972.1| kinase, putative [Ricinus communis] gi|223547058|gb|EEF48555.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 541 bits (1395), Expect = e-151, Method: Compositional matrix adjust.
Identities = 265/380 (69%), Positives = 315/380 (82%), Gaps = 4/380 (1%)
Query: 41 KFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILG 100
K +KRRR KLK+ FFK+NGGLLL+QQLSS E ++E+TK+FT +LEKATDNY+ +RILG
Sbjct: 343 KIIKRRRATKLKQKFFKRNGGLLLEQQLSSTESHVEQTKVFTSKELEKATDNYHTSRILG 402
Query: 101 QGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160
QGGQGTVYKGML DG +VA+KKSKLVDE ++QFINEVVILSQINHRNVVKL GCCLE+E
Sbjct: 403 QGGQGTVYKGMLTDGRVVAIKKSKLVDEDKLDQFINEVVILSQINHRNVVKLTGCCLETE 462
Query: 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220
VPLLVYEFIPNGTL+ Y+ + +EFPITWEMRLRIA EV+GA++YLHSA S+PIYHRDIK
Sbjct: 463 VPLLVYEFIPNGTLFQYIQNPNKEFPITWEMRLRIATEVAGALAYLHSAASMPIYHRDIK 522
Query: 221 SSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 280
SSNILLD+KYRAKV+DFG S++I ++QTH+TT VQGTFGYLDPEYF+SSQFTEKSDVYSF
Sbjct: 523 SSNILLDEKYRAKVADFGTSKSIAIEQTHVTTLVQGTFGYLDPEYFQSSQFTEKSDVYSF 582
Query: 281 GVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM 340
GVVLVELLTGQKPI S + E+RSL +FL M E+RLFE+L+ARVLKEG EEII +A
Sbjct: 583 GVVLVELLTGQKPISSLRSVEERSLATYFLMTMEENRLFEILDARVLKEGGREEIIAMAK 642
Query: 341 LGKRCLNMIGKKRPSMKEVAFELEGIRASIG-SSSLQHNCEEIHFVGGDNTRHSGTDYSS 399
+ ++CLN+ GKKRP MK VA ELEGIR+S G SS++Q + EE+ +V GD T SS
Sbjct: 643 MAEKCLNLNGKKRPKMKTVAIELEGIRSSQGVSSTIQQDYEEVDYVVGDYTASWDVASSS 702
Query: 400 TGSILNSVAYST--DADPLI 417
TGS LNS D PL+
Sbjct: 703 TGS-LNSTTIRARFDVKPLL 721
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147852023|emb|CAN82287.1| hypothetical protein VITISV_028337 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 531 bits (1368), Expect = e-148, Method: Compositional matrix adjust.
Identities = 257/386 (66%), Positives = 313/386 (81%), Gaps = 1/386 (0%)
Query: 33 LIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMDLEKATDN 92
+I W L + +KRRR+IK K FK+NGGLLL+QQLSS+EGN++KTKLFT +LEKATD
Sbjct: 23 VICAWLLYRVLKRRRKIKHKEKCFKRNGGLLLEQQLSSSEGNVDKTKLFTSKELEKATDR 82
Query: 93 YNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
YN NR++GQGGQGTVYKGML DG IVAVKK K+V + +EQFINEVVILSQINHRNVVKL
Sbjct: 83 YNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGKLEQFINEVVILSQINHRNVVKL 142
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
LGCCLE EVPLLVYE+IPNGTL ++HDQ EEFPITW+MRL+IA EV+GA+SYLHSA SI
Sbjct: 143 LGCCLEIEVPLLVYEYIPNGTLSEHIHDQNEEFPITWKMRLQIATEVAGALSYLHSAASI 202
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT 272
PIYHRDIKS+NILLDDKYRAKV+DFG S+++ +DQTHLTT+VQGTFGYLDPEYF+SSQFT
Sbjct: 203 PIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTKVQGTFGYLDPEYFQSSQFT 262
Query: 273 EKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332
EKSDVYSFG+VL+ELLTG+KPI S + E +SL +F+ +M EDRL ++L+ARV+KEG++
Sbjct: 263 EKSDVYSFGIVLIELLTGKKPILSIGSGEGKSLASYFIMSMKEDRLSDLLDARVVKEGRK 322
Query: 333 EEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEIHFVGGDNTRH 392
EEI +A L KRC+N+ GKKRP+M EVA ELE IR G + Q N +E+ + + TR
Sbjct: 323 EEINAIAFLAKRCINLNGKKRPTMMEVAMELERIRKCEGDFNAQENSDEVEYDTIELTRP 382
Query: 393 SGTDYSSTGSILNSVAYST-DADPLI 417
+STGS N+ A D PL+
Sbjct: 383 WDVASTSTGSCFNTNASPPLDVQPLL 408
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475620|ref|XP_002266785.2| PREDICTED: wall-associated receptor kinase-like 1-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 530 bits (1365), Expect = e-148, Method: Compositional matrix adjust.
Identities = 251/348 (72%), Positives = 302/348 (86%), Gaps = 2/348 (0%)
Query: 22 CCG--SGLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTK 79
C G +G+G +L+I W L K +KRR++IK K FK+NGGLLL+QQLSS+EGN++KTK
Sbjct: 456 CVGILAGVGTLLLVICAWWLYKVLKRRQKIKYKEKCFKRNGGLLLEQQLSSSEGNVDKTK 515
Query: 80 LFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVV 139
LFT +LEKATD YN NR++GQGGQGTVYKGML DG IVAVKK K+V + VEQFINEVV
Sbjct: 516 LFTSKELEKATDRYNENRVIGQGGQGTVYKGMLMDGRIVAVKKLKIVGDGKVEQFINEVV 575
Query: 140 ILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
ILSQINHRNVVKLLGCCLE+ VPLLVYEFIPNGTL ++HDQ EEFPITWEMRLRIAIEV
Sbjct: 576 ILSQINHRNVVKLLGCCLETAVPLLVYEFIPNGTLSEHIHDQNEEFPITWEMRLRIAIEV 635
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
+GA+SYLHSA SIPIYHRDIKS+NILLDDKYRAKV+DFG S+++ +DQTHLTT+VQGTFG
Sbjct: 636 AGALSYLHSAASIPIYHRDIKSTNILLDDKYRAKVADFGTSKSVAIDQTHLTTQVQGTFG 695
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319
YLDPEYF+SSQFTEKSDVYSFG+VL+ELLTG+KPI ST +EE +SL +F+ +MNEDRL
Sbjct: 696 YLDPEYFQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLS 755
Query: 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367
++L+A+V+KEGK+EEI +A L +RC+N+ GKKRP+M EVA ELE ++
Sbjct: 756 DLLDAQVVKEGKKEEINAIAFLARRCINLNGKKRPTMMEVAMELEILK 803
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255541802|ref|XP_002511965.1| kinase, putative [Ricinus communis] gi|223549145|gb|EEF50634.1| kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 528 bits (1361), Expect = e-147, Method: Compositional matrix adjust.
Identities = 262/345 (75%), Positives = 301/345 (87%)
Query: 25 SGLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKM 84
+GLG+ LLIG W L K KRR++ KL++ FFK+NGGLLLQQQLSS+E +IEKT +FT
Sbjct: 334 AGLGIPFLLIGTWWLYKVQKRRKDAKLRQRFFKRNGGLLLQQQLSSSESSIEKTNMFTAK 393
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI 144
+LEKATD+YN NRILGQGGQGTVYKGML DG +VA+KKSK+ DES EQFINEVVILSQI
Sbjct: 394 ELEKATDHYNENRILGQGGQGTVYKGMLTDGKVVAIKKSKIADESKTEQFINEVVILSQI 453
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
NHRNVVKLLGCCLE+EVPLLVYEFIPNGTLY +LHD +EEFPITWEMRLRIAIE A+S
Sbjct: 454 NHRNVVKLLGCCLETEVPLLVYEFIPNGTLYQHLHDPSEEFPITWEMRLRIAIETGSALS 513
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
YLHSA S+PIYHRDIKS+NILLDDKYRAKVSDFG S++I VDQTH+TTRVQGTFGYLDPE
Sbjct: 514 YLHSAASVPIYHRDIKSTNILLDDKYRAKVSDFGTSKSIAVDQTHVTTRVQGTFGYLDPE 573
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324
YF+SSQFTEKSDVYSFGVVLVELLTGQKPI S A E+RSL +FL +M ++RLFE+L+A
Sbjct: 574 YFQSSQFTEKSDVYSFGVVLVELLTGQKPISSARAVEERSLAMYFLLSMEQNRLFEILDA 633
Query: 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
RVLKEG +EEI+ VA L +RCLN+ GKKRP+M+ V E+E IRAS
Sbjct: 634 RVLKEGGKEEILAVAKLARRCLNLNGKKRPTMRTVVTEVERIRAS 678
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475622|ref|XP_003631717.1| PREDICTED: wall-associated receptor kinase-like 10-like, partial [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 525 bits (1352), Expect = e-146, Method: Compositional matrix adjust.
Identities = 254/386 (65%), Positives = 309/386 (80%)
Query: 26 GLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMD 85
LG +L++ W L +KRR++IK K F +NGGLLL+QQLSS EGNI+KTKLFT +
Sbjct: 306 ALGTLLLVLCAWWLYIVLKRRKKIKYKEKCFNRNGGLLLEQQLSSTEGNIDKTKLFTSKE 365
Query: 86 LEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN 145
LEKATD YN NR++GQGG+GTVYKGML DG IVAVKK K++ +S +EQFINEVVIL QIN
Sbjct: 366 LEKATDRYNENRVIGQGGEGTVYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQIN 425
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
HRNVVKLLGCCLE+EVPLLVYEFIPNGTL ++H Q EEFPITWE+RLRIA EV+GA+SY
Sbjct: 426 HRNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEIRLRIATEVAGALSY 485
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LHSA S+PIYHRDIKS+NILLDDKYRAKV+DFG S+ + +DQTHLTT+VQGTFGYLDPEY
Sbjct: 486 LHSAASVPIYHRDIKSTNILLDDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEY 545
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
F+SSQFTEKSDVYSFG+VL+ELLTG+KPI ST +EE +SL +F+ +MNEDRL ++L+A+
Sbjct: 546 FQSSQFTEKSDVYSFGIVLIELLTGKKPILSTASEEGKSLASYFILSMNEDRLSDLLDAQ 605
Query: 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEIHFV 385
V+KE ++EEI +A L +RC+N+ GKKRP+M EVA ELE IR G Q N EEI +
Sbjct: 606 VVKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFGAQENSEEIEYN 665
Query: 386 GGDNTRHSGTDYSSTGSILNSVAYST 411
+ ST S LN+ A S+
Sbjct: 666 TIELIGPWDVTSISTDSCLNTNASSS 691
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147765961|emb|CAN70207.1| hypothetical protein VITISV_007744 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 518 bits (1334), Expect = e-144, Method: Compositional matrix adjust.
Identities = 252/385 (65%), Positives = 305/385 (79%)
Query: 27 LGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMDL 86
LG +L++ W L +KRR++IK K F +NGGLLL+QQLSS+EGNI+KTKLFT +L
Sbjct: 292 LGTLLLVLCAWWLYIXLKRRKKIKYKEKCFNRNGGLLLEQQLSSSEGNIDKTKLFTSKEL 351
Query: 87 EKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH 146
EKATD YN NR++GQG QGT YKGML DG IVAVKK K++ +S +EQFINEVVIL QINH
Sbjct: 352 EKATDRYNENRVIGQGXQGTXYKGMLMDGRIVAVKKLKIMSDSKLEQFINEVVILCQINH 411
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
RNVVKLLGCCLE+EVPLLVYEFIPNGTL ++H Q EEFPITWEMRLRIA EV GA+SYL
Sbjct: 412 RNVVKLLGCCLETEVPLLVYEFIPNGTLSEHIHGQNEEFPITWEMRLRIATEVXGALSYL 471
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
HS SIPIYHRDIKS+NILLBDKYRAKV+DFG S+ + +DQTHLTT+VQGTFGYLDPEYF
Sbjct: 472 HSXASIPIYHRDIKSTNILLBDKYRAKVADFGISKFVAIDQTHLTTQVQGTFGYLDPEYF 531
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326
+SSQFTEKSDVYSFG+VL+ELLTG+KPI S +EE +SL +F+ +MNEDRL ++L+A+V
Sbjct: 532 QSSQFTEKSDVYSFGIVLIELLTGKKPILSIASEEGKSLASYFILSMNEDRLSDLLDAQV 591
Query: 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEIHFVG 386
+KE ++EEI +A L +RC+N+ GKKRP+M EVA ELE IR G Q N EEI +
Sbjct: 592 VKESRKEEINAIAFLARRCINLNGKKRPTMMEVAMELERIRKCQGDFRAQENFEEIEYNT 651
Query: 387 GDNTRHSGTDYSSTGSILNSVAYST 411
+ ST S LN+ A S+
Sbjct: 652 TELIGPWDVTSISTDSCLNTNASSS 676
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225455808|ref|XP_002274809.1| PREDICTED: wall-associated receptor kinase-like 9-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 513 bits (1322), Expect = e-143, Method: Compositional matrix adjust.
Identities = 253/382 (66%), Positives = 311/382 (81%), Gaps = 3/382 (0%)
Query: 41 KFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILG 100
K V+++ +I++K+ FFK+NGGLLLQQQ+SS++ EKTK+FT +LEKATDN+N NRILG
Sbjct: 335 KVVRKQLDIRVKKRFFKRNGGLLLQQQISSDKIAFEKTKIFTSDELEKATDNFNKNRILG 394
Query: 101 QGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160
QGGQGTVYKGML DG IVAVKKSK+VDE+ +E FINE+VILSQINHRNVV +LGCCLE+E
Sbjct: 395 QGGQGTVYKGMLNDGRIVAVKKSKIVDENQLEHFINEIVILSQINHRNVVGILGCCLETE 454
Query: 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220
VPLLVYEFI NGTL+ +HDQ EFP++WEMRLRIA+EVSGA+SYLHSA SIPIYHRDIK
Sbjct: 455 VPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRDIK 514
Query: 221 SSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 280
S+NILLDDKY+AKVSDFG SR+I +DQTHLTT VQGTFGYLDPEYF+SSQFTEKSDVYSF
Sbjct: 515 STNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVYSF 574
Query: 281 GVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM 340
GVVLVELLTGQKPI ST + E++SL F+ ++ E RLF++L+ARV+KEG++E+I+T A
Sbjct: 575 GVVLVELLTGQKPISSTRSPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIMTFAK 634
Query: 341 LGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEIHFVGGDNTRHSGTDYSST 400
L RCLN+ G+KRP+MKEV E++ IR S ++ N +E V + T D +ST
Sbjct: 635 LAGRCLNLNGRKRPTMKEVTTEIDNIRVSALHLNVDQNFQENACVVTEITEFLDMDDTST 694
Query: 401 --GSILNSVAYST-DADPLISN 419
GS L+ S+ D PL+ N
Sbjct: 695 SRGSCLDDTKESSFDVQPLLFN 716
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297734146|emb|CBI15393.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 506 bits (1304), Expect = e-141, Method: Compositional matrix adjust.
Identities = 249/373 (66%), Positives = 306/373 (82%), Gaps = 2/373 (0%)
Query: 41 KFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILG 100
K V+++ +I++K+ FFK+NGGLLLQQQ+SS++ EKTK+FT +LEKATDN+N NRILG
Sbjct: 215 KVVRKQLDIRVKKRFFKRNGGLLLQQQISSDKIAFEKTKIFTSDELEKATDNFNKNRILG 274
Query: 101 QGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160
QGGQGTVYKGML DG IVAVKKSK+VDE+ +E FINE+VILSQINHRNVV +LGCCLE+E
Sbjct: 275 QGGQGTVYKGMLNDGRIVAVKKSKIVDENQLEHFINEIVILSQINHRNVVGILGCCLETE 334
Query: 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220
VPLLVYEFI NGTL+ +HDQ EFP++WEMRLRIA+EVSGA+SYLHSA SIPIYHRDIK
Sbjct: 335 VPLLVYEFISNGTLFQLIHDQNSEFPLSWEMRLRIALEVSGALSYLHSACSIPIYHRDIK 394
Query: 221 SSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 280
S+NILLDDKY+AKVSDFG SR+I +DQTHLTT VQGTFGYLDPEYF+SSQFTEKSDVYSF
Sbjct: 395 STNILLDDKYKAKVSDFGTSRSISIDQTHLTTIVQGTFGYLDPEYFQSSQFTEKSDVYSF 454
Query: 281 GVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM 340
GVVLVELLTGQKPI ST + E++SL F+ ++ E RLF++L+ARV+KEG++E+I+T A
Sbjct: 455 GVVLVELLTGQKPISSTRSPEEKSLATHFILSLQESRLFDILDARVVKEGRKEDIMTFAK 514
Query: 341 LGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEIHFVGGDNTRHSGTDYSST 400
L RCLN+ G+KRP+MKEV E++ IR S ++ N +E V + T D +ST
Sbjct: 515 LAGRCLNLNGRKRPTMKEVTTEIDNIRVSALHLNVDQNFQENACVVTEITEFLDMDDTST 574
Query: 401 --GSILNSVAYST 411
GS L+ S+
Sbjct: 575 SRGSCLDDTKESS 587
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224053054|ref|XP_002297684.1| predicted protein [Populus trichocarpa] gi|222844942|gb|EEE82489.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 504 bits (1298), Expect = e-140, Method: Compositional matrix adjust.
Identities = 258/410 (62%), Positives = 320/410 (78%), Gaps = 4/410 (0%)
Query: 14 EYNSHSISCCGSGLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEG 73
E + I+ + GL +LL+G+W L K VK+R+ I+LK+ FFK+NGGLLLQQQLSS++G
Sbjct: 310 ELDKAKITFLSAATGLLLLLVGIWRLYKLVKKRKNIELKKKFFKRNGGLLLQQQLSSSDG 369
Query: 74 NIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQ 133
+I+KTK+FT +LEKATD +N NRILGQGGQGTVYKGM ADG IVAVKKS LVDE +E+
Sbjct: 370 SIQKTKIFTSKELEKATDRFNDNRILGQGGQGTVYKGMQADGMIVAVKKSILVDEEKLEE 429
Query: 134 FINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRL 193
FINEVVILSQ+NHRNVVKLLGCCLE+EVPLLVYEFIPNG L+ Y+HDQ EEF +WEMRL
Sbjct: 430 FINEVVILSQVNHRNVVKLLGCCLETEVPLLVYEFIPNGNLFEYIHDQKEEFEFSWEMRL 489
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
RIA EV+ A+SYLHSA SIP+YHRDIKS+NI+LD+K+RAKVSDFG SR+I +DQTHLTT
Sbjct: 490 RIATEVARALSYLHSAASIPVYHRDIKSTNIMLDEKFRAKVSDFGTSRSIAIDQTHLTTH 549
Query: 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313
VQGTFGYLDPEYF+SSQFT KSDVYSFGVVL ELL+GQKPI +EE SL F+ +
Sbjct: 550 VQGTFGYLDPEYFQSSQFTGKSDVYSFGVVLAELLSGQKPISYERSEERGSLATHFILLV 609
Query: 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373
E+++F++L+ R++ + +EEE+I VA L +RCLN+IG+KRP+M+EVA ELE IR S G+
Sbjct: 610 EENKIFDILDERLMGQDREEEVIAVANLARRCLNLIGRKRPTMREVAIELEQIRLSKGAL 669
Query: 374 SLQHNCEEIHFVGGDNTRH---SGTDYSST-GSILNSVAYSTDADPLISN 419
Q +E+ + + +G S T G N A S D PLIS+
Sbjct: 670 HPQQCSKELENIWDEVPNVWEIAGPPTSVTIGDFRNGTAPSLDVQPLISH 719
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 419 | ||||||
| TAIR|locus:2200562 | 748 | WAKL2 "wall associated kinase- | 0.894 | 0.501 | 0.565 | 3.1e-115 | |
| TAIR|locus:2019893 | 751 | RFO1 "RESISTANCE TO FUSARIUM O | 0.806 | 0.450 | 0.614 | 1.3e-114 | |
| TAIR|locus:2200552 | 730 | WAKL1 "wall associated kinase- | 0.785 | 0.450 | 0.613 | 3.5e-114 | |
| TAIR|locus:2205040 | 792 | AT1G69730 [Arabidopsis thalian | 0.813 | 0.430 | 0.602 | 3.6e-112 | |
| TAIR|locus:2016377 | 788 | AT1G19390 [Arabidopsis thalian | 0.787 | 0.418 | 0.622 | 5.9e-112 | |
| TAIR|locus:2019843 | 769 | WAKL10 "WALL ASSOCIATED KINASE | 0.897 | 0.488 | 0.546 | 3.3e-111 | |
| TAIR|locus:2032875 | 720 | AT1G16260 [Arabidopsis thalian | 0.892 | 0.519 | 0.552 | 4.8e-110 | |
| TAIR|locus:2030988 | 764 | AT1G17910 [Arabidopsis thalian | 0.866 | 0.475 | 0.555 | 4.9e-108 | |
| TAIR|locus:2126316 | 786 | AT4G31100 [Arabidopsis thalian | 0.816 | 0.435 | 0.569 | 1.7e-105 | |
| TAIR|locus:2126271 | 793 | AT4G31110 [Arabidopsis thalian | 0.816 | 0.431 | 0.566 | 5.8e-105 |
| TAIR|locus:2200562 WAKL2 "wall associated kinase-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1136 (405.0 bits), Expect = 3.1e-115, P = 3.1e-115
Identities = 216/382 (56%), Positives = 298/382 (78%)
Query: 41 KFVKRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRILG 100
KFV++RR++ R FF++NGG + EGN+E +++F+ +LEKATDN+N NR+LG
Sbjct: 364 KFVQKRRKLIRMRKFFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRVLG 423
Query: 101 QGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160
QGGQGTVYKGML DG IVAVK+SK VDE VE+FINEVV+L+QINHRN+VKLLGCCLE+E
Sbjct: 424 QGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLETE 483
Query: 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220
VP+LVYEF+PNG L LHD+++++ +TWE+RL IAIE++GA+SYLHSA S PIYHRDIK
Sbjct: 484 VPVLVYEFVPNGDLCKRLHDESDDYTMTWEVRLHIAIEIAGALSYLHSAASFPIYHRDIK 543
Query: 221 SSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 280
++NILLD++ RAKVSDFG SR++ +DQTHLTT+V GTFGY+DPEYF+SS+FTEKSDVYSF
Sbjct: 544 TTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQVAGTFGYVDPEYFQSSKFTEKSDVYSF 603
Query: 281 GVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM 340
GVVLVELLTG+KP +EE+R L F++A+ E+R+ ++++ R+ E +++++VA
Sbjct: 604 GVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVKENRVLDIVDDRIKDECNMDQVMSVAN 663
Query: 341 LGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSL--QHNCEE---IHFVGGDNTRHSGT 395
L +RCLN GKKRP+M+EV+ ELE IR+S S + + + EE + ++T G
Sbjct: 664 LARRCLNRKGKKRPNMREVSIELEMIRSSHYDSGIHIEDDDEEDDQAMELNFNDTWEVGA 723
Query: 396 DYSSTGSILNSVAYSTDADPLI 417
++ S+ N+ + ++DA+PL+
Sbjct: 724 --TAPASMFNNASPTSDAEPLV 743
|
|
| TAIR|locus:2019893 RFO1 "RESISTANCE TO FUSARIUM OXYSPORUM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1130 (402.8 bits), Expect = 1.3e-114, P = 1.3e-114
Identities = 210/342 (61%), Positives = 280/342 (81%)
Query: 41 KFVKRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRILG 100
KFVK+RR+I KRMFFK+NGG ++ GN++ +K+F+ +LEKATDN+N NR+LG
Sbjct: 369 KFVKKRRKIIRKRMFFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLG 428
Query: 101 QGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160
QGGQGTVYKGML DG IVAVK+SK++DE VE+FINEV +LSQINHRN+VKL+GCCLE+E
Sbjct: 429 QGGQGTVYKGMLVDGRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETE 488
Query: 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220
VP+LVYE IPNG L+ LH ++++ +TW++RLRI++E++GA++YLHSA S P+YHRD+K
Sbjct: 489 VPILVYEHIPNGDLFKRLHHDSDDYTMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVK 548
Query: 221 SSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 280
++NILLD+KYRAKVSDFG SR+I VDQTHLTT V GTFGYLDPEYF++SQFT+KSDVYSF
Sbjct: 549 TTNILLDEKYRAKVSDFGTSRSINVDQTHLTTLVAGTFGYLDPEYFQTSQFTDKSDVYSF 608
Query: 281 GVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE-EEIITVA 339
GVVLVEL+TG+KP EE+R LV F +AM ++R+ +++++R+ KEG E+++ VA
Sbjct: 609 GVVLVELITGEKPFSVMRPEENRGLVSHFNEAMKQNRVLDIVDSRI-KEGCTLEQVLAVA 667
Query: 340 MLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEE 381
L +RCL++ GKKRP+M+EV+ ELE IR+S L+ + EE
Sbjct: 668 KLARRCLSLKGKKRPNMREVSVELERIRSS--PEDLELHIEE 707
|
|
| TAIR|locus:2200552 WAKL1 "wall associated kinase-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1126 (401.4 bits), Expect = 3.5e-114, P = 3.5e-114
Identities = 202/329 (61%), Positives = 270/329 (82%)
Query: 41 KFVKRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRILG 100
K +K+RR I + FFK+NGG ++ +GN+E +K+F+ +L KATDN++ +R+LG
Sbjct: 377 KLIKKRRNINRSKKFFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRVLG 436
Query: 101 QGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160
QGGQGTVYKGML DG IVAVK+SK+VDE +E+FINE+V+LSQINHRN+VKLLGCCLE+E
Sbjct: 437 QGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLETE 496
Query: 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220
VP+LVYE+IPNG L+ LHD+++++ +TWE+RLRIAIE++GA++Y+HSA S PI+HRDIK
Sbjct: 497 VPILVYEYIPNGDLFKRLHDESDDYTMTWEVRLRIAIEIAGALTYMHSAASFPIFHRDIK 556
Query: 221 SSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 280
++NILLD+KYRAKVSDFG SR++ +DQTHLTT V GTFGY+DPEYF SSQ+T KSDVYSF
Sbjct: 557 TTNILLDEKYRAKVSDFGTSRSVTLDQTHLTTLVAGTFGYMDPEYFLSSQYTHKSDVYSF 616
Query: 281 GVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM 340
GVVLVEL+TG+KP+ +EE R L FL+AM E+R+ ++++ R+ E K E+++ VA
Sbjct: 617 GVVLVELITGEKPLSRVRSEEGRGLATHFLEAMKENRVIDIIDIRIKDESKLEQVMAVAK 676
Query: 341 LGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
L ++CLN GK RP+MKEV+ ELE IR+S
Sbjct: 677 LARKCLNRKGKNRPNMKEVSNELERIRSS 705
|
|
| TAIR|locus:2205040 AT1G69730 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
Identities = 206/342 (60%), Positives = 271/342 (79%)
Query: 41 KFVKRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRILG 100
KF+K++R++ K+ FFK+NGG S G +EKT +F+ +LEKAT+N+++NRILG
Sbjct: 395 KFIKKQRKLNQKKKFFKRNGGLLLQQQLISTVGMVEKTIVFSSRELEKATENFSSNRILG 454
Query: 101 QGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160
QGGQGTVYKGML DG IVAVKKSK+VDE +E+FINEVVILSQINHRN+VKLLGCCLE++
Sbjct: 455 QGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETK 514
Query: 161 VPLLVYEFIPNGTLYHYLHDQTEE-FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDI 219
VP+LVYEFIPNG L+ +LHD+ +E TW +RLRIAI+++GA+SYLHS+ S PIYHRD+
Sbjct: 515 VPVLVYEFIPNGNLFEHLHDEFDENIMATWNIRLRIAIDIAGALSYLHSSASSPIYHRDV 574
Query: 220 KSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYS 279
KS+NI+LD+KYRAKVSDFG SRT+ VD THLTT V GT GY+DPEYF+SSQFT+KSDVYS
Sbjct: 575 KSTNIMLDEKYRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYS 634
Query: 280 FGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVA 339
FGVVLVEL+TG+K I ++E+R+L +F+ AM E++LF++++AR+ ++ A
Sbjct: 635 FGVVLVELITGEKSISFLRSQENRTLATYFILAMKENKLFDIIDARIRDGCMLSQVTATA 694
Query: 340 MLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEE 381
+ ++CLN+ G+KRPSM+EV+ EL+ IR G LQ E
Sbjct: 695 KVARKCLNLKGRKRPSMREVSMELDSIRMPCGDMQLQECVSE 736
|
|
| TAIR|locus:2016377 AT1G19390 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1105 (394.0 bits), Expect = 5.9e-112, P = 5.9e-112
Identities = 206/331 (62%), Positives = 269/331 (81%)
Query: 40 RKFVKRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRIL 99
RKF+K+RR K KR FFK+NGG ++N+GN+EKT++F+ +LEKATDN++ +RIL
Sbjct: 398 RKFLKKRRMSKRKRKFFKRNGGLLLQQQLNTNKGNVEKTRIFSSRELEKATDNFSESRIL 457
Query: 100 GQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES 159
GQGGQGTVYKGML DG VAVKKSK+VDE +E+FINEVVILSQINHR+VVKLLGCCLE+
Sbjct: 458 GQGGQGTVYKGMLVDGRTVAVKKSKVVDEDKLEEFINEVVILSQINHRHVVKLLGCCLET 517
Query: 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDI 219
EVP LVYEFIPNG L+ ++H++++++ TW MRLRIA++++GA+SYLHSA S PIYHRDI
Sbjct: 518 EVPTLVYEFIPNGNLFQHIHEESDDYTKTWGMRLRIAVDIAGALSYLHSAASSPIYHRDI 577
Query: 220 KSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYS 279
KS+NILLD+KYR KVSDFG SR++ +D TH TT + GT GY+DPEY+ SSQ+T+KSDVYS
Sbjct: 578 KSTNILLDEKYRTKVSDFGTSRSVTIDHTHWTTVISGTVGYVDPEYYGSSQYTDKSDVYS 637
Query: 280 FGVVLVELLTGQKPIRS-TDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITV 338
FGVVLVEL+TG+KP+ + ++++E R L F AM E+R FE+++AR+ K E+++ V
Sbjct: 638 FGVVLVELITGEKPVITVSNSQEIRGLADHFRVAMKENRFFEIMDARIRDGCKPEQVMAV 697
Query: 339 AMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
A L +RCLN GKKRP M++V +LE I AS
Sbjct: 698 ANLARRCLNSKGKKRPCMRKVFTDLEKILAS 728
|
|
| TAIR|locus:2019843 WAKL10 "WALL ASSOCIATED KINASE (WAK)-LIKE 10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1098 (391.6 bits), Expect = 3.3e-111, P = 3.3e-111
Identities = 211/386 (54%), Positives = 289/386 (74%)
Query: 41 KFVKRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRILG 100
KF++R+R + K+ FFK+NGG ++ EGN++ T++F +LEKAT+N++ RILG
Sbjct: 381 KFIRRQRRLNQKKKFFKRNGGLLLQQQLTTTEGNVDSTRVFNSRELEKATENFSLTRILG 440
Query: 101 QGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160
+GGQGTVYKGML DG IVAVKKSK+VDE +E+FINEVVILSQINHRN+VKLLGCCLE++
Sbjct: 441 EGGQGTVYKGMLVDGRIVAVKKSKVVDEDKLEEFINEVVILSQINHRNIVKLLGCCLETD 500
Query: 161 VPLLVYEFIPNGTLYHYLHDQTEEFPIT-WEMRLRIAIEVSGAMSYLHSATSIPIYHRDI 219
VP+LVYEFIPNG L+ +LHD ++++ +T WE+RLRIA++++GA+SYLHSA S PIYHRDI
Sbjct: 501 VPILVYEFIPNGNLFEHLHDDSDDYTMTTWEVRLRIAVDIAGALSYLHSAASSPIYHRDI 560
Query: 220 KSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYS 279
KS+NI+LD+K+RAKVSDFG SRT+ VD THLTT V GT GY+DPEYF+SSQFT+KSDVYS
Sbjct: 561 KSTNIMLDEKHRAKVSDFGTSRTVTVDHTHLTTVVSGTVGYMDPEYFQSSQFTDKSDVYS 620
Query: 280 FGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVA 339
FGVVL EL+TG+K + ++E R+L +F AM E+RL ++++AR+ K ++ A
Sbjct: 621 FGVVLAELITGEKSVSFLRSQEYRTLATYFTLAMKENRLSDIIDARIRDGCKLNQVTAAA 680
Query: 340 MLGKRCLNMIGKKRPSMKEVAFELEGIRA--------SIGSSSLQHNCEEIHFVGGDNTR 391
+ ++CLNM G+KRPSM++V+ ELE IR+ S + + E + V ++
Sbjct: 681 KIARKCLNMKGRKRPSMRQVSMELEKIRSYSEDMQPYEYASENEEEKKETLVDVNVESRN 740
Query: 392 H-SGTDYSSTGSILNSVAYSTDADPL 416
+ S T SS SI + + +D +PL
Sbjct: 741 YVSVTAASSQYSIATTSSSRSDVEPL 766
|
|
| TAIR|locus:2032875 AT1G16260 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1087 (387.7 bits), Expect = 4.8e-110, P = 4.8e-110
Identities = 207/375 (55%), Positives = 280/375 (74%)
Query: 44 KRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGG 103
++R+ K KR FF++NGG S G++ +TK+F+ DLE ATD +NA+RILGQGG
Sbjct: 341 RKRKVAKQKRKFFQRNGGLLLQQQTSFLHGSVNRTKVFSSNDLENATDRFNASRILGQGG 400
Query: 104 QGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163
QGTVYKGML DG IVAVKKSK + E N+E+FINE+++LSQINHRNVVK+LGCCLE+EVP+
Sbjct: 401 QGTVYKGMLEDGMIVAVKKSKALKEENLEEFINEIILLSQINHRNVVKILGCCLETEVPI 460
Query: 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223
LVYEFIPN L+ +LH+ +E+FP++WE+RL IA EV+ A+SYLHSA SIPIYHRD+KS+N
Sbjct: 461 LVYEFIPNRNLFDHLHNPSEDFPMSWEVRLCIACEVADALSYLHSAVSIPIYHRDVKSTN 520
Query: 224 ILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVV 283
ILLD+K+RAKVSDFG SR++ +D THLTT VQGT GY+DPEY +S+ FT KSDVYSFGV+
Sbjct: 521 ILLDEKHRAKVSDFGISRSVAIDDTHLTTIVQGTIGYVDPEYLQSNHFTGKSDVYSFGVL 580
Query: 284 LVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGK 343
L+ELLTG+KP+ +E R L +FL+AM DRL E+L+AR+ +E EE++ VA L +
Sbjct: 581 LIELLTGEKPVSLLRRQEVRMLGAYFLEAMRNDRLHEILDARIKEECDREEVLAVAKLAR 640
Query: 344 RCLNMIGKKRPSMKEVAFELEGIRASI-GSSSLQHNCEEIHFVGGDNTRHSGTDYSSTGS 402
RCL++ + RP+M++V EL+ +++ G+ S N EE + YSS
Sbjct: 641 RCLSLNSEHRPTMRDVFIELDRMQSKRKGTQSQAQNGEEHAHIQIAMPESMSLSYSSPNI 700
Query: 403 ILNSVAYSTDADPLI 417
++ + ++S D PL+
Sbjct: 701 VVENSSFSLDTKPLM 715
|
|
| TAIR|locus:2030988 AT1G17910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
Identities = 205/369 (55%), Positives = 271/369 (73%)
Query: 40 RKFVKRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRIL 99
RK +++RR KR FFK+NGG ++ +G +EKTKLF+ +LEKATDN+N NR++
Sbjct: 401 RKLLRKRRMTNRKRKFFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRVI 460
Query: 100 GQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES 159
GQGGQGTVYKGML DG VAVKKS +VDE +++FINEV+ILSQINHR+VVKLLGCCLE+
Sbjct: 461 GQGGQGTVYKGMLVDGRSVAVKKSNVVDEDKLQEFINEVIILSQINHRHVVKLLGCCLET 520
Query: 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDI 219
EVP+LVYEFIPNG L+ +LH++ +++ W +R+RIA+++SGA SYLH+A PIYHRDI
Sbjct: 521 EVPILVYEFIPNGNLFQHLHEEFDDYTALWGVRMRIAVDISGAFSYLHTAACSPIYHRDI 580
Query: 220 KSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYS 279
KS+NILLD+KYRAKVSDFG SR++ +D TH TT + GT GY+DPEY+ SS FTEKSDVYS
Sbjct: 581 KSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTTVISGTVGYVDPEYYGSSHFTEKSDVYS 640
Query: 280 FGVVLVELLTGQKPIRS-TDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITV 338
FGVVLVEL+TG+KP+ + ++ +E L +F AM E+RLFE+++AR+ + K E++I V
Sbjct: 641 FGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARIRNDCKLEQVIAV 700
Query: 339 AMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEIHFVGGDNTRHSGTDYS 398
A L RCL GK RP M+EV+ LE I ++ +Q +E D T YS
Sbjct: 701 ANLALRCLKKTGKTRPDMREVSTALERICSAPEDFQVQIQIDE-----EDETTKLFRGYS 755
Query: 399 STGSILNSV 407
+ I S+
Sbjct: 756 GSTEIARSM 764
|
|
| TAIR|locus:2126316 AT4G31100 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1044 (372.6 bits), Expect = 1.7e-105, P = 1.7e-105
Identities = 196/344 (56%), Positives = 265/344 (77%)
Query: 40 RKFVKRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRIL 99
RKF+ +RR K K+ FFK+NGG ++ +G +EK ++FT +LEKAT+N++ NR+L
Sbjct: 391 RKFLVKRRMAKRKKKFFKRNGGLLLQQELNTRQGVVEKARIFTSKELEKATENFSENRVL 450
Query: 100 GQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES 159
G GGQGTVYKGML DG VAVKKSK++DE +++FINEVVILSQINHR+VVKLLGCCLE+
Sbjct: 451 GHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLET 510
Query: 160 EVPLLVYEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRD 218
EVP+LVYEFI NG L+ ++H++ +++ + W MRLRIA++++GA+SYLHSA S PIYHRD
Sbjct: 511 EVPILVYEFIINGNLFKHIHEEEADDYTMIWGMRLRIAVDIAGALSYLHSAASSPIYHRD 570
Query: 219 IKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVY 278
IKS+NILLD+KYRAKV+DFG SR++ +DQTH TT + GT GY+DPEY+RSSQ+TEKSDVY
Sbjct: 571 IKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYRSSQYTEKSDVY 630
Query: 279 SFGVVLVELLTGQKP-IRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIIT 337
SFGV+L EL+TG KP I + +E +L F AM E RL ++++AR+ + K E+++
Sbjct: 631 SFGVILAELITGDKPVIMVQNTQEIIALAEHFRVAMKERRLSDIMDARIRDDSKPEQVMA 690
Query: 338 VAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEE 381
VA L +CL+ G+ RP+M+EV ELE I S S +Q+ +E
Sbjct: 691 VANLAMKCLSSRGRNRPNMREVFTELERICTSPEDSQVQNRIDE 734
|
|
| TAIR|locus:2126271 AT4G31110 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1039 (370.8 bits), Expect = 5.8e-105, P = 5.8e-105
Identities = 195/344 (56%), Positives = 266/344 (77%)
Query: 40 RKFVKRRREIKLKRMFFKKNGGXXXXXXXSSNEGNIEKTKLFTKMDLEKATDNYNANRIL 99
RKF+ +RR K K+ FFK+NGG ++ EG +EKT++F +LEKAT+N++ NR+L
Sbjct: 400 RKFLIKRRITKRKKKFFKRNGGLLLLQELNTREGYVEKTRVFNSRELEKATENFSENRVL 459
Query: 100 GQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES 159
G GGQGTVYKGML DG VAVKKSK++DE +++FINEVVILSQINHR+VVKLLGCCLE+
Sbjct: 460 GHGGQGTVYKGMLVDGRTVAVKKSKVIDEDKLQEFINEVVILSQINHRHVVKLLGCCLET 519
Query: 160 EVPLLVYEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRD 218
EVP+LVYEFI NG L+ ++H++ ++++ + W MRLRIA++++GA+SYLHS+ S PIYHRD
Sbjct: 520 EVPMLVYEFIINGNLFKHIHEEESDDYTMLWGMRLRIAVDIAGALSYLHSSASSPIYHRD 579
Query: 219 IKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVY 278
IKS+NILLD+KYRAKV+DFG SR++ +DQTH TT + GT GY+DPEY++SSQ+TEKSDVY
Sbjct: 580 IKSTNILLDEKYRAKVADFGTSRSVTIDQTHWTTVISGTVGYVDPEYYQSSQYTEKSDVY 639
Query: 279 SFGVVLVELLTGQKP-IRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIIT 337
SFGV+L EL+TG KP I + +E +L F AM E RL ++++AR+ + K E+++
Sbjct: 640 SFGVILAELITGDKPVIMVQNTQEIVALAEHFRVAMKEKRLTDIIDARIRNDCKPEQVMA 699
Query: 338 VAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEE 381
VA + +CL+ GKKRP+M+EV ELE I S S + + +E
Sbjct: 700 VAKVAMKCLSSKGKKRPNMREVFTELERICTSPEDSQVHNRIDE 743
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00005799001 | SubName- Full=Chromosome chr3 scaffold_158, whole genome shotgun sequence; (970 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 419 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-55 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 9e-54 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-53 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-53 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-52 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-49 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 8e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-40 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-38 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-32 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 7e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 9e-31 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-30 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-30 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-30 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-30 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-30 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-29 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-29 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 9e-29 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-28 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-28 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-28 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-28 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-28 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-27 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-27 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-27 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-27 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-27 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 7e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 8e-27 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-26 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-26 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-25 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-25 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-25 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 2e-24 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-24 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-24 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-24 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-24 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 4e-24 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-24 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-24 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-24 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-23 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-23 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-23 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 6e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-23 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 8e-23 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-23 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-22 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 4e-22 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-22 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-22 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-22 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-21 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-21 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-21 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-21 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-21 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-21 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 4e-21 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-21 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-21 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-20 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-20 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-20 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-20 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-20 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-20 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-20 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 7e-20 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 7e-20 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 8e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-19 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 1e-19 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-19 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-19 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-19 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-19 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-19 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 4e-19 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-19 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 9e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-18 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-18 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-18 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-18 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-17 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-17 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-17 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-17 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-17 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 8e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-17 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-16 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-16 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-16 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-16 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 6e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-16 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-16 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 9e-16 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-15 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 1e-15 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-15 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-15 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-15 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-15 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 4e-15 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 4e-15 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 5e-15 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 6e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-14 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-14 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-14 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-14 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-14 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-14 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 4e-14 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-14 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 6e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-14 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 7e-14 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 7e-14 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 9e-14 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-13 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-13 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-13 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 3e-13 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-13 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-13 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 4e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-13 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-13 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 9e-13 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 9e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 1e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-12 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-12 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-12 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-12 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-12 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 6e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-12 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 7e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 9e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-11 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-11 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-11 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-11 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 7e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 9e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-10 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-10 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 3e-10 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-10 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-10 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-10 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 8e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-10 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 9e-10 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 9e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-10 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-09 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-09 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-09 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 2e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-09 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 8e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 8e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 9e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-08 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 8e-08 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-08 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-07 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 3e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 4e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 7e-07 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-06 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 7e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 2e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 8e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.002 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 183 bits (467), Expect = 2e-55
Identities = 81/271 (29%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 96 NRILGQGGQGTVYKGMLADGGI-----VAVKKSKL-VDESNVEQFINEVVILSQINHRNV 149
+ LG+G G VYKG L G VAVK K E +E+F+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
VKLLG C E E ++V E++P G L YL ++ L A++++ M YL
Sbjct: 64 VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE-- 120
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
S HRD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 121 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328
+FT KSDV+SFGV+L E+ T G++P E + RL
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYL------KKGYRLP-------KP 226
Query: 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
E+ + +C + RP+ E+
Sbjct: 227 PNCPPELYKLM---LQCWAEDPEDRPTFSEL 254
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 5e-55
Identities = 84/275 (30%), Positives = 127/275 (46%), Gaps = 28/275 (10%)
Query: 96 NRILGQGGQGTVYKGMLADGGI-----VAVKKSKLV-DESNVEQFINEVVILSQINHRNV 149
+ LG+G G VYKG L G VAVK K E +E+F+ E I+ +++H NV
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
VKLLG C E E +V E++ G L YL + ++ L A++++ M YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK--LSLSDLLSFALQIARGMEYLE-- 119
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
S HRD+ + N L+ + K+SDFG SR + D + + ++ PE +
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEG 178
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328
+FT KSDV+SFGV+L E+ T G++P EE + N RL
Sbjct: 179 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYL------KNGYRLP-------QP 225
Query: 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363
E+ + +C + RP+ E+ L
Sbjct: 226 PNCPPELYDLM---LQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 177 bits (452), Expect = 9e-54
Identities = 74/193 (38%), Positives = 108/193 (55%), Gaps = 10/193 (5%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKK-SKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
LG+GG GTVY G VA+K K S +E+ + E+ IL ++NH N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ LV E+ G+L L + E ++ + LRI +++ + YLH S I H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKEN--EGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 217 RDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ-FTEK 274
RD+K NILLD D + K++DFG S+ + D++ L T V GT Y+ PE ++EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEK 174
Query: 275 SDVYSFGVVLVEL 287
SD++S GV+L EL
Sbjct: 175 SDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 5e-53
Identities = 88/272 (32%), Positives = 135/272 (49%), Gaps = 23/272 (8%)
Query: 93 YNANRILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVE--QFINEVVILSQINHRNV 149
Y R LG G GTVYK G IVAVK K E + + E+ IL +++H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
V+L+ + + LV E+ G L+ YL P++ + +IA+++ + YLHS
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-YFRS 268
I HRD+K NILLD+ K++DFG ++ + + LTT V GT Y+ PE
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGG 173
Query: 269 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR-VL 327
+ + K DV+S GV+L ELLTG+ P + + L + + F+ +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQL---IRRILGPPLEFDEPKWSSGS 230
Query: 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+E K+ L K+CLN KRP+ +E+
Sbjct: 231 EEAKD--------LIKKCLNKDPSKRPTAEEI 254
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 176 bits (450), Expect = 7e-53
Identities = 74/208 (35%), Positives = 112/208 (53%), Gaps = 17/208 (8%)
Query: 96 NRILGQGGQGTVYKGMLADGG-----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNV 149
+ LG+G G VYKG L G VAVK K E E+F+ E I+ +++H N+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNI 63
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
V+LLG C + E +V E++P G L +L E +T + L++A++++ M YL
Sbjct: 64 VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE--KLTLKDLLQMALQIAKGMEYLE-- 119
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG---YLDPEYF 266
S HRD+ + N L+ + K+SDFG SR I D + G ++ PE
Sbjct: 120 -SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKR--GGGKLPIKWMAPESL 176
Query: 267 RSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ +FT KSDV+SFGV+L E+ T G++P
Sbjct: 177 KDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 2e-52
Identities = 87/285 (30%), Positives = 129/285 (45%), Gaps = 40/285 (14%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVK 151
+ LG+G G VYKG L VAVK K E + F+ E ++ ++ H NVV+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP------ITWEMRLRIAIEVSGAMSY 205
LLG C E E LV E++ G L YL FP ++ + L AI+++ M Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDP 263
L S HRD+ + N L+ + K+SDFG SR + D + G ++ P
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT-GGKLPIRWMAP 176
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322
E + FT KSDV+SFGV+L E+ T G P ++ + + E L
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATP----------------YPGLSNEEVLEYL 220
Query: 323 EA--RVLK-EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364
R+ K E +E+ + M C + + RP+ E+ LE
Sbjct: 221 RKGYRLPKPEYCPDELYEL-M--LSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 1e-49
Identities = 74/272 (27%), Positives = 116/272 (42%), Gaps = 37/272 (13%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESN-VEQFINEVVILSQINHRNVVKLLG 154
LG+G G VY G +VA+K K E+ + E+ IL ++ H N+V+L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
+ + LV E+ G L+ L + ++ + ++ A+ YLHS I
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRG---RLSEDEARFYLRQILSALEYLHSKG---I 118
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
HRD+K NILLD+ K++DFG +R + LTT V GT Y+ PE + +
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLARQLD-PGEKLTTFV-GTPEYMAPEVLLGKGYGKA 176
Query: 275 SDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334
D++S GV+L ELLTG+ P F LF + + + K
Sbjct: 177 VDIWSLGVILYELLTGKPP---------------FPGDDQLLELF-----KKIGKPKPPF 216
Query: 335 IITVAMLGKRCLNMIGK-------KRPSMKEV 359
+ ++I K KR + +E
Sbjct: 217 PPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 8e-42
Identities = 63/204 (30%), Positives = 109/204 (53%), Gaps = 14/204 (6%)
Query: 97 RILGQGGQGTVYKGMLAD-GGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLL 153
+LG+G G+VY + D G ++AVK +L E +E E+ ILS + H N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 154 GCCLESEVP-LLVY-EFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSAT 210
G + E L ++ E++ G+L L ++F E +R ++ ++YLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL----KKFGKLPEPVIRKYTRQILEGLAYLHSNG 121
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK-VDQTHLTTRVQGTFGYLDPEYFRSS 269
I HRDIK +NIL+D K++DFG ++ + ++ T V+GT ++ PE R
Sbjct: 122 ---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 270 QFTEKSDVYSFGVVLVELLTGQKP 293
++ +D++S G ++E+ TG+ P
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 3e-40
Identities = 78/264 (29%), Positives = 118/264 (44%), Gaps = 28/264 (10%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
+G+GG G VYK G VA+K KL + E+ INE+ IL + H N+VK G L
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIA---IEVSGAMSYLHSATSIPI 214
+ + +V EF G+L L + + IA E+ + YLHS I
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHSNG---I 119
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
HRDIK++NILL K+ DFG S ++ T + GT ++ PE + K
Sbjct: 120 IHRDIKAANILLTSDGEVKLIDFGLS--AQLSDTKARNTMVGTPYWMAPEVINGKPYDYK 177
Query: 275 SDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334
+D++S G+ +EL G+ P E + F A N L+ ++
Sbjct: 178 ADIWSLGITAIELAEGKPPYS-----ELPPMKALFKIATN--------GPPGLRNPEKWS 224
Query: 335 IITVAMLGKRCLNMIGKKRPSMKE 358
L K+CL +KRP+ ++
Sbjct: 225 DEFKDFL-KKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 76/267 (28%), Positives = 122/267 (45%), Gaps = 24/267 (8%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLL 153
+ +G+G G VY +DG + +K+ L + E E +NEV IL ++NH N++K
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65
Query: 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGAMSYLHSATSI 212
E +V E+ G L + Q +E P E L +++ A+ YLHS
Sbjct: 66 ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK-- 123
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT 272
I HRDIK NI L K+ DFG S+ + T V GT YL PE ++ +
Sbjct: 124 -ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYLSPELCQNKPYN 181
Query: 273 EKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332
KSD++S G VL EL T + P E +L+ L+ + + + ++ E +
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPF------EGENLLELALKILKGQ--YPPIPSQYSSELR- 232
Query: 333 EEIITVAMLGKRCLNMIGKKRPSMKEV 359
++ L ++RPS+ ++
Sbjct: 233 -NLV------SSLLQKDPEERPSIAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 125 bits (313), Expect = 4e-32
Identities = 81/280 (28%), Positives = 118/280 (42%), Gaps = 22/280 (7%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH-R 147
+Y R LG+G G VY D +VA+K K VE+F+ E+ IL+ +NH
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
N+VKL + LV E++ G+L L + P++ L I ++ A+ YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 208 SATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTHLTTRVQ-----GTFGYL 261
S I HRDIK NILLD D K+ DFG ++ + + + GT GY+
Sbjct: 119 SKGII---HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 262 DPEYFRSSQF---TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318
PE + SD++S G+ L ELLTG P S + +
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQ----TLKIILELP 231
Query: 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKE 358
L + + E + L K+ L K R S
Sbjct: 232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSS 271
|
Length = 384 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (307), Expect = 4e-32
Identities = 66/206 (32%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRN 148
NY ++G+G G VYKG+ L G VA+K+ L + E ++ + E+ +L + H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVSGAMSYLH 207
+VK +G S+ ++ E+ NG+L + + FP E + + + +V ++YLH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIK-KFGPFP---ESLVAVYVYQVLQGLAYLH 116
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
I HRDIK++NIL K++DFG + T D + V GT ++ PE
Sbjct: 117 EQGVI---HRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPEVIE 172
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKP 293
S + SD++S G ++ELLTG P
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 7e-32
Identities = 71/223 (31%), Positives = 107/223 (47%), Gaps = 35/223 (15%)
Query: 97 RILGQGGQGTVYKGMLA------DGGIVAVKKSK-LVDESNVEQFINEVVILSQINHRNV 149
R LG+G G V+ G D +VAVK K + F E +L+ H N+
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYL--HD---------QTEEFPITWEMRLRIAIE 198
VK G C E + P++V+E++ +G L +L H + +T L+IA++
Sbjct: 71 VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT---RVQ 255
++ M YL S + HRD+ + N L+ K+ DFG SR + TT RV
Sbjct: 131 IASGMVYLASQHFV---HRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVG 181
Query: 256 GT----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
G ++ PE +FT +SDV+SFGVVL E+ T G++P
Sbjct: 182 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-31
Identities = 85/282 (30%), Positives = 130/282 (46%), Gaps = 18/282 (6%)
Query: 97 RILGQGGQGTVYKGML-----ADGGIVAVKKSKLVDESNVEQ-FINEVVILSQINHRNVV 150
+ LG+G G V G VAVK E F E+ IL ++H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 151 KLLGCCLES--EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
K G C + L+ E++P+G+L YL ++ I + L + ++ M YL S
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ--INLKRLLLFSSQICKGMDYLGS 127
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG---TFGYLDPEY 265
I HRD+ + NIL++ + K+SDFG ++ + D+ + + G F Y PE
Sbjct: 128 QRYI---HRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APEC 183
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
R+S+F+ SDV+SFGV L EL T P +S AE R ++G M RL E+L+
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIAQGQMIVTRLLELLKEG 242
Query: 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367
V L K C + RPS ++ ++ +R
Sbjct: 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-30
Identities = 75/213 (35%), Positives = 119/213 (55%), Gaps = 15/213 (7%)
Query: 97 RILGQGGQGTVYKGMLADG-GI---VAVKK-SKLVDESNVEQFINEVVILSQINHRNVVK 151
R++G+G G VY G L D G AVK +++ D VEQF+ E +I+ +H NV+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60
Query: 152 LLGCCLESE-VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
LLG CL SE PL+V ++ +G L +++ +T P ++ + ++V+ M YL S
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN-PTVKDL-IGFGLQVAKGMEYLASKK 118
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI---KVDQTHLTTRVQGTFGYLDPEYFR 267
+ HRD+ + N +LD+ + KV+DFG +R I + H T + ++ E +
Sbjct: 119 FV---HRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQ 175
Query: 268 SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDA 299
+ +FT KSDV+SFGV+L EL+T G P D+
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS 208
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 64/214 (29%), Positives = 110/214 (51%), Gaps = 10/214 (4%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVK--KSKLVDESNVEQFINEVVILSQINHRNVVKLLG 154
+G+G G VYKG+L VAVK +S L + +F+ E IL Q +H N+VKL+G
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIG 59
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
C++ + +V E +P G+L +L + + + L+++++ + M YL S I
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESKNCI-- 115
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT-RVQGTFGYLDPEYFRSSQFTE 273
HRD+ + N L+ + K+SDFG SR + ++ Q + PE ++T
Sbjct: 116 -HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 274 KSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLV 306
+SDV+S+G++L E + G P ++ R +
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQTRERI 208
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 65/214 (30%), Positives = 111/214 (51%), Gaps = 20/214 (9%)
Query: 97 RILGQGGQGTVYKGML-ADGGI---VAVKKSKL--VDESNVEQFINEVVILSQINHRNVV 150
+ILG+G G+V +G L D G VAVK KL S +E+F++E + +H NV+
Sbjct: 5 KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 151 KLLGCCLESE------VPLLVYEFIPNGTLYHYL-HDQTEEFP--ITWEMRLRIAIEVSG 201
KL+G C E+ P+++ F+ +G L+ +L + + P + + L+ ++++
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV-QGTFGY 260
M YL + I HRD+ + N +L + V+DFG S+ I + R+ + +
Sbjct: 125 GMEYLSNRNFI---HRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ E +T KSDV++FGV + E+ T GQ P
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 64/209 (30%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN 148
+ Y +G+G G VYK A G VA+KK +L + N E INE++I+ H N
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPN 76
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTL----YHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
+V L + +V E++ G+L E I + R EV +
Sbjct: 77 IVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQ-IAYVCR-----EVLQGLE 130
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
YLHS I HRDIKS NILL K++DFG + + +++ + V GT ++ PE
Sbjct: 131 YLHSQNVI---HRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMAPE 186
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ + K D++S G++ +E+ G+ P
Sbjct: 187 VIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 64/190 (33%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESN-VEQFINEVVILSQINHRNVVKLLGCCL 157
+G+G G V G G VAVK K D+S + F+ E +++ + H N+V+LLG L
Sbjct: 14 IGKGEFGDVMLGDYR-GQKVAVKCLK--DDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70
Query: 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217
+ +V E++ G+L YL + IT +L A++V M YL HR
Sbjct: 71 QGNPLYIVTEYMAKGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHR 126
Query: 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 277
D+ + N+L+ + AKVSDFG ++ Q V+ T PE R +F+ KSDV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDV 182
Query: 278 YSFGVVLVEL 287
+SFG++L E+
Sbjct: 183 WSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 2e-30
Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 24/259 (9%)
Query: 99 LGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGC 155
+G+G G V+K + AD + A+K+ L ++ E+ I+E +L++++ +++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
L+ +V E+ NG L+ L Q P+ + R I++ +++LHS I
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLKMQRGR-PLPEDQVWRFFIQILLGLAHLHSKK---IL 123
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 275
HRDIKS N+ LD K+ D G ++ + D T+ + GT YL PE + EKS
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDKPYNEKS 182
Query: 276 DVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEI 335
DV++ GVVL E TG+ P DA +L+ ++ + F + ++
Sbjct: 183 DVWALGVVLYECCTGKHPF---DANNQGALILKIIRGV-----FPPVSQMYSQQ------ 228
Query: 336 ITVAMLGKRCLNMIGKKRP 354
+A L +CL ++RP
Sbjct: 229 --LAQLIDQCLTKDYRQRP 245
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 13/208 (6%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKLLG 154
LG+G G V G + A+K K K++ VE + E ILS+INH +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 155 CCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIP 213
++E L LV E+ P G L+ +L +E + E A E+ A+ YLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLS---KEGRFSEERARFYAAEIVLALEYLHSLG--- 113
Query: 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTE 273
I +RD+K NILLD K++DFG ++ + + + T GT YL PE + +
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GTPEYLAPEVLLGKGYGK 172
Query: 274 KSDVYSFGVVLVELLTGQKPIRSTDAEE 301
D +S GV+L E+LTG+ P + D +E
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKE 200
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 81/268 (30%), Positives = 122/268 (45%), Gaps = 23/268 (8%)
Query: 99 LGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
LG G G VY+G+ VAVK K D VE+F+ E ++ +I H N+V+LLG C
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 72
Query: 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217
++ EF+ G L YL + + + + L +A ++S AM YL I HR
Sbjct: 73 REPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKNFI---HR 128
Query: 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 277
D+ + N L+ + + KV+DFG SR + D + + PE ++F+ KSDV
Sbjct: 129 DLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 188
Query: 278 YSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEII 336
++FGV+L E+ T G P D + ++E+LE E E
Sbjct: 189 WAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKGYRMERPEGCPP 232
Query: 337 TVAMLGKRCLNMIGKKRPSMKEVAFELE 364
V L + C RPS E+ E
Sbjct: 233 KVYELMRACWQWNPSDRPSFAEIHQAFE 260
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 63/198 (31%), Positives = 104/198 (52%), Gaps = 6/198 (3%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
R LG G G V++G+ + VA+K K D + F EV L ++ H++++ L C
Sbjct: 12 RKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC 71
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
E ++ E + G+L +L E + + +A +V+ M+YL SI H
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRS-PEGQVLPVASLIDMACQVAEGMAYLEEQNSI---H 127
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 276
RD+ + NIL+ + KV+DFG +R IK + +L++ + + + PE F+ KSD
Sbjct: 128 RDLAARNILVGEDLVCKVADFGLARLIK-EDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186
Query: 277 VYSFGVVLVELLT-GQKP 293
V+SFG++L E+ T GQ P
Sbjct: 187 VWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 8e-29
Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 99 LGQGGQGTVYKGM-LADGGI---VAVK--KSKLVDESNVEQFINEVVILSQINHRNVVKL 152
LG G G V +G GG VAVK KS + + ++ F+ E I+ ++H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSD-IMDDFLKEAAIMHSLDHENLIRL 61
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHD-QTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
G L + ++V E P G+L L F I+ A++++ M YL S
Sbjct: 62 YGVVLTHPL-MMVTELAPLGSLLDRLRKDALGHFLIS--TLCDYAVQIANGMRYLESKRF 118
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT--FGYLDPEYFRSS 269
I HRD+ + NILL + K+ DFG R + ++ H F + PE R+
Sbjct: 119 I---HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKP 293
F+ SDV+ FGV L E+ T G++P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-29
Identities = 75/265 (28%), Positives = 117/265 (44%), Gaps = 26/265 (9%)
Query: 99 LGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFI-NEVVILSQINHRNVVKLLGCC 156
LGQG G VYK G I A+KK + + + + E+ L VVK G
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRL-RIAIEVSGAMSYLHSATSIPIY 215
+ +V E++ G+L L + + P E L IA ++ + YLH+ I
Sbjct: 69 YKEGEISIVLEYMDGGSL-ADLLKKVGKIP---EPVLAYIARQILKGLDYLHTKRHI--I 122
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 275
HRDIK SN+L++ K K++DFG S+ ++ T V GT Y+ PE + ++ +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAA 181
Query: 276 DVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF--LQAMNEDRLFEVLEARVLKEGKEE 333
D++S G+ L+E G+ P FF +QA+ + + E +
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPGQ------PSFFELMQAICDGPPPSLPAEEFSPEFR-- 233
Query: 334 EIITVAMLGKRCLNMIGKKRPSMKE 358
+ I+ CL KKRPS E
Sbjct: 234 DFIS------ACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 66/214 (30%), Positives = 105/214 (49%), Gaps = 20/214 (9%)
Query: 99 LGQGGQGTVYK-GMLADGGIVAVKKSKLVDESNVEQF--INEVVILSQINHRNVVK---- 151
LG+G G+VYK L+D A+K+ L S E+ +NE+ IL+ +NH N++
Sbjct: 8 LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEA 67
Query: 152 -LLGCCLESEVPLLVYEFIPNGTLYHYL-HDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
L G L +V E+ P G L + + + I + RI I++ + LH
Sbjct: 68 FLDGNKL-----CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
I HRD+KS+NILL K+ D G S KV + ++ GT Y+ PE ++
Sbjct: 123 K---ILHRDLKSANILLVANDLVKIGDLGIS---KVLKKNMAKTQIGTPHYMAPEVWKGR 176
Query: 270 QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
++ KSD++S G +L E+ T P + ++ R
Sbjct: 177 PYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR 210
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-28
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 12/204 (5%)
Query: 96 NRILGQGGQGTVYKGM---LADGGI-VAVKKSKL-VDESNVEQFINEVVILSQINHRNVV 150
R +G+G G VY+G+ + I VAVK K S E+F+ E I+ Q +H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
KL+G E+ V +V E P G L YL Q ++ + + + ++S A++YL S
Sbjct: 71 KLIGVITENPV-WIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
HRDI + N+L+ K+ DFG SR ++ + + ++ + ++ PE +
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRR 184
Query: 271 FTEKSDVYSFGVVLVELLT-GQKP 293
FT SDV+ FGV + E+L G KP
Sbjct: 185 FTSASDVWMFGVCMWEILMLGVKP 208
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 60/198 (30%), Positives = 101/198 (51%), Gaps = 6/198 (3%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
R LG G G V++G+ + VAVK K + + F+ E I+ ++ H +++L C
Sbjct: 12 RKLGAGQFGEVWEGLWNNTTPVAVKTLK-PGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
E +V E + G+L YL + + +A +V+ M+YL + I H
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGR-ALKLPQLIDMAAQVASGMAYLEAQNYI---H 126
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 276
RD+ + N+L+ + KV+DFG +R IK D + + PE ++F+ KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186
Query: 277 VYSFGVVLVELLT-GQKP 293
V+SFG++L E++T G+ P
Sbjct: 187 VWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 9e-28
Identities = 66/201 (32%), Positives = 102/201 (50%), Gaps = 10/201 (4%)
Query: 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
R LG G G V+ G VAVK K S E F+ E I+ ++ H +V+L
Sbjct: 11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
C E E +V E++ G+L +L + + + +A +++ M+YL S I
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKK-LRLPQLVDMAAQIAEGMAYLESRNYI--- 125
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSSQFTE 273
HRD+ + NIL+ + K++DFG +R I+ D T R F + PE +FT
Sbjct: 126 HRDLAARNILVGENLVCKIADFGLARLIEDD--EYTAREGAKFPIKWTAPEAANYGRFTI 183
Query: 274 KSDVYSFGVVLVELLT-GQKP 293
KSDV+SFG++L E++T G+ P
Sbjct: 184 KSDVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 9e-28
Identities = 76/279 (27%), Positives = 134/279 (48%), Gaps = 38/279 (13%)
Query: 97 RILGQGGQGTVYKGM---LADGGIVAVKKSKLVDES---NVEQFINEVVILSQINHRNVV 150
++LG G GTVYKG+ + + V L +E+ ++ ++E +++ ++H +VV
Sbjct: 13 KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+LLG CL S+V L+ + +P G L Y+ + + I + L ++++ MSYL
Sbjct: 73 RLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDN--IGSQYLLNWCVQIAKGMSYLEEKR 129
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG---TFGYLDPEYFR 267
+ HRD+ + N+L+ K++DFG ++ + VD+ +G ++ E
Sbjct: 130 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALESIL 184
Query: 268 SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326
+T KSDV+S+GV + EL+T G KP A E L+ +RL
Sbjct: 185 HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL------EKGERL-------- 230
Query: 327 LKEGKEEEIIT--VAMLGKRCLNMIGKKRPSMKEVAFEL 363
+ I T V M+ +C + + RP+ KE+ E
Sbjct: 231 ----PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEF 265
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 66/212 (31%), Positives = 120/212 (56%), Gaps = 23/212 (10%)
Query: 98 ILGQGGQGTVYKGMLADGG-IVAVKKSKL--VDESN-------VEQFINEVVILSQINHR 147
++G G G+VY GM A G ++AVK+ +L V S+ ++ E+ +L ++ H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVSGAMSYL 206
N+V+ LG L+++ + E++P G++ L + F E +R + ++ ++YL
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL-NNYGAFE---ETLVRNFVRQILKGLNYL 122
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR-----VQGTFGYL 261
H+ I HRDIK +NIL+D+K K+SDFG S+ ++ + T +QG+ ++
Sbjct: 123 HNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWM 179
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
PE + + +T K+D++S G ++VE+LTG+ P
Sbjct: 180 APEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 15/205 (7%)
Query: 99 LGQGGQGTVYKG--MLADGGIVAVKKSKLVDESNV---EQFINEVVILSQINHRNVVKLL 153
LG G G+V KG ++ G V V L E ++F+ E +++Q++H +V+L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIP 213
G C E +LV E P G L YL + E I +A +V+ M+YL S +
Sbjct: 63 GVCK-GEPLMLVMELAPLGPLLKYLKKRRE---IPVSDLKELAHQVAMGMAYLESKHFV- 117
Query: 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSSQF 271
HRD+ + N+LL ++++AK+SDFG SR + + G + + PE +F
Sbjct: 118 --HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF 175
Query: 272 TEKSDVYSFGVVLVELLT-GQKPIR 295
+ KSDV+S+GV L E + G KP
Sbjct: 176 SSKSDVWSYGVTLWEAFSYGAKPYG 200
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 62/210 (29%), Positives = 111/210 (52%), Gaps = 22/210 (10%)
Query: 96 NRILGQGGQGTVYKGMLADGG----IVAVK--KSKLVDESNVEQFINEVVILSQINHRNV 149
+++G G G V +G L G VA+K K+ D+ ++ F+ E I+ Q +H N+
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNI 67
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
++L G +S +++ E++ NG+L +L + +F T + + ++ M YL
Sbjct: 68 IRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKF--TVGQLVGMLRGIASGMKYLSEM 125
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR-----VQGTFGYLDPE 264
+ HRD+ + NIL++ KVSDFG SR ++ + TT+ ++ T PE
Sbjct: 126 NYV---HRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWT----APE 178
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+FT SDV+SFG+V+ E+++ G++P
Sbjct: 179 AIAYRKFTSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 82/292 (28%), Positives = 132/292 (45%), Gaps = 51/292 (17%)
Query: 99 LGQGGQGTVYKGMLADGG---------IVAVKKSKLVDESNVEQFINEVVILSQINHRNV 149
LG+G G VYKG L I +K++ +F E ++S + H N+
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ--EFRQEAELMSDLQHPNI 70
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYL-------------HDQTEEFPITWEMRLRIA 196
V LLG C + + +++E++ +G L+ +L D+T + + L IA
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG 256
I+++ M YL S HRD+ + N L+ + K+SDFG SR I + RVQ
Sbjct: 131 IQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDI---YSADYYRVQS 184
Query: 257 T----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQ 311
++ PE +FT +SD++SFGVVL E+ + G +P GF
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP-----------YYGF--- 230
Query: 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363
N++ + E++ +R L E+ V L C N I +RP K++ L
Sbjct: 231 -SNQE-VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRNVVKLLGC 155
+G G G VY + L G ++AVK+ ++ D +++ +E+ +L + H N+VK G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIPI 214
+ E + E+ GTL L E I E +R+ +++ ++YLHS I
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQLLEGLAYLHSHG---I 120
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG---YLDPEYFRSSQF 271
HRDIK +NI LD K+ DFG + +K + T + VQ G Y+ PE +
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKG 180
Query: 272 TEK---SDVYSFGVVLVELLTGQKP 293
+D++S G V++E+ TG++P
Sbjct: 181 KGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 90/289 (31%), Positives = 135/289 (46%), Gaps = 36/289 (12%)
Query: 99 LGQGGQGTVYK---GMLAD--GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLL 153
LG+G G+V L D G +VAVKK + ++ F E+ IL + H N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 154 GCCLESEVP--LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
G C + LV E++P G+L YL E + L A ++ M YL S
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER--LDHRKLLLYASQICKGMEYLGSKRY 129
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG---TFGYLDPEYFRS 268
+ HRD+ + NIL++ + R K+ DFG ++ + D+ + R G F Y PE
Sbjct: 130 V---HRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA-PESLTE 185
Query: 269 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR-----LFEVLE 323
S+F+ SDV+SFGVVL EL T S AE F++ M D+ ++ ++E
Sbjct: 186 SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE--------FMRMMGNDKQGQMIVYHLIE 237
Query: 324 ARVLKEGK-----EEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367
+LK + + K C N +RPS E+A ++E IR
Sbjct: 238 --LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 68/199 (34%), Positives = 105/199 (52%), Gaps = 16/199 (8%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDES--NVEQFINEVVILSQINHRNVVKLLGCC 156
LG G G V+ G VA+K ++ E + + FI E ++ +++H N+V+L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIK---MIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ +V E++ NG L +YL ++ + E L + +V AM YL S I H
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT--EWLLDMCSDVCEAMEYLESNGFI---H 123
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT---FGYLDPEYFRSSQFTE 273
RD+ + N L+ + KVSDFG +R + DQ T QGT + PE F S+F+
Sbjct: 124 RDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFDYSRFSS 180
Query: 274 KSDVYSFGVVLVELLTGQK 292
KSDV+SFGV++ E+ + K
Sbjct: 181 KSDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-27
Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 98 ILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF----INEVVILSQINHRNVVKL 152
LG+G G VYK G IVA+KK +L +E E + E+ +L ++ H N+VKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEE--EGIPSTALREISLLKELKHPNIVKL 63
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
L LV+E+ L YL + + I ++ ++Y HS
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSP--NLIKSIMYQLLRGLAYCHSHR-- 118
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-YFRSSQF 271
I HRD+K NIL++ K++DFG +R + T V T Y PE S +
Sbjct: 119 -ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEILLGSKHY 176
Query: 272 TEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
+ D++S G + E++TG KP+ D+E D
Sbjct: 177 STAVDIWSVGCIFAEMITG-KPLFPGDSEID 206
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 81/304 (26%), Positives = 130/304 (42%), Gaps = 51/304 (16%)
Query: 92 NYNANRILGQGGQGTVYKGM------LADGGIVAVKKSKL-VDESNVEQFINEVVILSQI 144
N + LG+G G V K A VAVK K S + ++E +L Q+
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLH---------------------DQTE 183
NH +V+KL G C + LL+ E+ G+L +L D +
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 184 EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243
E +T + A ++S M YL + + HRD+ + N+L+ + + K+SDFG SR +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177
Query: 244 KVDQTHLTTRVQGTF--GYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAE 300
+ +++ R +G ++ E +T +SDV+SFGV+L E++T G P E
Sbjct: 178 YEEDSYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236
Query: 301 EDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVA 360
RLF +L+ E E + L C KRP+ +++
Sbjct: 237 ----------------RLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADIS 280
Query: 361 FELE 364
ELE
Sbjct: 281 KELE 284
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 69/235 (29%), Positives = 112/235 (47%), Gaps = 35/235 (14%)
Query: 97 RILGQGGQGTVYKGMLAD------GGIVAVKKSKLVDESNVEQ---FINEVVILSQINHR 147
R LGQG G VY+G+ VA+K + + +++ + F+NE ++ + N
Sbjct: 12 RELGQGSFGMVYEGLAKGVVKGEPETRVAIKT--VNENASMRERIEFLNEASVMKEFNCH 69
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEE-------FPITWEMRLRIAIEVS 200
+VV+LLG + L+V E + G L YL + E P T + +++A E++
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-------KVDQTHLTTR 253
M+YL + HRD+ + N ++ + K+ DFG +R I K + L R
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVG 307
++ PE + FT KSDV+SFGVVL E+ T ++P + EE V
Sbjct: 187 ------WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 8e-27
Identities = 64/231 (27%), Positives = 104/231 (45%), Gaps = 34/231 (14%)
Query: 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVK---KSKLVDESNVEQFINEVVILSQIN- 145
D++ +I+G+G TV A+K K +L+ E V+ E +L+++N
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTE-EFPITWEMRLRIAIEVSGAMS 204
H ++KL + E V E+ PNG L Y+ + T R A E+ A+
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCT---RFYAA-EILLALE 116
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR--------------------TIK 244
YLHS I HRD+K NILLD K++DFG ++ I+
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173
Query: 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 295
++ + V GT Y+ PE + SD+++ G ++ ++LTG+ P R
Sbjct: 174 KNRRRFASFV-GTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFR 223
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 63/213 (29%), Positives = 106/213 (49%), Gaps = 19/213 (8%)
Query: 98 ILGQGGQGTVYKGMLADGGIVAVKK------SKLVDESNVEQFINEVVILSQINHRNVVK 151
+LG+G GTVY G+ G ++AVK+ + L E E+ EV +L + H N+V+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRL-RIAIEVSGAMSYLHSAT 210
LG CL+ + EF+P G++ L F E + ++ ++YLH+
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSIL----NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-----KVDQTHLTTRVQGTFGYLDPEY 265
+ HRDIK +N++L K+ DFG +R + +++ + GT ++ PE
Sbjct: 123 VV---HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
S + KSD++S G + E+ TG+ P+ S D
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 83/276 (30%), Positives = 129/276 (46%), Gaps = 34/276 (12%)
Query: 92 NYNANRILGQG--GQGTVYKGMLADGGIVAVKKSKLVDESNVEQF--INEVVILSQINHR 147
+Y R+LG+G G+ T+Y+ D +V K+ L S E+ +NE+VILS + H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQT----EEFPITWEMRLRIAIEVSGAM 203
N++ ++ L+ E+ GTLY + Q EE + W + ++ A+
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL-----FQIVSAV 114
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
SY+H A I HRDIK+ NI L K+ DFG S+ + + + T V GT Y+ P
Sbjct: 115 SYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSP 170
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323
E + ++ KSD+++ G VL ELLT + R+ DA +LV +Q
Sbjct: 171 ELCQGVKYNFKSDIWALGCVLYELLTLK---RTFDATNPLNLVVKIVQGNYTP------- 220
Query: 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ E+I L L +KRP+ EV
Sbjct: 221 ---VVSVYSSELI---SLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 67/196 (34%), Positives = 107/196 (54%), Gaps = 7/196 (3%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE 158
+G G G V+ G + VA+K + S E FI E ++ +++H +V+L G C E
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRD 218
LV+EF+ +G L YL Q +F + E L + ++V M+YL S+ I HRD
Sbjct: 71 RSPICLVFEFMEHGCLSDYLRAQRGKF--SQETLLGMCLDVCEGMAYLESSNVI---HRD 125
Query: 219 IKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVY 278
+ + N L+ + KVSDFG +R + DQ +T + + PE F S+++ KSDV+
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 279 SFGVVLVELLT-GQKP 293
SFGV++ E+ + G+ P
Sbjct: 186 SFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 62/194 (31%), Positives = 102/194 (52%), Gaps = 8/194 (4%)
Query: 98 ILGQGGQGTVYKGMLADGGIVAVK--KSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
+LG+G G V+KG L D VAVK K L E + +F++E IL Q +H N+VKL+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
C + + +V E +P G +L + +E + ++ A++ + M+YL S I
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKT--KQLVKFALDAAAGMAYLESKNCI--- 115
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 275
HRD+ + N L+ + K+SDFG SR + Q + PE +++ +S
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES 175
Query: 276 DVYSFGVVLVELLT 289
DV+S+G++L E +
Sbjct: 176 DVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 84/272 (30%), Positives = 126/272 (46%), Gaps = 20/272 (7%)
Query: 97 RILGQGGQGTV----YKGMLADGG-IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVV 150
R+LG+G G V Y G +VAVK K + N + E+ IL + H N+V
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 151 KLLGCCLES--EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
K GCC E + L+ E++P G+L YL + L A ++ M+YLHS
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHK----LNLAQLLLFAQQICEGMAYLHS 125
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG---TFGYLDPEY 265
I HRD+ + N+LLD+ K+ DFG ++ + + R G F Y E
Sbjct: 126 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYA-VEC 181
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
+ ++F+ SDV+SFGV L ELLT +S + + ++G M RL E+LE
Sbjct: 182 LKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE-MIGPKQGQMTVVRLIELLERG 240
Query: 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMK 357
+ + V +L K C K RP+ +
Sbjct: 241 MRLPCPKNCPQEVYILMKNCWETEAKFRPTFR 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 68/218 (31%), Positives = 108/218 (49%), Gaps = 11/218 (5%)
Query: 78 TKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFIN 136
KL T + + Y +GQG GTVY + +A G VA+K+ L + E IN
Sbjct: 6 EKLRTIVSVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIIN 65
Query: 137 EVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD-QTEEFPITWEMRLRI 195
E++++ + H N+V L L + +V E++ G+L + + +E I R
Sbjct: 66 EILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR--- 122
Query: 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ 255
E A+ +LHS I HRDIKS NILL K++DFG I +Q+ +T V
Sbjct: 123 --ECLQALEFLHSNQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV- 176
Query: 256 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
GT ++ PE + K D++S G++ +E++ G+ P
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 23/209 (11%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFIN--EVVILSQINHRNV 149
Y +G+G G VYK G IVA+KK KL ES E+ +L ++NH N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP------ITWEMRLRIAIEVSGAM 203
+KLL LV+EF+ + LY + D+ P +++ L+ +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQL-LQ-------GL 111
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
++ HS I HRD+K N+L++ + K++DFG +R+ T V T Y P
Sbjct: 112 AFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAP 167
Query: 264 E-YFRSSQFTEKSDVYSFGVVLVELLTGQ 291
E ++ D++S G + ELL+ +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 81/284 (28%), Positives = 140/284 (49%), Gaps = 37/284 (13%)
Query: 84 MDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQ 143
++L+K T I+G+G G V +G G VAVK K + + F+ E ++++
Sbjct: 3 LNLQKLT----LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKC--DVTAQAFLEETAVMTK 55
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
++H+N+V+LLG L + + +V E + G L ++L + ++ L+ +++V+ M
Sbjct: 56 LHHKNLVRLLGVILHNGL-YIVMELMSKGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGM 113
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR--TIKVDQTHLTTRVQGTFGYL 261
YL S + HRD+ + NIL+ + AKVSDFG +R ++ VD + L + +
Sbjct: 114 EYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WT 164
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320
PE + +F+ KSDV+S+GV+L E+ + G+ P M+ + E
Sbjct: 165 APEALKHKKFSSKSDVWSYGVLLWEVFSYGRAP----------------YPKMSLKEVKE 208
Query: 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364
+E E E V +L C KKRPS ++ +LE
Sbjct: 209 CVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE 252
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 56/184 (30%), Positives = 91/184 (49%), Gaps = 17/184 (9%)
Query: 118 VAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYH 176
VAVK + ++ E F+ EV ILS+++ N+ +LLG C ++ E++ NG L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 177 YLHDQTEEF----------PITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL 226
+L Q +++ L +A +++ M YL S + HRD+ + N L+
Sbjct: 109 FL--QKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNCLV 163
Query: 227 DDKYRAKVSDFGASRTI-KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLV 285
Y K++DFG SR + D + R ++ E +FT KSDV++FGV L
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLW 223
Query: 286 ELLT 289
E+LT
Sbjct: 224 EILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-24
Identities = 65/206 (31%), Positives = 109/206 (52%), Gaps = 15/206 (7%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVK 151
+++G G G V++G+L G VA+K K E + F++E I+ Q +H N+++
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGAMSYLHSAT 210
L G + + +++ E++ NG L YL D EF LR ++ M YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDMN 127
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD--QTHLTTRVQGTFGYLDPEYFRS 268
+ HRD+ + NIL++ KVSDFG SR ++ D T+ T+ + + PE
Sbjct: 128 YV---HRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 269 SQFTEKSDVYSFGVVLVELLT-GQKP 293
+FT SDV+SFG+V+ E+++ G++P
Sbjct: 185 RKFTSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 77/276 (27%), Positives = 138/276 (50%), Gaps = 32/276 (11%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVKKS-KLVDES-----NVEQFINEVVILSQINHRNV 149
++LG G GTVYKG+ + +G V + + K+++E+ NVE F++E +I++ ++H ++
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHL 71
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
V+LLG CL + LV + +P+G L Y+H+ + I ++ L ++++ M YL
Sbjct: 72 VRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDN--IGSQLLLNWCVQIAKGMMYLEER 128
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR-VQGTFGYLDPEYFRS 268
+ HRD+ + N+L+ K++DFG +R ++ D+ + ++ E
Sbjct: 129 R---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY 185
Query: 269 SQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327
+FT +SDV+S+GV + EL+T G KP E + ++LE
Sbjct: 186 RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----------------IPDLLEKGER 229
Query: 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363
I V M+ +C + RP KE+A E
Sbjct: 230 LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEF 265
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 23/215 (10%)
Query: 99 LGQGGQGTVYKGMLA------DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
LG+G G V+ D +VAVK K ES + F E +L+ + H+++V+
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLH---------DQTEEFP---ITWEMRLRIAIEVS 200
G C E L+V+E++ +G L +L E+ +T L IA +++
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQGTFG 259
M YL S+ HRD+ + N L+ K+ DFG SR I D + R
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
++ PE +FT +SD++SFGVVL E+ T G++P
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 66/210 (31%), Positives = 111/210 (52%), Gaps = 13/210 (6%)
Query: 99 LGQGGQGTVYKG---MLADGGIVAVKKSKLVDESNV-EQFINEVVILSQINHRNVVKLLG 154
LG G G V KG M VA+K K +E +V ++ + E I+ Q+++ +V+++G
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
C E+E +LV E G L +L + +E IT + + +VS M YL +
Sbjct: 63 VC-EAEALMLVMEMASGGPLNKFLSGKKDE--ITVSNVVELMHQVSMGMKYLEGKNFV-- 117
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSSQFT 272
HRD+ + N+LL +++ AK+SDFG S+ + D ++ R G + + PE +F+
Sbjct: 118 -HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 273 EKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301
+SDV+S+G+ + E + GQKP + E
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 79/219 (36%), Positives = 113/219 (51%), Gaps = 28/219 (12%)
Query: 97 RILGQGGQGTVYKGMLAD------GGI-VAVK--KSKLVDESNVEQFINEVVILSQINHR 147
LG G G VY+G D G I VAVK + D+ E F+ E ++S NH
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKE-FLKEAHLMSNFNHP 59
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD-QTEEFP---ITWEMRLRIAIEVSGAM 203
N+VKLLG CL +E ++ E + G L YL D + E F +T + L I ++V+
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDK-YRA----KVSDFGASRTI-KVDQTHLTTRVQGT 257
YL I HRD+ + N L+ +K Y A K+ DFG +R I K D + +G
Sbjct: 120 VYLEQMHFI---HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSD--YYRKEGEGL 174
Query: 258 FG--YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
++ PE +FT +SDV+SFGV++ E+LT GQ+P
Sbjct: 175 LPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 9e-24
Identities = 67/215 (31%), Positives = 105/215 (48%), Gaps = 21/215 (9%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRN 148
D+Y ++G G VY + L + VA+K+ L +++V++ EV +SQ NH N
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPN 60
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYH-----YLHDQTEEFPITWEMRLRIAIEVSGAM 203
VVK + + LV ++ G+L Y +E I ++ EV +
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLK-----EVLKGL 115
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF----G 259
YLHS I HRDIK+ NILL + K++DFG S ++ D T +V+ TF
Sbjct: 116 EYLHSNGQI---HRDIKAGNILLGEDGSVKIADFGVSASL-ADGGDRTRKVRKTFVGTPC 171
Query: 260 YLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKP 293
++ PE + K+D++SFG+ +EL TG P
Sbjct: 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 9e-24
Identities = 70/230 (30%), Positives = 106/230 (46%), Gaps = 16/230 (6%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGIV-AVK---KSKLVDESNVEQFINEVVILSQINHR 147
++ R++G+G G V D + A+K K K V++ +V +NE IL ++NH
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTL-YHYLHDQTEEFPITWEMRLRIAI-EVSGAMSY 205
+V L + E LV + + G L YH Q +F E +++ I E+ A+ Y
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHL--SQKVKFS---EEQVKFWICEIVLALEY 115
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LHS I HRDIK NILLD++ ++DF + + D LTT GT GY+ PE
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEV 170
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315
++ D +S GV E L G++P R + A
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVL 220
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 2e-23
Identities = 63/203 (31%), Positives = 106/203 (52%), Gaps = 11/203 (5%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNV--EQFINEVVILSQINHRNVVKLLG 154
+ LG G G V+ G VA+K ++E + E FI E ++ +++H +V+L G
Sbjct: 10 KELGSGQFGVVHLGKWRAQIKVAIKA---INEGAMSEEDFIEEAKVMMKLSHPKLVQLYG 66
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
C + + +V EF+ NG L +YL + + + +M L + +V M YL + I
Sbjct: 67 VCTQQKPLYIVTEFMENGCLLNYLRQRQGKL--SKDMLLSMCQDVCEGMEYLERNSFI-- 122
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
HRD+ + N L+ KVSDFG +R + D+ ++ + + PE F S+++ K
Sbjct: 123 -HRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 275 SDVYSFGVVLVELLT-GQKPIRS 296
SDV+SFGV++ E+ T G+ P
Sbjct: 182 SDVWSFGVLMWEVFTEGKMPFEK 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 61/207 (29%), Positives = 108/207 (52%), Gaps = 21/207 (10%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESN-----VEQFINEVVILSQINHRNVV 150
+LG G G+VY+G+ L DG AVK+ L D+ V+Q E+ +LS++ H N+V
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65
Query: 151 KLLGCCLESEVPLLVY-EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIE--VSGAMSYLH 207
+ LG E + L ++ E +P G+L +++ E +R+ + G + YLH
Sbjct: 66 QYLGTEREED-NLYIFLELVPGGSL----AKLLKKYGSFPEPVIRLYTRQILLG-LEYLH 119
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
++ HRDIK +NIL+D K++DFG ++ +V + +G+ ++ PE
Sbjct: 120 DRNTV---HRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 268 SS-QFTEKSDVYSFGVVLVELLTGQKP 293
+ +D++S G ++E+ TG+ P
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-23
Identities = 66/201 (32%), Positives = 111/201 (55%), Gaps = 17/201 (8%)
Query: 97 RILGQGGQGTVYKGMLAD--GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLG 154
+ +G+G G V ML D G VAVK K +++ + F+ E +++Q+ H N+V+LLG
Sbjct: 12 QTIGKGEFGDV---MLGDYRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 155 CCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIP 213
+E + L +V E++ G+L YL + + + L+ +++V AM YL + +
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEANNFV- 124
Query: 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTE 273
HRD+ + N+L+ + AKVSDFG ++ Q V+ T PE R +F+
Sbjct: 125 --HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFST 178
Query: 274 KSDVYSFGVVLVELLT-GQKP 293
KSDV+SFG++L E+ + G+ P
Sbjct: 179 KSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 3e-23
Identities = 62/208 (29%), Positives = 100/208 (48%), Gaps = 21/208 (10%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESN--VEQFINEVVILSQINHRNVVKLL 153
+G+G G VYK G +VA+KK ++ +E I E+ +L ++ H N+V+L
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 154 GCCLESEVP--LLVYEFIP---NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+V+E++ G L TE +++ ++ + YLHS
Sbjct: 65 EIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTES-----QIK-CYMKQLLEGLQYLHS 118
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQGTFGYLDPE-YF 266
I HRDIK SNIL+++ K++DFG +R K + T RV T Y PE
Sbjct: 119 NG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLL 174
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKPI 294
++++ + D++S G +L EL G KPI
Sbjct: 175 GATRYGPEVDMWSVGCILAELFLG-KPI 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 4e-23
Identities = 80/286 (27%), Positives = 138/286 (48%), Gaps = 39/286 (13%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGG--IVAVK----------KSKLVDESNVEQFINEVV 139
Y LG G G VYK + G ++A+K K K + ++ ++EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 140 IL-SQINHRNVVKLLGCCLESEVPLLVYEFI---PNGTLYHYLHDQTEEFPITWEMRL-R 194
I+ Q+ H N+V+ LE++ +V + I P G ++ L ++ + F E R+
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFT---EERIWN 117
Query: 195 IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254
I +++ A+ YLH I HRD+ +NI+L + + ++DFG ++ K ++ LT+ V
Sbjct: 118 IFVQMVLALRYLHKEKRI--VHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESKLTSVV 174
Query: 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314
GT Y PE ++ + EK+DV++FG +L ++ T Q P ST+ SL ++A+
Sbjct: 175 -GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM---LSLATKIVEAVY 230
Query: 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVA 360
E L EG E +T + CL + RP + +V+
Sbjct: 231 EP----------LPEGMYSEDVTDVI--TSCLTPDAEARPDIIQVS 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (244), Expect = 4e-23
Identities = 74/273 (27%), Positives = 119/273 (43%), Gaps = 33/273 (12%)
Query: 98 ILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLG 154
+G+G GTV K +DG I+ K+ + E +Q ++EV IL ++ H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 155 CCL--ESEVPLLVYEFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGAMSYLH--SA 209
+ ++ +V E+ G L + +E I E RI ++ A+ H S
Sbjct: 67 RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
+ HRD+K +NI LD K+ DFG ++ + D + T V GT Y+ PE
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-GTPYYMSPEQLNHM 185
Query: 270 QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV--GFF--LQAMNEDRLFEVLEAR 325
+ EKSD++S G ++ EL P + + + S + G F + L EV+
Sbjct: 186 SYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVI--- 242
Query: 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKE 358
K LN+ KRPS +E
Sbjct: 243 -----------------KSMLNVDPDKRPSTEE 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 6e-23
Identities = 74/287 (25%), Positives = 135/287 (47%), Gaps = 44/287 (15%)
Query: 98 ILGQGGQGTVY----KGMLADGG--IVAVKKSKLVDESNVEQ-FINEVVILSQINHRNVV 150
LG+G G V+ KG+ +GG +V VK + + N++ F E+ + +++H+NVV
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYL------HDQTEEFPITWEMRLRIAIEVSGAMS 204
+LLG C E+E ++ E+ G L +L ++ + P++ + ++ + +++ M
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
+L +A + HRD+ + N L+ + KVS S+ + + + +L PE
Sbjct: 132 HLSNARFV---HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323
+ F+ KSDV+SFGV++ E+ T G+ P ++++ EVL
Sbjct: 189 AVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG----------------LSDE---EVLN 229
Query: 324 ARVLKEGKEEEII------TVAMLGKRCLNMIGKKRPSMKEVAFELE 364
L+ GK E + + L RC + K RPS E+ L
Sbjct: 230 R--LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 8e-23
Identities = 66/212 (31%), Positives = 104/212 (49%), Gaps = 18/212 (8%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGI-VAVKKSKLVDES-----NVEQFINEVVILSQIN 145
N+ ++LGQG G VY D G +AVK+ +S V E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGAMS 204
H +V+ GC + E + E++P G++ DQ + + +T + + ++ +
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTRKYTRQILEGVE 118
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR---TIKVDQTHLTTRVQGTFGYL 261
YLHS I HRDIK +NIL D K+ DFGAS+ TI T + + V GT ++
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWM 174
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
PE + K+DV+S G +VE+LT + P
Sbjct: 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 8e-23
Identities = 66/211 (31%), Positives = 108/211 (51%), Gaps = 15/211 (7%)
Query: 99 LGQGGQGTVYKG---MLADGGIVAVK--KSKLVDESNVEQFINEVVILSQINHRNVVKLL 153
LG G GTV KG M VAVK K+ D + ++ + E ++ Q+++ +V+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIP 213
G C E+E +LV E G L +L +T + + +VS M YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFLQKNKH---VTEKNITELVHQVSMGMKYLEETNFV- 117
Query: 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSSQF 271
HRD+ + N+LL ++ AK+SDFG S+ + D+ + + G + + PE +F
Sbjct: 118 --HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175
Query: 272 TEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301
+ KSDV+SFGV++ E + GQKP + E
Sbjct: 176 SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE 206
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 96.5 bits (240), Expect = 8e-23
Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE 158
LG G G V G VA+K K S ++FI E ++ +++H +V+L G C +
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVCTK 70
Query: 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRD 218
+V E++ NG L +YL + + F L + +V M+YL S I HRD
Sbjct: 71 QRPIYIVTEYMSNGCLLNYLREHGKRF--QPSQLLEMCKDVCEGMAYLESKQFI---HRD 125
Query: 219 IKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSSQFTEKSD 276
+ + N L+DD+ KVSDFG SR + D+ T+ V F + PE S+F+ KSD
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDE--YTSSVGSKFPVRWSPPEVLLYSKFSSKSD 183
Query: 277 VYSFGVVLVELLT-GQKPIRSTDAEE 301
V++FGV++ E+ + G+ P + E
Sbjct: 184 VWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 18/218 (8%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGMLA--DGGIVAVK-KSKLVDESNVEQ----FINEVV 139
E D+ R LG G G VY+G+ DG V ++ K + ES EQ F+ E +
Sbjct: 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEAL 61
Query: 140 ILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD----QTEEFPITWEMRLRI 195
I+S+ NH+N+V+L+G E ++ E + G L +L + +T + L
Sbjct: 62 IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFC 121
Query: 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSDFGASRTI-KVDQTHLT 251
A +V+ YL I HRDI + N LL K AK++DFG +R I +
Sbjct: 122 ARDVAKGCKYLEENHFI---HRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKG 178
Query: 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
R ++ PE F FT K+DV+SFGV+L E+ +
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFS 216
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 73/279 (26%), Positives = 126/279 (45%), Gaps = 30/279 (10%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSK---LVDESNVEQFINEVVILSQIN 145
N+ + +G+G VYK + L DG +VA+KK + ++D + + E+ +L Q++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYL-HDQTEEFPITWEMRLRIAIEVSGAMS 204
H NV+K L +E+ +V E G L + H + ++ I + +++ A+
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
++HS I HRDIK +N+ + K+ D G R T + V GT Y+ PE
Sbjct: 121 HMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE- 323
+ + KSD++S G +L E+ Q P F+ MN L + +E
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSP--------------FYGDKMNLYSLCKKIEK 222
Query: 324 ---ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ + EE+ + RC+N +KRP + V
Sbjct: 223 CDYPPLPADHYSEELRDLV---SRCINPDPEKRPDISYV 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 4e-22
Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 99 LGQGGQGTVYKG-MLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
+G G G VYK +A G +VA+K KL + E E+ +L + H N+V G L
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70
Query: 158 ESEVPLLVYEFIPNGTL---YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
+ +V E+ G+L Y E I + R E ++YLH I
Sbjct: 71 RRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCR-----ETLKGLAYLHETGKI-- 123
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGAS----RTIKVDQTHLTTRVQGTFGYLDPEYF---R 267
HRDIK +NILL + K++DFG S TI ++ + GT ++ PE R
Sbjct: 124 -HRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-----GTPYWMAPEVAAVER 177
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKP 293
+ K D+++ G+ +EL Q P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 6e-22
Identities = 70/240 (29%), Positives = 119/240 (49%), Gaps = 23/240 (9%)
Query: 66 QQLSSNEGN----IEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYK----GMLADGGI 117
+ + S GN I+ T+L + E +N + + LG G G V + G+ +
Sbjct: 6 KVIESINGNEYVYIDPTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAV 65
Query: 118 --VAVKKSK-LVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGT 173
VAVK K S E ++E+ I+S + NH N+V LLG C L++ E+ G
Sbjct: 66 MKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 174 LYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAK 233
L ++L + E F ++ L + +V+ M++L S I HRD+ + N+LL K
Sbjct: 126 LLNFLRRKRESFLTLEDL-LSFSYQVAKGMAFLASKNCI---HRDLAARNVLLTHGKIVK 181
Query: 234 VSDFGASRTIKVDQTHLTTRVQGT----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
+ DFG +R I D ++ V+G ++ PE + +T +SDV+S+G++L E+ +
Sbjct: 182 ICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 7e-22
Identities = 75/311 (24%), Positives = 138/311 (44%), Gaps = 65/311 (20%)
Query: 91 DNYNANRILGQGGQGTVYK----GMLA--DGGIVAVKKSKLVDESNVE---QFINEVVIL 141
+N R +GQG G V++ G+L +VAVK K +E++ + F E ++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALM 62
Query: 142 SQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQT------------------- 182
++ +H N+VKLLG C + L++E++ G L +L ++
Sbjct: 63 AEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGL 122
Query: 183 EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242
P++ +L IA +V+ M+YL + HRD+ + N L+ + K++DFG SR
Sbjct: 123 NPLPLSCTEQLCIAKQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRN 179
Query: 243 I------KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIR 295
I K + ++ PE +++T +SDV+++GVVL E+ + G +P
Sbjct: 180 IYSADYYKASENDAI-----PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP-- 232
Query: 296 STDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK--EGKEEEIITVAMLGKRCLNMIGKKR 353
+ +E+ ++ V + VL + E+ L + C + + R
Sbjct: 233 -------------YYGMAHEEVIYYVRDGNVLSCPDNCPLELYN---LMRLCWSKLPSDR 276
Query: 354 PSMKEVAFELE 364
PS + L+
Sbjct: 277 PSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 9e-22
Identities = 63/208 (30%), Positives = 107/208 (51%), Gaps = 19/208 (9%)
Query: 99 LGQGGQGTVYKGML--ADGGIVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGC 155
LG G G V K +L G I+AVK +L ++E+ +Q + E+ IL + N +V G
Sbjct: 9 LGAGNSGVVSK-VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGA 67
Query: 156 CL-ESEVPLLVYEFIPNGTL---YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
++ + + E++ G+L + + E + +IA+ V ++YLH
Sbjct: 68 FYNNGDISICM-EYMDGGSLDKILKEVQGRIPERILG-----KIAVAVLKGLTYLHEKHK 121
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
I HRD+K SNIL++ + + K+ DFG S + V+ T GT Y+ PE + + +
Sbjct: 122 I--IHRDVKPSNILVNSRGQIKLCDFGVSGQL-VNSLAKTF--VGTSSYMAPERIQGNDY 176
Query: 272 TEKSDVYSFGVVLVELLTGQKPIRSTDA 299
+ KSD++S G+ L+EL TG+ P +
Sbjct: 177 SVKSDIWSLGLSLIELATGRFPYPPEND 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 1e-21
Identities = 55/213 (25%), Positives = 102/213 (47%), Gaps = 17/213 (7%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLV------DESNVEQFINEVVILSQI 144
+ + LG G + Y+ + G ++AVK+ V E VE E+ +++++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
NH +++++LG E L E++ G++ H L + + ++ +S
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLS 117
Query: 205 YLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDFGASRTIKVDQT---HLTTRVQGTFGY 260
YLH I HRD+K +N+L+D R +++DFGA+ + T ++ GT +
Sbjct: 118 YLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAF 174
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ PE R Q+ DV+S G V++E+ T + P
Sbjct: 175 MAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 1e-21
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 23/222 (10%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD--ESNVEQFINEVVILS 142
DLE +D LG G G+V K G V KK + S +Q + E+ I+
Sbjct: 6 DLETISD-------LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMH 58
Query: 143 QINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA 202
+ +V G L + EF+ G+L + PI E+ +IA+ V
Sbjct: 59 ECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYK---KGGPIPVEILGKIAVAVVEG 115
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI--KVDQTHLTTRVQGTFGY 260
++YL++ I HRDIK SNIL++ + + K+ DFG S + + T + GT Y
Sbjct: 116 LTYLYNVHRI--MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTY 168
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
+ PE + ++T KSDV+S G+ ++EL G+ P + D
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPF--AFSNID 208
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 1e-21
Identities = 77/299 (25%), Positives = 127/299 (42%), Gaps = 49/299 (16%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNV--EQFINEVVILSQINHR 147
+ Y ++G+G G V K A G IVA+KK K ++ + + EV +L Q+ H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP----------ITWEMRLRIAI 197
N+V L LV+E++ L + E P W++ L+
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVE-----RTLLELLEASPGGLPPDAVRSYIWQL-LQ--- 111
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD-QTHLTTRVQG 256
A++Y HS I HRDIK NIL+ + K+ DFG +R ++ + LT V
Sbjct: 112 ----AIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-A 163
Query: 257 TFGYLDPEYF-RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED-----RSLVGFFL 310
T Y PE + + + DV++ G ++ ELL G+ P+ D++ D + +G
Sbjct: 164 TRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE-PLFPGDSDIDQLYLIQKCLGPLP 222
Query: 311 QAMNED----------RLFEVLEARVLKEGKEEEIITVAM-LGKRCLNMIGKKRPSMKE 358
+ E E + L+ ++ + A+ K CL M K+R + E
Sbjct: 223 PSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-21
Identities = 74/275 (26%), Positives = 129/275 (46%), Gaps = 30/275 (10%)
Query: 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNV-----EQFINEVVILSQINHRNVV 150
++LG G GTVYKG+ DG V + + V N ++ ++E +++ + V
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+LLG CL S V L V + +P G L Y+ + + I + L ++++ MSYL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDR--IGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSS 269
+ + HRD+ + N+L+ K++DFG +R + +D+T + + ++ E
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR 186
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328
+FT +SDV+S+GV + EL+T G KP A E + ++LE
Sbjct: 187 RFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----------------IPDLLEKGERL 230
Query: 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363
I V M+ +C + + RP +E+ E
Sbjct: 231 PQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEF 265
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 2e-21
Identities = 75/289 (25%), Positives = 130/289 (44%), Gaps = 45/289 (15%)
Query: 99 LGQGGQGTVYKGMLADGG-----IVAVKKSKLVDESNVEQ---FINEVVILSQINHRNVV 150
LG+ G +YKG L G +VA+K K D +N +Q F E ++++++H N+V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYL--------------HDQTEEFPITWEMRLRIA 196
LLG + + +++E++ G L+ +L D T + + L IA
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQ 255
I+++ M YL S + H+D+ + NIL+ ++ K+SD G SR I D + +
Sbjct: 131 IQIAAGMEYLSSHFFV---HKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187
Query: 256 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMN 314
++ PE +F+ SD++SFGVVL E+ + G +P +E
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------------- 234
Query: 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363
+ E++ R L E+ + L C +RP K++ L
Sbjct: 235 ---VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRL 280
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-21
Identities = 83/288 (28%), Positives = 139/288 (48%), Gaps = 39/288 (13%)
Query: 97 RILGQGGQGTVYKGML-ADGGI--VAVKKSKLV--DESNVEQFINEVVILSQINHRNVVK 151
+ LG+G G+V +G L D I VAVK K+ S +E F++E V + + +H NV++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 152 LLGCCL---ESE---VPLLVYEFIPNGTLYHY-----LHDQTEEFPITWEMRLRIAIEVS 200
L+G CL ESE P+++ F+ +G L+ + L D + P +M ++ +++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPT--QMLVKFMTDIA 122
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV-QGTFG 259
M YL S + I HRD+ + N +L++ V+DFG S+ I + R+ +
Sbjct: 123 SGMEYLSSKSFI---HRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318
++ E +T KSDV+SFGV + E+ T GQ P + E + +L+ N
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE----IYDYLRQGNR--- 232
Query: 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
LK+ + + + L C + K RPS + + ELE
Sbjct: 233 --------LKQ-PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-21
Identities = 77/270 (28%), Positives = 125/270 (46%), Gaps = 27/270 (10%)
Query: 99 LGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVE-QFINEVVILSQINHRNVVKLLGCC 156
+G+G G V+ G L AD VAVK + +++ +F+ E IL Q +H N+V+L+G C
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ + +V E + G +L +TE + + +++ + M YL S I H
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFL--RTEGPRLKVKELIQMVENAAAGMEYLESKHCI---H 117
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT--RVQGTFGYLDPEYFRSSQFTEK 274
RD+ + N L+ +K K+SDFG SR + D + +T Q + PE +++ +
Sbjct: 118 RDLAARNCLVTEKNVLKISDFGMSRE-EEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176
Query: 275 SDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEE 333
SDV+SFG++L E + G P + ++ R E +E V E
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQTR----------------EAIEQGVRLPCPEL 220
Query: 334 EIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363
V L +RC +RPS V EL
Sbjct: 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 68/210 (32%), Positives = 103/210 (49%), Gaps = 20/210 (9%)
Query: 91 DNYNANRILGQGGQGTVYKGMLAD----GGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
D++ + LG G G V ML G A+K K+K+V VE +NE IL
Sbjct: 1 DDFEFIKTLGTGSFGRV---MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS 57
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
I H +V L G + LV E++P G L+ +L ++ FP A +V A+
Sbjct: 58 IRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFY--AAQVVLAL 114
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
YLHS I +RD+K N+LLD K++DFG ++ +K +T+ GT YL P
Sbjct: 115 EYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-GRTYTLC---GTPEYLAP 167
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
E S + + D ++ G+++ E+L G P
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 3e-21
Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 30/229 (13%)
Query: 115 GGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVPLLVYEFIPN 171
G VAVK K +++ E+ IL + H N+VK G C E L+ EF+P+
Sbjct: 33 GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92
Query: 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR 231
G+L YL + I + +L+ A+++ M YL S + HRD+ + N+L++ +++
Sbjct: 93 GSLKEYLPRNKNK--INLKQQLKYAVQICKGMDYLGSRQYV---HRDLAARNVLVESEHQ 147
Query: 232 AKVSDFGASRTIKVDQTHLTTR--VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
K+ DFG ++ I+ D+ + T + + + PE S+F SDV+SFGV L ELLT
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
Query: 290 GQKPIRSTDAEEDRSLVGFFLQ-------AMNEDRLFEVLEARVLKEGK 331
+ + S + FL+ M RL RVL+EGK
Sbjct: 208 Y--------CDSESSPMTLFLKMIGPTHGQMTVTRL-----VRVLEEGK 243
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 4e-21
Identities = 65/221 (29%), Positives = 110/221 (49%), Gaps = 17/221 (7%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL----VDESNVEQFINEVVILSQINH 146
Y R++G+G G V+ AD +V +K+ + DE Q NE +L ++H
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQ--NECQVLKLLSH 58
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
N+++ LE + ++V E+ P GTL Y+ + + + L +++ A+ ++
Sbjct: 59 PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSL-LDEDTILHFFVQILLALHHV 117
Query: 207 HSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
H+ I HRD+K+ NILLD K K+ DFG S+ + T V GT Y+ PE
Sbjct: 118 HTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT--VVGTPCYISPEL 172
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV 306
+ +KSD+++ G VL EL + + R+ +A +LV
Sbjct: 173 CEGKPYNQKSDIWALGCVLYELASLK---RAFEAANLPALV 210
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 4e-21
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 35/210 (16%)
Query: 98 ILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
LG+G G+VYK + + G V K V+E ++ I E+ IL Q + +VK G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL-QEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 158 ESEVPLLVYEF-----------IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA---M 203
++ +V E+ I N TL TEE IA + +
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTL-------TEE---------EIAAILYQTLKGL 112
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
YLHS I HRDIK+ NILL+++ +AK++DFG S D V GT ++ P
Sbjct: 113 EYLHSNKKI---HRDIKAGNILLNEEGQAKLADFGVS-GQLTDTMAKRNTVIGTPFWMAP 168
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
E + + K+D++S G+ +E+ G+ P
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.5 bits (228), Expect = 5e-21
Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 25/210 (11%)
Query: 99 LGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVK 151
+ +G G V+ LA G I A+K K+ ++ ++ V+Q + E ILSQ VVK
Sbjct: 1 ISKGAYGRVF---LAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57
Query: 152 LLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
L + + L LV E++P G L L R+ IA E+ A+ YLHS
Sbjct: 58 LY-YSFQGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDV-ARIYIA-EIVLALEYLHS-- 111
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ-------THLTTRVQGTFGYLDP 263
I HRD+K NIL+D K++DFG S+ V + R+ GT Y+ P
Sbjct: 112 -NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP 170
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
E ++ D +S G +L E L G P
Sbjct: 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 5e-21
Identities = 81/288 (28%), Positives = 140/288 (48%), Gaps = 36/288 (12%)
Query: 97 RILGQGGQGTVYKGMLA--DGGI--VAVK--KSKLVDESNVEQFINEVVILSQINHRNVV 150
R+LG+G G+V + L DG VAVK K+ + S++E+F+ E + + +H NV+
Sbjct: 5 RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 151 KLLGCCLESE------VPLLVYEFIPNGTLYHY-LHDQTEEFPITWEMR--LRIAIEVSG 201
KL+G L S +P+++ F+ +G L+ + L + E P T ++ +R I+++
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIAS 124
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQGTFGY 260
M YL S I HRD+ + N +L++ V+DFG S+ I D + +
Sbjct: 125 GMEYLSSKNFI---HRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKW 181
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319
L E + +T SDV++FGV + E++T GQ P + E + +L N RL
Sbjct: 182 LALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYN----YLIKGN--RLK 235
Query: 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367
+ + E++ + +C + K RPS + + +LE I
Sbjct: 236 QPPDCL-------EDVYELMC---QCWSPEPKCRPSFQHLRDQLELIW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 12/204 (5%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV 149
DN+ +G+G G V + G VAVKK L + E NEVVI+ H N+
Sbjct: 22 DNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNI 78
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
V++ L + +V EF+ G L D + E + + V A+S+LH+
Sbjct: 79 VEMYSSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ 134
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
I HRDIKS +ILL R K+SDFG + + + V GT ++ PE
Sbjct: 135 GVI---HRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPEVISRL 190
Query: 270 QFTEKSDVYSFGVVLVELLTGQKP 293
+ + D++S G++++E++ G+ P
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-20
Identities = 75/274 (27%), Positives = 125/274 (45%), Gaps = 29/274 (10%)
Query: 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINE 137
KL T + + Y +GQG GTV+ + +A G VA+K+ L + E INE
Sbjct: 7 KLRTIVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINE 66
Query: 138 VVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI 197
++++ ++ + N+V L L + +V E++ G+L D E + +
Sbjct: 67 ILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCR 122
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT 257
E A+ +LH+ I HRDIKS N+LL K++DFG I +Q+ +T V GT
Sbjct: 123 ECLQALEFLHANQVI---HRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 178
Query: 258 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN--- 314
++ PE + K D++S G++ +E++ G+ P + + L +L A N
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLN-----ENPLRALYLIATNGTP 233
Query: 315 ------------EDRLFEVLEARVLKEGKEEEII 336
D L LE V K G +E++
Sbjct: 234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 59/209 (28%), Positives = 103/209 (49%), Gaps = 16/209 (7%)
Query: 98 ILGQGGQGTVYKGM-LADGGIVAVKKSKL-VDESNVEQFINEVVILSQINH---RNVVKL 152
++G+G G VY+G + G +VA+K L + +V EV +LSQ+ N+ K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATS 211
G L+ ++ E+ G++ + E I+ +R EV A+ Y+H
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIR-----EVLVALKYIHKV-- 120
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ- 270
+ HRDIK++NIL+ + K+ DFG + + + + +T V GT ++ PE +
Sbjct: 121 -GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYWMAPEVITEGKY 178
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
+ K+D++S G+ + E+ TG P DA
Sbjct: 179 YDTKADIWSLGITIYEMATGNPPYSDVDA 207
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 90.3 bits (225), Expect = 2e-20
Identities = 62/216 (28%), Positives = 95/216 (43%), Gaps = 27/216 (12%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFIN-----EVVILSQIN 145
Y + LG+G VYK G IVA+KK KL + + IN E+ +L ++
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF------PITWEMRLRIAIEV 199
H N++ LL LV+EF+ L + D++ M LR
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME-TDLEKVIKDKSIVLTPADIKSYML-MTLR----- 113
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
+ YLHS I HRD+K +N+L+ K++DFG +R+ +T +V T
Sbjct: 114 --GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRW 167
Query: 260 YLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
Y PE F + + D++S G + ELL + P
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF 202
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 76/297 (25%), Positives = 128/297 (43%), Gaps = 52/297 (17%)
Query: 98 ILGQGGQGTVYKGMLAD------GGIVAVKKSKL-VDESNVEQFINEVVILSQI-NHRNV 149
LG+G G V K VAVK K E ++ ++E+ ++ I H+N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 150 VKLLGCCLESEVPLLVYEFI-------------PNGTLYHYLHDQTEEFPITWEMRLRIA 196
+ LLG C + +V E+ P G + E +T + + A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK-VDQTHLTTRVQ 255
+V+ M +L S I HRD+ + N+L+ + + K++DFG +R I +D TT +
Sbjct: 139 YQVARGMEFLASKKCI---HRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR 195
Query: 256 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMN 314
++ PE +T +SDV+SFGV+L E+ T G P EE
Sbjct: 196 LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE------------- 242
Query: 315 EDRLFEVLEARVLKEGKEEE-----IITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
LF+ +LKEG E + L + C + + +RP+ K++ +L+ +
Sbjct: 243 ---LFK-----LLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 2e-20
Identities = 72/249 (28%), Positives = 118/249 (47%), Gaps = 19/249 (7%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
+GQG GTVY + +A G VA+K+ L + E INE++++ + + N+V L L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 86
Query: 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217
+ +V E++ G+L D E + + E A+ +LHS I HR
Sbjct: 87 VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSNQVI---HR 139
Query: 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 277
DIKS NILL K++DFG I +Q+ +T V GT ++ PE + K D+
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 198
Query: 278 YSFGVVLVELLTGQKPIRSTDAEEDRSLVGF----------FLQAMNEDRLFEVLEARVL 327
+S G++ +E++ G+ P + + L+ L A+ D L LE V
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVD 258
Query: 328 KEGKEEEII 336
+ G +E++
Sbjct: 259 RRGSAKELL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 4e-20
Identities = 63/215 (29%), Positives = 103/215 (47%), Gaps = 21/215 (9%)
Query: 97 RILGQGGQGTVYKGML------ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
R LG+G G V+ D +VAVK K ++ + F E +L+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ-------TEEFP---ITWEMRLRIAIEVS 200
K G C+E + ++V+E++ +G L +L E +T L IA +++
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQGTFG 259
M YL S + HRD+ + N L+ + K+ DFG SR + D +
Sbjct: 131 AGMVYLASQHFV---HRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
++ PE +FT +SDV+S GVVL E+ T G++P
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-20
Identities = 69/202 (34%), Positives = 104/202 (51%), Gaps = 19/202 (9%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE 158
LG G G V+ G VAVK K S E F+ E I+ ++ H +V+L
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVV-- 70
Query: 159 SEVPL-LVYEFIPNGTLYHYLHD---QTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
SE P+ +V E++ G+L +L D + + P +M A +V+ M+Y+ I
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDM----AAQVAAGMAYIERMNYI-- 124
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSSQFT 272
HRD++S+NIL+ D K++DFG +R I + T R F + PE +FT
Sbjct: 125 -HRDLRSANILVGDGLVCKIADFGLARLI--EDNEYTARQGAKFPIKWTAPEAALYGRFT 181
Query: 273 EKSDVYSFGVVLVELLT-GQKP 293
KSDV+SFG++L EL+T G+ P
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 89.2 bits (221), Expect = 4e-20
Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 98 ILGQGGQGTVYKGMLADGG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKL 152
++G G G V +G L G VA+K K E F++E I+ Q +H N++ L
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
G +S +++ EF+ NG L +L +F + + + I + M YL +
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGI--AAGMKYLSEMNYV 128
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG------YLDPEYF 266
HRD+ + NIL++ KVSDFG SR ++ D + T + G + PE
Sbjct: 129 ---HRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAPEAI 183
Query: 267 RSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 4e-20
Identities = 69/277 (24%), Positives = 125/277 (45%), Gaps = 30/277 (10%)
Query: 25 SGLGLFILLIGMWGLRKFVKRRREIKLKRMFFKKNGGLLLQQQLSSNEGNIEKTKLFTKM 84
LG F++L + F++ R ++LKR ++ + + E +K+ +
Sbjct: 634 CTLGAFLVLALVAFGFVFIRGRNNLELKR----------VENEDGTWELQFFDSKVSKSI 683
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGGI-VAVKKSKLVDESNVEQFINEVVILSQ 143
+ + ++ +G +G YKG G+ VK+ V+ S I + + +
Sbjct: 684 TINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVN-SIPSSEIAD---MGK 739
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
+ H N+VKL+G C + L++E+I L L + ++WE R +IAI ++ A+
Sbjct: 740 LQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKAL 793
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
+LH S + ++ I++D K + + D + Y+ P
Sbjct: 794 RFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAP 847
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300
E + TEKSD+Y FG++L+ELLTG+ P DAE
Sbjct: 848 ETRETKDITEKSDIYGFGLILIELLTGKSP---ADAE 881
|
Length = 968 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 4e-20
Identities = 59/197 (29%), Positives = 104/197 (52%), Gaps = 9/197 (4%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE 158
LGQG G V+ G VA+K K S E F+ E ++ ++ H +V+L
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV-- 70
Query: 159 SEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217
SE P+ +V E++ G+L +L + ++ + + +A +++ M+Y+ + HR
Sbjct: 71 SEEPIYIVTEYMSKGSLLDFLKGEMGKY-LRLPQLVDMAAQIASGMAYVERMNYV---HR 126
Query: 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 277
D++++NIL+ + KV+DFG +R I+ ++ + + PE +FT KSDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 278 YSFGVVLVELLT-GQKP 293
+SFG++L EL T G+ P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 5e-20
Identities = 78/262 (29%), Positives = 125/262 (47%), Gaps = 23/262 (8%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
+GQG GTVY M +A G VA+++ L + E INE++++ + + N+V L L
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217
+ +V E++ G+L D E + + E A+ +LHS I HR
Sbjct: 88 VGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSNQVI---HR 140
Query: 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 277
DIKS NILL K++DFG I +Q+ +T V GT ++ PE + K D+
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPKVDI 199
Query: 278 YSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIIT 337
+S G++ +E++ G+ P + + L +L A N L+ ++ I
Sbjct: 200 WSLGIMAIEMIEGEPPYLN-----ENPLRALYLIATN--------GTPELQNPEKLSAIF 246
Query: 338 VAMLGKRCLNMIGKKRPSMKEV 359
L RCL+M +KR S KE+
Sbjct: 247 RDFL-NRCLDMDVEKRGSAKEL 267
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 6e-20
Identities = 81/285 (28%), Positives = 130/285 (45%), Gaps = 42/285 (14%)
Query: 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD----ESNVEQF 134
+LFTK++ RI G+G G VYKG+ D V K++D E +E
Sbjct: 4 ELFTKLE-----------RI-GKGSFGEVYKGI--DNRTKEVVAIKIIDLEEAEDEIEDI 49
Query: 135 INEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR 194
E+ +LSQ + + + G L+ ++ E++ G+ D + P+
Sbjct: 50 QQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL----DLLKPGPLEETYIAT 105
Query: 195 IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254
I E+ + YLHS I HRDIK++N+LL ++ K++DFG + + Q T V
Sbjct: 106 ILREILKGLDYLHSERKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV 162
Query: 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314
GT ++ PE + S + K+D++S G+ +EL G+ P ++D R L FL N
Sbjct: 163 -GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP--NSDLHPMRVL---FLIPKN 216
Query: 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
E ++ KE E CLN + RP+ KE+
Sbjct: 217 SPPTLEGQYSKPFKEFVEA-----------CLNKDPRFRPTAKEL 250
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 6e-20
Identities = 57/212 (26%), Positives = 105/212 (49%), Gaps = 24/212 (11%)
Query: 98 ILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESN----------VEQFINEVVILSQINH 146
++G+G G VY + G ++AVK+ +L V+ +E+ L ++H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYL--HDQTEEFPITWEMRLRIAIEVSGAMS 204
N+V+ LG E + E++P G++ L + + EE ++ +V ++
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-----QLVRFFTEQVLEGLA 122
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR-TIKVDQTHLTTRVQGTFGYLDP 263
YLHS I HRD+K+ N+L+D K+SDFG S+ + + +QG+ ++ P
Sbjct: 123 YLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179
Query: 264 EYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 293
E S ++ K D++S G V++E+ G++P
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 7e-20
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 11/197 (5%)
Query: 99 LGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
+G+G G V + + G +VAVKK L + E NEVVI+ H NVV++ L
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 158 ESEVPLLVYEFIPNGTLYHYL-HDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ +V EF+ G L + H + E I + + V A+S LH+ I H
Sbjct: 88 VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHAQGVI---H 139
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 276
RDIKS +ILL R K+SDFG + + + V GT ++ PE + + D
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPEVD 198
Query: 277 VYSFGVVLVELLTGQKP 293
++S G++++E++ G+ P
Sbjct: 199 IWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 7e-20
Identities = 58/194 (29%), Positives = 102/194 (52%), Gaps = 12/194 (6%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE 158
LG G G V+ G VA+K K S E F+ E ++ Q+ H +V+L +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVVTQ 72
Query: 159 SEVPLLVYEFIPNGTLYHYLHDQTEE-FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217
+ ++ E++ NG+L +L +T E +T + +A +++ M+++ I HR
Sbjct: 73 EPI-YIITEYMENGSLVDFL--KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYI---HR 126
Query: 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSSQFTEKS 275
D++++NIL+ + K++DFG +R I+ ++ T R F + PE FT KS
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNE--YTAREGAKFPIKWTAPEAINYGTFTIKS 184
Query: 276 DVYSFGVVLVELLT 289
DV+SFG++L E++T
Sbjct: 185 DVWSFGILLTEIVT 198
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 8e-20
Identities = 61/199 (30%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDESN--VEQFINEVVILSQINHRNVVKLLGC 155
+G+G G VYK + +VA+K L +E+ +E E+ LSQ + K G
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDL-EEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
L+ ++ E+ G+ L +E I + +R EV + YLH I
Sbjct: 68 FLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILR-----EVLLGLEYLHEEGKI-- 120
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
HRDIK++NILL ++ K++DFG S + + T V GT ++ PE + S + EK
Sbjct: 121 -HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEVIKQSGYDEK 178
Query: 275 SDVYSFGVVLVELLTGQKP 293
+D++S G+ +EL G+ P
Sbjct: 179 ADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 88.6 bits (220), Expect = 1e-19
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 19/207 (9%)
Query: 96 NRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF--INEVVILSQINHRNVVKL 152
NRI G+G G VY+ G IVA+KK ++ +E + + E+ +L + H N+V+L
Sbjct: 13 NRI-GEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVEL 71
Query: 153 L----GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
G L+S LV E+ L L + F + +++ + +++ + YLH
Sbjct: 72 KEVVVGKHLDS--IFLVMEYCEQ-DLASLLDNMPTPFSES-QVKC-LMLQLLRGLQYLHE 126
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-YFR 267
I HRD+K SN+LL DK K++DFG +RT + +T +V T Y PE
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLG 182
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPI 294
+ +T D+++ G +L ELL KP+
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAH-KPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 1e-19
Identities = 74/260 (28%), Positives = 129/260 (49%), Gaps = 31/260 (11%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGMLADGGI-------VAVKKSKLVDESNVE----QFI 135
E A + +R LGQG G VY+G +A G + VA+K V+E+ +F+
Sbjct: 2 EVAREKITMSRELGQGSFGMVYEG-IAKGVVKDEPETRVAIKT---VNEAASMRERIEFL 57
Query: 136 NEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYL-------HDQTEEFPIT 188
NE ++ + N +VV+LLG + + L++ E + G L YL + + P +
Sbjct: 58 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPS 117
Query: 189 WEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQ 247
+ +++A E++ M+YL++ + HRD+ + N ++ + + K+ DFG +R I + D
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY 174
Query: 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLV 306
+ ++ PE + FT SDV+SFGVVL E+ T ++P + E+ V
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
Query: 307 --GFFLQAMNE--DRLFEVL 322
G L + D LFE++
Sbjct: 235 MEGGLLDKPDNCPDMLFELM 254
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 20/214 (9%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGI-VAVKKSKLVDES-----NVEQFINEVVILSQIN 145
N+ ++LGQG G VY D G +A K+ + ES V E+ +L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 146 HRNVVKLLGCCLE-SEVPLLVY-EFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGA 202
H +V+ GC + +E L ++ E++P G++ DQ + + +T + + ++
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSV----KDQLKAYGALTESVTRKYTRQILEG 118
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR---TIKVDQTHLTTRVQGTFG 259
MSYLHS I HRDIK +NIL D K+ DFGAS+ TI + T + + V GT
Sbjct: 119 MSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS-VTGTPY 174
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
++ PE + K+DV+S G +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 13/205 (6%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVK 151
+++G G G V G L G VA+K K E F++E I+ Q +H N++
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
L G +S+ ++V E++ NG+L +L +F + + + I + M YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGI--ASGMKYLSDMGY 127
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG--YLDPEYFRSS 269
+ HRD+ + NIL++ KVSDFG SR ++ D T G + PE
Sbjct: 128 V---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR 184
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKP 293
+FT SDV+S+G+V+ E+++ G++P
Sbjct: 185 KFTSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 2e-19
Identities = 83/285 (29%), Positives = 126/285 (44%), Gaps = 42/285 (14%)
Query: 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD----ESNVEQF 134
+LFTK LEK +G+G G V+KG+ D V K++D E +E
Sbjct: 4 ELFTK--LEK----------IGKGSFGEVFKGI--DNRTQKVVAIKIIDLEEAEDEIEDI 49
Query: 135 INEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR 194
E+ +LSQ + V K G L+ ++ E++ G+ D E P+
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIAT 105
Query: 195 IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254
I E+ + YLHS I HRDIK++N+LL + K++DFG + + Q T V
Sbjct: 106 ILREILKGLDYLHSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162
Query: 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314
GT ++ PE + S + K+D++S G+ +EL G+ P E + FL N
Sbjct: 163 -GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPP-----HSELHPMKVLFLIPKN 216
Query: 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
E ++ LKE E CLN RP+ KE+
Sbjct: 217 NPPTLEGNYSKPLKEFVEA-----------CLNKEPSFRPTAKEL 250
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 2e-19
Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 10/197 (5%)
Query: 99 LGQGGQGTVYK-GMLADGGIVAVKK--SKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
+G+G G V+K G VA+KK + ++ Q + E+ L H VVKLL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
+LV E++P L L D EE P+ + ++Y+H+ I
Sbjct: 68 FPHGSGFVLVMEYMP-SDLSEVLRD--EERPLPEAQVKSYMRMLLKGVAYMHANG---IM 121
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-YFRSSQFTEK 274
HRD+K +N+L+ K++DFG +R ++ L + T Y PE + + ++
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 275 SDVYSFGVVLVELLTGQ 291
D+++ G + ELL G
Sbjct: 182 VDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 88.1 bits (218), Expect = 2e-19
Identities = 59/215 (27%), Positives = 107/215 (49%), Gaps = 18/215 (8%)
Query: 97 RILGQGGQGTVYKGMLADGG-----IVAVKKSKLVDESNVEQFI-NEVVILSQINHRNVV 150
++LG G GTVYKG+ G VA+K+ + + I +E +++ +++ +V
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+LLG CL S V L + + +P G L Y+ + + + L ++++ M+YL
Sbjct: 73 RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQY--LLNWCVQIAKGMNYLEERR 129
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG---TFGYLDPEYFR 267
+ HRD+ + N+L+ K++DFG ++ + D+ +G ++ E
Sbjct: 130 ---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEY--HAEGGKVPIKWMALESIL 184
Query: 268 SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301
+T +SDV+S+GV + EL+T G KP A E
Sbjct: 185 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 219
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 2e-19
Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 9/196 (4%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
+G+G G V G VAVK L + E NEVVI+ H+NVV++ L
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88
Query: 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217
E ++ EF+ G L D + + E + V A+ YLHS I HR
Sbjct: 89 VGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQGVI---HR 141
Query: 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 277
DIKS +ILL R K+SDFG I D + V GT ++ PE + + + D+
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTEVDI 200
Query: 278 YSFGVVLVELLTGQKP 293
+S G++++E++ G+ P
Sbjct: 201 WSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 2e-19
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 10/215 (4%)
Query: 84 MDLEKATDNYNANRILGQGGQGTVYKGMLADGGI-VAVKKSKLVDESNVEQFINEVVILS 142
++ E D +LG+G G VY + +A+K+ D V+ E+ + S
Sbjct: 1 LEYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHS 60
Query: 143 QINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA 202
+ HRN+V+ LG E+ + E +P G+L L + + + ++
Sbjct: 61 YLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEG 120
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRA--KVSDFGASRTIKVDQTHLTTRVQGTFGY 260
+ YLH I HRDIK N+L+ + Y K+SDFG S+ + T GT Y
Sbjct: 121 LKYLHDNQ---IVHRDIKGDNVLV-NTYSGVVKISDFGTSKRL-AGINPCTETFTGTLQY 175
Query: 261 LDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 293
+ PE + +D++S G +VE+ TG+ P
Sbjct: 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 69/214 (32%), Positives = 109/214 (50%), Gaps = 20/214 (9%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGI-VAVKKSKLVDES-----NVEQFINEVVILSQIN 145
N+ ++LGQG G VY AD G +AVK+ + ES V E+ +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 146 HRNVVKLLGCCLES-EVPLLVY-EFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGA 202
H +V+ GC + E L ++ E +P G++ DQ + + +T + + ++
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSI----KDQLKSYGALTENVTRKYTRQILEG 118
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR---TIKVDQTHLTTRVQGTFG 259
+SYLHS I HRDIK +NIL D K+ DFGAS+ TI + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS-VTGTPY 174
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
++ PE + K+D++S G +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-19
Identities = 53/187 (28%), Positives = 97/187 (51%), Gaps = 20/187 (10%)
Query: 117 IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLY 175
+VAVK + V ++ F+ E+ I+S++ + N+++LLG C+ + ++ E++ NG L
Sbjct: 46 LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 176 HYLHDQ--------TEEFP-ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL 226
+L + P ++ L +A++++ M YL S+ HRD+ + N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLV 162
Query: 227 DDKYRAKVSDFGASRTIKVDQTHLTTRVQG----TFGYLDPEYFRSSQFTEKSDVYSFGV 282
+ Y K++DFG SR + + R+QG ++ E +FT SDV++FGV
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219
Query: 283 VLVELLT 289
L E+ T
Sbjct: 220 TLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 66/220 (30%), Positives = 108/220 (49%), Gaps = 28/220 (12%)
Query: 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD----ESNVEQF 134
+LFTK++ RI G+G G V+KG+ D V K++D E +E
Sbjct: 4 ELFTKLE-----------RI-GKGSFGEVFKGI--DNRTQQVVAIKIIDLEEAEDEIEDI 49
Query: 135 INEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRL 193
E+ +LSQ + V K G L+ ++ E++ G+ L +EF I ++
Sbjct: 50 QQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK- 108
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
E+ + YLHS I HRDIK++N+LL ++ K++DFG + + Q T
Sbjct: 109 ----EILKGLDYLHSEKKI---HRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161
Query: 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
V GT ++ PE + S + K+D++S G+ +EL G+ P
Sbjct: 162 V-GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 57/200 (28%), Positives = 102/200 (51%), Gaps = 10/200 (5%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
+ LG G G V+ G + VAVK K S V+ F+ E ++ + H +V+L
Sbjct: 12 KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ E ++ E++ G+L +L E + + + +++ M+Y+ I H
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKNYI---H 126
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSSQFTEK 274
RD++++N+L+ + K++DFG +R I+ ++ T R F + PE FT K
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 275 SDVYSFGVVLVELLT-GQKP 293
SDV+SFG++L E++T G+ P
Sbjct: 185 SDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 29/269 (10%)
Query: 99 LGQGGQGTVYKGMLADGGI-VAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
+G+G G V G VAVKK L + E NEVVI+ +H NVV + L
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89
Query: 158 ESEVPLLVYEFIPNGTLYHYL-HDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ +V EF+ G L + H + E E + + V A+SYLH+ I H
Sbjct: 90 VGDELWVVMEFLEGGALTDIVTHTRMNE-----EQIATVCLSVLRALSYLHNQGVI---H 141
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 276
RDIKS +ILL R K+SDFG + + + V GT ++ PE + + D
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTEVD 200
Query: 277 VYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEII 336
++S G++++E++ G+ P + LQAM R+ + L RV ++
Sbjct: 201 IWSLGIMVIEMIDGEPPYFNEPP----------LQAMR--RIRDNLPPRV------KDSH 242
Query: 337 TVAMLGKRCLNMIGKKRPSMKEVAFELEG 365
V+ + + L+++ + PS + A EL
Sbjct: 243 KVSSVLRGFLDLMLVREPSQRATAQELLQ 271
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 4e-19
Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 19/231 (8%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGMLAD---GGIVAVKKSKLVDES----NVEQFINEVV 139
E + + R LGQG G VY+G D G K V+ES +F+NE
Sbjct: 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61
Query: 140 ILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYL-------HDQTEEFPITWEMR 192
++ +VV+LLG + + L+V E + +G L YL + P T +
Sbjct: 62 VMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEM 121
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTHLT 251
+++A E++ M+YL++ + HRD+ + N ++ + K+ DFG +R I + D
Sbjct: 122 IQMAAEIADGMAYLNAKKFV---HRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKG 178
Query: 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301
+ ++ PE + FT SD++SFGVVL E+ + ++P + E+
Sbjct: 179 GKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 6e-19
Identities = 57/193 (29%), Positives = 98/193 (50%), Gaps = 27/193 (13%)
Query: 117 IVAVKKSKLVDESNVEQ-FINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL- 174
+VAVK + N F+ EV ILS++ N+++LLG C++ + ++ E++ NG L
Sbjct: 48 LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 175 ----YHYLHDQTEE-----------FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDI 219
H+L D+ E I++ L +A++++ M YL +S+ HRD+
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDL 164
Query: 220 KSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG----TFGYLDPEYFRSSQFTEKS 275
+ N L+ + K++DFG SR + + R+QG ++ E +FT S
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYY---RIQGRAVLPIRWMAWECILMGKFTTAS 221
Query: 276 DVYSFGVVLVELL 288
DV++FGV L E+L
Sbjct: 222 DVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 9e-19
Identities = 72/237 (30%), Positives = 114/237 (48%), Gaps = 39/237 (16%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQF----INEVVIL 141
++ D ++ +G+G G VYK D G +VA+KK +L +E E F I E+ IL
Sbjct: 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60
Query: 142 SQINHRNVVKLLGCCLESEVPL----------LVYEFIPN-------GTLYHYLHDQTEE 184
Q+NHRN+V L + + L LV+E++ + L H+ D +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 185 FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244
F M+ ++ ++Y H + HRDIK SNILL++K + K++DFG +R
Sbjct: 121 F-----MK-----QLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYN 167
Query: 245 VDQTHLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300
+++ T T Y PE + + DV+S G +L EL T +KPI + E
Sbjct: 168 SEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPIFQANQE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 74/273 (27%), Positives = 126/273 (46%), Gaps = 46/273 (16%)
Query: 118 VAVKKSKL-VDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGTLY 175
VAVK K E ++ I+E+ ++ I H+N++ LLG C + ++ E+ G L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 176 HYLH-------------DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSS 222
YL Q E ++++ + A +V+ M YL S I HRD+ +
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCI---HRDLAAR 169
Query: 223 NILLDDKYRAKVSDFGASRTIK-VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFG 281
N+L+ + K++DFG +R I +D TT + ++ PE +T +SDV+SFG
Sbjct: 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG 229
Query: 282 VVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIIT--- 337
V+L E+ T G P EE LF ++LKEG + +
Sbjct: 230 VLLWEIFTLGGSPYPGVPVEE----------------LF-----KLLKEGHRMDKPSNCT 268
Query: 338 --VAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368
+ M+ + C + + +RP+ K++ +L+ I A
Sbjct: 269 NELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 20/214 (9%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGI-VAVKKSKL-VDESNVEQFIN----EVVILSQIN 145
N+ ++LG+G G VY AD G +AVK+ D + +N E+ +L +
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 146 HRNVVKLLGCCLESEVPLL--VYEFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGA 202
H +V+ GC + E L E++P G++ DQ + + +T + R ++
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSI----KDQLKAYGALTENVTRRYTRQILQG 118
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR---TIKVDQTHLTTRVQGTFG 259
+SYLHS I HRDIK +NIL D K+ DFGAS+ TI + T + + V GT
Sbjct: 119 VSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS-VTGTPY 174
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
++ PE + K+DV+S +VE+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNV--EQFINEVVILSQINHRNVVKLLG 154
LG+G G+V K L + G++ K+ D + +Q + E+ I +VK G
Sbjct: 7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66
Query: 155 CCL---ESEVPLLVYEFIPNGTL---YHYLHDQ---TEEFPITWEMRLRIAIEVSGAMSY 205
L S + + + E+ G+L Y + + E + +IA V +SY
Sbjct: 67 AFLDESSSSIGIAM-EYCEGGSLDSIYKKVKKRGGRIGEKVL-----GKIAESVLKGLSY 120
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG----YL 261
LHS I HRDIK SNILL K + K+ DFG S L + GTF Y+
Sbjct: 121 LHSRKII---HRDIKPSNILLTRKGQVKLCDFGVS-------GELVNSLAGTFTGTSFYM 170
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
PE + ++ SDV+S G+ L+E+ + P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 70/221 (31%), Positives = 116/221 (52%), Gaps = 23/221 (10%)
Query: 97 RILGQGGQGTVY---KGMLADGGIV----AVKKSKLVDESNVEQFINEVVILSQINHRNV 149
++LGQG G V+ K D G + +KK+ L V E IL+++NH +
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRT-KMERDILAEVNHPFI 60
Query: 150 VKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSGAMSY 205
VKL ++E L L+ +F+ G L+ L + TEE +++ +A E++ A+ +
Sbjct: 61 VKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE-----DVKFYLA-ELALALDH 113
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LHS + I +RD+K NILLD++ K++DFG S+ +D GT Y+ PE
Sbjct: 114 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEV 169
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV 306
T+ +D +SFGV++ E+LTG P + D +E +++
Sbjct: 170 VNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-18
Identities = 61/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 97 RILGQGGQGTVYKGM------LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
R LG+G G V+ D +VAVK K + + F E +L+ + H ++V
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMR-------------LRIAI 197
K G C + + ++V+E++ +G L +L + I + + L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQG 256
+++ M YL S + HRD+ + N L+ K+ DFG SR + D +
Sbjct: 131 QIASGMVYLASQHFV---HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 187
Query: 257 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
++ PE +FT +SDV+SFGV+L E+ T G++P
Sbjct: 188 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 4e-18
Identities = 69/246 (28%), Positives = 120/246 (48%), Gaps = 27/246 (10%)
Query: 98 ILGQGGQGTVYKGMLADGGI-----VAVKKSKLVDESNVEQ---FINEVVILSQINHRNV 149
+L +G G ++ G+L D V VK + D ++ Q + E +L ++H+N+
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKT--VKDHASEIQVTLLLQESCLLYGLSHQNI 70
Query: 150 VKLLGCCLE-SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR------IAIEVSGA 202
+ +L C+E E P ++Y ++ G L +L Q L +AI+++
Sbjct: 71 LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQ-QCRLGEANNPQALSTQQLVHMAIQIACG 129
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYL 261
MSYLH + H+DI + N ++D++ + K++D SR + H L ++
Sbjct: 130 MSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWM 186
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLV--GFFL-QAMN-ED 316
E + +++ SDV+SFGV+L EL+T GQ P D E + + G+ L Q +N D
Sbjct: 187 ALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQPINCPD 246
Query: 317 RLFEVL 322
LF V+
Sbjct: 247 ELFAVM 252
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 7e-18
Identities = 61/197 (30%), Positives = 103/197 (52%), Gaps = 9/197 (4%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE 158
LGQG G V+ G VA+K K E F+ E I+ ++ H +V L
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVV-- 70
Query: 159 SEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217
SE P+ +V EF+ G+L +L + ++ + + +A +++ M+Y+ I HR
Sbjct: 71 SEEPIYIVTEFMGKGSLLDFLKEGDGKY-LKLPQLVDMAAQIADGMAYIERMNYI---HR 126
Query: 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDV 277
D++++NIL+ D K++DFG +R I+ ++ + + PE +FT KSDV
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 278 YSFGVVLVELLT-GQKP 293
+SFG++L EL+T G+ P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 1e-17
Identities = 69/271 (25%), Positives = 122/271 (45%), Gaps = 46/271 (16%)
Query: 118 VAVKKSK-LVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGTLY 175
VAVK K E ++ ++E+ ++ I H+N++ LLG C + ++ E+ G L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 176 HYLH-------------DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSS 222
YL + + +T++ + +V+ M YL S I HRD+ +
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCI---HRDLAAR 166
Query: 223 NILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFG 281
N+L+ + K++DFG +R + +D TT + ++ PE +T +SDV+SFG
Sbjct: 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 226
Query: 282 VVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE-----I 335
V++ E+ T G P EE LF ++LKEG +
Sbjct: 227 VLMWEIFTLGGSPYPGIPVEE----------------LF-----KLLKEGHRMDKPANCT 265
Query: 336 ITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+ M+ + C + I RP+ K++ +L+ I
Sbjct: 266 NELYMMMRDCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 74/282 (26%), Positives = 133/282 (47%), Gaps = 50/282 (17%)
Query: 118 VAVK--KSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLV-YEFIPNGT 173
VAVK K D+ ++ I+E+ ++ I H+N++ LLG C + E PL V E+ G
Sbjct: 47 VAVKMLKDNATDK-DLADLISEMELMKLIGKHKNIINLLGVCTQ-EGPLYVIVEYAAKGN 104
Query: 174 LYHYLH-----------DQTE--EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220
L +L D T+ E ++++ + A +V+ M YL S I HRD+
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCI---HRDLA 161
Query: 221 SSNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYS 279
+ N+L+ + K++DFG +R + +D T+ + ++ PE +T +SDV+S
Sbjct: 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWS 221
Query: 280 FGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIIT- 337
FG+++ E+ T G P EE LF ++L+EG + +
Sbjct: 222 FGILMWEIFTLGGSPYPGIPVEE----------------LF-----KLLREGHRMDKPSN 260
Query: 338 ----VAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSL 375
+ ML + C + + +RP+ K++ L+ + A++ L
Sbjct: 261 CTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEEYL 302
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 74/243 (30%), Positives = 111/243 (45%), Gaps = 31/243 (12%)
Query: 97 RILGQGGQGTVYKGML-ADGGIVAVKK--SKLVDESNVEQF-INEVVILSQINHRNVVKL 152
R+LG+GG G V + A G + A KK K + + E +NE IL ++N R VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 153 LGCCLESEVPLLVYEFIPNGTL-YHYLHDQTEEFPITWEMR-LRIAIEVSGAMSYLHSAT 210
+ LV + G L +H H F E R + A E+ + LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFE---EGRAVFYAAEICCGLEDLHQER 122
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
I +RD+K NILLDD ++SD G + + QT + RV GT GY+ PE ++ +
Sbjct: 123 ---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNER 177
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330
+T D ++ G +L E++ GQ P + + R V R++KE
Sbjct: 178 YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-----------------ERLVKEV 220
Query: 331 KEE 333
+EE
Sbjct: 221 QEE 223
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-17
Identities = 59/212 (27%), Positives = 99/212 (46%), Gaps = 16/212 (7%)
Query: 97 RILGQGGQGTV----YKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
++LG+G G V KG + +KK ++ + +VE + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 153 LGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSAT 210
L C +++ L V E++ G L ++ ++ F E R R A E+ + +LH
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQ-RSGRFD---EPRARFYAAEIVLGLQFLHERG 116
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRT-IKVDQTHLTTRVQGTFGYLDPEYFRSS 269
I +RD+K N+LLD + K++DFG + I T T+ GT Y+ PE
Sbjct: 117 ---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIAPEILSYQ 171
Query: 270 QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ D ++ GV+L E+L GQ P D +E
Sbjct: 172 PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 1e-17
Identities = 70/235 (29%), Positives = 110/235 (46%), Gaps = 36/235 (15%)
Query: 97 RILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNV 149
R+LG+G G V MLA G + AVK K ++ + +VE + E ILS +
Sbjct: 1 RVLGKGSFGKV---MLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPF 57
Query: 150 VKLLGCCLES-EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLH 207
+ L CC ++ + V EF+ G L ++ ++ F E R R A E++ A+ +LH
Sbjct: 58 LTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQ-KSRRFD---EARARFYAAEITSALMFLH 113
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
I +RD+K N+LLD + K++DFG + + T+ GT Y+ PE +
Sbjct: 114 DKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322
+ D ++ GV+L E+L G P +A NED LFE +
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAP----------------FEAENEDDLFEAI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (202), Expect = 2e-17
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 22/205 (10%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVK--KSKLVDESNVEQFIN--EVVILSQIN-HRNVVKL 152
LG G G+VY G +VA+K K K + E+ +N EV L ++N H N+VKL
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKF---YSWEECMNLREVKSLRKLNEHPNIVKL 63
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEE-FPITWEMRLR-IAIEVSGAMSYLHSAT 210
E++ V+E++ G LY + D+ + F E +R I ++ ++++H
Sbjct: 64 KEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFS---ESVIRSIIYQILQGLAHIHKHG 119
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF-RSS 269
+HRD+K N+L+ K++DFG +R I+ + T V T Y PE RS+
Sbjct: 120 ---FFHRDLKPENLLVSGPEVVKIADFGLAREIR-SRPPYTDYV-STRWYRAPEILLRST 174
Query: 270 QFTEKSDVYSFGVVLVELLTGQKPI 294
++ D+++ G ++ EL T +P+
Sbjct: 175 SYSSPVDIWALGCIMAELYTL-RPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 2e-17
Identities = 66/203 (32%), Positives = 101/203 (49%), Gaps = 25/203 (12%)
Query: 98 ILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE---QFINEVVILSQINHRNVVKLL 153
ILG G GTVYK L I+AVK L + VE Q ++E+ IL + + ++
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPL--DITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRL-RIAIEVSGAMSYLHSATSI 212
G + EF+ G+L D + P E L RIA+ V ++YL S +
Sbjct: 66 GAFFVENRISICTEFMDGGSL-----DVYRKIP---EHVLGRIAVAVVKGLTYLWS---L 114
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTI--KVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
I HRD+K SN+L++ + + K+ DFG S + + +T++ GT Y+ PE Q
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQ 169
Query: 271 FTEKSDVYSFGVVLVELLTGQKP 293
+ SDV+S G+ +EL G+ P
Sbjct: 170 YGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 80.7 bits (200), Expect = 3e-17
Identities = 64/206 (31%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 99 LGQGGQGTVYKGMLADGGIV----AVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLG 154
LG GG G V + VKK +V+ E +E IL + NH +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHD--QTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
+ + ++ E+ G L+ L D +E + R IA V A YLH+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDE----YTARFYIACVVL-AFEYLHN---R 112
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT 272
I +RD+K N+LLD K+ DFG ++ +K Q T GT Y+ PE + +
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT--FCGTPEYVAPEIILNKGYD 170
Query: 273 EKSDVYSFGVVLVELLTGQKPIRSTD 298
D +S G++L ELLTG+ P D
Sbjct: 171 FSVDYWSLGILLYELLTGRPPFGEDD 196
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 3e-17
Identities = 69/237 (29%), Positives = 114/237 (48%), Gaps = 29/237 (12%)
Query: 74 NIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE 132
+ E +LF+K D EK + R +G G G VY + +VA+KK + + E
Sbjct: 1 DPEIAELFSKDDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNE 57
Query: 133 QF---INEVVILSQINHRNVVKLLGCCLESEVPLLVYEF-IPNGTLYHYLHDQTEEFPIT 188
++ I EV L Q+ H N ++ GC L LV E+ + + + +H + P+
Sbjct: 58 KWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKK----PL- 112
Query: 189 WEMRLRIAIEVSGAM---SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245
+ IA GA+ +YLHS I HRDIK+ NILL + K++DFG++ +
Sbjct: 113 --QEVEIAAICHGALQGLAYLHSHERI---HRDIKAGNILLTEPGTVKLADFGSASLVSP 167
Query: 246 DQTHLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
+ + GT ++ PE + Q+ K DV+S G+ +EL + P+ + +A
Sbjct: 168 ANSFV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 4e-17
Identities = 62/203 (30%), Positives = 100/203 (49%), Gaps = 16/203 (7%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKS-KLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
LG G G VYK + G+ A K ++ E +E F+ E+ ILS+ H N+V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR-IAIEVSGAMSYLHSATSIPIYH 216
++ EF G L + + E +T E ++R + ++ A+++LHS I H
Sbjct: 73 YENKLWILIEFCDGGAL-DSIMLELER-GLT-EPQIRYVCRQMLEALNFLHSHKVI---H 126
Query: 217 RDIKSSNILLDDKYRAKVSDFGAS-RTIKVDQTHLTTRVQGTFGYLDPEY-----FRSSQ 270
RD+K+ NILL K++DFG S + Q T GT ++ PE F+ +
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFKDNP 184
Query: 271 FTEKSDVYSFGVVLVELLTGQKP 293
+ K+D++S G+ L+EL + P
Sbjct: 185 YDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 5e-17
Identities = 53/176 (30%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 127 DESNVEQFINEVVILSQINHRNVVKLL--GCCLESEVPLLVYEFIPNGTLYHYLHDQTEE 184
+E +F E + +++ H N+V LL G + V+E++P TL L
Sbjct: 18 EEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYVPGRTLREVLAADG-- 74
Query: 185 FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL---DDKYRAKVSDFGAS- 240
+ R+ ++V A++ H+ I HRD+K NI++ + AKV DFG
Sbjct: 75 -ALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGT 130
Query: 241 -----RTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 291
R V TT V GT Y PE R T SD+Y++G++ +E LTGQ
Sbjct: 131 LLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 7e-17
Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 9/207 (4%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSK---LVDESNVEQFINEVVILSQINHR 147
N+ + +G+G VY+ L DG VA+KK + L+D I E+ +L Q+NH
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYL-HDQTEEFPITWEMRLRIAIEVSGAMSYL 206
NV+K +E +V E G L + H + ++ I + + +++ A+ ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
HS + HRDIK +N+ + K+ D G R T + V GT Y+ PE
Sbjct: 123 HSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPERI 178
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ + KSD++S G +L E+ Q P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 8e-17
Identities = 60/214 (28%), Positives = 108/214 (50%), Gaps = 21/214 (9%)
Query: 92 NYNANRILGQG--GQGTVYKGMLADGGIVAVKKSKL-VDESNVEQFINEVVILSQINHRN 148
YN R++G+G G+ + + + +D A+K+ +L S VE E V+L+++ H N
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQ-KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPN 59
Query: 149 VVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQ-----TEEFPITWEMRLRIAIEVSGA 202
+V E++ L +V E+ G L + Q E+ + W +++ + ++
Sbjct: 60 IVAFKES-FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQ---- 114
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
++H + HRDIKS NI L + K+ DFG++R + + T V GT Y+
Sbjct: 115 --HIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVP 168
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 296
PE + + + KSD++S G +L EL T + P ++
Sbjct: 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 8e-17
Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 10/211 (4%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKK--SKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
LG G G V K G++ +K + + Q I E+ +L + N +V G
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ E + G+L L + I E+ +++I V ++YL I H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIAVLRGLAYLREKHQI--MH 127
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 276
RD+K SNIL++ + K+ DFG S + +D + GT Y+ PE + + ++ +SD
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPERLQGTHYSVQSD 184
Query: 277 VYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307
++S G+ LVEL G+ PI DA+E ++ G
Sbjct: 185 IWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 8e-17
Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 25/209 (11%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVKKSKL-VDESNVEQFINEV-VILSQINHRNVVKLLGC 155
+G+G GTV K + G I+AVK+ + VDE ++ + ++ V++ + +VK G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 156 CLESEVPLLVYEF--IPNGTLYHYLHD-QTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
+ E I Y Y+++ P E+ +IA+ A++YL +
Sbjct: 72 LFREGDCWICMELMDISLDKFYKYVYEVLKSVIP--EEILGKIAVATVKALNYLK--EEL 127
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT-----TRVQGTFGYLDPEYFR 267
I HRD+K SNILLD K+ DFG S L TR G Y+ PE
Sbjct: 128 KIIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLVDSIAKTRDAGCRPYMAPERID 180
Query: 268 SSQ---FTEKSDVYSFGVVLVELLTGQKP 293
S + +SDV+S G+ L E+ TG+ P
Sbjct: 181 PSARDGYDVRSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 69/208 (33%), Positives = 99/208 (47%), Gaps = 17/208 (8%)
Query: 103 GQGTVYKGMLA----DGGIVAVK--KSKLVDESNVEQFI--NEVVILSQINHRNVVKLLG 154
G+G+ K +LA DG AVK + K+V ++ I V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHY 63
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIP 213
+E V +F+ G L+ +L + FP E R R A E++ A+ YLHS I
Sbjct: 64 SFQTTEKLYFVLDFVNGGELFFHLQRE-RSFP---EPRARFYAAEIASALGYLHS---IN 116
Query: 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTE 273
I +RD+K NILLD + ++DFG + + Q+ TT GT YL PE R +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQPYDN 175
Query: 274 KSDVYSFGVVLVELLTGQKPIRSTDAEE 301
D + G VL E+L G P D E
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 78/269 (28%), Positives = 120/269 (44%), Gaps = 22/269 (8%)
Query: 97 RILGQGGQGTVYKGML-ADGGIVAVKK--SKLVDESNVEQF-INEVVILSQINHRNVVKL 152
R+LG+GG G V + A G + A KK K + + E +NE IL ++N R VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 153 LGCCLESEVPLLVYEFIPNGTL-YHYLHDQTEEFPITWEMR-LRIAIEVSGAMSYLHSAT 210
+ LV + G L +H + F E R + A E++ + LH
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFD---EERAVFYAAEITCGLEDLHRER 122
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
I +RD+K NILLDD ++SD G + I +T + RV GT GY+ PE ++ +
Sbjct: 123 ---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYMAPEVVKNER 177
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330
+T D + G ++ E++ G+ P R + R V E R+ E E K
Sbjct: 178 YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV--------ERRVKEDQEEYSEKFS 229
Query: 331 KEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ I +L K +G + +EV
Sbjct: 230 EAARSICRQLLTKDPGFRLGCRGEGAEEV 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 25/219 (11%)
Query: 92 NYNANRILGQGGQGTVY--KGMLADGGIVAVKKSKL----VDESNVEQFINEVVILSQIN 145
Y + +G+G G +Y K +D +K+ L V E + EV++L+++
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASK--KEVILLAKMK 57
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ-----TEEFPITWEMRLRIAIEVS 200
H N+V E+ +V E+ G L ++ Q +E+ ++W +++S
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQIS 111
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYR-AKVSDFGASRTIKVDQTHLTTRVQGTFG 259
+ ++H I HRDIKS NI L AK+ DFG +R + D L GT
Sbjct: 112 LGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLN-DSMELAYTCVGTPY 167
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
YL PE ++ + K+D++S G VL EL T + P +
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 1e-16
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 12/210 (5%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKL-VDESNV-EQFINEVVILSQINHRNVVKLLGC 155
+G+G G VYKG G IVA+KK +L +E V I E+ +L ++ H N+V L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVSGAMSYLHSATSIPI 214
++ L++EF+ + L YL D + ++ + ++ + + HS +
Sbjct: 68 LMQESRLYLIFEFL-SMDLKKYL-DSLPKGQYMDAELVKSYLYQILQGILFCHSRR---V 122
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ-FTE 273
HRD+K N+L+D+K K++DFG +R + T V T Y PE S ++
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLLGSPRYST 181
Query: 274 KSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
D++S G + E+ T +KP+ D+E D+
Sbjct: 182 PVDIWSIGTIFAEMAT-KKPLFHGDSEIDQ 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 1e-16
Identities = 62/215 (28%), Positives = 104/215 (48%), Gaps = 33/215 (15%)
Query: 98 ILGQGGQGTVYKGMLADGGI---VAVKKSK-LVDESNVEQFINEVVILSQI-NHRNVVKL 152
++G+G G V + M+ G+ A+K K E++ F E+ +L ++ +H N++ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQT--EEFP-----------ITWEMRLRIAIEV 199
LG C + E+ P G L +L E P +T + L+ A +V
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
+ M YL I HRD+ + N+L+ + +K++DFG SR +V V+ T G
Sbjct: 129 ATGMQYLSEKQFI---HRDLAARNVLVGENLASKIADFGLSRGEEV-------YVKKTMG 178
Query: 260 -----YLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
++ E S +T KSDV+SFGV+L E+++
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 2e-16
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 98 ILGQGGQGTVYKGMLADGGI---VAVKKSK-LVDESNVEQFINEVVILSQIN-HRNVVKL 152
++G+G G V K + G+ A+K+ K + + F E+ +L ++ H N++ L
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQT--EEFP-----------ITWEMRLRIAIEV 199
LG C L E+ P+G L +L E P ++ + L A +V
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
+ M YL I HRD+ + NIL+ + Y AK++DFG SR +V V+ T G
Sbjct: 134 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 183
Query: 260 -----YLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
++ E S +T SDV+S+GV+L E+++
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 71/272 (26%), Positives = 127/272 (46%), Gaps = 48/272 (17%)
Query: 118 VAVK--KSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174
VAVK K D+ ++ ++E+ ++ I H+N++ LLG C + ++ E+ G L
Sbjct: 47 VAVKMLKDDATDK-DLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNL 105
Query: 175 YHYLHDQ----------TEEFP---ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKS 221
YL + T + P +T++ + A +V+ M YL S I HRD+ +
Sbjct: 106 REYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCI---HRDLAA 162
Query: 222 SNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 280
N+L+ + K++DFG +R + +D TT + ++ PE +T +SDV+SF
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 222
Query: 281 GVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE----- 334
GV+L E+ T G P EE LF ++LKEG +
Sbjct: 223 GVLLWEIFTLGGSPYPGIPVEE----------------LF-----KLLKEGHRMDKPANC 261
Query: 335 IITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+ M+ + C + + +RP+ K++ +L+ +
Sbjct: 262 THELYMIMRECWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 53/186 (28%), Positives = 96/186 (51%), Gaps = 19/186 (10%)
Query: 117 IVAVKKSKLVDESNVEQ-FINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLY 175
+VAVK + N F+ E+ I+S++ N+++LL C+ S+ ++ E++ NG L
Sbjct: 48 LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 176 HYLH--------DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD 227
+L ++ + I++ + +A +++ M YL +S+ HRD+ + N L+
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVG 164
Query: 228 DKYRAKVSDFGASRTIKVDQTHLTTRVQG----TFGYLDPEYFRSSQFTEKSDVYSFGVV 283
Y K++DFG SR + + R+QG ++ E +FT SDV++FGV
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYY---RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221
Query: 284 LVELLT 289
L E+LT
Sbjct: 222 LWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-16
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 13/209 (6%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGC 155
+G+G G VYK G IVA+KK +L DE I E+ +L ++NH N+V+LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 156 CLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
+ SE L LV+EF+ + L Y+ D + + + ++ ++Y HS +
Sbjct: 67 -VHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---V 120
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-YFRSSQFTE 273
HRD+K N+L+D + K++DFG +R V T V T Y PE S Q++
Sbjct: 121 LHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGSRQYST 179
Query: 274 KSDVYSFGVVLVELLTGQKPIRSTDAEED 302
D++S G + E++ ++P+ D+E D
Sbjct: 180 PVDIWSIGCIFAEMVN-RRPLFPGDSEID 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 3e-16
Identities = 73/268 (27%), Positives = 119/268 (44%), Gaps = 20/268 (7%)
Query: 97 RILGQGGQGTVYKGML-ADGGIVAVKK--SKLVDESNVEQF-INEVVILSQINHRNVVKL 152
R+LG+GG G V + A G + A K+ K + + E +NE IL ++N + VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMR-LRIAIEVSGAMSYLHSATS 211
+ LV + G L ++++ P E R L A E+ + LH +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLHRENT 123
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
+ +RD+K NILLDD ++SD G + +K+ + GT GY+ PE + ++
Sbjct: 124 V---YRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRY 178
Query: 272 TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331
T D + G ++ E++ GQ P R + R V + R+ E E K +
Sbjct: 179 TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEV--------DRRVLETEEVYSAKFSE 230
Query: 332 EEEIITVAMLGKRCLNMIGKKRPSMKEV 359
E + I +L K +G + EV
Sbjct: 231 EAKSICKMLLTKDPKQRLGCQEEGAGEV 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 3e-16
Identities = 63/216 (29%), Positives = 94/216 (43%), Gaps = 25/216 (11%)
Query: 98 ILGQGGQGTVYKGMLADG-------GIVAVKKSKLVDESNVEQFINEVVILSQIN---HR 147
+LG+G G V +LA+ I A+KK ++ VE + E I N H
Sbjct: 6 VLGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHP 62
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYL 206
+V L C + V E+ G L +H T+ F E R A V + YL
Sbjct: 63 FLVNLFACFQTEDHVCFVMEYAAGGDLM--MHIHTDVFS---EPRAVFYAACVVLGLQYL 117
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT-IKVDQTHLTTRVQGTFGYLDPEY 265
H I +RD+K N+LLD + K++DFG + + T+ GT +L PE
Sbjct: 118 HENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEV 172
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ +T D + GV++ E+L G+ P D EE
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 60/223 (26%), Positives = 103/223 (46%), Gaps = 10/223 (4%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKK--SKLVDESNVEQFINEVVILSQI 144
E D++ LG G G V+K G++ +K + + Q I E+ +L +
Sbjct: 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 60
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
N +V G + E + G+L L I ++ +++I V ++
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQILGKVSIAVIKGLT 117
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
YL I HRD+K SNIL++ + K+ DFG S + +D + GT Y+ PE
Sbjct: 118 YLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANSFVGTRSYMSPE 172
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307
+ + ++ +SD++S G+ LVE+ G+ PI DA+E + G
Sbjct: 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFG 215
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 6e-16
Identities = 60/213 (28%), Positives = 107/213 (50%), Gaps = 10/213 (4%)
Query: 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
+ LG G G V+ VAVK K S VE F+ E ++ + H +VKL
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HA 68
Query: 156 CLESEVPLLVYEFIPNGTLYHYLH-DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
+ E ++ EF+ G+L +L D+ + P+ + + +++ M+++ I
Sbjct: 69 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLP--KLIDFSAQIAEGMAFIEQRNYI-- 124
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
HRD++++NIL+ K++DFG +R I+ ++ + + PE FT K
Sbjct: 125 -HRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 275 SDVYSFGVVLVELLT-GQKPIRS-TDAEEDRSL 305
SDV+SFG++L+E++T G+ P ++ E R+L
Sbjct: 184 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-16
Identities = 73/283 (25%), Positives = 127/283 (44%), Gaps = 39/283 (13%)
Query: 98 ILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQFI--NEVVILSQINHRNVVKLLG 154
++G+G G V K + G IVA+KK ++ + + I E+ +L Q+ H N+V L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP--ITWEMRLRIAIEVSGAMSYLHSATSI 212
+ LV+EF+ H + D E++P + + ++ + + HS
Sbjct: 68 VFRRKKRLYLVFEFVD-----HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN-- 120
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF-RSSQF 271
I HRDIK NIL+ K+ DFG +RT+ T V T Y PE +++
Sbjct: 121 -IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKY 178
Query: 272 TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR-----SLVGFFLQA----MNEDRLFEVL 322
D+++ G ++ E+LTG+ P+ D++ D+ +G + ++ LF +
Sbjct: 179 GRAVDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237
Query: 323 EARVLKEGKEEE----------IITVAMLGKRCLNMIGKKRPS 355
L E KE E + + + K+CL + RPS
Sbjct: 238 ---RLPEVKEIEPLEKRFPKLSGLVLDLA-KQCLRIDPDDRPS 276
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 7e-16
Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 29/250 (11%)
Query: 99 LGQGGQGTVYKGMLADGGIVA-VKKSKLVDESNVE---QFINEVVILSQINHRNVVKLLG 154
+G G G V G G A V +L + + F+ EV ++NH NV++ LG
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRL--RIAIEVSGAMSYLHSATSI 212
C+ES LLV EF P G L +YL + + R+A EV+ + +LH A I
Sbjct: 63 QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFI 122
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG--YLDPEYFRSSQ 270
H D+ N L K+ D+G + + + + T+ +L PE
Sbjct: 123 ---HSDLALRNCQLTADLSVKIGDYGLALE-QYPEDYYITKDCHAVPLRWLAPELVEIRG 178
Query: 271 -------FTEKSDVYSFGVVLVEL----------LTGQKPIRSTDAEEDRSLVGFFLQAM 313
T+KS+++S GV + EL L+ ++ ++ E+D L L
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238
Query: 314 NEDRLFEVLE 323
DR +EV++
Sbjct: 239 YSDRWYEVMQ 248
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 9e-16
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 14/209 (6%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGG-IVAVKK---SKLVDESNVEQFINEVVILSQINH 146
D+ + +G G G V+ A+K +++ + NE +L +++H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
+++L + ++ E++P G L+ YL + + L A E+ A+ YL
Sbjct: 61 PFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSNSTGLFYASEIVCALEYL 117
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
HS I +RD+K NILLD + K++DFG ++ + D+T + GT YL PE
Sbjct: 118 HSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTW---TLCGTPEYLAPEVI 170
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKPIR 295
+S + D ++ G+++ E+L G P
Sbjct: 171 QSKGHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 9e-16
Identities = 67/215 (31%), Positives = 100/215 (46%), Gaps = 39/215 (18%)
Query: 96 NRILGQGGQGTVYKGM-LADGGIVAVKKSKLV-----DESNVEQFINEVVILSQINHRNV 149
NRI G G GTVYK + G + A+K V +++ Q E+ IL +NH NV
Sbjct: 80 NRI-GSGAGGTVYKVIHRPTGRLYALK----VIYGNHEDTVRRQICREIEILRDVNHPNV 134
Query: 150 VKLLGCCLE-----SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR-IAIEVSGAM 203
VK C + E+ +L+ EF+ G+L E I E L +A ++ +
Sbjct: 135 VK----CHDMFDHNGEIQVLL-EFMDGGSL--------EGTHIADEQFLADVARQILSGI 181
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
+YLH I HRDIK SN+L++ K++DFG SR + + V GT Y+ P
Sbjct: 182 AYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSP 237
Query: 264 EYFRSSQFTEK-----SDVYSFGVVLVELLTGQKP 293
E + D++S GV ++E G+ P
Sbjct: 238 ERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 66/212 (31%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINE-VVILSQINHRNVVK 151
+++G+G G V ADG AVK K ++ + + + E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEE-FPITWEMRLRI-AIEVSGAMSYLHSA 209
L ++ V +++ G L+ +L Q E FP E R R A E++ A+ YLHS
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHL--QRERSFP---EPRARFYAAEIASALGYLHS- 114
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
+ I +RD+K NILLD + ++DFG + ++ + T+ GT YL PE R
Sbjct: 115 --LNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQ 171
Query: 270 QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ D + G VL E+L G P S D E
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 65/280 (23%), Positives = 132/280 (47%), Gaps = 40/280 (14%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVKKS-KLVDESNVEQFINEV----VILSQINHRNVV 150
++LG G GTV+KG+ + +G + + + K + + + Q E+ + + ++H +V
Sbjct: 13 KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+LLG C + + L V + P G+L ++ + + + L ++++ M YL
Sbjct: 73 RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDS--LDPQRLLNWCVQIAKGMYYLEEHR 129
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFG-ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
+ HR++ + NILL +++DFG A D+ + + + ++ E
Sbjct: 130 MV---HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328
++T +SDV+S+GV + E+++ G +P R EV + +L+
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGM-------------------RPHEVPD--LLE 225
Query: 329 EGK---EEEIIT--VAMLGKRCLNMIGKKRPSMKEVAFEL 363
+G+ + +I T V M+ +C + RP+ KE+A E
Sbjct: 226 KGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEF 265
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 99 LGQGGQGTVYK-GMLADGGIVAVKK--SKLVDESNVEQF-INEVVILSQINHRNVVKLLG 154
LG+GG G V + A G + A KK K + + EQ +NE IL +++ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 155 CCLESEVPL-LVYEFIPNGTL-YHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSATS 211
E++ L LV + G L YH + FP E R A ++ + +LH
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFP---EARAIFYAAQIICGLEHLHQRR- 115
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
I +RD+K N+LLDD ++SD G + +K + R GT GY+ PE + +
Sbjct: 116 --IVYRDLKPENVLLDDHGNVRISDLGLAVELK-GGKKIKGRA-GTPGYMAPEVLQGEVY 171
Query: 272 TEKSDVYSFGVVLVELLTGQKPIR 295
D ++ G L E++ G+ P R
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 1e-15
Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 16/212 (7%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
++LG+G G V L G + A+KK ++ + +VE + E +L+ +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 153 LGCCLESEVPLL-VYEFIPNGTLYHYLHDQT--EEFPITWEMRLRIAIEVSGAMSYLHSA 209
L C +++ L V EF+ G L ++ D+ + + T+ A E+ + +LHS
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATF-----YAAEIVCGLQFLHSK 115
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
I +RD+K N++LD K++DFG + +T GT Y+ PE +
Sbjct: 116 GII---YRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGL 171
Query: 270 QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
++T D +SFGV+L E+L GQ P D +E
Sbjct: 172 KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 14/211 (6%)
Query: 97 RILGQGGQGTVYKGMLADG----GIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
++LG+G G V L I A+KK ++++ +VE + E +L+ +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 153 LGCCLESEVPLL-VYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSAT 210
L C +++ L V E++ G L ++ + F E R R A E+ + +LH
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDLMFHIQ-SSGRFD---EARARFYAAEIICGLQFLHKKG 116
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
I +RD+K N+LLD K++DFG + + +T GT Y+ PE + +
Sbjct: 117 II---YRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKGQK 172
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ E D +SFGV+L E+L GQ P D +E
Sbjct: 173 YNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 17/211 (8%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSK---LVDESNVEQFINEVVILSQINHR 147
N+ + +G+G VY+ L D VA+KK + ++D + + E+ +L Q+NH
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYH---YLHDQTEEFP--ITWEMRLRIAIEVSGA 202
NV+K L +E +V E G L Y Q P W + +++ A
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW----KYFVQLCSA 118
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
+ ++HS + HRDIK +N+ + K+ D G R T + V GT Y+
Sbjct: 119 VEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMS 174
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
PE + + KSD++S G +L E+ Q P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 3e-15
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 33/215 (15%)
Query: 98 ILGQGGQGTVYKGMLADGGI---VAVKKSK-LVDESNVEQFINEVVILSQINHR-NVVKL 152
++G+G G V K + G+ A+K+ K + + F E+ +L ++ H N++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQT--EEFP-----------ITWEMRLRIAIEV 199
LG C L E+ P+G L +L E P ++ + L A +V
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
+ M YL I HRD+ + NIL+ + Y AK++DFG SR +V V+ T G
Sbjct: 122 ARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTMG 171
Query: 260 -----YLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
++ E S +T SDV+S+GV+L E+++
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 3e-15
Identities = 70/234 (29%), Positives = 110/234 (47%), Gaps = 27/234 (11%)
Query: 76 EKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQF 134
E +LF K D EK + R +G G G VY +VA+KK + + E++
Sbjct: 13 EIAELFFKEDPEKL---FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKW 69
Query: 135 ---INEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEM 191
I EV L +I H N ++ GC L LV E+ G+ L + + P+
Sbjct: 70 QDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPL---Q 123
Query: 192 RLRIAIEVSGAM---SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248
+ IA GA+ +YLHS I HRDIK+ NILL + + K++DFG++ +
Sbjct: 124 EVEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASIASPANS 180
Query: 249 HLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
+ GT ++ PE + Q+ K DV+S G+ +EL + P+ + +A
Sbjct: 181 FV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 66/213 (30%), Positives = 93/213 (43%), Gaps = 26/213 (12%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKLLG 154
+GQGG G V+ D G IVA+K KS L + V + E IL+ +VKLL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 155 CCLESEVPLLVYEFIPNG---TLYH---YLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+ E L E++P G TL + L + F + EM A+ LH
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMA-EMFE--------AVDALHE 119
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS 268
+ HRD+K N L+D K++DFG S+ I V + V G+ Y+ PE R
Sbjct: 120 ---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGI-VTYAN---SVVGSPDYMAPEVLRG 172
Query: 269 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ D +S G +L E L G P + E
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 4e-15
Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 7/183 (3%)
Query: 119 AVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYL 178
++K+ +V S V + E +L+Q+N +V L E LV FI G L+H+L
Sbjct: 25 TIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHL 84
Query: 179 HDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238
Q E R A E+ A+ LH I +RD+K NILLD + + DFG
Sbjct: 85 --QREGRFDLSRARFYTA-ELLCALENLHKFNVI---YRDLKPENILLDYQGHIALCDFG 138
Query: 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
+ + + T GT YL PE +T+ D ++ GV+L E+LTG P +
Sbjct: 139 LCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197
Query: 299 AEE 301
E
Sbjct: 198 VNE 200
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 4e-15
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKS-KLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
LG G G VYK + G +A K + E +E ++ E+ IL+ NH +VKLLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79
Query: 158 ESEVPLLVYEFIPNGTLYHYLH--DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
++ EF P G + + D+ P ++++ I ++ A+ YLHS + I
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MKII 132
Query: 216 HRDIKSSNILLDDKYRAKVSDFGAS-RTIKVDQTHLTTRVQGTFGYLDPEY-----FRSS 269
HRD+K+ N+LL K++DFG S + +K Q GT ++ PE + +
Sbjct: 133 HRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCETMKDT 190
Query: 270 QFTEKSDVYSFGVVLVELLTGQKP 293
+ K+D++S G+ L+E+ + P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 68/250 (27%), Positives = 114/250 (45%), Gaps = 23/250 (9%)
Query: 54 MFFKKNGGLLLQQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLA 113
+ F KN LQ + + ++ K KM E ++N R LG G G V
Sbjct: 1 IQFLKN----LQLHKKKDSDSTKEPKRKNKMKYE----DFNFIRTLGTGSFGRVILATYK 52
Query: 114 DGGI--VAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168
+ VA+K KSK++ + V+ +E IL+ INH V L G + LV EF
Sbjct: 53 NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112
Query: 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD 228
+ G + +L + + FP ++ A ++ YL S+ I +RD+K N+LLD
Sbjct: 113 VIGGEFFTFLR-RNKRFPN--DVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDK 166
Query: 229 KYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELL 288
K++DFG ++ + T + GT Y+ PE + + +D ++ G+ + E+L
Sbjct: 167 DGFIKMTDFGFAKVVDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222
Query: 289 TGQKPIRSTD 298
G P + +
Sbjct: 223 VGCPPFYANE 232
|
Length = 340 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 5e-15
Identities = 67/234 (28%), Positives = 115/234 (49%), Gaps = 26/234 (11%)
Query: 97 RILGQGGQGTVYKGMLADG-------GIVAVKKSKLVDESNVEQFINEVVILSQINHRNV 149
++LG+G G V MLA+ I +KK ++ + +V+ + E IL+
Sbjct: 1 KVLGKGSFGKV---MLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPF 57
Query: 150 VKLLGCCLESEVPLL-VYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLH 207
+ L CC +++ L V E++ G L + ++ +F E R R A EV+ A+ +LH
Sbjct: 58 LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQ-RSRKFD---EPRSRFYAAEVTLALMFLH 113
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
I +RD+K NILLD + K++DFG + + TT GT Y+ PE +
Sbjct: 114 RHGVI---YRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQ 169
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321
++ D ++ GV++ E++ GQ P + D E+D F +++D L+ V
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDD-----LFESILHDDVLYPV 217
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 6e-15
Identities = 61/229 (26%), Positives = 115/229 (50%), Gaps = 34/229 (14%)
Query: 99 LGQGGQGTVYKGM---LADGGIVAVKKS--KLVDESN---VEQFINEVVILSQINHRNVV 150
LGQG ++KG+ + D G + + K++D+S+ E F ++SQ++H+++V
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
G C+ + ++V E++ G+L YL I+W +L +A +++ A+ +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 211 SIPIYHRDIKSSNILL----DDKYRA----KVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
+ H ++ + N+LL D K K+SD G S T+ + + L R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV-LPKEILLERIP----WVP 172
Query: 263 PEYFRSSQ-FTEKSDVYSFGVVLVELLTG-QKPIRSTDAE------EDR 303
PE + Q + +D +SFG L E+ +G KP+ + D++ EDR
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDR 221
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.2 bits (183), Expect = 6e-15
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 34/209 (16%)
Query: 98 ILGQGGQGTVYKGM-LADGGIVAVKKSKL-VDESNVEQF-INEVVILSQI---NHRNVVK 151
+G+G GTVYK L G VA+KK ++ + E + + E+ +L Q+ H N+V+
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65
Query: 152 LLGCC----LESEVPL-LVYEFIPNGTLYHYLHDQTEEFP--------ITWEMRLRIAIE 198
LL C + E+ L LV+E + L + P I MR +
Sbjct: 66 LLDVCHGPRTDRELKLTLVFEHVDQD-----LATYLSKCPKPGLPPETIKDLMR-----Q 115
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF 258
+ + +LHS I HRD+K NIL+ + K++DFG +R + LT+ V T
Sbjct: 116 LLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYS-FEMALTSVVV-TL 170
Query: 259 GYLDPEYFRSSQFTEKSDVYSFGVVLVEL 287
Y PE S + D++S G + EL
Sbjct: 171 WYRAPEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 61/228 (26%), Positives = 90/228 (39%), Gaps = 52/228 (22%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGC 155
+G G G VYK G ++AVK+ + E N ++ V+L + +VK G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY 82
Query: 156 ----------------CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
CL+ ++ + IP L + + +
Sbjct: 83 FITDSDVFICMELMSTCLD-KLLKRIQGPIPEDILGK------------------MTVAI 123
Query: 200 SGAMSYL---HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG 256
A+ YL H + HRD+K SNILLD K+ DFG S + + TR G
Sbjct: 124 VKALHYLKEKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK--TRSAG 176
Query: 257 TFGYLDPEYFRSSQFTEK----SDVYSFGVVLVELLTGQKPIRSTDAE 300
Y+ PE K +DV+S G+ LVEL TGQ P ++ E
Sbjct: 177 CAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE 224
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 69/241 (28%), Positives = 116/241 (48%), Gaps = 29/241 (12%)
Query: 86 LEKATDNYNANRILGQGGQGTV----YKGMLADGGIVAVKKSKLVDESNVEQFINEVVIL 141
L+ ++Y+ +++G+G G V +K + + K +++ S+ F E I+
Sbjct: 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97
Query: 142 SQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVS 200
+ N VV+L C + + L +V E++P G L + + + + P W + A EV
Sbjct: 98 AFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNY--DVPEKWA-KFYTA-EVV 152
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT---HLTTRVQGT 257
A+ +HS I HRD+K N+LLD K++DFG +K+D+T T V GT
Sbjct: 153 LALDAIHSMGLI---HRDVKPDNMLLDKHGHLKLADFGT--CMKMDETGMVRCDTAV-GT 206
Query: 258 FGYLDPEYFRSS----QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313
Y+ PE +S + + D +S GV L E+L G P + SLVG + + M
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD------SLVGTYSKIM 260
Query: 314 N 314
+
Sbjct: 261 D 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 58/235 (24%), Positives = 99/235 (42%), Gaps = 32/235 (13%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVKKSK--LVDESNV-EQFINEVVILSQINHRN 148
Y+ R++G+GG G VY VA+KK + L + + ++F+ E I + + H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD--QTEEFPITWEMR------LRIAIEVS 200
+V + C + + +I TL L Q E + L I ++
Sbjct: 64 IVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT-------- 252
+ Y+HS + HRD+K NILL + D+GA+ K+++ L
Sbjct: 124 ATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180
Query: 253 ---------RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
++ GT Y+ PE +E +D+Y+ GV+L ++LT P R
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235
|
Length = 932 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 60/210 (28%), Positives = 107/210 (50%), Gaps = 13/210 (6%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDESN--VEQFINEVVILSQINHRNVVKLLGC 155
+G+G G VYK G +VA+KK +L E+ I E+ +L ++NH N+VKLL
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67
Query: 156 CLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
+ +E L LV+EF+ + L ++ D + I + ++ +++ HS +
Sbjct: 68 -IHTENKLYLVFEFL-HQDLKKFM-DASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVL-- 122
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF-TE 273
HRD+K N+L++ + K++DFG +R V T V T Y PE ++ +
Sbjct: 123 -HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILLGCKYYST 180
Query: 274 KSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
D++S G + E++T ++ + D+E D+
Sbjct: 181 AVDIWSLGCIFAEMVT-RRALFPGDSEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 1e-14
Identities = 63/227 (27%), Positives = 94/227 (41%), Gaps = 29/227 (12%)
Query: 86 LEKATDNYNANRILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQFINEVVILSQI 144
L T + ++G+G G VYK G +VA+K ++++ E E IL +
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEEYNILRKY 59
Query: 145 -NHRNVVKLLGCCLESEVPL------LVYEFIPNGT---LYHYLHDQTEEFPITWEMRLR 194
NH N+ G ++ P LV E G+ L L + + W
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW----- 114
Query: 195 IAI---EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251
IA E ++YLH I HRDIK NILL K+ DFG S +
Sbjct: 115 IAYILRETLRGLAYLHENKVI---HRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 252 TRVQGTFGYLDPEYFRSSQ-----FTEKSDVYSFGVVLVELLTGQKP 293
T + GT ++ PE + + +SDV+S G+ +EL G+ P
Sbjct: 172 TFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 58/204 (28%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 99 LGQGGQGTVYK-GMLADGGIVAVKK---SKLVDESNVEQFINEVVILSQINHRNVVKLLG 154
LG+GG G V M A G + A KK +L E + E IL++++ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 155 CCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMR-LRIAIEVSGAMSYLHSATSI 212
+++ L LV + G L +++++ EE P E R ++ + +LH
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR-- 117
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT 272
I +RD+K N+LLD+ ++SD G + +K Q+ T GT G++ PE + ++
Sbjct: 118 -IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175
Query: 273 EKSDVYSFGVVLVELLTGQKPIRS 296
D ++ GV L E++ + P R+
Sbjct: 176 FSVDYFALGVTLYEMIAARGPFRA 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 17/205 (8%)
Query: 103 GQGTVYKGMLA----DGGIVAVK----KSKLVDESNVEQFINEVVILSQINHRNVVKLLG 154
G+G+ K +LA DG AVK K+ L + V+L + H +V L
Sbjct: 4 GKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHY 63
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIP 213
+E V +++ G L+ H Q E E R R A EV+ A+ YLHS +
Sbjct: 64 SFQTAEKLYFVLDYVNGGELF--FHLQRER--CFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTE 273
I +RD+K NILLD + ++DFG + V+ T+ GT YL PE R +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEPYDR 175
Query: 274 KSDVYSFGVVLVELLTGQKPIRSTD 298
D + G VL E+L G P S D
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRD 200
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 66/239 (27%), Positives = 104/239 (43%), Gaps = 46/239 (19%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
D++ +++G+G G V+ L G + A+K KS ++ + + E IL+
Sbjct: 1 DDFEVIKVIGRGAFGEVW---LVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 144 INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA 202
+ +VKL + E L LV E++P G L + L + + FP R IA E+ A
Sbjct: 58 ADSPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRK-DVFPEET-ARFYIA-ELVLA 113
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS--------RTIKVDQTHLT--- 251
+ +H I HRDIK NIL+D K++DFG R ++ +H
Sbjct: 114 LDSVHKLGFI---HRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 252 TRVQ-----------------GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
V GT Y+ PE R + + + D +S GV+L E+L G P
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 74/268 (27%), Positives = 126/268 (47%), Gaps = 27/268 (10%)
Query: 97 RILGQGGQGTV-YKGMLADGGIVAVKKSKLVDESNVEQFI--NEVVILSQINHRNVVKLL 153
R++G+G G V DG +KK L + S E+ E +LSQ+ H N+V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65
Query: 154 GCCLESEVPLL--VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
E E LL V F G LYH L +Q + ++ + ++++ A+ YLH
Sbjct: 66 ES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQV-VEWFVQIAMALQYLHEKH- 122
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
I HRD+K+ N+ L KV D G +R ++ +Q + + + GT Y+ PE F + +
Sbjct: 123 --ILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYMSPELFSNKPY 179
Query: 272 TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331
KSDV++ G + E+ T + + +A++ SLV + ++E + L
Sbjct: 180 NYKSDVWALGCCVYEMATLK---HAFNAKDMNSLV------------YRIIEGK-LPPMP 223
Query: 332 EEEIITVAMLGKRCLNMIGKKRPSMKEV 359
++ + L L+ +KRPS+K +
Sbjct: 224 KDYSPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 40/120 (33%), Positives = 66/120 (55%), Gaps = 5/120 (4%)
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
+I+I V ++YL I HRD+K SNIL++ + K+ DFG S + +D +
Sbjct: 103 KISIAVLRGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDS--MANS 157
Query: 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313
GT Y+ PE + + +T +SD++S G+ LVE+ G+ PI DA+E ++ G +
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG 217
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 26/208 (12%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGC 155
LG G G VYK + G++A +K++D E +E ++ E+ IL+ +H N+VKLL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAA--AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 70
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVS-GAMSYLHSATSIPI 214
++ EF G + + + E P+T E ++R+ + + A++YLH I
Sbjct: 71 FYYENNLWILIEFCAGGAVDAVMLEL--ERPLT-EPQIRVVCKQTLEALNYLHENK---I 124
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGAS----RTIKVDQTHLTTRVQGTFGYLDPEYF---- 266
HRD+K+ NIL K++DFG S RTI+ + + GT ++ PE
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEVVMCET 179
Query: 267 -RSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ + K+DV+S G+ L+E+ + P
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 65/238 (27%), Positives = 106/238 (44%), Gaps = 21/238 (8%)
Query: 85 DLEKATDNYNANRILGQGGQGTV----YKGMLADGGIVAVKKSKLVDESNVEQFINEVVI 140
DL ++Y +++G+G G V +K + + K +++ S+ F E I
Sbjct: 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 141 LSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVS 200
++ N VV+L + +V E++P G L + + + + P W R A EV
Sbjct: 97 MAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY--DVPEKWA-RFYTA-EVV 152
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260
A+ +HS I HRD+K N+LLD K++DFG + + GT Y
Sbjct: 153 LALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209
Query: 261 LDPEYFRSS----QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314
+ PE +S + + D +S GV L E+L G P + SLVG + + MN
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD------SLVGTYSKIMN 261
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 66/224 (29%), Positives = 109/224 (48%), Gaps = 18/224 (8%)
Query: 92 NYNANRILGQGGQGTVY----KGMLADGGIVAVK---KSKLVDES-NVEQFINEVVILSQ 143
N+ R+LG G G V+ G G + A+K K+ +V ++ E E +L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 144 INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA 202
+ + L +++ L L+ +++ G L+ +L+ Q E F + E+R+ IA E+ A
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY-QREHFTES-EVRVYIA-EIVLA 117
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
+ +LH + I +RDIK NILLD + ++DFG S+ ++ GT Y+
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMA 174
Query: 263 PEYFR--SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRS 304
PE R S + D +S GV+ ELLTG P + D E++
Sbjct: 175 PEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF-TVDGEQNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 12/217 (5%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHR 147
D Y +G+G G VYK +A+KK +L DE I E+ +L ++ H
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
N+V+L + LV+E++ H D + +F + ++ ++Y H
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHM--DSSPDFAKNPRLIKTYLYQILRGIAYCH 119
Query: 208 SATSIPIYHRDIKSSNILLDDKYRA-KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
S + HRD+K N+L+D + A K++DFG +R + T V T Y PE
Sbjct: 120 SHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPEIL 175
Query: 267 RSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
S ++ D++S G + E++ QKP+ D+E D
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVN-QKPLFPGDSEID 211
|
Length = 294 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 4e-14
Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 25/217 (11%)
Query: 99 LGQGGQGTVYKGML---ADG---GIVAVKKSKLVDESNV-EQFINEVVILSQINHRNVVK 151
LG+ G VYKG L A G VA+K K E + E+F +E ++ S++ H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYL-------------HDQTEEFPITWEMRLRIAIE 198
LLG + + +++ + + L+ +L D+T + + + I +
Sbjct: 73 LLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQ 132
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQGT 257
++ M +L +S + H+D+ + N+L+ DK K+SD G R + D L
Sbjct: 133 IAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189
Query: 258 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
++ PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 67/234 (28%), Positives = 110/234 (47%), Gaps = 27/234 (11%)
Query: 76 EKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF 134
+ +LF K D EK + R +G G G VY + + +VA+KK + + E++
Sbjct: 3 DVAELFFKDDPEKLFSDL---REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 135 ---INEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEM 191
I EV L ++ H N ++ GC L LV E+ G+ L + + P+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL--EVHKKPL---Q 113
Query: 192 RLRIAIEVSGAM---SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248
+ IA GA+ +YLHS I HRD+K+ NILL + K+ DFG++ +
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIMAPANX 170
Query: 249 HLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
+ GT ++ PE + Q+ K DV+S G+ +EL + P+ + +A
Sbjct: 171 FV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 59/287 (20%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIV--AVKKSKLVDESNVEQFINEVVILSQINHRN 148
D Y + ++ + Q ++YKG+ + ++ KK + ++ NE+ L +I+ N
Sbjct: 21 DKYTS-VLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNN 79
Query: 149 VVKLLGCCLESEVPL----LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
++K+ G ++ L L+ E+ G L L +E ++++ +L +AI+ +
Sbjct: 80 ILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD---KEKDLSFKTKLDMAIDCCKGLY 136
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
L+ T+ P ++++ S + L+ + Y+ K+ K+ + V Y +
Sbjct: 137 NLYKYTNKP--YKNLTSVSFLVTENYKLKI---ICHGLEKILSSPPFKNVN-FMVYFSYK 190
Query: 265 YFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322
S++T K D+YS GVVL E+ TG+ P + +E L
Sbjct: 191 MLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----------------- 233
Query: 323 EARVLKEGKEEEIITVAMLG-----KRCLNMIGKKRPSMKEVAFELE 364
++ + ++ L + C + KRP++KE+ + L
Sbjct: 234 ---IINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLS 277
|
Length = 283 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 12/204 (5%)
Query: 97 RILGQGGQGTVYKGML-ADGGIVAVKK--SKLVDESNVEQF-INEVVILSQINHRNVVKL 152
R+LG+GG G V + A G + A KK K + + E +NE IL ++N R VV L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMR-LRIAIEVSGAMSYLHSATS 211
+ LV + G L ++++ P E R + A E+ + L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQRER- 122
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
I +RD+K NILLDD+ ++SD G + I +T + RV GT GY+ PE + ++
Sbjct: 123 --IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYMAPEVINNEKY 178
Query: 272 TEKSDVYSFGVVLVELLTGQKPIR 295
T D + G ++ E++ GQ P R
Sbjct: 179 TFSPDWWGLGCLIYEMIQGQSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 61/210 (29%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
++LG+G G V+ L I A+KK ++ + +VE + E +LS +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 153 LGCCLESEVPLL-VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
L C +++ L V E++ G L ++ +F + A E+ + +LHS
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDLMFHIQ-SCHKFDLPRATFY--AAEIICGLQFLHSKG- 116
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
I +RD+K NILLD K++DFG + + T GT Y+ PE ++
Sbjct: 117 --IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY 173
Query: 272 TEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
D +SFGV+L E+L GQ P D EE
Sbjct: 174 NTSVDWWSFGVLLYEMLIGQSPFHGHDEEE 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 63/235 (26%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE--QFINEVVILSQINHRNV 149
Y + +G G G V + G VA+KK V + ++ + + E+ +L + H N+
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLY----------HYL----HDQTEEFP--ITWEMRL 193
+ LL + P +F +Y H + T++ +++ L
Sbjct: 62 IGLL----DILRPPSPEDF---NDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQI-L 113
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD---QTHL 250
R + YLHSA + HRD+K SNIL++ K+ DFG +R + D + L
Sbjct: 114 R-------GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163
Query: 251 T----TRVQGTFGYLDPEYFR-------SSQFTEKSDVYSFGVVLVELLTGQKPI 294
T TR ++R SS++T+ D++S G + ELLT KP+
Sbjct: 164 TEYVVTR-----------WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTR-KPL 206
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 9e-14
Identities = 55/200 (27%), Positives = 89/200 (44%), Gaps = 11/200 (5%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
+G G G VYK + G + A+K KL + E++++ H N+V G L
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76
Query: 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217
+ + EF G+L H P++ ++ E + YLHS + HR
Sbjct: 77 RRDKLWICMEFCGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKGKM---HR 130
Query: 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF---RSSQFTEK 274
DIK +NILL D K++DFG S I + + GT ++ PE R + +
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKGGYNQL 189
Query: 275 SDVYSFGVVLVELLTGQKPI 294
D+++ G+ +EL Q P+
Sbjct: 190 CDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 9e-14
Identities = 69/234 (29%), Positives = 109/234 (46%), Gaps = 27/234 (11%)
Query: 76 EKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQF 134
E LF K D E+ + +G G G VY + +VAVKK + E++
Sbjct: 9 EIADLFYKDDPEEIFVGLHE---IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKW 65
Query: 135 ---INEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEM 191
I EV L Q+ H N ++ GC L+ LV E+ G+ L + + P+
Sbjct: 66 QDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLL--EVHKKPL---Q 119
Query: 192 RLRIAIEVSGAM---SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248
+ IA GA+ +YLHS I HRDIK+ NILL + + K++DFG++ +
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMI---HRDIKAGNILLTEPGQVKLADFGSASKSSPANS 176
Query: 249 HLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
+ GT ++ PE + Q+ K DV+S G+ +EL + P+ + +A
Sbjct: 177 FV-----GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 1e-13
Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 15/205 (7%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKLVDESNVEQ---FINEVVILSQINHRNV 149
RILG G G + +G L VA+ L + +Q F+ E + L Q +H N+
Sbjct: 11 RILGTGRFGELCRGCLKLPSKRELPVAIHT--LRAGCSDKQRRGFLAEALTLGQFDHSNI 68
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
V+L G ++V E++ NG L +L + M + + + M YL
Sbjct: 69 VRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGL--ASGMKYL--- 123
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
+ + H+ + + +L++ K+S F + K + + T + + PE +
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYH 183
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKP 293
F+ SDV+SFG+V+ E+++ G++P
Sbjct: 184 HFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 63/231 (27%), Positives = 107/231 (46%), Gaps = 23/231 (9%)
Query: 92 NYNANRILGQGGQGTVYKGMLADG-------GIVAVKKSKLVD-ESNVEQFINEVVILSQ 143
N+ ++LG G G V+ G + ++K+ LV VE E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 144 INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVSG 201
+ + L ++E L L+ +++ G ++ +L+ Q + F E +R E+
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFS---EDEVRFYSGEIIL 116
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
A+ +LH + I +RDIK NILLD + ++DFG S+ ++ T GT Y+
Sbjct: 117 ALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 262 DPEYFRSSQFTEKS-DVYSFGVVLVELLTGQKPI-----RSTDAEEDRSLV 306
PE R K+ D +S G+++ ELLTG P R+T +E R ++
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRIL 224
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 64/240 (26%), Positives = 100/240 (41%), Gaps = 53/240 (22%)
Query: 89 ATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF----INEVVILSQ 143
+Y LG+G G VYK + G +VA+KK + +E + F + E+ IL +
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKK 63
Query: 144 INHRNVVKLLGCCLE-----SEVPLLVYEFIPNGTLYHYL-HDQTE--EFPITWEMRLRI 195
+ H NVV L+ +E VY P Y+ HD + E P +
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP------YMDHDLSGLLENP-------SV 110
Query: 196 AIEVSGA----------MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245
+ S ++YLH I HRDIK++NIL+D++ K++DFG +R
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 246 DQTHLT----------TRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
+ T + T Y PE ++T D++ G V E+ T +PI
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR-RPI 226
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 65/226 (28%), Positives = 100/226 (44%), Gaps = 46/226 (20%)
Query: 91 DNYNA-NRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF----INEVVILSQI 144
D Y NRI +G G VY+ G IVA+KK K+ E E F + E+ IL ++
Sbjct: 5 DEYEKLNRI-EEGTYGVVYRARDKKTGEIVALKKLKM--EKEKEGFPITSLREINILLKL 61
Query: 145 NHRNVVKLLGCCLESEVPL--------LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIA 196
H N+V + EV + +V E++ H L E +
Sbjct: 62 QHPNIVTV------KEVVVGSNLDKIYMVMEYVE-----HDLKSLMETMK----QPFLQS 106
Query: 197 IEVS-------GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249
EV +++LH I HRD+K+SN+LL+++ K+ DFG +R
Sbjct: 107 -EVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162
Query: 250 LTTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
T V T Y PE + +++ D++S G + ELLT +KP+
Sbjct: 163 YTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 3e-13
Identities = 64/223 (28%), Positives = 104/223 (46%), Gaps = 20/223 (8%)
Query: 92 NYNANRILGQGGQGTVY---KGMLADGG----IVAVKKSKLVDES-NVEQFINEVVILSQ 143
N+ ++LG G G V+ K D G + +KK+ +V ++ E E +L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 144 INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVSG 201
I + L +++ L L+ ++I G L+ +L Q E F E ++I E+
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFK---EQEVQIYSGEIVL 116
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
A+ +LH + I +RDIK NILLD ++DFG S+ D+ GT Y+
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 262 DPEYFR--SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
P+ R + D +S GV++ ELLTG P + D E++
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF-TVDGEKN 215
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 20/217 (9%)
Query: 99 LGQGGQGTVYKGM-LADGG-IVAVKKSKL--VDESNVEQFINEVVILSQIN---HRNVVK 151
+G+G G V+K L +GG VA+K+ ++ +E I EV +L + H NVV+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 152 LLGCCLES----EVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
L C S E L LV+E + + L YL D+ E + E + ++ + +L
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLLRGLDFL 126
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
HS + HRD+K NIL+ + K++DFG +R T V T Y PE
Sbjct: 127 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAPEVL 181
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
S + D++S G + E+ +KP+ ++ D+
Sbjct: 182 LQSSYATPVDLWSVGCIFAEMFR-RKPLFRGSSDVDQ 217
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 50/174 (28%), Positives = 85/174 (48%), Gaps = 10/174 (5%)
Query: 120 VKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLH 179
+KK +++ V+ E IL +++H +V ++ + + EF+ G L+ +L
Sbjct: 51 LKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLR 110
Query: 180 DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239
+ FP ++ E+ A YLHS I +RD+K N+LLD+K KV+DFG
Sbjct: 111 -KAGRFPN--DVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGF 164
Query: 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
++ + T + GT YL PE +S + D ++ GV+L E + G P
Sbjct: 165 AKKV----PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 3e-13
Identities = 51/206 (24%), Positives = 98/206 (47%), Gaps = 8/206 (3%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCC 156
LG+G TVYKG G IVA+K+ L +E I E+ ++ ++ H N+V+L
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVI 67
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+LV+E++ + L Y+ + ++ +++ H + H
Sbjct: 68 HTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLH 123
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ-FTEKS 275
RD+K N+L++ + K++DFG +R + + V T Y P+ S+ ++
Sbjct: 124 RDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSI 182
Query: 276 DVYSFGVVLVELLTGQKPIRSTDAEE 301
D++S G ++ E++TG+ T+ E+
Sbjct: 183 DIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 3e-13
Identities = 56/198 (28%), Positives = 91/198 (45%), Gaps = 21/198 (10%)
Query: 103 GQGTVYKGMLA----DGGIVAVKKSKLVDESNVE--QFINEVVILSQINHRNVVKLLGCC 156
G+G+ K +L DG +K+ + S E + EV +LS + H N+V+
Sbjct: 9 GEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF 68
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQ-----TEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
E+ +V ++ G LY ++ Q E+ + W +++ +A + ++H
Sbjct: 69 EENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA------LKHVHDRK- 121
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
I HRDIKS NI L K+ DFG +R + L GT YL PE + +
Sbjct: 122 --ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN-STVELARTCIGTPYYLSPEICENRPY 178
Query: 272 TEKSDVYSFGVVLVELLT 289
KSD+++ G VL E+ T
Sbjct: 179 NNKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 29/242 (11%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGGIV-AVK---KSKLVDESNVEQFINEVVI 140
L ++++ +++G+G G V V A+K K +++ S+ F E I
Sbjct: 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI 96
Query: 141 LSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
++ N +V+L + + L +V E++P G L + + + + P W R A EV
Sbjct: 97 MAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVNLMSNY--DIPEKWA-RFYTA-EV 151
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT---HLTTRVQG 256
A+ +HS I HRD+K N+LLD K++DFG +K+D T V G
Sbjct: 152 VLALDAIHSMGFI---HRDVKPDNMLLDKSGHLKLADFGT--CMKMDANGMVRCDTAV-G 205
Query: 257 TFGYLDPEYFRS----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312
T Y+ PE +S + + D +S GV L E+L G P SLVG + +
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY------ADSLVGTYSKI 259
Query: 313 MN 314
M+
Sbjct: 260 MD 261
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 71/289 (24%), Positives = 127/289 (43%), Gaps = 57/289 (19%)
Query: 99 LGQGGQGTVYKGML---ADGGIVAVKKSKLVDESNV-----------EQFINEVVILSQI 144
LGQG +YKG+L +D IV + S V F ++SQ+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIV----GPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL 58
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
+H+++VKL G C+ E ++V E++ G L +LH + + W +L +A +++ A+
Sbjct: 59 SHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115
Query: 205 YLHSATSIPIYHRDIKSSNILL-----DDKYR--AKVSDFGASRTIKVDQTHLTTRVQGT 257
YL + H ++ NIL+ ++ Y K+SD G T+ + + R+
Sbjct: 116 YLEDKKLV---HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV-LSREERVERIP-- 169
Query: 258 FGYLDPEYFR--SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMN 314
++ PE R + T +D +SFG L+E+ + G++P+ + + E F Q +
Sbjct: 170 --WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER----FYQDQH 223
Query: 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363
RL + +A L +C KRPS + + +L
Sbjct: 224 --RL------------PMPDCAELANLINQCWTYDPTKRPSFRAILRDL 258
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (171), Expect = 4e-13
Identities = 62/232 (26%), Positives = 101/232 (43%), Gaps = 40/232 (17%)
Query: 81 FTKMDLEKAT----DNYNANRILGQGGQGTVYKGMLADGGI-VAVKKSKLVDESNV--EQ 133
F + +L K D Y +G G G V G VA+KK +S + ++
Sbjct: 1 FYRQELNKTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKR 60
Query: 134 FINEVVILSQINHRNVVKLLGCCLESEVPL-------LVYEFIPNGTLYHY-----LHDQ 181
E+ +L ++H NV+ LL + L LV + L + L D
Sbjct: 61 TYRELRLLKHMDHENVIGLLDVFTPAS-SLEDFQDVYLVTHLM-GADLNNIVKCQKLSDD 118
Query: 182 TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241
+F + +++ LR + Y+HSA I HRD+K SNI +++ K+ DFG +R
Sbjct: 119 HIQF-LVYQI-LR-------GLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLAR 166
Query: 242 TIKVDQT-HLTTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQ 291
+ T ++ TR Y PE + + D++S G ++ ELLTG+
Sbjct: 167 HTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
+G G G VYK L G + AVK KL + E+ ++ + H N+V G L
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76
Query: 158 ESEVPLLVYEFIPNGTLYHYLH--DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
E + E+ G+L H E I + R E ++YLHS +
Sbjct: 77 SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCR-----ETLQGLAYLHSKGKM--- 128
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF---RSSQFT 272
HRDIK +NILL D K++DFG + I + + GT ++ PE ++ +
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGGYN 187
Query: 273 EKSDVYSFGVVLVELLTGQKPI 294
+ D+++ G+ +EL Q P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 59/203 (29%), Positives = 95/203 (46%), Gaps = 23/203 (11%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVKK-SKLVDESNVEQF-INEVVILSQINHRNVVKLLGC 155
+G+G G V+K + G IVA+KK + D+ +++ + E+ +L Q+ H N+V L+
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFP------ITWEMRLRIAIEVSGAMSYLHSA 209
LV+E+ + T+ + L P I W+ A+++ H
Sbjct: 69 FRRKRKLHLVFEYCDH-TVLNELEKNPRGVPEHLIKKIIWQTLQ--------AVNFCHKH 119
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF-RS 268
I HRD+K NIL+ + + K+ DFG +R + T V T Y PE
Sbjct: 120 NCI---HRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGD 175
Query: 269 SQFTEKSDVYSFGVVLVELLTGQ 291
+Q+ DV++ G V ELLTGQ
Sbjct: 176 TQYGPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 57/201 (28%), Positives = 83/201 (41%), Gaps = 22/201 (10%)
Query: 101 QGGQGTVYKGMLADGG----IVAVKKSKLVDESNVEQFINEVVIL-SQINHRNVVKLLGC 155
+G G+VY G I +KKS ++ ++ V E I+ Q V KL
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 156 CLESEVPLLVYEFIPNG---TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
+ LV E++ G +L L E++ + EV + LH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY------IAEVVLGVEDLHQRG-- 117
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT 272
I HRDIK N+L+D K++DFG SR ++ + GT YL PE
Sbjct: 118 -IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVGDD 171
Query: 273 EKSDVYSFGVVLVELLTGQKP 293
+ SD +S G V+ E L G P
Sbjct: 172 KMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 5e-13
Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 28/204 (13%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNV-EQFINEVV-------ILSQINHRNVV 150
LG+G GTVY ++ D VA ++ K++ E V E NE V +LS+++H +V
Sbjct: 8 LGKGSFGTVY--LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIV 65
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHD--QTEE-FP----ITWEMRLRIAIEVSGAM 203
K LE + ++ E+ L L + T + W ++L + +
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH----- 120
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
Y+H I HRD+K+ NI L + K+ DFG SR + + L T GT Y+ P
Sbjct: 121 -YMHQRR---ILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYYMSP 174
Query: 264 EYFRSSQFTEKSDVYSFGVVLVEL 287
E + + KSD++S G +L E+
Sbjct: 175 EALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 6e-13
Identities = 64/265 (24%), Positives = 122/265 (46%), Gaps = 26/265 (9%)
Query: 97 RILGQGGQGTVYKGMLADG----GIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
R++G+G V L + VKK + D+ +++ E + Q ++ +
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 153 LGCCLESEVPLL-VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
L C ++E L V E++ G L ++ Q + + E + E+S A++YLH
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LPEEHARFYSAEISLALNYLHERG- 116
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
I +RD+K N+LLD + K++D+G + + T+ GT Y+ PE R +
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAPEILRGEDY 173
Query: 272 TEKSDVYSFGVVLVELLTGQKP---IRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328
D ++ GV++ E++ G+ P + S+D + + ED LF+V+ + ++
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT----------EDYLFQVILEKQIR 223
Query: 329 EGKEEEIITVAMLGKRCLNMIGKKR 353
+ + ++L K LN K+R
Sbjct: 224 IPRSLSVKAASVL-KSFLNKDPKER 247
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 45/174 (25%), Positives = 84/174 (48%), Gaps = 24/174 (13%)
Query: 137 EVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP--NGTLYHYLHDQTEEFPITWEMRLR 194
E ++L +NH +V+++ + + +V +P + LY YL ++ PI + L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPI--DQALI 161
Query: 195 IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254
I ++ + YLH+ I HRD+K+ NI ++D + + D GA++ V L +
Sbjct: 162 IEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG--L 216
Query: 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELL------------TGQKPIRS 296
GT PE ++ K+D++S G+VL E+L T ++ ++S
Sbjct: 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS 270
|
Length = 357 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 25/213 (11%)
Query: 98 ILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH-RNVVKLLGCC 156
++G G G VYKG G +A K V E+ E+ +L + +H RN+ G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72
Query: 157 LESEVP------LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
++ P LV EF G++ + + T+ + E I E+ +S+LH
Sbjct: 73 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-TKGNTLKEEWIAYICREILRGLSHLHQHK 131
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGAS----RTIKVDQTHLTTRVQGTFGYLDPEYF 266
I HRDIK N+LL + K+ DFG S RT+ T + GT ++ PE
Sbjct: 132 VI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEVI 183
Query: 267 RSSQ-----FTEKSDVYSFGVVLVELLTGQKPI 294
+ + KSD++S G+ +E+ G P+
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEV-VILSQINHRNVVK 151
+++G+G G V A+ AVK K ++ + + ++E V+L + H +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSAT 210
L ++ V ++I G L+++L Q E + E R R A E++ A+ YLHS
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHL--QRERCFL--EPRARFYAAEIASALGYLHS-- 114
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
+ I +RD+K NILLD + ++DFG + ++ T+ GT YL PE
Sbjct: 115 -LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ D + G VL E+L G P S + E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 69/223 (30%), Positives = 119/223 (53%), Gaps = 43/223 (19%)
Query: 99 LGQGGQGTVYKGMLAD---GGIVAVKK--SKLVDESNVEQFINEVVILSQI-NHRNVVKL 152
LG+G G V+K + D +VA+KK + ++ ++ E++ L ++ +H N+VKL
Sbjct: 15 LGKGAYGIVWKAI--DRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKL 72
Query: 153 LGCCLESEVPL---LVYEFIPNGTLYH------YLHDQTEEFPITWEMRLRIAIEVSGAM 203
L +++E LV+E++ T H L D + + I +++ L+ A+
Sbjct: 73 LNV-IKAENDKDIYLVFEYME--TDLHAVIRANILEDVHKRY-IMYQL-LK-------AL 120
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTH----LTTRVQGTF 258
Y+HS I HRD+K SNILL+ R K++DFG +R++ ++++ LT V T
Sbjct: 121 KYIHSGNVI---HRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV-ATR 176
Query: 259 GYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI---RST 297
Y PE S+++T+ D++S G +L E+L G KP+ ST
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG-KPLFPGTST 218
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 76/243 (31%), Positives = 113/243 (46%), Gaps = 40/243 (16%)
Query: 93 YNANRILGQGGQGTV-YKGMLADGGIVAVKKSKLVD-ESNVEQFIN----EVVILSQINH 146
Y +R+LG G GTV ++DG AVK +VD E E N EV L +
Sbjct: 34 YWISRVLGSGATGTVLCAKRVSDGEPFAVK---VVDMEGMSEADKNRAQAEVCCLLNCDF 90
Query: 147 RNVVKLLGCCLESEVP------------LLVYEFIPNGTLYHYLHD--QTEEFPITWEMR 192
++VK C E LV ++ G L + +T E
Sbjct: 91 FSIVK----CHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAG 146
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR----TIKVDQT 248
L + I+V A+ ++HS I HRDIKS+NILL K+ DFG S+ T+ D
Sbjct: 147 L-LFIQVLLAVHHVHSKHMI---HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDD-- 200
Query: 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE--DRSLV 306
+ GT Y+ PE +R +++K+D++S GV+L ELLT ++P + EE ++L
Sbjct: 201 -VGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLA 259
Query: 307 GFF 309
G +
Sbjct: 260 GRY 262
|
Length = 496 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 58/204 (28%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVE-QFINEVVILSQINHRN 148
D+Y LG+G TVYKG +G +VA+K +L +E I E +L + H N
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHAN 64
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGAMSYLH 207
+V L E LV+E++ + L Y+ P ++ L ++ +SY+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFL---FQLLRGLSYIH 120
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-YF 266
I HRD+K N+L+ D K++DFG +R V +H + T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSV-PSHTYSNEVVTLWYRPPDVLL 176
Query: 267 RSSQFTEKSDVYSFGVVLVELLTG 290
S++++ D++ G + VE++ G
Sbjct: 177 GSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 59/214 (27%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH-RNVVKLLGC 155
++G G G VYKG G +A K V E E+ E+ +L + +H RN+ G
Sbjct: 22 EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81
Query: 156 CLESEVP------LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
++ P LV EF G++ L T+ + + I E+ +++LH+
Sbjct: 82 FIKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGAS----RTIKVDQTHLTTRVQGTFGYLDPEY 265
I HRDIK N+LL + K+ DFG S RT+ T + GT ++ PE
Sbjct: 141 KVI---HRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-----GTPYWMAPEV 192
Query: 266 FR-----SSQFTEKSDVYSFGVVLVELLTGQKPI 294
+ + +SD++S G+ +E+ G P+
Sbjct: 193 IACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 1e-12
Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 99 LGQGGQGTVYKGMLADGGIV-AVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCC 156
LG+G G+VYK + G+ A+K+ +L +DES Q I E+ IL + +V G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRL-RIAIEVSGAMSYLHSATSIPIY 215
+ E++ G+L L+ E L RI V + +L +I
Sbjct: 69 FIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI--I 125
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTI--KVDQTHLTTRVQGTFGYLDPEYFRS----- 268
HRD+K +N+L++ + K+ DFG S + + +T++ G Y+ PE +S
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI-----GCQSYMAPERIKSGGPNQ 180
Query: 269 -SQFTEKSDVYSFGVVLVELLTGQKP 293
+T +SDV+S G+ ++E+ G+ P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-12
Identities = 57/229 (24%), Positives = 100/229 (43%), Gaps = 31/229 (13%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL-VDESNV-EQFINEVVILSQINHR 147
D Y +G+G G VYK G +VA+KK++L +DE + + E+ +L ++
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 148 N-VVKLLGCCLESEVPLLVYEFIPNGTLY---HYLHDQTEEF----------PITWEMRL 193
+V+LL +E V E +LY YL ++F P+ +
Sbjct: 61 IYIVRLL--DVEH-----VEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTHLTT 252
++ +++ H + HRD+K N+L+D K K++D G R + T
Sbjct: 114 SFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH 170
Query: 253 RVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300
+ T Y PE S+ ++ D++S G + E+ Q P+ D+E
Sbjct: 171 EIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ-PLFPGDSE 217
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/219 (28%), Positives = 107/219 (48%), Gaps = 20/219 (9%)
Query: 92 NYNANRILGQGGQGTVYKGMLADG-------GIVAVKKSKLVDESNVEQFINEVVILSQI 144
++N +LG+G G V MLA+ I +KK ++ + +VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQ 57
Query: 145 NHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
+ + L C ++ L V E++ G L +++ Q +F + A E+S +
Sbjct: 58 DKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKF--KEPQAVFYAAEISVGL 114
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV-QGTFGYLD 262
+LH I +RD+K N++LD + K++DFG + VD +TTR GT Y+
Sbjct: 115 FFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG--VTTRTFCGTPDYIA 169
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
PE + + D +++GV+L E+L GQ P D +E
Sbjct: 170 PEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 57/214 (26%), Positives = 100/214 (46%), Gaps = 18/214 (8%)
Query: 93 YNANRILGQGGQGTVYKGMLADGGI-VAVKK--SKLVDESNVEQFINEVVILSQINHRNV 149
Y + +G G QG V GI VAVKK ++++ ++ E+V+L +NH+N+
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82
Query: 150 VKLLGC-----CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
+ LL LE + + + + L +H + + +++ + ++ +
Sbjct: 83 ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSY-----LLYQMLCGIK 137
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
+LHSA I HRD+K SNI++ K+ DFG +RT + + T T Y PE
Sbjct: 138 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVVTRYYRAPE 192
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
+ E D++S G ++ EL+ G + TD
Sbjct: 193 VILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 39/238 (16%)
Query: 96 NRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESN----VEQFIN----------EVVI 140
LG+G G V K G IVA+KK K+++ SN Q + E+ I
Sbjct: 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73
Query: 141 LSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVS 200
+++I H N++ L+ +E + LV + I L + + +T I +++
Sbjct: 74 MNEIKHENIMGLVDVYVEGDFINLVMD-IMASDLKKVVDRKIR---LTESQVKCILLQIL 129
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR----------TIKVDQT-- 248
++ LH HRD+ +NI ++ K K++DFG +R K +
Sbjct: 130 NGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 249 --HLTTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
+T++V T Y PE + ++ D++S G + ELLTG KP+ + E D+
Sbjct: 187 REEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPLFPGENEIDQ 242
|
Length = 335 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 3e-12
Identities = 60/216 (27%), Positives = 102/216 (47%), Gaps = 14/216 (6%)
Query: 92 NYNANRILGQGGQGTVY----KGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHR 147
++N +LG+G G V KG I +KK ++ + +VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 148 NVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
+ L C ++ L V E++ G L + + Q F + A E++ + +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRF--KEPHAVFYAAEIAIGLFFL 117
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV-QGTFGYLDPEY 265
HS I +RD+K N++LD + K++DFG + D +TT+ GT Y+ PE
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEI 172
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ + D ++FGV+L E+L GQ P D +E
Sbjct: 173 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 27/214 (12%)
Query: 97 RILGQGGQGTVYKGMLADGGI-VAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
R LG G G V+ + +D VAVKK L D +V+ + E+ I+ +++H N+VK+
Sbjct: 11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70
Query: 156 CLESEVPL--------------LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201
S L +V E++ L + E+ P++ E ++
Sbjct: 71 LGPSGSDLTEDVGSLTELNSVYIVQEYMETD-----LANVLEQGPLSEEHARLFMYQLLR 125
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTHLTTRVQG--TF 258
+ Y+HSA + HRD+K +N+ ++ + K+ DFG +R + +H +G T
Sbjct: 126 GLKYIHSANVL---HRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTK 182
Query: 259 GYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQ 291
Y P S + +T+ D+++ G + E+LTG+
Sbjct: 183 WYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 59/221 (26%), Positives = 102/221 (46%), Gaps = 10/221 (4%)
Query: 99 LGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVE-QFINEVVILSQINHRNVVKLLGCC 156
LG+G TV+KG +VA+K+ +L E I EV +L + H N+V L
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
LV+E++ + L YL D +++ ++ +SY H I H
Sbjct: 73 HTERCLTLVFEYLDS-DLKQYL-DNCGNLMSMHNVKI-FMFQLLRGLSYCHKRK---ILH 126
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-YFRSSQFTEKS 275
RD+K N+L+++K K++DFG +R V + V T Y P+ S++++
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSTEYSTPI 185
Query: 276 DVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316
D++ G +L E+ TG+ + +E+ L+ L E+
Sbjct: 186 DMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEE 226
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-12
Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 34/235 (14%)
Query: 91 DNYNANRILGQGGQGTVY----KGMLADGGIVA---VKKSKLVDESNVEQFINEVVILSQ 143
+++ ++G+G G V K A G I A +KKS L+ + V F E ILS
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREK---ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSI 57
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLH---DQTEEFPITWEM-RLRIAIEV 199
N + +L + + LV E+ P G L L+ DQ +E + + L +AI
Sbjct: 58 SNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS 117
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
M Y+H RDIK N+L+D K++DFG++ + ++ + GT
Sbjct: 118 VHQMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168
Query: 260 YLDPEYFRSSQFTEKS------DVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF 308
Y+ PE + K D +S GV+ E++ G+ P E S +
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF-----HEGTSAKTY 218
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 92 NYNANRILGQGGQGTVYKGMLADG-------GIVAVKKSKLVDESNVEQFINEVVILSQI 144
++N +LG+G G V MLA+ I +KK ++ + +VE + E +L+
Sbjct: 1 DFNFLMVLGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP 57
Query: 145 NHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEF--PITWEMRLRIAIEVSG 201
+ L C ++ L V E++ G L +++ Q +F P + A E++
Sbjct: 58 GKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPHA----VFYAAEIAI 112
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV-QGTFGY 260
+ +LHS I +RD+K N++LD + K++DFG + TTR GT Y
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDY 167
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ PE + + D ++FGV+L E+L GQ P D +E
Sbjct: 168 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 4e-12
Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 14/163 (8%)
Query: 133 QFINEVVILSQINHRNVVKLLGCCLESEVPLLV---YEFIPNGTLYHYLHD---QTEEFP 186
Q NE++ L ++NH N++K+ ++ Y+F LY +++D ++ P
Sbjct: 209 QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWKDRP 264
Query: 187 ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246
+ + R I ++ A+ Y+H I HRDIK NI L+ + + DFG + + +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIHDKKLI---HRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320
Query: 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
+ GT PE + E +D++S G++L+++L+
Sbjct: 321 REAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 16/207 (7%)
Query: 103 GQGTVYKGML----ADGGIVA---VKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
G+GT K +L A G A +KK ++ + V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYS 63
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIPI 214
+ V E++ G L+ +L + + E R R E+ A+ YLHS I
Sbjct: 64 FQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGK---I 116
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
+RD+K N++LD K++DFG + D + T GT YL PE + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC-GTPEYLAPEVLEDNDYGRA 175
Query: 275 SDVYSFGVVLVELLTGQKPIRSTDAEE 301
D + GVV+ E++ G+ P + D E+
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHEK 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 66/249 (26%), Positives = 109/249 (43%), Gaps = 35/249 (14%)
Query: 98 ILGQGGQGT---VYKGML---ADGGIVAVKKSKLVDESNVEQF-------INEVVILSQI 144
I G G+GT VYK DG A+KK K + EQ+ E+ +L ++
Sbjct: 4 IEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFK----GDKEQYTGISQSACREIALLREL 59
Query: 145 NHRNVVKLLGCCLESEVPL--LVYEFIPNGTLYHYLHD--QTEEFPITWEMRLRIAIEVS 200
H NVV L+ LE L++++ + L+ + Q + I M + ++
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQIL 118
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILL----DDKYRAKVSDFGASRTIKVDQTHLTT--RV 254
+ YLHS + HRD+K +NIL+ ++ K+ D G +R L V
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 255 QGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313
T Y PE ++ +T+ D+++ G + ELLT +PI + + F +
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT-LEPIFKGREAKIKKSNPFQRDQL 234
Query: 314 NEDRLFEVL 322
+R+FEVL
Sbjct: 235 --ERIFEVL 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 6e-12
Identities = 72/258 (27%), Positives = 114/258 (44%), Gaps = 59/258 (22%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGG-IVAVK---KSKLVDESNVEQFINEVVILSQINH 146
D++ + +++G+G G V D G I A+K KS+++++ V E IL++ ++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 147 RNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSGA 202
VVKL + E L L+ E++P G + L + TEE E R IA E A
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-----ETRFYIA-ETILA 113
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ------- 255
+ +H I HRDIK N+LLD K K+SDFG +K ++H T +
Sbjct: 114 IDSIHKLGYI---HRDIKPDNLLLDAKGHIKLSDFGLCTGLK--KSHRTEFYRILSHALP 168
Query: 256 --------------------------------GTFGYLDPEYFRSSQFTEKSDVYSFGVV 283
GT Y+ PE F + + ++ D +S GV+
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 284 LVELLTGQKPIRSTDAEE 301
+ E+L G P S + +E
Sbjct: 229 MYEMLVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 6e-12
Identities = 66/252 (26%), Positives = 105/252 (41%), Gaps = 50/252 (19%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGG-IVAVK---KSKLVDESNVEQFINEVVILSQINH 146
D++ + +++G+G G V D G I A+K K+ ++++ V E IL + +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSGAM 203
VVK+ + L+ EF+P G + L + +EE + IA E A+
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEE-----ATQFYIA-ETVLAI 114
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG------------------------- 238
+H I HRDIK N+LLD K K+SDFG
Sbjct: 115 DAIHQLGFI---HRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 239 ---------ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
+ T K ++ L GT Y+ PE F + + + D +S GV++ E+L
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 290 GQKPIRSTDAEE 301
G P S +E
Sbjct: 232 GYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 7e-12
Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 22/204 (10%)
Query: 97 RILGQGGQGT---VYKGM-LADGGIVAVKKSKLVDESNVEQFIN--EVVILSQIN-HRNV 149
+ILG+ G+GT V K G A+K K +S +EQ N E+ L +++ H N+
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNI 60
Query: 150 VKLLGCCLESEVP--LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR-IAIEVSGAMSYL 206
++L+ + + LV+E + + LY + + P E R++ ++ ++ ++
Sbjct: 61 LRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLP---EKRVKSYMYQLLKSLDHM 116
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
H I+HRDIK NIL+ D K++DFG+ R I + T T Y PE
Sbjct: 117 HR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY--TEYISTRWYRAPECL 170
Query: 267 RSSQF-TEKSDVYSFGVVLVELLT 289
+ + K D+++ G V E+L+
Sbjct: 171 LTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 7e-12
Identities = 60/243 (24%), Positives = 106/243 (43%), Gaps = 19/243 (7%)
Query: 97 RILGQGGQGTVYKGMLADG----GIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
R++G+G V L + VKK + D+ +++ E + Q + +
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 153 LGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSAT 210
L C ++ L LV E++ G L ++ Q + P E R A E+ A+++LH
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ-RKLP---EEHARFYAAEICIALNFLHERG 116
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
I +RD+K N+LLD K++D+G + + T+ GT Y+ PE R +
Sbjct: 117 ---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED-----RLFEVLEAR 325
+ D ++ GV++ E++ G+ P D + + Q + E R V +
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASH 232
Query: 326 VLK 328
VLK
Sbjct: 233 VLK 235
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-12
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 120 VKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYL 178
+KK + D+ +++ E + NH +V L C V EF+ G L ++
Sbjct: 28 IKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM 87
Query: 179 HDQTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF 237
Q + P E R + E+S A+++LH I +RD+K N+LLD + K++D+
Sbjct: 88 QRQ-RKLP---EEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 140
Query: 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---I 294
G + + T+ GT Y+ PE R + D ++ GV++ E++ G+ P +
Sbjct: 141 GMCKE-GIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199
Query: 295 RSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328
+D + + ED LF+V+ + ++
Sbjct: 200 GMSDNPDQNT----------EDYLFQVILEKQIR 223
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 9e-12
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQF----INEVVIL---SQINHRNVV 150
+G G GTVYK G VA+K ++ ++N + + EV +L +H N+V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRV--QTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 151 KLLGCCL------ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
+L+ C E++V L V+E + + L YL D+ + E + + +
Sbjct: 66 RLMDVCATSRTDRETKVTL-VFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
+LH+ I HRD+K NIL+ + K++DFG +R I Q LT V T Y PE
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLAR-IYSCQMALTPVVV-TLWYRAPE 177
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
S + D++S G + E+ +KP+ ++E D+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPLFCGNSEADQ 215
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 67/238 (28%), Positives = 101/238 (42%), Gaps = 23/238 (9%)
Query: 103 GQGTVYKGML----ADGGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
G+GT K +L A G A+K K ++ + V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 63
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIPI 214
+ V E+ G L+ +L + + E R R E+ A+ YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRD---V 116
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
+RDIK N++LD K++DFG + D + T GT YL PE + +
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRA 175
Query: 275 SDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL--EARVLKEG 330
D + GVV+ E++ G+ P + D E F L M E R L EA+ L G
Sbjct: 176 VDWWGLGVVMYEMMCGRLPFYNQDHERL-----FELILMEEIRFPRTLSPEAKSLLAG 228
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 31/213 (14%)
Query: 98 ILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
I+G+GG G VY AD G + K +D+ ++ E + L N R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTG--KMYAMKCLDKKRIKMKQGETLAL---NERIMLSLVST-- 53
Query: 158 ESEVPLLV---YEF-----------IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
+ P +V Y F + NG HY Q F EMR A E+ +
Sbjct: 54 -GDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-EKEMRF-YATEIILGL 110
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
++H+ + +RD+K +NILLD+ ++SD G + + H + GT GY+ P
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 264 EYF-RSSQFTEKSDVYSFGVVLVELLTGQKPIR 295
E + + + +D +S G +L +LL G P R
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 64.5 bits (158), Expect = 1e-11
Identities = 43/158 (27%), Positives = 73/158 (46%), Gaps = 12/158 (7%)
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
++ N +KL + +L+ ++I +G L+ L + E E++ I ++ A++
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLL--KKEGKLSEAEVKK-IIRQLVEALN 123
Query: 205 YLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
LH I H DIK N+L D K R + D+G + I + GT Y P
Sbjct: 124 DLHKHNII---HNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY-----DGTLDYFSP 175
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
E + + D ++ GV+ ELLTG+ P + + EE
Sbjct: 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE 213
|
Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 48/217 (22%), Positives = 87/217 (40%), Gaps = 23/217 (10%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLG 154
+ + K +VAVKK L + +++ E++ Q+ H N++ +
Sbjct: 8 KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66
Query: 155 CCLESEVPLLVYEFIPNGT----LYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+ +V + G+ L + + E I + ++ +V A+ Y+HS
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK-----DVLNALDYIHSKG 121
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRT-IKVDQTHLTTRVQGTFG-----YLDPE 264
I HR +K+S+ILL + +S S + IK + +L PE
Sbjct: 122 FI---HRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE 178
Query: 265 YFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
+ + + EKSD+YS G+ EL G P + A
Sbjct: 179 VLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA 215
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 54/216 (25%), Positives = 93/216 (43%), Gaps = 30/216 (13%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKK--SKLVDESNVEQFINEVVILSQINH 146
T+ Y + +G G G V G VA+KK ++ E+ +L + H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 147 RNVVKLLGCCLE-SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
N++ L + E V E + GT H L P+ + ++ + Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELL--GTDLHRL---LTSRPLEKQFIQYFLYQILRGLKY 123
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
+HSA + HRD+K SNIL+++ K+ DFG +R + +T GY+ Y
Sbjct: 124 VHSAGVV---HRDLKPSNILINENCDLKICDFGLAR---IQDPQMT-------GYVSTRY 170
Query: 266 FRSSQ-------FTEKSDVYSFGVVLVELLTGQKPI 294
+R+ + + + D++S G + E+L G KP+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 64/229 (27%), Positives = 106/229 (46%), Gaps = 28/229 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF----INEVVILSQIN 145
Y +GQG G V+K IVA+KK + +E E F + E+ IL +
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLK 69
Query: 146 HRNVVKLLGCCLESEVP--------LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI 197
H NVV L+ C P LV+EF + L L ++ +F ++ E++ + +
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS-EIKKVMKM 127
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI---KVDQTHL-TTR 253
++G + Y+H I HRD+K++NIL+ K++DFG +R K + + T R
Sbjct: 128 LLNG-LYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 254 VQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
V T Y PE + D++ G ++ E+ T + PI + E+
Sbjct: 184 VV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPIMQGNTEQ 230
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 4e-11
Identities = 63/224 (28%), Positives = 99/224 (44%), Gaps = 39/224 (17%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQ-FINEVVILSQINHRN 148
Y +G+G G V G VA+KK + Q + E+ IL + H N
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHEN 64
Query: 149 VVKLLGC----CLES--EVPLLVYEFIPNGTLYHYL------HDQTEEFPITWEMRLRIA 196
++ +L ES +V +V E + LY + +D + F +++ LR
Sbjct: 65 IIGILDIIRPPSFESFNDV-YIVQELMET-DLYKLIKTQHLSNDHIQYF--LYQI-LR-- 117
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-----LT 251
+ Y+HSA + HRD+K SN+LL+ K+ DFG +R D H LT
Sbjct: 118 -----GLKYIHSANVL---HRDLKPSNLLLNTNCDLKICDFGLARIA--DPEHDHTGFLT 167
Query: 252 TRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
V T Y PE S +T+ D++S G +L E+L+ +P+
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 5e-11
Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 12/208 (5%)
Query: 99 LGQGGQGTVYKG--MLADGGIVAVKKSKLVDESNVE-QFINEVVILSQINHRNVVKLLGC 155
LG+G TVYKG L D +VA+K+ +L E I EV +L + H N+V L
Sbjct: 14 LGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
+ LV+E++ + L YL D + ++L + + G ++Y H +
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMH-NVKLFLFQLLRG-LNYCHRRK---VL 126
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-YFRSSQFTEK 274
HRD+K N+L++++ K++DFG +R + + V T Y P+ S+ ++ +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQ 185
Query: 275 SDVYSFGVVLVELLTGQKPIRSTDAEED 302
D++ G + E+ TG+ + EE
Sbjct: 186 IDMWGVGCIFYEMSTGRPLFPGSTVEEQ 213
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 5e-11
Identities = 38/104 (36%), Positives = 57/104 (54%), Gaps = 8/104 (7%)
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
+IA+ + A+ YLHS S+ HRD+K SN+L++ + K+ DFG S + VD T
Sbjct: 107 KIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNGQVKLCDFGISGYL-VDSVAKTID 163
Query: 254 VQGTFGYLDPEYF----RSSQFTEKSDVYSFGVVLVELLTGQKP 293
G Y+ PE + KSDV+S G+ ++EL TG+ P
Sbjct: 164 A-GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 5e-11
Identities = 65/252 (25%), Positives = 105/252 (41%), Gaps = 50/252 (19%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIV----AVKKSKLVDESNVEQFINEVVILSQINH 146
+++ + +++G+G G V D G V ++K+ ++++ V E IL + +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSGAM 203
VVK+ + L+ EF+P G + L + TEE E + IA E A+
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEE-----ETQFYIA-ETVLAI 114
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG------------------------- 238
+H I HRDIK N+LLD K K+SDFG
Sbjct: 115 DSIHQLGFI---HRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 239 ---------ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
+ T K ++ L GT Y+ PE F + + + D +S GV++ E+L
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 290 GQKPIRSTDAEE 301
G P S +E
Sbjct: 232 GYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 58/203 (28%), Positives = 102/203 (50%), Gaps = 14/203 (6%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVKK---SKLVDESNVEQFINEVVILSQINHRNVVKLLG 154
LG+GG G V + + G + A KK +L +S + + E IL ++N +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59
Query: 155 CCLESEVPL-LVYEFIPNGTL-YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
ES+ L LV + G L YH + E + E + + +++ + +LHS +
Sbjct: 60 YAFESKTHLCLVMSLMNGGDLKYHIYN--VGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT 272
I +RD+K N+LLDD+ ++SD G + +K +T T+ GT GY+ PE + ++
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYS 172
Query: 273 EKSDVYSFGVVLVELLTGQKPIR 295
D ++ G + E++ G+ P +
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTPFK 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 61/243 (25%), Positives = 114/243 (46%), Gaps = 24/243 (9%)
Query: 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKG--MLADGGIVAVKKSKLVDESNVE-QFI 135
K+ T + LEK LG+G TV+KG L + +VA+K+ +L E I
Sbjct: 4 KMETYIKLEK----------LGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAI 52
Query: 136 NEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI 195
EV +L + H N+V L + LV+E++ + L Y+ D + ++I
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSM---HNVKI 108
Query: 196 AI-EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254
+ ++ ++Y H + HRD+K N+L++++ K++DFG +R V + V
Sbjct: 109 FLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEV 165
Query: 255 QGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313
T Y P+ SS+++ + D++ G + E+ +G+ + E++ L+ L
Sbjct: 166 V-TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTP 224
Query: 314 NED 316
E+
Sbjct: 225 TEE 227
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 7e-11
Identities = 60/213 (28%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 98 ILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL 157
I+G+GG G VY AD G + K +D+ ++ E + L N R ++ L+
Sbjct: 1 IIGRGGFGEVYGCRKADTG--KMYAMKCLDKKRIKMKQGETLAL---NERIMLSLVST-- 53
Query: 158 ESEVPLLV---YEF-----------IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
+ P +V Y F + NG HY Q F EMR A E+ +
Sbjct: 54 -GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEA-EMRF-YAAEIILGL 110
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
++H+ + +RD+K +NILLD+ ++SD G + + H + GT GY+ P
Sbjct: 111 EHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 264 EYF-RSSQFTEKSDVYSFGVVLVELLTGQKPIR 295
E + + +D +S G +L +LL G P R
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 39/225 (17%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKK-SKLVDE-SNVEQFINEVVILSQINHR 147
Y +G G G V + G VA+KK D + ++ + E+ IL H
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 148 NVVKLLGCCLESEVPL-----LVYEFIPNGTLYHYLH-DQTEEFPITWE-MR------LR 194
N++ + L +V + + + L+H +H DQ P+T E +R LR
Sbjct: 65 NIIAIRDI-LRPPGADFKDVYVVMDLMES-DLHHIIHSDQ----PLTEEHIRYFLYQLLR 118
Query: 195 IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI----KVDQTHL 250
+ Y+HSA + HRD+K SN+L+++ ++ DFG +R + + +
Sbjct: 119 -------GLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFM 168
Query: 251 TTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
T V T Y PE ++T D++S G + E+L G++ +
Sbjct: 169 TEYV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 9e-11
Identities = 64/267 (23%), Positives = 107/267 (40%), Gaps = 68/267 (25%)
Query: 91 DNYNANRILGQGGQGTV-YKGMLADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
++++ +++G+G G V G I A+K KS++ + + E +L++ +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEM------RLRIAIEVS 200
VV L +++ L+ EF+P G L L I ++ R +A E
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTML--------IKYDTFSEDVTRFYMA-ECV 111
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS-------------------- 240
A+ +H I HRDIK NIL+D K+SDFG S
Sbjct: 112 LAIEAVHKLGFI---HRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKS 168
Query: 241 --------RTIKVDQTHLT--TRVQ----------------GTFGYLDPEYFRSSQFTEK 274
++ VD +LT ++ Q GT Y+ PE F + ++
Sbjct: 169 NKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE 228
Query: 275 SDVYSFGVVLVELLTGQKPIRSTDAEE 301
D +S G ++ E L G P S ++ E
Sbjct: 229 CDWWSLGAIMFECLIGWPPFCSENSHE 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 67/247 (27%), Positives = 101/247 (40%), Gaps = 36/247 (14%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH 146
EKAT Y A +IL KK +V + V + E +L H
Sbjct: 16 EKATGRYYAMKIL---------------------KKEVIVAKDEVAHTLTENRVLQNSRH 54
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSY 205
+ L + V E+ G L+ +L + + E R R E+ A+ Y
Sbjct: 55 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDY 110
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LHS ++ +RD+K N++LD K++DFG + D + T GT YL PE
Sbjct: 111 LHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 167
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL--E 323
+ + D + GVV+ E++ G+ P + D E+ F L M E R L E
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-----FELILMEEIRFPRTLSPE 222
Query: 324 ARVLKEG 330
A+ L G
Sbjct: 223 AKSLLSG 229
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 71/267 (26%), Positives = 132/267 (49%), Gaps = 34/267 (12%)
Query: 56 FKKNGGLLLQQQLS--SNEGNIEKTKLFTKMDLEKATD-NYNANRILGQGGQGTVYKGML 112
F+ N L +++ S +N G E + D+ ++ + +Y I+G G G VY+ +
Sbjct: 28 FEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAIC 87
Query: 113 ADGG-IVAVKKSKLVDESNVEQFIN-EVVILSQINHRNVVKL-----LGCCLESEVPL-- 163
D VA+KK L D Q+ N E++I+ +NH N++ L C ++E +
Sbjct: 88 IDTSEKVAIKKV-LQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFL 142
Query: 164 -LVYEFIPNGTLYHYL-HDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKS 221
+V EFIP T++ Y+ H + + + ++ A++Y+HS I HRD+K
Sbjct: 143 NVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKP 198
Query: 222 SNILLDDK-YRAKVSDFGASRTIKVDQ---THLTTRVQGTFGYLDPE-YFRSSQFTEKSD 276
N+L+D + K+ DFG+++ + Q +++ +R Y PE ++ +T D
Sbjct: 199 QNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----YRAPELMLGATNYTTHID 253
Query: 277 VYSFGVVLVELLTGQKPIRSTDAEEDR 303
++S G ++ E++ G PI S + D+
Sbjct: 254 LWSLGCIIAEMILGY-PIFSGQSSVDQ 279
|
Length = 440 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 24/226 (10%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYK-GMLADGGIVAVKKSKLVDESNVEQFINEVVILSQ 143
L TD + +G+G G VYK DG + AVK + + + E ++ S
Sbjct: 16 SLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSL 75
Query: 144 INHRNVVKLLGCCLESEVPL-----LVYEFIPNGTLYHYLHD-----QTEEFPITWEMRL 193
NH NVVK G +++ + LV E G++ + Q + +
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAM------ 129
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
I+ + GA+ L + I HRD+K +NILL + K+ DFG S + + T
Sbjct: 130 -ISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS 188
Query: 254 VQGTFGYLDPEYFRSSQ-----FTEKSDVYSFGVVLVELLTGQKPI 294
V GT ++ PE Q + + DV+S G+ +EL G P+
Sbjct: 189 V-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 72/258 (27%), Positives = 106/258 (41%), Gaps = 45/258 (17%)
Query: 99 LGQGGQGTVYKGMLADG---GIVAVKKSKLVDESNVEQ--FINEVVILSQINHRNVVKLL 153
+G G G V G + G V VK+ + V S EQ F+ E + H N+++ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRL--RIAIEVSGAMSYLHSATS 211
G C E LLV EF P G L YL + +T + R+A E++ + +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNF 121
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRT-------IKVDQTHLTTR---------VQ 255
I H D+ N LL K+ D+G S + DQ + R V
Sbjct: 122 I---HSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178
Query: 256 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRS---------TDAEEDRSL 305
G +D T++S+V+S GV + EL G +P R T E+ L
Sbjct: 179 GNLLVVDQ--------TKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKL 230
Query: 306 VGFFLQAMNEDRLFEVLE 323
L+ DR +EV++
Sbjct: 231 PKPRLKLPLSDRWYEVMQ 248
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 3e-10
Identities = 60/219 (27%), Positives = 97/219 (44%), Gaps = 17/219 (7%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKLLG 154
+G+G G VY+ D I A+K K ++V + V I E IL + ++G
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 155 CCLESEVP---LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVSGAMSYLHSAT 210
+ LV +++ G L+ +L + F E R + I E+ A+ +LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR-FS---EDRAKFYIAELVLALEHLHKYD 116
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
I +RD+K NILLD + DFG S+ + T GT YL PE +
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 271 -FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF 308
+T+ D +S GV++ E+ G P + D ++ + F
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF 211
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 46/165 (27%), Positives = 73/165 (44%), Gaps = 20/165 (12%)
Query: 137 EVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIA 196
E+ IL I+HR ++ L+ +V + Y D + + L A
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV--------MPKYKCDLFTYVDRSGPLPLEQA 187
Query: 197 IEVS----GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT 252
I + A++YLH I HRD+K+ NI LD+ A + DFGA+ K+D T
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAA--CKLDAHPDTP 242
Query: 253 RVQGTFGYLD---PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
+ G G L+ PE + K+D++S G+VL E+ +
Sbjct: 243 QCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 26/204 (12%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE-QFINEVVILSQINHRNVVKLLGCC 156
LG+G TVYKG+ +G +VA+K + E V I E +L + H N+V L
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDII 72
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPI-------TWEMRLRIAIEVSGAMSYLHSA 209
E V+E Y+H ++ I + +RL ++ ++Y+H
Sbjct: 73 HTKETLTFVFE---------YMHTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAYIHGQ 122
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV-DQTHLTTRVQGTFGYLDPEYFR- 267
I HRD+K N+L+ K++DFG +R + QT+ + V T Y P+
Sbjct: 123 H---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLG 177
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQ 291
++ ++ D++ G + +E+L GQ
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 4e-10
Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 12/102 (11%)
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDP 263
YLHSA I HRDIK N+L++ K+ DFG +R + D++ H+T V + Y P
Sbjct: 118 YLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YRAP 173
Query: 264 EYFRSSQ-FTEKSDVYSFGVVLVELLTG------QKPIRSTD 298
E S+ +T D++S G + ELL Q PI+ D
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD 215
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 55/211 (26%), Positives = 97/211 (45%), Gaps = 27/211 (12%)
Query: 97 RILGQGGQGTVYKGMLADG-------GIVAVKKSKLV-DESNVEQFINEVVILSQINHRN 148
++LG+GG G V++ G + +KK+ +V ++ + E IL + H
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLH------DQTEEFPITWEMRLRIAIEVSGA 202
+V L+ L+ E++ G L+ +L + T F ++ E+S A
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS---------EISLA 112
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
+ +LH I +RD+K NILLD + K++DFG + + + +T GT Y+
Sbjct: 113 LEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKE-SIHEGTVTHTFCGTIEYMA 168
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
PE S + D +S G ++ ++LTG P
Sbjct: 169 PEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-10
Identities = 66/239 (27%), Positives = 100/239 (41%), Gaps = 25/239 (10%)
Query: 103 GQGTVYKGML----ADGGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
G+GT K +L A G A+K K ++ + V + E +L H + L
Sbjct: 4 GKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYS 63
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIPI 214
+ V E+ G L+ +L + + E R R E+ A+ YLHS +
Sbjct: 64 FQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCD---V 116
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRT-IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTE 273
+RD+K N++LD K++DFG + I T GT YL PE + +
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLEDNDYGR 174
Query: 274 KSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL--EARVLKEG 330
D + GVV+ E++ G+ P + D E F L M E R L EA+ L G
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEEIRFPRTLSPEAKSLLAG 228
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 54/190 (28%), Positives = 93/190 (48%), Gaps = 13/190 (6%)
Query: 118 VAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHY 177
V K L DE +E+ L+ +H +VK + LL+ E+ G L
Sbjct: 96 VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQ 155
Query: 178 LHDQTEE-FPIT-WEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235
+ + +E P +E+ L + ++ A+ +HS + HRD+KS+NI L K+
Sbjct: 156 IKQRLKEHLPFQEYEVGL-LFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLG 211
Query: 236 DFGASR----TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 291
DFG S+ ++ +D + + GT YL PE + ++++K+D++S GV+L ELLT
Sbjct: 212 DFGFSKQYSDSVSLD---VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH 268
Query: 292 KPIRSTDAEE 301
+P + E
Sbjct: 269 RPFKGPSQRE 278
|
Length = 478 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 5e-10
Identities = 53/201 (26%), Positives = 99/201 (49%), Gaps = 13/201 (6%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVKKSKLVDESN-VEQF-INEVVILSQINHRNVVKLLGC 155
+G+G GTV+K + IVA+K+ +L D+ V + E+ +L ++ H+N+V+L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD- 66
Query: 156 CLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
L S+ L LV+E+ + L Y + I E+ ++ +++ HS +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKYFDSCNGD--IDPEIVKSFMFQLLKGLAFCHSHN---V 120
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-YFRSSQFTE 273
HRD+K N+L++ K++DFG +R + + V T Y P+ F + ++
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYST 179
Query: 274 KSDVYSFGVVLVELLTGQKPI 294
D++S G + EL +P+
Sbjct: 180 SIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 8e-10
Identities = 38/119 (31%), Positives = 65/119 (54%), Gaps = 11/119 (9%)
Query: 180 DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239
D + +P+ + LR + +V+ M +L S I HRD+ + N+LL D AK+ DFG
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCI---HRDVAARNVLLTDGRVAKICDFGL 258
Query: 240 SRTIKVDQTHLTTRVQGT----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+R I D ++ V+G ++ PE +T +SDV+S+G++L E+ + G+ P
Sbjct: 259 ARDIMNDSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 8e-10
Identities = 70/285 (24%), Positives = 105/285 (36%), Gaps = 71/285 (24%)
Query: 87 EKATDNYNANRILGQGGQGTV--------YKGMLADGGIVAVKKSKL-VDESNVEQFINE 137
E D ++LG G G V K + VAVK K S + ++E
Sbjct: 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCN--TVAVKMLKEGATASEHKALMSE 60
Query: 138 VVILSQI-NHRNVVKLLGCCLESEVPLLV-YEFIPNGTLYHYLHDQTEEFPITWE----- 190
+ IL I NH NVV LLG C + PL+V EF G L ++L + E F E
Sbjct: 61 LKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQ 120
Query: 191 -MRLRIAIEVSGAMSYLHSATSIPIYHR-------------------------------- 217
R R +E S + + + ++ R
Sbjct: 121 RGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180
Query: 218 ------------------DIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT-RVQGTF 258
D+ + NILL + K+ DFG +R I D ++ +
Sbjct: 181 FQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 259 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEED 302
++ PE +T +SDV+SFGV+L E+ + G P E+
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 9e-10
Identities = 48/169 (28%), Positives = 73/169 (43%), Gaps = 17/169 (10%)
Query: 135 INEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP--NGTLYHYLHDQTEEFPITWEMR 192
E IL INH ++++L G ++ L+ +P LY YL + I ++
Sbjct: 131 ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAK-RNIAIC-DI- 184
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT 252
L I V A+ YLH I HRDIK+ NI ++ + DFGA+ VD
Sbjct: 185 LAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAA-CFPVDIN--AN 238
Query: 253 RVQGTFGYL---DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
+ G G + PE + D++S G+VL E+ T + D
Sbjct: 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKD 287
|
Length = 391 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 9e-10
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHR 147
+D + +G+G G V+K + +G AVK + + + E+ E IL + +H
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNILKALSDHP 75
Query: 148 NVVKLLGCCLESEVP-----LLVYEFIPNGTLYHYLH------DQTEEFPITWEMRLRIA 196
NVVK G + +V LV E G++ + ++ EE I + I
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY-----IL 130
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG 256
E + +LH +I HRD+K +NILL + K+ DFG S + + T V G
Sbjct: 131 HEALMGLQHLHVNKTI---HRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-G 186
Query: 257 TFGYLDPEYFRSSQ-----FTEKSDVYSFGVVLVELLTGQKPI 294
T ++ PE Q + + DV+S G+ +EL G P+
Sbjct: 187 TPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 9e-10
Identities = 58/233 (24%), Positives = 93/233 (39%), Gaps = 70/233 (30%)
Query: 93 YNANRILGQGGQGTVYKGMLADGGI----VAVKK--SKLVDESNVEQFINEVVILSQINH 146
Y + +G G QG V A + VA+KK + ++ ++ E+V++ +NH
Sbjct: 18 YQNLKPIGSGAQGIV---CAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNH 74
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA---- 202
+N++ LL F P +L EEF + + +E+ A
Sbjct: 75 KNIIGLLNV------------FTPQKSL--------EEF-----QDVYLVMELMDANLCQ 109
Query: 203 ----------MSY-----------LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241
MSY LHSA I HRD+K SNI++ K+ DFG +R
Sbjct: 110 VIQMDLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 166
Query: 242 TIKVDQT---HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 291
T ++ TR Y PE + E D++S G ++ E++ G
Sbjct: 167 TAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 9e-10
Identities = 40/141 (28%), Positives = 62/141 (43%), Gaps = 37/141 (26%)
Query: 180 DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239
D+ + P+T E + + +V+ M +L S I HRD+ + NILL + K+ DFG
Sbjct: 163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGL 219
Query: 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ-----------------FTEKSDVYSFGV 282
+R I Y DP+Y R +T +SDV+SFGV
Sbjct: 220 ARDI----------------YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGV 263
Query: 283 VLVELLT-GQKPIRSTDAEED 302
+L E+ + G P +E+
Sbjct: 264 LLWEIFSLGASPYPGVQIDEE 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 1e-09
Identities = 35/98 (35%), Positives = 52/98 (53%), Gaps = 10/98 (10%)
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI----KVDQTHLTTRVQGT 257
+ Y+HSA + HRD+K N+L++ K+ DFG +R + +T V T
Sbjct: 117 GLKYIHSANVL---HRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-AT 172
Query: 258 FGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPI 294
Y PE S Q +T+ DV+S G +L ELL G+KP+
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 36/91 (39%), Positives = 50/91 (54%), Gaps = 6/91 (6%)
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
Y+HSA + HRD+K SN+LL+ K+ DFG +RT +T V T Y PE
Sbjct: 123 YIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPE 178
Query: 265 -YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
S++T DV+S G + ELL G+KP+
Sbjct: 179 LLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 54/213 (25%), Positives = 94/213 (44%), Gaps = 36/213 (16%)
Query: 93 YNANRILGQGGQGTV---YKGMLADGGIVAVKK--SKLVDESNVEQFINEVVILSQINHR 147
Y + +G G QG V Y +L VA+KK ++++ ++ E+V++ +NH+
Sbjct: 19 YQNLKPIGSGAQGIVCAAYDAVLDRN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHY--------LHD----QTEEFPITWEMRLRI 195
N++ LL F P +L + L D Q + + E +
Sbjct: 77 NIISLLNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ 255
++ + +LHSA I HRD+K SNI++ K+ DFG +RT + + T
Sbjct: 125 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYV 179
Query: 256 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELL 288
T Y PE + E D++S G ++ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 1e-09
Identities = 59/238 (24%), Positives = 98/238 (41%), Gaps = 38/238 (15%)
Query: 97 RILGQGGQGTVYKGMLADGGIV-AVK---KSKLVDESNVEQFINEVVILSQINHRNVVKL 152
++LG+G G V+ L G + A+K K +++ + V++ + E IL+ ++H + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEE-FPITWEMRLRIAIEVSGAMSYLHSATS 211
LV ++ P G L+ L Q + R A EV A+ YLH
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE-VARFYAA-EVLLALEYLHL--- 121
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDF------------------GASRTIKVDQTHLTTR 253
+ I +RD+K NILL + +SDF SR V+ T
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETF 181
Query: 254 VQ----------GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ GT Y+ PE D ++ G++L E+L G P + ++ +E
Sbjct: 182 SEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-09
Identities = 67/287 (23%), Positives = 131/287 (45%), Gaps = 50/287 (17%)
Query: 99 LGQGGQGTVYKGMLA------DGGIVAVKKSKLV----DESNVE---QFINEVVILSQIN 145
LG+G + +Y G+L D G K+ K++ D S+ + F ++ Q++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
H+++V L G C+ ++V EF+ G L ++H +++ W + ++A +++ A+SY
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASALSY 120
Query: 206 LHSATSIPIYHRDIKSSNILL-----DDKYRA--KVSDFGASRTIKVDQTHLTTRVQGTF 258
L + H ++ + NILL D + K+SD G T+ + + R+
Sbjct: 121 LEDKDLV---HGNVCTKNILLAREGIDGECGPFIKLSDPGIPITV-LSRQECVERIP--- 173
Query: 259 GYLDPEYFRSSQ-FTEKSDVYSFGVVLVEL-LTGQKPIRSTDAEEDRSLVGFFLQAMNED 316
++ PE S+ + +D +SFG L E+ G+ P++ D++L ++
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK------DKTLA-------EKE 219
Query: 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363
R +E V KE +A L C+N +RP + + ++
Sbjct: 220 RFYEGQCMLVTPSCKE-----LADLMTHCMNYDPNQRPFFRAIMRDI 261
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 67/300 (22%), Positives = 126/300 (42%), Gaps = 64/300 (21%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQ------------------------- 133
LGQG + +Y G L G ++ ++ DE + +
Sbjct: 3 LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62
Query: 134 FINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRL 193
F ++SQ++H ++ + G C+ ++V EF+ +G L L + P+ W++
Sbjct: 63 FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKI-- 120
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA-------KVSDFGASRTIKVD 246
+A +++ A+SYL + H ++ + NILL A K+SD G S T +
Sbjct: 121 TVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTA-LS 176
Query: 247 QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVEL-LTGQKPIRS-TDAEEDR 303
+ R+ ++ PE + + +D +SFG L+E+ G+ P++ T +E++R
Sbjct: 177 REERVERIP----WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232
Query: 304 SLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363
F + + RL E +A L +CL +RPS + + +L
Sbjct: 233 -----FYE--KKHRL------------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 5e-09
Identities = 37/118 (31%), Positives = 63/118 (53%), Gaps = 11/118 (9%)
Query: 181 QTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240
+ +E + E L + +V+ MS+L S I HRD+ + NILL K+ DFG +
Sbjct: 205 EEDELALDTEDLLSFSYQVAKGMSFLASKNCI---HRDLAARNILLTHGRITKICDFGLA 261
Query: 241 RTIKVDQTHLTTRVQGT----FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
R I+ D ++ V+G ++ PE + +T +SDV+S+G++L E+ + G P
Sbjct: 262 RDIRNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 63/256 (24%), Positives = 111/256 (43%), Gaps = 48/256 (18%)
Query: 128 ESNVEQFINEVVILSQINHRNVVKLLGCCLE--SEVPLLVYEFIPNGTLYHYLHDQTEEF 185
E Q + EV ++ ++ H+N+V+ + L ++ ++ EF G L + + F
Sbjct: 53 EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMF 112
Query: 186 -PITWEMRLRIAIEVSGAMSYLHSATSIP----IYHRDIKSSNILLDDKYR--------- 231
I + I ++ A++Y H+ P + HRD+K NI L R
Sbjct: 113 GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQA 172
Query: 232 --------AKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF--RSSQFTEKSDVYSFG 281
AK+ DFG S+ I ++ + GT Y PE + + +KSD+++ G
Sbjct: 173 NNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALG 230
Query: 282 VVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE--ARVLKEGKEEEIITVA 339
++ EL +G+ P F +A N +L L+ + +GK +E+
Sbjct: 231 CIIYELCSGKTP---------------FHKANNFSQLISELKRGPDLPIKGKSKEL---N 272
Query: 340 MLGKRCLNMIGKKRPS 355
+L K LN+ K+RPS
Sbjct: 273 ILIKNLLNLSAKERPS 288
|
Length = 1021 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 35/120 (29%), Positives = 60/120 (50%), Gaps = 11/120 (9%)
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
+HS + HRDIK N+LLD +++DFG+ + D T ++ GT Y+ PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174
Query: 266 FRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320
++ ++ + D +S GV + E+L G+ P + SLV + + MN + F+
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHEERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 36/223 (16%)
Query: 93 YNANRILGQGGQGTV---YKGMLADGGIVAVKK--SKLVDESNVEQFINEVVILSQINHR 147
Y + +G G QG V Y +L VA+KK ++++ ++ E+V++ +NH+
Sbjct: 26 YQNLKPIGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHY--------LHD----QTEEFPITWEMRLRI 195
N++ LL F P +L + L D Q + + E +
Sbjct: 84 NIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYL 131
Query: 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ 255
++ + +LHSA I HRD+K SNI++ K+ DFG +RT + + T
Sbjct: 132 LYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYV 186
Query: 256 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
T Y PE + E D++S G ++ E++ G TD
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 8e-09
Identities = 63/248 (25%), Positives = 96/248 (38%), Gaps = 58/248 (23%)
Query: 97 RILGQGGQGTVYKGMLADGGIV----AVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
+ LG G G V D + ++K +++ + V E IL++ ++ VVKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVSGAMSYLHSATS 211
+ + V ++IP G + L + E FP E+ R I E++ A+ +H
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL-IRMEVFP---EVLARFYIAELTLAIESVHKMGF 122
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFG--------------------------------- 238
I HRDIK NIL+D K++DFG
Sbjct: 123 I---HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDD 179
Query: 239 -------------ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLV 285
R K Q L + GT Y+ PE +T+ D +S GV+L
Sbjct: 180 VSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILF 239
Query: 286 ELLTGQKP 293
E+L GQ P
Sbjct: 240 EMLVGQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 8e-09
Identities = 62/243 (25%), Positives = 101/243 (41%), Gaps = 40/243 (16%)
Query: 97 RILGQGGQGTVY----KGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
+++ G G VY K + + K L+ + ++Q E IL+ + VV +
Sbjct: 7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSM 66
Query: 153 LGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEM-RLRIAIEVSGAMSYLHSAT 210
C E++ L +V E++ G L + + +M R+ A E A+ YLH+
Sbjct: 67 F-CSFETKRHLCMVMEYVEGGDCATLLKNIG---ALPVDMARMYFA-ETVLALEYLHNYG 121
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR----------------- 253
I HRD+K N+L+ K++DFG S K+ LTT
Sbjct: 122 ---IVHRDLKPDNLLITSMGHIKLTDFGLS---KIGLMSLTTNLYEGHIEKDTREFLDKQ 175
Query: 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313
V GT Y+ PE + + D ++ G++L E L G P EE F Q +
Sbjct: 176 VCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQVI 229
Query: 314 NED 316
++D
Sbjct: 230 SDD 232
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 36/119 (30%), Positives = 60/119 (50%), Gaps = 5/119 (4%)
Query: 186 PITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245
+T E + + +V+ M +L S I HRD+ + NILL + K+ DFG +R I
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLASRKCI---HRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 246 DQTHLTT-RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEED 302
D ++ + ++ PE +T +SDV+SFGV+L E+ + G P +E+
Sbjct: 232 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 10/209 (4%)
Query: 98 ILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESN--VEQFINEVVILSQINHRNVVKLLG 154
++G+G G V K + IVA+KK K +E+ E + E+ +L + N+V+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
LV+E++ L + EE P ++ + + +H I
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-----ELLEEMP-NGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
HRDIK N+L+ K+ DFG +R + T T Y PE + + +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 275 SDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
D++S G +L EL GQ P+ ++E D+
Sbjct: 182 VDMWSVGCILGELSDGQ-PLFPGESEIDQ 209
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 58/214 (27%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRNV 149
Y ++G+G G V + G VA+KK V E S+ + + E+ +L + H ++
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61
Query: 150 VKLLGCCL-----ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
V++ L E + +V+E + + H + ++ +T E ++ A+
Sbjct: 62 VEIKHIMLPPSRREFKDIYVVFELM--ESDLHQVIKANDD--LTPEHHQFFLYQLLRALK 117
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD--QTHLTTRVQGTFGYLD 262
Y+H+A ++HRD+K NIL + + K+ DFG +R D T T Y
Sbjct: 118 YIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 263 PEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPI 294
PE S S++T D++S G + E+LTG KP+
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL 207
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-08
Identities = 47/199 (23%), Positives = 86/199 (43%), Gaps = 22/199 (11%)
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRL-RIAIEVSGA 202
+ H N+++ LG C+E+ LLV+E+ G L YL + + + L R+A E++
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT-IKVDQTHLTTRVQGTFGYL 261
++++H + H D+ N L KV D+G + K D +L
Sbjct: 112 VTHMHKHNFL---HSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 262 DPEYFRS-------SQFTEKSDVYSFGVVLVEL----------LTGQKPIRSTDAEEDRS 304
PE ++ T+ S+V++ GV L EL L+ ++ + ++
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK 228
Query: 305 LVGFFLQAMNEDRLFEVLE 323
L L+ +R +EVL+
Sbjct: 229 LFKPQLELPYSERWYEVLQ 247
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 49/196 (25%), Positives = 77/196 (39%), Gaps = 48/196 (24%)
Query: 140 ILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
IL++ ++ VVKL + + V ++IP G + L + F R IA E+
Sbjct: 54 ILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLL-IRLGIFEEDLA-RFYIA-EL 110
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG--------------------- 238
+ A+ +H I HRDIK NIL+D K++DFG
Sbjct: 111 TCAIESVHKMGFI---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 239 ----------------ASRTIKVDQTHLTTRVQ-----GTFGYLDPEYFRSSQFTEKSDV 277
+ ++ + R GT Y+ PE + +T+ D
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227
Query: 278 YSFGVVLVELLTGQKP 293
+S GV+L E+L GQ P
Sbjct: 228 WSVGVILYEMLVGQPP 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 4e-08
Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 46/242 (19%)
Query: 81 FTKMDLEKAT----DNYNANRILGQGGQGTVYKGMLADGGI-VAVKKSKLVDES--NVEQ 133
F + +L K + Y +G G G+V G+ VAVKK +S + ++
Sbjct: 3 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 62
Query: 134 FINEVVILSQINHRNVVKLL-----GCCLE--SEVPLLVYEF---IPNGTLYHYLHDQTE 183
E+ +L + H NV+ LL LE ++V L+ + + N L D
Sbjct: 63 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 122
Query: 184 EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243
+F I +R + Y+HSA I HRD+K SN+ +++ K+ DFG +R
Sbjct: 123 QFLIYQILR---------GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 170
Query: 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQ-------FTEKSDVYSFGVVLVELLTGQKPIRS 296
+ T GY+ ++R+ + + + D++S G ++ ELLTG+
Sbjct: 171 DDEMT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
Query: 297 TD 298
TD
Sbjct: 221 TD 222
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 7e-08
Identities = 33/110 (30%), Positives = 55/110 (50%), Gaps = 11/110 (10%)
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-----SQ 270
HRDIK NIL+D +++DFG+ + D T ++ GT Y+ PE ++ +
Sbjct: 125 HRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGK 184
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320
+ + D +S GV + E+L G+ P + SLV + + MN F+
Sbjct: 185 YGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKERFQ 228
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 52/186 (27%), Positives = 79/186 (42%), Gaps = 25/186 (13%)
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
N+V L + + LV + G L+ ++ I E R A E+ A+ LH
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN---IPEECVKRWAAEMVVALDALH 102
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
I RD+ +NILLDD+ +++ F R +V+ + V+ Y PE
Sbjct: 103 REG---IVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAVENM--YCAPEVGG 155
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDA---------------EEDRSLVGFFLQA 312
S+ TE D +S G +L ELLTG+ + + EE RSL+ LQ
Sbjct: 156 ISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQF 215
Query: 313 MNEDRL 318
+RL
Sbjct: 216 NPTERL 221
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 8e-08
Identities = 33/119 (27%), Positives = 57/119 (47%), Gaps = 12/119 (10%)
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
+ S + HRDIK N+LLD +++DFG+ + D T + GT Y+ PE
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 266 FRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN-EDRL 318
++ ++ + D +S GV + E+L G+ P + SLV + + MN ++
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA------ESLVETYGKIMNHKEHF 227
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 1e-07
Identities = 58/240 (24%), Positives = 108/240 (45%), Gaps = 23/240 (9%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVE-QFINEVVILSQINHRNVVKLLGCCL 157
+G+G G VYK DG K ++ + + E+ +L ++ H NV+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68
Query: 158 E--SEVPLLVYEFIPNGTLYHYLH----DQTEEFPITW--EMRLRIAIEVSGAMSYLHSA 209
L++++ + L+H + + + P+ M + ++ + YLH+
Sbjct: 69 SHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127
Query: 210 TSIPIYHRDIKSSNILL----DDKYRAKVSDFGASRTIKVDQTHLTT--RVQGTFGYLDP 263
+ HRD+K +NIL+ ++ R K++D G +R L V TF Y P
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 264 EYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322
E ++ +T+ D+++ G + ELLT + PI E+ ++ F + DR+F V+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPFHHDQL--DRIFSVM 241
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.6 bits (124), Expect = 2e-07
Identities = 59/218 (27%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE-QFINEVVILSQINHRNVVKLLGCC 156
LG+G TVYKG G +VA+K+ +L E I E +L + H N+V L
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII 72
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMR---------LRIAIEVSGAMSYLH 207
+ LV+E++ + L Y+ ++ M LR ++Y H
Sbjct: 73 HTKKTLTLVFEYL-DTDLKQYM----DDCGGGLSMHNVRLFLFQLLR-------GLAYCH 120
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV-DQTHLTTRVQGTFGYLDPEYF 266
+ HRD+K N+L+ ++ K++DFG +R V +T+ V T Y P+
Sbjct: 121 QRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPDVL 175
Query: 267 R-SSQFTEKSDVYSFGVVLVELLTGQKPI--RSTDAEE 301
S++++ D++ G + E+ TG+ P+ STD E+
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGR-PLFPGSTDVED 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-07
Identities = 30/95 (31%), Positives = 53/95 (55%), Gaps = 8/95 (8%)
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT 257
+V+ M +L S + HRD+ + N+L+ + K+ DFG +R I D +++ T
Sbjct: 247 QVANGMEFLASKNCV---HRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISK--GST 301
Query: 258 F---GYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289
F ++ PE ++ +T SDV+SFG++L E+ T
Sbjct: 302 FLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 57/240 (23%), Positives = 108/240 (45%), Gaps = 23/240 (9%)
Query: 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVE-QFINEVVILSQINHRNVVKLLGCCL 157
+G+G G VYK DG K ++ + + E+ +L ++ H NV+ L L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68
Query: 158 E--SEVPLLVYEFIPNGTLYHYLH----DQTEEFPITWE--MRLRIAIEVSGAMSYLHSA 209
L++++ + L+H + + + P+ M + ++ + YLH+
Sbjct: 69 SHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN 127
Query: 210 TSIPIYHRDIKSSNILL----DDKYRAKVSDFGASRTIKVDQTHLTT--RVQGTFGYLDP 263
+ HRD+K +NIL+ ++ R K++D G +R L V TF Y P
Sbjct: 128 W---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184
Query: 264 EYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322
E ++ +T+ D+++ G + ELLT + PI E+ ++ + + DR+F V+
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTSE-PIFHCRQEDIKTSNPYHHDQL--DRIFNVM 241
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 35/127 (27%), Positives = 63/127 (49%), Gaps = 9/127 (7%)
Query: 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNIL 225
Y+ + + + L D E T ++ L +V+ M +L S + HRD+ + N+L
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDL-LSFTYQVARGMEFLASKNCV---HRDLAARNVL 269
Query: 226 LDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF---GYLDPEYFRSSQFTEKSDVYSFGV 282
L K+ DFG +R I D +++ TF ++ PE + +T SDV+S+G+
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYVSK--GSTFLPVKWMAPESIFDNLYTTLSDVWSYGI 327
Query: 283 VLVELLT 289
+L E+ +
Sbjct: 328 LLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 53/240 (22%), Positives = 102/240 (42%), Gaps = 43/240 (17%)
Query: 81 FTKMDLEKAT----DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNV--EQ 133
F + ++ K + Y + + +G G G+V + G VA+KK +S + ++
Sbjct: 1 FYREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKR 60
Query: 134 FINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD--------QTE-- 183
E+ +L + H NV+ LL + + D QT+
Sbjct: 61 AYRELTLLKHMQHENVIGLL-------------DVFTSAVSGDEFQDFYLVMPYMQTDLQ 107
Query: 184 ---EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240
P++ + + ++ + Y+HSA I HRD+K N+ +++ K+ DFG +
Sbjct: 108 KIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164
Query: 241 RTIKVDQT-HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
R + T ++ TR Y PE + + + D++S G ++ E+LTG+ + D
Sbjct: 165 RHADAEMTGYVVTR-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 20/150 (13%)
Query: 101 QGGQGTVYKGMLADGG----IVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
+G G VY G + + VKK+ +++++ V Q E L+ +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 157 LESEVPLLVYEFIPNGTLYHYLH-----DQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
+ LV E++ G + LH D+ EM ++ EV+ A+ YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDE--------EMAVKYISEVALALDYLHRHG- 124
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASR 241
I HRD+K N+L+ ++ K++DFG S+
Sbjct: 125 --IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 1e-06
Identities = 61/255 (23%), Positives = 96/255 (37%), Gaps = 56/255 (21%)
Query: 97 RILGQGGQGTVYKGMLADGGIV----AVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152
+ LG G G V D + ++K ++ + V E IL++ ++ VV+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
+ + V ++IP G + L + FP R IA E++ A+ +H I
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLL-IRMGIFPEDLA-RFYIA-ELTCAVESVHKMGFI 123
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFG---------------------------------- 238
HRDIK NIL+D K++DFG
Sbjct: 124 ---HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 239 ------------ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVE 286
R + Q L + GT Y+ PE + +T+ D +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 287 LLTGQKPIRSTDAEE 301
+L GQ P + E
Sbjct: 241 MLVGQPPFLAQTPLE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 3e-06
Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 24/219 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNV--EQFINEVVILSQINHR 147
D Y + +G G GTV + G VA+KK +S + ++ E+ +L + H
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 148 NVVKLLGCCLESEVP------LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201
NV+ LL LV F+ H++ E I + + ++
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQF-----LVYQMLK 129
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGY 260
+ Y+H+A I HRD+K N+ +++ K+ DFG +R + T ++ TR Y
Sbjct: 130 GLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTR-----WY 181
Query: 261 LDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
PE + +T+ D++S G ++ E+LTG+ + D
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 5e-06
Identities = 60/237 (25%), Positives = 102/237 (43%), Gaps = 50/237 (21%)
Query: 81 FTKMDLEKAT----DNYNANRILGQGGQGTV---YKGMLADGGIVAVKKSKLVDES--NV 131
F + +L K + Y +G G G+V Y L VAVKK +S +
Sbjct: 1 FYRQELNKTVWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQK--VAVKKLSRPFQSLIHA 58
Query: 132 EQFINEVVILSQINHRNVVKLL-----GCCLE--SEVPL---LVYEFIPNGTLYHYLHDQ 181
+ E+ +L + H NV+ LL +E +EV L L+ + N L D+
Sbjct: 59 RRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDE 118
Query: 182 TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241
+F I +R + Y+HSA I HRD+K SN+ +++ ++ DFG +R
Sbjct: 119 HVQFLIYQLLR---------GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR 166
Query: 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQ-------FTEKSDVYSFGVVLVELLTGQ 291
+ T GY+ ++R+ + + + D++S G ++ ELL G+
Sbjct: 167 QADDEMT----------GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 43/172 (25%), Positives = 76/172 (44%), Gaps = 11/172 (6%)
Query: 135 INEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP--NGTLYHYLHDQTEEFPITWEMR 192
++E +L +++H V+ LL + + LV +P LY YL + P+
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLR--PLGLAQV 262
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD-QTHLT 251
+A ++ A+ Y+H I HRDIK+ N+L++ + DFGA+ + T
Sbjct: 263 TAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319
Query: 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
+ GT PE +T D++S G+V+ E + S ++R
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371
|
Length = 461 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 48/187 (25%), Positives = 76/187 (40%), Gaps = 42/187 (22%)
Query: 91 DNYNANRILGQGGQGTVYKGMLAD-----GGIVAVKKSKLVDESNVEQFINEVVILSQIN 145
D++ + LG+G G VYK L + G +KK+ + VE ++NE V +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKAT--EYGAVEIWMNERV---RRA 186
Query: 146 HRN-VVKLLGCCLES-----EVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRL----- 193
N + LE E LV+ + TL + Q++EFP E L
Sbjct: 187 CPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLM--QSKEFPYNVEPYLLGKVQ 244
Query: 194 --------------RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA-KVSDFG 238
I ++ A+ LHS I HRD+K NI+ + + K+ D G
Sbjct: 245 DLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG 301
Query: 239 ASRTIKV 245
A+ ++V
Sbjct: 302 AAADLRV 308
|
Length = 566 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 7e-05
Identities = 39/126 (30%), Positives = 60/126 (47%), Gaps = 12/126 (9%)
Query: 72 EGN----IEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYK----GMLADGGI--VAVK 121
EGN I+ T+L E DN + LG G G V + G+ + + VAVK
Sbjct: 15 EGNNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVK 74
Query: 122 KSKLVDESN-VEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLH 179
K ++ E ++E+ ILS + H+N+V LLG C L++ E+ G L ++L
Sbjct: 75 MLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLR 134
Query: 180 DQTEEF 185
+ E F
Sbjct: 135 KKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 12/99 (12%)
Query: 97 RILGQGGQGTVYKGMLADGGI--------VAVKKSKLVDESNVEQ-FINEVVILSQIN-H 146
RILG G G V +G G+ VAVK K S+ +Q ++E+ I++ + H
Sbjct: 43 RILGSGAFGKVVEG--TAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPH 100
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF 185
N+V LLG C +S ++ E+ G L +YLH + F
Sbjct: 101 LNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 2e-04
Identities = 29/114 (25%), Positives = 48/114 (42%), Gaps = 22/114 (19%)
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD----------------DKYRAKVSDF 237
+I + A+ Y H T + + H D+K NIL++ D R ++ D
Sbjct: 235 QIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDL 292
Query: 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 291
G D+ H T + T Y PE + +D++S G ++ EL TG+
Sbjct: 293 GGC----CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 31/103 (30%), Positives = 45/103 (43%), Gaps = 17/103 (16%)
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF---------GASRTIKVDQTHLTT 252
++YLH I HR+IK+S+IL+ +S G + D +T
Sbjct: 113 GLNYLHQNGYI---HRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169
Query: 253 RVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKP 293
V +L PE R + KSD+YS G+ EL TG+ P
Sbjct: 170 SVLP---WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 8e-04
Identities = 31/144 (21%), Positives = 55/144 (38%), Gaps = 15/144 (10%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV--KLLG 154
++L G VY D V +K + EV IL + + + K+L
Sbjct: 4 KLLKGGLTNRVYLLGTKDEDYV-LKINP--SREKGADREREVAILQLLARKGLPVPKVLA 60
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
L+ E+I TL ++ E+ IA +++ ++ LH + +
Sbjct: 61 SGESDGWSYLLMEWIEGETLDEVSEEEKED----------IAEQLAELLAKLHQLPLLVL 110
Query: 215 YHRDIKSSNILLDDKYRAKVSDFG 238
H D+ NIL+DD + D+
Sbjct: 111 CHGDLHPGNILVDDGKILGIIDWE 134
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.002
Identities = 34/119 (28%), Positives = 54/119 (45%), Gaps = 8/119 (6%)
Query: 75 IEKTKLFTKMDLEKATDNYNANRILGQGGQG-----TVYKGMLADGGI-VAVKKSKLVDE 128
I+ T+L E + + + LG G G T Y +D + VAVK K
Sbjct: 19 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH 78
Query: 129 SN-VEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF 185
E ++E+ +LS + NH N+V LLG C L++ E+ G L ++L + + F
Sbjct: 79 LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 419 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.86 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.86 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.85 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.84 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.81 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.79 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.78 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.75 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.71 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.71 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.68 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.5 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.47 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.45 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.27 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.26 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.17 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.17 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.08 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.05 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.96 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.85 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.81 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.73 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.57 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.47 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.47 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.46 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.44 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.38 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.36 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.32 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.31 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.22 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.1 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.08 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.01 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.0 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.0 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.91 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.76 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.72 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.62 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.6 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.55 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.47 | |
| PLN02236 | 344 | choline kinase | 97.34 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.24 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.24 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.24 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.14 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.11 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.01 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.84 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.77 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.68 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.68 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.55 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.5 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.47 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.9 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.89 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.83 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.74 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.69 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.64 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.53 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-58 Score=438.99 Aligned_cols=291 Identities=46% Similarity=0.768 Sum_probs=256.3
Q ss_pred cccccCHHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEE
Q 014725 77 KTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156 (419)
Q Consensus 77 ~~~~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 156 (419)
....|++.++..+|++|+..+.||+|+||.||+|...++..||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56779999999999999999999999999999999999999999987765443145699999999999999999999999
Q ss_pred ecCCc-ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 014725 157 LESEV-PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235 (419)
Q Consensus 157 ~~~~~-~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 235 (419)
.+.+. .+|||||+++|+|.++|+..... +++|.+|++||.++|+||+|||+...++||||||||.|||+|+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 99984 99999999999999999986654 79999999999999999999999988889999999999999999999999
Q ss_pred ecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 236 DFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
|||+++..............||.+|+|||++..+..+.++|||||||+|+||+||+.|.+...+.....+..|....+..
T Consensus 220 DFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~ 299 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEE 299 (361)
T ss_pred CccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHC
Confidence 99999765431111111117999999999999999999999999999999999999998876655566688888888888
Q ss_pred cchhHHHHHhhc-cCCCH-HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 316 DRLFEVLEARVL-KEGKE-EEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 316 ~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.++.+++|+.+. ...+. .+...+..++.+|++.+|..||+|.+|+++|+.+..
T Consensus 300 ~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 300 GKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred cchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 899999999987 45454 678889999999999999999999999999966543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=393.06 Aligned_cols=263 Identities=37% Similarity=0.566 Sum_probs=221.1
Q ss_pred CccccCcccccCcEEEEEEEecCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-cceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESE-VPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~ 168 (419)
.....+.||+|+||+||+|.++....||||++.... ....+.|.+|+.+|.+++|||||+++|+|.+.. ..++||||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy 121 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEY 121 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEe
Confidence 344456699999999999999765569999987533 222568999999999999999999999999887 78999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~ 247 (419)
+++|+|.++++.. ....+++..+++++.|||+||.|||+.++ ||||||||+|||++.++ ++||+|||+++......
T Consensus 122 ~~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~ 198 (362)
T KOG0192|consen 122 MPGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK 198 (362)
T ss_pred CCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc
Confidence 9999999999885 23469999999999999999999999885 99999999999999997 99999999998765432
Q ss_pred ceeeecccccCCccCccccc--cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 248 THLTTRVQGTFGYLDPEYFR--SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~--~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||........ ...+....
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---------------~~~v~~~~ 262 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---------------ASAVVVGG 262 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---------------HHHHHhcC
Confidence 2334467999999999999 56999999999999999999999999988765221 12222233
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCC
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~ 373 (419)
.+...+..++..+..++.+||+.||..||++.+++..|+.+.......
T Consensus 263 ~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~ 310 (362)
T KOG0192|consen 263 LRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA 310 (362)
T ss_pred CCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence 444555668889999999999999999999999999999998766543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-52 Score=393.24 Aligned_cols=260 Identities=32% Similarity=0.457 Sum_probs=229.6
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.....+...+.||+|-||.||.|.+++...||+|.++.... ..+.|.+|+++|++|+|+|||+++++|..++..+||||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE 281 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTE 281 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEE
Confidence 33344556788999999999999998888999999886532 34789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
||+.|+|.+||+... +..+...+.+.++.|||.|++||++++ +|||||..+||||+++..+||+||||++....+.
T Consensus 282 ~m~~GsLl~yLr~~~-~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~ 357 (468)
T KOG0197|consen 282 YMPKGSLLDYLRTRE-GGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDE 357 (468)
T ss_pred ecccCcHHHHhhhcC-CCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCc
Confidence 999999999999733 335889999999999999999999999 9999999999999999999999999999655555
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
........-+..|.|||.+..+.+|.|||||||||+||||+| |+.||.+....+ +.+.++...
T Consensus 358 Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e----------------v~~~le~Gy 421 (468)
T KOG0197|consen 358 YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE----------------VLELLERGY 421 (468)
T ss_pred eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH----------------HHHHHhccC
Confidence 545555556778999999999999999999999999999999 999998876644 566677777
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+.+.|..|+..+.+++..||+.+|++|||+..+...|+.+..
T Consensus 422 Rlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 RLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred cCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 888899999999999999999999999999999999998764
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-52 Score=372.59 Aligned_cols=248 Identities=29% Similarity=0.401 Sum_probs=210.2
Q ss_pred CccccCcccccCcEEEEEEEecC-CCEEEEEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc-ceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEV-PLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~ 168 (419)
+.+..+.||+|..|+||++.++. +..+|+|.+.. .+....+++.+|+++++..+|||||.++|+|..... ..++|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 34456789999999999999864 66789999854 455667899999999999999999999999999885 9999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|++|+|++++...+ .+++...-+++.+|++||.|||+ ++ ||||||||.|||++..|.+||+|||.++.+-..
T Consensus 160 MDgGSLd~~~k~~g---~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG---RIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred cCCCCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999998753 49999999999999999999996 66 999999999999999999999999999876543
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh--
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR-- 325 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 325 (419)
...++.||..|||||.+.+..|+.++||||||++++|+++|+.||........ .+.+++..-
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~--------------~~~~Ll~~Iv~ 296 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL--------------DIFELLCAIVD 296 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC--------------CHHHHHHHHhc
Confidence 55678899999999999999999999999999999999999999986521111 122222221
Q ss_pred -hccCCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 326 -VLKEGKEE-EIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 326 -~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..+..|.+ +.+++..++..||++||.+||++.|+++.
T Consensus 297 ~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 297 EPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred CCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 22333444 78899999999999999999999999763
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-49 Score=362.63 Aligned_cols=205 Identities=30% Similarity=0.533 Sum_probs=184.7
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..++|...+.||+|+||+||+|+++ ++..||||.+... .....+.+..|+.+|+.++|||||.+++++..++..|+|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 3467888899999999999999964 5789999987654 566677889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC------CcEEEeecCC
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK------YRAKVSDFGA 239 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~------~~~kl~Dfgl 239 (419)
||||+||+|.+|++..+ .+++.....++.|+|.||++||+++ ||||||||+||||+.+ -.+||+|||+
T Consensus 88 MEyC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred EEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 99999999999999865 4899999999999999999999999 9999999999999764 5689999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhh
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~ 301 (419)
|+.+.. .....+.+|++-|||||++..++|+.|+|+||+|+++|++++|+.||+.....+
T Consensus 162 AR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 162 ARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 998763 334466889999999999999999999999999999999999999998766654
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=354.33 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=207.1
Q ss_pred cCccccCcccccCcEEEEEEE-ecCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEe-EEecCCc-ceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLG-CCLESEV-PLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 165 (419)
.+|++.+.||+|.||.||++. ..+|..+|.|.++. .+....+....|+.+|++|+|||||++++ -+.++.. .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 457888999999999999999 46789999998764 45566778999999999999999999998 4554444 8999
Q ss_pred EeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-CCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 166 YEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSATS-IPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
||||++|+|...++.. ..+..+++..+|+++.|++.||..+|..-+ .-|+||||||.||+++.+|.+||+||||++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 9999999999999763 334569999999999999999999999331 12999999999999999999999999999987
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
..... .....+|||.||+||.+.+..|+.+|||||+||++|||+.-+.||.+..-.+ +.+.+.
T Consensus 179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~----------------L~~KI~ 241 (375)
T KOG0591|consen 179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS----------------LCKKIE 241 (375)
T ss_pred cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH----------------HHHHHH
Confidence 65443 3455789999999999999999999999999999999999999998763221 111112
Q ss_pred HhhccCCC-HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARVLKEGK-EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..-.+..| .-....+.+|+..|+..||+.||+...++.
T Consensus 242 qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~ 280 (375)
T KOG0591|consen 242 QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQ 280 (375)
T ss_pred cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHH
Confidence 22122233 445677999999999999999998544433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=377.89 Aligned_cols=247 Identities=26% Similarity=0.407 Sum_probs=213.8
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.+|...+.||+|||..||.+++ ..|..||+|.+.. ......+.+.+|+++.+.|+|||||+++++|++.++.|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999997 7899999998753 34566788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
|+|++++|..+++.. .++++.++..++.||+.||.|||+++ |+|||||..|+|++++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999999843 36999999999999999999999999 999999999999999999999999999987644
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. ....+.+|||.|.|||++....++..+||||+|||||-|++|++||....-.+ ....+...
T Consensus 172 ~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke-------ty~~Ik~~---------- 233 (592)
T KOG0575|consen 172 G-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE-------TYNKIKLN---------- 233 (592)
T ss_pred c-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH-------HHHHHHhc----------
Confidence 3 34556799999999999999999999999999999999999999997654332 11111111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....|.....+..+||.++|+.+|.+|||+.+|+.
T Consensus 234 ~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 234 EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 11234455567889999999999999999999976
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=399.11 Aligned_cols=262 Identities=31% Similarity=0.470 Sum_probs=227.1
Q ss_pred HHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCC
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESE 160 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 160 (419)
....+....+.||+|.||+||+|... +...||||.++..... ...+|.+|+++++.++|||||+++|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 34556677789999999999999943 3457999999976655 7789999999999999999999999999999
Q ss_pred cceEEEeecCCCCHHHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTE-----------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK 229 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 229 (419)
..++|+|||..|||.+||..... +.+++..+.+.||.|||.|+.||-++. +|||||..+|+||.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 99999999999999999975321 234889999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCceecccCCceeee-cccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHH
Q 014725 230 YRAKVSDFGASRTIKVDQTHLTT-RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 230 ~~~kl~Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 307 (419)
..|||+||||++..-..+.+... ...-..+|||||.+..+++|.+||||||||+|||+++ |+.||.+...++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------ 713 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------ 713 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------
Confidence 99999999999987655555433 4445789999999999999999999999999999999 999998876654
Q ss_pred HHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+.+.+..+-.-+.|.+++.+++.|+..||+.+|.+||+++||-..|+....
T Consensus 714 ----------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 714 ----------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ----------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 334444444467899999999999999999999999999999999987643
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=361.98 Aligned_cols=255 Identities=26% Similarity=0.342 Sum_probs=204.7
Q ss_pred HHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-------hhhHHHHHHHHHHHhcCCCcccccEEeEEecC
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-------ESNVEQFINEVVILSQINHRNVVKLLGCCLES 159 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 159 (419)
...+.|.+.+.||+|+||.|-+|.. ++++.||||+++... ........+|+++|++|+|||||++++++...
T Consensus 169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence 3567788999999999999999995 568899999875421 11223457999999999999999999999999
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC---CcEEEee
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSD 236 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~D 236 (419)
+..|+||||++||+|.+++-.++ .+.+..-..++.|++.|+.|||+.| |+||||||+|||+..+ ..+||+|
T Consensus 249 ds~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 249 DSSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred CceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecc
Confidence 99999999999999999998765 3777777889999999999999999 9999999999999665 7899999
Q ss_pred cCCceecccCCceeeecccccCCccCccccccCCC---CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh
Q 014725 237 FGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF---TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313 (419)
Q Consensus 237 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 313 (419)
||+|+... ....+.+.+|||.|.|||++.+..+ ..+.|+||+||+||-+++|.+||....... .+.+.+.+
T Consensus 323 FGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~eQI~~-- 396 (475)
T KOG0615|consen 323 FGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKEQILK-- 396 (475)
T ss_pred cchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHHHHhc--
Confidence 99999865 4455678899999999999987543 348899999999999999999997654321 12211111
Q ss_pred cccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
++... -...-.+...+..+||.+||..||+.|||+.|+++-
T Consensus 397 --G~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h 437 (475)
T KOG0615|consen 397 --GRYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH 437 (475)
T ss_pred --Ccccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence 11000 001112345678899999999999999999999763
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=345.94 Aligned_cols=244 Identities=28% Similarity=0.382 Sum_probs=204.2
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
...++|++.+.||+|+||.||.++.. .++.+|+|.++. ......+...+|..+|.+++||.||+++..|++.+..|
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy 101 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY 101 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence 34577999999999999999999964 477899997653 33445678899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+|+||+.||.|...|++.. .+++....-++.+|+.||.|||+++ ||||||||+|||+|.+|+++|+||||++..
T Consensus 102 lVld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 102 LVLDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EEEeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 9999999999999998655 4889988889999999999999999 999999999999999999999999999865
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
... .....+++||+.|||||++.+..|+.++|.||||+++|||++|..||...+..+. ...+..++
T Consensus 176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-------~~~I~~~k------ 241 (357)
T KOG0598|consen 176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-------YDKILKGK------ 241 (357)
T ss_pred ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-------HHHHhcCc------
Confidence 432 2334458999999999999999999999999999999999999999987664331 11111111
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCC
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRP 354 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 354 (419)
....+.-......+++.+.|..+|++|.
T Consensus 242 ---~~~~p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 ---LPLPPGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred ---CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence 1122222455688999999999999995
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=376.31 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=225.1
Q ss_pred cCccccCcccccCcEEEEEEEecC----CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLAD----GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
....+.+.||.|.||.||+|+++- ...||||.++.. .+.+..+|+.|+.+|.+++||||++|.|+.......++|
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIi 708 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMII 708 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEE
Confidence 445678899999999999999753 346999999874 456778999999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
.|||++|+|+.||+.+.. .+++.++.-++.+||.|++||.+.+ +|||||..+|||++.+...|++||||+|.+..
T Consensus 709 TEyMENGsLDsFLR~~DG--qftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvled 783 (996)
T KOG0196|consen 709 TEYMENGSLDSFLRQNDG--QFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 783 (996)
T ss_pred hhhhhCCcHHHHHhhcCC--ceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeeccc
Confidence 999999999999998764 4899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCceeeeccc--ccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 246 DQTHLTTRVQ--GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 246 ~~~~~~~~~~--gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
+.....+... -+.+|.|||.+....+|.+|||||||++|||.++ |..||......+ +...+
T Consensus 784 d~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd----------------VIkaI 847 (996)
T KOG0196|consen 784 DPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD----------------VIKAI 847 (996)
T ss_pred CCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH----------------HHHHH
Confidence 4433223222 3468999999999999999999999999999988 999987665543 45566
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
+...+-+.|.+|+..+.+|+..||++|..+||++.+|+..|+++.
T Consensus 848 e~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI 892 (996)
T KOG0196|consen 848 EQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI 892 (996)
T ss_pred HhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence 677777889999999999999999999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=348.79 Aligned_cols=254 Identities=29% Similarity=0.457 Sum_probs=207.6
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC--cceEEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE--VPLLVY 166 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv~ 166 (419)
..+|...+.||+|+||.||++...+ |...|||.....+....+.+.+|+.+|++++|||||+++|...... .+++.|
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 4567788999999999999999754 8899999887654444677899999999999999999999855444 689999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~ 245 (419)
||+++|+|.+++.+.+. .+++..+..++.||+.||.|||+++ ++||||||+|||++. ++.+||+|||+++....
T Consensus 96 Ey~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~ 170 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLES 170 (313)
T ss_pred eccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCcccccccc
Confidence 99999999999998764 4999999999999999999999999 999999999999999 79999999999987653
Q ss_pred --CCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCC-ChhhhccHHHHHHHHhcccchhHH
Q 014725 246 --DQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRST-DAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 246 --~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
..........||+.|||||++..+ ....++|||||||++.||+||+.||... ...+ .. ..+
T Consensus 171 ~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~------~~---------~~i 235 (313)
T KOG0198|consen 171 KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE------AL---------LLI 235 (313)
T ss_pred ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH------HH---------HHH
Confidence 222334457799999999999864 3345999999999999999999999763 1111 11 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
......+..+...+....+++.+|+..+|.+|||+.++++..
T Consensus 236 g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 236 GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 111122344555667789999999999999999999998754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=335.07 Aligned_cols=263 Identities=25% Similarity=0.341 Sum_probs=207.3
Q ss_pred cCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
+.|+....+|+|+||+||++++++ |+.||||++.... +...+-.++|+++|++++|||+|.++.+|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467888899999999999999754 7899999986543 3445667899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
||+. ++.+-|.....+ ++...+.+++.|++.|+.|+|+++ +|||||||+|||++.++.+||+|||.|+.+...
T Consensus 82 ~~dh-TvL~eLe~~p~G--~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNG--VPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecch-HHHHHHHhccCC--CCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 9987 444556655543 888999999999999999999999 999999999999999999999999999987643
Q ss_pred ceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh-
Q 014725 248 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR- 325 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 325 (419)
....+..+.|.+|.|||.+.+ .+|+...||||+||++.||++|.+-|.+....+.-......+....+. ..++....
T Consensus 155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~pr-hq~iF~~N~ 233 (396)
T KOG0593|consen 155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPR-HQSIFSSNP 233 (396)
T ss_pred cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHH-HHHHhccCC
Confidence 233455678999999999887 789999999999999999999999999877655433333322222111 11111110
Q ss_pred ----hc----------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 ----VL----------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ----~~----------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+. ...-.....-+.+++..||+.||++|++-++++.
T Consensus 234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 00 0001122346789999999999999999988864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-46 Score=355.96 Aligned_cols=263 Identities=29% Similarity=0.442 Sum_probs=207.9
Q ss_pred HHhcCccccCcccccCcEEEEEEEe------cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCcccccEEeEEecC
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML------ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQI-NHRNVVKLLGCCLES 159 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~ 159 (419)
...++|++.+.||+|+||.||+|.+ ..+..||+|++.... ......+.+|+.++..+ +||||++++++|...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 3457899999999999999999974 224579999886532 33456789999999999 899999999988764
Q ss_pred -CcceEEEeecCCCCHHHHhhccCC-------------------------------------------------------
Q 014725 160 -EVPLLVYEFIPNGTLYHYLHDQTE------------------------------------------------------- 183 (419)
Q Consensus 160 -~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 183 (419)
...+++|||+++|+|.+++.....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 457899999999999999975321
Q ss_pred ----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce-eeecccccC
Q 014725 184 ----EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTF 258 (419)
Q Consensus 184 ----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~ 258 (419)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ ......+++
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 124788899999999999999999998 999999999999999999999999999865332221 122334667
Q ss_pred CccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHH
Q 014725 259 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIIT 337 (419)
Q Consensus 259 ~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 337 (419)
.|+|||++.+..++.++|||||||++|||++ |..||......+. +......+ .....+...+..
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~---------~~~~~~~~~~~~ 305 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDG---------TRMRAPENATPE 305 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcC---------CCCCCCCCCCHH
Confidence 8999999999999999999999999999997 9999976543221 11111111 111123344567
Q ss_pred HHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 338 VAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 338 l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 8999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=381.56 Aligned_cols=265 Identities=31% Similarity=0.492 Sum_probs=224.0
Q ss_pred hcCccccCcccccCcEEEEEEEecC--CC----EEEEEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD--GG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~--~~----~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
..+....+.||+|.||.||.|...+ +. .||+|.+.. .+.+...+|++|..+|+.++|||||+++|+|.+....
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 4566778899999999999999643 33 489998875 4566778999999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 163 LLVYEFIPNGTLYHYLHDQTE----EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
++++|||++|+|..||++... ...++....+.++.|||+|+.||++++ +|||||..+|+||++...+||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence 999999999999999998521 335889999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecc-cccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 239 ASRTIKVDQTHLTTRV-QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
+|+.....+.+..... .-...|||||.+..+.++.|+|||||||+|||++| |..||...+..+.
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v-------------- 913 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEV-------------- 913 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHH--------------
Confidence 9996544443333222 34578999999999999999999999999999999 9999988766542
Q ss_pred chhH-HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCC
Q 014725 317 RLFE-VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSS 374 (419)
Q Consensus 317 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~ 374 (419)
.. .+... +-+.|..|+..+++++..||+.+|++||++..|++.+..+....-...
T Consensus 914 --~~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~ 969 (1025)
T KOG1095|consen 914 --LLDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI 969 (1025)
T ss_pred --HHHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence 22 22222 456688899999999999999999999999999999998876554433
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-46 Score=347.68 Aligned_cols=267 Identities=25% Similarity=0.323 Sum_probs=213.3
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Ccce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 163 (419)
..+.|+.+++||+|+||.||+|++ .+|+.||+|++.... +.......+|+.+|++|+||||+++.+...+. ...|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 346688889999999999999995 568899999987644 44556778999999999999999999998876 6889
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
||+|||+. +|.-++....- .+++.++..++.|++.||+|+|.++ |+|||||..|||||.+|.+||+|||||+++
T Consensus 195 lVFeYMdh-DL~GLl~~p~v--kft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGV--KFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEecccc-hhhhhhcCCCc--ccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeec
Confidence 99999976 88888876433 4899999999999999999999999 999999999999999999999999999988
Q ss_pred ccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh--H
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF--E 320 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 320 (419)
........+..+-|..|.|||.+.+ ..|+.+.|+||.||||.||++|++.|.+.++.+.-...-.......++.|. .
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~k 348 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSK 348 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccccc
Confidence 7766665666677999999999876 589999999999999999999999999988765433332222212222221 0
Q ss_pred H-----HHHhh-----ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 V-----LEARV-----LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~-----~~~~~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+ +.+.. ..+.....+....+|+..+|..||.+|.|+.++++
T Consensus 349 LP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 349 LPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred CCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0 00000 00001223456778999999999999999988875
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=337.64 Aligned_cols=263 Identities=24% Similarity=0.360 Sum_probs=212.4
Q ss_pred HHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
...+.|++.+.||.|.-++||+|+. ..+..||||++.... ....+.+.+|+..|+.++||||++++..|..+...|+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 3456799999999999999999994 557899999987533 23368899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|.||.+|++.+.+...-.. -+++..+..|+.++++||.|||.+| .||||||+.||||+.+|.|||+|||.+..+..
T Consensus 103 mpfMa~GS~ldIik~~~~~-Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~ 178 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD-GLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFD 178 (516)
T ss_pred ehhhcCCcHHHHHHHHccc-cccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecc
Confidence 9999999999999875443 3899999999999999999999999 99999999999999999999999999876654
Q ss_pred CCceee---ecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 246 DQTHLT---TRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 246 ~~~~~~---~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
...... ..+.||++|||||++.. ..|+.|+||||||++..||.+|..||..+.+.+. ....+.+..-.
T Consensus 179 ~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv------Ll~tLqn~pp~- 251 (516)
T KOG0582|consen 179 SGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV------LLLTLQNDPPT- 251 (516)
T ss_pred cCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH------HHHHhcCCCCC-
Confidence 332221 45689999999999644 4799999999999999999999999988776442 22222221100
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
........+........+.+++..||+.||.+|||++++++
T Consensus 252 ~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 252 LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00001111112233457999999999999999999999865
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-46 Score=318.76 Aligned_cols=265 Identities=24% Similarity=0.285 Sum_probs=215.1
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChh--hHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDES--NVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|...+.||+|.||.||+|++ ..|+.||||+++..... ......+|++.|+.++||||+.++++|...+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4688889999999999999995 56889999998764332 24567899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|++ .+|...+++... .++...+..++.++++||+|||.+. |+||||||.|+|++++|.+||+||||++.+....
T Consensus 82 fm~-tdLe~vIkd~~i--~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKDKNI--ILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhccccc--ccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 996 599999987653 6899999999999999999999999 9999999999999999999999999999987554
Q ss_pred ceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH---
Q 014725 248 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE--- 323 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 323 (419)
...... +-|..|.|||.+.+ ..|+...||||.||++.||+.|.+-|.+...-+.-...-.++....++.|.++..
T Consensus 156 ~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpd 234 (318)
T KOG0659|consen 156 RIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPD 234 (318)
T ss_pred cccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccccccc
Confidence 443333 56899999998876 5799999999999999999999888888766554444444444444444433211
Q ss_pred H---h-----hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 324 A---R-----VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 324 ~---~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
- . ........+.....+|+..|+..||.+|.|++|.++.
T Consensus 235 Y~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 235 YVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 0 0011122344567899999999999999999999875
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=346.17 Aligned_cols=268 Identities=25% Similarity=0.318 Sum_probs=218.4
Q ss_pred HHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhh-HHHHHHHHHHHhcCC-CcccccEEeEEecCC-cce
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESN-VEQFINEVVILSQIN-HRNVVKLLGCCLESE-VPL 163 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~ 163 (419)
...++|.+.+.||.|+||.||+|+. ..+..||||+.+..-... .-.=++|+.-|++++ ||||+++.+++.+.+ ..+
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 3467899999999999999999994 568889999876422221 122368999999998 999999999999888 899
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+|||||+ .+|.++++++ +..+++..+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+||||||..
T Consensus 87 fVfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 87 FVFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred eeHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccc
Confidence 9999995 5999999887 347999999999999999999999999 999999999999999999999999999987
Q ss_pred ccCCceeeecccccCCccCcccc-ccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH-
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYF-RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV- 321 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~-~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 321 (419)
.... ..+..+.|..|.|||++ +.+-|+.+.|+|++|||++|+.+-++-|.+..+.+.......++.....+.+.+.
T Consensus 161 ~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~ 238 (538)
T KOG0661|consen 161 RSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY 238 (538)
T ss_pred ccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence 5433 33556789999999985 5678999999999999999999999999998887766655556555544444331
Q ss_pred -HHHhhcc-----------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 322 -LEARVLK-----------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 322 -~~~~~~~-----------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
+...+.. ........+..+|+.+|+.+||.+|||+.+.++..
T Consensus 239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p 292 (538)
T KOG0661|consen 239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP 292 (538)
T ss_pred HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence 1111111 11123567889999999999999999999998743
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-46 Score=354.94 Aligned_cols=267 Identities=29% Similarity=0.441 Sum_probs=222.1
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecC--C---CEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeE
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLAD--G---GIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGC 155 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~--~---~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 155 (419)
..++...++..+.++||+|+||.||+|.+.. + ..||||..+. .......+|++|+++|+.++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 3445555666777999999999999999643 2 2389998874 446778899999999999999999999999
Q ss_pred EecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 014725 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235 (419)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 235 (419)
+......++|||+|+||+|.+||++... .++..++++++.+.|.||+|||+++ ++||||..+|+|++.++.+||+
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKIS 304 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKIS 304 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeC
Confidence 9999999999999999999999998765 4899999999999999999999999 9999999999999999999999
Q ss_pred ecCCceecccCCceeee-cccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHh
Q 014725 236 DFGASRTIKVDQTHLTT-RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAM 313 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~ 313 (419)
||||++... ...... ...-+..|+|||.+....++.++|||||||++||+++ |..||.+....+. ..
T Consensus 305 DFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v-------~~-- 373 (474)
T KOG0194|consen 305 DFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV-------KA-- 373 (474)
T ss_pred ccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-------HH--
Confidence 999987643 111111 1234678999999999999999999999999999999 8899988776531 11
Q ss_pred cccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCC
Q 014725 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGS 372 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~ 372 (419)
.+.....+...+...+..+..++.+||..+|++||+|.++.+.|+.+......
T Consensus 374 ------kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~ 426 (474)
T KOG0194|consen 374 ------KIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA 426 (474)
T ss_pred ------HHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence 11122333445557777899999999999999999999999999998766544
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=348.73 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=213.9
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
...|.....||+|+.|.||.|.. ..++.||||+.........+-+.+|+.+|+..+|+|||.+++.+...+..|+||||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy 351 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY 351 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence 35677778999999999999994 56788999998887777778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
++||+|.+.+.... +++.++..|+.++++||+|||.++ |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus 352 m~ggsLTDvVt~~~----~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~ 424 (550)
T KOG0578|consen 352 MEGGSLTDVVTKTR----MTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS 424 (550)
T ss_pred cCCCchhhhhhccc----ccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence 99999999987654 899999999999999999999999 99999999999999999999999999988765443
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
.....+|||.|||||+.....|+++.||||||++.+||+-|.+||-..++-. ..++-.. + .....
T Consensus 425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Plr-----AlyLIa~-n--------g~P~l 489 (550)
T KOG0578|consen 425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-----ALYLIAT-N--------GTPKL 489 (550)
T ss_pred -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHH-----HHHHHhh-c--------CCCCc
Confidence 4556779999999999999999999999999999999999999996533321 1111000 0 11122
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+......+.+++.+||+.|+.+||++.|+|+
T Consensus 490 k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 KNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 334556678999999999999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=336.58 Aligned_cols=246 Identities=20% Similarity=0.363 Sum_probs=201.7
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCChh---hHHHHHHHHHHHhcCCCcccccEEeEEec----CCcceEEEeec
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDES---NVEQFINEVVILSQINHRNVVKLLGCCLE----SEVPLLVYEFI 169 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~~ 169 (419)
..||+|++|.||+|.+ +++.||||.+...... ..+.+.+|+.+|++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 5889999998754332 25678899999999999999999999876 34678999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
++|+|.+++.... .+++....+++.|++.||.|||+. + ++||||||+|||++.++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDKEK---DLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhhCC---CCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 9999999998643 488999999999999999999985 6 7899999999999999999999999987653221
Q ss_pred eeeecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 249 HLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+. . .. +.....
T Consensus 178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~---~----~~--------i~~~~~ 239 (283)
T PHA02988 178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI---Y----DL--------IINKNN 239 (283)
T ss_pred ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH---H----HH--------HHhcCC
Confidence 23457899999999976 6899999999999999999999999986654321 1 11 001111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
....+..++..+.+++.+||+.||++|||+.+|++.|+.++.
T Consensus 240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 112233456789999999999999999999999999998753
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=343.90 Aligned_cols=252 Identities=28% Similarity=0.398 Sum_probs=212.9
Q ss_pred HHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCc
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEV 161 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 161 (419)
.....+|.+.+.||+|+|++|++|+. ..++.+|||++.. ..+...+....|-..|.+| .||.|++|+.-|.++..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 44567899999999999999999995 4578999997642 2344456677899999999 79999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
+|+|+||+++|+|.++|++.+ .+++.....++.+|+.||+|||++| ||||||||+|||+|.|+++||+|||-|+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 999999999999999999875 4899989999999999999999999 9999999999999999999999999999
Q ss_pred ecccCCce------------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHH
Q 014725 242 TIKVDQTH------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF 309 (419)
Q Consensus 242 ~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 309 (419)
.+...... ....++||..|.+||++..+..++.+|+|+|||++|+|+.|.+||....+.-
T Consensus 223 ~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl-------- 294 (604)
T KOG0592|consen 223 ILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL-------- 294 (604)
T ss_pred cCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH--------
Confidence 87532111 1245889999999999999999999999999999999999999998765422
Q ss_pred HHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 310 LQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+++-+. .+....+...++...+|+.+.|..||.+|+|..+|-+
T Consensus 295 --------iFqkI~-~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 295 --------IFQKIQ-ALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred --------HHHHHH-HhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 111111 1223456666788999999999999999999988755
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-46 Score=351.03 Aligned_cols=266 Identities=27% Similarity=0.473 Sum_probs=216.0
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
.++++..+.+.+...||+|.||+||+|.+. +.||||.++.. ..++.+.|++|+..+++-+|.||+-+.|||.....
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 556667777888899999999999999985 46999998764 45678899999999999999999999999998777
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.+|..+|+|.+|..+++.... .++..+.+.|+.||++|+.|||.++ |||||||..||++.++++|||+||||+.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~et--kfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQET--KFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccchhh--hhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 999999999999999997654 3788899999999999999999999 9999999999999999999999999997
Q ss_pred ecccC-CceeeecccccCCccCcccccc---CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 242 TIKVD-QTHLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 242 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
....- ........-|...|||||+++. .+|+..+||||||+|+|||+||..||.....+.. ......+.
T Consensus 537 vk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqI-------ifmVGrG~ 609 (678)
T KOG0193|consen 537 VKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQI-------IFMVGRGY 609 (678)
T ss_pred eeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhhe-------EEEecccc
Confidence 54321 1111223347788999999864 5799999999999999999999999984333321 11111111
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
+.. . ......+++.++.+|+..||..++++||.+.+|+..|+.+..+
T Consensus 610 l~p----d-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 610 LMP----D-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cCc----c-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 100 0 0112346677899999999999999999999999998887654
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=333.41 Aligned_cols=256 Identities=21% Similarity=0.358 Sum_probs=208.4
Q ss_pred hcCccccCcccccCcEEEEEEEec----CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..+|++.+.||+|+||.||+|.+. .+..||+|..+... ......+.+|+..++.++||||+++++++..++..++
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 456889999999999999999853 35689999887543 3345678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++|+|.+++..... .+++..++.++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+....
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~ 158 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEG--QLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK 158 (266)
T ss_pred EEEeCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence 9999999999999986432 5899999999999999999999998 9999999999999999999999999876543
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
...........++..|+|||.+.+..++.++|||||||++||+++ |..||......+. .....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~-------~~~~~--------- 222 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV-------IKAVE--------- 222 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH-------HHHHH---------
Confidence 222121222335678999999999999999999999999999875 9999976654321 11111
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.......+..++..+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 223 DGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1111223445667799999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=343.05 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=211.3
Q ss_pred HHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC----Ch-hhHHHHHHHHHHHhcCC-CcccccEEeEEecC
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV----DE-SNVEQFINEVVILSQIN-HRNVVKLLGCCLES 159 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~ 159 (419)
....++|.+.+.||+|+||.|+.|.. ..+..||+|.+... .. ...+.+.+|+.+++.++ ||||+++++++...
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 35567899999999999999999985 46789999965432 11 23456778999999998 99999999999999
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-CcEEEeecC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDFG 238 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfg 238 (419)
...++||||+.||+|.+++.+.. ++.+.....++.|++.|++|||+++ |+||||||+|||++.+ +++||+|||
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g---~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKG---RLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcC---CCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccc
Confidence 99999999999999999999833 4889999999999999999999999 9999999999999999 999999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCC-CC-cccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ-FT-EKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
++.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|..||+....... +. .+..+
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l------~~-ki~~~ 238 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL------YR-KIRKG 238 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH------HH-HHhcC
Confidence 998764 2334456778999999999999877 75 899999999999999999999987433221 11 11111
Q ss_pred chhHHHHHhhccCCCHHH-HHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 317 RLFEVLEARVLKEGKEEE-IITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
....+... ...+..|+.+|+..+|.+|+|+.+|+ .-.-++.
T Consensus 239 ----------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~ 280 (370)
T KOG0583|consen 239 ----------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK 280 (370)
T ss_pred ----------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence 11222333 66789999999999999999999998 4444443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=339.12 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=205.6
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
....++|++++.||+|+||.||+|+.+ .|..+|+|+++.. ...+.+..+.|-.+|...++|+||+++..|++.+++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 345688999999999999999999964 5788999988753 345677889999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
||||||++||++..+|.... .|++.....++.+++.|+..||+.| +|||||||+|+|||..|++||+||||+..
T Consensus 217 YLiMEylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~g 290 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTG 290 (550)
T ss_pred EEEEEecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccch
Confidence 99999999999999998765 5899999999999999999999999 99999999999999999999999999853
Q ss_pred cccC----------------------C-c-----e------------------eeecccccCCccCccccccCCCCcccc
Q 014725 243 IKVD----------------------Q-T-----H------------------LTTRVQGTFGYLDPEYFRSSQFTEKSD 276 (419)
Q Consensus 243 ~~~~----------------------~-~-----~------------------~~~~~~gt~~y~aPE~~~~~~~s~~~D 276 (419)
+... . . . .....+|||.|||||++.+..|+..+|
T Consensus 291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD 370 (550)
T KOG0605|consen 291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD 370 (550)
T ss_pred hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence 3110 0 0 0 011256999999999999999999999
Q ss_pred eechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC
Q 014725 277 VYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS 355 (419)
Q Consensus 277 i~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 355 (419)
.||||||+|||+.|.+||...++.+.......+...+ ..+.......+..+||.+|+. ||++|.-
T Consensus 371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-------------~fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-------------KFPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-------------cCCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999999999888766433222222211 112222333678899999999 9999976
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=347.85 Aligned_cols=263 Identities=27% Similarity=0.418 Sum_probs=208.7
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEe------cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCcccccEEeEE
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGML------ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQI-NHRNVVKLLGCC 156 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 156 (419)
......++|++.+.||+|+||.||+|.+ ..+..||||.++... ....+.+.+|+.+++.+ +||||++++++|
T Consensus 29 ~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 29 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 3445566899999999999999999973 235579999986432 33456788999999999 899999999999
Q ss_pred ecCCcceEEEeecCCCCHHHHhhccCC-----------------------------------------------------
Q 014725 157 LESEVPLLVYEFIPNGTLYHYLHDQTE----------------------------------------------------- 183 (419)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 183 (419)
.+.+..++||||+++|+|.+++.....
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999999965321
Q ss_pred -------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 184 -------------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 184 -------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
...+++..++.++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++...
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~ 265 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIR 265 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceecc
Confidence 124788999999999999999999998 9999999999999999999999999998654
Q ss_pred cCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 245 VDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 245 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
...... .....++..|+|||++.+..++.++|||||||++|||++ |..||........ +... +
T Consensus 266 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~---------~ 330 (375)
T cd05104 266 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKM---------I 330 (375)
T ss_pred CcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHH---------H
Confidence 332211 122335678999999999999999999999999999998 8999876543211 1111 1
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
........+...+..+.+++.+||+.+|++||++.+|++.|++
T Consensus 331 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~ 373 (375)
T cd05104 331 KEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ 373 (375)
T ss_pred HhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence 1111111122234578999999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=336.70 Aligned_cols=263 Identities=25% Similarity=0.383 Sum_probs=205.3
Q ss_pred hcCccccCcccccCcEEEEEEEecC-----------------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCccccc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-----------------GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVK 151 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 151 (419)
.++|.+.+.||+|+||.||+|.+.+ +..||+|.+... .......|.+|+.++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 3578899999999999999998532 236999987654 3344567999999999999999999
Q ss_pred EEeEEecCCcceEEEeecCCCCHHHHhhccC----------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCee
Q 014725 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQT----------------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215 (419)
Q Consensus 152 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ii 215 (419)
+++++.+.+..++||||+++++|.+++.... ....+++..+++++.||+.||.|||+.+ |+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence 9999999999999999999999999986532 1124788899999999999999999998 99
Q ss_pred ecCCCCCcEEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh--CCC
Q 014725 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQK 292 (419)
Q Consensus 216 H~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t--g~~ 292 (419)
||||||+|||++.++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 9999999999999999999999999865433222 2233445788999999988899999999999999999987 567
Q ss_pred CCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 293 PIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 293 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
||......+. ............ .......+..++..+.+++.+||+.+|.+|||+.+|.+.|+
T Consensus 241 p~~~~~~~~~---~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 241 PYGELTDEQV---IENAGEFFRDQG------RQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCcCCHHHH---HHHHHHHhhhcc------ccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 7765543221 111111110000 00011122344567999999999999999999999998886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=345.60 Aligned_cols=247 Identities=32% Similarity=0.513 Sum_probs=209.4
Q ss_pred ccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 93 YNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
...++-||+|+.|.||+|++. ++.||||+++..++ .+++-|+.|+||||+.+.|+|.....+|||||||..|
T Consensus 126 IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~G 197 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQG 197 (904)
T ss_pred hhhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccccc
Confidence 344577999999999999995 67899999864332 3678899999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeee
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT 252 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 252 (419)
-|...|+... +++......|..+||.|+.|||.+. |||||||.-||||+.+..+||+|||-++..... ....
T Consensus 198 qL~~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkM 269 (904)
T KOG4721|consen 198 QLYEVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKM 269 (904)
T ss_pred cHHHHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--hhhh
Confidence 9999998654 5888899999999999999999999 999999999999999999999999999876543 3345
Q ss_pred cccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCH
Q 014725 253 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332 (419)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (419)
.++||..|||||++++...++|+||||||||||||+||..||...+..... .-+-...+....|.
T Consensus 270 SFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------------wGVGsNsL~LpvPs 334 (904)
T KOG4721|consen 270 SFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------------WGVGSNSLHLPVPS 334 (904)
T ss_pred hhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------------EeccCCcccccCcc
Confidence 678999999999999999999999999999999999999999765543210 11111223345577
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 333 EEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 333 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.++.-|.-|+++||+..|..||++.+++.-|+-....+
T Consensus 335 tcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel 372 (904)
T KOG4721|consen 335 TCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL 372 (904)
T ss_pred cCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence 78888999999999999999999999999887554433
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=327.99 Aligned_cols=256 Identities=23% Similarity=0.403 Sum_probs=210.4
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.++|++.+.||+|+||.||+|...++..||+|...... ...+.+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 46789999999999999999998888889999876533 23578999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++........
T Consensus 84 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSDEG-GKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 99999999976432 25888999999999999999999998 999999999999999999999999999876433322
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......++..|+|||++....++.++|||||||++|+|+| |..||........ ...... ....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~~---------~~~~ 223 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV-------MSALQR---------GYRM 223 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH-------HHHHHc---------CCCC
Confidence 2233345678999999988889999999999999999998 9999976543321 111111 0111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
+.....+..+.+++.+||+.+|++||++.++.+.|+++
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 12223455789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=339.18 Aligned_cols=266 Identities=25% Similarity=0.363 Sum_probs=218.2
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhh-HHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESN-VEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
...+...+.+.||+|-||.|.++....+..||||+++...... ...|..|+++|.+|+||||++++|+|..++..++|+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~ 614 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT 614 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence 3455677889999999999999999888999999998755444 488999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+|+.++.... +.-....+|+.||+.|++||.+.+ +|||||.++|+|++.++++||+|||+++.+-..
T Consensus 615 EYmEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg 690 (807)
T KOG1094|consen 615 EYMENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG 690 (807)
T ss_pred HHHhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccC
Confidence 9999999999998864322 345566789999999999999999 999999999999999999999999999976554
Q ss_pred Ccee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh--CCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 247 QTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 247 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
..+. ....+-+.+|||||.+..+++|.+||||+||+++||+++ ...||.....++. .+..-...... .
T Consensus 691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~------~ 761 (807)
T KOG1094|consen 691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQ------G 761 (807)
T ss_pred CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCC------C
Confidence 4443 345667789999999999999999999999999999876 7889876544321 11111111111 1
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.......|.-++..+++++.+||..+..+||+++++...|.+.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1122344667788999999999999999999999999888753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=346.06 Aligned_cols=263 Identities=27% Similarity=0.448 Sum_probs=208.7
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEe
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCL 157 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 157 (419)
+....++|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.+ +||||++++++|.
T Consensus 33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~ 112 (374)
T cd05106 33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT 112 (374)
T ss_pred ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence 3455668999999999999999999842 2347999998753 333456788999999999 8999999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCC------------------------------------------------------
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTE------------------------------------------------------ 183 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 183 (419)
+.+..++||||+++|+|.+++.....
T Consensus 113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (374)
T cd05106 113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS 192 (374)
T ss_pred CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence 99999999999999999999864211
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 184 -------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 184 -------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
..++++..+++++.||+.||.|||+++ ++||||||+|||+++++.+||+|||+++.........
T Consensus 193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~ 269 (374)
T cd05106 193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV 269 (374)
T ss_pred ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence 124788899999999999999999998 9999999999999999999999999998654322211
Q ss_pred -eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 251 -TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 251 -~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||........ +..........
T Consensus 270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~---------------~~~~~~~~~~~ 334 (374)
T cd05106 270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK---------------FYKMVKRGYQM 334 (374)
T ss_pred eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH---------------HHHHHHcccCc
Confidence 122335678999999998899999999999999999997 9999976433211 11111111111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
..+...+..+.+++.+||+.+|.+|||+.+|++.|+++
T Consensus 335 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 335 SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 12222346789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=313.66 Aligned_cols=237 Identities=28% Similarity=0.399 Sum_probs=203.5
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|+..+.||.|+||+|.+++.+ +|..+|+|.+.. ....+.+...+|..+|+.+.||+++++++.|.+.+..++|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 356778899999999999999964 577899998754 3445667888999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||++||.|..++++.. ++++....-++.||+.||+|||+.+ |++|||||+|||+|.+|.+||+|||.|+....
T Consensus 123 meyv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~ 196 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG 196 (355)
T ss_pred EeccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence 99999999999999755 4899999999999999999999999 99999999999999999999999999998653
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. ..+.+|||.|+|||.+....+..++|.|||||++|||+.|..||....+.. ..+ .++...
T Consensus 197 r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~-------iY~--------KI~~~~ 257 (355)
T KOG0616|consen 197 R----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQ-------IYE--------KILEGK 257 (355)
T ss_pred c----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHH-------HHH--------HHHhCc
Confidence 3 556799999999999999999999999999999999999999998766532 111 111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCC
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKR 353 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~R 353 (419)
-..|.-....+.+|+...|+.|-.+|
T Consensus 258 --v~fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 258 --VKFPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --ccCCcccCHHHHHHHHHHHhhhhHhh
Confidence 23355556678899999999999988
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=326.12 Aligned_cols=257 Identities=26% Similarity=0.411 Sum_probs=210.7
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..++|++.+.||+|+||.||+|.+.+++.||+|.++... ...+.+.+|+.++++++||||+++++++...+..+++|||
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 456789999999999999999998778889999886543 2346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.......
T Consensus 83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999997654 235899999999999999999999998 99999999999999999999999999987653222
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
........+..|+|||++.+..++.++||||||++++||+| |+.||........ .... .....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~---------~~~~~ 222 (261)
T cd05068 159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV-------LQQV---------DQGYR 222 (261)
T ss_pred cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHH---------HcCCC
Confidence 21222223457999999998899999999999999999999 9999976543321 1111 11111
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
...+...+..+.+++.+|++.+|.+||++.++++.|+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 122334456799999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=328.05 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=215.0
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
....+|.+.+.||+|+||.||+|...++..+|+|.+..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 34567888999999999999999988889999999887666556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 83 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~ 158 (261)
T cd05148 83 LMEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV 158 (261)
T ss_pred ecccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence 9999999999986543 35899999999999999999999998 9999999999999999999999999997654322
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
.. .....++..|+|||.+....++.++||||||+++++|++ |+.||......+. ...+....
T Consensus 159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~----------------~~~~~~~~ 221 (261)
T cd05148 159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV----------------YDQITAGY 221 (261)
T ss_pred cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH----------------HHHHHhCC
Confidence 11 223345678999999988899999999999999999998 8999976543221 11111111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
....+..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 1223345556789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=325.13 Aligned_cols=251 Identities=27% Similarity=0.420 Sum_probs=204.9
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
++|.+.+.||+|+||.||++.+.++..+|+|...... ...+.+.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 4578889999999999999998888889999876432 234678999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQRQG--KLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999976432 4889999999999999999999998 9999999999999999999999999988654332222
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...+..+. ....... ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~-------~~~i~~~---------~~~~ 221 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV-------VEMISRG---------FRLY 221 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCC---------CCCC
Confidence 223335668999999988889999999999999999999 8999976543321 1111111 0111
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
.+...+..+.+++.+||+.+|.+||++.++++.|
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 1222345689999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=325.47 Aligned_cols=255 Identities=31% Similarity=0.466 Sum_probs=209.8
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
..|.+.+.||+|+||.||+|.+. .+..+|+|..... ......+.+|+++++.++||||+++++++..++..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 45788899999999999999965 4778999987643 334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECNR-QEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 99999999976432 35899999999999999999999998 999999999999999999999999999876543322
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......++..|+|||.+.+..++.++|||||||++|||++ |..||...+..+. .+.+......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~ 224 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YELLEKGYRM 224 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHHHCCCCC
Confidence 2222334678999999998999999999999999999998 9999976544321 1111111122
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
..+...+..+.+++.+||+.+|++||++.++++.|+.+
T Consensus 225 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 33344567799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=337.18 Aligned_cols=248 Identities=25% Similarity=0.380 Sum_probs=211.1
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..|...+.||+|.||.||+|.+. .++.||+|.+... .....+.+.+|+.+|.+++++||.++|+.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 34666788999999999999964 5778999998753 345578899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
|.||++.+.+.... .+++..+.-++.+++.||.|||.++ .+|||||+.|||+..+|.+||+|||++-.......
T Consensus 93 ~~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 99999999998643 3477788889999999999999999 99999999999999999999999999988765544
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
.. .+++|||.|||||++....|+.++||||||++.+||++|.+|+....+.. ..-++.+...+
T Consensus 167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr----------------vlflIpk~~PP 229 (467)
T KOG0201|consen 167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR----------------VLFLIPKSAPP 229 (467)
T ss_pred cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce----------------EEEeccCCCCC
Confidence 43 67889999999999998899999999999999999999999998766532 22222222233
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+...+.+++..||+.+|+.||++.++++
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 334466677999999999999999999998875
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=328.11 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=209.7
Q ss_pred cCccccCcccccCcEEEEEEEecCC------CEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADG------GIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~------~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
++|++.+.||+|+||.||+|..... ..+|+|...... ......+.+|+.+++.++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 4688899999999999999986432 478999876433 344567899999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC
Q 014725 164 LVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY 230 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 230 (419)
++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999976421 135888999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHH
Q 014725 231 RAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGF 308 (419)
Q Consensus 231 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 308 (419)
.++|+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------ 235 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 999999999986543222 12233456788999999988899999999999999999998 9999976554321
Q ss_pred HHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
.+.+........+..++..+.+|+.+||+.+|.+||++.+|++.|+.
T Consensus 236 ----------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 236 ----------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred ----------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 11111122223345567789999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=328.95 Aligned_cols=251 Identities=25% Similarity=0.323 Sum_probs=201.7
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377789999999999999996 568899999875422 2233467899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988865432 25899999999999999999999999 9999999999999999999999999998753222
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
......||..|+|||++.+..++.++|||||||++|||++|+.||......... ........ ...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~~~~----------~~~ 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDRRVK----------EDQ 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHHHhh----------ccc
Confidence 123446899999999999999999999999999999999999999865432110 00111100 001
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
...+......+.+|+.+||+.||.+||+ +.++++
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 1223344567889999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=334.65 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=218.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc-ceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEV-PLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lv 165 (419)
.++|...+++|+|+||.++..+. .++..+++|++.... ....+...+|+.++++++|||||.+.+.|.+++. .+||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 36789999999999999999985 456789999877543 3344578899999999999999999999999988 8999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|+||+||+|.+.+.+.. +..++++.+++++.|++.|+.|||+.+ |+|||||+.||+++.++.+||+|||+|+....
T Consensus 83 m~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~ 158 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNP 158 (426)
T ss_pred EeecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCC
Confidence 99999999999998876 346999999999999999999999888 99999999999999999999999999998775
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. ....+..||+.||.||.+.+.+|..|+|||||||++|||++-+.+|...+.... ..-+...
T Consensus 159 ~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L----------------i~ki~~~ 221 (426)
T KOG0589|consen 159 ED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL----------------ILKINRG 221 (426)
T ss_pred ch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH----------------HHHHhhc
Confidence 54 234567799999999999999999999999999999999999999987665431 1112222
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
...+.+.....++..++..|++.+|..||++.+++.+.
T Consensus 222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 34456677788899999999999999999999999873
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=337.97 Aligned_cols=246 Identities=27% Similarity=0.407 Sum_probs=208.2
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|.+.+.||+|+||+||||+.+ +.+.||+|.+.. ..+...+.+.+|+++++.++||||+.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 57888999999999999999964 467899997653 234456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+.| +|..+|.+.. .++++.+..++.++..||.|||+.+ |+|||+||+|||++.++.+|++|||+++.... .
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~ 153 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-N 153 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-C
Confidence 9976 9999998765 4999999999999999999999999 99999999999999999999999999998654 4
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
+...+.+.|||.|||||...++.|+..+|+||+||++||+++|++||-...... +.+.+-.. .
T Consensus 154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~----------------Lv~~I~~d-~ 216 (808)
T KOG0597|consen 154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQ----------------LVKSILKD-P 216 (808)
T ss_pred ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHH----------------HHHHHhcC-C
Confidence 455567889999999999999999999999999999999999999996432211 11111110 1
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+......+..++...|..||.+|.|-.+++.
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1234466678999999999999999999888764
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=327.59 Aligned_cols=249 Identities=39% Similarity=0.598 Sum_probs=198.5
Q ss_pred ccCcccccCcEEEEEEEec-----CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 95 ANRILGQGGQGTVYKGMLA-----DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 95 ~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+.+.||.|.||.||+|.+. .+..|+||.++.. .....+.|.+|++.+++++||||++++|++.+.+..++|+||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4578999999999999976 2457999998653 334578999999999999999999999999988889999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+ ++|+||+++||++++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999999862 225899999999999999999999998 99999999999999999999999999987632222
Q ss_pred -eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 249 -HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 249 -~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
...........|+|||.+.+..++.++||||||+++|||++ |+.||......+ +.+.+....
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----------------~~~~~~~~~ 222 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----------------IIEKLKQGQ 222 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----------------HHHHHHTTE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------ccccccccc
Confidence 22233446778999999999999999999999999999999 789987664432 111112222
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
....+..++..+.+++.+||+.+|.+|||+.+|++.|
T Consensus 223 ~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 2233444566799999999999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-44 Score=338.91 Aligned_cols=261 Identities=29% Similarity=0.481 Sum_probs=225.8
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEecC---CC--EEEEEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEEecC
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLAD---GG--IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLES 159 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~---~~--~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 159 (419)
++.........+.||.|-||.||+|.+.+ |. .||||..+. .+..+.+.|+.|..+|+.++||||++++|+|.+.
T Consensus 384 yel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~ 463 (974)
T KOG4257|consen 384 YELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ 463 (974)
T ss_pred ceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc
Confidence 33444445567789999999999999643 22 589999886 4556678999999999999999999999999754
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
..|+|||+++-|.|.+||+.... .++......++.||+.||.|||+.. +|||||..+|||+.+...+||+||||
T Consensus 464 -P~WivmEL~~~GELr~yLq~nk~--sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGL 537 (974)
T KOG4257|consen 464 -PMWIVMELAPLGELREYLQQNKD--SLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGL 537 (974)
T ss_pred -ceeEEEecccchhHHHHHHhccc--cchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccch
Confidence 56999999999999999998665 4888999999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
++....+..+..+...-+..|||||.+.-.+++.+||||.|||.+||++. |..||.+....+ +
T Consensus 538 SR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD----------------V 601 (974)
T KOG4257|consen 538 SRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD----------------V 601 (974)
T ss_pred hhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc----------------e
Confidence 99988777666666666788999999999999999999999999999988 999998765433 2
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.-.++...+.+.|++|++.++.|+.+||+.+|.+||++.++...|..+..
T Consensus 602 I~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 602 IGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 33345556678899999999999999999999999999999999988754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=323.30 Aligned_cols=252 Identities=27% Similarity=0.415 Sum_probs=205.7
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
++|.+.+.||+|+||.||+|.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++.+....+++|||+.
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4578889999999999999998777789999876433 234678999999999999999999999999889999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+++|.+++..... .+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~l~~~i~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999976433 4899999999999999999999998 9999999999999999999999999988654333222
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
.....++..|+|||++.+..++.++||||||+++|||++ |..||......+. .. ..... ....
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~---~~----~~~~~---------~~~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET---VE----KVSQG---------LRLY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH----HHhcC---------CCCC
Confidence 222335678999999988889999999999999999999 9999976553221 11 11110 1111
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.+......+.+++.+||+.+|.+||++.+|++.|+
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 222 RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 12223467899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=326.49 Aligned_cols=256 Identities=29% Similarity=0.454 Sum_probs=208.4
Q ss_pred hcCccccCcccccCcEEEEEEEecC------CCEEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
.++|.+.+.||+|+||.||+|...+ +..||+|.++..... ..+.+.+|+++++.++||||+++++++......
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 3568888999999999999998643 468999998754433 457899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc
Q 014725 163 LLVYEFIPNGTLYHYLHDQTE-----------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR 231 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 231 (419)
+++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCe
Confidence 999999999999999975421 234788999999999999999999998 999999999999999999
Q ss_pred EEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHH
Q 014725 232 AKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFF 309 (419)
Q Consensus 232 ~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 309 (419)
+||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~------- 233 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV------- 233 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH-------
Confidence 999999999765332221 1223345788999999999999999999999999999999 9999976554321
Q ss_pred HHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 310 LQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.... ........+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus 234 ~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 234 IECI---------TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred HHHH---------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1111 111111223345567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-43 Score=331.79 Aligned_cols=257 Identities=26% Similarity=0.482 Sum_probs=206.4
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CC----EEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GG----IVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
..+|+..+.||+|+||.||+|.+.. +. .||+|.++.. .....+.+.+|+.+++.++||||++++++|... ..+
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 3468999999999999999998643 33 3899998653 334557899999999999999999999999764 568
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+++||+++|+|.+++..... .+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~ 159 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (316)
T ss_pred eeeecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence 99999999999999987543 4888999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 244 KVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 244 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
....... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+. . ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~---------~~ 223 (316)
T cd05108 160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------S---------SI 223 (316)
T ss_pred cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------H---------HH
Confidence 5332221 122334678999999999999999999999999999998 9999976543321 1 11
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+........+..+...+.+++.+||+.+|.+||++.+++..|..+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 224 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11111112223344568899999999999999999999999887743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=321.67 Aligned_cols=256 Identities=25% Similarity=0.410 Sum_probs=208.5
Q ss_pred hcCccccCcccccCcEEEEEEEecC----CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD----GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
.++|++.+.||+|+||.||+|.+.. ...||+|..... .......|.+|+.+++.++||||+++++++.+.+..++
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 3568899999999999999999743 347899987653 33445678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
+|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++...
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 83 ITEYMENGSLDKFLRENDG--KFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEEcCCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999999976543 5899999999999999999999988 9999999999999999999999999998765
Q ss_pred cCC-ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 245 VDQ-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 245 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......+. .....
T Consensus 158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~-------~~~~~-------- 222 (266)
T cd05033 158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV-------IKAVE-------- 222 (266)
T ss_pred ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH-------HHHHH--------
Confidence 222 122222335678999999998999999999999999999998 9999965543221 11111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.....+.+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 223 -~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 223 -DGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111122234456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=329.74 Aligned_cols=265 Identities=22% Similarity=0.242 Sum_probs=202.5
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|++.+.||+|+||.||+|++. ++..+|+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999975 5678999987643 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|++++.+..+.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99987776554332 24889999999999999999999998 9999999999999999999999999998764333
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc---------ccch
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN---------EDRL 318 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---------~~~~ 318 (419)
........|++.|+|||++.+..++.++|||||||++|||++|+.||......+............. ....
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 3233345689999999999988899999999999999999999999987554322111110000000 0000
Q ss_pred hHHHHHhhc------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARVL------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+... .......+..+.+++.+||+.||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 0001123456899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=326.07 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=211.2
Q ss_pred cCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|+.++++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56888999999999999999842 234689998876666666789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 165 VYEFIPNGTLYHYLHDQT----------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
+|||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999997532 1224899999999999999999999998 999999999999999999999
Q ss_pred eecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHH
Q 014725 235 SDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
+|||+++........ ......++..|+|||++.+..++.++|||||||++++|++ |..||......+. ...
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~-------~~~ 234 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV-------IEC 234 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH
Confidence 999999865332221 1223345778999999998899999999999999999998 9999876554321 111
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
...+. ....+...+..+.+++.+||+.+|.+|||+.+|++.|+++...
T Consensus 235 i~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~ 282 (288)
T cd05093 235 ITQGR---------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA 282 (288)
T ss_pred HHcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence 11111 1111223445799999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=326.54 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=212.4
Q ss_pred cCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
.+|.+.+.||+|+||.||+|... ++..+++|..........+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 45788899999999999999843 245688998876666666789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc
Q 014725 165 VYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR 231 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 231 (419)
||||+++++|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999975421 224889999999999999999999999 999999999999999999
Q ss_pred EEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHH
Q 014725 232 AKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFF 309 (419)
Q Consensus 232 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 309 (419)
++|+|||+++....... .......++..|+|||++.+..++.++|||||||++|||+| |+.||......+.
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~------- 234 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV------- 234 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------
Confidence 99999999976543222 12233446788999999998999999999999999999999 9999876554321
Q ss_pred HHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 310 LQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
........ ....+...+..+.+++.+||+.+|++||++.+|+++|+++.+.
T Consensus 235 ~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 235 IECITQGR---------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHhCCC---------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 11111111 1112233456789999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=334.66 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=204.8
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46899999999999999999975 4789999987642 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 e~~~g~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNLG---VLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 9999999999997543 4889999999999999999999999 99999999999999999999999999976533
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
......||+.|+|||++.+..++.++|||||||++|||++|..||......+..... .. +. ..+....
T Consensus 154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~~-~~-----~~~~~~~ 221 (333)
T cd05600 154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL---KY-WK-----ETLQRPV 221 (333)
T ss_pred ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH---Hh-cc-----ccccCCC
Confidence 223456899999999999999999999999999999999999999876543321100 00 00 0000000
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
...........+.+++.+||..+|.+||++.++++.
T Consensus 222 ~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 222 YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 000011335678899999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=330.34 Aligned_cols=244 Identities=24% Similarity=0.332 Sum_probs=201.5
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46889999999999999999975 5789999987542 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++.....++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNSG---RFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 9999999999997643 4889999999999999999999999 999999999999999999999999999765322
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+. .......
T Consensus 155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~---------- 213 (291)
T cd05612 155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI-------YEKILAG---------- 213 (291)
T ss_pred ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhC----------
Confidence 1234689999999999988999999999999999999999999976544321 1111000
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
....+......+.+++.+||+.||.+||+ +.++++
T Consensus 214 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 214 KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 01122333557889999999999999995 666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=332.87 Aligned_cols=265 Identities=27% Similarity=0.385 Sum_probs=206.5
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|++.+.||+|+||.||++... ++..+|+|..... .....+.+.+|+++++.++||||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 468999999999999999999975 5678899987653 33445679999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+. |+||||||+|||++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcCC--EEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 999999999997643 48899999999999999999998532 999999999999999999999999998765322
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh--------------
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM-------------- 313 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------- 313 (419)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...+..+............
T Consensus 158 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (331)
T cd06649 158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRP 235 (331)
T ss_pred --ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccc
Confidence 1233468999999999999999999999999999999999999997655432211100000000
Q ss_pred -------------cccchhHHHHHhh----ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 314 -------------NEDRLFEVLEARV----LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 314 -------------~~~~~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
......+..+... ...........+.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 236 PGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000011111110 011112345679999999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=332.84 Aligned_cols=241 Identities=24% Similarity=0.300 Sum_probs=197.8
Q ss_pred CcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 97 RILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
+.||+|+||.||++.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999996 46789999987642 2334567889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeee
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT 252 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 252 (419)
+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~ 153 (323)
T cd05571 81 ELFFHLSRER---VFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Cccc
Confidence 9999987643 4899999999999999999999999 9999999999999999999999999987532211 2223
Q ss_pred cccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCH
Q 014725 253 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332 (419)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (419)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ....... ....+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------~~~~~~~----------~~~~p~ 216 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILME----------EIRFPR 216 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH-------HHHHHcC----------CCCCCC
Confidence 45699999999999999999999999999999999999999976543221 0111000 012233
Q ss_pred HHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 333 EEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 333 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
.....+.+++.+||+.||++|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 217 TLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 4456788999999999999999 7888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=334.30 Aligned_cols=245 Identities=25% Similarity=0.311 Sum_probs=201.7
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 467899999999999999999975 5788999987532 223456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++.... .+++.....++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 97 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG---RFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred EcCCCCChHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999998643 4788899999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. ....||+.|+|||++.+..++.++|||||||++|||++|..||........ ........
T Consensus 171 ~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-------~~~i~~~~-------- 231 (329)
T PTZ00263 171 RT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI-------YEKILAGR-------- 231 (329)
T ss_pred Cc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH-------HHHHhcCC--------
Confidence 22 234689999999999999999999999999999999999999976543221 11111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
...+......+.+++.+||+.||.+||+ +.+++.
T Consensus 232 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 232 --LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred --cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1112223456889999999999999997 566653
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=348.80 Aligned_cols=252 Identities=24% Similarity=0.310 Sum_probs=206.5
Q ss_pred cCccccCcccccCcEEEEEEEec-C-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-D-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..|.+.+.||+|+||.||+|... + +..||+|............+.+|+.+++.++||||+++++++...+..++||||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~ 146 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY 146 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence 34899999999999999999853 3 567888887665566667788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
+++|+|.+++... ....++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999988653 22346889999999999999999999998 9999999999999999999999999998764322
Q ss_pred c-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 248 T-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 248 ~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ... ++.. .
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~-------~~~--------~~~~-~ 287 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI-------MQQ--------VLYG-K 287 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHH--------HHhC-C
Confidence 2 223455699999999999999999999999999999999999999976543221 010 0000 0
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+......+.+++.+||+.+|++||++.+++.
T Consensus 288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11122334567899999999999999999998864
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-43 Score=339.24 Aligned_cols=264 Identities=27% Similarity=0.394 Sum_probs=210.2
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEecC------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCC-CcccccEEeEEe
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLV-DESNVEQFINEVVILSQIN-HRNVVKLLGCCL 157 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~ 157 (419)
++...++|.+.+.||+|+||.||+|++.. +..||||++... .....+.+.+|+.+++.+. ||||+++++++.
T Consensus 32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~ 111 (400)
T cd05105 32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT 111 (400)
T ss_pred eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence 34456789999999999999999998531 236999998653 3334567999999999996 999999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCC------------------------------------------------------
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTE------------------------------------------------------ 183 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------ 183 (419)
+.+..++||||+++|+|.+++.....
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (400)
T cd05105 112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM 191 (400)
T ss_pred cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence 99999999999999999999865311
Q ss_pred ---------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014725 184 ---------------------------------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224 (419)
Q Consensus 184 ---------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni 224 (419)
...+++..+..++.|++.||.|||+.+ ++||||||+||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Ni 268 (400)
T cd05105 192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNV 268 (400)
T ss_pred hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhE
Confidence 124788888999999999999999998 99999999999
Q ss_pred EECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhh
Q 014725 225 LLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEED 302 (419)
Q Consensus 225 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 302 (419)
|++.++.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 9999999999999999865432221 1223346788999999998899999999999999999997 9999876433211
Q ss_pred ccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 303 RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
..... ........+...+..+.+++.+||+.+|++||++.+|.+.|+++.
T Consensus 349 ------~~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 349 ------FYNKI---------KSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred ------HHHHH---------hcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 11111 111111223345667999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-43 Score=320.16 Aligned_cols=251 Identities=28% Similarity=0.422 Sum_probs=204.6
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
.+|++.+.||+|+||.||+|.+.++..+|+|....... ....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 34778899999999999999987777899998754322 23578899999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRERKG--KLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 9999999976443 5899999999999999999999999 9999999999999999999999999998654322222
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
.....++..|+|||.+.+..++.++||||||+++|||++ |..||......+. ... +.......
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~---------~~~~~~~~ 221 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV-------VES---------VSAGYRLY 221 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH-------HHH---------HHcCCcCC
Confidence 222224457999999998899999999999999999999 8999976544321 011 11111112
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
.+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 2333566799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=319.33 Aligned_cols=254 Identities=28% Similarity=0.421 Sum_probs=206.9
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|||++++++++. ....+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM 82 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence 457889999999999999999988888899998875333 3467899999999999999999999885 45679999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 83 SKGSLLDFLKDGEG-RALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 99999999976432 24899999999999999999999998 999999999999999999999999999875433222
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......++..|+|||.+.+..++.++||||||+++|+|++ |..||...+..+. ... +......
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~-------~~~---------~~~~~~~ 222 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV-------LEQ---------VERGYRM 222 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHH---------HHcCCCC
Confidence 2222335668999999988899999999999999999999 8999976543221 111 1111112
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
..+...+..+.+++.+|++.+|.+|||+.++.+.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 2334455679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=337.37 Aligned_cols=262 Identities=31% Similarity=0.467 Sum_probs=230.6
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
+.++-...+....++||-|.||.||.|.|+. .-.||||.++... -..++|+.|+.+|+.++|||+|+++|+|..+..+
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4455555556677899999999999999865 4579999988643 3468999999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
|||.|||..|+|.+||++.... .++.-.++.++.||..|++||..++ +|||||..+|+|+.++..+|++||||++.
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~-ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRS-EVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhchh-hcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999986543 4777788999999999999999999 99999999999999999999999999999
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
+..+...........+.|.|||.+..+.++.|+|||+|||+|||+.| |..||.+.+-.+ +..+
T Consensus 415 MtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq----------------VY~L 478 (1157)
T KOG4278|consen 415 MTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYGL 478 (1157)
T ss_pred hcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH----------------HHHH
Confidence 87766655555556788999999999999999999999999999999 999998876543 4566
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
++...+...+..|++.+++|++.||+++|.+||++.|+-+.++.+
T Consensus 479 LEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 479 LEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred HhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 677777888999999999999999999999999999999988754
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=324.81 Aligned_cols=257 Identities=28% Similarity=0.447 Sum_probs=205.9
Q ss_pred HhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
..++|++.+.||+|+||.||+|.+. .+..||+|+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4677999999999999999999853 2457999987543 23345678999999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTE-------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
.++||||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999975322 124678889999999999999999998 999999999999999999999
Q ss_pred eecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHH
Q 014725 235 SDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
+|||+++......... .....+++.|+|||++.+..++.++|||||||++|||++ |..||........ ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~-------~~~ 233 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV-------LRF 233 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHH
Confidence 9999987654322221 122345778999999998899999999999999999999 7889876544321 111
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.... .....+...+..+.+++.+||+.+|++|||+.|+++.|+
T Consensus 234 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VMEG---------GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HHcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 1111 111223344567899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=320.07 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=209.2
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
...++|++.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.++++++|||++++++++. .+..+++||
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 34567899999999999999999988889999998765433 3467899999999999999999999874 556899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++..... ..+++.++..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 81 YMENGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred cCCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 9999999999876432 35899999999999999999999998 9999999999999999999999999998765332
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
........++..|+|||++....++.++||||||++++|+++ |+.||......+. ... +....
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~---------~~~~~ 220 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV-------IQN---------LERGY 220 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH-------HHH---------HHcCC
Confidence 222223345678999999998889999999999999999999 9999976543321 111 11111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
....+...+..+.+++.+||+.+|++||++.+++..|+.
T Consensus 221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 221 RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112233345679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-43 Score=336.95 Aligned_cols=248 Identities=27% Similarity=0.401 Sum_probs=210.9
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.+-|++.+.||.|+-|.|-+|++ ..|+.+|||.+... .......+.+|+.+|+.+.|||++++++++.+..++|+|
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 45689999999999999999996 56899999987543 233456688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
.||+++|.|.+++-.++ ++++.+..+++.||+.|+.|+|..+ |+||||||+|+|+|.++++||+|||+|..-.
T Consensus 91 lEyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~- 163 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV- 163 (786)
T ss_pred EEecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc-
Confidence 99999999999998765 5899999999999999999999999 9999999999999999999999999997633
Q ss_pred CCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
....-.+.||+|+|.|||++.+..| +.++||||.|||||.|+||+.||++..... .+.++..+
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-------LLlKV~~G-------- 227 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-------LLLKVQRG-------- 227 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-------HHHHHHcC--------
Confidence 2233456789999999999999888 489999999999999999999998544322 11111111
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..+.|...+.+..+|+.+|+..||++|.|+.||++-
T Consensus 228 --~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 228 --VFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred --cccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 234456667789999999999999999999999773
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=304.49 Aligned_cols=268 Identities=24% Similarity=0.350 Sum_probs=216.0
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEE-ecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC---
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE--- 160 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 160 (419)
++....++|++.+.||+|||.-||++. ..++..+|+|++.....++.+..++|++..++++|||+++++++...+.
T Consensus 15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~ 94 (302)
T KOG2345|consen 15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG 94 (302)
T ss_pred cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence 444567899999999999999999999 5678899999999888788899999999999999999999999876543
Q ss_pred --cceEEEeecCCCCHHHHhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 014725 161 --VPLLVYEFIPNGTLYHYLHDQTEE-FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF 237 (419)
Q Consensus 161 --~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 237 (419)
..|++++|...|+|.+.+.....+ ..+++.+.++|+.+|++||++||+..+ ++.||||||.|||+.+.+.++|.||
T Consensus 95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEec
Confidence 489999999999999999875433 369999999999999999999999874 6999999999999999999999999
Q ss_pred CCceecccCCcee--------eecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHH
Q 014725 238 GASRTIKVDQTHL--------TTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV 306 (419)
Q Consensus 238 gl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 306 (419)
|.++.....-... .....-|..|.|||.+. +...++++|||||||+||+|+.|..||+..-. ...++
T Consensus 174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSl- 251 (302)
T KOG2345|consen 174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSL- 251 (302)
T ss_pred cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeE-
Confidence 9987653211110 11233688999999885 35678999999999999999999999964322 11110
Q ss_pred HHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 307 GFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
...+....+..+.....++.+.++++.|++.||.+||++.+++..++.+
T Consensus 252 -----------aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 252 -----------ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred -----------EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 0112222222333334677899999999999999999999999988765
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=318.75 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=207.2
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.++|.+.+.||+|+||.||+|.+.++..||+|+...... ..+.+.+|+.+++.++||||+++++++. ....++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~ 82 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM 82 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence 467999999999999999999987777899999875332 3467899999999999999999999875 45679999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 83 SKGSLLDFLKGEMG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCcHHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 99999999976432 24789999999999999999999998 999999999999999999999999999876433322
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......++..|+|||+..+..++.++||||||+++|||+| |..||......+. ... +......
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~-------~~~---------~~~~~~~ 222 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-------LDQ---------VERGYRM 222 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH-------HHH---------HhcCCCC
Confidence 2223346678999999988899999999999999999999 8889876543221 000 1111111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
..+...+..+.+++.+|++.+|.+||++.++++.|+..
T Consensus 223 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 22344566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=322.89 Aligned_cols=256 Identities=27% Similarity=0.454 Sum_probs=206.2
Q ss_pred cCccccCcccccCcEEEEEEEe-----cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-----ADGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
+.|++.+.||+|+||.||+|.. ..+..+++|..... .......+.+|+.+++.++||||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4678889999999999999984 24568999998743 33445678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC
Q 014725 165 VYEFIPNGTLYHYLHDQTE--------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY 230 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 230 (419)
+|||+++++|.+++..... ...+++.+...++.|++.||.|||+++ ++|+||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999864321 124788999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHH
Q 014725 231 RAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGF 308 (419)
Q Consensus 231 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 308 (419)
.+||+|||+++....... .......++..|+|||++.+..++.++|||||||+++||++ |..||......+
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~------- 234 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE------- 234 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence 999999999986543221 12233345678999999988889999999999999999998 999987654322
Q ss_pred HHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
+.+.+........+...+..+.+++.+||+.+|.+||++.+|++.|..
T Consensus 235 ---------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 235 ---------VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred ---------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111111111122333455678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=324.41 Aligned_cols=264 Identities=31% Similarity=0.463 Sum_probs=207.2
Q ss_pred hcCccccCcccccCcEEEEEEEec-----CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEec--CCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-----DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE--SEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 162 (419)
..+|++.+.||+|+||.||++... ++..||+|.+........+.+.+|+++++.++||||+++++++.. ....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 82 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL 82 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence 357888999999999999999742 477899999887666667889999999999999999999998754 3467
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~ 157 (284)
T cd05081 83 RLVMEYLPYGSLRDYLQKHRE--RLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKV 157 (284)
T ss_pred EEEEEecCCCCHHHHHHhcCc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCccccc
Confidence 899999999999999976432 4899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCceee--ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc----
Q 014725 243 IKVDQTHLT--TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED---- 316 (419)
Q Consensus 243 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 316 (419)
......... ....++..|+|||++.+..++.++|||||||+++||++|..|+....... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~--------~~~~~~~~~~~ 229 (284)
T cd05081 158 LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF--------MRMMGNDKQGQ 229 (284)
T ss_pred ccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh--------hhhcccccccc
Confidence 643322111 11223456999999998899999999999999999999887764332110 1110000
Q ss_pred ----chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 317 ----RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 317 ----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.+.+.+........+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 230 MIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred cchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11112222212222344556799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=326.42 Aligned_cols=264 Identities=24% Similarity=0.317 Sum_probs=200.7
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56999999999999999999964 57889999876432 22345678999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++ +|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCGN--LMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 975 99998876433 4788999999999999999999998 99999999999999999999999999976532221
Q ss_pred eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch---------
Q 014725 249 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL--------- 318 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------- 318 (419)
......+++.|+|||++.+ ..++.++|||||||++|||+||+.||......+................+
T Consensus 159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd07871 159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF 237 (288)
T ss_pred -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence 1233457899999998865 56899999999999999999999999876554322111111100000000
Q ss_pred hHHHHHhhccC----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARVLKE----GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+..... ..........+++.+||+.||.+|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000000 00112346789999999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=369.87 Aligned_cols=265 Identities=26% Similarity=0.429 Sum_probs=208.7
Q ss_pred HHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
+.....|...+.||+|+||.||+|.. .++..||+|++...... ...|++.+++++||||++++++|.+.+..++|
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 33445677888999999999999996 56889999988653322 23468899999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.++++. ++|..+.+++.|++.||+|||.....+|+||||||+||+++.++..++. ||.......
T Consensus 762 ~Ey~~~g~L~~~l~~------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~ 834 (968)
T PLN00113 762 HEYIEGKNLSEVLRN------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT 834 (968)
T ss_pred EeCCCCCcHHHHHhc------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc
Confidence 999999999999962 7899999999999999999996655559999999999999999888875 665543221
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. ....+|+.|+|||++.+..++.++|||||||++|||+||+.||+.... .......|.............+++.
T Consensus 835 ~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 908 (968)
T PLN00113 835 D-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPS 908 (968)
T ss_pred C-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcc
Confidence 1 123578999999999999999999999999999999999999954322 1223334443333333333334443
Q ss_pred hcc--CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 326 VLK--EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 326 ~~~--~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
... ..+..+..++.+++.+||+.+|++||||.||++.|+++..
T Consensus 909 ~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 909 IRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred ccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 322 2344566778899999999999999999999999998754
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=332.43 Aligned_cols=246 Identities=25% Similarity=0.320 Sum_probs=201.9
Q ss_pred HhcCccccCcccccCcEEEEEEEecC--CCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD--GGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
..++|.+.+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 34569999999999999999998643 358999987532 2334567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 lv~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 9999999999999998654 4889999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+.... ........
T Consensus 182 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-------~~~i~~~~------ 244 (340)
T PTZ00426 182 DTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI-------YQKILEGI------ 244 (340)
T ss_pred CCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH-------HHHHhcCC------
Confidence 322 2345689999999999988899999999999999999999999986544221 11111110
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
...+......+.+++.+||+.+|.+|+ +++++++
T Consensus 245 ----~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 245 ----IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ----CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 112233345678999999999999995 7877765
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=323.70 Aligned_cols=264 Identities=28% Similarity=0.440 Sum_probs=212.1
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEecC------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEE
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCC 156 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 156 (419)
+++...++|++.+.||+|+||.||++...+ ...+|+|..... .......+.+|+.++.++ +||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344556779999999999999999998642 357899987653 334456788999999999 799999999999
Q ss_pred ecCCcceEEEeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 157 LESEVPLLVYEFIPNGTLYHYLHDQT-------------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
.+.+..+++|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~N 162 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARN 162 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceee
Confidence 99999999999999999999997531 2346899999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhh
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~ 301 (419)
|+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 242 (293)
T cd05053 163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 242 (293)
T ss_pred EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence 999999999999999998764332211 122235678999999988899999999999999999998 999987654332
Q ss_pred hccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
. .+.+........+......+.+++.+||..+|++|||+.++++.|+.+.
T Consensus 243 ~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 243 L----------------FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred H----------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 1111111112233344567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=330.30 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=203.6
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|.+.+.||+|+||.||++... +++.||+|.++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46899999999999999999964 6788999987642 2234567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYED--QFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 99999999999987532 4899999999999999999999999 999999999999999999999999999876544
Q ss_pred CceeeecccccCCccCccccc------cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 247 QTHLTTRVQGTFGYLDPEYFR------SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||........ +.........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~-- 227 (330)
T cd05601 156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRF-- 227 (330)
T ss_pred CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCc--
Confidence 433334456899999999986 45678999999999999999999999976543221 1111111000
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
............+.+++..|++ +|.+||++.+++.
T Consensus 228 -----~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 -----LKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred -----cCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 0011112234568889999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=320.30 Aligned_cols=261 Identities=25% Similarity=0.404 Sum_probs=211.4
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-----CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEec-CCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-----GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLE-SEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~ 161 (419)
..++|.+.+.||+|+||.||+|.+.+ +..|++|++... .....+.+.+|+.+++.++||||+++++++.+ ...
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 35689999999999999999999765 678999987643 34456778999999999999999999998776 467
Q ss_pred ceEEEeecCCCCHHHHhhccCCC-----CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEE-----FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSD 236 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~-----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 236 (419)
.++++||+++++|.+++...... ..+++..++.++.|++.||.|||+.+ ++|+||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999999764322 45899999999999999999999998 99999999999999999999999
Q ss_pred cCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhc
Q 014725 237 FGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 237 fgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
||+++.+....... .....++..|+|||++.+..++.++||||||+++||+++ |+.||...+..+. .....
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM-------AAYLK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH-------HHHHH
Confidence 99998654332221 222345678999999998889999999999999999999 9999976544321 11111
Q ss_pred ccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
. ......+..++..+.+++.+||..+|++|||+.++++.|+.+.+
T Consensus 234 ~---------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 234 D---------GYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred c---------CCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 11111222345678999999999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=322.53 Aligned_cols=259 Identities=26% Similarity=0.423 Sum_probs=206.4
Q ss_pred cCccccCcccccCcEEEEEEEecC-CC--EEEEEEccc-CChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLAD-GG--IVAVKKSKL-VDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~-~~--~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 165 (419)
++|++.+.||+|+||.||+|...+ +. .+++|..+. ......+.+.+|+.+++++ +||||+++++++.+.+..+++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 578899999999999999999754 32 478888764 3334456789999999999 799999999999999999999
Q ss_pred EeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcE
Q 014725 166 YEFIPNGTLYHYLHDQT-------------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA 232 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 232 (419)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999997532 1124889999999999999999999998 9999999999999999999
Q ss_pred EEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHH
Q 014725 233 KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQ 311 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 311 (419)
||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |..||......+. ..
T Consensus 159 kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-------~~ 229 (297)
T cd05089 159 KIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-------YE 229 (297)
T ss_pred EECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HH
Confidence 99999998643211 11111223557999999988889999999999999999998 9999976554321 11
Q ss_pred HhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.+........+...+..+.+++.+||+.+|.+||++.++++.|+.+....
T Consensus 230 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 230 ---------KLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred ---------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 11111112223344567899999999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=327.60 Aligned_cols=241 Identities=26% Similarity=0.298 Sum_probs=195.4
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 99 LGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
||+|+||.||+|... ++..||+|.+.. ........+.+|+.+++.++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999975 477899998753 2334456788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecc
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 254 (419)
.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ......
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~ 153 (312)
T cd05585 81 FHHLQREG---RFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF 153 (312)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence 99997643 4899999999999999999999999 9999999999999999999999999987543222 223345
Q ss_pred cccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHH
Q 014725 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334 (419)
Q Consensus 255 ~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (419)
.||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +..... . ....+...
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~-~----------~~~~~~~~ 216 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQ-E----------PLRFPDGF 216 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHc-C----------CCCCCCcC
Confidence 689999999999999999999999999999999999999976543221 111110 0 11223344
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 335 IITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 335 ~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
...+.+++.+||+.||.+||++..+.+.|
T Consensus 217 ~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 217 DRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 56788999999999999998654443333
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=319.40 Aligned_cols=256 Identities=24% Similarity=0.411 Sum_probs=203.5
Q ss_pred cCccccCcccccCcEEEEEEEec-CCC----EEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGG----IVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
++|++.+.||+|+||+||+|.+. ++. .+++|...... ......+..|+..++.++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 45778899999999999999964 333 47888775432 233467788888999999999999999886 455789
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
++||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQHRD--SLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999976443 4899999999999999999999998 9999999999999999999999999998754
Q ss_pred cCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 245 VDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 245 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
.... .......++..|+|||++.+..++.++||||||+++|||++ |..||........ .+.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~----------------~~~~ 224 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV----------------PDLL 224 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----------------HHHH
Confidence 3322 12233456778999999998899999999999999999998 9999977654321 1111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
........+..+...+.+++.+||..+|.+|||+.|+++.|..+..
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 225 EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 1111111222234567889999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=321.71 Aligned_cols=258 Identities=29% Similarity=0.436 Sum_probs=207.4
Q ss_pred CccccCcccccCcEEEEEEEecC------CCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 92 NYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
+|++.+.||+|+||.||+|.... ...+++|...... ......+.+|+.+++.++||||+++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 47788999999999999998532 2468888876433 3445678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 165 VYEFIPNGTLYHYLHDQT---------------------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~---------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
++||+.+++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999986421 1124789999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhh
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~ 301 (419)
|++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||++++||+| |..||.......
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 99999999999999999865332221 1222345678999999988889999999999999999999 999997654432
Q ss_pred hccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
. .+.+........+...+..+.+++.+||+.+|.+||++.++++.|+++..
T Consensus 238 ~----------------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 238 L----------------FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H----------------HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 1 11111111122233445678999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=315.80 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=206.1
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.++|.+.+.||+|+||.||+|.+.++..+|+|...... ...+.+.+|+.+++.++|||++++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM 82 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence 35688999999999999999998777789999876433 23467889999999999999999999875 45679999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||+++........
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 83 GKGSLLDFLKEGDG-KYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 99999999976432 34789999999999999999999998 999999999999999999999999999875433222
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......++..|+|||...+..++.++||||||+++|||+| |..||......+. .. .. ......
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~----~~---------~~~~~~ 222 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LE----QV---------ERGYRM 222 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HH---------HcCCCC
Confidence 2223345678999999988899999999999999999999 9999976543221 11 11 011111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
..+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 2233456679999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=330.87 Aligned_cols=262 Identities=28% Similarity=0.432 Sum_probs=206.6
Q ss_pred HhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCcccccEEeEEecC-
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVD-ESNVEQFINEVVILSQI-NHRNVVKLLGCCLES- 159 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 159 (419)
..++|++.+.||+|+||.||+|... .++.||+|++.... ....+.+..|+.++.++ +||||++++++|...
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 3467999999999999999999742 24689999887532 33446788899999999 899999999988654
Q ss_pred CcceEEEeecCCCCHHHHhhccCC--------------------------------------------------------
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTE-------------------------------------------------------- 183 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 183 (419)
...+++|||+++++|.+++.....
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 567899999999999999864321
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce-eeecccccCCc
Q 014725 184 --EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGY 260 (419)
Q Consensus 184 --~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y 260 (419)
..++++..+..++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++........ ......++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 125889999999999999999999998 999999999999999999999999999875432221 12234456789
Q ss_pred cCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHH
Q 014725 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVA 339 (419)
Q Consensus 261 ~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 339 (419)
+|||++.+..++.++|||||||+++||++ |..||......+. ..... ........+......+.
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~---------~~~~~~~~~~~~~~~~~ 306 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRL---------KEGTRMRAPEYATPEIY 306 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHH---------hccCCCCCCccCCHHHH
Confidence 99999999999999999999999999998 9999976433221 11111 11111122333456789
Q ss_pred HHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 340 MLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 340 ~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+++.+||+.+|++||++.+|++.|+++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=322.11 Aligned_cols=261 Identities=26% Similarity=0.326 Sum_probs=205.5
Q ss_pred cCHHHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC--------------hhhHHHHHHHHHHHhcCC
Q 014725 81 FTKMDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD--------------ESNVEQFINEVVILSQIN 145 (419)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~e~~~l~~l~ 145 (419)
+...+-....+.|.+.+.||+|.||.|-+|+. .+++.||||++.... ....+...+|+.+|++++
T Consensus 87 ~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~ 166 (576)
T KOG0585|consen 87 YDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH 166 (576)
T ss_pred ecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC
Confidence 33444455678899999999999999999995 568899999754311 112467899999999999
Q ss_pred CcccccEEeEEec--CCcceEEEeecCCCCHHHHhhccCCCCC-CCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCC
Q 014725 146 HRNVVKLLGCCLE--SEVPLLVYEFIPNGTLYHYLHDQTEEFP-ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSS 222 (419)
Q Consensus 146 h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~ 222 (419)
|||||+|+.+..+ .+..|||+|||..|.+...= ...+ +++.+.++++.++..||+|||.++ ||||||||.
T Consensus 167 H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p----~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPs 239 (576)
T KOG0585|consen 167 HPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP----PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPS 239 (576)
T ss_pred CcCeeEEEEeecCcccCceEEEEEeccCCccccCC----CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchh
Confidence 9999999999875 46789999999988775422 2223 899999999999999999999999 999999999
Q ss_pred cEEECCCCcEEEeecCCceecccC----CceeeecccccCCccCccccccCC----CCcccceechhHHHHHHHhCCCCC
Q 014725 223 NILLDDKYRAKVSDFGASRTIKVD----QTHLTTRVQGTFGYLDPEYFRSSQ----FTEKSDVYSFGVVLVELLTGQKPI 294 (419)
Q Consensus 223 Nill~~~~~~kl~Dfgl~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Di~slG~~l~el~tg~~p~ 294 (419)
|+||+++|++||+|||.+..+... .........|||.|+|||.+.++. .+.+.||||+||+||.|+.|+.||
T Consensus 240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF 319 (576)
T KOG0585|consen 240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF 319 (576)
T ss_pred heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence 999999999999999999876322 111123467999999999987632 357899999999999999999999
Q ss_pred CCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 295 RSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
.+....+. ...++...+..+...+....+.+|+.++|++||++|.++.+|..-.
T Consensus 320 ~~~~~~~l---------------~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 320 FDDFELEL---------------FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred ccchHHHH---------------HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence 76544321 1222233333333345567899999999999999999999986644
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=334.48 Aligned_cols=252 Identities=25% Similarity=0.334 Sum_probs=205.0
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|.+.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999975 6889999987642 2244567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRKD---VFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 9999999999998652 4899999999999999999999998 999999999999999999999999999865433
Q ss_pred C----------------------------ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCC
Q 014725 247 Q----------------------------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298 (419)
Q Consensus 247 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~ 298 (419)
. ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 112234568999999999999999999999999999999999999998765
Q ss_pred hhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHH
Q 014725 299 AEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS-MKEVAFE 362 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~ 362 (419)
.... ......-. ...........+..+.+++.+|+. +|.+||+ +.++++.
T Consensus 235 ~~~~------~~~i~~~~-------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 235 LQET------YNKIINWK-------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HHHH------HHHHhccC-------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 4321 11100000 000111111135678899999997 9999999 9999873
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=322.16 Aligned_cols=269 Identities=30% Similarity=0.446 Sum_probs=207.0
Q ss_pred cCc-cccCcccccCcEEEEEEEe-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Cc
Q 014725 91 DNY-NANRILGQGGQGTVYKGML-----ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EV 161 (419)
Q Consensus 91 ~~y-~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 161 (419)
++| ...+.||+|+||+||++.. .++..||+|...... ......+.+|+++++.++||||+++++++... ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 344 8889999999999988653 356789999886543 33456788999999999999999999988754 35
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.+++|||+++++|.+++... .+++..++.++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++
T Consensus 83 ~~lv~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~ 155 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 155 (283)
T ss_pred EEEEecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccc
Confidence 78999999999999999753 3899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCcee--eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 242 TIKVDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 242 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
......... .....++..|+|||.+.+..++.++||||||++++||+||..||........ ..............+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~ 234 (283)
T cd05080 156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLI 234 (283)
T ss_pred ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhh
Confidence 654322111 1223356679999999888999999999999999999999999865432110 0000000001111122
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
+.++.......+...+..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 235 ELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 222222222334455678999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=330.25 Aligned_cols=251 Identities=23% Similarity=0.278 Sum_probs=199.6
Q ss_pred CccccCcccccCcEEEEEEEec----CCCEEEEEEcccC----ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcc
Q 014725 92 NYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLV----DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 162 (419)
+|++.+.||+|+||.||++... ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4888999999999999999853 5788999987532 223345688899999999 599999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 99999999999999997643 4889999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.............||+.|+|||++.+. .++.++|||||||++|||+||+.||......... ..+......
T Consensus 155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~~~~~~~------ 225 (332)
T cd05614 155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ---SEVSRRILK------ 225 (332)
T ss_pred ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH---HHHHHHHhc------
Confidence 543333333446799999999998865 4789999999999999999999999754322111 001111000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
.....+......+.+++.+||+.||++|| ++.++++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 ----CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 01122233456788999999999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=314.41 Aligned_cols=247 Identities=29% Similarity=0.433 Sum_probs=199.5
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
+.||+|+||.||+|.+. +++.+|+|..... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 46999999999999964 6888999986543 344456799999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee-ec
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT-TR 253 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~ 253 (419)
.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........... ..
T Consensus 81 ~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTEGP--RLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 999975432 4889999999999999999999998 99999999999999999999999999875432111111 11
Q ss_pred ccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCH
Q 014725 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332 (419)
Q Consensus 254 ~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (419)
...+..|+|||.+.+..++.++||||||+++|||++ |..||........ ...+........+.
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~----------------~~~~~~~~~~~~~~ 219 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT----------------REAIEQGVRLPCPE 219 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH----------------HHHHHcCCCCCCcc
Confidence 123457999999998899999999999999999998 8899875543221 11111111222333
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 333 EEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 333 ~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
..+..+.+++.+||+.+|++|||+.+|+++|+
T Consensus 220 ~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 44567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=327.85 Aligned_cols=241 Identities=24% Similarity=0.306 Sum_probs=197.4
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
+.||+|+||.||++... ++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999964 5789999987642 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeee
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT 252 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 252 (419)
+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... .....
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~ 153 (328)
T cd05593 81 ELFFHLSRER---VFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMK 153 (328)
T ss_pred CHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccc
Confidence 9999887543 4899999999999999999999998 999999999999999999999999998753221 12223
Q ss_pred cccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCH
Q 014725 253 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332 (419)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (419)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. ....... ....+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~-------~~~~~~~----------~~~~p~ 216 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILME----------DIKFPR 216 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH-------HHHhccC----------CccCCC
Confidence 45689999999999988999999999999999999999999976543321 1111000 011223
Q ss_pred HHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 333 EEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 333 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
.....+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 217 TLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 3455688999999999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=312.54 Aligned_cols=247 Identities=28% Similarity=0.454 Sum_probs=201.5
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCHH
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLY 175 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 175 (419)
+.||+|+||.||+|...++..+|+|...... ......+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3699999999999998888899999876543 333457899999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeeccc
Q 014725 176 HYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ 255 (419)
Q Consensus 176 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 255 (419)
+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++...............
T Consensus 81 ~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (250)
T cd05085 81 SFLRKKKD--ELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ 155 (250)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence 99876432 4789999999999999999999998 999999999999999999999999998764332222222233
Q ss_pred ccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHH
Q 014725 256 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334 (419)
Q Consensus 256 gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (419)
++..|+|||++.+..++.++||||||+++|++++ |..||........ .... ........+...
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~-------~~~~---------~~~~~~~~~~~~ 219 (250)
T cd05085 156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA-------REQV---------EKGYRMSCPQKC 219 (250)
T ss_pred CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHHH---------HcCCCCCCCCCC
Confidence 4667999999998899999999999999999998 9999976543321 0111 111111223344
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 335 IITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 335 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
+..+.+++.+|++.+|.+||++.++++.|.
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 567999999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=328.38 Aligned_cols=241 Identities=26% Similarity=0.305 Sum_probs=197.1
Q ss_pred CcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 97 RILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
+.||+|+||.||++.. .++..||+|.+... .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999996 46789999987642 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeee
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT 252 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~ 252 (419)
+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~ 153 (323)
T cd05595 81 ELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK 153 (323)
T ss_pred cHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence 9999887543 4899999999999999999999998 9999999999999999999999999987532211 1223
Q ss_pred cccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCH
Q 014725 253 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332 (419)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (419)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ...... . ....+.
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~-~----------~~~~p~ 216 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILM-E----------EIRFPR 216 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhc-C----------CCCCCC
Confidence 45689999999999999999999999999999999999999976544321 000000 0 011233
Q ss_pred HHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 333 EEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 333 ~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
.....+.+++.+||+.||.+|| ++.++++
T Consensus 217 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 217 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 4456788999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=316.55 Aligned_cols=255 Identities=27% Similarity=0.468 Sum_probs=200.6
Q ss_pred ccccCcccccCcEEEEEEEecCCC---EEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC------Cc
Q 014725 93 YNANRILGQGGQGTVYKGMLADGG---IVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES------EV 161 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~~~---~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 161 (419)
|.+.+.||+|+||.||+|.+.++. .+|+|..+.. .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 356788999999999999975433 5899987643 345567899999999999999999999987532 24
Q ss_pred ceEEEeecCCCCHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 162 PLLVYEFIPNGTLYHYLHDQT---EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
.+++|||+++|+|.+++.... ....+++.....++.|++.||.|||+++ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence 689999999999999875321 2234889999999999999999999998 9999999999999999999999999
Q ss_pred CceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 239 ASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 239 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
+++......... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||......+ .. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~----~~~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IY----DYLRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH----HHHHcC
Confidence 998764332211 122345678999999999999999999999999999999 889997654322 11 111111
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
. ....+...+..+.+++.+||+.+|++|||+.+|++.|+++
T Consensus 231 ~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 N---------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C---------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1 1112233455689999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=316.49 Aligned_cols=257 Identities=27% Similarity=0.410 Sum_probs=210.5
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
...++|.+.+.||+|+||.||+|...++..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+....+++||
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 34578999999999999999999988788899998775332 34678999999999999999999999998889999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~i~~~~~-~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 82 YMSKGSLLDFLKSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred ccCCCCHHHHHhcccc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999986542 25899999999999999999999998 9999999999999999999999999998764322
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
........++..|+|||.+.+..++.++||||||+++++|++ |+.||........ . ... ....
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~----~~~---------~~~~ 221 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREV---L----EQV---------ERGY 221 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H----HHH---------HcCC
Confidence 222222334568999999998889999999999999999999 9999976543221 1 111 1111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
....+...+..+.+++.+|++.+|.+||++.++.+.|+.
T Consensus 222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 222 RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 112233345679999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=327.88 Aligned_cols=264 Identities=26% Similarity=0.397 Sum_probs=203.8
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
..++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|+++++.++||||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 3478999999999999999999975 4677888877653 3344567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
||+++++|.+++.... .+++.....++.|++.||.|||+. + ++|+||||+|||+++++.+||+|||++.....
T Consensus 83 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~ 156 (333)
T cd06650 83 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (333)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence 9999999999997643 478899999999999999999975 5 99999999999999999999999999875432
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHH--------------
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQ-------------- 311 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-------------- 311 (419)
. ......|+..|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus 157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (333)
T cd06650 157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP 233 (333)
T ss_pred h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence 1 12234689999999999988999999999999999999999999976543221100000000
Q ss_pred ------Hhc-----ccchhHHHHHhhccC---C-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 312 ------AMN-----EDRLFEVLEARVLKE---G-KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 312 ------~~~-----~~~~~~~~~~~~~~~---~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... ........+...... . .......+.+++.+||+.||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~ 298 (333)
T cd06650 234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV 298 (333)
T ss_pred ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence 000 000011111111110 0 0113456889999999999999999999975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=333.73 Aligned_cols=255 Identities=22% Similarity=0.320 Sum_probs=203.1
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
...++|++.+.||+|+||.||++... ++..||+|.+.. ........+.+|+.+++.++||||+++++++.+....+
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34568999999999999999999964 578899998753 22234456789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|.+++... .+++.....++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999998753 3788888899999999999999998 999999999999999999999999999876
Q ss_pred ccCCceeeecccccCCccCccccccC----CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSS----QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +........
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~-- 264 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMDHKN-- 264 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH------HHHHHcCCC--
Confidence 43333233456799999999998653 478999999999999999999999986543211 111111000
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKK--RPSMKEVAFE 362 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 362 (419)
..........+..+.+++.+||+.+|.+ ||++.++++.
T Consensus 265 -----~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 265 -----SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred -----cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 0001111133567889999999999987 9999999653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=322.48 Aligned_cols=264 Identities=24% Similarity=0.331 Sum_probs=196.0
Q ss_pred cCccccCcccccCcEEEEEEEec--CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcC---CCcccccEEeEEe-----c
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA--DGGIVAVKKSKLVD--ESNVEQFINEVVILSQI---NHRNVVKLLGCCL-----E 158 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~ 158 (419)
++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 47899999999999999999863 46789999876432 22334566777777665 6999999999985 2
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
....++||||++ ++|.+++...... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 346789999996 6999998764332 4899999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+................+
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~ 233 (290)
T cd07862 156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW 233 (290)
T ss_pred ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhc
Confidence 99865432 2233456899999999998889999999999999999999999999876543321111000000000000
Q ss_pred hHHH---HHhh---cc----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVL---EARV---LK----EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~---~~~~---~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.... .... .. .........+.+++.+||+.+|++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 234 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 0000 0000 00 000123456789999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=321.25 Aligned_cols=256 Identities=25% Similarity=0.388 Sum_probs=205.9
Q ss_pred cCccccCcccccCcEEEEEEEecC------CCEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 91 DNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLVDE-SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.+|++.+.||+|+||.||+|...+ +..||+|....... ...+.+.+|+.++..++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~ 84 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS 84 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence 347778899999999999998632 46799999875433 33467889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC
Q 014725 164 LVYEFIPNGTLYHYLHDQT-------------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY 230 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 230 (419)
+++||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++
T Consensus 85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKL 161 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCC
Confidence 9999999999999985321 1234788899999999999999999998 99999999999999999
Q ss_pred cEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHH
Q 014725 231 RAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGF 308 (419)
Q Consensus 231 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 308 (419)
.+||+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||......+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------ 235 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------ 235 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence 999999999886543222 11223345788999999988889999999999999999998 8889876543221
Q ss_pred HHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
.+.+........+..++..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus 236 ----------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 ----------IEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred ----------HHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111122344566779999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=319.35 Aligned_cols=255 Identities=28% Similarity=0.427 Sum_probs=207.2
Q ss_pred cCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
.+|...+.||+|+||.||++... ++..+|+|............+.+|+++++.++||||+++++++.+....++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 46778899999999999999742 345789998877666667889999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcE
Q 014725 165 VYEFIPNGTLYHYLHDQTE------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA 232 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 232 (419)
+|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999976431 124789999999999999999999998 9999999999999999999
Q ss_pred EEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHH
Q 014725 233 KVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 310 (419)
||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------- 233 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA-------- 233 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--------
Confidence 99999999765432221 1222335678999999998899999999999999999998 9999865443321
Q ss_pred HHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 311 QAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
............+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 234 --------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 234 --------IECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred --------HHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 0111111111223344567899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=324.64 Aligned_cols=264 Identities=28% Similarity=0.438 Sum_probs=211.0
Q ss_pred HHHhcCccccCcccccCcEEEEEEEecC--------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEE
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLAD--------GGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCC 156 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 156 (419)
+...++|.+.+.||+|+||.||++...+ ...+|+|..... .......+.+|+.+++.+ +||||+++++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3345679999999999999999998532 246999988753 234456788999999999 799999999999
Q ss_pred ecCCcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 157 LESEVPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
.+.+..++||||+++++|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~N 170 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 170 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHh
Confidence 999999999999999999999976432 124889999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhh
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~ 301 (419)
|+++.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+
T Consensus 171 ill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred eEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 999999999999999987653221111 112224568999999998889999999999999999998 889987654322
Q ss_pred hccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
. .+.+........+......+.+++.+||+.+|.+||++.+|++.|+++...
T Consensus 251 ~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 L----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred H----------------HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1 111111111223344556788999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=314.60 Aligned_cols=256 Identities=24% Similarity=0.394 Sum_probs=208.6
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
...++|++.+.||+|+||.||++...++..+|+|..... ....+.+.+|+.+++.++|+||+++++++.+ ...+++||
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 345789999999999999999999877788999987643 2345678999999999999999999999887 77899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 81 FMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred eCCCCcHHHHHHhCCc-cccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 9999999999976432 35788999999999999999999988 9999999999999999999999999997654332
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
........++..|+|||++....++.++|+|||||++++++| |..||...+.... ..... ...
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~-------~~~~~---------~~~ 220 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV-------IRALE---------RGY 220 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHh---------CCC
Confidence 222223345678999999998889999999999999999999 9999976543221 11111 111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
..+.+...+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus 221 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 221 RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 112223445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.62 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=203.5
Q ss_pred ccccCcccccCcEEEEEEEecC----CCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc-----
Q 014725 93 YNANRILGQGGQGTVYKGMLAD----GGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV----- 161 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 161 (419)
|.+.+.||+|+||.||+|.... +..||+|+++.. .......+.+|+..++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678899999999999999643 357999987743 33445689999999999999999999999876554
Q ss_pred -ceEEEeecCCCCHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 014725 162 -PLLVYEFIPNGTLYHYLHDQT---EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF 237 (419)
Q Consensus 162 -~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 237 (419)
.+++|||+++++|..++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 789999999999999986532 2235899999999999999999999998 999999999999999999999999
Q ss_pred CCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 238 GASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 238 gl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
|+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+. ...
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~-------~~~--- 227 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI-------YDY--- 227 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHH---
Confidence 9998764332221 122235678999999988899999999999999999999 8899876543221 111
Q ss_pred cchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 316 DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
+........+......+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 228 ------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 ------LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred ------HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111222344556799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-42 Score=333.02 Aligned_cols=259 Identities=23% Similarity=0.278 Sum_probs=198.5
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..+|++.+.||+|+||.||++.+ ..++.||+|... ...+.+|+++++.++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 36799999999999999999996 457889999643 24578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+. ++|..++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 165 ~~-~~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 165 YK-TDLYCYLAAKR---NIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred CC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 94 78988887543 4889999999999999999999998 99999999999999999999999999975433222
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhc----cHHHHHHHHhcc---------
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR----SLVGFFLQAMNE--------- 315 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~--------- 315 (419)
.......||+.|+|||++.+..++.++|||||||++|||++|..||......... .....+......
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~ 317 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDA 317 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcch
Confidence 2334457999999999999889999999999999999999999887543211100 001111110000
Q ss_pred -cchhHHHHHhh---c-c--CC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 316 -DRLFEVLEARV---L-K--EG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 316 -~~~~~~~~~~~---~-~--~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+.+...... . . .. ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 318 QANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000000 0 0 00 0123457889999999999999999999985
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=331.01 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=198.3
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-----cce
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESE-----VPL 163 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 163 (419)
+|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 5888999999999999999964 5789999987642 2234467889999999999999999999886432 469
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAND---DLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhcc---cCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 68999887543 4899999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCc--eeeecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHH--------HH
Q 014725 244 KVDQT--HLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF--------LQ 311 (419)
Q Consensus 244 ~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--------~~ 311 (419)
..... .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||............... ..
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32211 11234568999999999876 67899999999999999999999999765543211111000 00
Q ss_pred HhcccchhHHHHHhhccCC------CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 312 AMNEDRLFEVLEARVLKEG------KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.+......+.+........ .......+.+++.+||+.+|++|||+.|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 0111111111111000000 01123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=335.79 Aligned_cols=245 Identities=27% Similarity=0.370 Sum_probs=207.2
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCc
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEV 161 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 161 (419)
....++|.+.++||+|+||+|+++..+ +++.+|||.++. ....+.+..+.|..++... +||.++.++.+|+..++
T Consensus 364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~ 443 (694)
T KOG0694|consen 364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH 443 (694)
T ss_pred cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence 345578999999999999999999975 467899998764 3455678889999998888 49999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.|+||||+.||++..+.+.. .+++....-++..|+.||+|||+++ |||||||.+|||+|.+|++||+||||++
T Consensus 444 l~fvmey~~Ggdm~~~~~~~----~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcK 516 (694)
T KOG0694|consen 444 LFFVMEYVAGGDLMHHIHTD----VFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCK 516 (694)
T ss_pred EEEEEEecCCCcEEEEEecc----cccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccc
Confidence 99999999999955444422 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
..-. ......+++|||.|||||++.+..|+.+.|.|||||+||||+.|..||.+.++++. + ..+
T Consensus 517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~------F---------dsI 580 (694)
T KOG0694|consen 517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV------F---------DSI 580 (694)
T ss_pred ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH------H---------HHH
Confidence 6432 23356789999999999999999999999999999999999999999998887652 1 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
+.. ...+|...+.+...++.++|..+|++|.-+
T Consensus 581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred hcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 123466677788999999999999999865
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.04 Aligned_cols=262 Identities=23% Similarity=0.329 Sum_probs=217.9
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEecCC-CEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeE-Eec----
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLADG-GIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGC-CLE---- 158 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~---- 158 (419)
+.....++++.+.|.+|||+.||+|.+..+ ..+|+|+....++...+.+.+|+++|+.|+ |||||.+++. ...
T Consensus 32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~ 111 (738)
T KOG1989|consen 32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN 111 (738)
T ss_pred EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence 345567788999999999999999998776 899999988888999999999999999996 9999999993 221
Q ss_pred --CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 014725 159 --SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSD 236 (419)
Q Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 236 (419)
.-+.+|.||||.||+|-+++..+.... |++.++++|+.|+++|+.+||... +||||||||-+||||+.+++.||||
T Consensus 112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred CceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCc
Confidence 124679999999999999999765553 999999999999999999999987 5699999999999999999999999
Q ss_pred cCCceecccCC-cee-------eecccccCCccCcccc---ccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccH
Q 014725 237 FGASRTIKVDQ-THL-------TTRVQGTFGYLDPEYF---RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSL 305 (419)
Q Consensus 237 fgl~~~~~~~~-~~~-------~~~~~gt~~y~aPE~~---~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~ 305 (419)
||.+.-..... ... .....-|+.|+|||.+ .+...++|+|||+|||+||-|+....||+....
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~------ 263 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK------ 263 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc------
Confidence 99987532211 110 0123368999999975 577899999999999999999999999975422
Q ss_pred HHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 306 VGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
..++......+........|..||..||+.+|++||++.+|+..+-.+..
T Consensus 264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 23344444445556788899999999999999999999999998877643
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=319.36 Aligned_cols=257 Identities=28% Similarity=0.419 Sum_probs=208.2
Q ss_pred HhcCccccCcccccCcEEEEEEEecC------CCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
..++|.+.+.||+|+||.||+|...+ +..||+|...... ......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 34678899999999999999998643 3579999976442 3445678899999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTE-------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence 9999999999999999975321 224788899999999999999999998 999999999999999999999
Q ss_pred eecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHH
Q 014725 235 SDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
+|||+++........ ......++..|+|||.+.+..++.++|||||||++||++| |..||...+..+. ...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-------~~~ 233 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV-------LKF 233 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH-------HHH
Confidence 999998765433221 2233446788999999988889999999999999999998 9999976554331 111
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
+........+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus 234 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 234 ---------VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 1111111223334667999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=335.21 Aligned_cols=250 Identities=29% Similarity=0.504 Sum_probs=214.9
Q ss_pred ccCcccccCcEEEEEEEe-cCC----CEEEEEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 95 ANRILGQGGQGTVYKGML-ADG----GIVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 95 ~~~~ig~G~fg~Vy~~~~-~~~----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..++||+|+||+||+|.+ ..+ -+||+|.+.. ...+...+++.|+..|.+++|||+++++++|.... ..||.+|
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~ 778 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQL 778 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHh
Confidence 357899999999999996 333 3689998654 34455688999999999999999999999998766 7899999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
++.|+|.+|++..+. ++-.+..+.|..|||+||.|||++. ++||||..+|+|+..-..+|+.|||+++.+..+..
T Consensus 779 mP~G~LlDyvr~hr~--~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 779 MPLGCLLDYVREHRD--NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred cccchHHHHHHHhhc--cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999998654 4888899999999999999999998 99999999999999999999999999998875544
Q ss_pred eee-ecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 249 HLT-TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 249 ~~~-~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
... ....-.+.|||-|.+....|+.++|||||||++||++| |..|+.+....+ +...+....
T Consensus 854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e----------------I~dlle~ge 917 (1177)
T KOG1025|consen 854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE----------------IPDLLEKGE 917 (1177)
T ss_pred cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH----------------hhHHHhccc
Confidence 333 23334568999999999999999999999999999999 999999887755 444555555
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
+-+.|+.+...++.++.+||..|+..||+++++..++.++
T Consensus 918 RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ 957 (1177)
T KOG1025|consen 918 RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM 957 (1177)
T ss_pred cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence 5677888889999999999999999999999999988764
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.14 Aligned_cols=245 Identities=30% Similarity=0.437 Sum_probs=198.9
Q ss_pred cccccCcEEEEEEEe---cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 98 ILGQGGQGTVYKGML---ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
.||+|+||.||+|.+ .++..+|+|..+... ....+.+.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999975 346789999876432 334578999999999999999999999885 45678999999999
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee-
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT- 251 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~- 251 (419)
+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||.||+++.++.+||+|||+++..........
T Consensus 81 ~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQKNK---HVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 9999997543 4889999999999999999999998 99999999999999999999999999987643332211
Q ss_pred -ecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 252 -TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 252 -~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
....++..|+|||.+....++.++|||||||++|||++ |..||......+. .+.+.......
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~----------------~~~i~~~~~~~ 218 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV----------------TQMIESGERME 218 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHHCCCCCC
Confidence 22234578999999988889999999999999999998 9999976544321 11111111222
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
.+...+..+.+++.+||+.+|.+||++.+|.+.|++
T Consensus 219 ~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 219 CPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred CCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 334456678999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=331.87 Aligned_cols=256 Identities=23% Similarity=0.324 Sum_probs=201.5
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
....++|++.+.||+|+||.||++... +++.+|+|.+.. ......+.+.+|+.+++.++||||+++++++.++...
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 344578999999999999999999975 477899998753 2233445688999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++|+|.+++... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~ 191 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMK 191 (370)
T ss_pred EEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEeccccee
Confidence 9999999999999999653 3788889999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCccCccccccC----CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSS----QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
.............||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +........
T Consensus 192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~~- 264 (370)
T cd05621 192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHKN- 264 (370)
T ss_pred cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCc-
Confidence 654333333456799999999998754 378899999999999999999999976543221 111111000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKK--RPSMKEVAFE 362 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 362 (419)
.............+.+++..|+..++.+ ||++.++++.
T Consensus 265 ------~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 265 ------SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred ------ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 0001111223456788999999855543 8899998774
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=315.37 Aligned_cols=256 Identities=27% Similarity=0.461 Sum_probs=207.0
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CC---EEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GG---IVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
.++|...+.||+|+||.||+|.... ++ .+|+|..... .....+.+.+|+++++.++|||++++.+++.+.+..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 4568888999999999999999643 32 6899987654 34445779999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHDG--EFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 9999999999999976432 4899999999999999999999998 9999999999999999999999999998664
Q ss_pred cCCceeee--cccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 245 VDQTHLTT--RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 245 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
........ ....+..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....+
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~~~i-------- 223 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VMKAI-------- 223 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HHHHH--------
Confidence 32221111 1223457999999988889999999999999999998 999997554322 11111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
......+.+...+..+.+++.+||+.+|++||++.+|++.|+++
T Consensus 224 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 224 -NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 11111222334556789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=313.13 Aligned_cols=247 Identities=28% Similarity=0.432 Sum_probs=198.7
Q ss_pred cccccCcEEEEEEEec---CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCC
Q 014725 98 ILGQGGQGTVYKGMLA---DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGT 173 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 173 (419)
.||+|+||.||+|.+. .+..||+|...... ....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999863 34469999886543 334567999999999999999999999885 457799999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee--
Q 014725 174 LYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT-- 251 (419)
Q Consensus 174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-- 251 (419)
|.+++..... .+++..+++++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...........
T Consensus 81 L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSGKKD--EITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9999975432 5899999999999999999999998 99999999999999999999999999986543322221
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (419)
....++..|+|||++.+..++.++|||||||++||+++ |..||......+. ...+........
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~~~~~~~~~~ 219 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV----------------MSFIEQGKRLDC 219 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH----------------HHHHHCCCCCCC
Confidence 11223578999999988889999999999999999996 9999976544321 111111112233
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 331 KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 331 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
+..++..+.+++.+||..+|++||++.+|.+.|+.+
T Consensus 220 ~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 220 PAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 445567899999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=318.16 Aligned_cols=257 Identities=28% Similarity=0.412 Sum_probs=205.2
Q ss_pred HhcCccccCcccccCcEEEEEEEecC------CCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
..++|.+.+.||+|+||.||+|.+.+ +..||+|...... ......|.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 35678999999999999999999753 4578999876433 3344679999999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC---cEEE
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTE----EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY---RAKV 234 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl 234 (419)
.++||||+++++|.+++..... ...+++..+++++.||+.||.|||+.+ ++|+||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 9999999999999999976432 125899999999999999999999998 99999999999998654 5999
Q ss_pred eecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHH
Q 014725 235 SDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
+|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||......+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---------- 230 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---------- 230 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH----------
Confidence 9999998653222111 112223568999999998899999999999999999997 9999986554321
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
...+........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 231 ------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 231 ------MEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred ------HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1111111112223344567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=316.15 Aligned_cols=260 Identities=23% Similarity=0.340 Sum_probs=208.8
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||+|+. .++..||+|.+.. ........+.+|+++++.++||||+++++++.+.+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999996 4678999997653 23344567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999999886432 2235788999999999999999999998 99999999999999999999999999887543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
... ......+++.|+|||.+.+..++.++|+||||+++|||++|+.||........ . +....... .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~----~-~~~~~~~~--------~ 224 (267)
T cd08228 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF----S-LCQKIEQC--------D 224 (267)
T ss_pred hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH----H-HHHHHhcC--------C
Confidence 221 11234578899999999888899999999999999999999999865432110 0 11111100 0
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
.........+..+.+++.+||+.+|++||++.+|++.|++++
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 011112234567999999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=325.43 Aligned_cols=241 Identities=25% Similarity=0.349 Sum_probs=195.8
Q ss_pred CcccccCcEEEEEEEe----cCCCEEEEEEcccC----ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 97 RILGQGGQGTVYKGML----ADGGIVAVKKSKLV----DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+.||+|+||.||++.. ..++.||+|.+... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999985 34778999987642 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (323)
T cd05584 82 LSGGELFMHLEREG---IFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG- 154 (323)
T ss_pred CCCchHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-
Confidence 99999999997643 4788888999999999999999999 9999999999999999999999999987543222
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... .... ... ..
T Consensus 155 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~-------~~~~--------~~~--~~ 217 (323)
T cd05584 155 TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT-------IDKI--------LKG--KL 217 (323)
T ss_pred CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH-------HHHH--------HcC--CC
Confidence 122345689999999999988899999999999999999999999986553221 1111 110 11
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
..+......+.+++.+||+.+|.+|| ++.+++.
T Consensus 218 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 22333455788999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=343.75 Aligned_cols=258 Identities=26% Similarity=0.323 Sum_probs=207.7
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC--
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESE-- 160 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-- 160 (419)
.....++|.+.+.||+|+||+||+|.. .+++.||||.+... .......+.+|+..+..++|+|++++++.+...+
T Consensus 27 ~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~ 106 (496)
T PTZ00283 27 AKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPR 106 (496)
T ss_pred ccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccccc
Confidence 344567999999999999999999985 46889999987543 3455667889999999999999999988765432
Q ss_pred ------cceEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEE
Q 014725 161 ------VPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAK 233 (419)
Q Consensus 161 ------~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 233 (419)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|
T Consensus 107 ~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vk 183 (496)
T PTZ00283 107 NPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVK 183 (496)
T ss_pred CcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEE
Confidence 2579999999999999997532 2346899999999999999999999998 99999999999999999999
Q ss_pred EeecCCceecccCC-ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH
Q 014725 234 VSDFGASRTIKVDQ-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 234 l~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
|+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......+. + ..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~-~~ 256 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------M-HK 256 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------H-HH
Confidence 99999998754322 2223446799999999999999999999999999999999999999976543221 1 11
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.. .......+...+..+.+++.+||+.+|.+||++.+++..
T Consensus 257 ~~---------~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 TL---------AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred Hh---------cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 00 001112234455679999999999999999999999763
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=321.32 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=205.4
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CC--EEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GG--IVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 164 (419)
.++|++.+.||+|+||.||+|.+.+ +. .+++|..... .......+.+|+.++.++ +||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 3578889999999999999999643 43 4677776543 334556789999999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc
Q 014725 165 VYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR 231 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 231 (419)
||||+++++|.+++..... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence 9999999999999975421 225789999999999999999999998 999999999999999999
Q ss_pred EEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHH
Q 014725 232 AKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 232 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 310 (419)
+||+|||+++..... .......++..|+|||++.+..++.++|||||||+++||+| |..||...+..+. .
T Consensus 163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~ 233 (303)
T cd05088 163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------Y 233 (303)
T ss_pred EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH-------H
Confidence 999999998643211 11111224567999999988889999999999999999998 9999975543321 1
Q ss_pred HHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 311 QAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
... ........+...+..+.+++.+||+.+|++||++.+++..|..+....
T Consensus 234 ~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~ 284 (303)
T cd05088 234 EKL---------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 284 (303)
T ss_pred HHH---------hcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 111 011111122234456899999999999999999999999998875543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=321.30 Aligned_cols=263 Identities=25% Similarity=0.423 Sum_probs=211.2
Q ss_pred HHhcCccccCcccccCcEEEEEEEec--------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEe
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA--------DGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCL 157 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 157 (419)
...++|.+.+.||+|+||.||+|... ++..+|+|..... .......+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 44677889999999999999999742 2347899987643 234457789999999999 8999999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni 224 (419)
.....+++|||+++++|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||||+||
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 168 (304)
T cd05101 92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNV 168 (304)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceE
Confidence 99999999999999999999976421 124788899999999999999999998 99999999999
Q ss_pred EECCCCcEEEeecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhh
Q 014725 225 LLDDKYRAKVSDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEED 302 (419)
Q Consensus 225 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 302 (419)
+++.++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~ 248 (304)
T cd05101 169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 248 (304)
T ss_pred EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence 99999999999999998764332221 222345678999999988889999999999999999998 8888876543321
Q ss_pred ccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 303 RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.... ........+..++..+.+++.+||+.+|.+||++.+|++.|+++...
T Consensus 249 -------~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 249 -------FKLL---------KEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred -------HHHH---------HcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 1111 11111122334556789999999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=333.01 Aligned_cols=251 Identities=27% Similarity=0.373 Sum_probs=200.5
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||+|... +++.||||.+... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47899999999999999999974 5789999987642 2334466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999997643 4899999999999999999999999 999999999999999999999999998764321
Q ss_pred Cce-------------------------------------eeecccccCCccCccccccCCCCcccceechhHHHHHHHh
Q 014725 247 QTH-------------------------------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289 (419)
Q Consensus 247 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t 289 (419)
... ......||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 100 0112468999999999999999999999999999999999
Q ss_pred CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 014725 290 GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS---MKEVAF 361 (419)
Q Consensus 290 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~ 361 (419)
|..||......+. ........ ..............+.+++.+|+. +|.+|++ +.+++.
T Consensus 235 G~~Pf~~~~~~~~------~~~i~~~~-------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 235 GYPPFCSDNPQET------YRKIINWK-------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCCCHHHH------HHHHHcCC-------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 9999986654321 11110000 000001111234567889999996 9999998 888766
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=312.81 Aligned_cols=251 Identities=29% Similarity=0.460 Sum_probs=208.4
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.++|++.+.||+|+||.||+|... ++.||+|....... ..+++.+|+.+++.++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 457888999999999999999875 78899999876544 5678999999999999999999999999989999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999976543 24899999999999999999999999 99999999999999999999999999987532211
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
....+..|+|||++....++.++||||||++++|+++ |..||......+. .... ......
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~---------~~~~~~ 218 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPHV---------EKGYRM 218 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHH---------hcCCCC
Confidence 2234667999999988899999999999999999998 9999976543321 1111 111111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
..+...+..+.+++.+||..+|.+||++.+++++|+.+
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 219 EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 22333456789999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=316.39 Aligned_cols=248 Identities=23% Similarity=0.399 Sum_probs=210.7
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
...+|++.+.||+|.||.|-+|.. ..|+.||||.++. .++++.-.+.+|+++|+.|+||||+.++.+|++.+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 356799999999999999999995 6799999997653 456677789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||..+|.|.+|+.+.. .+++.+...++.||..|+.|+|.++ ++|||||.+|||+|.|+++||+||||+..+.
T Consensus 131 vMEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~ 204 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYA 204 (668)
T ss_pred EEEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhc
Confidence 999999999999999765 4999999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeecccccCCccCccccccCCCC-cccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.. ....+++|+|-|.+||...+..|. +..|-|||||+||-|+.|..||++.+-... .+.+..+...
T Consensus 205 ~~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l-------vrQIs~GaYr---- 271 (668)
T KOG0611|consen 205 DK--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL-------VRQISRGAYR---- 271 (668)
T ss_pred cc--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH-------HHHhhccccc----
Confidence 33 334568999999999999998884 899999999999999999999998765321 1111111111
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.+..+.....||++||..+|++|.|+.+|..-
T Consensus 272 -------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 -------EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred -------CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 11223346679999999999999999998653
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-43 Score=313.69 Aligned_cols=269 Identities=25% Similarity=0.329 Sum_probs=213.2
Q ss_pred HHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcc--cCChhhHHHHHHHHHHHhcCCCcccccEEeEEec-----
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSK--LVDESNVEQFINEVVILSQINHRNVVKLLGCCLE----- 158 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----- 158 (419)
......|...+.||+|+||.|+.+.+ .+|..||||++. ..+....++..+|+++|+.++|+||+.+++.+.-
T Consensus 18 ~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 18 FEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred EeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34456677789999999999999996 467899999987 4556677889999999999999999999999865
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
-...|+|+|+| +.+|...++... .++......++.|+++||.|+|+.+ |+||||||.|+|++.+..+||+|||
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccc
Confidence 34679999999 669999998654 4899999999999999999999999 9999999999999999999999999
Q ss_pred CceecccC-CceeeecccccCCccCccccc-cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 239 ASRTIKVD-QTHLTTRVQGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 239 l~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
||+..... .....+..+-|..|.|||.+. ...|+.+.||||.||++.||++|+.-|.+.+..+.-.+.........++
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 99987532 122335667899999999864 5789999999999999999999999999888766544444333333222
Q ss_pred chhHHH--------HHhhcc-CCC-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 317 RLFEVL--------EARVLK-EGK-----EEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 317 ~~~~~~--------~~~~~~-~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.+..+- ...... ..+ ....+...+|+.+||..||.+|+|+.|.++-
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 222221 111100 001 1233567889999999999999999999774
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=332.97 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=210.3
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCC-CcccccEEeEE
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVD-ESNVEQFINEVVILSQIN-HRNVVKLLGCC 156 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 156 (419)
+++...++|.+.+.||+|+||.||+|++. .+..||+|+++... ....+.+.+|+.++.++. ||||+++++++
T Consensus 31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 35556677888999999999999999864 23579999987542 333457889999999997 99999999999
Q ss_pred ecCCcceEEEeecCCCCHHHHhhccCC-----------------------------------------------------
Q 014725 157 LESEVPLLVYEFIPNGTLYHYLHDQTE----------------------------------------------------- 183 (419)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~----------------------------------------------------- 183 (419)
...+..++||||+++|+|.++++....
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 999999999999999999999975321
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014725 184 ------------------------------------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKS 221 (419)
Q Consensus 184 ------------------------------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp 221 (419)
...+++..++.++.|++.||.|||+.+ ++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCc
Confidence 123677888999999999999999988 99999999
Q ss_pred CcEEECCCCcEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCCh
Q 014725 222 SNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDA 299 (419)
Q Consensus 222 ~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~ 299 (419)
+|||+++++.+||+|||+++....... .......++..|+|||.+.+..++.++||||||++++||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986532221 11223346788999999998889999999999999999998 8999876543
Q ss_pred hhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 300 EEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.+. . .+.+........+......+.+++.+||+.+|.+||++.+|++.|+++
T Consensus 348 ~~~------~---------~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 348 NEQ------F---------YNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred hHH------H---------HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 221 0 111111111122334456799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=315.56 Aligned_cols=257 Identities=28% Similarity=0.424 Sum_probs=208.2
Q ss_pred hcCccccCcccccCcEEEEEEEecCC----CEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADG----GIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
.++|.+.+.||+|+||.||+|.+.+. ..+|+|...... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 45688889999999999999986432 468999876544 4556789999999999999999999998875 55789
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++...
T Consensus 84 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 158 (270)
T cd05056 84 VMELAPLGELRSYLQVNKY--SLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158 (270)
T ss_pred EEEcCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence 9999999999999976433 4899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
...........++..|+|||.+....++.++||||||++++|+++ |..||......+. .......
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~~~~------- 224 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV-------IGRIENG------- 224 (270)
T ss_pred cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH-------HHHHHcC-------
Confidence 433222233335568999999988889999999999999999986 9999976654321 0111111
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.....+...+..+.+++.+|+..+|.+|||+.+++..|+++..
T Consensus 225 --~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 225 --ERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1112233455679999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=332.36 Aligned_cols=251 Identities=24% Similarity=0.319 Sum_probs=197.4
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.|...+.||+|+||+||+|.. .++..||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 588899999999999999996 45778999987542 23445678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999997643 4888889999999999999999998 9999999999999999999999999976431100
Q ss_pred c----------------------------------------------eeeecccccCCccCccccccCCCCcccceechh
Q 014725 248 T----------------------------------------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFG 281 (419)
Q Consensus 248 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG 281 (419)
. .......||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 001235699999999999988999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHH--HhccCCCCCCCHHHH
Q 014725 282 VVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKR--CLNMIGKKRPSMKEV 359 (419)
Q Consensus 282 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~~p~~RPt~~ev 359 (419)
|++|||+||..||......+.. ....... ..............+.+++.+ |+..+|..||++.++
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~------~~i~~~~-------~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQ------LKVINWE-------NTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHH------HHHHccc-------cccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 9999999999999875543211 0000000 000011111234567778877 455666679999999
Q ss_pred HH
Q 014725 360 AF 361 (419)
Q Consensus 360 l~ 361 (419)
+.
T Consensus 303 l~ 304 (381)
T cd05626 303 KA 304 (381)
T ss_pred hc
Confidence 76
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=323.85 Aligned_cols=265 Identities=25% Similarity=0.413 Sum_probs=210.7
Q ss_pred HHhcCccccCcccccCcEEEEEEEecC--------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEe
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLAD--------GGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCL 157 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 157 (419)
....+|.+.+.||+|+||.||+|.... ...+|+|..... .....+.+.+|+.+++++ +||||+++++++.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 344578999999999999999997421 236899987643 234457899999999999 7999999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQT-------------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni 224 (419)
+.+..+++|||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Ni 165 (334)
T cd05100 89 QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNV 165 (334)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceE
Confidence 9999999999999999999997532 1234788999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhh
Q 014725 225 LLDDKYRAKVSDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEED 302 (419)
Q Consensus 225 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 302 (419)
+++.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 245 (334)
T cd05100 166 LVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 245 (334)
T ss_pred EEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999998654322111 122234567999999999999999999999999999998 8899876543321
Q ss_pred ccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhC
Q 014725 303 RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIG 371 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~ 371 (419)
.... ........+...+..+.+++.+||+.+|.+||++.++++.|+.+.....
T Consensus 246 -------~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~ 298 (334)
T cd05100 246 -------FKLL---------KEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS 298 (334)
T ss_pred -------HHHH---------HcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence 1111 1111112233445678999999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=313.27 Aligned_cols=259 Identities=25% Similarity=0.387 Sum_probs=210.5
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||+|... +++.+|+|.++. ......+.+.+|++++++++|+|++++++++.+.+..+++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 67999999999999999999975 788999997753 23344678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999987532 2335899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
... ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....... .. .... +...
T Consensus 159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-~~~~---------~~~~ 223 (267)
T cd08224 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-LCKK---------IEKC 223 (267)
T ss_pred CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH----HH-HHhh---------hhcC
Confidence 221 1223457889999999988889999999999999999999999986543210 00 0001 1111
Q ss_pred hccCCCH-HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 326 VLKEGKE-EEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 326 ~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
.....+. .....+.+++.+||..+|++|||+.+|+++|+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1111222 44567899999999999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.20 Aligned_cols=256 Identities=26% Similarity=0.418 Sum_probs=206.9
Q ss_pred hcCccccCcccccCcEEEEEEEec-C---CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-D---GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~---~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..+|++.+.||+|+||.||+|.+. + +..+|+|.++.. .....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 357888999999999999999863 2 236899987643 23445688999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++..... .+++.+++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....
T Consensus 83 v~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDG--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 157 (267)
T ss_pred EEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence 9999999999999976543 4899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCceeee--cccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 245 VDQTHLTT--RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 245 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
........ ...++..|+|||++.+..++.++|+||||++++|+++ |..||......+. . ......
T Consensus 158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~----~~~~~~----- 225 (267)
T cd05066 158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---I----KAIEEG----- 225 (267)
T ss_pred cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---H----HHHhCC-----
Confidence 43222221 1223567999999998899999999999999999887 9999976554321 1 111110
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
...+.+...+..+.+++.+|++.+|.+||++.++++.|+++
T Consensus 226 ----~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 ----YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred ----CcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 11122233456789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=319.02 Aligned_cols=260 Identities=27% Similarity=0.415 Sum_probs=206.5
Q ss_pred HHhcCccccCcccccCcEEEEEEEecC------CCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCC
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 160 (419)
...++|++.+.||+|+||.||+|...+ +..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 456789999999999999999997532 4479999876433 233456889999999999999999999999999
Q ss_pred cceEEEeecCCCCHHHHhhccCC-------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEE
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTE-------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAK 233 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~-------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 233 (419)
..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 234567788999999999999999998 99999999999999999999
Q ss_pred EeecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHH
Q 014725 234 VSDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQ 311 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 311 (419)
|+|||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+. ..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~-------~~ 232 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV-------LK 232 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HH
Confidence 99999988654322211 122335678999999998899999999999999999999 7889876544321 11
Q ss_pred HhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
..... .....+...+..+.+++.+||+.+|++|||+.++++.|++.
T Consensus 233 ~~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 233 FVMDG---------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred HHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11000 01112233456799999999999999999999999988864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=320.12 Aligned_cols=263 Identities=25% Similarity=0.385 Sum_probs=198.7
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 67899999876432 2233467889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|++ ++|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 84 ~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHPG--GLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 995 688888875432 4888999999999999999999999 9999999999999999999999999987543222
Q ss_pred ceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh---cccchhHHH-
Q 014725 248 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM---NEDRLFEVL- 322 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~- 322 (419)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|..||......... ........ ....+....
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQ--LERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhCCCChhhccchhh
Confidence 12233457899999999865 45889999999999999999999999865432111 11111100 000000000
Q ss_pred ----HH-hhccCCCH---------HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 ----EA-RVLKEGKE---------EEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ----~~-~~~~~~~~---------~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+ ......+. .....+.+++.+||+.||.+|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 00 00000000 01245779999999999999999999975
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=315.72 Aligned_cols=257 Identities=28% Similarity=0.478 Sum_probs=205.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCC----EEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGG----IVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.++|++.+.||+|+||+||+|.+. ++. .||+|..+.. .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 356888899999999999999853 343 4899987653 33445678899999999999999999999975 4578
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+++||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++..
T Consensus 85 l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKD--RIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred EEEEcCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence 99999999999999976433 4899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 244 KVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 244 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
....... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||........ . ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~-------------~~ 223 (279)
T cd05109 160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI---P-------------DL 223 (279)
T ss_pred ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---H-------------HH
Confidence 4332221 122234678999999988899999999999999999998 9999976543221 1 11
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+........+...+..+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 11111112223345678899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.42 Aligned_cols=264 Identities=25% Similarity=0.418 Sum_probs=210.0
Q ss_pred HHhcCccccCcccccCcEEEEEEEec--------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEe
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA--------DGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCL 157 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 157 (419)
...++|.+.+.||+|+||.||+|... ....+|+|..+.. .......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 34467889999999999999999742 2346899987743 234456788999999999 6999999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni 224 (419)
+.+..+++|||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ ++||||||+||
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni 165 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV 165 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence 98999999999999999999976321 235889999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhh
Q 014725 225 LLDDKYRAKVSDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEED 302 (419)
Q Consensus 225 ll~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 302 (419)
|+++++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 245 (314)
T cd05099 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL 245 (314)
T ss_pred EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999999999999998654322111 112224467999999998899999999999999999999 8999976544321
Q ss_pred ccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 303 RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
..... .......+..++..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus 246 -------~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~ 297 (314)
T cd05099 246 -------FKLLR---------EGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV 297 (314)
T ss_pred -------HHHHH---------cCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence 11111 11111223344567889999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=330.04 Aligned_cols=248 Identities=26% Similarity=0.335 Sum_probs=195.2
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|+..+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+++++.++|+||+++++++.+.+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 45667789999999999999964 5789999987643 334456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+.. ..++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~- 222 (353)
T PLN00034 154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM- 222 (353)
T ss_pred CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-
Confidence 9999986532 2567778899999999999999998 9999999999999999999999999998754321
Q ss_pred eeeecccccCCccCcccccc-----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 249 HLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.......||..|+|||++.. ...+.++|||||||++|||++|+.||......+..... .. ..
T Consensus 223 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~----~~---------~~ 289 (353)
T PLN00034 223 DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLM----CA---------IC 289 (353)
T ss_pred ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHH----HH---------Hh
Confidence 12234568999999998743 23456899999999999999999999743221110000 00 00
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.......+......+.+++.+||+.+|++|||+.|+++.
T Consensus 290 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 001112233455679999999999999999999999873
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=313.85 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=205.1
Q ss_pred cCccccCcccccCcEEEEEEEecC-C---CEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLAD-G---GIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~-~---~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..|++.+.||+|+||.||+|.... + ..||+|..... .......|..|+.+++.++||||+++++++.++...++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 357888999999999999999643 2 36999987653 344567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 84 TEFMENGALDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred EecCCCCcHHHHHhhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999999976533 4899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCcee--eeccc--ccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 246 DQTHL--TTRVQ--GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 246 ~~~~~--~~~~~--gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
..... ..... .+..|+|||++.+..++.++|||||||++||+++ |..||......+. .....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~-------~~~i~------ 225 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV-------INAIE------ 225 (269)
T ss_pred CccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH-------HHHHH------
Confidence 22111 11111 2357999999998999999999999999999887 9999976554321 11110
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.......+..++..+.+++.+||+.+|.+||++.+|+..|+++
T Consensus 226 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 226 ---QDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ---cCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0011122234456788999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=324.39 Aligned_cols=244 Identities=25% Similarity=0.339 Sum_probs=195.0
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHH---hcCCCcccccEEeEEecCCcceEE
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVIL---SQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l---~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
|++.+.||+|+||.||+|.+. +++.||||.++.. .....+.+.+|..++ +.++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 677899999999999999964 5789999987632 223345666676655 566899999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++++|..++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHTD----VFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 9999999999888642 4899999999999999999999998 99999999999999999999999999875322
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. .......|++.|+|||.+.+..++.++|||||||++|||++|+.||...+..+. .... ...
T Consensus 154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~-------~~~i--------~~~- 216 (324)
T cd05589 154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV-------FDSI--------VND- 216 (324)
T ss_pred CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH-------HHHH--------HhC-
Confidence 21 222345689999999999999999999999999999999999999986654321 1111 000
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+||+ +.++++
T Consensus 217 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 217 -EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 01123334566889999999999999995 555544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=311.90 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=204.1
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-----hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-----ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
++|.+.+.||+|++|.||+|.. .++.++|+|.+.... ......+.+|++++++++||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999996 457899999865422 1234578899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
++||+++++|.+++.... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG---ALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 999999999999987643 4788999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCceee--ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 245 VDQTHLT--TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 245 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
....... ....++..|+|||++.+..++.++||||||+++|||++|+.||........ ... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~---------~~ 220 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA------IFK---------IA 220 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH------HHH---------Hh
Confidence 3221111 234578899999999998999999999999999999999999975433221 001 00
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
........+......+.+++.+||..+|.+|||+.++++.
T Consensus 221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 221 TQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 1111122333455678999999999999999999999763
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=319.35 Aligned_cols=261 Identities=27% Similarity=0.420 Sum_probs=209.0
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCcccccEEeEEec
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVD-ESNVEQFINEVVILSQI-NHRNVVKLLGCCLE 158 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 158 (419)
....++|.+.+.||+|+||.||++... .+..+|+|..+... ....+.+.+|+.+++++ +||||+++++++..
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 344567999999999999999999742 23479999876543 33456789999999999 79999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
.+..+++|||+++|+|.+++..... ..+++.++..++.|++.||.|||+.+ ++|+||||+|||++.++.++|+|||
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999999976432 23899999999999999999999998 9999999999999999999999999
Q ss_pred CceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 239 ASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 239 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||........ +
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~------- 253 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------F------- 253 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------H-------
Confidence 99865433221 1222345778999999998899999999999999999998 9999876543221 1
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.+.+........+...+..+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 254 --~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 254 --YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 111111111112223345799999999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=325.55 Aligned_cols=241 Identities=24% Similarity=0.298 Sum_probs=196.1
Q ss_pred CcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 97 RILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
+.||+|+||.||++.. .++..||+|.+... .......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999996 46789999987642 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
+|..++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (325)
T cd05594 81 ELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATM 153 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccc
Confidence 9999887543 48999999999999999999997 67 9999999999999999999999999987543222 122
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||+||..||...+.... ....... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~-------~~~i~~~----------~~~~p 216 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL-------FELILME----------EIRFP 216 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH-------HHHHhcC----------CCCCC
Confidence 345689999999999999999999999999999999999999976543321 0110000 01122
Q ss_pred HHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
......+.+++.+||+.||.+|+ ++.++++
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 217 RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 33445688999999999999996 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=314.26 Aligned_cols=260 Identities=24% Similarity=0.358 Sum_probs=209.2
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||+|.. .++..+|+|.+... .......+.+|+.+++.++||||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688899999999999999995 57889999976542 2334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999987422 2335899999999999999999999998 99999999999999999999999999876543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
... ......++..|+|||++.+..++.++|+||||+++|+|++|..||......... ...... ...
T Consensus 159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~--------~~~ 224 (267)
T cd08229 159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS-----LCKKIE--------QCD 224 (267)
T ss_pred CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH-----Hhhhhh--------cCC
Confidence 222 122345889999999999888999999999999999999999999654322110 000000 000
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
............+.+++.+||+.+|.+|||+.+|++.++++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 011112345567999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=312.73 Aligned_cols=249 Identities=27% Similarity=0.435 Sum_probs=197.5
Q ss_pred CcccccCcEEEEEEEecC-CC--EEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLAD-GG--IVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|.+.+ +. .+++|..+.. .....+.+.+|++++.++ +||||+++++++...+..+++|||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999754 33 4688887643 344556889999999999 799999999999999999999999999
Q ss_pred CCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 172 GTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 172 g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
++|.+++..... ...+++..++.++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 999999975321 124789999999999999999999988 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
++...... ........+..|+|||++....++.++|||||||+++||++ |..||...+..+. ....
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~-------~~~~---- 224 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YEKL---- 224 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH-------HHHH----
Confidence 98642211 11111223567999999988899999999999999999997 9999976443221 1111
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
........+......+.+++.+||+.+|.+|||+.+++..|+++
T Consensus 225 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~ 268 (270)
T cd05047 225 -----PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 268 (270)
T ss_pred -----hCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence 11111112223445688999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=309.62 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=206.1
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|.+.+.||+|+||.||+|... ++..|++|.+.. ........+.+|+++++.++|||++++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4778899999999999999964 578899998753 2345567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999998753 235899999999999999999999998 99999999999999999999999999887643322
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......|++.|+|||++.+..++.++|+||||+++++|++|+.||........ ..... .....
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~---------~~~~~ 219 (256)
T cd08529 157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL-------ILKII---------RGVFP 219 (256)
T ss_pred -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHH---------cCCCC
Confidence 22334578999999999988899999999999999999999999976653221 11110 01111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..+......+.+++.+||+.+|++||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred CCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 2222445679999999999999999999999763
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=331.01 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=197.7
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|.+.+.||+|+||.||++.. .+++.||+|.+... .....+.+.+|+++++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 4688999999999999999986 46789999987532 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999999999997643 4888999999999999999999999 999999999999999999999999999643210
Q ss_pred Cce----------------------------------------------eeecccccCCccCccccccCCCCcccceech
Q 014725 247 QTH----------------------------------------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSF 280 (419)
Q Consensus 247 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~sl 280 (419)
... ......||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 0012469999999999998999999999999
Q ss_pred hHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCC---CCHH
Q 014725 281 GVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKR---PSMK 357 (419)
Q Consensus 281 G~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~ 357 (419)
||++|||++|..||......+. +....... ..............+.+++.+|+. +|.+| +++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHET------YRKIINWR-------ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHH------HHHHHccC-------CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999976554321 11110000 000001111234568889999997 66665 5888
Q ss_pred HHHHH
Q 014725 358 EVAFE 362 (419)
Q Consensus 358 evl~~ 362 (419)
+++..
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 88764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=321.77 Aligned_cols=240 Identities=24% Similarity=0.334 Sum_probs=192.4
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|... +++.||+|.++.. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999974 4678999987642 223345566677777654 899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG---RFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence 99999987643 4889999999999999999999998 9999999999999999999999999997643222 223
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. ...+.. .....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~-------~~~i~~----------~~~~~~ 216 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL-------FDSILN----------DRPHFP 216 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHc----------CCCCCC
Confidence 445689999999999998999999999999999999999999987654321 111100 011223
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMK-EVA 360 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl 360 (419)
......+.+++.+||+.+|.+||++. +++
T Consensus 217 ~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 33455688999999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=317.04 Aligned_cols=251 Identities=25% Similarity=0.332 Sum_probs=201.6
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
+|+..+.||+|+||.||++... ++..||+|++.... ......+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4788899999999999999964 57899999876422 2223557889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||++++++.++|+|||+++......
T Consensus 81 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMGN-PGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 9999999988865432 25899999999999999999999998 9999999999999999999999999998753222
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
. .....|++.|+|||++.+..++.++||||+||++|||++|..||......... ..+.. .+.. ..
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~---------~~~~-~~ 221 (285)
T cd05605 157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVER---------RVKE-DQ 221 (285)
T ss_pred c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHH---------Hhhh-cc
Confidence 1 22346899999999999889999999999999999999999999865432210 00111 1111 11
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
...+...+..+.+++.+||+.||.+|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 122334566789999999999999999 6777754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=322.86 Aligned_cols=243 Identities=25% Similarity=0.365 Sum_probs=192.6
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|... ++..||+|.++.. .......+.+|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999964 5788999987642 233456688899999988 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|.+++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCcc
Confidence 99999887543 4899999999999999999999999 999999999999999999999999998753211 1222
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhh--hccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE--DRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ......+..+..... . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~--~~ 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------Q--IR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------C--CC
Confidence 34578999999999999999999999999999999999999997433221 111111111111111 0 11
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
.+......+.+++.+||+.||.+||+.
T Consensus 224 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 224 IPRSLSVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence 233345568899999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=310.53 Aligned_cols=249 Identities=29% Similarity=0.458 Sum_probs=202.8
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEe-cCCcceEEEeec
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL-ESEVPLLVYEFI 169 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 169 (419)
++|.+.+.||+|+||.||++... +..+|+|..+.. ...+.+.+|+.++++++|+|++++++++. +....+++|||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 46888999999999999999875 778999987643 23467899999999999999999999765 456789999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 99999999976543 24889999999999999999999998 9999999999999999999999999987643221
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
....++..|+|||++.+..++.++|||||||++|||++ |+.||......+. .... ......
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~-------~~~~---------~~~~~~ 218 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-------VPRV---------EKGYKM 218 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHH---------hcCCCC
Confidence 12234568999999998899999999999999999998 9999875443221 1111 111111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
..+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 DAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 22334556789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.04 Aligned_cols=259 Identities=23% Similarity=0.329 Sum_probs=203.2
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecC
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLES 159 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 159 (419)
.++....++|.+.+.||+|+||.||++... +++.+|+|.+.. ........+.+|+.+++.++||||+++++++.+.
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 344556689999999999999999999975 467899998753 2233445678999999999999999999999999
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
...++||||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999999999999998753 3788888999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCccccccC----CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSS----QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
++..............||+.|+|||++... .++.++|||||||++|||++|..||...+.... +......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcC
Confidence 987654333333456799999999998753 378999999999999999999999986554221 1111111
Q ss_pred cchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 014725 316 DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKK--RPSMKEVAFE 362 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 362 (419)
.. .............+.+++..|+..++.+ ||++.++++.
T Consensus 263 ~~-------~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KN-------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CC-------cccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 00 0001112234556888999999844433 7788888764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=317.87 Aligned_cols=263 Identities=24% Similarity=0.376 Sum_probs=204.3
Q ss_pred hcCccccCcccccCcEEEEEEEecC---------------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD---------------GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLL 153 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~ 153 (419)
.++|++.+.||+|+||.||++...+ ...||+|..... .......+.+|++++++++|||+++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 4679999999999999999987532 124899987653 334456799999999999999999999
Q ss_pred eEEecCCcceEEEeecCCCCHHHHhhccCC---------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014725 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTE---------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224 (419)
Q Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni 224 (419)
+++......++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence 999999999999999999999999865321 123688899999999999999999998 99999999999
Q ss_pred EECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh--CCCCCCCCChhh
Q 014725 225 LLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQKPIRSTDAEE 301 (419)
Q Consensus 225 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t--g~~p~~~~~~~~ 301 (419)
++++++.+||+|||++......... ......++..|+|||++.+..++.++|||||||++++|++ +..||......+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 9999999999999999765432221 1222345678999999988899999999999999999998 667877654432
Q ss_pred hccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.... ..+..... ........+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus 241 ~~~~---~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIEN---TGEFFRNQ------GRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHHH---HHHhhhhc------cccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 1110 11100000 000011112234567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=328.80 Aligned_cols=203 Identities=28% Similarity=0.425 Sum_probs=175.7
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||+||+|... +++.||+|.+... .......+.+|+.++..++||||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999864 5789999987642 2234467888999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKKD---TLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 9999999999998643 4899999999999999999999999 999999999999999999999999998754321
Q ss_pred Cc----------------------------------eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCC
Q 014725 247 QT----------------------------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 292 (419)
Q Consensus 247 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~ 292 (419)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 10 00123579999999999999999999999999999999999999
Q ss_pred CCCCCCh
Q 014725 293 PIRSTDA 299 (419)
Q Consensus 293 p~~~~~~ 299 (419)
||.....
T Consensus 235 Pf~~~~~ 241 (363)
T cd05628 235 PFCSETP 241 (363)
T ss_pred CCCCCCH
Confidence 9986554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=321.76 Aligned_cols=243 Identities=25% Similarity=0.369 Sum_probs=192.1
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|... +++.+|+|.++.. .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5678999987642 334456678899888776 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|..++.... .+++..+..++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (329)
T cd05618 81 GDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT 153 (329)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence 99999887543 4899999999999999999999999 9999999999999999999999999987532211 122
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhh--ccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED--RSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....+........ ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~----------~~~ 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK----------QIR 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC----------CCC
Confidence 345689999999999999999999999999999999999999964222110 11111111111111 112
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
.+......+.+++.+||+.||.+||+.
T Consensus 224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 233445678899999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=329.94 Aligned_cols=261 Identities=24% Similarity=0.305 Sum_probs=200.8
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-----cce
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESE-----VPL 163 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 163 (419)
+|++.+.||+|+||.||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478889999999999999996 46889999987642 2334567889999999999999999999998766 679
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ---PLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 58888776433 5899999999999999999999999 999999999999999999999999999875
Q ss_pred ccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh---
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF--- 319 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 319 (419)
............+++.|+|||.+.+. .++.++|||||||++|||++|+.||...+....... +..........
T Consensus 154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~g~~~~~~~~ 230 (372)
T cd07853 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL---ITDLLGTPSLEAMR 230 (372)
T ss_pred ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCCHHHHH
Confidence 43333333445678999999998764 578999999999999999999999987654432111 11111100000
Q ss_pred -------HHHHHhhcc--------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 320 -------EVLEARVLK--------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 320 -------~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..+...... .........+.+++.+||+.||.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 000000000 0111224568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=310.22 Aligned_cols=251 Identities=29% Similarity=0.466 Sum_probs=203.9
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
.+|.+.+.||+|+||.||+|.+.++..+|+|.+..... ....+.+|+++++.++|||++++++++......+++|||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 46788899999999999999987788999998764322 23578999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.........
T Consensus 83 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQRG--KFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 9999999976433 4789999999999999999999998 9999999999999999999999999987654322221
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
.....++..|+|||.+.++.++.++||||||+++|||++ |..||........ ..... ......
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~---------~~~~~~ 221 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV-------VETIN---------AGFRLY 221 (256)
T ss_pred cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH-------HHHHh---------CCCCCC
Confidence 222235678999999998899999999999999999998 9999976543221 11111 101111
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
.+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus 222 ~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1222346799999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=305.32 Aligned_cols=265 Identities=22% Similarity=0.247 Sum_probs=205.8
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhh--HHHHHHHHHHHhcCCCcccccEEeEEec--CCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESN--VEQFINEVVILSQINHRNVVKLLGCCLE--SEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 164 (419)
.+.|+..+.|++|+||.||+|++ +++..||+|+++...+.. --.-++|+.+|.+.+|||||.+-.+... -+..|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 35577889999999999999996 457889999998754322 2345899999999999999999888764 356899
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
|||||+. +|...+..... ++...++..++.|+++|++|||.+. |+||||||+|+|+++.|.+||+||||||.+.
T Consensus 155 VMe~~Eh-DLksl~d~m~q--~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQ--PFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhccC--CCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999975 99999987664 5888899999999999999999999 9999999999999999999999999999887
Q ss_pred cCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.... ..+..+-|..|.|||.+.+ ..|+.+.|+||+|||+.||+++++-|.+..+.+.....-..+....+.-|.....
T Consensus 229 sp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 229 SPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSE 307 (419)
T ss_pred CCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccc
Confidence 5532 2344556999999998776 5799999999999999999999999998876654433333333222221111100
Q ss_pred H--------------hhccCCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 A--------------RVLKEGKEE-EIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~--------------~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. .+....... ....=.+|+...|..||.+|-|+.|.++
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 0 000111111 2245567999999999999999999865
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=330.27 Aligned_cols=250 Identities=23% Similarity=0.302 Sum_probs=195.4
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
+|...+.||+|+||.||+|.. .+++.+|+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999996 45778999987642 23345678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++|+|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRMG---IFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 999999999997643 4788889999999999999999999 9999999999999999999999999975331000
Q ss_pred ----------------------------------------------ceeeecccccCCccCccccccCCCCcccceechh
Q 014725 248 ----------------------------------------------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFG 281 (419)
Q Consensus 248 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG 281 (419)
........||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 0001234689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC---HHH
Q 014725 282 VVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS---MKE 358 (419)
Q Consensus 282 ~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~e 358 (419)
|++|||++|+.||...+..+.. ....... ................+++.+|+ .+|.+|++ +.+
T Consensus 236 vil~elltG~~Pf~~~~~~~~~------~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQ------MKVINWQ-------TSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHH------HHHHccC-------CCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 9999999999999876543211 0000000 00011111223445677777765 59999997 666
Q ss_pred HHH
Q 014725 359 VAF 361 (419)
Q Consensus 359 vl~ 361 (419)
++.
T Consensus 302 i~~ 304 (382)
T cd05625 302 IKA 304 (382)
T ss_pred Hhc
Confidence 654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=294.43 Aligned_cols=250 Identities=27% Similarity=0.345 Sum_probs=209.3
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|++.+.||+|-||.||.|+. .++-.||+|.+... ......++.+|+++-+.|+||||++++++|.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 346788999999999999999996 45678999986532 22334678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
++||..+|+|...|.+.... .+++.....+..|+|.||.|+|..+ ||||||||+|+|++.++.+|++|||-+....
T Consensus 100 ilEya~~gel~k~L~~~~~~-~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK-RFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EEEecCCchHHHHHHhcccc-cccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 99999999999999865433 5888888999999999999999999 9999999999999999999999999986532
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.......+||..|.+||...+..++...|+|++|++.||++.|..||......+ ..+.+..
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e-------tYkrI~k--------- 236 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE-------TYKRIRK--------- 236 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH-------HHHHHHH---------
Confidence 344567889999999999999999999999999999999999999997655322 1111111
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.....+........++|.+|+..+|.+|.+..|++.-
T Consensus 237 -~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 237 -VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 1122344555678999999999999999999999763
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=322.09 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=195.9
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCC-cccccEEeEEecCCcceEEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINH-RNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~ 166 (419)
+|++.+.||+|+||.||+|... +++.||+|.+... .....+.+..|..++..++| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999965 4678999987632 23445678889999999976 56888999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQVG---KFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 9999999999987643 4889999999999999999999998 999999999999999999999999998753222
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+. .......
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~~i~~~---------- 216 (324)
T cd05587 155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL-------FQSIMEH---------- 216 (324)
T ss_pred C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcC----------
Confidence 1 123345689999999999999999999999999999999999999986654321 1111110
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
....+......+.+++.+||+.+|.+||+.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 217 NVSYPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 111223344568899999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=308.43 Aligned_cols=248 Identities=29% Similarity=0.449 Sum_probs=199.4
Q ss_pred CcccccCcEEEEEEEecC----CCEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLAD----GGIVAVKKSKLVDE-SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|.+.. +..+|+|....... ...+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999998532 25799998775433 34567899999999999999999999876 4567999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 99999998654 4899999999999999999999998 99999999999999999999999999987643332221
Q ss_pred e--cccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 252 T--RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 252 ~--~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
. ...++..|+|||.+.+..++.++||||||+++|||++ |..||...+..+. ... ... ....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~----~~~---------~~~~ 217 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAM----LES---------GERL 217 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHH----HHc---------CCcC
Confidence 1 1223467999999998899999999999999999998 9999976543221 111 111 1111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
..+...+..+.+++.+||..+|++||++.+|++.|+++.
T Consensus 218 ~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 223344567899999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=315.05 Aligned_cols=257 Identities=26% Similarity=0.447 Sum_probs=206.3
Q ss_pred hcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
.++|++.+.||+|+||.||+|... ++..+|+|.+.... ......+.+|+.+++.++||||+++++++.++...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467899999999999999999863 35689999876533 34456799999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCC-------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 163 LLVYEFIPNGTLYHYLHDQTE-------------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999974321 124788899999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhh
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~ 301 (419)
|+++.++.++|+|||+++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||......+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998765332211 1122234667999999988899999999999999999998 888986554332
Q ss_pred hccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
......... ....+...+..+.+++.+||+.+|.+|||+.|+++.|++
T Consensus 241 -------~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 241 -------VIYYVRDGN---------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -------HHHHHhcCC---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 111111111 111233455679999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=321.21 Aligned_cols=241 Identities=23% Similarity=0.330 Sum_probs=195.0
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|... +++.||+|.+... .....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 4678999987642 233456678899998866 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
++|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~ 153 (321)
T cd05591 81 GDLMFQIQRSR---KFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT 153 (321)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence 99999987543 4889999999999999999999999 9999999999999999999999999987543222 223
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ........ ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~-------~~~i~~~~----------~~~p 216 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL-------FESILHDD----------VLYP 216 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcCC----------CCCC
Confidence 345689999999999988999999999999999999999999987654321 11111110 1112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCC-------CHHHHHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRP-------SMKEVAF 361 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RP-------t~~evl~ 361 (419)
......+.+++.+||+.+|++|| ++.++++
T Consensus 217 ~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 217 VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 22345688999999999999999 6677754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=315.33 Aligned_cols=270 Identities=29% Similarity=0.415 Sum_probs=204.4
Q ss_pred cCccccCcccccCcEEEEEEEe-----cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Ccc
Q 014725 91 DNYNANRILGQGGQGTVYKGML-----ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVP 162 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 162 (419)
..|.+.+.||+|+||.||++.. .++..||+|.+.... ......+.+|+.+++.++|||++++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3468889999999999999984 246789999986543 34456799999999999999999999998875 567
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++++|.+++.+... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~--~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 899999999999999976432 4899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCce--eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 243 IKVDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 243 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
....... ......++..|+|||++.+..++.++|||||||++|||+|++.|.......... ................
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 237 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHGQMTVTRLVR 237 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hcccccccccHHHHHH
Confidence 6433221 122345677899999998888999999999999999999987764322110000 0000000000000111
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.+......+.+...+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 1111111222334566899999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-42 Score=308.23 Aligned_cols=268 Identities=25% Similarity=0.302 Sum_probs=208.3
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCcc-cccEEeEEecCC-----
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRN-VVKLLGCCLESE----- 160 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~----- 160 (419)
...|...+.||+|+||+||+|+. .+|+.||+|++....+ ..-....+|+.+++.++|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 34466677899999999999995 5678999999876433 23456789999999999999 999999998877
Q ss_pred -cceEEEeecCCCCHHHHhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 161 -VPLLVYEFIPNGTLYHYLHDQTEE-FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 161 -~~~lv~e~~~~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
..++|+||++ .+|..++...... ..++...+..++.||+.||+|||+++ |+||||||+|||++++|.+||+|||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG 165 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG 165 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence 7889999995 5999999876532 23667889999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
+|+.+...... .+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+..+.+.....-.......++.
T Consensus 166 lAra~~ip~~~-yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~ 244 (323)
T KOG0594|consen 166 LARAFSIPMRT-YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKD 244 (323)
T ss_pred hHHHhcCCccc-ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccC
Confidence 99976533322 3445689999999998876 799999999999999999999999998877544333333333333333
Q ss_pred hhHHHHH-----hhccCC-CHH----H---HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 318 LFEVLEA-----RVLKEG-KEE----E---IITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 318 ~~~~~~~-----~~~~~~-~~~----~---~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
|.....- ...... +.. . .....+++.+||+.+|.+|.|+...+..
T Consensus 245 Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 245 WPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 3322110 000000 111 1 1367889999999999999999999875
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=321.20 Aligned_cols=238 Identities=26% Similarity=0.361 Sum_probs=193.3
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|... +++.||+|.+... .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 5788999987632 233456678888888876 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT 153 (320)
T ss_pred chHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence 99999887643 4889999999999999999999999 9999999999999999999999999987542221 223
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. ...+.... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-------~~~i~~~~----------~~~~ 216 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEAILNDE----------VVYP 216 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcCC----------CCCC
Confidence 345689999999999999999999999999999999999999986654321 11111110 1112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMKE 358 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~e 358 (419)
......+.+++.+||+.||.+||++.+
T Consensus 217 ~~~~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 217 TWLSQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCC
Confidence 234456889999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=322.20 Aligned_cols=252 Identities=28% Similarity=0.420 Sum_probs=204.9
Q ss_pred ccCHHHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCCh---hhHHHHHHHHHHHhcCCCcccccEEeE
Q 014725 80 LFTKMDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDE---SNVEQFINEVVILSQINHRNVVKLLGC 155 (419)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~ 155 (419)
.|.++|.+. .|...+.||.|+||.||.|++ .+...||||+...... ....+++.|+..|++++|||.+.+.||
T Consensus 18 LF~k~DPEk---lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgC 94 (948)
T KOG0577|consen 18 LFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGC 94 (948)
T ss_pred HHccCCHHH---HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccce
Confidence 455555554 356678899999999999996 5677899999876543 345678999999999999999999999
Q ss_pred EecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 014725 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235 (419)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 235 (419)
+......|+||||| -|+-.+++.-... ++-+..+..|+.+.+.||.|||+++ .||||||..|||+++.|.|||+
T Consensus 95 yLre~TaWLVMEYC-lGSAsDlleVhkK--plqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLa 168 (948)
T KOG0577|consen 95 YLREHTAWLVMEYC-LGSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLA 168 (948)
T ss_pred eeccchHHHHHHHH-hccHHHHHHHHhc--cchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeec
Confidence 99999999999999 5677777765433 5888999999999999999999999 9999999999999999999999
Q ss_pred ecCCceecccCCceeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH
Q 014725 236 DFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
|||.+..... ...++|||.|||||++. .++|+-++||||||+++.||...++|+...+.... +
T Consensus 169 DFGSAsi~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA-------L-- 234 (948)
T KOG0577|consen 169 DFGSASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-------L-- 234 (948)
T ss_pred cccchhhcCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH-------H--
Confidence 9999876543 34468999999999864 57899999999999999999999999876654331 1
Q ss_pred hcccchhHHHHHhhccCC-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 313 MNEDRLFEVLEARVLKEG-KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+ ...-.+.. ..+....|..++..||+.-|.+|||..+++.
T Consensus 235 ------YHI-AQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 235 ------YHI-AQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred ------HHH-HhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 111 11111111 3456678999999999999999999877644
|
|
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=308.14 Aligned_cols=249 Identities=33% Similarity=0.494 Sum_probs=205.4
Q ss_pred CcccccCcEEEEEEEecC----CCEEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLAD----GGIVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|.... +..+++|........ ..+.+.+|++.++.++|+|++++++++.+....+++|||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999754 778999998764333 367899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCC------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 172 GTLYHYLHDQTE------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 172 g~L~~~l~~~~~------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
++|.+++..... ...+++..++.++.|++.||.|||+++ ++|+||+|+||+++.++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999987521 246899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 246 DQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 246 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
... .......++..|+|||.+....++.++||||||++++||++ |..||......+. .... .
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~---------~ 221 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV-------LEYL---------R 221 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHH---------H
Confidence 321 12234457889999999988899999999999999999999 6999987644321 1111 1
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.......+...+..+.+++.+||+.+|.+||++.++++.|+
T Consensus 222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11112233444678999999999999999999999998773
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=326.28 Aligned_cols=251 Identities=24% Similarity=0.425 Sum_probs=215.7
Q ss_pred CccccCcccccCcEEEEEEEecC--CC--EEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLAD--GG--IVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~--~~--~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.....++||+|.||.|++|.|.. |+ .||||.++..... ...+|++|+.+|.+|+|||++++||+..+ ....+||
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ 189 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVF 189 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHh
Confidence 34455789999999999999754 33 5899998875544 67899999999999999999999999987 6778999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
|+++.|+|.+.|++. ....+....+..++.|||.|+.||..++ +|||||..+|+|+-....+||+||||.+.+...
T Consensus 190 ELaplGSLldrLrka-~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 190 ELAPLGSLLDRLRKA-KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hhcccchHHHHHhhc-cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 999999999999983 3346888899999999999999999999 999999999999998889999999999988754
Q ss_pred Cceee--ecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 247 QTHLT--TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 247 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
..... ....-.+.|+|||.++...++.+||||+|||++|||+| |..||.+..... +.+.+|
T Consensus 266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD 329 (1039)
T KOG0199|consen 266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNID 329 (1039)
T ss_pred CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcc
Confidence 43332 22234568999999999999999999999999999999 899999877643 455666
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
...+...+..|++.+++++.+||..+|.+|||+..|.+.+
T Consensus 330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 6667778889999999999999999999999999997544
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=330.13 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=197.5
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.+|++.+.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36899999999999999999964 5789999987532 1233466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRLG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 9999999999997643 4788888999999999999999999 999999999999999999999999997532100
Q ss_pred C------------------------------------------ceeeecccccCCccCccccccCCCCcccceechhHHH
Q 014725 247 Q------------------------------------------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVL 284 (419)
Q Consensus 247 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l 284 (419)
. ........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 0 0001234699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCC---CHHHHHH
Q 014725 285 VELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP---SMKEVAF 361 (419)
Q Consensus 285 ~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP---t~~evl~ 361 (419)
|||++|+.||......+.. ....... ..............+.+++.+|+ .+|.+|+ ++.++++
T Consensus 235 yell~G~~Pf~~~~~~~~~------~~i~~~~-------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQ------LKVINWE-------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eehhhCCCCCCCCCHHHHH------HHHhccC-------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 9999999999876543311 0000000 00001111223445777888876 5999999 7888865
Q ss_pred H
Q 014725 362 E 362 (419)
Q Consensus 362 ~ 362 (419)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=315.28 Aligned_cols=263 Identities=25% Similarity=0.380 Sum_probs=204.9
Q ss_pred hcCccccCcccccCcEEEEEEEec-----------------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCccccc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-----------------DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVK 151 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 151 (419)
.++|++.+.||+|+||.||++... ++..+|+|..... .......+.+|+.+++.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence 357999999999999999998632 2346899988753 3444578999999999999999999
Q ss_pred EEeEEecCCcceEEEeecCCCCHHHHhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTE--------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 152 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
+++++...+..+++|||+++++|.+++..... ...+++..+..++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence 99999999999999999999999999976431 124778899999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh--CCCCCCCCChh
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQKPIRSTDAE 300 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t--g~~p~~~~~~~ 300 (419)
|+++.++.++|+|||+++......... .....++..|+|||...++.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999998654322211 222334678999999888889999999999999999998 77888755443
Q ss_pred hhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 301 EDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
+... ......... ........+..++..+.+++.+||+.+|.+||++.+|++.|+
T Consensus 241 ~~~~---~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIE---NTGEFFRDQ------GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHH---HHHHHHhhc------cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 2111 010000000 000011122344567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=314.08 Aligned_cols=246 Identities=22% Similarity=0.288 Sum_probs=194.8
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 99 LGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
||+|+||+||++... +++.+|+|.+.... ....+.+..|+.+++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999964 67899999875422 22345678899999999999999999999999999999999999999
Q ss_pred HHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeec
Q 014725 175 YHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253 (419)
Q Consensus 175 ~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 253 (419)
.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.++|+|||++........ ....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence 98875422 2335899999999999999999999998 99999999999999999999999999976543222 2234
Q ss_pred ccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHH
Q 014725 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEE 333 (419)
Q Consensus 254 ~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (419)
..||+.|+|||++.+..++.++|||||||++|||++|+.||......... ...... .... ....+..
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~--------~~~~--~~~~~~~ 223 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN---KELKQR--------ILND--SVTYPDK 223 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH---HHHHHh--------hccc--CCCCccc
Confidence 56899999999999999999999999999999999999999764432110 000000 0000 0122334
Q ss_pred HHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 334 EIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 334 ~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
.+..+.+++.+||+.+|.+|| ++.++++
T Consensus 224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 556789999999999999999 5555654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=306.04 Aligned_cols=247 Identities=29% Similarity=0.483 Sum_probs=201.7
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCHH
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDE-SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLY 175 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 175 (419)
+.||+|+||.||++.+.+++.||+|....... .....+.+|+++++.++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 46999999999999987789999998775433 35678999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee-ecc
Q 014725 176 HYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT-TRV 254 (419)
Q Consensus 176 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~-~~~ 254 (419)
+++..... .+++..+..++.+++.||.|||+++ ++||||+|+||+++.++.++|+|||++........... ...
T Consensus 81 ~~l~~~~~--~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKKKN--RLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 99976433 4789999999999999999999998 99999999999999999999999999976542211111 122
Q ss_pred cccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHH
Q 014725 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEE 333 (419)
Q Consensus 255 ~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (419)
.++..|+|||.+.++.++.++|+||||++++||+| |..||......... ..+........+..
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~----------------~~~~~~~~~~~~~~ 219 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR----------------ERIESGYRMPAPQL 219 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH----------------HHHhcCCCCCCCcc
Confidence 23567999999988899999999999999999999 88998765432211 11111111122334
Q ss_pred HHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 334 EIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 334 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.+..+.+++.+||..+|.+|||+.||++.|+
T Consensus 220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 5567999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=308.23 Aligned_cols=250 Identities=31% Similarity=0.476 Sum_probs=195.4
Q ss_pred CcccccCcEEEEEEEecC----CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEe-cCCcceEEEeecC
Q 014725 97 RILGQGGQGTVYKGMLAD----GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCL-ESEVPLLVYEFIP 170 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~ 170 (419)
+.||+|+||.||+|.+.+ ...+|+|..... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 468999999999998532 347999987543 3445678899999999999999999999876 4556799999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce-
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH- 249 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 249 (419)
+++|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+|||+++++.+||+|||+++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSETH--NPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 9999999976433 3677888899999999999999998 999999999999999999999999999765322111
Q ss_pred --eeecccccCCccCccccccCCCCcccceechhHHHHHHHhC-CCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 250 --LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG-QKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 250 --~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
......++..|+|||.+.+..++.++|||||||++|||++| ..||......+. .... .. ..
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~---~~~~---~~----------~~ 219 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI---TVYL---LQ----------GR 219 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHHH---hc----------CC
Confidence 11223456789999999888999999999999999999995 566654433221 1111 00 00
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
....+...+..+.+++.+||+.+|++||++.+|++.|+++.
T Consensus 220 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 220 RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11112233457889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=322.79 Aligned_cols=262 Identities=28% Similarity=0.413 Sum_probs=203.9
Q ss_pred HhcCccccCcccccCcEEEEEEEe------cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCcccccEEeEEecC-
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML------ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQI-NHRNVVKLLGCCLES- 159 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~- 159 (419)
..++|++.+.||+|+||.||+|.+ .+++.||||.++... ......+.+|+.++..+ +||||+++++++...
T Consensus 5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 346799999999999999999973 246789999987532 33456788999999999 689999999988654
Q ss_pred CcceEEEeecCCCCHHHHhhccCC--------------------------------------------------------
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTE-------------------------------------------------------- 183 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~-------------------------------------------------------- 183 (419)
...+++|||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 467899999999999999865321
Q ss_pred --------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce-eeecc
Q 014725 184 --------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRV 254 (419)
Q Consensus 184 --------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~ 254 (419)
...+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++........ .....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 123678888999999999999999998 999999999999999999999999999765322211 11223
Q ss_pred cccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHH
Q 014725 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEE 333 (419)
Q Consensus 255 ~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (419)
.++..|+|||.+.+..++.++||||||+++|+|++ |..||........ ........ .....+..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~---------~~~~~~~~ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEG---------TRMRAPDY 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhcc---------CCCCCCCC
Confidence 45678999999988899999999999999999997 9999876433211 11111111 11111222
Q ss_pred HHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 334 EIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 334 ~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
....+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 33468899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=321.70 Aligned_cols=238 Identities=27% Similarity=0.323 Sum_probs=194.2
Q ss_pred CcccccCcEEEEEEEe----cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 97 RILGQGGQGTVYKGML----ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
+.||+|+||.||++.. .++..+|+|.+.... ......+.+|++++++++||||+++++++.+.+..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999885 357889999876422 2234567789999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 82 ~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~ 154 (318)
T cd05582 82 GGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK 154 (318)
T ss_pred CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence 999999997543 4899999999999999999999999 9999999999999999999999999987653321 12
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (419)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+..+. ....... ....
T Consensus 155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-------~~~i~~~----------~~~~ 217 (318)
T cd05582 155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET-------MTMILKA----------KLGM 217 (318)
T ss_pred eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH-------HHHHHcC----------CCCC
Confidence 2345689999999999988899999999999999999999999976544321 1111000 0112
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 014725 331 KEEEIITVAMLGKRCLNMIGKKRPSMKE 358 (419)
Q Consensus 331 ~~~~~~~l~~li~~cl~~~p~~RPt~~e 358 (419)
+......+.+++.+||+.||.+||++.+
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 3334556889999999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=310.27 Aligned_cols=268 Identities=25% Similarity=0.308 Sum_probs=200.9
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-----cce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE-----VPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 163 (419)
+-.|...+++|.|+||.||+|... +++.||||+....... -.+|+++|+.++|||||++.-+|.... ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345777899999999999999964 4689999998654432 246999999999999999998886432 345
Q ss_pred EEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCce
Q 014725 164 LVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDFGASR 241 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfgl~~ 241 (419)
+||||++. +|.++++... .+..++...+.-++.||++||.|||+.+ |+||||||.|+|+|.+ |.+||+|||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999965 9999888521 1224666777889999999999999988 9999999999999976 899999999999
Q ss_pred ecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
.+...... ....-|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+..+.--..-.+......+.+..
T Consensus 175 ~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~ 252 (364)
T KOG0658|consen 175 VLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKS 252 (364)
T ss_pred eeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence 87654433 33456889999999876 5899999999999999999999999998665543222222222222222211
Q ss_pred HHHH-------hhcc-----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhcH
Q 014725 321 VLEA-------RVLK-----EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF--ELEGIR 367 (419)
Q Consensus 321 ~~~~-------~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~i~ 367 (419)
+... .+.. -......+...+++.++|+.+|.+|.++.|++. ..+.++
T Consensus 253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr 313 (364)
T KOG0658|consen 253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR 313 (364)
T ss_pred cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence 1111 1111 122344567899999999999999999999875 334443
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=312.01 Aligned_cols=256 Identities=26% Similarity=0.411 Sum_probs=205.9
Q ss_pred cCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
++|+..+.||+|+||.||+|+.. +...+++|........ ..+.+.+|++++++++||||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888999999999999999954 2357899987654333 4578999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCC------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEE------FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF 237 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 237 (419)
+||||+++++|.+++...... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999765422 25899999999999999999999999 999999999999999999999999
Q ss_pred CCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 238 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
|++...............++..|+|||.+.+..++.++||||||+++++|++ |..||....... +.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~-------~~~~~~~~ 234 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE-------VLNRLQAG 234 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH-------HHHHHHcC
Confidence 9987543322222333456778999999988889999999999999999999 888986543322 11111111
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
. .....+...+..+.+++.+||+.+|.+||++.+++..|.
T Consensus 235 ~--------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 235 K--------LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred C--------cCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1 111122344567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=307.40 Aligned_cols=250 Identities=24% Similarity=0.341 Sum_probs=204.2
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
+|++.+.||+|+||.||++... ++..+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..+++|||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4788899999999999999964 5788999987542 3345577889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... ..+++...+.++.|++.||.|||+++ ++|+||||+||++++++.++|+|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQRG-KLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 99999998875432 24789999999999999999999998 99999999999999999999999999976543222
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.... ........ ...
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-------~~~~~~~~---------~~~ 219 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL-------ILKVCQGS---------YKP 219 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH-------HHHHhcCC---------CCC
Confidence 22335688999999999988899999999999999999999999976543221 11111111 111
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.+......+.+++.+||+.+|.+||++.+++..
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 223344568899999999999999999999764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=307.74 Aligned_cols=248 Identities=27% Similarity=0.417 Sum_probs=201.7
Q ss_pred CcccccCcEEEEEEEecC--CC--EEEEEEcccCCh-hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLAD--GG--IVAVKKSKLVDE-SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~--~~--~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|++|.||+|.+.+ +. .+|+|....... ...+.+.+|+.++++++||||+++++.+.+ ...+++|||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999999643 22 689998876554 566789999999999999999999999988 888999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee-
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL- 250 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 250 (419)
++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.........
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999987543 35899999999999999999999998 9999999999999999999999999998764422211
Q ss_pred -eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 251 -TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 251 -~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
.....++..|+|||++.+..++.++|||||||+++||++ |+.||......+. ...... .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~~~~------------~~~~~ 220 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQI---LKKIDK------------EGERL 220 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh------------cCCcC
Confidence 123446788999999998899999999999999999999 9999976544321 110100 00111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
..+...+..+.+++.+||+.+|.+||++.+|++.|.
T Consensus 221 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 ERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 122334567999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=314.56 Aligned_cols=263 Identities=26% Similarity=0.402 Sum_probs=206.7
Q ss_pred hcCccccCcccccCcEEEEEEEecC-----------------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCccccc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-----------------GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVK 151 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-----------------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 151 (419)
.++|++.+.||+|+||.||+|...+ +..||+|.+... .....+.+.+|++++++++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 4678999999999999999998543 235899987653 2345678999999999999999999
Q ss_pred EEeEEecCCcceEEEeecCCCCHHHHhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTE--------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 152 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
+++++..++..+++|||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++|+||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 99999999999999999999999999976431 125899999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh--CCCCCCCCChh
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT--GQKPIRSTDAE 300 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t--g~~p~~~~~~~ 300 (419)
|+++.++.++|+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ +..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 99999999999999999865433221 2233446778999999988889999999999999999998 77788654432
Q ss_pred hhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 301 EDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
+. ........... ........+...+..+.+++.+||+.+|.+|||+.+|++.|+
T Consensus 241 ~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 241 QV---IENAGHFFRDD------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHhccccc------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 11111111100 001111122334467999999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=319.78 Aligned_cols=241 Identities=24% Similarity=0.333 Sum_probs=195.7
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 166 (419)
+|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+..|..++..+ +||+|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999975 4678999987642 223345567788888777 5899999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQVG---RFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 9999999999987643 4889999999999999999999998 999999999999999999999999999754322
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||........ ...+ ...
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~-------~~~i--------~~~-- 216 (323)
T cd05616 155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSI--------MEH-- 216 (323)
T ss_pred C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHH-------HHHH--------HhC--
Confidence 2 122345689999999999999999999999999999999999999987654321 1111 110
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
....+......+.+++.+||+.+|.+|++.
T Consensus 217 ~~~~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 217 NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred CCCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 112233445678899999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=319.57 Aligned_cols=244 Identities=24% Similarity=0.344 Sum_probs=194.1
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|... +++.+|+|.+... .....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999964 5678999987642 233456688999999888 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|..++.... .+++..+..++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR---KLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT 153 (327)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence 99999887543 4899999999999999999999998 9999999999999999999999999987532211 223
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|..||................+..... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------~~~~p 223 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK----------PIRIP 223 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC----------CCCCC
Confidence 34568999999999999999999999999999999999999997543322211111111111110 11123
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMK 357 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~ 357 (419)
......+.+++.+||+.||.+||++.
T Consensus 224 ~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 224 RFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 33445688999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=317.67 Aligned_cols=240 Identities=26% Similarity=0.348 Sum_probs=192.5
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|.+. +++.||+|.++.. .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999975 4678999987642 123345567788888764 899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|.+++.... .+++.....++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05619 81 GDLMFHIQSCH---KFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKT 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cce
Confidence 99999997643 4889999999999999999999998 9999999999999999999999999987532221 122
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. .+..... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~-------~~~i~~~----------~~~~~ 216 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL-------FQSIRMD----------NPCYP 216 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhC----------CCCCC
Confidence 345689999999999998999999999999999999999999986554321 1111100 01112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMK-EVA 360 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl 360 (419)
......+.+++.+||+.+|.+||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 RWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 23345688999999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=315.48 Aligned_cols=250 Identities=28% Similarity=0.424 Sum_probs=205.4
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..+|.+.+.||+|+||.||+|.. .+++.+|+|.+........+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 45789999999999999999996 46789999988765555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++... .+++.++..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~~L~~~~~~~----~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 9999999998643 3788999999999999999999998 99999999999999999999999999876433221
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ .. ..... .....
T Consensus 172 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~----~~~~~--------~~~~~ 236 (296)
T cd06654 172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LIATN--------GTPEL 236 (296)
T ss_pred -ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HH----HHhcC--------CCCCC
Confidence 12234588999999999988899999999999999999999999976543221 00 00000 00011
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+......+.+++.+||..+|.+||++.+++.
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 122344566889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=319.06 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=198.1
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||++... +++.||+|.+.. ......+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47899999999999999999964 578999998753 22334466889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 99999999999976432 4889999999999999999999999 999999999999999999999999998765443
Q ss_pred CceeeecccccCCccCcccccc-----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.........||+.|+|||++.. ..++.++|||||||++|||++|+.||......+. ............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~- 228 (331)
T cd05597 156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKEHFQ- 228 (331)
T ss_pred CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCccc-
Confidence 3333334568999999999863 4578899999999999999999999976543221 111111110000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCC--CCCCHHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGK--KRPSMKEVAFE 362 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~--~RPt~~evl~~ 362 (419)
........+..+.+++.+|+..++. .||++.++++.
T Consensus 229 -----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h 266 (331)
T cd05597 229 -----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH 266 (331)
T ss_pred -----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence 0011112345678888887765333 37888888764
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=318.62 Aligned_cols=241 Identities=25% Similarity=0.344 Sum_probs=195.6
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||+||+|... ++..||+|.+... .......+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999975 4678999987642 233456678899999888 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (318)
T cd05570 81 GDLMFHIQRSG---RFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTT 153 (318)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Ccc
Confidence 99999887653 4899999999999999999999998 9999999999999999999999999987532221 122
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.... ....... ....+
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~-------~~~i~~~----------~~~~~ 216 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL-------FQSILED----------EVRYP 216 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH-------HHHHHcC----------CCCCC
Confidence 334689999999999999999999999999999999999999976553221 1111111 01122
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCH-----HHHHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSM-----KEVAF 361 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~-----~evl~ 361 (419)
...+..+.+++.+||+.||.+||++ .+++.
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 217 RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 3345678999999999999999999 66654
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=311.79 Aligned_cols=254 Identities=25% Similarity=0.345 Sum_probs=202.6
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|++.+.||+|+||.||+|.. .++..+|+|+...........+.+|+.+++.++||||+++++++...+..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 45799999999999999999996 46788999988765555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++.......
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd06646 88 CGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI- 160 (267)
T ss_pred CCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-
Confidence 99999999987543 4889999999999999999999998 9999999999999999999999999998654221
Q ss_pred eeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 249 HLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.......++..|+|||.+. ...++.++|||||||+++||++|..||......+... ........ .+
T Consensus 161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~~---~~- 229 (267)
T cd06646 161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNFQ---PP- 229 (267)
T ss_pred cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCCC---CC-
Confidence 1123345888999999874 3457889999999999999999999986543321100 00000000 00
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
........+..+.+++.+||+.+|++|||+.++++.
T Consensus 230 -~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 230 -KLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred -CCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 001112334578999999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=310.51 Aligned_cols=248 Identities=23% Similarity=0.313 Sum_probs=195.1
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 99 LGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
||+|+||.||++... +++.+|+|.+... .......+..|+++++.++||||+++++++.+....++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999964 5889999987532 112234556799999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecc
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 254 (419)
.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~ 154 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR 154 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence 988865432 24889999999999999999999998 9999999999999999999999999987654322 22334
Q ss_pred cccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHH
Q 014725 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334 (419)
Q Consensus 255 ~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (419)
.|+..|+|||++.+..++.++|||||||++|||++|+.||......... .. ........ .. .......
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~--~~-~~~~~~~~--------~~-~~~~~~~ 222 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK--EE-LKRRTLED--------EV-KFEHQNF 222 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH--HH-HHHHhhcc--------cc-ccccccC
Confidence 6899999999999888999999999999999999999999754332110 00 11110000 00 0011233
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 335 IITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 335 ~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
...+.+++.+||+.+|.+||++.|+++.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~ 252 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPR 252 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence 456899999999999999999988765443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=309.99 Aligned_cols=257 Identities=28% Similarity=0.471 Sum_probs=206.7
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CC----EEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GG----IVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.++|++.+.||+|+||.||+|.+.+ +. .+|+|...... ......+.+|+.++++++||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 3568888999999999999999643 32 58999876543 3455788999999999999999999999987 7889
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~ 159 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKD--NIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 159 (279)
T ss_pred EEEecCCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccc
Confidence 99999999999999986543 4899999999999999999999988 999999999999999999999999999876
Q ss_pred ccCCceee-ecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 244 KVDQTHLT-TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 244 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
........ ....++..|+|||.+....++.++|+||||++++|+++ |+.||......+. .+.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-------~~~--------- 223 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI-------PDL--------- 223 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHH-------HHH---------
Confidence 43222111 12223568999999988899999999999999999999 9999977654321 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+........+..+...+.+++.+||..+|.+||++.++++.|+++..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred HhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11111112223344568899999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=318.21 Aligned_cols=240 Identities=25% Similarity=0.347 Sum_probs=192.7
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|.+. ++..||+|.++.. .....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 46999999999999975 5778999987642 123345667788888754 899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|..++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG---RFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA 153 (316)
T ss_pred CcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence 99999987643 4889999999999999999999998 9999999999999999999999999987532211 223
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. ....... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~-------~~~~~~~----------~~~~~ 216 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL-------FESIRVD----------TPHYP 216 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhC----------CCCCC
Confidence 445689999999999999999999999999999999999999976554321 1111000 11122
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMK-EVA 360 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~-evl 360 (419)
......+.+++.+||+.||.+||++. +++
T Consensus 217 ~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 217 RWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 23445688999999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=312.67 Aligned_cols=270 Identities=29% Similarity=0.411 Sum_probs=208.5
Q ss_pred cCccccCcccccCcEEEEEEEec-----CCCEEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEec--CCcc
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-----DGGIVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLE--SEVP 162 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~ 162 (419)
+.|.+.+.||+|+||.||+|.+. .+..+|+|.+...... ..+.|.+|+++++.++||||+++++++.. ....
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45777899999999999999854 2578999988754443 56789999999999999999999999877 5578
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+++|||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~--~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCcc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 999999999999999986543 4899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCcee--eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 243 IKVDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 243 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
........ .....++..|+|||.+.+..++.++||||||++++||+||..|+............. .........+.+
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 237 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLE 237 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHH
Confidence 65322211 112234567999999988899999999999999999999999986543221100000 000000001111
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.+........+..++..+.+++.+||+.+|.+|||+.||+++|+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 238 LLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 2222222222344557799999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=318.78 Aligned_cols=237 Identities=26% Similarity=0.366 Sum_probs=189.7
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHH-HHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVV-ILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||+||+|... +++.||+|.+... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999974 6889999987532 1222344555554 56789999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..... ....
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (323)
T cd05575 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTT 153 (323)
T ss_pred CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCcc
Confidence 99999987643 4889999999999999999999999 999999999999999999999999998753221 1223
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. +.... ... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i~---------~~~--~~~~ 216 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNIL---------NKP--LRLK 216 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHHH---------cCC--CCCC
Confidence 345689999999999999999999999999999999999999976544321 11110 000 1112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMK 357 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~ 357 (419)
......+.+++.+||+.+|.+||++.
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 217 PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 23356788999999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=318.62 Aligned_cols=254 Identities=21% Similarity=0.326 Sum_probs=198.4
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|.+.+.||+|+||.||+++.. +++.||+|.+.. ........+.+|..++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47899999999999999999964 567899998753 12233456888999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFED--RLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 99999999999986432 4888999999999999999999999 999999999999999999999999999876544
Q ss_pred CceeeecccccCCccCcccccc-----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...+..+. ............
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~- 228 (331)
T cd05624 156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEERFQ- 228 (331)
T ss_pred CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCccc-
Confidence 3333344569999999999875 4678899999999999999999999976543221 111111000000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKK--RPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~ 361 (419)
........+..+.+++.+|+..++.+ |+++.++++
T Consensus 229 -----~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 229 -----FPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred -----CCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 01111223456888999999865544 457777764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=317.28 Aligned_cols=264 Identities=23% Similarity=0.338 Sum_probs=200.4
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|.+.+.||+|+||.||+|+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56899999999999999999964 56789999876432 22335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++ +|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 86 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCGN--IMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 975 88888876433 4788999999999999999999998 99999999999999999999999999976433221
Q ss_pred eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH------
Q 014725 249 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV------ 321 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 321 (419)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...+..+................+..+
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (309)
T cd07872 160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF 238 (309)
T ss_pred -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence 1223457899999998865 56889999999999999999999999876554321111111000000000000
Q ss_pred HHHhhccC-------CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 LEARVLKE-------GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+...... ........+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00000000 01123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=344.10 Aligned_cols=261 Identities=24% Similarity=0.344 Sum_probs=205.5
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+++++.++||||+++++++.+.+..+++|
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57999999999999999999974 5789999987642 2334567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCC--------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 167 EFIPNGTLYHYLHDQTE--------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~--------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
||++|++|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999999864211 123567788999999999999999998 9999999999999999999999999
Q ss_pred CceecccCCc-----------------eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhh
Q 014725 239 ASRTIKVDQT-----------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301 (419)
Q Consensus 239 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~ 301 (419)
+++....... .......||+.|+|||++.+..++.++|||||||++|||+||..||...+...
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9987521110 01123468999999999999999999999999999999999999997643321
Q ss_pred hccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhcHH
Q 014725 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP-SMKEVAFELEGIRA 368 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~i~~ 368 (419)
.. .... + ..+. ........+..+.+++.+|++.||++|| ++.++++.|+....
T Consensus 239 i~-----~~~~-----i---~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS-----YRDV-----I---LSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh-----hhhh-----c---cChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 0000 0 0000 0011123445688999999999999996 57778887877643
|
|
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.39 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=204.8
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
|++..++++.....||+|+||.||+|.+. ++..||+|..........+.+.+|+.+++.++||||+++++++..++..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34556677777789999999999999964 56789999887666666778999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCcee
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRT 242 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~ 242 (419)
+++||+++++|.+++.........++..+..++.|++.||.|||+.+ ++||||||+||+++. ++.++|+|||++..
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~ 158 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKR 158 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence 99999999999999986433212378888899999999999999998 999999999999976 67999999999876
Q ss_pred cccCCceeeecccccCCccCccccccC--CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
...... ......+++.|+|||++.+. .++.++||||||+++|+|++|..||.......... ..
T Consensus 159 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~----~~---------- 223 (268)
T cd06624 159 LAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM----FK---------- 223 (268)
T ss_pred cccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH----hh----------
Confidence 532221 12234578999999998664 37889999999999999999999996543221100 00
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+......+.+++.+||+.+|.+|||+.+++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 224 VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00000111223344567889999999999999999999975
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=304.40 Aligned_cols=250 Identities=29% Similarity=0.404 Sum_probs=205.8
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|+..+.||+|+||.||.+.. .++..+++|.+... .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588899999999999999985 45788999986543 345567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.... ...+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999998653 235899999999999999999999998 99999999999999999999999999987643332
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......+++.|+|||.+.+..++.++||||||++++||++|..||......+. ..... .. ...
T Consensus 157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~---------~~~ 219 (256)
T cd08221 157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QG---------NYT 219 (256)
T ss_pred -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cC---------CCC
Confidence 22345689999999999888899999999999999999999999976443221 11100 01 011
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1123345678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.76 Aligned_cols=237 Identities=26% Similarity=0.362 Sum_probs=188.6
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHH-HHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVV-ILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|+.. ++..||+|.+... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999974 5788999987532 1222344555554 67889999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
++|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++..... ....
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~ 153 (321)
T cd05603 81 GELFFHLQRER---CFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETT 153 (321)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcc
Confidence 99998887543 4788889999999999999999998 999999999999999999999999998753221 1223
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+.... . ... ... ....+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~-~~i--------~~~--~~~~~ 216 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------Y-DNI--------LHK--PLQLP 216 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------H-HHH--------hcC--CCCCC
Confidence 345689999999999988999999999999999999999999976543221 1 111 000 11223
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMK 357 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~ 357 (419)
......+.+++.+||+.+|.+||+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 217 GGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 33455788999999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=305.91 Aligned_cols=239 Identities=23% Similarity=0.401 Sum_probs=190.1
Q ss_pred CcccccCcEEEEEEEecC-------------CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 97 RILGQGGQGTVYKGMLAD-------------GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
+.||+|+||.||+|.... ...+++|............+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998532 1258888876655555567899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc-------EEEee
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR-------AKVSD 236 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-------~kl~D 236 (419)
++|||+++++|..++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++|
T Consensus 81 lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKSD--VLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999999875433 4899999999999999999999998 999999999999986654 89999
Q ss_pred cCCceecccCCceeeecccccCCccCccccc-cCCCCcccceechhHHHHHHH-hCCCCCCCCChhhhccHHHHHHHHhc
Q 014725 237 FGASRTIKVDQTHLTTRVQGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELL-TGQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 237 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Di~slG~~l~el~-tg~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+.. ....
T Consensus 156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~~~~ 223 (262)
T cd05077 156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------RFYE 223 (262)
T ss_pred CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------HHHh
Confidence 9998654322 2234788899999886 467899999999999999998 588888654332210 0000
Q ss_pred ccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
. .. .........+.+++.+||+.+|.+||++.+|++.+
T Consensus 224 -~--------~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 224 -G--------QC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -c--------Cc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 00 01111235688999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=310.03 Aligned_cols=251 Identities=26% Similarity=0.384 Sum_probs=198.9
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|++.+.||+|+||.||+|.+ .+++.+|+|..... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 3678889999999999999996 46788999987543 334456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|..+. .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999997652 3678888999999999999999998 999999999999999999999999999765322
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......|+..|+|||++.+..++.++|+||||+++|+|++|+.||................... .+.....
T Consensus 149 -~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 219 (279)
T cd06619 149 -IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI--------VDEDPPV 219 (279)
T ss_pred -cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH--------hccCCCC
Confidence 2233568999999999999899999999999999999999999997543222111110000000 0000000
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.........+.+++.+||+.+|.+||++.++++.
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 1112234568899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=306.99 Aligned_cols=252 Identities=34% Similarity=0.541 Sum_probs=201.0
Q ss_pred ccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHH--HHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 93 YNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVE--QFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
|++.+.||+|+||+||++.... ++.+|+|........... ...+|+.++++++||||+++++++.+....+++|||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 6778999999999999999755 558999998775543322 3456999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++.... .+++..++.++.|++.||.+||+.+ ++|+||||+||+++.++.++|+|||.+.... ....
T Consensus 81 ~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~ 153 (260)
T PF00069_consen 81 PGGSLQDYLQKNK---PLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNE 153 (260)
T ss_dssp TTEBHHHHHHHHS---SBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTS
T ss_pred ccccccccccccc---ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccc
Confidence 9999999998332 4899999999999999999999998 9999999999999999999999999997642 2222
Q ss_pred eeecccccCCccCccccc-cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~-~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......++..|+|||++. +..++.++||||+|+++++|++|..||................. .......
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~-- 223 (260)
T PF00069_consen 154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK--------RPLPSSS-- 223 (260)
T ss_dssp EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH--------THHHHHT--
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc--------ccccccc--
Confidence 334556899999999998 88899999999999999999999999987632222111111100 0000000
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+.+++.+||+.+|++||++.++++
T Consensus 224 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 224 QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000111267999999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=306.65 Aligned_cols=253 Identities=25% Similarity=0.358 Sum_probs=192.5
Q ss_pred CcccccCcEEEEEEEecC---CCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 97 RILGQGGQGTVYKGMLAD---GGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
+.||+|+||.||+|...+ +..+|+|...... ......+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 369999999999998643 3578999876543 233457889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 173 TLYHYLHDQTE--EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 173 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+|.+++..... ....++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 99999975332 234677788899999999999999998 9999999999999999999999999987543222211
Q ss_pred -eecccccCCccCccccccC-------CCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 251 -TTRVQGTFGYLDPEYFRSS-------QFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 251 -~~~~~gt~~y~aPE~~~~~-------~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.....++..|+|||++.+. .++.++||||||+++|||++ |..||......+... . ..... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~---~~~~~-~~~~ 230 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y---TVREQ-QLKL 230 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H---Hhhcc-cCCC
Confidence 1234567889999998642 35789999999999999996 999997655432110 0 00000 0000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.. ..........+.+++.+|+ .+|++|||+.+|+..|+
T Consensus 231 ~~----~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 231 PK----PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CC----CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 00 1111123446788999999 68999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=314.63 Aligned_cols=263 Identities=28% Similarity=0.400 Sum_probs=202.7
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|++.+.||+|+||.||++... ++..+|+|..... ......++.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 46889999999999999999965 4677888887643 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
+++++|.+++.... .+++..+..++.|++.||.|||+. + ++|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 153 (308)
T cd06615 81 MDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 153 (308)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc-
Confidence 99999999997653 488999999999999999999984 6 999999999999999999999999998754322
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc------------
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE------------ 315 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~------------ 315 (419)
......++..|+|||++.+..++.++||||||+++++|++|+.||...+.................
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPP 231 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCC
Confidence 123346889999999998888999999999999999999999999754432211111000000000
Q ss_pred -----cchhHHHHHhhc---cCCC-HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 316 -----DRLFEVLEARVL---KEGK-EEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 316 -----~~~~~~~~~~~~---~~~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
....+..+.... ...+ ......+.+++.+||..+|++|||+.+|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000111111100 0001 1234568999999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=305.22 Aligned_cols=270 Identities=24% Similarity=0.361 Sum_probs=200.8
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC--CCcccccEEeEEecCC----cceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI--NHRNVVKLLGCCLESE----VPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~----~~~l 164 (419)
+.....++||+|.||.||+|.+. ++.||||++.. ...+.|.+|-++.+.. +|+||++++++-.... .++|
T Consensus 210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred CchhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 44555688999999999999995 58999999874 4567899998888765 7999999998866444 7899
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------CCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT------SIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
|++|.+.|+|.+||..+. ++|....+++..+++||+|||+.. .++|+|||||++||||..|++..|+|||
T Consensus 286 Vt~fh~kGsL~dyL~~nt----isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG 361 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKANT----ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG 361 (534)
T ss_pred EeeeccCCcHHHHHHhcc----ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence 999999999999999765 899999999999999999999743 4679999999999999999999999999
Q ss_pred CceecccCCce-eeecccccCCccCccccccCC-C-----CcccceechhHHHHHHHhCCCCCCCCChhhhc-cHHHHHH
Q 014725 239 ASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQ-F-----TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR-SLVGFFL 310 (419)
Q Consensus 239 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~-----s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~ 310 (419)
||..+...... .....+||.+|||||++.+.. + -.+.||||+|.|||||++...-+......+-. .....+-
T Consensus 362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 99988643222 123367999999999997631 2 24799999999999999976544311111100 0000000
Q ss_pred HHhcccchhHH-HHHhhccCCCH-----HHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 311 QAMNEDRLFEV-LEARVLKEGKE-----EEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 311 ~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
....-+++.+. +.+..++..+. .....+.+.++.||..||+.|.|+.=+.+++.++..
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 00000111111 11122222221 224568899999999999999999999998888764
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.22 Aligned_cols=250 Identities=27% Similarity=0.467 Sum_probs=202.9
Q ss_pred CccccCcccccCcEEEEEEEecCCCEEEEEEcccCC------hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD------ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
+|...+.||+|+||.||+|...+++.+|+|.+.... ......+.+|+++++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 477889999999999999998888899999876422 22345688999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++++|.+++.+.. .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRFG---PLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 99999999999997643 4789999999999999999999998 99999999999999999999999999876532
Q ss_pred CC-----ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 246 DQ-----THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 246 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
.. ........++..|+|||++.+..++.++||||||+++++|++|..||...+..... ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~----- 223 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIGAH----- 223 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhhhc-----
Confidence 11 11122345889999999999888999999999999999999999999765432210 000000
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.......+......+.+++.+||+.+|.+||++.+++.
T Consensus 224 ---~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 224 ---RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred ---cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00111223344567899999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=317.37 Aligned_cols=255 Identities=21% Similarity=0.317 Sum_probs=198.6
Q ss_pred cCccccCcccccCcEEEEEEEecC-CCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|.+.+.||+|+||.||++.... +..+|+|.+.. ........+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468899999999999999999754 67899998753 12233455888999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.+... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFED--RLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 99999999999986432 4889999999999999999999999 999999999999999999999999999765433
Q ss_pred CceeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 247 QTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.........||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+. +..........
T Consensus 156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~-- 227 (332)
T cd05623 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHKERF-- 227 (332)
T ss_pred CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHH------HHHHhCCCccc--
Confidence 333334457999999999986 34688999999999999999999999976543321 11111110000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKK--RPSMKEVAFE 362 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~~ 362 (419)
............+.+++.+|+..++.+ |+++.++++.
T Consensus 228 ----~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 228 ----QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 001111234566888999988654444 6888888764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=307.89 Aligned_cols=247 Identities=27% Similarity=0.381 Sum_probs=204.1
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|++.+.||.|+||.||+|... ++..+|+|...... ......+.+|+.+++.++|||++++++++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 46888999999999999999964 57889999876532 34456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++... ++++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 152 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM- 152 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccc-
Confidence 9999999998754 4899999999999999999999998 9999999999999999999999999998765432
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
.......+++.|+|||++.+..++.++||||||+++|+|+||..||...+.... .... ......
T Consensus 153 ~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~-------~~~~---------~~~~~~ 216 (274)
T cd06609 153 SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV-------LFLI---------PKNNPP 216 (274)
T ss_pred cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH-------HHHh---------hhcCCC
Confidence 122334578899999999988899999999999999999999999976543211 0000 011111
Q ss_pred CCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEE-EIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+.. .+..+.+++.+||..+|++|||+.++++
T Consensus 217 ~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCcccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111 4557899999999999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=317.17 Aligned_cols=242 Identities=26% Similarity=0.332 Sum_probs=190.6
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHH-HHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEV-VILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||+||+|... +++.+|+|.+.... ......+..|. .+++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 46999999999999975 46789999875321 12223444444 456788999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
++|.+++.... .+++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~ 153 (325)
T cd05602 81 GELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT 153 (325)
T ss_pred CcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence 99999997643 4778888889999999999999999 9999999999999999999999999987543221 123
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|..||......+. +... .... ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i---------~~~~--~~~~ 216 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YDNI---------LNKP--LQLK 216 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH------HHHH---------HhCC--cCCC
Confidence 345699999999999999999999999999999999999999976554321 1110 0000 1112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
......+.+++.+||+.+|.+||++.+.+..
T Consensus 217 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 217 PNITNSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred CCCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 2345568899999999999999998754433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=305.56 Aligned_cols=248 Identities=27% Similarity=0.490 Sum_probs=201.5
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh---------hhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE---------SNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
+|.+.+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 4778899999999999999964 578899997754321 123568899999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+||++++++.++|+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG---AFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 999999999999999997643 4888999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCce-----eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 242 TIKVDQTH-----LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 242 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
........ ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........ +.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~------ 222 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IF------ 222 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HH------
Confidence 76422111 11234578899999999988899999999999999999999999976443211 00
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... .......+...+..+.+++.+||+.+|.+||++.+|++
T Consensus 223 ---~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 ---KIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 000 01112233345567899999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=310.64 Aligned_cols=251 Identities=27% Similarity=0.354 Sum_probs=199.9
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.|+..+.||+|+||.||++... +++.+|+|.+.... ......+.+|+.+++.++|+|++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 3677789999999999999964 57899999875422 2233567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 156 (285)
T ss_pred ecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc
Confidence 9999999999865432 24889999999999999999999998 9999999999999999999999999987643222
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
. .....|+..|+|||++.+..++.++|||||||++|+|++|+.||........... ... ... ...
T Consensus 157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~---~~~---------~~~-~~~ 221 (285)
T cd05630 157 T--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VER---------LVK-EVQ 221 (285)
T ss_pred c--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH---HHh---------hhh-hhh
Confidence 1 1234689999999999988999999999999999999999999976432211000 000 000 001
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
...+......+.+++.+||+.+|.+||| +.|+++
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1122334456889999999999999999 778876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=302.81 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=202.3
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-CcceEEEe
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES-EVPLLVYE 167 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e 167 (419)
+|++.+.||+|++|.||++... +++.+|+|++... .....+.+.+|++++++++|||++++++.+... ...+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4888999999999999999964 4678999987542 234456788999999999999999999987643 45789999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++..... ..+++.+++.++.+++.||.+||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~~-~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKG-KLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 9999999999986432 35899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
.......+++.|+|||++.+..++.++||||||+++++|++|+.||...+.... ... . .....
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~-~---------~~~~~ 219 (257)
T cd08223 157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYR-I---------IEGKL 219 (257)
T ss_pred -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHH-H---------HhcCC
Confidence 222345588999999999999999999999999999999999999976543221 000 0 01111
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+......+.+++.+||+.+|.+|||+.++++
T Consensus 220 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1223445567999999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=320.10 Aligned_cols=261 Identities=26% Similarity=0.337 Sum_probs=198.2
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC----
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESE---- 160 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~---- 160 (419)
...++|++.+.||+|+||.||++... .+..||+|++.. ........+.+|+.+++.++||||+++++++...+
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 34588999999999999999999964 578999998753 23344567889999999999999999999986543
Q ss_pred --cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 161 --VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 161 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
..++||||+++ +|.+.+.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg 168 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 168 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCC
Confidence 46899999965 66666642 3788889999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc--
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED-- 316 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 316 (419)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..... ..........
T Consensus 169 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~ 243 (359)
T cd07876 169 LARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW---NKVIEQLGTPSA 243 (359)
T ss_pred CccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCcH
Confidence 99764322 2223456899999999999999999999999999999999999999876543210 0011100000
Q ss_pred ch--------hHHHHHhhc------------------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 317 RL--------FEVLEARVL------------------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 317 ~~--------~~~~~~~~~------------------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.+ ......... ..........+.+++.+||+.||++|||+.|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 244 EFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000000000 00011123568899999999999999999999873
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=332.19 Aligned_cols=260 Identities=23% Similarity=0.329 Sum_probs=193.2
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecC--------
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES-------- 159 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-------- 159 (419)
...+|.+.+.||+|+||.||+|... ++..||||++.... ....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 4568999999999999999999974 57899999875422 2345799999999999999999886432
Q ss_pred CcceEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeec
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDF 237 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Df 237 (419)
...++||||+++ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 235689999974 777776542 12335899999999999999999999999 99999999999998665 6999999
Q ss_pred CCceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 238 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
|+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||.+....+... . ..+.....
T Consensus 216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~-i~~~~~~p 290 (440)
T PTZ00036 216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--R-IIQVLGTP 290 (440)
T ss_pred ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHhCCC
Confidence 9998654322 2233568999999999865 468999999999999999999999998765432211 1 11111000
Q ss_pred ---chhH------------HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 317 ---RLFE------------VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 317 ---~~~~------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+.. .....+....+...+..+.+|+.+||+.+|.+|||+.|+++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000 00000011112223457889999999999999999999985
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=316.29 Aligned_cols=242 Identities=24% Similarity=0.338 Sum_probs=195.6
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 166 (419)
+|+..+.||+|+||.||+|... +++.||+|.+... .....+.+..|..+++.+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4777899999999999999964 5788999987632 2334466788999998885 578889999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQVG---KFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 9999999999987643 4899999999999999999999998 999999999999999999999999998754322
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+. +...
T Consensus 155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~-------~~~--------i~~~-- 216 (323)
T cd05615 155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL-------FQS--------IMEH-- 216 (323)
T ss_pred C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH-------HHH--------HHhC--
Confidence 1 122345689999999999988999999999999999999999999987654321 111 1110
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMK 357 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 357 (419)
....+......+.+++.+||+.+|.+|++..
T Consensus 217 ~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 217 NVSYPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred CCCCCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0112333445688999999999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=309.36 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=202.7
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|++.+.||+|+||.||++.+. ++..+|+|.+... .......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46888999999999999999975 6789999987643 344457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
+++++|..++........+++..+..++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC-
Confidence 99999999987643333589999999999999999999974 6 999999999999999999999999998765322
Q ss_pred ceeeecccccCCccCccccccC------CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 248 THLTTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~------~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
......+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||........ .... ..+
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~---------~~~ 222 (286)
T cd06622 157 --LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQL---------SAI 222 (286)
T ss_pred --ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHH---------HHH
Confidence 12234578899999998554 358899999999999999999999965432211 0000 011
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. .......+......+.+++.+||+.+|.+||++.+++.
T Consensus 223 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 223 V-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred h-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 1 11112234446677899999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=308.14 Aligned_cols=249 Identities=24% Similarity=0.330 Sum_probs=200.6
Q ss_pred ccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 93 YNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
|++.+.||+|+||.||+|.... +..+++|..........+.+.+|+++++.++|||++++++++......++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 6778899999999999999754 667888888766666677899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
++|..++.... .++++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....... ...
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~ 160 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRR 160 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-ccc
Confidence 99999886533 25899999999999999999999998 9999999999999999999999999987643221 122
Q ss_pred ecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 252 TRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
....++..|+|||++. +..++.++|||||||++|||++|+.||........ ........ ..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~------~~~~~~~~--------~~ 226 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE--------PP 226 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH------HHHHhhcC--------CC
Confidence 3345889999999974 34578899999999999999999999976543221 11111000 00
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+++.+||+.+|.+||++.++++
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01112234567899999999999999999999865
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=311.94 Aligned_cols=257 Identities=28% Similarity=0.503 Sum_probs=202.7
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCC----EEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGG----IVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.++|+..+.||+|+||.||+|.+. ++. .+|+|...... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 345778899999999999999864 333 47888876533 23345788999999999999999999998754 467
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+++||+++|+|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~ 159 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKD--NIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (303)
T ss_pred eeehhcCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence 99999999999999876543 4789999999999999999999998 999999999999999999999999999875
Q ss_pred ccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 244 KVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 244 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... ......++..|+|||++.+..++.++||||||+++|||++ |..||......+.. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-------~~~-------- 224 (303)
T cd05110 160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------DLL-------- 224 (303)
T ss_pred cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHH--------
Confidence 432221 1222345678999999998899999999999999999998 99999765433211 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
........+..+...+.+++.+||..+|++||++.++++.|+.+..
T Consensus 225 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 225 -EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred -HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111111122334568899999999999999999999999988743
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=308.60 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=203.2
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.+.|++.+.||+|+||.||+|... ++..+++|..........+.+.+|+.+++.++|||++++++++..++..++||||
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 90 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF 90 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence 367889999999999999999975 4788999998776666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|..++.+... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 91 ~~~~~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 164 (292)
T cd06644 91 CPGGAVDAIMLELDR--GLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL- 164 (292)
T ss_pred CCCCcHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence 999999988865432 4899999999999999999999998 9999999999999999999999999987543221
Q ss_pred eeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 249 HLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.......+++.|+|||++. ...++.++|||||||++|||++|..||........ .........
T Consensus 165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~------ 232 (292)
T cd06644 165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSEP------ 232 (292)
T ss_pred cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhcCCC------
Confidence 1123345788999999984 34568899999999999999999999875443211 111110000
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+......+.+++.+||+.+|++||++.++++
T Consensus 233 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 233 --PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred --ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 001112234456889999999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.03 Aligned_cols=250 Identities=27% Similarity=0.408 Sum_probs=206.0
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..+|.+.+.||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 46799999999999999999996 56889999998765555567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.+. .+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 9999999998653 3788999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......+++.|+|||.+.+..++.++|+|||||++|++++|..||...+...... .... ......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~--------~~~~~~ 235 (297)
T cd06656 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIAT--------NGTPEL 235 (297)
T ss_pred -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eecc--------CCCCCC
Confidence 1223457889999999998889999999999999999999999997654322100 0000 000011
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+......+.+++.+||+.+|++||++.+|++
T Consensus 236 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 236 QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 122334456889999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=309.57 Aligned_cols=263 Identities=25% Similarity=0.345 Sum_probs=199.7
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4788899999999999999974 5789999987643 223346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
++ ++|.+++........+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 689888876544446899999999999999999999998 9999999999999999999999999997654322
Q ss_pred eeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh--cccch---hHH-
Q 014725 249 HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM--NEDRL---FEV- 321 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~---~~~- 321 (419)
.......+++.|+|||++.+. .++.++|||||||++++|+||+.||......... ........ .+..+ ...
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhcchhhH
Confidence 112233568899999988654 5789999999999999999999999865433211 00000000 00000 000
Q ss_pred -HHHhhc-------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 -LEARVL-------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 -~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...... .........++.+++.+||+.||.+|||+.+|+.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000 0001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=304.36 Aligned_cols=250 Identities=25% Similarity=0.409 Sum_probs=205.2
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|++.+.||+|+||.||+|...+ +..+++|.+..... .+.+.+|+++++.++||||+++++++.+....++++||
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~ 79 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY 79 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence 4678999999999999999999765 78899998865432 67899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 80 ~~~~~L~~~l~~~~~--~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (256)
T cd06612 80 CGAGSVSDIMKITNK--TLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA 154 (256)
T ss_pred CCCCcHHHHHHhCcc--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence 999999999975432 5899999999999999999999998 99999999999999999999999999886543321
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......++..|+|||++.+..++.++||||||+++++|++|+.||......... .. .... .....
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~-------~~~~~ 219 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNK-------PPPTL 219 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccC-------CCCCC
Confidence 223344788999999999889999999999999999999999999765443210 00 0000 00001
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+......+.+++.+||+.+|++|||+.+|+.
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 220 SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 112234457899999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=317.45 Aligned_cols=242 Identities=26% Similarity=0.362 Sum_probs=191.3
Q ss_pred CcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHH-HHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVV-ILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|.. .+++.+|+|.+... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999996 46789999987532 2233345555654 56778999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|..++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~ 153 (325)
T cd05604 81 GELFFHLQRER---SFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT 153 (325)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence 99998887543 4899999999999999999999999 9999999999999999999999999987532211 122
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. +..... . . ...+
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~~~-~--------~--~~~~ 216 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNILH-K--------P--LVLR 216 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHHHc-C--------C--ccCC
Confidence 345689999999999999999999999999999999999999976553321 111110 0 0 0111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
......+.+++.+|++.+|.+||++.+.++.
T Consensus 217 ~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~ 247 (325)
T cd05604 217 PGASLTAWSILEELLEKDRQRRLGAKEDFLE 247 (325)
T ss_pred CCCCHHHHHHHHHHhccCHHhcCCCCCCHHH
Confidence 2234567889999999999999998644433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=302.97 Aligned_cols=251 Identities=32% Similarity=0.507 Sum_probs=204.3
Q ss_pred ccccCcccccCcEEEEEEEecC-----CCEEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 93 YNANRILGQGGQGTVYKGMLAD-----GGIVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
+.+.+.||.|+||.||++...+ +..+|+|........ ..+.+.+|+..++.++||||+++++++.+.+..+++|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 3567889999999999999754 378999998754433 5678999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++...... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.....
T Consensus 81 e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPK-ELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred eccCCCCHHHHHHhhhhc-cCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999999764421 2899999999999999999999998 999999999999999999999999999876544
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.........+++.|+|||.+.+..++.++||||||+++++|++ |..||........ .... ...
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~-------~~~~---------~~~ 220 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV-------LEYL---------KKG 220 (258)
T ss_pred cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH-------HHHH---------hcC
Confidence 3322222336789999999988889999999999999999998 8888876443221 1111 111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
.....+...+..+.+++.+|+..+|.+|||+.++++.|
T Consensus 221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 221 YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11122233566799999999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=313.47 Aligned_cols=264 Identities=24% Similarity=0.355 Sum_probs=200.4
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|.+.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56899999999999999999964 57889999876432 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
++ ++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~~--~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCGN--SINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 96 589998876433 4789999999999999999999998 99999999999999999999999999876432221
Q ss_pred eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh--
Q 014725 249 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR-- 325 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 325 (419)
......+++.|+|||.+.+ ..++.++|||||||++|||+||+.||...+..+................+...+...
T Consensus 160 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 160 -TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred -cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 1223346889999998865 457889999999999999999999998765533211111000000011111111000
Q ss_pred -------hcc----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 -------VLK----EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 -------~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... .........+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000 001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=308.72 Aligned_cols=250 Identities=25% Similarity=0.315 Sum_probs=198.9
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
|+..+.||+|+||+||+|.+. +++.+|+|.+.... ......+.+|+++++.++|+|++++.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 667788999999999999964 57889999875422 22335578899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988875432 25899999999999999999999998 9999999999999999999999999997653222
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......|+..|+|||++.+..++.++|+|||||++|||++|..||........... ........ ..
T Consensus 157 -~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~---~~~~~~~~----------~~ 222 (285)
T cd05632 157 -SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREE---VDRRVLET----------EE 222 (285)
T ss_pred -cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhhhcc----------cc
Confidence 12334689999999999988999999999999999999999999986543221100 01000000 01
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
..+......+.+++..||+.+|.+||+ +.+++.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 122334456889999999999999999 455544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=307.54 Aligned_cols=238 Identities=25% Similarity=0.403 Sum_probs=188.5
Q ss_pred cccccCcEEEEEEEecC-------------------------CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccE
Q 014725 98 ILGQGGQGTVYKGMLAD-------------------------GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKL 152 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l 152 (419)
.||+|+||.||+|.... ...|++|............+.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 59999999999997421 12588888765544455678899999999999999999
Q ss_pred EeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC--
Q 014725 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-- 230 (419)
Q Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-- 230 (419)
++++.+....++||||+++|+|..++..... .+++..+..++.|++.||+|||+.+ ++||||||+|||++.++
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999876433 4788999999999999999999998 99999999999997643
Q ss_pred -----cEEEeecCCceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHH-hCCCCCCCCChhhhc
Q 014725 231 -----RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELL-TGQKPIRSTDAEEDR 303 (419)
Q Consensus 231 -----~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~-tg~~p~~~~~~~~~~ 303 (419)
.+|++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......+..
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~ 231 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE 231 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH
Confidence 3899999988643221 12346788999998865 56899999999999999995 699999765443211
Q ss_pred cHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 304 SLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
. + .... ...+......+.+++.+||+.+|++|||+.+|++.|
T Consensus 232 ~----~------------~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 232 R----F------------YEKK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H----H------------HHhc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 0 0 0000 011111234688999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=323.04 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=193.9
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|+..+.||+|+||.||++... ++..||+|.+... .......+.+|+.++..++||||+++++.+.+.+..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999964 5788999987632 2334567888999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKKD---TLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 9999999999997643 4889999999999999999999999 999999999999999999999999998754221
Q ss_pred Cc----------------------------------eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCC
Q 014725 247 QT----------------------------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 292 (419)
Q Consensus 247 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~ 292 (419)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 10 00123469999999999999999999999999999999999999
Q ss_pred CCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 293 PIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 293 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
||........ +....... ..............+.+++.+|+ .+|.+|++.
T Consensus 235 Pf~~~~~~~~------~~~i~~~~-------~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~ 284 (360)
T cd05627 235 PFCSETPQET------YRKVMNWK-------ETLVFPPEVPISEKAKDLILRFC-TDSENRIGS 284 (360)
T ss_pred CCCCCCHHHH------HHHHHcCC-------CceecCCCCCCCHHHHHHHHHhc-cChhhcCCC
Confidence 9986654321 11111000 00000011112345777888876 499999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=303.90 Aligned_cols=247 Identities=30% Similarity=0.484 Sum_probs=201.2
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
++|.+.+.||+|+||.||++.. ++..+|+|...... ..+.+.+|+.+++.++|||++++++++... ..+++|||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 4588899999999999999975 57789999876532 346789999999999999999999998754 4799999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---- 153 (254)
T cd05083 82 KGNLVNFLRTRGR-ALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---- 153 (254)
T ss_pred CCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence 9999999976542 35889999999999999999999998 999999999999999999999999998764321
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
......+..|+|||.+.+..++.++|+||||++++||++ |+.||......+. ... +.......
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~---------~~~~~~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KEC---------VEKGYRME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHH---------HhCCCCCC
Confidence 112234567999999988899999999999999999998 9999976554321 111 11111122
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
.+...+..+.+++.+||+.+|.+||++.+|++.|++
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 233445678899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=311.76 Aligned_cols=250 Identities=26% Similarity=0.419 Sum_probs=206.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..+|.+.+.||.|+||.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++++.+.+..++|+||
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 97 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY 97 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence 35699999999999999999985 56889999988765555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|..++... .+++.++..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~ 170 (296)
T cd06655 98 LAGGSLTDVVTET----CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS 170 (296)
T ss_pred cCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc
Confidence 9999999988653 3899999999999999999999999 99999999999999999999999999876543222
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......++..|+|||.+.+..++.++|||||||++|+|++|+.||...+..... ...... .....
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~--------~~~~~ 235 (296)
T cd06655 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATN--------GTPEL 235 (296)
T ss_pred -cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhc--------CCccc
Confidence 122345888999999999888999999999999999999999999776543211 000000 00001
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+......+.+++.+||..+|.+||++.+++.
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 122334557889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=306.12 Aligned_cols=250 Identities=31% Similarity=0.464 Sum_probs=198.7
Q ss_pred CcccccCcEEEEEEEecC-------CCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 97 RILGQGGQGTVYKGMLAD-------GGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+.||+|+||.||+|...+ +..+|+|.+.... ......+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2468999875432 24457789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccC----CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-----cEEEeecCC
Q 014725 169 IPNGTLYHYLHDQT----EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-----RAKVSDFGA 239 (419)
Q Consensus 169 ~~~g~L~~~l~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-----~~kl~Dfgl 239 (419)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++ .++|+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999997532 1234788999999999999999999988 99999999999999877 899999999
Q ss_pred ceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 240 SRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 240 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
++........ ......++..|+|||++.+..++.++|||||||++|||+| |..||......+. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~-------~~~~---- 226 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV-------LQHV---- 226 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH-------HHHH----
Confidence 8765322211 1122345678999999999999999999999999999998 9999975543221 1111
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
........+...+..+.+++.+||..+|.+||++.+|++.|++
T Consensus 227 -----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 -----TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred -----hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111112233445678999999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=306.36 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=201.6
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|.+.+.||+|+||.||+|... ++..+|+|..+.........+.+|+.+++.++||||+++++++...+..+++|||
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 357888899999999999999964 5788999988765555556788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.... .+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...... .
T Consensus 88 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~ 160 (267)
T cd06645 88 CGGGSLQDIYHVTG---PLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITAT-I 160 (267)
T ss_pred cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCc-c
Confidence 99999999987543 4899999999999999999999998 999999999999999999999999998765422 1
Q ss_pred eeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 249 HLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.......|+..|+|||++. ...++.++|+|||||++|+|++|..||......... . .... .... .+.
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~--~----~~~~-~~~~---~~~ 230 (267)
T cd06645 161 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL--F----LMTK-SNFQ---PPK 230 (267)
T ss_pred cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH--H----hhhc-cCCC---CCc
Confidence 1223446899999999874 456889999999999999999999998654432210 0 0000 0000 000
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. ......+..+.+++.+||+.+|++||++.+|++
T Consensus 231 ~--~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 L--KDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred c--cccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 0 001123346889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=302.64 Aligned_cols=254 Identities=26% Similarity=0.314 Sum_probs=209.5
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-CCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..+.|++.+.||.|.-|+||++.+++ +..+|+|.+.. .......+...|-+||+.++||.++.+|..++.++..|+
T Consensus 75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl 154 (459)
T KOG0610|consen 75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCL 154 (459)
T ss_pred CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEE
Confidence 34568888999999999999999865 47899998653 223445667889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
+||||+||+|....+++..+ .+++..+.-++.+|+.||+|||-.| ||+|||||+||||.++|++.|+||.|+....
T Consensus 155 ~meyCpGGdL~~LrqkQp~~-~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 155 VMEYCPGGDLHSLRQKQPGK-RFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred EEecCCCccHHHHHhhCCCC-ccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 99999999999998877654 6999999999999999999999999 9999999999999999999999999975431
Q ss_pred c---------------------------------CCc----------------------eeeecccccCCccCccccccC
Q 014725 245 V---------------------------------DQT----------------------HLTTRVQGTFGYLDPEYFRSS 269 (419)
Q Consensus 245 ~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~ 269 (419)
. ... .....++||-.|+|||++++.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 0 000 012246799999999999999
Q ss_pred CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccC
Q 014725 270 QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMI 349 (419)
Q Consensus 270 ~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~ 349 (419)
..+.++|.|+|||++|||+.|..||.+....+. +..++.+.+.-.........+.+||++.|.+|
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T---------------l~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET---------------LRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh---------------HHHHhcCCCcCCCCCcchhHHHHHHHHHhccC
Confidence 999999999999999999999999998766432 33333333333333355678999999999999
Q ss_pred CCCCCC----HHHHHH
Q 014725 350 GKKRPS----MKEVAF 361 (419)
Q Consensus 350 p~~RPt----~~evl~ 361 (419)
|.+|.. +.||-+
T Consensus 376 P~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIKR 391 (459)
T ss_pred hhhhhccccchHHhhc
Confidence 999987 566643
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.77 Aligned_cols=253 Identities=23% Similarity=0.368 Sum_probs=200.3
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecC------
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLES------ 159 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------ 159 (419)
.+++.|++.+.||+|+||.||+|... ++..+|+|...... .....+.+|+.+++++ +||||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46678999999999999999999964 57789999876543 3346788999999998 699999999998753
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
...+++|||+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKG-NTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 357899999999999999986432 35889999999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
+....... .......|+..|+|||++. ...++.++|||||||++|||++|..||......... .....
T Consensus 158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------~~~~~ 230 (272)
T cd06637 158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------FLIPR 230 (272)
T ss_pred ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------HHHhc
Confidence 97653222 1223456889999999986 346788999999999999999999999754432211 00000
Q ss_pred ccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...........+..+.+++.+||..+|.+|||+.++++
T Consensus 231 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 ---------NPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred ---------CCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00011112234457899999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=310.25 Aligned_cols=263 Identities=24% Similarity=0.314 Sum_probs=193.7
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcC---CCcccccEEeEEecC-----C
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQI---NHRNVVKLLGCCLES-----E 160 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~ 160 (419)
+|++.+.||+|+||+||+|... +++.||+|.+.... ......+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5888999999999999999965 57889999876422 22223456677776665 799999999988642 3
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..+++|||++ ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 4689999997 589888876432 24899999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||.......................+..
T Consensus 156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (288)
T cd07863 156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233 (288)
T ss_pred ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence 8654221 22334578999999999988999999999999999999999999976544321110000000000000000
Q ss_pred HHH---Hhh-------ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLE---ARV-------LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~---~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... ... ...........+.+++.+||+.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000 00011123456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=304.80 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=204.9
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..|+..+.||+|+||.||+|.+. ++..||+|...... ......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999974 57889999876432 34567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~i~~~----~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (277)
T cd06640 84 LGGGSALDLLRAG----PFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 156 (277)
T ss_pred CCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence 9999999998643 4788999999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......++..|+|||++.+..++.++|+|||||++|||+||..||......... ..+......
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~~~ 219 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNNPP 219 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCCCC
Confidence 223345788999999998888999999999999999999999999765433210 001111112
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
......+..+.+++.+||+.+|.+||++.+++..
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 2344566779999999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=315.18 Aligned_cols=253 Identities=27% Similarity=0.364 Sum_probs=212.0
Q ss_pred HHHhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCC---hhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCc
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVD---ESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEV 161 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~ 161 (419)
......|.+.+.||+|.||.||+++... |+.+|+|.+.... ....+.+.+|+.+|+.+. ||||+.+.+.+.+...
T Consensus 31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~ 110 (382)
T KOG0032|consen 31 EDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDS 110 (382)
T ss_pred ccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCe
Confidence 3456679999999999999999999765 8899999875432 234578999999999998 9999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC----CCcEEEeec
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD----KYRAKVSDF 237 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~----~~~~kl~Df 237 (419)
.++|||++.||.|.+.+... .+++.....++.|++.++.|||+.+ ++||||||+|+|+.. ++.+|++||
T Consensus 111 ~~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DF 183 (382)
T KOG0032|consen 111 VYLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDF 183 (382)
T ss_pred EEEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeC
Confidence 99999999999999999876 2899999999999999999999999 999999999999953 357999999
Q ss_pred CCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 238 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
|++..... .......+||+.|+|||++....|+..+||||+|+++|.|++|..||.......... .+...+
T Consensus 184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~ 254 (382)
T KOG0032|consen 184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD 254 (382)
T ss_pred CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC
Confidence 99998765 445667889999999999999999999999999999999999999998776543211 111111
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+ ....+.-........+++..|+..||..|+|+.++++
T Consensus 255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 1 1112222344567889999999999999999999988
|
|
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=301.45 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=202.5
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-----hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-----ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
+|+..+.||+|+||.||+|... ++..|++|...... ....+.+.+|+.+++.++||||+++++++.+....+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4777899999999999999975 68899999875432 23557789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
+||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKYG---SFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999997643 4889999999999999999999998 99999999999999999999999999876543
Q ss_pred CCceeeecccccCCccCccccccCC-CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||........ .... ...
T Consensus 155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~---------~~~ 217 (258)
T cd06632 155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKI---------GRS 217 (258)
T ss_pred cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHH---------Hhc
Confidence 22 223456889999999987766 89999999999999999999999976542211 0000 000
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
......+......+.+++.+||+.+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0111223334567889999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=302.34 Aligned_cols=238 Identities=26% Similarity=0.453 Sum_probs=190.8
Q ss_pred CcccccCcEEEEEEEecCCC-----------EEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 97 RILGQGGQGTVYKGMLADGG-----------IVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
+.||+|+||.||+|.+.+.. .+++|........ ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 46999999999999976433 4777776543333 5788999999999999999999999988 778999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-------cEEEeecC
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-------RAKVSDFG 238 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-------~~kl~Dfg 238 (419)
|||+++|+|.+++..... .+++..++.++.||+.||.|||+++ ++||||||+||+++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREKN--NVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 999999999999987543 4889999999999999999999998 99999999999999887 79999999
Q ss_pred CceecccCCceeeecccccCCccCccccccC--CCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..||......+.. ..+. ..
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~~---~~ 222 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFYQ---DQ 222 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHHh---cC
Confidence 9876433 2223467789999998876 78999999999999999999 57888665432211 0000 00
Q ss_pred cchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 316 DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
. ..+......+.+++.+||..+|.+|||+.+|++.|+
T Consensus 223 ~------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 223 H------------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred C------------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0 001111157889999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=301.48 Aligned_cols=254 Identities=25% Similarity=0.359 Sum_probs=206.5
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|++.+.||+|+||.||+|... ++..+++|..........+.+.+|+.+++.++||||+++++++.+....+++|||
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~ 81 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY 81 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence 367899999999999999999964 5678999998766555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~- 155 (262)
T cd06613 82 CGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI- 155 (262)
T ss_pred CCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence 99999999987642 24889999999999999999999998 9999999999999999999999999987654321
Q ss_pred eeeecccccCCccCccccccC---CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 249 HLTTRVQGTFGYLDPEYFRSS---QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~---~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.......++..|+|||.+.+. .++.++|+||||++++||+||+.||.......... .. ..... ..
T Consensus 156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~~-~~~~~-----~~ 223 (262)
T cd06613 156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------LI-SKSNF-----PP 223 (262)
T ss_pred hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------HH-HhccC-----CC
Confidence 122334578899999998776 88999999999999999999999997655432110 00 00000 00
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+..+.+++.+||..+|.+|||+.+|+.
T Consensus 224 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 001112334567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=307.99 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=205.8
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|.+.+.||+|+||.||+|.+. ++..+|+|..........+.+.+|+++++.++||||+++++.+.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 467999999999999999999974 5788999998776666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 999999999876433 4899999999999999999999999 99999999999999999999999999876433221
Q ss_pred eeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 249 HLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
......+++.|+|||.+. ...++.++|+||||+++|||++|+.||...+.... ...... ..
T Consensus 159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~-~~------ 224 (280)
T cd06611 159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LLKILK-SE------ 224 (280)
T ss_pred -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HHHHhc-CC------
Confidence 223345889999999874 34577899999999999999999999976543221 111000 00
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
......+......+.+++.+||+.+|.+||++.++++.
T Consensus 225 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 225 -PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred -CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 00011122344578899999999999999999999763
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=318.26 Aligned_cols=263 Identities=24% Similarity=0.316 Sum_probs=198.8
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-----
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES----- 159 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 159 (419)
...++|.+.+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 35678999999999999999999964 5788999987642 334456788999999999999999999988643
Q ss_pred -CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 160 -EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
...++||||+++ +|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg 164 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 164 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCc
Confidence 246899999965 67776643 3788889999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH--------HH
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF--------FL 310 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--------~~ 310 (419)
+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....... ..
T Consensus 165 ~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred ccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99764322 222345689999999999998999999999999999999999999987654321100000 00
Q ss_pred HHhcccchhHHHHHh---------------hc---cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 311 QAMNEDRLFEVLEAR---------------VL---KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~---------------~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.... ..+....... .. ..........+.+++.+||+.||.+|||+.|+++.
T Consensus 243 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQ-PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred Hhhc-HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 0000 0000000000 00 00011123567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=308.13 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=201.5
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.|+..+.||+|+||.||+|.+. ++..||+|...... ....+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 4666788999999999999864 46789999876432 344567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKPG----PLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 999999988642 4889999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
......++..|+|||++.+..++.++|||||||+++||++|+.||........ ... +.......
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-------~~~---------~~~~~~~~ 220 (277)
T cd06642 157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV-------LFL---------IPKNSPPT 220 (277)
T ss_pred hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH-------Hhh---------hhcCCCCC
Confidence 12234578899999999988999999999999999999999999875433221 000 11111112
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.....+..+.+++.+||+.+|++||++.+++..
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 223445678999999999999999999999873
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=305.71 Aligned_cols=240 Identities=24% Similarity=0.407 Sum_probs=191.6
Q ss_pred CcccccCcEEEEEEEecC--------CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 97 RILGQGGQGTVYKGMLAD--------GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+.||+|+||.||+|.... ...+++|..........+.+.+|+.+++.++|||++++++++......++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 224788877655455567889999999999999999999999998999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc--------EEEeecCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR--------AKVSDFGAS 240 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--------~kl~Dfgl~ 240 (419)
+++|+|.+++..... .+++..++.++.||+.||.|||+.+ ++||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKNKN--LINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 999999999986543 4889999999999999999999998 999999999999987765 699999988
Q ss_pred eecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCC-CCCCCCChhhhccHHHHHHHHhcccch
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQ-KPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .||...+......
T Consensus 156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-------------- 216 (258)
T cd05078 156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-------------- 216 (258)
T ss_pred cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH--------------
Confidence 654321 22457889999999986 45799999999999999999984 6665443322100
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.... ....+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 217 --~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 217 --FYED--RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --HHHc--cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000 11122233456899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=303.72 Aligned_cols=253 Identities=26% Similarity=0.339 Sum_probs=191.0
Q ss_pred CcccccCcEEEEEEEecC---CCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 97 RILGQGGQGTVYKGMLAD---GGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
+.||+|+||.||+|...+ ...+++|...... ......+.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 359999999999997543 3468888765432 334567889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce-
Q 014725 173 TLYHYLHDQTE--EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH- 249 (419)
Q Consensus 173 ~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~- 249 (419)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976432 123567788899999999999999998 999999999999999999999999998654322211
Q ss_pred eeecccccCCccCcccccc-------CCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 250 LTTRVQGTFGYLDPEYFRS-------SQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~-------~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
......++..|+|||++.. ..++.++|||||||++|||++ |..||......+. ......... ...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~~~-~~~ 230 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVREQD-IKL 230 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhhccC-ccC
Confidence 1122345678999998743 356889999999999999999 7888876543321 011111110 000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.....+...+..+.+++..|| .+|++|||+.+|++.|.
T Consensus 231 ----~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 231 ----PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred ----CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 011122334456778888898 59999999999998873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=300.56 Aligned_cols=249 Identities=23% Similarity=0.340 Sum_probs=203.9
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|++.+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999996 45788999987642 334456889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999999876432 24789999999999999999999998 99999999999999999999999999976543221
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
. .....|++.|+|||++.+..++.++|+|||||++++|++|+.||...+..+. +...... ...
T Consensus 157 ~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~~----------~~~ 219 (256)
T cd08218 157 L-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIRG----------SYP 219 (256)
T ss_pred h-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhcC----------CCC
Confidence 1 2234578899999999988899999999999999999999999975443221 1111110 011
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+......+.+++.+||+.+|++||++.+|++
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 223344567999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=316.94 Aligned_cols=261 Identities=22% Similarity=0.287 Sum_probs=196.6
Q ss_pred HHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecC-----
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLES----- 159 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 159 (419)
...++|.+.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 4567899999999999999999996 457789999876432 23345678999999999999999999987543
Q ss_pred -CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 160 -EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
...++++|++ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ----KLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999988 78998887642 4899999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHH--------
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF-------- 309 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-------- 309 (419)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+........
T Consensus 164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (343)
T cd07878 164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEV 239 (343)
T ss_pred cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 99865432 233468999999999876 57899999999999999999999999765432211000000
Q ss_pred HHHhcccchhHHHHHhhccCCC--------HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 310 LQAMNEDRLFEVLEARVLKEGK--------EEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
............+.. . ...+ ......+.+++.+||+.||.+|||+.+++..
T Consensus 240 ~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 240 LKKISSEHARKYIQS-L-PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHhcchhhHHHHhhc-c-ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000000000000 0 0000 0112357799999999999999999999863
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=301.76 Aligned_cols=249 Identities=27% Similarity=0.413 Sum_probs=196.3
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-----hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Ccc
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-----ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVP 162 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 162 (419)
.+|...+.||+|+||.||+|... .+..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 46889999999999999999964 57899999875321 23346788999999999999999999998753 567
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++++||+++++|.+++.... .+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 89999999999999997643 4788999999999999999999998 99999999999999999999999999876
Q ss_pred cccCCc--eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 243 IKVDQT--HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 243 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||...+.... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~--------- 220 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFK--------- 220 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHH---------
Confidence 532111 111234578899999999988899999999999999999999999975533221 111
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+......+..++ +||..+|++||++.||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 221 IATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred HhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 0000011122333345566676 788899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=302.77 Aligned_cols=253 Identities=26% Similarity=0.387 Sum_probs=201.7
Q ss_pred CccccCcccccCcEEEEEEEecC--CCEEEEEEcccC----------ChhhHHHHHHHHHHHhc-CCCcccccEEeEEec
Q 014725 92 NYNANRILGQGGQGTVYKGMLAD--GGIVAVKKSKLV----------DESNVEQFINEVVILSQ-INHRNVVKLLGCCLE 158 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~ 158 (419)
+|.+.+.||+|+||.||+|.+.. +..+|+|.+... ......++.+|+.++.+ ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999754 678999976532 22334567788888875 699999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCCcEEEee
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKYRAKVSD 236 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~D 236 (419)
++..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988542 223358999999999999999999996 56 99999999999999999999999
Q ss_pred cCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 237 FGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 237 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
||++....... ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ .....
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~-------~~~~~-- 226 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL-------ATKIV-- 226 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH-------HHHHh--
Confidence 99998754332 23345688999999999988899999999999999999999999975443221 00000
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
...............+.+++.+||+.||++||++.|+..+++
T Consensus 227 ------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 227 ------EAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ------hccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000001111123457899999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=320.24 Aligned_cols=246 Identities=28% Similarity=0.405 Sum_probs=204.2
Q ss_pred cccccCcEEEEEEEecCC-CEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCHHH
Q 014725 98 ILGQGGQGTVYKGMLADG-GIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYH 176 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 176 (419)
.||+|+||+||.|++.++ ..+|||.+...+....+.+.+|+.+-++|+|.|||+++|.+.+++..-+.||-++||+|.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 599999999999997654 4689999888777777889999999999999999999999999999999999999999999
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCceecccCCceeeeccc
Q 014725 177 YLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTHLTTRVQ 255 (419)
Q Consensus 177 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 255 (419)
+|+..=+...-++.++-.+..||++||.|||++. |||||||-+|+|++ -.|.+||+|||-++.+..- .....++.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~TETFT 737 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCTETFT 737 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Cccccccc
Confidence 9987543212277888889999999999999999 99999999999995 5789999999999876422 22345667
Q ss_pred ccCCccCccccccC--CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHH
Q 014725 256 GTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEE 333 (419)
Q Consensus 256 gt~~y~aPE~~~~~--~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (419)
||.-|||||++..+ .|+.++|||||||++.||.||++||......... .+ ++-.-..-++.|.+
T Consensus 738 GTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA----MF----------kVGmyKvHP~iPee 803 (1226)
T KOG4279|consen 738 GTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA----MF----------KVGMYKVHPPIPEE 803 (1226)
T ss_pred cchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh----hh----------hhcceecCCCCcHH
Confidence 99999999999764 5889999999999999999999999755433211 01 00001112455677
Q ss_pred HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 334 EIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 334 ~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+...++.+|+.++|.+||++++++.
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 7888999999999999999999999986
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=303.27 Aligned_cols=268 Identities=24% Similarity=0.374 Sum_probs=203.9
Q ss_pred HHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC--CCcccccEEeEEecCC----
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI--NHRNVVKLLGCCLESE---- 160 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~~---- 160 (419)
....+...+.+.||+|.||.||+|.++ |+.||||++...++ ..+.+|.++.+.+ +|+||+.+++.-..+.
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 344566788899999999999999996 88899999986544 5678888888865 9999999998765433
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-----cCCCCeeecCCCCCcEEECCCCcEEEe
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-----ATSIPIYHRDIKSSNILLDDKYRAKVS 235 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~iiH~Dlkp~Nill~~~~~~kl~ 235 (419)
.+|||.+|.+.|||.|||.+. .++....++++..+|.||++||. +|.+.|.|||||+.|||+..++...|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 568999999999999999874 38899999999999999999995 567889999999999999999999999
Q ss_pred ecCCceecccCCcee---eecccccCCccCccccccCC----C--CcccceechhHHHHHHHhC----------CCCCCC
Q 014725 236 DFGASRTIKVDQTHL---TTRVQGTFGYLDPEYFRSSQ----F--TEKSDVYSFGVVLVELLTG----------QKPIRS 296 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~----~--s~~~Di~slG~~l~el~tg----------~~p~~~ 296 (419)
|+|||.......... ....+||.+|||||++...- + -..+||||||.|+||++.. +.||..
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 999998765443222 34567999999999986531 1 2469999999999999763 345543
Q ss_pred CChhhhccHHHHHHHHhcccchhHHHHHhh-ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 297 TDAEEDRSLVGFFLQAMNEDRLFEVLEARV-LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.-+.+. ..+.....+-.++ +.+.+ ..-...+....+.+|++.||..+|.-|-|+--+-+.|.++..
T Consensus 439 ~Vp~DP--s~eeMrkVVCv~~----~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDP--SFEEMRKVVCVQK----LRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCCCC--CHHHHhcceeecc----cCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 322111 0000110000001 01111 112234667789999999999999999999999999888753
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=306.54 Aligned_cols=263 Identities=25% Similarity=0.362 Sum_probs=206.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|++.+.||+|+||+||++... ++..+|+|..... .....+.+.+|+++++.++||||+++++++......++|||
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 356888899999999999999964 5778999986643 23445788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
|+++++|.+++.... ++++..+..++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~ 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG---PIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS 157 (284)
T ss_pred cCCCCCHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh
Confidence 999999999987643 48999999999999999999997 46 999999999999999999999999998654221
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHH-HHHHHHhcccchhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV-GFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 325 (419)
. .....|+..|+|||++.+..++.++|||||||++++|+||..||......+..... ..+.. .+.......
T Consensus 158 ~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~ 229 (284)
T cd06620 158 I---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILD-----LLQQIVQEP 229 (284)
T ss_pred c---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHH-----HHHHHhhcc
Confidence 1 12346899999999998889999999999999999999999999865442211000 00000 001111110
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.........+..+.+++.+||+.+|.+|||+.|+++...-+
T Consensus 230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~ 270 (284)
T cd06620 230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270 (284)
T ss_pred CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence 01111122556789999999999999999999999865443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=316.01 Aligned_cols=192 Identities=26% Similarity=0.450 Sum_probs=164.4
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
...+|.+.+.||+|+||.||+|... ++..||+|.... .....|+.++++++||||+++++++.+....++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~------~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK------GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc------cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 4567999999999999999999975 456889997432 223568999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
++. ++|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTKRSR--PLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 994 688888876433 5899999999999999999999998 999999999999999999999999999753221
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCC
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~ 294 (419)
.......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1223456899999999999999999999999999999999965554
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=320.49 Aligned_cols=262 Identities=23% Similarity=0.297 Sum_probs=200.5
Q ss_pred HhcCccccCcccccCcEEEEEEEec---CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA---DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
...+|.+.+.||+|+||.||++... .+..||+|..... ....+|+.+++.++||||+++++++......+++
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 3467999999999999999999853 3467899987542 2356899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
||++. ++|.+++... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.++|+|||+++....
T Consensus 165 ~e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~ 237 (392)
T PHA03207 165 MPKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDA 237 (392)
T ss_pred ehhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCc
Confidence 99995 6888888433 25899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc-------
Q 014725 246 DQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR------- 317 (419)
Q Consensus 246 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------- 317 (419)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+............+........
T Consensus 238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred ccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 3221 22345689999999999999999999999999999999999999976544322111111211111100
Q ss_pred ---hhHHHHH---hhccCC--C-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 318 ---LFEVLEA---RVLKEG--K-----EEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 318 ---~~~~~~~---~~~~~~--~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
+...... ...... + ......+.+++.+||..+|.+|||+.|++..
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 0000000 000000 0 1123467889999999999999999999875
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=307.24 Aligned_cols=197 Identities=24% Similarity=0.403 Sum_probs=160.9
Q ss_pred cCcccccCcEEEEEEEec---CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEec--CCcceEEEeecC
Q 014725 96 NRILGQGGQGTVYKGMLA---DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE--SEVPLLVYEFIP 170 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 170 (419)
.+.||+|+||+||+|... ++..+|+|.+.... ....+.+|+.+++.++||||+++++++.. +...+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 467999999999999964 45789999876432 23457889999999999999999998864 345789999985
Q ss_pred CCCHHHHhhccC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----CCCCcEEEeecCCc
Q 014725 171 NGTLYHYLHDQT------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL----DDKYRAKVSDFGAS 240 (419)
Q Consensus 171 ~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfgl~ 240 (419)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 58888875321 1235889999999999999999999999 9999999999999 45678999999999
Q ss_pred eecccCCc--eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCC
Q 014725 241 RTIKVDQT--HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298 (419)
Q Consensus 241 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~ 298 (419)
+....... .......||+.|+|||++.+ ..++.++||||+||+++||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643221 12234568999999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=316.79 Aligned_cols=261 Identities=24% Similarity=0.332 Sum_probs=198.9
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-----
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES----- 159 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 159 (419)
...++|.+.+.||+|+||.||++... .++.||||++... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 34678999999999999999999964 5778999987642 334456788999999999999999999987543
Q ss_pred -CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 160 -EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
...++||||+++ +|.+++.. .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG 171 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFG 171 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-----cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCC
Confidence 346999999964 77777753 3788889999999999999999998 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc--
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED-- 316 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-- 316 (419)
+++..... .......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.. ..+.......
T Consensus 172 ~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~ 246 (364)
T cd07875 172 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGTPCP 246 (364)
T ss_pred CccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCH
Confidence 99764322 1223456899999999999999999999999999999999999999876643321 1111100000
Q ss_pred chhH--------HHHHhh--------------c----cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 317 RLFE--------VLEARV--------------L----KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 317 ~~~~--------~~~~~~--------------~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.... ...... . ..........+.+++.+||+.||.+|||+.++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 0000 000000 0 00011123467899999999999999999999763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=315.24 Aligned_cols=240 Identities=25% Similarity=0.291 Sum_probs=186.5
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC---CCcccccEEeEEecCCcceEEEeecCC
Q 014725 99 LGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI---NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
||+|+||+||+|... ++..||+|.+... .......+..|..++... +||||+++++++.+....++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999964 5789999987532 122334455677776655 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~---~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~ 153 (330)
T cd05586 81 GELFWHLQKEG---RFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT 153 (330)
T ss_pred ChHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence 99999987543 4899999999999999999999999 9999999999999999999999999987543221 223
Q ss_pred ecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCC
Q 014725 252 TRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (419)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||...+..+. ........ . ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~-------~~~i~~~~--------~-~~~ 217 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM-------YRNIAFGK--------V-RFP 217 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH-------HHHHHcCC--------C-CCC
Confidence 345689999999998754 489999999999999999999999976543321 11111000 0 000
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCC----HHHHHH
Q 014725 331 KEEEIITVAMLGKRCLNMIGKKRPS----MKEVAF 361 (419)
Q Consensus 331 ~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~ 361 (419)
.......+.+++.+||+.+|.+||+ +.++++
T Consensus 218 ~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 218 KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 1123456789999999999999995 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=309.37 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=202.2
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh---hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE---SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|+..+.||+|+||.||+|... ++..+|+|....... ...+.+.+|+++++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 46888999999999999999975 488999998764322 24567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+.+++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQPG-KCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCCC-CccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 99999999999875432 35899999999999999999999998 999999999999999999999999998754321
Q ss_pred Cce----------------------------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCC
Q 014725 247 QTH----------------------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298 (419)
Q Consensus 247 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~ 298 (419)
... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 110 1112457889999999998889999999999999999999999997655
Q ss_pred hhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC----HHHHHH
Q 014725 299 AEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS----MKEVAF 361 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt----~~evl~ 361 (419)
.... + ..+.............+..+.+++.+||+.+|++||+ +.+++.
T Consensus 237 ~~~~------~---------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDET------F---------SNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHH------H---------HHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 4321 1 1111111111111224667999999999999999999 555544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=329.09 Aligned_cols=265 Identities=19% Similarity=0.262 Sum_probs=194.4
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC------cccccEEeEEe
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINH------RNVVKLLGCCL 157 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~ 157 (419)
++...+++|++.+.||+|+||+||+|.+. .++.||||+++.... ....+..|+.+++.++| ++++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~-~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK-YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh-hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 34455788999999999999999999964 467899999864322 23445667777766654 45888999887
Q ss_pred cC-CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCC-----
Q 014725 158 ES-EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKY----- 230 (419)
Q Consensus 158 ~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~----- 230 (419)
.. ...++|||++ +++|.+++.+.. .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMKHG---PFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccc
Confidence 54 4678999988 778998887643 58999999999999999999998 47 99999999999998765
Q ss_pred -----------cEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCCh
Q 014725 231 -----------RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299 (419)
Q Consensus 231 -----------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~ 299 (419)
.+||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred ccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 49999999876422 223446799999999999999999999999999999999999999987665
Q ss_pred hhhccHHHHHHHHhc--------ccchhHHHHHh--------------hccCC---CHHHHHHHHHHHHHHhccCCCCCC
Q 014725 300 EEDRSLVGFFLQAMN--------EDRLFEVLEAR--------------VLKEG---KEEEIITVAMLGKRCLNMIGKKRP 354 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~--------------~~~~~---~~~~~~~l~~li~~cl~~~p~~RP 354 (419)
.+............. ........... ..... .......+.+|+.+||+.||.+||
T Consensus 351 ~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 430 (467)
T PTZ00284 351 LEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRL 430 (467)
T ss_pred HHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCC
Confidence 432222111110000 00000000000 00000 001134578999999999999999
Q ss_pred CHHHHHH
Q 014725 355 SMKEVAF 361 (419)
Q Consensus 355 t~~evl~ 361 (419)
|+.|+++
T Consensus 431 ta~e~L~ 437 (467)
T PTZ00284 431 NARQMTT 437 (467)
T ss_pred CHHHHhc
Confidence 9999986
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=301.38 Aligned_cols=255 Identities=29% Similarity=0.476 Sum_probs=200.2
Q ss_pred ccccCcccccCcEEEEEEEec----CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC------
Q 014725 93 YNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESE------ 160 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 160 (419)
|.+.+.||+|+||.||+|.+. .+..+|+|.+... .....+++.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567789999999999999853 3578999987643 3445677899999999999999999999886532
Q ss_pred cceEEEeecCCCCHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQT---EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF 237 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 237 (419)
..++++||+++|+|.+++.... ....+++...+.++.|++.||+|||+.+ ++||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2368899999999998875321 2235788999999999999999999998 999999999999999999999999
Q ss_pred CCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 238 GASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 238 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
|+++........ ......+++.|++||.+....++.++|||||||++|||++ |+.||...+..+. ..... ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~---~~~~~---~~ 231 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI---YNYLI---KG 231 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH---HHHHH---cC
Confidence 999865432211 1222345678999999998889999999999999999999 8899876544321 11110 00
Q ss_pred cchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 316 DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
. ....+...+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 232 ~----------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 232 N----------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred C----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0111223446799999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=317.57 Aligned_cols=201 Identities=29% Similarity=0.406 Sum_probs=175.2
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-C-----cccccEEeEEecCCcceE
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQIN-H-----RNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~l 164 (419)
+|.+.+.||+|+||.|-+|.+. +++.||||+++.... -..+...|+.+|..|+ | -|+|+++++|...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 8999999999999999999964 588999999986543 3466788999999997 4 389999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC--CcEEEeecCCcee
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK--YRAKVSDFGASRT 242 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfgl~~~ 242 (419)
|+|.+ ..+|.++++.+.-. .++...+..++.||+.||.+||+.+ |||+||||+||||.+- ..+||+|||.++.
T Consensus 266 VfELL-~~NLYellK~n~f~-Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKFR-GLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99999 56999999986544 4899999999999999999999999 9999999999999543 3799999999987
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhh
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 302 (419)
....- ...+.+..|.|||++.+.+|+.+.||||||||+.||++|.+-|.+.++.+.
T Consensus 341 ~~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQ 396 (586)
T KOG0667|consen 341 ESQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQ 396 (586)
T ss_pred cCCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHH
Confidence 54221 245678899999999999999999999999999999999888888776654
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=299.18 Aligned_cols=249 Identities=27% Similarity=0.389 Sum_probs=197.9
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-----hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Ccc
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-----ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVP 162 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 162 (419)
.+|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47889999999999999999964 57899999865321 23356788999999999999999999998764 457
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+++|||+++++|.+++.... .+++....+++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 89999999999999987543 3788889999999999999999999 99999999999999999999999999876
Q ss_pred cccCCc--eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 243 IKVDQT--HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 243 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
...... .......++..|+|||++.+..++.++|||||||++|||++|+.||........ .. +
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~---------~ 220 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IF---------K 220 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HH---------H
Confidence 532111 112234588899999999888899999999999999999999999975432221 00 0
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+......+.+++.+|+. +|.+||++.+|++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 221 IATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred HhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 000111122334455678889999995 9999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=337.26 Aligned_cols=259 Identities=23% Similarity=0.368 Sum_probs=200.6
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC--
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES-- 159 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-- 159 (419)
+.+...++|.+.+.||+|+||+||+|.+. .+..+|+|.+... .......+..|+.+++.++||||++++++|.+.
T Consensus 7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 34455678999999999999999999975 4567888887642 344557789999999999999999999988643
Q ss_pred CcceEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC----CCeeecCCCCCcEEECC------
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATS----IPIYHRDIKSSNILLDD------ 228 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~----~~iiH~Dlkp~Nill~~------ 228 (419)
...|+||||+++++|.++|.... ....+++..++.|+.||+.||.|||+.+. .+|+||||||+||||+.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 46799999999999999997632 22358999999999999999999998542 23999999999999964
Q ss_pred -----------CCcEEEeecCCceecccCCceeeecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCC
Q 014725 229 -----------KYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIR 295 (419)
Q Consensus 229 -----------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~ 295 (419)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||+||||+||..||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 2358999999998654221 2234568999999999854 458899999999999999999999997
Q ss_pred CCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 296 STDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....... ....+. ... .......+..+.+|+..||+.+|.+||++.+++.
T Consensus 245 ~~~~~~q------li~~lk---------~~p-~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 245 KANNFSQ------LISELK---------RGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred cCCcHHH------HHHHHh---------cCC-CCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 5433211 111111 000 0011223456899999999999999999999984
|
|
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=321.69 Aligned_cols=261 Identities=24% Similarity=0.339 Sum_probs=196.3
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..+|.+.+.||+|+||.||+|.+. .++.||||.... ..+.+|++++++++||||+++++++...+..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 347999999999999999999975 467899996432 3467899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+. ++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 242 ~~-~~L~~~l~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 242 YR-SDLYTYLGARLR--PLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred cC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 94 789888875432 5899999999999999999999998 99999999999999999999999999986543221
Q ss_pred e-eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCC-hhhhccHHHHHHHHhccc----------
Q 014725 249 H-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD-AEEDRSLVGFFLQAMNED---------- 316 (419)
Q Consensus 249 ~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~-~~~~~~~~~~~~~~~~~~---------- 316 (419)
. ......||..|+|||++.+..++.++|||||||++|||++|..|+-... ..........+.+.+...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 2234569999999999999999999999999999999999887653322 111111111111111100
Q ss_pred ---chhHHHHHhh----ccCCC-------HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 317 ---RLFEVLEARV----LKEGK-------EEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 317 ---~~~~~~~~~~----~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
++........ ..... ......+.+|+.+||+.||.+|||+.|+++.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0000000000 00000 0112357889999999999999999999863
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=297.35 Aligned_cols=248 Identities=26% Similarity=0.410 Sum_probs=201.9
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|+..+.||+|+||.||++.. .+++.+|+|.+... .....+.+.+|+.+++.++|||++++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 588899999999999999996 45778999987543 234467889999999999999999999999989999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfgl~~~~~~~~ 247 (419)
+++++|.+++..... ..+++..++.++.+++.||.|||+++ ++|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRCN-SLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 999999999976432 34889999999999999999999998 9999999999999855 468999999998754322
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
......++..|+|||.+.+..++.++||||||+++++|++|+.||...+.... ..... ....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~------~~~~~----------~~~~ 218 (256)
T cd08220 157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL------VLKIM----------SGTF 218 (256)
T ss_pred --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH------HHHHH----------hcCC
Confidence 12234578899999999988899999999999999999999999976543221 11110 0011
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+......+.+++.+||+.+|.+|||+.+++.
T Consensus 219 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1122334567899999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=300.12 Aligned_cols=253 Identities=21% Similarity=0.305 Sum_probs=189.5
Q ss_pred CcccccCcEEEEEEEecCCC---EEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 97 RILGQGGQGTVYKGMLADGG---IVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~---~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
+.||+|+||.||+|...++. .+++|...... ....+.+.+|+.+++.++||||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 35999999999999854433 46677665432 344578999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC-cee
Q 014725 173 TLYHYLHDQTE-EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ-THL 250 (419)
Q Consensus 173 ~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~ 250 (419)
+|.+++.+... ....++..+..++.||+.||.|||+.+ ++||||||+|||++.++.++|+|||++....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 99999986432 224667778899999999999999998 9999999999999999999999999986432111 112
Q ss_pred eecccccCCccCcccccc-------CCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 251 TTRVQGTFGYLDPEYFRS-------SQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~-------~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||......+. +....... .....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~~-~~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVIKDQ-QVKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHhhc-ccccC
Confidence 234457889999998753 245789999999999999997 5778865443221 11111111 11111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
++ .........+.+++..|| .+|++||++.+|++.|.
T Consensus 231 ~~----~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KP----QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CC----ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11 111223456788999999 67999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=305.99 Aligned_cols=265 Identities=25% Similarity=0.332 Sum_probs=203.6
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|++.+.||+|+||.||+|.+. +++.||+|.++.. .....+.+.+|+++++.++|+||+++++++...+..+++||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 46889999999999999999975 4778999987642 33345778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|++++.+..+..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999877766554432 4889999999999999999999998 9999999999999999999999999998765443
Q ss_pred ceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc--------cc-
Q 014725 248 THLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE--------DR- 317 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------~~- 317 (419)
........++..|+|||++.+. .++.++||||||+++|+|++|+.||......+.............. ..
T Consensus 155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 3233445678899999999887 8899999999999999999999999765443211111100000000 00
Q ss_pred -----hhHHHHH-hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 -----LFEVLEA-RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 -----~~~~~~~-~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+.... ......+...+..+.+++.+||..+|++||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 0000000 0000112223577999999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=298.30 Aligned_cols=249 Identities=27% Similarity=0.443 Sum_probs=202.1
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|.+.+.||+|+||.||+|... +++.+++|.+..... ...+.+.+|+.+++.++|+||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 5888999999999999999964 678999998765443 3677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHGR---ILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhcC---CCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 99999999997643 4788899999999999999999999 99999999999999999999999999987654332
Q ss_pred eeee---cccccCCccCccccccCC---CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 249 HLTT---RVQGTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 249 ~~~~---~~~gt~~y~aPE~~~~~~---~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
.... ...++..|+|||++.+.. ++.++||||||++++++++|..||...+.... . ... ...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~--~~~-~~~------- 221 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---I--MFH-VGA------- 221 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---H--HHH-Hhc-------
Confidence 2211 345788999999998766 88999999999999999999999975432111 0 000 000
Q ss_pred HHhhccCCCH--HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLKEGKE--EEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~--~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
......+. .....+.+++.+||+.+|.+|||+.+++.
T Consensus 222 --~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 --GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred --CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00111111 22556789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=305.83 Aligned_cols=263 Identities=23% Similarity=0.323 Sum_probs=203.9
Q ss_pred cCHHHHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEe-
Q 014725 81 FTKMDLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCL- 157 (419)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~- 157 (419)
..++.+....++|++.+.||+|+||.||++... ++..+|+|....... ....+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 334667778899999999999999999999964 567899998764322 235688899999999 6999999999884
Q ss_pred ----cCCcceEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcE
Q 014725 158 ----ESEVPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA 232 (419)
Q Consensus 158 ----~~~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 232 (419)
.++..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 3456799999999999999886421 2235888999999999999999999998 9999999999999999999
Q ss_pred EEeecCCceecccCCceeeecccccCCccCcccccc-----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHH
Q 014725 233 KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 307 (419)
+|+|||+++....... ......|++.|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~----- 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA----- 237 (286)
T ss_pred EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----
Confidence 9999999886543221 2233458999999998753 4578899999999999999999999976543221
Q ss_pred HHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
... ...... . ....+......+.+++.+||+.+|++|||+.||++.
T Consensus 238 -~~~-~~~~~~-----~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 238 -LFK-IPRNPP-----P--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred -Hhh-ccccCC-----C--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000 000000 0 001112233468899999999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=306.49 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=199.8
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
|.....||+|+||.||++... ++..||||.+........+.+.+|+..++.++||||+++++.+...+..++||||+++
T Consensus 24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~ 103 (292)
T cd06658 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103 (292)
T ss_pred HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCC
Confidence 344467999999999999964 5788999988765555667899999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
++|.+++... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.++|+|||++........ ..
T Consensus 104 ~~L~~~~~~~----~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~ 175 (292)
T cd06658 104 GALTDIVTHT----RMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KR 175 (292)
T ss_pred CcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cC
Confidence 9999988543 3789999999999999999999998 99999999999999999999999999875432221 12
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....|+..|+|||.+.+..++.++||||||++++||++|+.||......... .... ....... ...
T Consensus 176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~-------~~~~-----~~~~~~~--~~~ 241 (292)
T cd06658 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM-------RRIR-----DNLPPRV--KDS 241 (292)
T ss_pred ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHH-----hcCCCcc--ccc
Confidence 3345889999999998888999999999999999999999999765432210 0000 0000000 011
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
......+..++.+||..+|.+|||+.++++.
T Consensus 242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1234468889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=309.35 Aligned_cols=261 Identities=20% Similarity=0.257 Sum_probs=194.1
Q ss_pred ccCccccc--CcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 95 ANRILGQG--GQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 95 ~~~~ig~G--~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
+.++||+| +||+||++.. .++..||+|++... .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 7899999986 46788999988653 2334466788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++|+|.+++...... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++++||+...........
T Consensus 82 ~~~~l~~~~~~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHFMD-GMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhccC-CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 999999999754322 4889999999999999999999998 999999999999999999999999865433211110
Q ss_pred ------eeecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc-------
Q 014725 250 ------LTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN------- 314 (419)
Q Consensus 250 ------~~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~------- 314 (419)
......++..|+|||++.+ ..++.++|||||||+++||++|+.||........ ..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 235 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTT 235 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccc
Confidence 1122346778999999876 4689999999999999999999999975433211 0000000000
Q ss_pred --ccc-------------hhHHHH---------HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 --EDR-------------LFEVLE---------ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 --~~~-------------~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+. +.+... ..............+.+++.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 000 000000 00000111223457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=298.51 Aligned_cols=256 Identities=26% Similarity=0.409 Sum_probs=205.6
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|++.+.||.|+||+||+|... ++..+++|...... ......+.+|++.++.++|+|++++++.+......+++||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47899999999999999999964 57789999876432 23567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++........+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999986543235899999999999999999999998 99999999999999999999999999876654322
Q ss_pred e---eeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 249 H---LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 249 ~---~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
. ......|+..|+|||++... .++.++|+|||||++++|++|+.||........ +....... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~~~------~~ 225 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV------LMLTLQND------PP 225 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh------HHHHhcCC------CC
Confidence 2 22344688999999998776 789999999999999999999999976543221 11111100 00
Q ss_pred hhccCC-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEG-KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...... ....+..+.+++.+||+.+|++||++.+|++
T Consensus 226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 1244567899999999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=298.00 Aligned_cols=251 Identities=27% Similarity=0.399 Sum_probs=203.1
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEec--CCcceEEE
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLE--SEVPLLVY 166 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 166 (419)
+|++.+.||+|+||.||++.. .++..+|+|.+.. ......+.+.+|+.+++.++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478889999999999999996 4577899998754 234455678899999999999999999998764 34578999
Q ss_pred eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 167 EFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLH-----SATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH-----~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
||+++++|.+++.... ....+++..++.++.|++.||.||| +.+ ++|+||+|+||+++.++.+||+|||++
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccc
Confidence 9999999999997632 2346899999999999999999999 666 999999999999999999999999999
Q ss_pred eecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
......... .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+... ..+..
T Consensus 158 ~~~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~------- 222 (265)
T cd08217 158 KILGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKI------- 222 (265)
T ss_pred ccccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHH-------
Confidence 876533321 233458999999999998889999999999999999999999998655322 11111
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
........+...+..+.+++.+|++.+|.+||++.+|++.
T Consensus 223 --~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 223 --KEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1111122334556679999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=299.57 Aligned_cols=252 Identities=25% Similarity=0.465 Sum_probs=202.8
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC------hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD------ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
+|+..+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 478889999999999999995 567899999876422 1235678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCceec
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTI 243 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~ 243 (419)
||||+++++|.+++.+.. ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG---AFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 999999999999997643 5889999999999999999999998 99999999999998776 5999999998776
Q ss_pred ccCCce---eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 244 KVDQTH---LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 244 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
...... ......++..|+|||.+.+..++.++||||+|+++++|++|..||......... ... .+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~~---------~~ 222 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---ALI---------FK 222 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HHH---------HH
Confidence 432111 122345788999999998888999999999999999999999999654322110 000 01
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+......+.+++.+||..+|.+||++.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 223 IASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred HhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11111122334455677899999999999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=302.89 Aligned_cols=259 Identities=22% Similarity=0.356 Sum_probs=203.2
Q ss_pred CHHHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEec-
Q 014725 82 TKMDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLE- 158 (419)
Q Consensus 82 ~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~- 158 (419)
+..++....+.|++.+.||+|+||.||+|.. .+++.+|+|...... .....+..|+.+++++ +||||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 3455556778999999999999999999997 457789999876543 3346688899999998 79999999999853
Q ss_pred -----CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEE
Q 014725 159 -----SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAK 233 (419)
Q Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 233 (419)
....+++|||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 4567999999999999999976432 24788889999999999999999998 99999999999999999999
Q ss_pred EeecCCceecccCCceeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH
Q 014725 234 VSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF 308 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 308 (419)
|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|..||.........
T Consensus 162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----- 235 (282)
T cd06636 162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----- 235 (282)
T ss_pred EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-----
Confidence 999999876432211 123345889999999875 346788999999999999999999999754432211
Q ss_pred HHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
................+..+.+++.+||+.+|.+|||+.||++
T Consensus 236 ----------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 236 ----------FLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ----------hhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000111111112234567999999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=289.91 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=201.6
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++.|++.+.||+|.|+.||++.. ..|+.+|+|.+.. ......+++.+|+.+.+.|+||||+++.+...+.+..|+|
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 456788889999999999999885 4577888887543 2334678899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEEeecCCcee
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKVSDFGASRT 242 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl~~~ 242 (419)
+|+++|++|..-+-.. ...++...-..+.||+.+|.|+|.++ |||||+||+|+++-+ ..-+||+|||++..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 9999999997766543 34778888889999999999999999 999999999999943 34599999999998
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
+. +........|||+|||||+++..+|+..+|||+-||+||-|+.|.+||.+.+... +.+-+
T Consensus 163 l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r----------------lye~I 224 (355)
T KOG0033|consen 163 VN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR----------------LYEQI 224 (355)
T ss_pred eC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH----------------HHHHH
Confidence 76 3444456779999999999999999999999999999999999999998744322 11111
Q ss_pred HHhhcc---CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLK---EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...-.. ..-....+...+|+++||..||.+|.|+.|.++
T Consensus 225 ~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 225 KAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred hccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 111100 011223456788999999999999999877654
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=302.98 Aligned_cols=264 Identities=25% Similarity=0.317 Sum_probs=200.4
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|+..+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 47889999999999999999975 57899999875432 2234568899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|..++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNPR---GVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999988888765432 4899999999999999999999998 9999999999999999999999999998764332
Q ss_pred ceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh--------cccch
Q 014725 248 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM--------NEDRL 318 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~ 318 (419)
. ......++..|+|||.+.+ ..++.++||||||+++++|++|..||......+............ .....
T Consensus 155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T cd07847 155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233 (286)
T ss_pred c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence 1 1223357889999999876 567899999999999999999999998765433211111000000 00000
Q ss_pred hHHH-HHhhccC-----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVL-EARVLKE-----GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~-~~~~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.... .+..... ........+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000 0000000 00122456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.48 Aligned_cols=252 Identities=28% Similarity=0.397 Sum_probs=203.2
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|+..+.||+|+||.||++.+. +++.+|+|.+.... ....+.+.+|++++++++||||+++++++......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 36788899999999999999975 57889999876542 34556789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
+++++|.+++.... ..+++..+..++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999998653 358899999999999999999999 77 9999999999999999999999999987653221
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
.. ...++..|+|||.+.+..++.++||||||+++++|++|..||...+.... ........... . ..
T Consensus 156 ~~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~---------~-~~ 221 (265)
T cd06605 156 AK---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVN---------E-PP 221 (265)
T ss_pred hh---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhc---------C-CC
Confidence 11 15688899999999988999999999999999999999999975532111 11111111100 0 01
Q ss_pred cCCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 328 KEGKEE-EIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 328 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+.. ....+.+++.+||..+|++|||+.+++.
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 111222 4567899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=307.18 Aligned_cols=197 Identities=24% Similarity=0.407 Sum_probs=160.2
Q ss_pred cCcccccCcEEEEEEEecC---CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEec--CCcceEEEeecC
Q 014725 96 NRILGQGGQGTVYKGMLAD---GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE--SEVPLLVYEFIP 170 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~ 170 (419)
...||+|+||.||+|...+ +..||+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 3579999999999999643 4689999876432 23467889999999999999999999854 456789999986
Q ss_pred CCCHHHHhhcc------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----CCCCcEEEeecCCc
Q 014725 171 NGTLYHYLHDQ------TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL----DDKYRAKVSDFGAS 240 (419)
Q Consensus 171 ~g~L~~~l~~~------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfgl~ 240 (419)
++|.+++... .....+++..+..++.|++.||.|||+.+ ++||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5787777532 11235889999999999999999999998 9999999999999 56678999999999
Q ss_pred eecccCCce--eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCC
Q 014725 241 RTIKVDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298 (419)
Q Consensus 241 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~ 298 (419)
+........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 876432211 1234568999999999876 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=300.72 Aligned_cols=261 Identities=24% Similarity=0.318 Sum_probs=202.5
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|++.+.||+|+||.||+|.+. ++..||+|+..... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 5888999999999999999964 67899999876533 33456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+ +++|.+++.... .++++.+++.++.||+.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999987644 35899999999999999999999998 99999999999999999999999999987654332
Q ss_pred eeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc----------
Q 014725 249 HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR---------- 317 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------- 317 (419)
.......++..|+|||.+.+. .++.++||||+|++++||+||..||........ ............
T Consensus 155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07832 155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSL 231 (286)
T ss_pred CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCc
Confidence 223344688999999998654 468999999999999999999888866543221 111111111000
Q ss_pred --hhHHHHHhh----ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 --LFEVLEARV----LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 --~~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+..+..... ......+....+.+++.+||+.+|.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 232 PDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred chhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000 00001123467899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=304.45 Aligned_cols=263 Identities=24% Similarity=0.338 Sum_probs=200.3
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|++.+.||+|+||.||+|.+. +++.+|+|...... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999975 47899999865422 2235678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|..+..... .+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYPN---GLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 999999988766432 3899999999999999999999998 9999999999999999999999999988654332
Q ss_pred ceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH----
Q 014725 248 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL---- 322 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 322 (419)
.......++..|+|||++.+ ..++.++||||||++++||++|+.||......+.............. ......
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 232 (286)
T cd07846 155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP-RHQEIFQKNP 232 (286)
T ss_pred -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch-hhHHHhccch
Confidence 22233457889999999865 45788999999999999999999999765432211000000000000 000000
Q ss_pred --HHhhcc---------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 --EARVLK---------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 --~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...... ......+..+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000 011233567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=298.67 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=198.3
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh----------hhHHHHHHHHHHHhcCCCcccccEEeEEecCC
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE----------SNVEQFINEVVILSQINHRNVVKLLGCCLESE 160 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 160 (419)
+|...+.||+|+||.||+|... +++.+|+|.+..... ...+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4778899999999999999864 578899998653211 12346788999999999999999999999999
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG---RFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 9999999999999999998653 5889999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCce-eeecccccCCccCccccccCC--CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 241 RTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 241 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
+........ ......++..|+|||.+.... ++.++|+||||++++++++|..||...+.... ...... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~-~~ 228 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFKLGN-KR 228 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHHhhc-cc
Confidence 764322111 123345788999999987654 88999999999999999999999965433211 000000 00
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. ...........+..+.+++.+||+.+|.+||++.+|++
T Consensus 229 ~~----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 229 SA----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred cC----CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 00 00001111234567899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=298.94 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=201.8
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
-|...+.||+|+||.||+|.. .++..+|+|...... ......+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 367788999999999999986 457889999875432 334567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++... .+++..+..++.|++.|+.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~l~~~i~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 999999998643 4889999999999999999999998 99999999999999999999999999876543221
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
......++..|+|||.+.+..++.++|+|||||++++|++|..||........ ... +.......
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-------~~~---------~~~~~~~~ 220 (277)
T cd06641 157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV-------LFL---------IPKNNPPT 220 (277)
T ss_pred hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH-------HHH---------HhcCCCCC
Confidence 12234578899999999888899999999999999999999999975443211 000 11111112
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.+...+..+.+++.+||+.+|.+||++.++++.
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 221 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 233445678899999999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=302.19 Aligned_cols=243 Identities=27% Similarity=0.354 Sum_probs=200.4
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|.+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46889999999999999999964 5789999987542 2334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~---~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKSG---RFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 9999999999997653 4899999999999999999999998 999999999999999999999999999875433
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
.....+++.|+|||.+.+...+.++||||||+++++|++|..||...+.... .......
T Consensus 155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~---------- 213 (290)
T cd05580 155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI-------YEKILEG---------- 213 (290)
T ss_pred ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHhcC----------
Confidence 2334688999999999888889999999999999999999999976553210 1110000
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVA 360 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl 360 (419)
....+......+.+++.+||..+|.+|| ++.|++
T Consensus 214 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 214 KVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred CccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1112233356788999999999999999 555554
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.01 Aligned_cols=262 Identities=25% Similarity=0.321 Sum_probs=204.5
Q ss_pred cCHHHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEec
Q 014725 81 FTKMDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLE 158 (419)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 158 (419)
+...++..+.++|.+.+.||+|+||.||++.. .+++.+|+|...... .....+.+|+.+++++ +|||++++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44566777889999999999999999999997 457789999876432 2346678899999998 79999999999875
Q ss_pred C-----CcceEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcE
Q 014725 159 S-----EVPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA 232 (419)
Q Consensus 159 ~-----~~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 232 (419)
. ...++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 4 35799999999999999886421 2235899999999999999999999998 9999999999999999999
Q ss_pred EEeecCCceecccCCceeeecccccCCccCccccccC-----CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHH
Q 014725 233 KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-----QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 307 (419)
||+|||++......... .....|+..|+|||.+... .++.++|||||||++|||++|+.||........
T Consensus 168 kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~----- 241 (291)
T cd06639 168 KLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT----- 241 (291)
T ss_pred EEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-----
Confidence 99999998765432211 2234578899999997643 368999999999999999999999976543221
Q ss_pred HHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.... ..... .....+......+.+++.+||+.+|++||++.++++
T Consensus 242 -~~~~-~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 242 -LFKI-PRNPP-------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred -HHHH-hcCCC-------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0010 00000 000112233456899999999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=303.68 Aligned_cols=251 Identities=28% Similarity=0.427 Sum_probs=205.3
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|.+.+.||+|+||.||++.. .++..+|+|..........+.+.+|+.+++.++|||++++++++...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 36899999999999999999986 45788999988655555567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.+. .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 98 ~~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 9999999998753 3788899999999999999999998 99999999999999999999999999876543322
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......+++.|+|||.+....++.++|+||||+++|++++|..||...+........ ... .....
T Consensus 171 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~------~~~--------~~~~~ 235 (293)
T cd06647 171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATN--------GTPEL 235 (293)
T ss_pred -ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh------hcC--------CCCCC
Confidence 222345888999999998888999999999999999999999999765442211000 000 00001
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..+......+.+++.+||+.+|.+||++.+++..
T Consensus 236 ~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 236 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1122334568899999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=300.80 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=193.9
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHH-HhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVI-LSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|++.+.||+|+||.||+|.+. ++..||+|+++... ......+..|+.. ++.++||||+++++++..++..+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888999999999999999975 58899999876532 2233455666665 566789999999999999999999999
Q ss_pred ecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 168 FIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 168 ~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|++ ++|.+++... .....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 996 6888887653 2234689999999999999999999987 6 99999999999999999999999999876532
Q ss_pred CCceeeecccccCCccCcccccc----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRS----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.. ......++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||........ .. ...
T Consensus 157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-----~~---------~~~ 220 (283)
T cd06617 157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ-----QL---------KQV 220 (283)
T ss_pred cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH-----HH---------HHH
Confidence 21 1223457889999998865 4568899999999999999999999964322110 01 111
Q ss_pred HHHhhccCC-CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 LEARVLKEG-KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~-~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... ..... ....+..+.+++.+||..+|.+||++.++++
T Consensus 221 ~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 221 VEE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred Hhc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 00111 1224567899999999999999999999976
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=295.92 Aligned_cols=252 Identities=27% Similarity=0.374 Sum_probs=207.2
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE-SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|++.+.||+|++|.||+|... +++.+++|+...... ...+.+.+|+..+..++|||++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36888999999999999999976 488999998776443 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
+++++|.+++... ..+++..++.++.|++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999865 258999999999999999999999 88 9999999999999999999999999998764332
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
.. .....++..|+|||.+.+..++.++|+||||+++|+|+||..||............... . ....
T Consensus 155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~----------~~~~ 220 (264)
T cd06623 155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI---C----------DGPP 220 (264)
T ss_pred Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH---h----------cCCC
Confidence 22 12345788999999999889999999999999999999999999766421111111111 0 1111
Q ss_pred cCCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 328 KEGKEE-EIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 328 ~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
...+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus 221 ~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 221 PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 122223 55679999999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=303.77 Aligned_cols=255 Identities=23% Similarity=0.303 Sum_probs=201.9
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||++... .++.|++|.+.... ......+.+|+.+++.++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888999999999999999975 46789999876432 233467889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNIG---ALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 9999999999997643 4899999999999999999999998 999999999999999999999999998642110
Q ss_pred C--------------ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH
Q 014725 247 Q--------------THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 247 ~--------------~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
. ........++..|+|||.+.+..++.++|+|||||++|||++|..||.+....+ ....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~-------~~~~ 227 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE-------LFGQ 227 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence 0 001122457889999999988889999999999999999999999997654322 1111
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
...... .........+..+.+++.+||+.+|++||+..++.+.|+.
T Consensus 228 ~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 228 VISDDI-------EWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred HHhccc-------CCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 000000 0001111345668999999999999999998777776654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=301.90 Aligned_cols=247 Identities=26% Similarity=0.388 Sum_probs=198.4
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..+|...+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+++++.++|||++++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356888899999999999999964 5789999987532 233446788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||++ |++.+++..... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~e~~~-g~l~~~~~~~~~--~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~ 167 (307)
T cd06607 94 MEYCL-GSASDILEVHKK--PLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSP 167 (307)
T ss_pred HHhhC-CCHHHHHHHccc--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCC
Confidence 99996 577777764332 4899999999999999999999998 99999999999999999999999999876432
Q ss_pred CCceeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
. ....+++.|+|||++. ...++.++||||||+++|||+||..||...+..... .....
T Consensus 168 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~~-------- 228 (307)
T cd06607 168 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-------- 228 (307)
T ss_pred C-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHhc--------
Confidence 2 2345788999999874 456889999999999999999999999765433210 00000
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..............+.+++.+||+.+|++||++.+|+..
T Consensus 229 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 229 -NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred -CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000011122345678999999999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=297.98 Aligned_cols=248 Identities=23% Similarity=0.389 Sum_probs=209.9
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
+-|.+..+||+|+||.||+|.++ .|+.+|||++.. +.+.+++..|+.++++++.|++|++||.+.....+|+|||||
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 34677889999999999999964 588999999876 445788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
..|++.+.++.... ++++.++..++...+.||+|||... -||||||..|||++-+|.+||+|||.+..+.... .
T Consensus 111 GAGSiSDI~R~R~K--~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A 184 (502)
T KOG0574|consen 111 GAGSISDIMRARRK--PLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A 184 (502)
T ss_pred CCCcHHHHHHHhcC--CccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence 99999999987543 6999999999999999999999988 7899999999999999999999999997764322 2
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH-HHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL-EARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 328 (419)
...++.|||.|||||++..-.|..++||||||++..||..|++||....+... ++-+. .+....
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA---------------IFMIPT~PPPTF 249 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA---------------IFMIPTKPPPTF 249 (502)
T ss_pred hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce---------------eEeccCCCCCCC
Confidence 34567899999999999999999999999999999999999999976554321 11110 011122
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..|......+.++++.||-..|++|-|+.++++
T Consensus 250 ~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 335566788999999999999999999888765
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=302.10 Aligned_cols=262 Identities=24% Similarity=0.376 Sum_probs=196.8
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE-SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|++.+.||+|+||.||+|... ++..||+|.+..... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67899999999999999999975 578899998764322 2234577899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++ +|.+++..... .+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~~--~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCGG--GLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 974 99998876543 4889999999999999999999998 99999999999999999999999999875432211
Q ss_pred eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc---ccchhHHHH-
Q 014725 249 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN---EDRLFEVLE- 323 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~- 323 (419)
......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... ......... ++.+.....
T Consensus 159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ--LHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH--HHHHHHhcCCCChhhhhhhhhc
Confidence 1122346788999999865 45889999999999999999999999765421110 000100000 000000000
Q ss_pred ------------HhhccCC--CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ------------ARVLKEG--KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ------------~~~~~~~--~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....... .......+.+++.+||+.+|.+|||+.+++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000 0011256788999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=303.89 Aligned_cols=246 Identities=26% Similarity=0.374 Sum_probs=199.3
Q ss_pred ccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCC
Q 014725 95 ANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGT 173 (419)
Q Consensus 95 ~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 173 (419)
....||+|+||.||+|... ++..||+|.+........+.+.+|+.+++.++|||++++++++..++..+++|||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999964 578999999865544556778899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeec
Q 014725 174 LYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253 (419)
Q Consensus 174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~ 253 (419)
|..++... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++....... .....
T Consensus 105 L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~ 176 (297)
T cd06659 105 LTDIVSQT----RLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKS 176 (297)
T ss_pred HHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccc
Confidence 99987542 3889999999999999999999998 9999999999999999999999999987543322 12233
Q ss_pred ccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHH
Q 014725 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEE 333 (419)
Q Consensus 254 ~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 333 (419)
..|+..|+|||++.+..++.++|||||||+++||++|+.||......+.. ....... .........
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-------~~~~~~~-------~~~~~~~~~ 242 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM-------KRLRDSP-------PPKLKNAHK 242 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhccC-------CCCccccCC
Confidence 56889999999999888999999999999999999999999765433210 1110000 000011122
Q ss_pred HHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 334 EIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 334 ~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
....+.+++.+||+.+|.+||++.++++.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 34568899999999999999999999884
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=286.01 Aligned_cols=257 Identities=28% Similarity=0.405 Sum_probs=203.5
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC--------hhhHHHHHHHHHHHhcC-CCcccccEE
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD--------ESNVEQFINEVVILSQI-NHRNVVKLL 153 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~l~ 153 (419)
+.-.....+|...+.||.|..++|-++.. ..++..|+|++.... ....+.-.+|+.+|+++ .||||+++.
T Consensus 10 ~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~ 89 (411)
T KOG0599|consen 10 DAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQ 89 (411)
T ss_pred hhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEee
Confidence 33445567788899999999999998885 457788998764321 12234456799999998 599999999
Q ss_pred eEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEE
Q 014725 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAK 233 (419)
Q Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 233 (419)
++++.+...++|+|.|+.|.|.+||.... .++++...+|+.|+..|++|||..+ |+||||||+|||+|++.++|
T Consensus 90 D~yes~sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 90 DVYESDAFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred eeccCcchhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceE
Confidence 99999999999999999999999999765 5899999999999999999999999 99999999999999999999
Q ss_pred EeecCCceecccCCceeeecccccCCccCccccccC------CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHH
Q 014725 234 VSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 307 (419)
|+|||.++.+.... .....+|||+|+|||.++.. .|+...|+|+.||+||-|+.|..||......-
T Consensus 164 isDFGFa~~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml------ 235 (411)
T KOG0599|consen 164 ISDFGFACQLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML------ 235 (411)
T ss_pred EeccceeeccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH------
Confidence 99999998865433 33457899999999998643 57889999999999999999999985322110
Q ss_pred HHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.++.+-+++.. ...+.=.+......+|+.+||+.||.+|.|.+|.+.
T Consensus 236 -MLR~ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 -MLRMIMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -HHHHHHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 11111111100 000111233456889999999999999999999986
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=309.28 Aligned_cols=251 Identities=25% Similarity=0.369 Sum_probs=203.3
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 166 (419)
...|++.++||+||.+.||++...+.+.+|+|++.. .+.....-|.+|+..|.+|+ |.+|+++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 456899999999999999999988888999998653 56677888999999999995 999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||= ..+|..+|++.... ...| .+..+..||+.++.++|++| |||.||||.|+|+-. |.+||+|||.|.....+
T Consensus 440 E~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPD 512 (677)
T ss_pred ecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCcc
Confidence 976 56999999886643 2334 67788999999999999999 999999999999975 58999999999988765
Q ss_pred Ccee-eecccccCCccCccccccCC-----------CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc
Q 014725 247 QTHL-TTRVQGTFGYLDPEYFRSSQ-----------FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 247 ~~~~-~~~~~gt~~y~aPE~~~~~~-----------~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
.+.. ...-+||+.||+||.+.... .++++|||||||+||+|+-|+.||.......
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~------------- 579 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQI------------- 579 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHH-------------
Confidence 4443 35668999999999985432 4679999999999999999999997544321
Q ss_pred ccchhHHHHHhhccCCCHHH-HHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 EDRLFEVLEARVLKEGKEEE-IITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.++..+.++....+++.-- ..++.++++.||+.||++||++.++|+
T Consensus 580 -aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 580 -AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred -HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 1233444443322332211 122899999999999999999999976
|
|
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=315.28 Aligned_cols=245 Identities=25% Similarity=0.431 Sum_probs=194.2
Q ss_pred cccCcccccCcEEEEEEEecC-CCEEE---EEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc--ceEEE
Q 014725 94 NANRILGQGGQGTVYKGMLAD-GGIVA---VKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEV--PLLVY 166 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~~-~~~va---vK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lv~ 166 (419)
+....||+|+|-+||+|.+.. |-.|| ||.-.. .++...+.|..|+.+|+.|+||||+++++++.+... ..+|.
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 446789999999999999743 55565 332222 234556899999999999999999999999987665 67899
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~ 245 (419)
|++..|+|..|+.+.+. ++.+.+..|+.||++||.|||++. +||||||||-+||+|+. .|.|||+|+|||.....
T Consensus 123 EL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred ecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999998764 788999999999999999999987 56999999999999975 57899999999987643
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. ...++|||.|||||.+. ..|....||||||+.++||+|+..||....... ..+..+.....+..+..+-
T Consensus 199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A--QIYKKV~SGiKP~sl~kV~--- 269 (632)
T KOG0584|consen 199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA--QIYKKVTSGIKPAALSKVK--- 269 (632)
T ss_pred cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH--HHHHHHHcCCCHHHhhccC---
Confidence 22 23378999999999987 889999999999999999999999997544321 1111111111111111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+++.++|.+|+.. ..+|||+.|+|.
T Consensus 270 ---------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 270 ---------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ---------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 24689999999999 999999999976
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=298.52 Aligned_cols=253 Identities=26% Similarity=0.412 Sum_probs=206.7
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
...+.|+..+.||+|+||.||+|.+. ++..+++|.+..... ..+.+.+|++.++.++|+|++++++++...+..++++
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 35667888899999999999999975 678899998876544 5577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999998754 25899999999999999999999988 999999999999999999999999998654322
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
.. ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......... ..... ... .
T Consensus 170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~~~~-~~~-------~ 234 (286)
T cd06614 170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FLITT-KGI-------P 234 (286)
T ss_pred hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-cCC-------C
Confidence 21 122334788999999998888999999999999999999999999765443210 00000 000 0
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
........+..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 235 PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 01111224567899999999999999999999976
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=302.56 Aligned_cols=261 Identities=21% Similarity=0.323 Sum_probs=195.7
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|++.+.||+|+||.||+|... +|..+|+|.+... .......+.+|+.+++.++||||+++++++.+....++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 5888899999999999999974 5788999987642 222335678899999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
++ ++|.+++..... .+++..++.++.||++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CD-QDLKKYFDSCNG--DIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 96 588888765432 4899999999999999999999998 99999999999999999999999999986543221
Q ss_pred eeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc---cchh---HH
Q 014725 249 HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE---DRLF---EV 321 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~ 321 (419)
......++..|+|||++.+. .++.++|||||||++|+|+||..|+........ ........... ..+. +.
T Consensus 155 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd07839 155 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKL 231 (284)
T ss_pred -CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhc
Confidence 12234578899999998764 478999999999999999999988643322111 01111110000 0000 00
Q ss_pred HHHhhc---------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 LEARVL---------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+.... ..........+.+++.+||+.||.+|||+.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 0011123457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=298.01 Aligned_cols=246 Identities=26% Similarity=0.423 Sum_probs=199.9
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCC---CcccccEEeEEecCCcceEEE
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV-DESNVEQFINEVVILSQIN---HRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~ 166 (419)
.|+..+.||+|+||.||+|.+ .++..+|+|.+... .......+.+|+.+++.++ |||++++++++.+....++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 477889999999999999996 56789999987643 3344567889999999986 999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++... .+++...+.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999998653 4889999999999999999999998 999999999999999999999999999876543
Q ss_pred CceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. ......|+..|+|||.+.++ .++.++|+|||||++|+|++|..||......... . .....
T Consensus 155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~------~-~~~~~--------- 217 (277)
T cd06917 155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM------M-LIPKS--------- 217 (277)
T ss_pred cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh------h-ccccC---------
Confidence 32 22334688999999988654 5689999999999999999999999765432210 0 00000
Q ss_pred hccCCCH-HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKE-EEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~-~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+. .....+.+++.+||+.+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 0011111 14457889999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=289.94 Aligned_cols=247 Identities=29% Similarity=0.410 Sum_probs=204.9
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
.|...+.||+|++|.||++... ++..+++|+.........+.+.+|++.++.++|||++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3778899999999999999975 678899999876555566889999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+++|.+++.... ..+++..+..++.|++.||.+||..+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999998753 25899999999999999999999988 99999999999999999999999999877654332
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (419)
.....++..|+|||.+.+..++.++|+||||+++++|++|..||...+....... .. .......
T Consensus 154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~~-------------~~~~~~~ 217 (253)
T cd05122 154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---IA-------------TNGPPGL 217 (253)
T ss_pred ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HH-------------hcCCCCc
Confidence 3345688999999999888899999999999999999999999976543221100 00 0000111
Q ss_pred --CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 331 --KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 331 --~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.......+.+++.+||+.+|++|||+.++++
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1112457899999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=297.84 Aligned_cols=247 Identities=25% Similarity=0.376 Sum_probs=200.3
Q ss_pred ccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 93 YNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
|...+.||+|++|.||++.. .++..+++|+.........+.+.+|+.+++.++|||++++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 44457899999999999996 46788999988765555567789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
++|.+++... .+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........ ..
T Consensus 101 ~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 172 (285)
T cd06648 101 GALTDIVTHT----RMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR 172 (285)
T ss_pred CCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence 9999998762 4889999999999999999999998 99999999999999999999999998875433221 22
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....|++.|+|||.+.+..++.++||||||++++||++|+.||...+.... . ....... .+ ....+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~-~~~~~~~-----~~--~~~~~ 238 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------M-KRIRDNL-----PP--KLKNL 238 (285)
T ss_pred ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------H-HHHHhcC-----CC--CCccc
Confidence 334588999999999888899999999999999999999999975443221 0 0000000 00 00111
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+..+.+++.+||+.+|++||++.++++
T Consensus 239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 224457999999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=314.79 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=206.2
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCE-EEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGI-VAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~-vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.+.|.++..||.|+||.||+|..++... .|.|.+........+.|+-|+++|+.+.||+||++++.|.-.+.+++..||
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 3456777889999999999999876554 456777666777889999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
|.||-.+..+-.-.. .+++.++.-++.|++.||.|||++. |||||||..|||++-+|.++|+|||.+..... ..
T Consensus 111 C~GGAVDaimlEL~r--~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~ 184 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGR--VLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TR 184 (1187)
T ss_pred cCCchHhHHHHHhcc--ccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HH
Confidence 999999998877554 5999999999999999999999999 99999999999999999999999999865332 23
Q ss_pred eeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 249 HLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.....++|||.|||||+.. ..+|+.++||||||++|.||..+.+|-....+. ...+.....+
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM------RVllKiaKSe------- 251 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVLLKIAKSE------- 251 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH------HHHHHHhhcC-------
Confidence 3456788999999999864 468999999999999999999999986543332 1111111110
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+ ...-.|......+.+++.+||..||..||++.++++
T Consensus 252 P-PTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 252 P-PTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred C-CcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 0 011124455677999999999999999999999875
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=299.15 Aligned_cols=264 Identities=22% Similarity=0.340 Sum_probs=196.9
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++++|.+.+.||+|+||.||+|.. .+++.+|+|.+.... ......+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 357899999999999999999986 457899999876432 222346788999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+. ++|.+++..... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG--GLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9995 688777765432 4778888899999999999999998 999999999999999999999999998764332
Q ss_pred CceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc--ccchhHHHH
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN--EDRLFEVLE 323 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 323 (419)
... .....+++.|+|||.+.+. .++.++|||||||+++||++|..||......... +.. ...... .......+.
T Consensus 157 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~ 233 (291)
T cd07870 157 SQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-LEK-IWTVLGVPTEDTWPGVS 233 (291)
T ss_pred CCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-HHH-HHHHcCCCChhhhhhhh
Confidence 211 2233468899999998754 5788999999999999999999999765432111 110 100000 000000000
Q ss_pred -------Hhhc---cC------CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 -------ARVL---KE------GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 -------~~~~---~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.... .. ........+.+++.+|++.||.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 234 KLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000 00 00011356789999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=301.90 Aligned_cols=260 Identities=25% Similarity=0.319 Sum_probs=199.1
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh-----hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE-----SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
+|...+.||+|+||.||+|... +++.||+|.+..... .....+..|+++++.++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4788899999999999999964 578999998765332 2335677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999997654 25899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc---c----
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED---R---- 317 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~---- 317 (419)
.... .....+++.|+|||.+.+ ..++.++|||||||+++||++|..||......+.. .......... .
T Consensus 155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 230 (298)
T cd07841 155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPGV 230 (298)
T ss_pred CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhhc
Confidence 3211 122346788999998854 46789999999999999999998888755432211 1111100000 0
Q ss_pred --hhHHHHHhhcc-----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 --LFEVLEARVLK-----EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 --~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+.......... .........+.+++.+||+.+|++|||+.|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 00000000000 011223467889999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=294.56 Aligned_cols=249 Identities=25% Similarity=0.393 Sum_probs=201.2
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|.+.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+.+++.++||||+++++.+.+....++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 5788899999999999999974 5788999987543 223446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~ 247 (419)
+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999976433 24799999999999999999999998 99999999999998885 46999999987654322
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
. ......|++.|+|||++.+..++.++|+||||++++||++|..||......+ ....... .. .
T Consensus 157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~---------~ 219 (257)
T cd08225 157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GY---------F 219 (257)
T ss_pred c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-cc---------C
Confidence 1 1223458889999999988889999999999999999999999997544322 1111111 00 1
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+.+++.+||+.+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 APISPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 1112233456899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=296.40 Aligned_cols=255 Identities=25% Similarity=0.383 Sum_probs=201.3
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCC-----
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESE----- 160 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~----- 160 (419)
..+++|++.+.||+|+||.||+|... +++.+++|....... ..+.+.+|+.+++++ +||||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45789999999999999999999974 567899998765443 346789999999999 7999999999997644
Q ss_pred -cceEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 161 -VPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 161 -~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4799999999999999987532 1235899999999999999999999998 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCcccccc-----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 313 (419)
++....... .......++..|+|||++.. ..++.++||||||+++++|++|+.||........ ..+..
T Consensus 159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~ 231 (275)
T cd06608 159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------LFKIP 231 (275)
T ss_pred cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------HHHhh
Confidence 987653322 12233458899999998753 3467899999999999999999999975432211 11110
Q ss_pred cccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... ......+......+.+++.+||..||++|||+.++++
T Consensus 232 -~~~-------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 232 -RNP-------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -ccC-------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 000 0011112234567899999999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=298.84 Aligned_cols=257 Identities=17% Similarity=0.248 Sum_probs=186.8
Q ss_pred HhcCccccCcccccCcEEEEEEEecCC----CEEEEEEcccCChhhH-----------HHHHHHHHHHhcCCCcccccEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADG----GIVAVKKSKLVDESNV-----------EQFINEVVILSQINHRNVVKLL 153 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~l~ 153 (419)
..++|.+.+.||+|+||.||+|...++ ..+|+|.......... .....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346899999999999999999997543 4566665433221110 1122334456677899999999
Q ss_pred eEEecCC----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC
Q 014725 154 GCCLESE----VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK 229 (419)
Q Consensus 154 ~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 229 (419)
+++.... ..++++|++. .++.+.+.... ..++..+..++.|++.||.|||+.+ ++||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 9876543 3367788763 46766665432 3578888999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCceecccCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhh-
Q 014725 230 YRAKVSDFGASRTIKVDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED- 302 (419)
Q Consensus 230 ~~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~- 302 (419)
+.++|+|||+++.+...... ......||+.|+|||++.+..++.++|||||||+++||++|+.||........
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~ 242 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL 242 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH
Confidence 99999999999876432211 12234699999999999999999999999999999999999999986632211
Q ss_pred cc-HHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 303 RS-LVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 303 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
.. ....+... +..... ....++..+.+++..|++.+|++||++.++++.|
T Consensus 243 ~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 243 IHAAKCDFIKR--------LHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHhHHHHHHH--------hhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 00 00001111 111111 1223356799999999999999999999999876
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=293.63 Aligned_cols=268 Identities=24% Similarity=0.365 Sum_probs=226.1
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecC------CCEEEEEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEE
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCC 156 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~ 156 (419)
.++....++++...++-+|.||.||.|.+.+ .+.|.+|.++. .++-+...++.|.-.+..+.|||+.++.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 4455566788999999999999999997543 34577787765 3445677899999999999999999999998
Q ss_pred ecC-CcceEEEeecCCCCHHHHhh-----ccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC
Q 014725 157 LES-EVPLLVYEFIPNGTLYHYLH-----DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY 230 (419)
Q Consensus 157 ~~~-~~~~lv~e~~~~g~L~~~l~-----~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 230 (419)
.+. ..+++++.++..|+|..||. +......++..+...++.|++.|++|||+++ +||.||..+|++||+..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 754 67899999999999999998 3333445777888999999999999999999 99999999999999999
Q ss_pred cEEEeecCCceecccCCceee-ecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHH
Q 014725 231 RAKVSDFGASRTIKVDQTHLT-TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGF 308 (419)
Q Consensus 231 ~~kl~Dfgl~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 308 (419)
++||+|=.|+|.+...+.+.- .....+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+.
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm------ 507 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM------ 507 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH------
Confidence 999999999998766554432 34446778999999999999999999999999999999 9999998888763
Q ss_pred HHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
...+.+..+...|.+|+.++..++.-||..+|++||++++++.-|.+....+
T Consensus 508 ----------~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 508 ----------EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred ----------HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 3344455556678899999999999999999999999999999998876544
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.29 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=200.8
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
+|++.+.||+|++|.||+|+.. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5888999999999999999975 57889999876543 233467788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 75 89998876554446899999999999999999999998 99999999999999999999999999976533211
Q ss_pred eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH-----H
Q 014725 250 LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL-----E 323 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 323 (419)
......++..|++||++.+ ..++.++|||||||++|+|++|+.||...+..+.............+..+.... .
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 1223346889999998865 457899999999999999999999998665432211100000000000000000 0
Q ss_pred Hh-------hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 AR-------VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~-------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. .........+..+.+++.+|++.+|.+||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00 000011123456889999999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.53 Aligned_cols=260 Identities=25% Similarity=0.298 Sum_probs=200.3
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--CcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 166 (419)
++|...+.||.|++|.||++.+. +++.+|+|.+.... ......+.+|+++++.++||||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46888899999999999999974 57789999876432 24457789999999999999999999998654 3679999
Q ss_pred eecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999999876422 2335888999999999999999999998 99999999999999999999999999875432
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...... ........... ...
T Consensus 158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-~~~~~~~~~~~-~~~ 231 (287)
T cd06621 158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPL-GPIELL-SYIVNMPNPEL-KDE 231 (287)
T ss_pred cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCC-ChHHHH-HHHhcCCchhh-ccC
Confidence 21 1234578899999999988999999999999999999999999976532110 111111 11111000000 000
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+.+++.+||+.+|.+|||+.|+++
T Consensus 232 --~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 232 --PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred --CCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0001123567899999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=299.04 Aligned_cols=261 Identities=23% Similarity=0.302 Sum_probs=199.3
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--CcceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 165 (419)
++|++.+.||+|+||.||+|... ++..+|+|.++... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 57888999999999999999975 57889999876433 22334577899999999999999999998877 889999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||++ ++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMKQ--PFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 599998876443 5899999999999999999999998 99999999999999999999999999987654
Q ss_pred CCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc---c------
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN---E------ 315 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~------ 315 (419)
... ......+++.|+|||.+.+. .++.++|+||||+++++|++|..||........... ...... .
T Consensus 159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 234 (293)
T cd07843 159 PLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK---IFKLLGTPTEKIWPGF 234 (293)
T ss_pred Ccc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHhCCCchHHHHHh
Confidence 321 12234478899999998754 468999999999999999999999976554321110 000000 0
Q ss_pred --------cchhHHHHHhhccCCCHH-HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 316 --------DRLFEVLEARVLKEGKEE-EIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 316 --------~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+.......+....+.. ....+.+++.+||+.+|++|||+.|++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000111111111 3566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=301.14 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=197.5
Q ss_pred CccccCcccccCcEEEEEEEec---CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Ccce
Q 014725 92 NYNANRILGQGGQGTVYKGMLA---DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVPL 163 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 163 (419)
+|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999974 47899999887632 33446788899999999999999999999988 7889
Q ss_pred EEEeecCCCCHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC----CCcEEEeec
Q 014725 164 LVYEFIPNGTLYHYLHDQTE--EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD----KYRAKVSDF 237 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~----~~~~kl~Df 237 (419)
+||||+++ +|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999965 77777654322 235889999999999999999999999 999999999999999 999999999
Q ss_pred CCceecccCCc--eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhcc------HHHH
Q 014725 238 GASRTIKVDQT--HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRS------LVGF 308 (419)
Q Consensus 238 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~------~~~~ 308 (419)
|+++....... .......+++.|+|||++.+ ..++.++|||||||++++|++|+.||.......... ....
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99986543222 12234467889999998766 457899999999999999999999997654432000 0000
Q ss_pred HHHHhcc------------cchhHHHHHhhccCCC-----------HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 309 FLQAMNE------------DRLFEVLEARVLKEGK-----------EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 309 ~~~~~~~------------~~~~~~~~~~~~~~~~-----------~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+...+.. .......+.......+ ......+.+++.+||+.+|++|||+.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 0000000000000001 022346889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-39 Score=298.69 Aligned_cols=262 Identities=24% Similarity=0.346 Sum_probs=197.6
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|+..+.||+|+||.||+|... ++..||+|++.... ......+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5888999999999999999964 57899999876432 22345788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+. ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 95 689998876432 35899999999999999999999998 99999999999999999999999999876532211
Q ss_pred eeeecccccCCccCccccccCC-CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc-chh----HHH
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED-RLF----EVL 322 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~-~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~----~~~ 322 (419)
......++..|+|||++.+.. ++.++||||||+++|||+||+.||......+. ............ .+. ...
T Consensus 156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred -ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhhhhHHH
Confidence 122234688899999887644 68899999999999999999999976553321 111110000000 000 000
Q ss_pred ---HH--hhcc----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 ---EA--RVLK----EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ---~~--~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. .... .........+.+++.+||+.||.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00 0000 001112345788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=295.27 Aligned_cols=247 Identities=26% Similarity=0.326 Sum_probs=203.2
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
+|++.+.||+|+||.||+|... ++..+|+|..... .....+.+.+|++++++++||||+++++++.+....++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5888999999999999999975 5888999987642 22446789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+.+++|.+++... .++++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999999765 25889999999999999999999998 9999999999999999999999999988754332
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
......|+..|+|||.+.+..++.++|+||||+++|+|++|..||........ ..+...... ..
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~----------~~ 218 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR----DQIRAKQET----------AD 218 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHH----HHHHHHhcc----------cc
Confidence 22334578899999999888899999999999999999999999986653211 111111110 11
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCH--HHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSM--KEVA 360 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~--~evl 360 (419)
...+...+..+.+++.+||+.+|.+||++ .|++
T Consensus 219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 219 VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 22333445789999999999999999999 5553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=307.14 Aligned_cols=265 Identities=23% Similarity=0.339 Sum_probs=197.7
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-----cc
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESE-----VP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~ 162 (419)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+... .......+.+|+.+++.++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 47899999999999999999996 45789999988643 2334567889999999999999999999876443 46
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++++||+. ++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~~~----~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIKTQ----HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 89999996 4888877543 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCce--eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 243 IKVDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 243 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
....... ......|++.|+|||.+.+ ..++.++|||||||++++|++|+.||...+.................+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLN 235 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence 5432211 1123467899999998654 568999999999999999999999997654322111110000000001111
Q ss_pred HHHHHh-------hc--cC-----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 320 EVLEAR-------VL--KE-----GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 320 ~~~~~~-------~~--~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.+.+.. .. .. ........+.+++.+||+.+|.+|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 236 CIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 100000 00 00 001224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=298.49 Aligned_cols=247 Identities=26% Similarity=0.403 Sum_probs=197.5
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
|...+.||+|+||.||+|... ++..+|+|.+... .......+.+|+++++.++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 677889999999999999964 5788999987632 223446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+. |+|.+++..... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 107 ~~-g~l~~~~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 96 578777765332 4899999999999999999999998 999999999999999999999999998654321
Q ss_pred eeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 249 HLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
....+++.|+|||++. .+.++.++|||||||++|||++|+.||......... ..+....
T Consensus 179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---------------~~~~~~~ 240 (317)
T cd06635 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------------YHIAQNE 240 (317)
T ss_pred ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHHhcc
Confidence 2345788999999973 457889999999999999999999998764332210 0111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
............+.+++.+||+.+|.+||++.+|++.+-.
T Consensus 241 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1111122345578999999999999999999999875543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=319.44 Aligned_cols=268 Identities=19% Similarity=0.289 Sum_probs=190.1
Q ss_pred HhcCccccCcccccCcEEEEEEEecC--CCEEEEE------------------EcccCChhhHHHHHHHHHHHhcCCCcc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD--GGIVAVK------------------KSKLVDESNVEQFINEVVILSQINHRN 148 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~--~~~vavK------------------~~~~~~~~~~~~~~~e~~~l~~l~h~n 148 (419)
..++|++.+.||+|+||+||++..+. +...+.| ... ........+.+|+.+++.++|||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 1111111 111 11223456889999999999999
Q ss_pred cccEEeEEecCCcceEEEeecCCCCHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014725 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTE--EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL 226 (419)
Q Consensus 149 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill 226 (419)
|+++++++.+.+..++++|++. ++|.+++..... ...........++.||+.||.|||+++ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 577777754321 112345667789999999999999998 9999999999999
Q ss_pred CCCCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCC-CCCCCChhhhccH
Q 014725 227 DDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK-PIRSTDAEEDRSL 305 (419)
Q Consensus 227 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~-p~~~~~~~~~~~~ 305 (419)
+.++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|.. |+..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 999999999999998765443333344679999999999999999999999999999999999875 4443322111111
Q ss_pred HHHHHHH--hcc------cchhHHHHHhhccCCCH---------HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 306 VGFFLQA--MNE------DRLFEVLEARVLKEGKE---------EEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 306 ~~~~~~~--~~~------~~~~~~~~~~~~~~~~~---------~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....... ... .++...++.......+. .....+.+++.+||+.||.+|||+.|++.
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 1111000 000 01111111100000000 11234677899999999999999999986
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=290.65 Aligned_cols=248 Identities=26% Similarity=0.382 Sum_probs=204.8
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|++.+.||+|+||.||++... ++..+|+|..... .......+.+|+++++.++||||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 5788899999999999999854 5778999987643 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999987632 1235899999999999999999999998 999999999999999999999999999876443
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..+. .... .....
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~---------~~~~~ 218 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-------RYKV---------QRGKY 218 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHH---------hcCCC
Confidence 22234578899999999988899999999999999999999999976654321 1111 11111
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+......+.+++.+|++.+|++||++.++++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 2223355667999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=290.03 Aligned_cols=249 Identities=27% Similarity=0.386 Sum_probs=199.4
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Ccc
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV-----DESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVP 162 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~ 162 (419)
.+|++.+.||+|+||.||+|.+ .++..+|+|..... .......+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4789999999999999999996 45789999986431 223456788999999999999999999998764 457
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++++||+++++|.+++.... .+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG---ALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 89999999999999987543 4788899999999999999999998 99999999999999999999999999986
Q ss_pred cccCC--ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 243 IKVDQ--THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 243 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
..... ........++..|+|||++.+..++.++|+|||||++++|++|+.||........ + .+
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~---------~~ 220 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------I---------FK 220 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------H---------HH
Confidence 53211 1111234588999999999988899999999999999999999999975433211 1 11
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+......+.+++.+||. +|..||+..+++.
T Consensus 221 ~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 221 IATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111111223345566779999999999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=296.47 Aligned_cols=263 Identities=25% Similarity=0.303 Sum_probs=199.6
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC--CcceEEEe
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVPLLVYE 167 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 167 (419)
|++.+.||+|+||.||+|... ++..+|+|.+... .......+.+|+.+++.++|||++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 667889999999999999975 4788999998754 233446788999999999999999999999887 78999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9974 8988887643 25899999999999999999999998 9999999999999999999999999998765443
Q ss_pred ceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH------
Q 014725 248 THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE------ 320 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 320 (419)
........++..|+|||.+.+ ..++.++||||||++++||+||+.||.......................+..
T Consensus 155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07840 155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPW 234 (287)
T ss_pred cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchh
Confidence 222233456788999998765 4678999999999999999999999976654322111110000000000000
Q ss_pred --------HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 --------VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 --------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.............++..+.+++.+||+.+|.+||++.++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 235 FENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 00000000001112567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=289.10 Aligned_cols=250 Identities=30% Similarity=0.403 Sum_probs=206.5
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|.+.+.||+|+||.||++.+. ++..+++|.+.... ......+.+|+++++.++|||++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5888899999999999999975 57889999876543 35567789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999998642 1235899999999999999999999998 9999999999999999999999999998764433
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
.......|++.|+|||.+.+..++.++|+||+|+++++|++|..||........ . ... .....
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~-~~~---------~~~~~ 220 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------A-LKI---------LKGQY 220 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH------H-HHH---------hcCCC
Confidence 223334688999999999888899999999999999999999999976543221 1 110 01111
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+......+.+++.+||..+|++|||+.++++
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1223344567899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=297.22 Aligned_cols=261 Identities=26% Similarity=0.333 Sum_probs=197.7
Q ss_pred ccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 93 YNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
|++.+.||+|++|.||+|.. .++..||+|++.... ......+.+|+++++.++|||++++++++.+.+..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 66788999999999999996 468899999876432 233467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
+ ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 689999876542 24899999999999999999999998 999999999999999999999999999765322111
Q ss_pred eeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc-c-------hhH
Q 014725 250 LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED-R-------LFE 320 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~-------~~~ 320 (419)
.....++..|+|||++.+. .++.++||||||+++|+|++|+.||........ ............ . +.+
T Consensus 156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchh
Confidence 1223468899999987654 578999999999999999999999976654321 111000000000 0 000
Q ss_pred HHHHhh------ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARV------LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...... ...........+.+++.+||+.+|.+|||+.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 00011223356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=297.65 Aligned_cols=263 Identities=22% Similarity=0.317 Sum_probs=196.1
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCc-----
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEV----- 161 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~----- 161 (419)
++|++.+.||+|+||.||+|.+. ++..||+|...... ......+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47889999999999999999964 57899999865432 223457888999999995 6999999999987665
Q ss_pred ceEEEeecCCCCHHHHhhccCC--CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecC
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTE--EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFG 238 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg 238 (419)
.+++|||+++ +|.+++..... ...+++..++.++.||+.||.|||+.+ ++||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 89888865432 235899999999999999999999998 999999999999998 8899999999
Q ss_pred CceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc--
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE-- 315 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-- 315 (419)
+++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||......+.. .. +......
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~-~~~~~~~~~ 232 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LH-IFKLLGTPT 232 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-HHHHhCCCC
Confidence 9876532211 1122346788999998865 45789999999999999999999999765443211 10 0110000
Q ss_pred cchh-HH---HH--------HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 316 DRLF-EV---LE--------ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 316 ~~~~-~~---~~--------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.... .. .. +.............+.+++.+||..+|.+||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 00 00 00000001123456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=290.20 Aligned_cols=242 Identities=27% Similarity=0.327 Sum_probs=195.8
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 99 LGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
||.|+||.||++... +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.++...+++|||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999975 4789999987542 223456789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecc
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 254 (419)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~ 152 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF 152 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence 99997643 4889999999999999999999998 9999999999999999999999999998764332 22334
Q ss_pred cccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHH
Q 014725 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334 (419)
Q Consensus 255 ~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (419)
.+++.|+|||.+.+..++.++|+||||+++|+|++|..||........ .... ...........+...
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~---------~~~~~~~~~~~~~~~ 219 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYN---------DILKGNGKLEFPNYI 219 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHH---------HHhccCCCCCCCccc
Confidence 678999999999888899999999999999999999999976552110 0011 111101112223333
Q ss_pred HHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 335 IITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 335 ~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
...+.+++.+||+.+|.+||+ +.|+++
T Consensus 220 ~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 567999999999999999999 555544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=288.65 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=206.2
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--CcceEEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVPLLVY 166 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 166 (419)
+|...+.||+|++|.||+|... ++..+++|...... ....+.+.+|+..+++++||||+++++.+.+. ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999976 68889999876543 24567899999999999999999999999988 8889999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999998654 5899999999999999999999988 999999999999999999999999999876543
Q ss_pred Cce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 QTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
... ......++..|+|||.+.+...+.++||||||+++++|++|..||....... ...... ....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~---------~~~~ 220 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKI---------GSSG 220 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhc---------cccC
Confidence 321 1233457889999999988889999999999999999999999997665111 001110 0011
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+...+..+.+++.+|++.+|++||++.+++.
T Consensus 221 ~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 221 EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 112233344678999999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=303.88 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=199.1
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecC------
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLES------ 159 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 159 (419)
..++|+..+.||+|+||.||+|... ++..||+|.+.. ........+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999964 678999998753 2334456788899999999999999999998643
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
...++||||+. ++|.+++... +++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~~-----l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQMD-----LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhhc-----CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 34689999995 5888877532 788889999999999999999998 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc--cc
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE--DR 317 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~ 317 (419)
++...... ......++..|+|||.+.+..++.++|||||||++++|++|+.||...+..... ..+...... ..
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~ 239 (353)
T cd07850 165 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW---NKIIEQLGTPSDE 239 (353)
T ss_pred ceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCCHH
Confidence 98754322 123345788999999999999999999999999999999999999766542210 001000000 00
Q ss_pred hhHH-----------------------HHHhhc----cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 318 LFEV-----------------------LEARVL----KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 318 ~~~~-----------------------~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
+... ...... .......+..+.+++.+||+.||.+|||+.|++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000 000000 00011235568899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=286.87 Aligned_cols=247 Identities=26% Similarity=0.421 Sum_probs=204.3
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|++.+.||+|++|.||++... +++.+++|....... ...+.+.+|++++++++|||++++++++.+....+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 5788899999999999999865 577899998876443 4567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKFG---PFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 99999999997653 5899999999999999999999998 99999999999999999999999999987654332
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
. .....++..|+|||.+.+..++.++||||||+++++|++|..||......... .... .....
T Consensus 155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~------~~~~----------~~~~~ 217 (254)
T cd06627 155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL------FRIV----------QDDHP 217 (254)
T ss_pred c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHh----------ccCCC
Confidence 2 23345788999999998888899999999999999999999999755432110 0000 00111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+......+.+++.+||..+|++|||+.+++.
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 222334567889999999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=294.62 Aligned_cols=243 Identities=26% Similarity=0.388 Sum_probs=197.7
Q ss_pred CcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCHH
Q 014725 97 RILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLY 175 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 175 (419)
..||+|+||.||++.. .++..||+|+...........+.+|+.+++.++|||++++++++...+..+++|||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5699999999999987 467899999886655555677999999999999999999999999999999999999999999
Q ss_pred HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeeccc
Q 014725 176 HYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ 255 (419)
Q Consensus 176 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 255 (419)
+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... .......
T Consensus 106 ~~~~~~----~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 106 DIVTHT----RMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 987543 3789999999999999999999998 9999999999999999999999999987654322 1223345
Q ss_pred ccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHH
Q 014725 256 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEI 335 (419)
Q Consensus 256 gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 335 (419)
|++.|+|||.+.+..++.++|+||||+++|+|++|..||......+... ...... ... ........
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~---~~~~~~---------~~~--~~~~~~~~ 243 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK---MIRDNL---------PPK--LKNLHKVS 243 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhhC---------Ccc--cCCcccCC
Confidence 8899999999988889999999999999999999999997654432110 000000 000 00112234
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 336 ITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 336 ~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+.+++.+||+.+|.+||++.+++.
T Consensus 244 ~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 244 PSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 56888999999999999999999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=322.22 Aligned_cols=264 Identities=29% Similarity=0.437 Sum_probs=220.2
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec----C----CCEEEEEEccc-CChhhHHHHHHHHHHHhcC-CCcccccEEe
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA----D----GGIVAVKKSKL-VDESNVEQFINEVVILSQI-NHRNVVKLLG 154 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~----~----~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~ 154 (419)
.++...++..+.+.||+|.||.|++|... . ...||||..+. ....+.+.+..|+++|+.+ +||||+.++|
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 45566666677779999999999999842 1 34699999875 3345678899999999999 6999999999
Q ss_pred EEecCCcceEEEeecCCCCHHHHhhccC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014725 155 CCLESEVPLLVYEFIPNGTLYHYLHDQT-----EE--------FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKS 221 (419)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~-----~~--------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp 221 (419)
+|.+.+..++|+||+..|+|.+|++... .. ..++....+.++.|||.|++||++.. ++||||..
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa 446 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA 446 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence 9999999999999999999999998765 00 13888999999999999999999998 99999999
Q ss_pred CcEEECCCCcEEEeecCCceecccCCceeeecccc--cCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCC
Q 014725 222 SNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG--TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTD 298 (419)
Q Consensus 222 ~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~ 298 (419)
+|||++.+..+||+|||+++..............+ ...|||||.+....++.++||||||++|||++| |..||.+..
T Consensus 447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999999999765544444333332 456999999999999999999999999999999 999998744
Q ss_pred hhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 299 AEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.... +.+.+.+..+...|..+..++++++..||+.+|++||++.++.+.++.+
T Consensus 527 ~~~~---------------l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTEE---------------LLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred cHHH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 2211 2334445555667788889999999999999999999999999999985
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=292.82 Aligned_cols=242 Identities=23% Similarity=0.307 Sum_probs=187.4
Q ss_pred cccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHh---cCCCcccccEEeEEecCCcceEEEeecC
Q 014725 98 ILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILS---QINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
.||+|+||.||++... ++..+|+|.+.... ......+.+|..+++ ..+|||++.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999974 57899999765321 122233445544443 3479999999999999899999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQHG---VFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 999999987643 4899999999999999999999999 9999999999999999999999999987543221
Q ss_pred eecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 251 TTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
.....|+..|+|||.+.+ ..++.++|||||||++++|++|..||.......... .... .......
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~----~~~~----------~~~~~~~ 217 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRM----------TLTVNVE 217 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH----HHHH----------hhcCCcC
Confidence 123458999999999864 568999999999999999999999997654322110 0000 0011122
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAFE 362 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 362 (419)
.+...+..+.+++.+||+.||.+|| +++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 3344556789999999999999999 58888663
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=297.37 Aligned_cols=266 Identities=26% Similarity=0.350 Sum_probs=199.3
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCC---
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESE--- 160 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--- 160 (419)
+...++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 345678999999999999999999975 57889999876432 233456788999999999999999999987654
Q ss_pred -------cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEE
Q 014725 161 -------VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAK 233 (419)
Q Consensus 161 -------~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 233 (419)
..++|+||+++ ++..++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+|
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~k 156 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL--VHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIK 156 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEE
Confidence 78999999976 7777776542 24899999999999999999999998 99999999999999999999
Q ss_pred EeecCCceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH
Q 014725 234 VSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
|+|||++...............++..|+|||.+.+ ..++.++|||||||+++||++|+.||......+.. ..+...
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~---~~~~~~ 233 (302)
T cd07864 157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL---ELISRL 233 (302)
T ss_pred eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHH
Confidence 99999998764433222223346788999998765 45789999999999999999999999765432211 111111
Q ss_pred hcc---cchhHHHH--------Hh-----hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 313 MNE---DRLFEVLE--------AR-----VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 313 ~~~---~~~~~~~~--------~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... ..+..+.. .. .........+..+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 234 CGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred hCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 100 00000000 00 000001123467899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=298.03 Aligned_cols=263 Identities=25% Similarity=0.339 Sum_probs=198.0
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Ccce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~ 163 (419)
..++|++.+.||+|+||.||+|... ++..||+|.+.... ......+.+|+.++++++|+|++++++++.+. +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 3467999999999999999999974 58899999876432 22233567899999999999999999998765 4679
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 85 lv~e~~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~ 158 (309)
T cd07845 85 LVMEYCE-QDLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY 158 (309)
T ss_pred EEEecCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeec
Confidence 9999996 58888887643 35899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc--cchhH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE--DRLFE 320 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 320 (419)
..... ......++..|+|||.+.+ ..++.++|||||||++|||++|..||...+..+..... ...... .....
T Consensus 159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~---~~~~~~~~~~~~~ 234 (309)
T cd07845 159 GLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI---IQLLGTPNESIWP 234 (309)
T ss_pred CCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCChhhch
Confidence 53321 1222345788999999865 56789999999999999999999999876544321111 111100 00000
Q ss_pred HHHHh-------hccC-------CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEAR-------VLKE-------GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~-------~~~~-------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..... .... ........+.+++.+||+.||++|||+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 0000 00112456788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=293.07 Aligned_cols=260 Identities=22% Similarity=0.279 Sum_probs=193.5
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCC-CcccccEEeEEecC--CcceEEEe
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQIN-HRNVVKLLGCCLES--EVPLLVYE 167 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e 167 (419)
|++.+.||+|+||.||+|... ++..+|+|+.+.. .........+|+..+.++. |||++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 667889999999999999964 5788999987643 2222234567888898885 99999999999987 88999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|++ ++|.+++.... ..+++..++.++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 996 58888887543 25899999999999999999999998 999999999999999 999999999998654322
Q ss_pred ceeeecccccCCccCccccc-cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHH--------HHHhcccch
Q 014725 248 THLTTRVQGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF--------LQAMNEDRL 318 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~-~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~~~ 318 (419)
. .....++..|+|||++. +..++.++|||||||++|||++|..||...+..+........ .+.......
T Consensus 154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (282)
T cd07831 154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH 231 (282)
T ss_pred C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence 2 12345788999999764 456789999999999999999999999876543311100000 000000000
Q ss_pred hHHHHHhh----ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARV----LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+.. ........+..+.+++.+||+.+|.+||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000000 00001234578999999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=291.03 Aligned_cols=243 Identities=30% Similarity=0.382 Sum_probs=197.1
Q ss_pred ccccCcEEEEEEEecC-CCEEEEEEcccCCh---hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 99 LGQGGQGTVYKGMLAD-GGIVAVKKSKLVDE---SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
||+|+||.||++...+ ++.+++|.+..... ...+.+.+|++++++++||||+++++.+......+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999764 88999998764322 4556789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc------
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT------ 248 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~------ 248 (419)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99998644 4899999999999999999999998 99999999999999999999999999876433211
Q ss_pred -eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 249 -HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 249 -~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
.......++..|+|||.......+.++||||||+++++|++|..||......+. + .......
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~-~~~~~~~---------- 217 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------F-QNILNGK---------- 217 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHhcCC----------
Confidence 122334578899999999888899999999999999999999999976553321 1 1100000
Q ss_pred cCCCHH--HHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 328 KEGKEE--EIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 328 ~~~~~~--~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
...+.. .+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 218 IEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred cCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 111112 2567899999999999999999966665554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=302.50 Aligned_cols=266 Identities=24% Similarity=0.333 Sum_probs=199.3
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcC-CCcccccEEeEEecC--Ccc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQI-NHRNVVKLLGCCLES--EVP 162 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~ 162 (419)
..++|.+.+.||+|+||.||+|.+. ++..+|+|++.. ........+.+|+.+++++ +||||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4577899999999999999999975 577899998743 2233445678899999999 999999999998654 357
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||++ ++|..++... .+++..+..++.||+.||.|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 5999888754 4788999999999999999999998 99999999999999999999999999986
Q ss_pred cccCCce----eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH-----
Q 014725 243 IKVDQTH----LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA----- 312 (419)
Q Consensus 243 ~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~----- 312 (419)
....... ......|+..|+|||.+.+ ..++.++||||||+++|+|+||+.||......+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHH
Confidence 6433221 2233458899999998754 56789999999999999999999999765543321111000000
Q ss_pred ---hcccchhHHHHHhhc------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 313 ---MNEDRLFEVLEARVL------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 313 ---~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
+........++.... .......+..+.+++.+||+.+|.+|||+.++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000001110000 00011135678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=292.50 Aligned_cols=241 Identities=23% Similarity=0.300 Sum_probs=191.4
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 99 LGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
||+|+||+||++... ++..+|+|.+... .......+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999854 5789999987532 122345678899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecc
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 254 (419)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++...... ......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~~~ 154 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG--KKIKGR 154 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC--Cccccc
Confidence 999976543 25899999999999999999999998 999999999999999999999999998765331 122334
Q ss_pred cccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHH
Q 014725 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334 (419)
Q Consensus 255 ~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (419)
.++..|+|||.+.+..++.++||||||+++++|++|+.||.......... ....... ......+...
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~----------~~~~~~~~~~ 221 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTL----------EMAVEYPDKF 221 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhccc----------cccccCCccC
Confidence 57889999999988889999999999999999999999997654321100 0000000 0011222334
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHH
Q 014725 335 IITVAMLGKRCLNMIGKKRPSMKE 358 (419)
Q Consensus 335 ~~~l~~li~~cl~~~p~~RPt~~e 358 (419)
...+.+++.+||+.+|.+||+..+
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCc
Confidence 567899999999999999995444
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=302.74 Aligned_cols=269 Identities=22% Similarity=0.309 Sum_probs=201.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-----Cc
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES-----EV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 161 (419)
.++|.+.+.||+|+||+||+|.. .++..||+|.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 45799999999999999999996 45789999987642 233445678899999999999999999988644 34
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++++||+. ++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSSQ---TLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 68988887543 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHH--------H
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQ--------A 312 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~--------~ 312 (419)
...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+............. .
T Consensus 157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07858 157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235 (337)
T ss_pred ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhh
Confidence 754332 22233457889999998765 4689999999999999999999999976543221111110000 0
Q ss_pred hcccchhHHHHHhhc------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhc
Q 014725 313 MNEDRLFEVLEARVL------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE--LEGI 366 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~i 366 (419)
.........+..... ..........+.+++.+||+.+|.+|||+.++++. +..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred cCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 000011111100000 00112345668899999999999999999999875 4443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=294.01 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=193.8
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|...+.||+|+||.||++... ++..+|+|.+.... ......+.+|+.++.++. ||||+++++++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 4556678999999999999964 57899999876432 344567889999999996 99999999999998899999999
Q ss_pred cCCCCHHHHhh---ccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 169 IPNGTLYHYLH---DQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 169 ~~~g~L~~~l~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
+. +++.++.. ... ...+++..+..++.+++.||.|||+. + ++||||||+||+++.++.+||+|||+++...
T Consensus 85 ~~-~~l~~l~~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MD-ISLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cc-CCHHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 85 46655432 221 23589999999999999999999975 6 9999999999999999999999999987653
Q ss_pred cCCceeeecccccCCccCccccccC---CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSS---QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
... ......|+..|+|||++.+. .++.++|||||||++|||++|+.||..... ............
T Consensus 160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~----- 227 (288)
T cd06616 160 DSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGD----- 227 (288)
T ss_pred cCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCCC-----
Confidence 222 12233578899999998766 689999999999999999999999975431 111111111100
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.+..........+..+.+++.+||+.+|.+|||+.+|+..
T Consensus 228 -~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 228 -PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred -CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0111111223355679999999999999999999999773
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=293.94 Aligned_cols=247 Identities=24% Similarity=0.370 Sum_probs=196.5
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
..|...+.||+|+||.||+|... ++..+|+|.... ........+.+|+++++.++|||++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 34667788999999999999964 577899998753 22334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+. |+|.+++.... .++++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 95 EYCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (308)
T ss_pred EccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence 9996 68888776433 24889999999999999999999998 999999999999999999999999998765432
Q ss_pred CceeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 247 QTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
....+++.|+|||.+. ...++.++|||||||++|+|++|..||...+..+.. .... .
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-------~~~~--------~ 228 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------YHIA--------Q 228 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-------HHHh--------h
Confidence 2345788999999974 356788999999999999999999998664432210 0000 0
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
..............+.+++.+||+.+|.+||++.+++...
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~ 268 (308)
T cd06634 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR 268 (308)
T ss_pred cCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence 0001111223456789999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=294.82 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=208.6
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.+-|.+.+.||+|.|.+|-+|++ -.|..||||.+... +.....++.+|++.|+.++|||||++|.+...+...|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34577889999999999999985 46889999987643 2334467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE-CCCCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL-DDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill-~~~~~~kl~Dfgl~~~~~~ 245 (419)
|+=++|+|.+||-+...+ +.+....+++.||+.|+.|+|+.+ +|||||||+|+.+ ..-|-+||+|||++-.+..
T Consensus 97 ELGD~GDl~DyImKHe~G--l~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~P 171 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEG--LNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQP 171 (864)
T ss_pred EecCCchHHHHHHhhhcc--ccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCC
Confidence 999999999999887664 899999999999999999999999 9999999999877 4567899999999977654
Q ss_pred CCceeeecccccCCccCccccccCCCC-cccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.. ...+.+|+..|.|||.+.+..|+ ++.|||||||+||-|++|+.||......+. +..++|=
T Consensus 172 G~--kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDC 234 (864)
T KOG4717|consen 172 GK--KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDC 234 (864)
T ss_pred cc--hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhcc
Confidence 33 34567899999999999998886 789999999999999999999975443321 2222221
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....|.....++.+||..||..||.+|.+.++|..
T Consensus 235 --KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 235 --KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred --cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 23456677788999999999999999999998864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=301.35 Aligned_cols=269 Identities=25% Similarity=0.334 Sum_probs=205.6
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-----cce
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESE-----VPL 163 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~ 163 (419)
+|.+.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999975 48899999876533 344567899999999999999999999988765 779
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
++|||++ ++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 58988887543 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCc--eeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH--------
Q 014725 244 KVDQT--HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA-------- 312 (419)
Q Consensus 244 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~-------- 312 (419)
..... .......++..|+|||.+.+. .++.++|+||||+++++|++|+.||......+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhh
Confidence 54321 112334578899999999887 8899999999999999999999999877654321111100000
Q ss_pred hcccchhHHHHHhhc------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhcH
Q 014725 313 MNEDRLFEVLEARVL------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE--LEGIR 367 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~i~ 367 (419)
.........+..... .......+..+.+++.+||+.+|.+||++.+++.. +++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 234 ITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred ccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 000001111110000 00011234668899999999999999999999873 55443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=292.74 Aligned_cols=262 Identities=24% Similarity=0.304 Sum_probs=200.7
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
|.+.+.||+|++|.||+|... ++..+++|.+..... .....+.+|+.+++.++||||+++++++..+...++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 567789999999999999964 678899998764322 34567889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++ +|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~ 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence 75 8888887643 35899999999999999999999999 9999999999999999999999999998765433 1
Q ss_pred eeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH---H-
Q 014725 250 LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE---A- 324 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~- 324 (419)
......++..|+|||.+.+. .++.++|+||||+++|+|+||+.||...+..+................+..... .
T Consensus 154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd05118 154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233 (283)
T ss_pred cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhh
Confidence 22234578889999998776 789999999999999999999999976654332111100000000000000000 0
Q ss_pred --hh-------ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 --RV-------LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 --~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. ...........+.+++.+||+.+|.+||++.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00 00011234567899999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=292.93 Aligned_cols=255 Identities=24% Similarity=0.281 Sum_probs=201.3
Q ss_pred CccccCcccccCcEEEEEEEec----CCCEEEEEEcccCC----hhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcc
Q 014725 92 NYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLVD----ESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 162 (419)
+|++.+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4778899999999999999842 46789999875321 22345688999999999 599999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 99999999999999987543 4889999999999999999999988 99999999999999999999999999887
Q ss_pred cccCCceeeecccccCCccCccccccCC--CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
.............|+..|+|||.+.+.. .+.++||||||++++||++|..||........ ... ....
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~-~~~~-------- 223 (288)
T cd05583 155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSE-ISRR-------- 223 (288)
T ss_pred cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHH-HHHH--------
Confidence 5443332233455889999999987654 78899999999999999999999964322110 000 0000
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
... .....+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 224 ~~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 224 ILK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred HHc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 000 0112233345678899999999999999999988877765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=301.11 Aligned_cols=266 Identities=22% Similarity=0.327 Sum_probs=200.3
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEec----CCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLE----SEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 162 (419)
.++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 478999999999999999999964 5889999987643 22345678889999999999999999998763 3467
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSDQ---PLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999995 68999886543 4899999999999999999999998 99999999999999999999999999976
Q ss_pred cccCCce---eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH--------HH
Q 014725 243 IKVDQTH---LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF--------FL 310 (419)
Q Consensus 243 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--------~~ 310 (419)
....... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 1223468899999999765 4688999999999999999999999976554321111100 00
Q ss_pred HHhcccchhHHHHHhhcc-CC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 311 QAMNEDRLFEVLEARVLK-EG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~-~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.....+.+.+........ .. ....+..+.+++.+||+.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 294 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH 294 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 011111111111110000 00 12235678999999999999999999998773
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=294.83 Aligned_cols=266 Identities=23% Similarity=0.324 Sum_probs=195.6
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc-----
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEV----- 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 161 (419)
.++|++.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++...+.
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 457999999999999999999964 57899999875432 2223456789999999999999999999876543
Q ss_pred ---ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 162 ---PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 162 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
.++||||+. ++|.+++..... .+++.+++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCE-HDLAGLLSNKNV--KFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCC-cCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 499999996 588888765432 4899999999999999999999998 9999999999999999999999999
Q ss_pred CceecccCCce---eeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc
Q 014725 239 ASRTIKVDQTH---LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 239 l~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
++......... ......++..|+|||.+.+. .++.++||||||+++|||++|..||....................
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT 244 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99865432211 11234567889999988664 478899999999999999999999977654332211111111000
Q ss_pred ccch-----hHHHHHhhccCC----------CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 EDRL-----FEVLEARVLKEG----------KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 ~~~~-----~~~~~~~~~~~~----------~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+.. ....+....... +......+.+++.+||..+|.+|||+.++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 0000 000000000000 0011245678999999999999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=292.63 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=196.3
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|++.+.||+|++|.||+|... +++.||+|...... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 57899999999999999999975 57889999875432 2334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCceecccC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~ 246 (419)
|++ ++|.+++..... ..+++..+..++.||+.||.|||+++ ++|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 995 588888765432 24678888899999999999999998 999999999999985 567999999999765332
Q ss_pred CceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch------h
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL------F 319 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~ 319 (419)
. .......+++.|+|||++.+ ..++.++||||||+++|+|+||..||......+................+ .
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (294)
T PLN00009 157 V-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235 (294)
T ss_pred c-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccch
Confidence 1 11123356889999998866 45789999999999999999999999765543211100000000000000 0
Q ss_pred HHHHH--hhccC----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 320 EVLEA--RVLKE----GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 320 ~~~~~--~~~~~----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..... ..... ........+.+++.+|++.+|++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 236 DYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 00000 01123456889999999999999999999986
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=331.11 Aligned_cols=253 Identities=26% Similarity=0.357 Sum_probs=206.1
Q ss_pred HHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..+-+|.-...||.|.||.||.|.. ++|...|+|.++.. .......+.+|+.++..++|||+|+++|+-.+.+..+|
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence 3456788889999999999999995 55777899976542 33445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
.||||++|+|.+.+.... ..++.....+..|++.|+.|||++| ||||||||+||+++.+|.+|++|||.|....
T Consensus 1312 FMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred HHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEec
Confidence 999999999999987643 2566666678899999999999999 9999999999999999999999999998876
Q ss_pred cCCcee---eecccccCCccCccccccC---CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 245 VDQTHL---TTRVQGTFGYLDPEYFRSS---QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 245 ~~~~~~---~~~~~gt~~y~aPE~~~~~---~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
...... .....||+.|||||++.+. ....+.||||||||++||+||+.||...+.+-. +
T Consensus 1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~a---------------I 1450 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWA---------------I 1450 (1509)
T ss_pred CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhH---------------H
Confidence 543222 2345699999999999753 456799999999999999999999987665321 2
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+..+...-.++.|.....+=.+++.+||+.||++|=++.|+++
T Consensus 1451 My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1451 MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 2223333345566667777889999999999999977776644
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=292.13 Aligned_cols=261 Identities=20% Similarity=0.251 Sum_probs=194.2
Q ss_pred ccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 95 ANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 95 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
+.+.+|.|+++.||++.. ++..||+|+.... .....+.+.+|+.+++.++||||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 344555666666666655 6889999997653 3455678999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc----
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT---- 248 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~---- 248 (419)
+|.+++...... .+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (314)
T cd08216 85 SCEDLLKTHFPE-GLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160 (314)
T ss_pred CHHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence 999999865332 4888999999999999999999998 99999999999999999999999998875532211
Q ss_pred --eeeecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh----cccc---
Q 014725 249 --HLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM----NEDR--- 317 (419)
Q Consensus 249 --~~~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~----~~~~--- 317 (419)
.......++..|+|||++.. ..++.++|||||||+++||++|+.||........ ......... ....
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 238 (314)
T cd08216 161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPL 238 (314)
T ss_pred cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhh
Confidence 11123446778999999876 3588999999999999999999999986543221 111000000 0000
Q ss_pred ----hh--------HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 318 ----LF--------EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 318 ----~~--------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.. ..................+.+++.+||+.+|++|||+.++++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 00 0000001111122344678899999999999999999999873
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=290.10 Aligned_cols=251 Identities=25% Similarity=0.306 Sum_probs=196.5
Q ss_pred CccccCcccccCcEEEEEEEe----cCCCEEEEEEcccCC----hhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcc
Q 014725 92 NYNANRILGQGGQGTVYKGML----ADGGIVAVKKSKLVD----ESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 162 (419)
+|++.+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|+.+++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999986 367889999876422 22346788899999999 599999999999998899
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 99999999999999997643 4788999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCccCccccccC--CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
.............|+..|+|||.+... .++.++||||||+++|+|++|..||....... ...........
T Consensus 155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~------ 226 (290)
T cd05613 155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILK------ 226 (290)
T ss_pred cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhc------
Confidence 644332233345688999999998753 46789999999999999999999996432211 11111111000
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
.....+......+.+++.+||+.+|.+|| +..+++.
T Consensus 227 -----~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 227 -----SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred -----cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 01122334456788999999999999997 4555543
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=284.78 Aligned_cols=244 Identities=27% Similarity=0.291 Sum_probs=190.0
Q ss_pred CcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHH-hcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVIL-SQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|... +++.||+|...... ......+..|..++ ...+|||++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 56999999999999964 57899999876432 12223345555444 455899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
++|.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.... .
T Consensus 82 ~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~ 150 (260)
T cd05611 82 GDCASLIKTLG---GLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N 150 (260)
T ss_pred CCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence 99999997643 4889999999999999999999998 99999999999999999999999999876432 2
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
....++..|+|||.+.+..++.++||||||+++++|++|..||...+.... + ........ .......
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~-~~~~~~~~------~~~~~~~ 217 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------F-DNILSRRI------NWPEEVK 217 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------H-HHHHhccc------CCCCccc
Confidence 234578899999999888899999999999999999999999976543221 0 00000000 0001112
Q ss_pred HHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 332 EEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 332 ~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
...+..+.+++.+||+.+|++||++.++.+.|.
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~ 250 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS 250 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence 234567899999999999999998766655443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=294.52 Aligned_cols=262 Identities=21% Similarity=0.305 Sum_probs=196.1
Q ss_pred Cccccc--CcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQG--GQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G--~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
..||+| +||+||++.+ .+++.||+|..... .....+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456776 9999999997 46889999987643 234457789999999999999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee-
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL- 250 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 250 (419)
++|.+++...... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++||+.+..........
T Consensus 84 ~~l~~~l~~~~~~-~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYFPE-GMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 9999998865432 4889999999999999999999998 9999999999999999999999998654322111100
Q ss_pred -----eecccccCCccCccccccC--CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc------
Q 014725 251 -----TTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR------ 317 (419)
Q Consensus 251 -----~~~~~gt~~y~aPE~~~~~--~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 317 (419)
.....++..|+|||++.+. .++.++|||||||+++||++|+.||......... ........
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~------~~~~~~~~~~~~~~ 233 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML------LQKLKGPPYSPLDI 233 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH------HHHhcCCCCCCccc
Confidence 0112245679999998763 4789999999999999999999999765432210 00000000
Q ss_pred --------------------h----------hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHh
Q 014725 318 --------------------L----------FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF--ELEG 365 (419)
Q Consensus 318 --------------------~----------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~ 365 (419)
+ ...............+...+.+++.+||+.||++|||+.++++ .++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~ 313 (328)
T cd08226 234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ 313 (328)
T ss_pred cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence 0 0000011111223345677899999999999999999999975 3444
Q ss_pred cHH
Q 014725 366 IRA 368 (419)
Q Consensus 366 i~~ 368 (419)
++.
T Consensus 314 ~~~ 316 (328)
T cd08226 314 VKE 316 (328)
T ss_pred HHH
Confidence 443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=289.96 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=203.4
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 165 (419)
++|.+.+.||+|+||.||+|... ++..+|+|..... .....+.+.+|+.+++.++ ||||+++++++.+.+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46889999999999999999974 6889999987542 2334567889999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999998653 5899999999999999999999998 99999999999999999999999999986643
Q ss_pred CCc-------------------eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHH
Q 014725 246 DQT-------------------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV 306 (419)
Q Consensus 246 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 306 (419)
... .......++..|+|||......++.++||||||++++++++|..||........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---- 230 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT---- 230 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH----
Confidence 221 122334578899999999888899999999999999999999999986653211
Q ss_pred HHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCH----HHHHH
Q 014725 307 GFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM----KEVAF 361 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~----~evl~ 361 (419)
+.... ......+...+..+.+++.+||+.+|.+||++ .+++.
T Consensus 231 --~~~~~-----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 231 --FQKIL-----------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred --HHHHH-----------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 10000 11122333445678999999999999999999 66653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=290.79 Aligned_cols=243 Identities=27% Similarity=0.403 Sum_probs=193.5
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
|...+.||+|+||+||+|... ++..+++|.+... .......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 666778999999999999964 5778999987542 223446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+. ++|.+++..... ++++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~~--~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHKK--PLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 95 578887765432 5899999999999999999999998 99999999999999999999999999864321
Q ss_pred eeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 249 HLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.....|+..|+|||++. ...++.++|||||||++|+|++|..||...+..... ...... .
T Consensus 174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~---------~ 236 (313)
T cd06633 174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN---------D 236 (313)
T ss_pred --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhc---------C
Confidence 22346888999999974 456889999999999999999999998765432211 000000 0
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
............+.+++.+||+.+|.+||++.+++.
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 001111223346889999999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=305.02 Aligned_cols=204 Identities=32% Similarity=0.513 Sum_probs=176.2
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC------Ccce
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLES------EVPL 163 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~ 163 (419)
.|...+.||+|+||.||+|++ ..|+.||||.++.. .....+...+|+++|++++|||||++++.-.+. ....
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 456678899999999999995 56899999987752 334567889999999999999999999876543 3568
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC--CCC--cEEEeecCC
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD--DKY--RAKVSDFGA 239 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~--~~kl~Dfgl 239 (419)
+|||||.+|||...+.+..+..-+++.+.+.+..++..||.|||+++ |+||||||.||++- ++| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999998777667999999999999999999999999 99999999999992 333 479999999
Q ss_pred ceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChh
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~ 300 (419)
|+.+..+. ......||..|++||.... ..|+..+|.|||||++|+.+||..||......
T Consensus 171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p 230 (732)
T KOG4250|consen 171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP 230 (732)
T ss_pred cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence 99875443 6677889999999999984 88999999999999999999999999765443
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=284.88 Aligned_cols=248 Identities=22% Similarity=0.287 Sum_probs=191.0
Q ss_pred HHHHHhcCccccCcc--cccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCC
Q 014725 85 DLEKATDNYNANRIL--GQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESE 160 (419)
Q Consensus 85 ~~~~~~~~y~~~~~i--g~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 160 (419)
+.....++|.+.+.+ |+|+||.||++.. .++..+|+|.......... |+.....+ +|||++++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 334445677777776 9999999999996 4567888888654221111 22222222 7999999999999999
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeecCC
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGA 239 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl 239 (419)
..++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence 9999999999999999997653 5899999999999999999999999 99999999999999988 999999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
++..... ....++..|+|||++.+..++.++||||||++++||++|..||........ ... ......
T Consensus 157 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~-~~~~~~------ 223 (267)
T PHA03390 157 CKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLE-SLLKRQ------ 223 (267)
T ss_pred ceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHH-HHHHhh------
Confidence 8765322 223578999999999988999999999999999999999999975433211 000 011100
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS-MKEVAF 361 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~ 361 (419)
. ............+.+++.+||+.+|.+||+ +.++++
T Consensus 224 ---~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ---Q--KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---c--ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0 011122245567899999999999999996 688864
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=290.84 Aligned_cols=253 Identities=25% Similarity=0.404 Sum_probs=195.0
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVD-ESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 165 (419)
..++|.+.+.||+|+||.||+|.+.+ +..||||.++... ......+..|+.++... .||||+++++++.+....+++
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 34678889999999999999999865 8889999986432 23445677788777666 499999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
|||+. ++|.+++..... .+++..+..++.|++.||.|||+ .+ ++||||+|+||++++++.+||+|||++....
T Consensus 93 ~e~~~-~~l~~l~~~~~~--~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 93 MELMS-TCLDKLLKRIQG--PIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eeccC-cCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 99985 577777765332 58999999999999999999997 46 9999999999999999999999999987654
Q ss_pred cCCceeeecccccCCccCccccccCC----CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQ----FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
.... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||........ ..........
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~~--- 236 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE-----VLTKILQEEP--- 236 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH-----HHHHHhcCCC---
Confidence 3221 12234778999999987553 78899999999999999999999965332110 0111111100
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
............+.+++.+||+.+|.+||++.+++..
T Consensus 237 -----~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 -----PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred -----CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0001111244578999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=285.83 Aligned_cols=241 Identities=22% Similarity=0.300 Sum_probs=186.9
Q ss_pred cccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHH---HHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 98 ILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVV---ILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
.||+|+||.||+|... +++.||+|.+.... ......+..|.. .++..+||||+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999964 57899999865321 111222344433 4445679999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+++|..++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+|||++.......
T Consensus 81 g~~L~~~l~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQHG---VFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 999999887543 5899999999999999999999998 9999999999999999999999999987653221
Q ss_pred eecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 251 TTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
.....|+..|+|||.+.++ .++.++||||+|++++||++|+.||.......... .... .......
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~----------~~~~~~~ 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRM----------TLTMAVE 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHH----------hhccCCC
Confidence 2234689999999998754 68999999999999999999999997653221100 0000 0001112
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
.+...+..+.+++.+|+..+|.+|| ++.++++
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 2333456799999999999999999 8888875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=286.57 Aligned_cols=259 Identities=27% Similarity=0.355 Sum_probs=195.3
Q ss_pred ccccCcccccCcEEEEEEEecC-CCEEEEEEcccCC--hhhHHHHHHHHHHHhcC---CCcccccEEeEEecCCc-----
Q 014725 93 YNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVD--ESNVEQFINEVVILSQI---NHRNVVKLLGCCLESEV----- 161 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~----- 161 (419)
|++.+.||+|+||.||+|.+.. +..+|+|...... ......+.+|+.+++++ +|||++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5678899999999999999764 7899999886432 22234566787777665 69999999999988776
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.+++|||+. ++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999996 489998876433 24899999999999999999999998 9999999999999999999999999997
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc-c--ch
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE-D--RL 318 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-~--~~ 318 (419)
....... .....++..|+|||.+.+..++.++|+|||||+++||++|..||......+. ... +...... . .+
T Consensus 156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~--~~~-~~~~~~~~~~~~~ 230 (287)
T cd07838 156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQ--LDK-IFDVIGLPSEEEW 230 (287)
T ss_pred eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHH--HHH-HHHHcCCCChHhc
Confidence 7543221 1223478899999999988999999999999999999999999976554321 111 1111100 0 00
Q ss_pred h-------HHHHHhhc---cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 F-------EVLEARVL---KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~-------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. ........ ..........+.+++.+||+.+|.+||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 00000000 0111233466789999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=297.02 Aligned_cols=268 Identities=22% Similarity=0.298 Sum_probs=199.7
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES 159 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 159 (419)
..++....++|.+.+.||+|+||.||+|.. .++..||+|++... .....+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 445667789999999999999999999985 46789999987643 223346788999999999999999999988643
Q ss_pred ------CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEE
Q 014725 160 ------EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAK 233 (419)
Q Consensus 160 ------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 233 (419)
...+++++++ +++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3357888876 78998887643 3889999999999999999999999 99999999999999999999
Q ss_pred EeecCCceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH----
Q 014725 234 VSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF---- 308 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~---- 308 (419)
|+|||+++..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...+..........
T Consensus 161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999998764321 223457889999998866 5688999999999999999999999976544321110000
Q ss_pred ----HHHHhcccchhHHHHHhhc-cCC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 309 ----FLQAMNEDRLFEVLEARVL-KEG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 309 ----~~~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.............+..... ... .......+.+++.+|++.+|.+||++.+++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000000000000000 000 00124568899999999999999999998764
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=298.13 Aligned_cols=261 Identities=24% Similarity=0.361 Sum_probs=195.6
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecC---------
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES--------- 159 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------- 159 (419)
..+|.+.+.||.|+||.||+|... ++..||+|++........+.+.+|+++++.++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 468999999999999999999964 5789999988766556667889999999999999999999876543
Q ss_pred -----CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC-CCCcEE
Q 014725 160 -----EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAK 233 (419)
Q Consensus 160 -----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~k 233 (419)
...++||||++ ++|.+++... .+++..+..++.||+.||.|||+.+ ++||||||+||+++ +++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQG----PLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34689999996 5898888642 4889999999999999999999998 99999999999997 456789
Q ss_pred EeecCCceecccCCcee--eecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH
Q 014725 234 VSDFGASRTIKVDQTHL--TTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 310 (419)
|+|||+++......... .....++..|+|||.+.. ..++.++|||||||++|+|++|+.||......+.... ..
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~---~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL---IL 232 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH
Confidence 99999998654221111 122357889999998654 5688899999999999999999999976554322110 00
Q ss_pred HHhcc------cchhHHHHHhh-----ccCC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 311 QAMNE------DRLFEVLEARV-----LKEG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 311 ~~~~~------~~~~~~~~~~~-----~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..... ........... .... .......+.+++.+||+.+|.+|||+.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 00000 00000000000 0000 1123356889999999999999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=319.78 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=190.7
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEec--------
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLE-------- 158 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 158 (419)
-..+|+..+.||+||||.||+++.+ ||+.||||++... .......+.+|+..|++|+|||||+++..+.+
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 3456888899999999999999964 7999999998764 34455678999999999999999998743221
Q ss_pred ---------------------------------------------------------C----------------------
Q 014725 159 ---------------------------------------------------------S---------------------- 159 (419)
Q Consensus 159 ---------------------------------------------------------~---------------------- 159 (419)
+
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 0
Q ss_pred --------------------------------CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHh
Q 014725 160 --------------------------------EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207 (419)
Q Consensus 160 --------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH 207 (419)
...||-||||+...|.+++.++.-. -.....|+++.+|+.||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHHH
Confidence 1147889999988888888765421 135678999999999999999
Q ss_pred hcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc-----------------cCCceeeecccccCCccCccccccC-
Q 014725 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK-----------------VDQTHLTTRVQGTFGYLDPEYFRSS- 269 (419)
Q Consensus 208 ~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~- 269 (419)
+.| ||||||||.||++|++..|||+|||+++... .......+..+||.-|+|||++.+.
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~ 791 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS 791 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence 999 9999999999999999999999999998721 0111123567799999999998764
Q ss_pred --CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhc
Q 014725 270 --QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLN 347 (419)
Q Consensus 270 --~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 347 (419)
.|+.|+|+||||+|++||+ .||....+.. .++...+...+... .....+..+.-..+|.++++
T Consensus 792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa------~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~ 856 (1351)
T KOG1035|consen 792 SNKYNSKIDMYSLGIVLFEML---YPFGTSMERA------SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS 856 (1351)
T ss_pred cccccchhhhHHHHHHHHHHh---ccCCchHHHH------HHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence 5999999999999999998 4665432211 12222222211110 11133344556779999999
Q ss_pred cCCCCCCCHHHHHH
Q 014725 348 MIGKKRPSMKEVAF 361 (419)
Q Consensus 348 ~~p~~RPt~~evl~ 361 (419)
.||++|||+.|++.
T Consensus 857 hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 857 HDPSKRPTATELLN 870 (1351)
T ss_pred CCCccCCCHHHHhh
Confidence 99999999999875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=285.66 Aligned_cols=262 Identities=24% Similarity=0.333 Sum_probs=196.2
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh-hhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEeec
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE-SNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
|.+.+.||+|+||.||+|... +++.|++|+...... .......+|+..+++++ |||++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 667889999999999999975 467899998764322 22234567999999998 999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
+++|.+++..... ..+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRKG-KPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 8899998876542 35899999999999999999999998 99999999999999999999999999986543221
Q ss_pred eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc----------cch
Q 014725 250 LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE----------DRL 318 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~ 318 (419)
.....++..|+|||++.. ..++.++|+||||++++||++|+.||......+.............. ..+
T Consensus 155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 223457889999998754 56789999999999999999999999766543221100000000000 000
Q ss_pred hHHHHHhh---ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARV---LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+.... ...........+.+++.+||+.+|.+|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 234 GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000000 00000111456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=294.82 Aligned_cols=262 Identities=25% Similarity=0.338 Sum_probs=195.9
Q ss_pred hcCcc-ccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhh--------------HHHHHHHHHHHhcCCCcccccEE
Q 014725 90 TDNYN-ANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESN--------------VEQFINEVVILSQINHRNVVKLL 153 (419)
Q Consensus 90 ~~~y~-~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~l~ 153 (419)
.++|. +.+.||+|+||+||+|.+. +++.||+|......... ...+.+|+++++.++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 35565 4577999999999999964 58899999875432211 12477899999999999999999
Q ss_pred eEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEE
Q 014725 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAK 233 (419)
Q Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 233 (419)
+++...+..+++|||++ ++|.+++.... .+++.....++.|++.||.|||+.+ ++|+||+|+||+++.++.++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~k 159 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI---RLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICK 159 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEE
Confidence 99999999999999996 68999887533 4889999999999999999999998 99999999999999999999
Q ss_pred EeecCCceecccCC-------------ceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCCh
Q 014725 234 VSDFGASRTIKVDQ-------------THLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299 (419)
Q Consensus 234 l~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~ 299 (419)
|+|||+++...... ........++..|+|||.+.+. .++.++|||||||+++||++|+.||...+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 160 IADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred ECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999997654111 1111223467889999998764 468999999999999999999999987654
Q ss_pred hhhccHHHHHHHHhc---ccchhHHHH--------Hh---hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 300 EEDRSLVGFFLQAMN---EDRLFEVLE--------AR---VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~---~~~~~~~~~--------~~---~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+.. ..+..... ...+.+... .. ............+.+++.+||+.+|++||++.+++.
T Consensus 240 ~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 240 IDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 3211 11111110 000000000 00 000001122456889999999999999999999986
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=283.78 Aligned_cols=249 Identities=24% Similarity=0.298 Sum_probs=195.3
Q ss_pred CccccCcccccCcEEEEEEEecC-CCEEEEEEccc-----CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKL-----VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~-----~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
+|.+.+.||+|+||.||++.+.. +..+++|..+. .......++..|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 58888999999999999998643 33344444332 1223344677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 166 YEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
|||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988752 22335899999999999999999999998 999999999999986 469999999987654
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
... .......|++.|+|||.+.+..++.++|+||||+++++|++|..||........ .... ..
T Consensus 157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~------~~~~----------~~ 219 (260)
T cd08222 157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV------VLRI----------VE 219 (260)
T ss_pred CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH------HHHH----------Hc
Confidence 322 222334578899999999888889999999999999999999999965432211 1110 01
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
......+...+..+.+++.+||..+|++||++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1112233455668899999999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=271.28 Aligned_cols=249 Identities=26% Similarity=0.412 Sum_probs=196.9
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEccc-CChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEeec
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL-VDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.+.+..||.|+.|+|++++.+ .|...|||.... .+.+..++++..+.++...+ +|+||+.+|||..+...++.||.|
T Consensus 94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM 173 (391)
T KOG0983|consen 94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM 173 (391)
T ss_pred hhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH
Confidence 344567999999999999975 477899998754 45566778888888777664 899999999999999999999998
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
...++.++..... ++++..+-++...+..||.||.+++. |+|||+||+|||+|+.|++||+|||++-.+-....
T Consensus 174 -s~C~ekLlkrik~--piPE~ilGk~tva~v~AL~YLKeKH~--viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA- 247 (391)
T KOG0983|consen 174 -STCAEKLLKRIKG--PIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA- 247 (391)
T ss_pred -HHHHHHHHHHhcC--CchHHhhhhhHHHHHHHHHHHHHhcc--eeecccCccceEEccCCCEEeecccccceeecccc-
Confidence 4566677765443 58888888999999999999999874 99999999999999999999999999987643332
Q ss_pred eeecccccCCccCcccccc---CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 250 LTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~---~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
.+...|-+.|||||.+.- ..|+.++||||||++++||.||+.||.+.+.+-. + +..+++...
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~--------ltkvln~eP 312 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------V--------LTKVLNEEP 312 (391)
T ss_pred -cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------H--------HHHHHhcCC
Confidence 344568899999999864 4688999999999999999999999998665321 1 111222111
Q ss_pred -ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 327 -LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 327 -~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.......+...+.+++..||..|+.+||.+.++++.
T Consensus 313 P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 313 PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 011112366789999999999999999999998763
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=290.76 Aligned_cols=247 Identities=24% Similarity=0.326 Sum_probs=202.0
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.+.|+.-+.||+||||.||-+.. ..|+.+|.|++.. .........++|-.+|.+++.+.||.+-..+...+.+++|
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 45678889999999999999985 4577889887532 1122334578899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
+..|+||+|.-+|.+.+.. -+++....-++.+|+.||++||+.. ||+||+||+|||+|+.|+++|+|+|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~-gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNP-GFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccCCC-CCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 9999999999988876653 5899999999999999999999999 99999999999999999999999999998765
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.... ...+||.+|||||++.++.|+...|.|||||++|||+.|+.||....+.... +++.+..- .
T Consensus 340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~------------eEvdrr~~-~ 404 (591)
T KOG0986|consen 340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR------------EEVDRRTL-E 404 (591)
T ss_pred CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH------------HHHHHHHh-c
Confidence 4433 3347999999999999999999999999999999999999999866543211 11111110 0
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCC
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPS 355 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 355 (419)
.....+....++...+.+..|+.||.+|.-
T Consensus 405 ~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 405 DPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred chhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 112345666778888999999999999954
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=297.20 Aligned_cols=252 Identities=27% Similarity=0.369 Sum_probs=208.1
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
+.......|.+...||+|.|+.|.+|++ ..+..||||.+.. .+......+.+|+++|..++|||||+++.+......
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ 129 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT 129 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence 3345567899999999999999999996 4578999998754 233445668999999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.|+||||+.+|.+.+|+..... +.+.....++.|+..|++|||+++ |+|||||++||||+.+.++||+|||++.
T Consensus 130 lylV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~ 203 (596)
T KOG0586|consen 130 LYLVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFST 203 (596)
T ss_pred eEEEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccce
Confidence 9999999999999999998764 556788889999999999999999 9999999999999999999999999998
Q ss_pred ecccCCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
.+. ........+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.+.+...
T Consensus 204 ~~~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv-------------- 267 (596)
T KOG0586|consen 204 FFD--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV-------------- 267 (596)
T ss_pred eec--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh--------------
Confidence 875 3344566789999999999998776 58999999999999999999999876543321100
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+... ...+.-....+.++++++|-.+|.+|+++.++.+
T Consensus 268 -l~gk--~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 268 -LRGK--YRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred -eeee--ecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 0000 1112222345788999999999999999988854
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=292.19 Aligned_cols=266 Identities=23% Similarity=0.296 Sum_probs=194.9
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCC------
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESE------ 160 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 160 (419)
.++|++.+.||+|+||.||+|... +++.+|+|++.... ......+.+|+++++.++||||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 578999999999999999999964 57889999875432 222346788999999999999999999876543
Q ss_pred --cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 161 --VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 161 --~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
..++||||+.+ +|...+.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.++|+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35899999964 7777776533 25899999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCce----------eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHH
Q 014725 239 ASRTIKVDQTH----------LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 239 l~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 307 (419)
+++........ ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865422111 1123456888999998765 457899999999999999999999997655433211111
Q ss_pred HHHHHhcccchh------HHHHHhhccCCC-------HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 308 FFLQAMNEDRLF------EVLEARVLKEGK-------EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 308 ~~~~~~~~~~~~------~~~~~~~~~~~~-------~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.......+..+. ...+.......+ ......+.+++.+||+.+|.+|||+.+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 100000000000 000000000000 112256889999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=293.63 Aligned_cols=264 Identities=22% Similarity=0.303 Sum_probs=199.3
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEec-CCcc
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLE-SEVP 162 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~ 162 (419)
...+++|++.+.||+|+||.||+|... ++..||+|++.. ......+.+.+|+++++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 346788999999999999999999954 688999998643 223345678899999999999999999999875 5578
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++++||+ +++|.+++... .+++.....++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||++..
T Consensus 86 ~lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSR----PLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 8999998 56898888643 3778888899999999999999999 99999999999999999999999999875
Q ss_pred cccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH--------HHHHh
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF--------FLQAM 313 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~~~ 313 (419)
.... .....++..|+|||.+.+ ..++.++||||||+++++|+||+.||.............. +....
T Consensus 158 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 4321 123356888999998765 5789999999999999999999999977654321111110 00110
Q ss_pred cccchhHHHHHhhc-cCCC-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 314 NEDRLFEVLEARVL-KEGK-----EEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 314 ~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
......+....... ...+ ......+.+++.+||+.+|.+|||+.+++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00111111111000 0111 1234678999999999999999999998664
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=278.01 Aligned_cols=242 Identities=26% Similarity=0.352 Sum_probs=201.4
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|...++||+|.||.|-+++- ..++.+|+|+++. ........-+.|-++|+..+||.+..+.-.|+..+..|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 457799999999999999999994 5688899998764 234445666789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||..||.|.-+|.+.. .+++....-+-..|..||.|||+++ ||+||||.+|+|+|.+|++||+||||++.-
T Consensus 246 VMeyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~- 318 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEE- 318 (516)
T ss_pred EEEEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhc-
Confidence 999999999998887643 4777777778899999999999998 999999999999999999999999999753
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.........++|||.|+|||++..+.|+.+.|.|.+||++|||++|+.||...+... +++++--
T Consensus 319 I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k----------------LFeLIl~ 382 (516)
T KOG0690|consen 319 IKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK----------------LFELILM 382 (516)
T ss_pred ccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH----------------HHHHHHh
Confidence 233445678899999999999999999999999999999999999999997655432 3332211
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCC
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRP 354 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 354 (419)
. ....|....++...|+...|..||.+|.
T Consensus 383 e-d~kFPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 383 E-DLKFPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred h-hccCCccCCHHHHHHHHHHhhcChHhhc
Confidence 1 1123444555677888899999999995
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=294.28 Aligned_cols=265 Identities=22% Similarity=0.303 Sum_probs=198.8
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESE- 160 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~- 160 (419)
.+....++|.+.+.||+|+||.||+|.. .++..||+|+.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 3455678899999999999999999985 46889999987532 2233456889999999999999999999987554
Q ss_pred -----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 014725 161 -----VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235 (419)
Q Consensus 161 -----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 235 (419)
..++||||+ +++|.+++... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++|+
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~ 160 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKHE----KLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKIL 160 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEe
Confidence 348999999 77998888642 4899999999999999999999998 9999999999999999999999
Q ss_pred ecCCceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHH--------
Q 014725 236 DFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV-------- 306 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~-------- 306 (419)
|||++...... .....+++.|+|||.+.+ ..++.++|+||||+++++|++|..||...+........
T Consensus 161 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 236 (343)
T cd07880 161 DFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236 (343)
T ss_pred ecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99998764322 123357889999999876 46889999999999999999999999865532210000
Q ss_pred HHHHHHhcccchhHHHHHhhc------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 307 GFFLQAMNEDRLFEVLEARVL------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+...+.............. ..........+.+++.+|++.+|.+|||+.+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000011100000000000000 0001123346889999999999999999999984
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=294.62 Aligned_cols=264 Identities=22% Similarity=0.333 Sum_probs=194.7
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC------
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESE------ 160 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 160 (419)
.++|...+.||+|+||.||+|.. .++..||+|++... .......+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 47899999999999999999996 46889999987542 2223456889999999999999999999987543
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..++|+||+. .+|..+.. ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEecccc-cCHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 3589999996 47776652 14789999999999999999999998 999999999999999999999999998
Q ss_pred eecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH--------HHH
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF--------FLQ 311 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--------~~~ 311 (419)
+..... .....++..|+|||.+.+ ..++.++|||||||+++||++|+.||...+.......... +..
T Consensus 165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07879 165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQ 240 (342)
T ss_pred cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence 764321 123457889999999876 4688999999999999999999999986543221100000 000
Q ss_pred HhcccchhHHHHHhh---ccCC---CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH--HHhc
Q 014725 312 AMNEDRLFEVLEARV---LKEG---KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE--LEGI 366 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~---~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~--L~~i 366 (419)
............... .... .......+.+++.+||+.||.+||++.+++.. ++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 241 KLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000000000000000 0000 01123467899999999999999999999853 5554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=285.64 Aligned_cols=259 Identities=27% Similarity=0.364 Sum_probs=199.1
Q ss_pred ccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 93 YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
|+..+.||+|+||.||+|... +++.+|+|...... ....+.+.+|+.+++.++|||++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999975 48899999877542 334467889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
+ ++|.+++.... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 7 59999998753 24899999999999999999999998 99999999999999999999999999987543322
Q ss_pred eeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc---ccchhHH----
Q 014725 250 LTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN---EDRLFEV---- 321 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---- 321 (419)
......++..|+|||.+.+. .++.++||||||++++||++|..||......+.. ....+... +..+...
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 230 (282)
T cd07829 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL---FKIFQILGTPTEESWPGVTKLP 230 (282)
T ss_pred ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHHHhCCCcHHHHHhhcccc
Confidence 12223457789999998766 8899999999999999999999999765533211 11111100 0000000
Q ss_pred -----HHH---hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 -----LEA---RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 -----~~~---~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... .............+.+++.+||+.+|++||++.+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 231 DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 000 0000001112457899999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=290.83 Aligned_cols=263 Identities=23% Similarity=0.290 Sum_probs=192.6
Q ss_pred CccccCcccccCcEEEEEEEecC---CCEEEEEEcccC--ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecC----Cc
Q 014725 92 NYNANRILGQGGQGTVYKGMLAD---GGIVAVKKSKLV--DESNVEQFINEVVILSQI-NHRNVVKLLGCCLES----EV 161 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~ 161 (419)
+|.+.+.||+|+||.||++.... +..+|+|++... .....+.+.+|+.+++.+ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 57888999999999999999643 678999987642 223356788999999999 599999999875432 35
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++++||+. ++|.+++.... .+++..+..++.||+.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ---PLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 678889885 68999886533 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCce---eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHH--------
Q 014725 242 TIKVDQTH---LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF-------- 309 (419)
Q Consensus 242 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~-------- 309 (419)
........ ......|+..|+|||++.+ ..++.++|||||||++++|++|..||...+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 233 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 65432211 1233468999999998765 46899999999999999999999999765532211000000
Q ss_pred HHHhcccchhHHHHHhhcc------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 310 LQAMNEDRLFEVLEARVLK------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+............... .........+.+++.+||+.+|.+|||+.+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 234 LSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000000000000000000 000112456889999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=294.85 Aligned_cols=262 Identities=23% Similarity=0.310 Sum_probs=198.2
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc---
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV--- 161 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--- 161 (419)
...++|.+.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++|||++++++++...+.
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999975 5778999987642 23344667889999999999999999998866554
Q ss_pred ---ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 162 ---PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 162 ---~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
.++|+||+ +++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKCQ----KLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 79999998 67999988752 4899999999999999999999998 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHH--------HH
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG--------FF 309 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~--------~~ 309 (419)
++...... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||............. .+
T Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHH
Confidence 99765322 223457889999998865 467899999999999999999999997654432110000 00
Q ss_pred HHHhcccchhHHHHHhhccC------CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 310 LQAMNEDRLFEVLEARVLKE------GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+........+....... ........+.+++.+||+.+|.+|||+.+|+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00111000111111000000 00112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=271.92 Aligned_cols=206 Identities=25% Similarity=0.394 Sum_probs=172.0
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-----CCEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCcccccEEeEEec-CC
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-----GGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRNVVKLLGCCLE-SE 160 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~ 160 (419)
....|+....||+|+||.||+|.-.+ +..+|+|+++.... .......+|+.+++.++|||++.+..++.+ +.
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 34568889999999999999997332 23689999876432 223567899999999999999999999987 77
Q ss_pred cceEEEeecCCCCHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC----CcEEE
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQ--TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK----YRAKV 234 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl 234 (419)
..++++||.+. +|.+.|+-. .....++..++..|+.||+.|+.|||++. |+||||||.|||+..+ |.|||
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEe
Confidence 88999999975 898888643 22357899999999999999999999999 9999999999999877 89999
Q ss_pred eecCCceecccCCce--eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCC
Q 014725 235 SDFGASRTIKVDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~ 298 (419)
+|||+++.+...-.. ....++-|..|.|||.+.+ ..||.+.|||+.||++.||+|-.+-|.+..
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E 244 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGRE 244 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchh
Confidence 999999988654322 2345667999999999876 579999999999999999999988886544
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=275.22 Aligned_cols=236 Identities=31% Similarity=0.356 Sum_probs=194.0
Q ss_pred ccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 99 LGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
||+|+||.||++... +++.+|+|...... ......+.+|+.+++.++||||+++++.+..+...+++|||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999975 47889999876432 23456789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecc
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~ 254 (419)
.+++.... .+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF 153 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence 99998653 4899999999999999999999988 9999999999999999999999999998754332 122344
Q ss_pred cccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHH
Q 014725 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334 (419)
Q Consensus 255 ~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (419)
.++..|+|||...+...+.++|+||||+++|++++|..||...+.... ...... .....+...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-------~~~~~~----------~~~~~~~~~ 216 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI-------YEKILK----------DPLRFPEFL 216 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHhc----------CCCCCCCCC
Confidence 578899999999888899999999999999999999999976553211 111000 111223333
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHH
Q 014725 335 IITVAMLGKRCLNMIGKKRPSMKE 358 (419)
Q Consensus 335 ~~~l~~li~~cl~~~p~~RPt~~e 358 (419)
+..+.+++.+||..+|++||++.+
T Consensus 217 ~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CHHHHHHHHHHhcCCHhhCCCccc
Confidence 567899999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=250.61 Aligned_cols=263 Identities=22% Similarity=0.331 Sum_probs=201.6
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|.-.++||+|.||+||+|+.. .++.||+|++... ++......++|+-+++.++|+|||+++++...+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555678999999999999964 4678999987753 344456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
|+ .+|..|...... .++......++.|+++||.++|+++ +.|||+||.|+||+.+|.+|++|||+++.+...-.
T Consensus 83 cd-qdlkkyfdslng--~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLNG--DLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhcCC--cCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 589888876544 4888999999999999999999999 99999999999999999999999999998764432
Q ss_pred eeeecccccCCccCccccccC-CCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHH---
Q 014725 249 HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE--- 323 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 323 (419)
- .+..+-|..|.+|.++.+. -|+...|+||.||++.|+.. |++.|.+.+..+.-...-+.+....++.|..+-.
T Consensus 157 c-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd 235 (292)
T KOG0662|consen 157 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD 235 (292)
T ss_pred e-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence 2 2333468899999998774 68999999999999999988 7777777766544333333344444444433211
Q ss_pred HhhccCCCH-----HHH----HHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARVLKEGKE-----EEI----ITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~-----~~~----~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
-...+.++. +.. ..=.+++.+.+.-+|.+|.++.+.++
T Consensus 236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 111111111 111 22346788888899999999887754
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.64 Aligned_cols=258 Identities=24% Similarity=0.358 Sum_probs=212.3
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEe---
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCL--- 157 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~--- 157 (419)
++.+...++.|++.+.||.|.+|.||+++. ++++..|+|+....... .+++..|.++|+.+ +|||++.++|++.
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 445566788899999999999999999994 56788899987654333 36778899999988 6999999999986
Q ss_pred --cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 014725 158 --ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235 (419)
Q Consensus 158 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 235 (419)
.++.+|||||||.+||..++++... +..+.|..+..|+..++.||.+||... ++|||||-.|||++.++.|||+
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 3568899999999999999998866 557999999999999999999999999 9999999999999999999999
Q ss_pred ecCCceecccCCceeeecccccCCccCccccccC-----CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH
Q 014725 236 DFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-----QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 310 (419)
|||++..+.... ....+..|||.|||||++... .|+..+|+||||++..||.-|.+|+....+.. +
T Consensus 166 DFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------a- 236 (953)
T KOG0587|consen 166 DFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------A- 236 (953)
T ss_pred eeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------h-
Confidence 999998865433 334567799999999998653 46789999999999999999999987655432 1
Q ss_pred HHhcccchhHHHH-HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 311 QAMNEDRLFEVLE-ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 311 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
++.+.. +......+......+.++|..||..|..+||++.++++
T Consensus 237 -------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 237 -------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred -------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 111111 11112235566788999999999999999999988865
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=270.89 Aligned_cols=252 Identities=25% Similarity=0.328 Sum_probs=192.1
Q ss_pred ccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecCC
Q 014725 95 ANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 95 ~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
-...||.|+||+|+|-.+ ..|+..|||++.... ....++++.|.+...+- ++||||+++|.+..++..|+.||+|+
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 346799999999999886 458899999987643 45667888888765554 79999999999999999999999994
Q ss_pred CCHHHHhhc--cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 172 GTLYHYLHD--QTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 172 g~L~~~l~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
-||+.+... ......+++..+-.|+.-...||.||.+... |||||+||+|||++..|.+||+|||.+-.+.. +.
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si 222 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI 222 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence 577766543 1112248888888888899999999998653 99999999999999999999999999876532 22
Q ss_pred eeecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh-
Q 014725 250 LTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV- 326 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 326 (419)
..+.-.|-..|||||.+.. ..|+.+|||||||++|+|+.||+.|+...+.. .++..+....+. +.+
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~sv-----feql~~Vv~gdp------p~l~ 291 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSV-----FEQLCQVVIGDP------PILL 291 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHH-----HHHHHHHHcCCC------Ceec
Confidence 2344457889999999864 35889999999999999999999999765431 111111111110 000
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
......+....+..++.-|+-+|.++||.+.++.+.
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~ 327 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF 327 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence 011122355678999999999999999999998764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=306.22 Aligned_cols=146 Identities=28% Similarity=0.381 Sum_probs=131.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++......++|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 367999999999999999999975 5789999987642 233456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
|||+.+++|.+++.... .+++..++.++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++
T Consensus 83 mEy~~g~~L~~li~~~~---~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYG---YFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999997643 4788999999999999999999998 9999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=267.70 Aligned_cols=257 Identities=23% Similarity=0.334 Sum_probs=199.4
Q ss_pred CcccccCcEEEEEEE-ecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 97 RILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
+.||+|+|+.|-.+. ..++..+|||++.........+..+|++++.+.+ |+||++++++|++++..|||||-|.||+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 679999999999888 5788999999987666666788999999999995 99999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc---EEEeecCCceecccC-----
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR---AKVSDFGASRTIKVD----- 246 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfgl~~~~~~~----- 246 (419)
...|.+.. -+++.+..++..+|+.||.+||.+| |.|||+||+|||..+... +||+||.|.......
T Consensus 164 LshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 99998765 4899999999999999999999999 999999999999965543 899999987654321
Q ss_pred -CceeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 247 -QTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 247 -~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
.+....+.+|+..|||||+.. ..-|+.+.|.|||||++|-|++|..||.+.-..+-.+-....-+... +.+++
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ-~~LFe 316 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQ-NKLFE 316 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHH-HHHHH
Confidence 111223456889999999753 24688999999999999999999999987654332111110000000 11222
Q ss_pred HHHHhhccCCCHHHH----HHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 VLEARVLKEGKEEEI----ITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~----~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
-+... ..+.|...+ .+..+++...+..++.+|.++.+++.
T Consensus 317 sIQEG-kYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 317 SIQEG-KYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHhcc-CCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 22221 234454443 44567888889999999999888876
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=263.75 Aligned_cols=250 Identities=23% Similarity=0.289 Sum_probs=196.5
Q ss_pred HhcCccc-cCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEec----CCc
Q 014725 89 ATDNYNA-NRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLE----SEV 161 (419)
Q Consensus 89 ~~~~y~~-~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~ 161 (419)
.+++|.+ -++||-|-.|.|-.+..+ .++.+|+|.+... ....+|+++--.. .|||||.+++++.+ ...
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 4566765 367999999999999864 5778999987643 4467788876666 59999999999864 356
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC---CCCcEEEeecC
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD---DKYRAKVSDFG 238 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfg 238 (419)
+.+|||.|+||.|.+.+++++.. ++++.+...|+.||..|+.|||+.+ |.||||||+|+|.+ .|-.+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~-afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQ-AFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHcccc-cchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 78999999999999999987643 6999999999999999999999999 99999999999995 45679999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
+|+.... .....+.+-||.|.|||++....|+...|+||+||++|-|++|.+||-...... +.++.-
T Consensus 210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a-----------ispgMk 276 (400)
T KOG0604|consen 210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-----------ISPGMK 276 (400)
T ss_pred cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc-----------CChhHH
Confidence 9987442 233445678999999999999999999999999999999999999996544311 111100
Q ss_pred hHHHHHhhccCCCHHH----HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 319 FEVLEARVLKEGKEEE----IITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~----~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..+.. -..++|..+ .+...++|+.+|..+|.+|.|+.+++..
T Consensus 277 ~rI~~--gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h 322 (400)
T KOG0604|consen 277 RRIRT--GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH 322 (400)
T ss_pred hHhhc--cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence 11111 112333333 3556789999999999999999999763
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=271.60 Aligned_cols=263 Identities=23% Similarity=0.333 Sum_probs=206.3
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCC-C-cc----cccEEeEEecCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQIN-H-RN----VVKLLGCCLESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~n----iv~l~~~~~~~~~ 161 (419)
.+.+|.+...+|+|+||.|-.+.+.. +..||||+++..... .+..+-|+++|+++. + |+ ++++.++|.-.++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kY-reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKY-REAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHH-hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 37899999999999999999999644 578999998875443 356677999999994 2 33 7788888988999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-------------
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD------------- 228 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~------------- 228 (419)
.++|+|.+ |-|+.+++..+.. .+++...+..++.|++.++++||+.+ ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N~y-~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKENNY-IPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccCCc-cccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 6799999988654 36888999999999999999999999 999999999999931
Q ss_pred -------CCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhh
Q 014725 229 -------KYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301 (419)
Q Consensus 229 -------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~ 301 (419)
+..++|+|||.|+...... ...+.|..|.|||++.+-.++..+||||+||||+||.||...|...+..+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 3458999999998744322 45678999999999999999999999999999999999999998887655
Q ss_pred hccHHHHHHHHhcccchhHH----------HH------H-------------hhccCCCHHHHHHHHHHHHHHhccCCCC
Q 014725 302 DRSLVGFFLQAMNEDRLFEV----------LE------A-------------RVLKEGKEEEIITVAMLGKRCLNMIGKK 352 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~----------~~------~-------------~~~~~~~~~~~~~l~~li~~cl~~~p~~ 352 (419)
.-...+.+++.+....+... ++ + .........+...+.+|+++||..||.+
T Consensus 317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~ 396 (415)
T KOG0671|consen 317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR 396 (415)
T ss_pred HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence 43344333332211111111 00 0 0001122345667999999999999999
Q ss_pred CCCHHHHHH
Q 014725 353 RPSMKEVAF 361 (419)
Q Consensus 353 RPt~~evl~ 361 (419)
|+|+.|++.
T Consensus 397 RiTl~EAL~ 405 (415)
T KOG0671|consen 397 RITLREALS 405 (415)
T ss_pred cccHHHHhc
Confidence 999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=277.13 Aligned_cols=260 Identities=28% Similarity=0.427 Sum_probs=201.7
Q ss_pred HHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCCh-------hhHHHHHHHHHHHhcCCCcccccEEeEEe-
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDE-------SNVEQFINEVVILSQINHRNVVKLLGCCL- 157 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~- 157 (419)
....++|-...+||+|||+.||+|.+ ...+.||+|+-..+.. .-.+...+|..+-+.|.||.||++|+++.
T Consensus 459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL 538 (775)
T ss_pred cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence 34567899999999999999999995 5577899997544321 12345678999999999999999999986
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC---CCCcEEE
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD---DKYRAKV 234 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl 234 (419)
+.+.+|-|.|||+|.+|+-||+... .+++.+...|+.||+.||.||.+.. +||||-||||.|||+. .-|.+||
T Consensus 539 DtdsFCTVLEYceGNDLDFYLKQhk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 539 DTDSFCTVLEYCEGNDLDFYLKQHK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccccceeeeeecCCCchhHHHHhhh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEe
Confidence 5678899999999999999998765 4899999999999999999999987 5699999999999994 4578999
Q ss_pred eecCCceecccCCce------eeecccccCCccCcccccc----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhcc
Q 014725 235 SDFGASRTIKVDQTH------LTTRVQGTFGYLDPEYFRS----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRS 304 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~ 304 (419)
+||||++....+... ......||.+|++||.+.- ...+.+.||||.||++|+.+-|+.||.......+.
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI- 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI- 693 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH-
Confidence 999999987543322 3456779999999998753 35688999999999999999999999876544321
Q ss_pred HHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 305 LVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+.++.+...-.- ..+.-+-...+...+|++||+..-++|....++..
T Consensus 694 --------LqeNTIlkAtEV--qFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 694 --------LQENTILKATEV--QFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred --------Hhhhchhcceec--cCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 111111111110 01111223345778999999999999988877754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=303.90 Aligned_cols=258 Identities=24% Similarity=0.329 Sum_probs=210.7
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecC
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLES 159 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 159 (419)
.++.-..++|.+.+.||+|+||.|..++.+ .++.||.|+++. .......-|..|-.+|.--+.+-|+.+.-.|.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 445556788999999999999999999975 467889998764 3445557799999999999999999999999999
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
.++|+||||++||+|..++.+.. .+++....-++..|+.||.-||+.| +|||||||+|||+|..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 99999999999999999998765 4888888889999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCcccccc-----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
+-.+..++.......+|||.|.+||++.. +.|++.+|.||+||++|||+.|..||.. .++.+.+...++
T Consensus 222 Clkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa------dslveTY~KIm~ 295 (1317)
T KOG0612|consen 222 CLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA------DSLVETYGKIMN 295 (1317)
T ss_pred HHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH------HHHHHHHHHHhc
Confidence 98888777777888899999999999852 6799999999999999999999999963 334444444444
Q ss_pred ccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC---HHHHHH
Q 014725 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS---MKEVAF 361 (419)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt---~~evl~ 361 (419)
........ .....+....+||.+.+. +|+.|.. +.++..
T Consensus 296 hk~~l~FP-------~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 296 HKESLSFP-------DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN 337 (1317)
T ss_pred hhhhcCCC-------cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence 33222211 112345567777766554 6677766 666643
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=292.00 Aligned_cols=261 Identities=21% Similarity=0.262 Sum_probs=170.7
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-----CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeE------Ee
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-----GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGC------CL 157 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~ 157 (419)
..++|.+.+.||+|+||.||+|++.+ +..||+|+...... .+.+.+| .+....+.++..++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 56789999999999999999999754 57899998764322 1222222 1222222333322221 24
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCCCC-----------------CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEF-----------------PITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~-----------------~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk 220 (419)
+....++||||+++++|.+++....... ......+..++.|++.||.|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 5567899999999999999987543110 1123345679999999999999998 9999999
Q ss_pred CCcEEECC-CCcEEEeecCCceecccCCceeeecccccCCccCccccccC----------------------CCCcccce
Q 014725 221 SSNILLDD-KYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS----------------------QFTEKSDV 277 (419)
Q Consensus 221 p~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~~~Di 277 (419)
|+|||++. ++.+||+|||+++..............+++.|+|||.+... .++.++||
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99999985 67999999999987654444444556789999999975422 23446799
Q ss_pred echhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc--cchhHHHHHhhcc------CCCHHHHHHHHHHHHHHhccC
Q 014725 278 YSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE--DRLFEVLEARVLK------EGKEEEIITVAMLGKRCLNMI 349 (419)
Q Consensus 278 ~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~ 349 (419)
|||||++|||+++..|++..... ....+. .... ..+...+.+.... ...........+|+.+||+.|
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~----~~~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQ----FNRQLK-RNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHH----HHHHHH-hcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 99999999999977664321110 000000 0000 0011111110000 000011223458999999999
Q ss_pred CCCCCCHHHHHH
Q 014725 350 GKKRPSMKEVAF 361 (419)
Q Consensus 350 p~~RPt~~evl~ 361 (419)
|.+|||+.++++
T Consensus 438 P~kR~ta~e~L~ 449 (566)
T PLN03225 438 GRQRISAKAALA 449 (566)
T ss_pred cccCCCHHHHhC
Confidence 999999999987
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=273.23 Aligned_cols=244 Identities=25% Similarity=0.334 Sum_probs=201.6
Q ss_pred HHhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcc
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 162 (419)
....+|.....||+|+||.|.+|..+. ...+|||+++.. ...+.+--+.|-++|+.. +-|.++++..+|+.-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 344568999999999999999998654 457899987642 233445556777888877 568999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
|+||||+.||+|--.+++-+. +.+....-+|.+||-||-+||+++ ||+||||.+|||+|.+|++||+|||+++.
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKE 499 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 499 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccc
Confidence 999999999999988887553 777888889999999999999999 99999999999999999999999999975
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
-- .......+++|||.|+|||.+...+|+.+.|.|||||+||||+.|+.||++.++.+ +.+.+
T Consensus 500 ni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~aI 562 (683)
T KOG0696|consen 500 NI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQAI 562 (683)
T ss_pred cc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHH
Confidence 32 23344567899999999999999999999999999999999999999999988765 22222
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS 355 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 355 (419)
... ...+|.....+...+....+...|.+|..
T Consensus 563 ~eh-nvsyPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 563 MEH-NVSYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HHc-cCcCcccccHHHHHHHHHHhhcCCccccC
Confidence 221 23456666777888889999999999953
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=266.56 Aligned_cols=220 Identities=22% Similarity=0.194 Sum_probs=176.4
Q ss_pred cCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCHHHHhhc
Q 014725 102 GGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD 180 (419)
Q Consensus 102 G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 180 (419)
|.||.||++.+ .+++.+|+|.+.... .+.+|...+....||||+++++++.+.+..+++|||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 89999999996 457889999886532 233455555556799999999999999999999999999999999876
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecccccCCc
Q 014725 181 QTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260 (419)
Q Consensus 181 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 260 (419)
.. .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.++++|||++...... .....++..|
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 43 4899999999999999999999998 999999999999999999999999987654321 1223456789
Q ss_pred cCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHH
Q 014725 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM 340 (419)
Q Consensus 261 ~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 340 (419)
+|||.+.+..++.++|+||+|+++|||++|..|+........ . ......+......+.+
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~------------~---------~~~~~~~~~~~~~~~~ 207 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN------------T---------HTTLNIPEWVSEEARS 207 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc------------c---------ccccCCcccCCHHHHH
Confidence 999999888899999999999999999999988754321100 0 0000122233456889
Q ss_pred HHHHHhccCCCCCCCHH
Q 014725 341 LGKRCLNMIGKKRPSMK 357 (419)
Q Consensus 341 li~~cl~~~p~~RPt~~ 357 (419)
++.+|++.||.+||++.
T Consensus 208 li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 208 LLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHccCCHHHhcCCC
Confidence 99999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=261.70 Aligned_cols=236 Identities=30% Similarity=0.419 Sum_probs=193.3
Q ss_pred CcEEEEEEEecC-CCEEEEEEcccCChhh-HHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCHHHHhhc
Q 014725 103 GQGTVYKGMLAD-GGIVAVKKSKLVDESN-VEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD 180 (419)
Q Consensus 103 ~fg~Vy~~~~~~-~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 180 (419)
+||.||+|...+ +..+|+|......... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 689999999864 8899999987654433 68899999999999999999999999998999999999999999999976
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecccccCCc
Q 014725 181 QTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260 (419)
Q Consensus 181 ~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 260 (419)
... +++..++.++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+....... ......++..|
T Consensus 81 ~~~---~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 152 (244)
T smart00220 81 RGR---LSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY 152 (244)
T ss_pred ccC---CCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence 442 789999999999999999999998 9999999999999999999999999998765432 23345578899
Q ss_pred cCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHH--HHHHH
Q 014725 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEE--EIITV 338 (419)
Q Consensus 261 ~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l 338 (419)
++||.+....++.++||||||++++++++|..||........ . .+.+........... .+..+
T Consensus 153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~------~---------~~~~~~~~~~~~~~~~~~~~~~ 217 (244)
T smart00220 153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE------L---------FKKIGKPKPPFPPPEWKISPEA 217 (244)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH------H---------HHHHhccCCCCccccccCCHHH
Confidence 999999888899999999999999999999999976322110 1 111111110100111 44679
Q ss_pred HHHHHHHhccCCCCCCCHHHHHH
Q 014725 339 AMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 339 ~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+++.+|+..+|++||++.++++
T Consensus 218 ~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 218 KDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHccCCchhccCHHHHhh
Confidence 99999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=284.24 Aligned_cols=241 Identities=24% Similarity=0.279 Sum_probs=195.1
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.++.|.+...+|.|+|+.|-.+.. ..++..++|++.... .+-.+|+.++... +||||+++.+.+.+....|+||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 367788889999999999999885 457788999876542 2234577666555 7999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE-CCCCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL-DDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill-~~~~~~kl~Dfgl~~~~~~ 245 (419)
|++.++-+.+.+..... . ...+..|+.+|+.|+.|||++| ++||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~~---~-~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPE---F-CSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcch---h-HHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 99999988888776542 2 2667789999999999999999 9999999999999 6899999999999987654
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. ....+-|..|.|||++....|++++|+||||++||+|++|+.||....... .+...+..
T Consensus 469 ~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~---------- 528 (612)
T KOG0603|consen 469 S----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQM---------- 528 (612)
T ss_pred h----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcC----------
Confidence 4 223346889999999999999999999999999999999999998765541 12222211
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
............+|+.+||+.||.+||++.++...
T Consensus 529 --~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h 563 (612)
T KOG0603|consen 529 --PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH 563 (612)
T ss_pred --CccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence 12224445678899999999999999999999653
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=279.24 Aligned_cols=242 Identities=25% Similarity=0.297 Sum_probs=203.3
Q ss_pred cCccccCcccccCcEEEEEEEecCCC-EEEEEE---cccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGG-IVAVKK---SKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~-~vavK~---~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.+++.+..||-||||.|=++..++.. .+|+|. .+..+..+.+....|-.+|...+.|.||++|.-|.++...|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 34566678999999999998875443 366654 44566777788999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
|-|-||.|+..|++.+ .++..+..-++..++.|++|||+++ ||+|||||+|++++.+|.+||.|||.|+.....
T Consensus 500 EaClGGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999999765 4788888888999999999999999 999999999999999999999999999986543
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
..+-+++|||.|.|||.+.+...+.++|.||||+++|||++|.+||.+.++....++ ++...-
T Consensus 574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~---------------ILkGid 636 (732)
T KOG0614|consen 574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL---------------ILKGID 636 (732)
T ss_pred --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH---------------HHhhhh
Confidence 345678999999999999999999999999999999999999999999887543211 111212
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCC
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPS 355 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt 355 (419)
....|........+|+++.+..+|.+|.-
T Consensus 637 ~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 637 KIEFPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence 23445556667888999999999999975
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=259.77 Aligned_cols=265 Identities=22% Similarity=0.323 Sum_probs=199.1
Q ss_pred cCccccCcccccCcEEEEEEEecC-CCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEec--------C
Q 014725 91 DNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLE--------S 159 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~ 159 (419)
..|.-..+||+|.||.||+|+..+ ++.||+|+.... ...-....++|+.+|..++|+|++.++..|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345556789999999999999654 667899876542 22334567899999999999999999988753 2
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
...|+||.+|+. +|.-+|..... .++..++.+++.++..||.|+|+.. |+|||+||+|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~~v--r~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNRKV--RFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCccc--cccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 347999999965 88888876543 4888899999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCcee---eecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 240 SRTIKVDQTHL---TTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 240 ~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
++.+....... .+..+-|..|.+||.+.+ ..|+++.|||..||++.||+|+.+-+.+..+.....+..........
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk 250 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK 250 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence 98775332221 233445899999998765 68999999999999999999999999888776654444433333322
Q ss_pred cchhHH-----HHHhhccCCC-------HHH------HHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 316 DRLFEV-----LEARVLKEGK-------EEE------IITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 316 ~~~~~~-----~~~~~~~~~~-------~~~------~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+-|... .......+.+ .+. ..+..+|+..++..||.+|+++.+++.
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 222111 1010000011 111 125678999999999999999888764
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=281.14 Aligned_cols=265 Identities=18% Similarity=0.201 Sum_probs=182.3
Q ss_pred HhcCccccCcccccCcEEEEEEEe-----------------cCCCEEEEEEcccCChhhHHHHH--------------HH
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-----------------ADGGIVAVKKSKLVDESNVEQFI--------------NE 137 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~~--------------~e 137 (419)
..++|++.++||+|+||+||+|.+ .+++.||||++........++|. .|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999974 23457999998764433333333 46
Q ss_pred HHHHhcCCCccc-----ccEEeEEec--------CCcceEEEeecCCCCHHHHhhccCC---------------------
Q 014725 138 VVILSQINHRNV-----VKLLGCCLE--------SEVPLLVYEFIPNGTLYHYLHDQTE--------------------- 183 (419)
Q Consensus 138 ~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~--------------------- 183 (419)
+.++.+++|.++ ++++++|.. .+..++||||+++++|.++++....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 667777766544 677777753 3567999999999999999874321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecccccCCccCc
Q 014725 184 EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263 (419)
Q Consensus 184 ~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP 263 (419)
...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..............+|+.|+||
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 113467788899999999999999998 99999999999999999999999999976543222222223357899999
Q ss_pred cccccCCC----------------------CcccceechhHHHHHHHhCCC-CCCCCChhhhcc-HHHHHHHHhcccchh
Q 014725 264 EYFRSSQF----------------------TEKSDVYSFGVVLVELLTGQK-PIRSTDAEEDRS-LVGFFLQAMNEDRLF 319 (419)
Q Consensus 264 E~~~~~~~----------------------s~~~Di~slG~~l~el~tg~~-p~~~~~~~~~~~-~~~~~~~~~~~~~~~ 319 (419)
|.+..... ..+.||||+||++++|++|.. |+.......... ........+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r----- 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR----- 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-----
Confidence 98754321 234799999999999999875 765432211100 0000000000
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCC---CCCCCHHHHHH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIG---KKRPSMKEVAF 361 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p---~~RPt~~evl~ 361 (419)
....................+++.++|..+| .+|+|+.|+++
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 0000000111122334568889999999766 68999999975
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=271.65 Aligned_cols=242 Identities=26% Similarity=0.347 Sum_probs=188.6
Q ss_pred cCcccccCcEEEEEEEe-cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCC
Q 014725 96 NRILGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
.+.||+|.||+||-|.+ ++|+.||||.+.. ....+..++.+|+.+|+.++||.||.+...|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G- 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG- 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence 47899999999999996 5689999997643 2334447899999999999999999999999999999999999955
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC---CcEEEeecCCceecccCCce
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfgl~~~~~~~~~~ 249 (419)
+..+.+-... ...+++..-.-+..||+.||.|||.++ |+|+||||+|||+.+. .++||+|||.|+..... .
T Consensus 648 DMLEMILSsE-kgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s 721 (888)
T KOG4236|consen 648 DMLEMILSSE-KGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S 721 (888)
T ss_pred hHHHHHHHhh-cccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence 5555444322 235888888888999999999999999 9999999999999543 47999999999987643 3
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
....++|||.|+|||++++..|...-|+||.||++|--++|..||.......++ ...+........|.
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ--IQNAaFMyPp~PW~---------- 789 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ--IQNAAFMYPPNPWS---------- 789 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH--hhccccccCCCchh----------
Confidence 345678999999999999999999999999999999999999999754332211 11111111111221
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~ev 359 (419)
+......+||...|+..-.+|-+...-
T Consensus 790 ---eis~~AidlIn~LLqVkm~kRysvdk~ 816 (888)
T KOG4236|consen 790 ---EISPEAIDLINNLLQVKMRKRYSVDKS 816 (888)
T ss_pred ---hcCHHHHHHHHHHHHHHHHHhcchHhh
Confidence 223456778888888888888776543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=269.77 Aligned_cols=207 Identities=26% Similarity=0.396 Sum_probs=175.0
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
...|-.++.||-|+||.|.+++..| ...+|.|.+... ...+......|-.||+..+.+-||+||-.|.+.+.+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 3457788999999999999998544 557899976543 244556788899999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|+|++||++-.+|.+.+ -+.+.....++.++..|+++.|..| +|||||||+|||||.+|++||+||||+.-+.-
T Consensus 708 MdYIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRW 781 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 781 (1034)
T ss_pred EeccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeecccccccee
Confidence 99999999999998765 3777777778889999999999999 99999999999999999999999999864421
Q ss_pred ---------CCce--------------------------------eeecccccCCccCccccccCCCCcccceechhHHH
Q 014725 246 ---------DQTH--------------------------------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVL 284 (419)
Q Consensus 246 ---------~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l 284 (419)
.+.. .....+||+.|+|||++....|+..+|.||.||+|
T Consensus 782 THdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil 861 (1034)
T KOG0608|consen 782 THDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVIL 861 (1034)
T ss_pred ccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHH
Confidence 0000 01125699999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChhhh
Q 014725 285 VELLTGQKPIRSTDAEED 302 (419)
Q Consensus 285 ~el~tg~~p~~~~~~~~~ 302 (419)
|||+.|+.||-...+.+.
T Consensus 862 ~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 862 YEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHhhCCCCccCCCCCcc
Confidence 999999999987666543
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=281.28 Aligned_cols=245 Identities=27% Similarity=0.383 Sum_probs=187.7
Q ss_pred ccccCcccccCcEE-EEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeecC
Q 014725 93 YNANRILGQGGQGT-VYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 93 y~~~~~ig~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
|...+.+|.|+.|+ ||+|.. +++.||||++-. .-..-..+|+..|+.- .|||||++++.-.++...|+..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 55567899999986 699999 488999998753 2234567899999988 59999999988888899999999994
Q ss_pred CCCHHHHhhccCCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---C--CcEEEeecCCceecc
Q 014725 171 NGTLYHYLHDQTEE-FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---K--YRAKVSDFGASRTIK 244 (419)
Q Consensus 171 ~g~L~~~l~~~~~~-~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~--~~~kl~Dfgl~~~~~ 244 (419)
.+|.+++...... ....-...+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 5999999874111 11111334678889999999999988 999999999999965 3 568999999999886
Q ss_pred cCCcee--eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 245 VDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 245 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... .....||.+|+|||++.....+.++||||+||++|+.++ |..||...-..+...+. .+..+..
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~-------~~~~L~~- 734 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILT-------GNYTLVH- 734 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhc-------Cccceee-
Confidence 543322 345679999999999999888899999999999999999 59999865443211000 0111111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
-....++ +..+||.+|++++|..||++.+|+.
T Consensus 735 ------L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 735 ------LEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred ------eccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 0111122 6788999999999999999999964
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=251.76 Aligned_cols=248 Identities=23% Similarity=0.372 Sum_probs=198.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 164 (419)
.++|.+.+.||+|+|..|..+++. ..+.+|+|.++. ++.++..-.+.|-.+..+. +||.+|.+..+|......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 467999999999999999999964 467889887653 4555666677788888776 79999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
|.||++||+|--.++++. .++++...-+...|..||.|||++| ||+||||.+|+|+|..|++||+|||+++.-
T Consensus 329 vieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~- 401 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEG- 401 (593)
T ss_pred EEEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcC-
Confidence 999999999977776554 3888888889999999999999999 999999999999999999999999998753
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhc-cHHHHHHHHhcccchhHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR-SLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 323 (419)
.......++++|||.|.|||.+++..|....|.|+|||+++||+.|+.||+.....+.. +..++..+. ++.
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------ile 473 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------ILE 473 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------Hhh
Confidence 23344567789999999999999999999999999999999999999999754332211 111222221 122
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCC
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRP 354 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 354 (419)
..++ .|.........+++..|.+||.+|.
T Consensus 474 kqir--iprslsvkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 474 KQIR--IPRSLSVKASHVLKGFLNKDPKERL 502 (593)
T ss_pred hccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence 2221 2333344566788889999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=248.74 Aligned_cols=265 Identities=24% Similarity=0.304 Sum_probs=197.8
Q ss_pred ccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCcccccEEeEEecC-----CcceE
Q 014725 93 YNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRNVVKLLGCCLES-----EVPLL 164 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~l 164 (419)
.+..+.||-|+||+||.+++ ++|+.||+|++...-. ..-+.+.+|+++|...+|.|++..++...-. .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 34468899999999999996 6789999998765322 3446789999999999999999988876532 24578
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
+.|+| ..+|...+-.. ..++...+.-+..||++||+|||+.+ |.||||||.|+|+++|-.+||+||||++...
T Consensus 135 ~TELm-QSDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELM-QSDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHH-HhhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 88888 45887777643 35888888889999999999999999 9999999999999999999999999999877
Q ss_pred cCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc--------
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE-------- 315 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-------- 315 (419)
.+....++..+-|..|.|||.+.+ ..|+.+.||||.||++.||+..+..|..-.+.+.-.+....+.....
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE 287 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE 287 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence 666666666677999999999887 57999999999999999999999888776655443333222221111
Q ss_pred cchhHHHHHhhcc---------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 316 DRLFEVLEARVLK---------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 316 ~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
+.-..++....+. ..+.....+-..+...++..||+.|.+..+.+.-+.
T Consensus 288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~ 345 (449)
T KOG0664|consen 288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY 345 (449)
T ss_pred hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence 1111111111110 001112233455677889999999999888876543
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=234.37 Aligned_cols=209 Identities=26% Similarity=0.388 Sum_probs=169.8
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc-CChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcc
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL-VDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 162 (419)
++...+....+..||+|++|.|-+-++ .+|...|+|++.. .+.+..++.++|+.+..+. .+|.+|.++|........
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv 120 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV 120 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence 444555566677899999999988875 5688899998765 2344456788888876655 799999999999999999
Q ss_pred eEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 163 LLVYEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
++.||.|+ .||+.+..+- ..+..+++..+-+|+..+..||.|||++-. +||||+||.|||++.+|++|++|||.+-
T Consensus 121 wIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~--vIHRDvKPsNiLIn~~GqVKiCDFGIsG 197 (282)
T KOG0984|consen 121 WICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLS--VIHRDVKPSNILINYDGQVKICDFGISG 197 (282)
T ss_pred EEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhh--hhhccCCcceEEEccCCcEEEcccccce
Confidence 99999994 5888877652 233468999999999999999999999764 9999999999999999999999999997
Q ss_pred ecccCCceeeecccccCCccCcccccc----CCCCcccceechhHHHHHHHhCCCCCCCCCh
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRS----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~ 299 (419)
.+..+- ..+.-.|-..|||||.+.. ..|+-++||||||++++||.+++.||+....
T Consensus 198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 754321 1122347788999998753 4789999999999999999999999986543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=232.01 Aligned_cols=210 Identities=38% Similarity=0.573 Sum_probs=183.1
Q ss_pred ccccCcEEEEEEEecC-CCEEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCHHH
Q 014725 99 LGQGGQGTVYKGMLAD-GGIVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYH 176 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 176 (419)
||+|++|.||++...+ +..+++|........ ..+.+.+|+..++.++|++++++++++......++++|++++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999754 889999998764432 35679999999999999999999999999899999999999999999
Q ss_pred HhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCceecccCCceeeeccc
Q 014725 177 YLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRTIKVDQTHLTTRVQ 255 (419)
Q Consensus 177 ~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~~~~~~~~~ 255 (419)
++.... ..+++..+..++.++++++.+||+.+ ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~ 154 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV 154 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence 998653 24889999999999999999999998 999999999999999 89999999999987643321 122345
Q ss_pred ccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHH
Q 014725 256 GTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334 (419)
Q Consensus 256 gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (419)
+...|++||.+... .++.++|+|++|+++++|
T Consensus 155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------- 187 (215)
T cd00180 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------- 187 (215)
T ss_pred CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------------------
Confidence 78899999999877 888999999999999999
Q ss_pred HHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 335 IITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 335 ~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 358889999999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-32 Score=228.58 Aligned_cols=257 Identities=22% Similarity=0.351 Sum_probs=194.4
Q ss_pred HhcCccccCcccccCcEEEEEEE-ecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecC--CcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLES--EVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~l 164 (419)
..++|++.+.+|+|.++.||.|. ..++..++||.++... .+.+.+|+.+|+.|. ||||+++++...+. ..+.+
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 45789999999999999999999 4678889999988644 467899999999997 99999999998764 46789
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCceec
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDFGASRTI 243 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfgl~~~~ 243 (419)
|+||+++.+...+.. .++...+...+.+++.||.|+|+.| |.|||+||.|++||.. ..++|+|+|||.++
T Consensus 113 iFE~v~n~Dfk~ly~------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLYP------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHhh------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 999999988877654 2666778889999999999999999 9999999999999865 56999999999988
Q ss_pred ccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh---
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF--- 319 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--- 319 (419)
........ .+.+..|--||.+-. ..|+..-|+|||||++..|+..+.||-......+ ++.. +......+.+.
T Consensus 184 Hp~~eYnV--RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVk-IakVLGt~el~~Yl 259 (338)
T KOG0668|consen 184 HPGKEYNV--RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVK-IAKVLGTDELYAYL 259 (338)
T ss_pred CCCceeee--eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHH-HHHHhChHHHHHHH
Confidence 76544322 235677889998865 6789999999999999999999999854332211 1111 11111111111
Q ss_pred ------------HHHHHhhcc--------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 320 ------------EVLEARVLK--------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 320 ------------~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.++....+. +...-..++..+++.+.|..|-.+|||+.|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 111111110 000111356788999999999999999999865
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-30 Score=230.65 Aligned_cols=199 Identities=37% Similarity=0.551 Sum_probs=173.4
Q ss_pred ccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 93 YNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
|.+.+.||+|++|.||++...+ +..+++|........ ..+.+.+|++.++.++|+|++++++++......++++|+++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 5667899999999999999865 788999998765444 56789999999999999999999999999899999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|.||+++.++.++|+|||++..........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~ 155 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL 155 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence 9999999986542 1788999999999999999999998 9999999999999999999999999998765432112
Q ss_pred eecccccCCccCcccc-ccCCCCcccceechhHHHHHHHhCCCCCCC
Q 014725 251 TTRVQGTFGYLDPEYF-RSSQFTEKSDVYSFGVVLVELLTGQKPIRS 296 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~-~~~~~s~~~Di~slG~~l~el~tg~~p~~~ 296 (419)
.....++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus 156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 2334577889999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=248.41 Aligned_cols=268 Identities=20% Similarity=0.196 Sum_probs=206.7
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCC------CcccccEEeEEec
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQIN------HRNVVKLLGCCLE 158 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~ 158 (419)
-+....+|.+....|+|-|++|..|.+. .+..||||++..+ +...+.=+.|+++|++|+ --|+++++..|..
T Consensus 427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~h 505 (752)
T KOG0670|consen 427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKH 505 (752)
T ss_pred hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhh
Confidence 3455678999999999999999999964 4779999998764 334455678999999995 2489999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-CcEEEeec
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDF 237 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Df 237 (419)
..++|||+|.+ ..+|.+.|...+...-|....+..++.|+..||..|...+ |+|.||||+|||+++. ..+|||||
T Consensus 506 knHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDf 581 (752)
T KOG0670|consen 506 KNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDF 581 (752)
T ss_pred cceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccC
Confidence 99999999988 6799999998877667888999999999999999999999 9999999999999865 56899999
Q ss_pred CCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 238 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
|.|........ +.+.-+..|.|||.+.+..|+...|+||.||+||||.||+..|++......-.+.......+.+..
T Consensus 582 GSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~Km 658 (752)
T KOG0670|consen 582 GSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKM 658 (752)
T ss_pred ccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHH
Confidence 99976543322 222335569999999999999999999999999999999999998776554333322221111110
Q ss_pred hh------HH--------------------------------HHHhhcc--CCC---HHHHHHHHHHHHHHhccCCCCCC
Q 014725 318 LF------EV--------------------------------LEARVLK--EGK---EEEIITVAMLGKRCLNMIGKKRP 354 (419)
Q Consensus 318 ~~------~~--------------------------------~~~~~~~--~~~---~~~~~~l~~li~~cl~~~p~~RP 354 (419)
+- +. +...+.. ..+ ......|.+|+..|+..||.+|.
T Consensus 659 lRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRi 738 (752)
T KOG0670|consen 659 LRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRI 738 (752)
T ss_pred hhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcC
Confidence 00 00 0000000 012 23346688899999999999999
Q ss_pred CHHHHHH
Q 014725 355 SMKEVAF 361 (419)
Q Consensus 355 t~~evl~ 361 (419)
|..+.|.
T Consensus 739 t~nqAL~ 745 (752)
T KOG0670|consen 739 TVNQALK 745 (752)
T ss_pred CHHHHhc
Confidence 9998865
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=260.35 Aligned_cols=255 Identities=26% Similarity=0.351 Sum_probs=206.2
Q ss_pred HHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
...++|.....+|+|+||.|||+++ ..+...|+|.++.....+..-..+|+-+++..+||||+.++|.+...+..++.|
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 3457789999999999999999996 457889999999877777888899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
|||.+|+|.+..+-.. ++++.++..++.+.++||+|||+.+ =+|||||-.|||+++.|.+|++|||.+..+...
T Consensus 92 EycgggslQdiy~~Tg---plselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVTG---PLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EecCCCcccceeeecc---cchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence 9999999999877543 6999999999999999999999999 789999999999999999999999998765432
Q ss_pred CceeeecccccCCccCcccc---ccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 247 QTHLTTRVQGTFGYLDPEYF---RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~---~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
......+.||+.|||||+. +.+.|...+|||++|++..|+---+.|.....+... +..+.... .
T Consensus 166 -i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-------l~LmTkS~-----~ 232 (829)
T KOG0576|consen 166 -IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-------LFLMTKSG-----F 232 (829)
T ss_pred -hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-------HHHhhccC-----C
Confidence 2334567899999999975 457899999999999999999888877543332211 11110000 0
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+.............+-++++.|+..+|.+||++..++.
T Consensus 233 qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 233 QPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 01111222344567889999999999999999876643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=238.96 Aligned_cols=132 Identities=26% Similarity=0.376 Sum_probs=111.7
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-----C---cccccEEeEEec--
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-----H---RNVVKLLGCCLE-- 158 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~-- 158 (419)
..+|.+.++||-|.|++||++.+ .+.+.||+|+.+.... -.+..+.|+++|++++ | .+||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqh-YtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQH-YTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhH-HHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 37899999999999999999996 4567899999875432 3466788999999883 3 369999999974
Q ss_pred --CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014725 159 --SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL 226 (419)
Q Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill 226 (419)
+.+.+||+|++ |.+|..+|....-+ -++...+.+|+.||+.||.|||+... |||-||||+|||+
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~Yr-Glpl~~VK~I~~qvL~GLdYLH~ecg--IIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSNYR-GLPLSCVKEICRQVLTGLDYLHRECG--IIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhCCC-CCcHHHHHHHHHHHHHHHHHHHHhcC--ccccCCCcceeee
Confidence 45779999999 78999999875544 38899999999999999999999874 9999999999999
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=234.10 Aligned_cols=261 Identities=24% Similarity=0.309 Sum_probs=195.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecC------C
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLES------E 160 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~ 160 (419)
..+|.-.+.+|.|.- .|..+.+ -.+++||+|+... .+....+...+|...+..++|+||++++.++.-. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 456777888999988 5655553 3578999998643 2344457788999999999999999999998643 3
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..|+|||+|+ .+|.+.+.. .++-.++..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||++
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 5699999994 599988873 2677888899999999999999999 999999999999999999999999999
Q ss_pred eecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
+.-..+ ...+..+.|..|.|||++-+..+.+.+||||+||++.||++|+.-|.+.+..+.-......++...+.-..+
T Consensus 166 r~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 166 RTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred cccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHH
Confidence 864332 456777889999999999988899999999999999999999999987654332111111111110000000
Q ss_pred H----------------------HHHhh---ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 321 V----------------------LEARV---LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 321 ~----------------------~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
+ +.+.. ..+.+........+++.+||-.+|++|-++.+++.-
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H 310 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH 310 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence 0 00000 001111223456789999999999999999999763
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=252.06 Aligned_cols=196 Identities=23% Similarity=0.364 Sum_probs=167.2
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--------hhhHHHHHHHHHHHhcCC---CcccccEEeEEec
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--------ESNVEQFINEVVILSQIN---HRNVVKLLGCCLE 158 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~ 158 (419)
..|...+.+|+|+||.|++|.++ +...|+||.+.... ....-..-.|+.+|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45888999999999999999975 45678888654311 111223557999999997 9999999999999
Q ss_pred CCcceEEEeec-CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 014725 159 SEVPLLVYEFI-PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF 237 (419)
Q Consensus 159 ~~~~~lv~e~~-~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 237 (419)
++.+|++||.. ++-+|.+++..+. .+++.....|+.||+.|+++||+++ |||||||-+|+.++.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp---~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP---RMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC---ccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 99999999966 5669999998765 4899999999999999999999999 999999999999999999999999
Q ss_pred CCceecccCCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCC
Q 014725 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIR 295 (419)
Q Consensus 238 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~ 295 (419)
|.+..... .....++||..|.|||++.+..| +..-|||++|++||-++....||.
T Consensus 715 gsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99876543 33456789999999999999877 567899999999999998888874
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=224.82 Aligned_cols=255 Identities=21% Similarity=0.295 Sum_probs=187.0
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeE-EecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGC-CLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~-~~~~~~~~lv 165 (419)
..+.|.+.+.+|+|.||.+.++.++. .+.+++|-+... .....+|.+|...--.| .|.||+.-|+. |+..+.++++
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 34678999999999999999999765 567888876542 34467899998876666 58999998876 5566778899
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE-CC-CCcEEEeecCCceec
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL-DD-KYRAKVSDFGASRTI 243 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill-~~-~~~~kl~Dfgl~~~~ 243 (419)
+||++.|+|.+-+...+ +-+....+++.|++.|+.|+|+++ +||||||.+|||| +. ...+||+|||+.+..
T Consensus 101 qE~aP~gdL~snv~~~G----igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~ 173 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAAG----IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKV 173 (378)
T ss_pred eccCccchhhhhcCccc----ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeeccccccc
Confidence 99999999998887644 677788899999999999999999 9999999999999 33 347999999998764
Q ss_pred ccCCceeeecccccCCccCccccccC-----CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSS-----QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
... .....-+..|.+||.+... ...+.+|||+||++++.++||+.||.. ....+...+.|... .... .
T Consensus 174 g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk-a~~~d~~Y~~~~~w-~~rk-~ 246 (378)
T KOG1345|consen 174 GTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK-ASIMDKPYWEWEQW-LKRK-N 246 (378)
T ss_pred Cce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh-hhccCchHHHHHHH-hccc-C
Confidence 322 2223346679999986432 346789999999999999999999983 22233333333221 1111 0
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
... +.......+....+.++-+..+|++|=-..++.++..
T Consensus 247 ~~~------P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk 286 (378)
T KOG1345|consen 247 PAL------PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK 286 (378)
T ss_pred ccC------chhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence 000 1111223455777888889999999966666655543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-30 Score=220.40 Aligned_cols=283 Identities=17% Similarity=0.187 Sum_probs=228.3
Q ss_pred HHhcCccccCcccccCcEEEEEEE-ecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC-cccccEEeEEecCCcceEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINH-RNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv 165 (419)
...++|.+++.||+|+||.+|.|. ..+|..||||....... ..++..|..+.+.|++ ..|+.+..+..+.....+|
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 346789999999999999999999 57799999998664322 2457789999999975 7888999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEEeecCCcee
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKVSDFGASRT 242 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl~~~ 242 (419)
|+++ |.+|.+++.-... .++..+++-++-|++.-++|+|.++ ++||||||+|+|..- -..+.++||||++.
T Consensus 90 MdLL-GPsLEdLfnfC~R--~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk 163 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSR--RFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK 163 (341)
T ss_pred eecc-CccHHHHHHHHhh--hhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhh
Confidence 9998 8899998876554 4888999999999999999999999 999999999999953 34699999999998
Q ss_pred cccCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 243 IKVDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 243 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
+....+. ......||..|.+-..+.+.+.+.+.|+-|+|.+|.++..|..||.+..+.......+.+...-
T Consensus 164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK--- 240 (341)
T KOG1163|consen 164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK--- 240 (341)
T ss_pred hccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh---
Confidence 7543222 2244669999999999888899999999999999999999999999988765444333322211
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCcccccccCC
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEIHFVGG 387 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~~~~~ 387 (419)
............+.++...+..|-....++-|....+.+.+.-+...++-...-..+|.......
T Consensus 241 ------~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~ 305 (341)
T KOG1163|consen 241 ------MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKS 305 (341)
T ss_pred ------cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHh
Confidence 11111122334566788999999999999999999999999998888888888888887765433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=219.10 Aligned_cols=277 Identities=16% Similarity=0.190 Sum_probs=223.6
Q ss_pred HhcCccccCcccccCcEEEEEEE-ecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 166 (419)
..-+|++.++||+|+||..+.|+ +-++++||||.....+ ..-++..|....+.|. .++|+.++-+..++.+..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 34579999999999999999999 4678999999765432 2356778888888885 699999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-----CCcEEEeecCCce
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-----KYRAKVSDFGASR 241 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfgl~~ 241 (419)
|++ |-||.+++.-.+. .++.+++..+|.|++.-++|+|++. +|.|||||+|+||.. ...+.++|||+|+
T Consensus 104 dLL-GPSLEDLFD~CgR--~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCGR--RFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHhcC--cccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 998 8899998876554 4899999999999999999999999 999999999999953 3358999999999
Q ss_pred ecccCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 242 TIKVDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 242 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
.+....+. ......||.+||+-..+.+.+.+.+.|+-|||-++++++.|..||.+..+.......+.+-..-..
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 88654332 234567999999999999999999999999999999999999999998776543322222111111
Q ss_pred cchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCcccc
Q 014725 316 DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEI 382 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~ 382 (419)
-.+ .......+.++...+...-..+..+-|....+...+..+...++.......+|..
T Consensus 258 T~i---------~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~Dg~yDW~~ 315 (449)
T KOG1165|consen 258 TPI---------EVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETDDGEYDWMG 315 (449)
T ss_pred CCH---------HHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 111 1123345667888888888899999999999999999999999988888888854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.6e-28 Score=227.65 Aligned_cols=273 Identities=22% Similarity=0.219 Sum_probs=205.1
Q ss_pred CccccCcccccCcEEEEEEEecCC--CEEEEEEcccCChhhHHHHHHHHHHHhcCCC----cccccEEeEE-ecCCcceE
Q 014725 92 NYNANRILGQGGQGTVYKGMLADG--GIVAVKKSKLVDESNVEQFINEVVILSQINH----RNVVKLLGCC-LESEVPLL 164 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~l 164 (419)
+|.+.+.||+|+||.||++..... ..+|+|............+..|..++..+.. +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997654 4788887665433322367788888888862 6899999999 47778899
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-----CcEEEeecCC
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-----YRAKVSDFGA 239 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-----~~~kl~Dfgl 239 (419)
||+.+ |.+|.++..... ...++..+..+++.|++.+|++||+.| ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99988 889999886655 346999999999999999999999999 9999999999999754 4699999999
Q ss_pred ceecc--cCCc----ee---eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH
Q 014725 240 SRTIK--VDQT----HL---TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 240 ~~~~~--~~~~----~~---~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 310 (419)
++.+. .... .. .....||..|++++++.+.+.+.+.|+||++.++.|++.|..||........... +.
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~---~~ 250 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK---FE 250 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH---HH
Confidence 99332 2211 11 1245699999999999999999999999999999999999999976554322111 11
Q ss_pred HHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCccc
Q 014725 311 QAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEE 381 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~ 381 (419)
+ ..............+..+..+...+-..+...+|....+...|+......+........|+
T Consensus 251 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~~~~~~~~dw~ 312 (322)
T KOG1164|consen 251 K---------DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEGSKEDSPFDWE 312 (322)
T ss_pred H---------HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcCCCCCCCCccc
Confidence 1 1011110101222344566666667779999999999999999887766544444444444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-29 Score=228.72 Aligned_cols=201 Identities=24% Similarity=0.367 Sum_probs=167.3
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEec----CCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCC
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESE 160 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~ 160 (419)
+......|...++||+|.|++||++.+. ....||+|.+..... ...+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4445677899999999999999999954 356899999876443 356899999999994 899999999999999
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecCC
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGA 239 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl 239 (419)
...+|+||++.....+++.. ++...+..++..++.||.++|..| ||||||||.|+|.+. .+.-.|+||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999998874 667788899999999999999999 999999999999975 56789999999
Q ss_pred ceecccC-------C------------------------------------ceeeecccccCCccCcccccc-CCCCccc
Q 014725 240 SRTIKVD-------Q------------------------------------THLTTRVQGTFGYLDPEYFRS-SQFTEKS 275 (419)
Q Consensus 240 ~~~~~~~-------~------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~~~ 275 (419)
+...... . ........||++|.|||++.. ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 8721100 0 000112459999999999754 5678999
Q ss_pred ceechhHHHHHHHhCCCCCCCC
Q 014725 276 DVYSFGVVLVELLTGQKPIRST 297 (419)
Q Consensus 276 Di~slG~~l~el~tg~~p~~~~ 297 (419)
||||.||+++.+++++.||-..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ceeeccceeehhhccccccccC
Confidence 9999999999999999998543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=265.53 Aligned_cols=195 Identities=21% Similarity=0.200 Sum_probs=139.4
Q ss_pred cCCC-cccccEEeEE-------ecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 014725 143 QINH-RNVVKLLGCC-------LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214 (419)
Q Consensus 143 ~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 214 (419)
.++| +||++++++| .+....+.++||+ +++|.++|.... ..+++.+++.++.||+.||.|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 4556 6888888887 2334667888987 669999997543 35899999999999999999999999 9
Q ss_pred eecCCCCCcEEECC-------------------CCcEEEeecCCceecccCC---------------ceeeecccccCCc
Q 014725 215 YHRDIKSSNILLDD-------------------KYRAKVSDFGASRTIKVDQ---------------THLTTRVQGTFGY 260 (419)
Q Consensus 215 iH~Dlkp~Nill~~-------------------~~~~kl~Dfgl~~~~~~~~---------------~~~~~~~~gt~~y 260 (419)
+||||||+||||+. ++.+|++|||+++...... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 4456666777665421100 0001124578899
Q ss_pred cCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHH
Q 014725 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM 340 (419)
Q Consensus 261 ~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 340 (419)
||||++.+..++.++|||||||+||||++|..|+...... ..... .................
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~-----~~~~~-------------~~~~~~~~~~~~~~~~~ 243 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT-----MSSLR-------------HRVLPPQILLNWPKEAS 243 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH-----HHHHH-------------HhhcChhhhhcCHHHHH
Confidence 9999999999999999999999999999988876421110 00000 00000001111234567
Q ss_pred HHHHHhccCCCCCCCHHHHHH
Q 014725 341 LGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 341 li~~cl~~~p~~RPt~~evl~ 361 (419)
++.+||+++|.+||++.|+++
T Consensus 244 ~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 244 FCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHhCCCChhhCcChHHHhh
Confidence 888999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=205.10 Aligned_cols=169 Identities=22% Similarity=0.287 Sum_probs=127.3
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
|+|.+++..... .+++..++.++.|++.||.|||+.+ ||+|||++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEVRGR--PLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 689999986432 5999999999999999999999875 999999999999999 99988654322
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCC
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK 331 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 331 (419)
..||+.|+|||++.+..++.++|||||||++|||+||+.||....... .............. +. ....+
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~------~~-~~~~~ 132 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS--AILEILLNGMPADD------PR-DRSNL 132 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc--HHHHHHHHHhccCC------cc-ccccH
Confidence 258999999999999999999999999999999999999996543211 11111111111000 00 00111
Q ss_pred HHHHH--HHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 332 EEEII--TVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 332 ~~~~~--~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
..... .+.+++.+||+.+|.+||++.++++.+..+..
T Consensus 133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 22222 58999999999999999999999998876643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=217.05 Aligned_cols=180 Identities=18% Similarity=0.137 Sum_probs=136.7
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEec--CCCEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCcccccEEeE
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLA--DGGIVAVKKSKLV-----DESNVEQFINEVVILSQINHRNVVKLLGC 155 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~ 155 (419)
-+......++|.+.+.||+|+||+||+|.+. ++..+|||+.... .....+.|.+|+++|+.++|+|+++.+..
T Consensus 10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~ 89 (365)
T PRK09188 10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA 89 (365)
T ss_pred ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence 3445566788999999999999999999864 4677899985432 22345679999999999999999853322
Q ss_pred EecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCcEEECCCCcEEE
Q 014725 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDI-KSSNILLDDKYRAKV 234 (419)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl 234 (419)
.+..++||||++|++|... .. .. ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||
T Consensus 90 ---~~~~~LVmE~~~G~~L~~~-~~------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikL 153 (365)
T PRK09188 90 ---TGKDGLVRGWTEGVPLHLA-RP------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAV 153 (365)
T ss_pred ---cCCcEEEEEccCCCCHHHh-Cc------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEE
Confidence 2457999999999999632 11 11 1457889999999999998 999999 999999999999999
Q ss_pred eecCCceecccCCcee-------eecccccCCccCccccccCC------CCccccee
Q 014725 235 SDFGASRTIKVDQTHL-------TTRVQGTFGYLDPEYFRSSQ------FTEKSDVY 278 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~s~~~Di~ 278 (419)
+|||+++.+....... .....+++.|+|||.+...+ .+..+|-|
T Consensus 154 iDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW 210 (365)
T PRK09188 154 IDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW 210 (365)
T ss_pred EECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence 9999999765432111 13456888999999986432 23446666
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.3e-26 Score=198.62 Aligned_cols=249 Identities=22% Similarity=0.332 Sum_probs=194.7
Q ss_pred ccccCcccccCcEEEEEEEecCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 93 YNANRILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
..+..+|.+...|..|+|+++.+ .+++|+++. ......+.|..|.-.|+-+.||||+.+++.|.......++..||+
T Consensus 192 lnl~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp 270 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMP 270 (448)
T ss_pred hhhhhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeecc
Confidence 34456788999999999999644 455565543 233344679999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEe--ecCCceecccCCc
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS--DFGASRTIKVDQT 248 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~--Dfgl~~~~~~~~~ 248 (419)
.|+|...|++...- ..+..+..+++.++++|+.|||+..+. |.---|.+..+++|++.+++|+ |--++.
T Consensus 271 ~gslynvlhe~t~v-vvd~sqav~faldiargmaflhslep~-ipr~~lns~hvmidedltarismad~kfsf------- 341 (448)
T KOG0195|consen 271 FGSLYNVLHEQTSV-VVDHSQAVRFALDIARGMAFLHSLEPM-IPRFYLNSKHVMIDEDLTARISMADTKFSF------- 341 (448)
T ss_pred chHHHHHHhcCccE-EEecchHHHHHHHHHhhHHHHhhcchh-hhhhhcccceEEecchhhhheecccceeee-------
Confidence 99999999987543 477788899999999999999998753 4444689999999999988875 221111
Q ss_pred eeeecccccCCccCccccccCCCC---cccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFT---EKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s---~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
......-.|.||+||.++..+.+ .++|+|||.+++|||.|...||....+.+-. ..+--..
T Consensus 342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg---------------mkialeg 405 (448)
T KOG0195|consen 342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG---------------MKIALEG 405 (448)
T ss_pred -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh---------------hhhhhcc
Confidence 11122346889999999875543 5899999999999999999999877665421 1122233
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
++...|+.....+..|+.-|+..||.+||.+..|+-.|+++.
T Consensus 406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 445566777778999999999999999999999999998763
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-23 Score=198.34 Aligned_cols=260 Identities=31% Similarity=0.406 Sum_probs=196.6
Q ss_pred ccccCcccccCcEEEEEEEecCCCEEEEEEcccCChh---hHHHHHHHHHHHhcCCCc-ccccEEeEEecCCcceEEEee
Q 014725 93 YNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDES---NVEQFINEVVILSQINHR-NVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 168 (419)
|.+.+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 677889999999999999986 77888887653222 467899999999999987 799999999777778999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~ 247 (419)
+.++++.+++........+.......++.|++.++.|+|+.+ ++|||+||+||+++..+ .++++|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977765431124788899999999999999999999 99999999999999988 79999999998654433
Q ss_pred ce-----eeecccccCCccCcccccc---CCCCcccceechhHHHHHHHhCCCCCCCCChh-hhccHHHHHHHHhcccch
Q 014725 248 TH-----LTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE-EDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 248 ~~-----~~~~~~gt~~y~aPE~~~~---~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~ 318 (419)
.. ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... ............... ..
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 235 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-SL 235 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-cc
Confidence 22 2356679999999999987 57889999999999999999999997665431 000011111100000 00
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
. ..............+.+++..|+..+|..|.+..+....
T Consensus 236 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 236 A----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred c----cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 0 000000001223468889999999999999998877664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-25 Score=224.94 Aligned_cols=253 Identities=21% Similarity=0.282 Sum_probs=188.2
Q ss_pred cccCcccccCcEEEEEEEec-CCCEEEEEEcc-----cCChhhH-HHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 94 NANRILGQGGQGTVYKGMLA-DGGIVAVKKSK-----LVDESNV-EQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~-----~~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
...+.+|.|++|.|+..... .....+.|... ....... ..+..|+.+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45678999999977777643 23333333321 1112221 22667888888899999998888887777666669
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
|||++ +|..++.... .++...+..++.|++.|+.|+|+.| +.|||+||+|++++.++.+||+|||.+..+...
T Consensus 401 E~~~~-Dlf~~~~~~~---~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG---KLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhccc---ccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 9999998652 3777888889999999999999999 999999999999999999999999999887644
Q ss_pred Cc---eeeecccccCCccCccccccCCCCc-ccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 247 QT---HLTTRVQGTFGYLDPEYFRSSQFTE-KSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 247 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~-~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
.. ......+|+..|+|||.+.+..|.+ ..||||.|++++.|++|+.||......+............ ..
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~---~~---- 546 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQR---NI---- 546 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccc---cc----
Confidence 33 4556788999999999999998875 6999999999999999999997655443321000000000 00
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...........+.....++.+||+.+|.+|-|+.+|++
T Consensus 547 -~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 547 -FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred -ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00001112234456788999999999999999999986
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=186.26 Aligned_cols=172 Identities=13% Similarity=0.141 Sum_probs=133.4
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChh---hHHH------HHHHHHHHhcCCCcccccEEeEEec
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDES---NVEQ------FINEVVILSQINHRNVVKLLGCCLE 158 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~------~~~e~~~l~~l~h~niv~l~~~~~~ 158 (419)
...++|+..+.+|.|+||.||+... ++..+|+|.+...... .... +.+|+..+.+++||+|..+.+++..
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 4578999999999999999999666 5778999988643222 2222 5789999999999999999988664
Q ss_pred C--------CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC
Q 014725 159 S--------EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY 230 (419)
Q Consensus 159 ~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 230 (419)
. +..+++|||++|.+|.++.. ++. ....+++.+|..+|+.+ ++|||++|+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 3 35789999999999988732 332 24568999999999999 99999999999999988
Q ss_pred cEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHH
Q 014725 231 RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELL 288 (419)
Q Consensus 231 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~ 288 (419)
++|+|||........... ..+.....+..++|+||||+++..+.
T Consensus 173 -i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 -LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred -EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 999999987654211110 01233445667999999999987664
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.9e-23 Score=178.52 Aligned_cols=139 Identities=19% Similarity=0.162 Sum_probs=107.4
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChh--h-------H-----------------HHHHHHHHHHhcCCCccc
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDES--N-------V-----------------EQFINEVVILSQINHRNV 149 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~ni 149 (419)
...||+|+||.||+|...+|+.||||..+..... . . ....+|++.+..+.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999999878999999987643211 0 0 122349999999988776
Q ss_pred ccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeecCCCCCcEEECC
Q 014725 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL-HSATSIPIYHRDIKSSNILLDD 228 (419)
Q Consensus 150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~Dlkp~Nill~~ 228 (419)
.....+. ....++||||++++++....... ..+++.....++.|++.+|.++ |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 4433322 22348999999988776543322 2488899999999999999999 6888 99999999999998
Q ss_pred CCcEEEeecCCceec
Q 014725 229 KYRAKVSDFGASRTI 243 (419)
Q Consensus 229 ~~~~kl~Dfgl~~~~ 243 (419)
++.++|+|||++...
T Consensus 153 ~~~v~LiDFG~a~~~ 167 (190)
T cd05147 153 DGKLYIIDVSQSVEH 167 (190)
T ss_pred CCcEEEEEccccccC
Confidence 478999999999753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.8e-24 Score=213.82 Aligned_cols=250 Identities=21% Similarity=0.250 Sum_probs=180.8
Q ss_pred CccccCcccccCcEEEEEEEecCCCEEEEEEcccC-ChhhHHHHHHHHHH--HhcCCCcccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV-DESNVEQFINEVVI--LSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+|...+.||++.|=.|.+|++++|. |+||.+-.. +.-..+.|.++++- ...++|||++++.-.-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 6777899999999999999998776 888875432 23344444444332 5556899999998877777788899999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc--cC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK--VD 246 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~--~~ 246 (419)
.. .+|.|.+..+ .-+...+...|+.|++.||..+|..+ |+|||||.+||||+.-.-+.|+||...+..- .+
T Consensus 103 vk-hnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VK-HNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hh-hhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 85 4888888643 34777888899999999999999999 9999999999999999999999998765432 22
Q ss_pred Cce----eeecccccCCccCccccccC----------C-CCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHH
Q 014725 247 QTH----LTTRVQGTFGYLDPEYFRSS----------Q-FTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 247 ~~~----~~~~~~gt~~y~aPE~~~~~----------~-~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~ 310 (419)
+.. ...+...-.+|.|||.+... . .+++.||||+||+++||++ |++||.... +..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~aY-- 247 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LLAY-- 247 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HHhH--
Confidence 211 12233344679999986431 2 6789999999999999999 788885321 1111
Q ss_pred HHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 311 QAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
+..+.......+.... . ..+..|+..|++.||.+|.++.+.++.-++
T Consensus 248 r~~~~~~~e~~Le~Ie-d-------~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKIE-D-------VSLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred hccCccCHHHHHHhCc-C-------ccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 0111111111121111 1 148889999999999999999999887543
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1e-21 Score=171.70 Aligned_cols=139 Identities=24% Similarity=0.226 Sum_probs=110.0
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChh--------------------------hHHHHHHHHHHHhcCCCccc
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDES--------------------------NVEQFINEVVILSQINHRNV 149 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni 149 (419)
...||+|+||.||+|.+.+|+.||||........ ....+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4689999999999999878999999987643210 01224578999999999987
Q ss_pred ccEEeEEecCCcceEEEeecCCCCHHHH-hhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEEC
Q 014725 150 VKLLGCCLESEVPLLVYEFIPNGTLYHY-LHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLD 227 (419)
Q Consensus 150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~ 227 (419)
.....+... ..++||||++++++... +.. ..++......++.|++.++.++|+ .+ |+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~ 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE
Confidence 554444332 34899999998855443 332 247788889999999999999999 88 99999999999999
Q ss_pred CCCcEEEeecCCceecc
Q 014725 228 DKYRAKVSDFGASRTIK 244 (419)
Q Consensus 228 ~~~~~kl~Dfgl~~~~~ 244 (419)
++.++|+|||++....
T Consensus 153 -~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 -DGKPYIIDVSQAVELD 168 (190)
T ss_pred -CCCEEEEEcccceecC
Confidence 7899999999997653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=169.47 Aligned_cols=187 Identities=14% Similarity=0.068 Sum_probs=140.3
Q ss_pred cccCcccccCcEEEEEEEecCCCEEEEEEcccCChh----hHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEee
Q 014725 94 NANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDES----NVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.+...|++|+||+||.+.. .+.+++.+.+.....- ....+.+|+++|++|+ |+++++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 4567899999999997766 6777887766654331 1225789999999995 5889999886 346999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC-CCCcEEECCCCcEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDI-KSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl-kp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
++|.+|...+.. . ...++.|++.+|.++|++| |+|||| ||+|||++.++.++|+|||++.......
T Consensus 80 I~G~~L~~~~~~---------~-~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~ 146 (218)
T PRK12274 80 LAGAAMYQRPPR---------G-DLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA 146 (218)
T ss_pred ecCccHHhhhhh---------h-hHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence 999998654321 1 1346789999999999999 999999 7999999999999999999998654332
Q ss_pred ce----e--------eecccccCCccCccccccC-CCC-cccceechhHHHHHHHhCCCCCCCCC
Q 014725 248 TH----L--------TTRVQGTFGYLDPEYFRSS-QFT-EKSDVYSFGVVLVELLTGQKPIRSTD 298 (419)
Q Consensus 248 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~~~Di~slG~~l~el~tg~~p~~~~~ 298 (419)
.. . ......++.|++|+...-. ..+ .+.+.++-|+.+|.++|+..|.-...
T Consensus 147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 10 0 1112257788888865432 333 56788899999999999998865443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=176.10 Aligned_cols=233 Identities=21% Similarity=0.290 Sum_probs=151.0
Q ss_pred CccccCcccccCcEEEEEEEecC-CCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCC----------cccccEEeEEe
Q 014725 92 NYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVD---ESNVEQFINEVVILSQINH----------RNVVKLLGCCL 157 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~niv~l~~~~~ 157 (419)
.+...+.||.|+++.||.+++.. ++++|+|...... ....+++.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 34556889999999999999854 7899999865422 2356677777655554322 11222222211
Q ss_pred ---------cC---C-----cceEEEeecCCCCHHHHhhc---cC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 014725 158 ---------ES---E-----VPLLVYEFIPNGTLYHYLHD---QT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216 (419)
Q Consensus 158 ---------~~---~-----~~~lv~e~~~~g~L~~~l~~---~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 216 (419)
.. . +.+++|+-+ .++|.+++.. .. ....+....++.+..|+.+.+++||..| ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 11 1 236778877 5688887643 21 1223445566778899999999999999 999
Q ss_pred cCCCCCcEEECCCCcEEEeecCCceecccCCceeeecccccCCccCcccccc--------CCCCcccceechhHHHHHHH
Q 014725 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS--------SQFTEKSDVYSFGVVLVELL 288 (419)
Q Consensus 217 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~Di~slG~~l~el~ 288 (419)
+||+|+|++++.+|.++|+||+........ ... ...+..|.+||.... -.++.+.|.|+||+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~---~~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR---YRC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEE---EEG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCce---eec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 999999999999999999999877654321 111 234578999997643 25788999999999999999
Q ss_pred hCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCC
Q 014725 289 TGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKR 353 (419)
Q Consensus 289 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 353 (419)
+|..||........... ....+. +.++.+..||..+|+.+|.+|
T Consensus 245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999987644322100 123344 788889999999999999988
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1e-21 Score=189.39 Aligned_cols=218 Identities=25% Similarity=0.476 Sum_probs=162.2
Q ss_pred HhcCCCcccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 014725 141 LSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220 (419)
Q Consensus 141 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk 220 (419)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.... ..+++.....+..+|+.||.|||... + ..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeec
Confidence 356889999999999999999999999999999999998743 35899999999999999999999865 2 3999999
Q ss_pred CCcEEECCCCcEEEeecCCceecccC-CceeeecccccCCccCccccccC-------CCCcccceechhHHHHHHHhCCC
Q 014725 221 SSNILLDDKYRAKVSDFGASRTIKVD-QTHLTTRVQGTFGYLDPEYFRSS-------QFTEKSDVYSFGVVLVELLTGQK 292 (419)
Q Consensus 221 p~Nill~~~~~~kl~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~s~~~Di~slG~~l~el~tg~~ 292 (419)
+.|+++|....+||+|||+....... .........-...|.|||.++.. ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321 11111112234579999998763 14678999999999999999999
Q ss_pred CCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 293 PIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 293 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
||+........ .+.+.. +..+ ....+.+.+.. ..+....+..++.+||..+|..||++..|...++.+..
T Consensus 157 ~~~~~~~~~~~--~eii~~-~~~~-~~~~~rP~i~~--~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 157 PFDLRNLVEDP--DEIILR-VKKG-GSNPFRPSIEL--LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK 226 (484)
T ss_pred ccccccccCCh--HHHHHH-HHhc-CCCCcCcchhh--hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence 99864433221 111111 1110 00000011100 01334478899999999999999999999998887755
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.5e-21 Score=199.12 Aligned_cols=201 Identities=21% Similarity=0.308 Sum_probs=161.3
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC---CcccccEEeEEecC
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN---HRNVVKLLGCCLES 159 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~ 159 (419)
..+.+.....|.+.+.||+|+||.||+|...+++.||+|..+....-. |.--.+++.+|+ -+.|..+..+..-.
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccC
Confidence 344566678899999999999999999998889999999876543321 111123333443 24455555555667
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC-------CCCcE
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-------DKYRA 232 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-------~~~~~ 232 (419)
+..++|+||.+.|+|.++++... .++|...+.++.|+++.++.||..+ |||+||||+|+||. +...+
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~~~---~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINTNK---VMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred CcceeeeeccccccHHHhhccCC---CCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccce
Confidence 77899999999999999998433 5899999999999999999999999 99999999999993 34569
Q ss_pred EEeecCCceeccc-CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCC
Q 014725 233 KVSDFGASRTIKV-DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 292 (419)
Q Consensus 233 kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~ 292 (419)
+|+|||.+-.+.. .+.......++|-.+-.+|...+..++.+.|.|.|+.+++-|+.|+.
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 9999999976653 22335566778999999999999999999999999999999999874
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.8e-20 Score=164.85 Aligned_cols=136 Identities=15% Similarity=0.180 Sum_probs=105.9
Q ss_pred cccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-----CCcccccEEeEEecCC---c-ceE
Q 014725 94 NANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI-----NHRNVVKLLGCCLESE---V-PLL 164 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~l 164 (419)
.-.+.||+|+||.||. +.+....+||+.........+.+.+|+.+++.+ +||||++++|++.++. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3457899999999996 433333479987665444567899999999999 5799999999998764 3 237
Q ss_pred EEee--cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHH-HHHhhcCCCCeeecCCCCCcEEECC----CCcEEEeec
Q 014725 165 VYEF--IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM-SYLHSATSIPIYHRDIKSSNILLDD----KYRAKVSDF 237 (419)
Q Consensus 165 v~e~--~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~iiH~Dlkp~Nill~~----~~~~kl~Df 237 (419)
|+|| +.+++|.+++.+. .+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 5579999999753 25544 35577888777 9999999 999999999999963 347999995
Q ss_pred CCc
Q 014725 238 GAS 240 (419)
Q Consensus 238 gl~ 240 (419)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=173.78 Aligned_cols=196 Identities=23% Similarity=0.233 Sum_probs=140.9
Q ss_pred CCcccccEEeEEec---------------------------CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHH
Q 014725 145 NHRNVVKLLGCCLE---------------------------SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI 197 (419)
Q Consensus 145 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~ 197 (419)
+|||||++.++|.+ ....|+||.-.+ .+|..|+..+. .+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 59999999988753 234688998774 49999997654 45556667889
Q ss_pred HHHHHHHHHhhcCCCCeeecCCCCCcEEE--CCCC--cEEEeecCCceecccCCc-----eeeecccccCCccCcccccc
Q 014725 198 EVSGAMSYLHSATSIPIYHRDIKSSNILL--DDKY--RAKVSDFGASRTIKVDQT-----HLTTRVQGTFGYLDPEYFRS 268 (419)
Q Consensus 198 ~i~~~l~~LH~~~~~~iiH~Dlkp~Nill--~~~~--~~kl~Dfgl~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~ 268 (419)
|++.|+.|||.++ |.|||+|++|||+ |+|+ .+.|+|||.+-....... .......|...-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999999 9999999999999 4443 578999998754322111 11123447788999998754
Q ss_pred CC------CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHH
Q 014725 269 SQ------FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLG 342 (419)
Q Consensus 269 ~~------~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 342 (419)
.+ --.++|.|+.|.+.||+++...||....+.... .........+..+..+++.+.+++
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~---------------~r~Yqe~qLPalp~~vpp~~rqlV 490 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD---------------TRTYQESQLPALPSRVPPVARQLV 490 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec---------------hhhhhhhhCCCCcccCChHHHHHH
Confidence 22 125899999999999999999999763221100 000112233455677788899999
Q ss_pred HHHhccCCCCCCCHHHHHHHH
Q 014725 343 KRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 343 ~~cl~~~p~~RPt~~evl~~L 363 (419)
...|+.||++||+..-....|
T Consensus 491 ~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 491 FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHhcCCccccCCccHHHhHH
Confidence 999999999999865444433
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5e-22 Score=191.57 Aligned_cols=225 Identities=26% Similarity=0.301 Sum_probs=176.5
Q ss_pred cccccCcEEEEEEEe----cCCCEEEEEEcccCCh--hhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEeecC
Q 014725 98 ILGQGGQGTVYKGML----ADGGIVAVKKSKLVDE--SNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
.+|+|+||.|+++.. +.+..+|.|..+.... ........|..++...+ ||.++++...++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 379999999998763 3355677776543211 11124566788888886 9999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+|.|...+.... .+++.....+...++-+++++|+.+ ++|||+|++||+++.+|++++.|||+++..-.....
T Consensus 81 gg~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~- 153 (612)
T KOG0603|consen 81 GGDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA- 153 (612)
T ss_pred cchhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc-
Confidence 999988777544 3666666777788999999999999 999999999999999999999999999875432222
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (419)
+||..|||||.+. ....+.|.||||++++||+||..||.. +. ...++ ......
T Consensus 154 ----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~---~~----------------~~~Il--~~~~~~ 206 (612)
T KOG0603|consen 154 ----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG---DT----------------MKRIL--KAELEM 206 (612)
T ss_pred ----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch---HH----------------HHHHh--hhccCC
Confidence 8999999999998 567899999999999999999999976 10 01111 112344
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 331 KEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 331 ~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
+.........++..++..+|..|.-.
T Consensus 207 p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 207 PRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred chhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 66667778888889999999998754
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-19 Score=157.89 Aligned_cols=134 Identities=22% Similarity=0.296 Sum_probs=112.8
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCCh--------hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDE--------SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
+.||+|++|.||+|.. ++..+++|+...... .....+.+|+.++..+.|+|++....++.+.+..+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999988 577889997543211 1124578899999999999988877777777888999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++|++|.+++.... + .+..++.+++.+|.++|+.+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 81 ~~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986432 2 77889999999999999999 99999999999999 78999999998754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.4e-19 Score=159.80 Aligned_cols=142 Identities=19% Similarity=0.141 Sum_probs=110.6
Q ss_pred CccccCcccccCcEEEEEEE--ecCCCEEEEEEcccCChh------------------------hHHHHHHHHHHHhcCC
Q 014725 92 NYNANRILGQGGQGTVYKGM--LADGGIVAVKKSKLVDES------------------------NVEQFINEVVILSQIN 145 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~ 145 (419)
-|.+.+.||+|+||.||+|. ..+|+.||+|........ ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 48889999999999999998 567899999987643210 1123568999999997
Q ss_pred Cc--ccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 146 HR--NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 146 h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
+. .+++++++ ...++||||+++.+|..+.... ..+.......++.|++.++.+||+.+. ++||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhh
Confidence 53 34455543 2358999999998887654322 235566678899999999999999874 9999999999
Q ss_pred EEECCCCcEEEeecCCceec
Q 014725 224 ILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~ 243 (419)
|+++ ++.++|+|||.+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVEL 198 (237)
T ss_pred EEEE-CCCEEEEEChhhhcc
Confidence 9999 889999999988653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.4e-20 Score=178.37 Aligned_cols=173 Identities=25% Similarity=0.371 Sum_probs=129.0
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..|+.|++|...+|.+||.........++.....++.|++.|+.| ++ .+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 578999999999999999865555557888889999999999999 66 899999999999999999999999998
Q ss_pred eecccCC-----ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhc
Q 014725 241 RTIKVDQ-----THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 241 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
....... ....+...||..||+||++.+..|+.++||||||++|+||+. =..++.-.. +..-++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~----------t~~d~r 473 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA----------TLTDIR 473 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH----------hhhhhh
Confidence 7765433 223455679999999999999999999999999999999997 222221110 111111
Q ss_pred ccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHH
Q 014725 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKE 358 (419)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e 358 (419)
.+.+. +......+.=+.++.+++.+.|.+||++.+
T Consensus 474 ~g~ip---------~~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 474 DGIIP---------PEFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred cCCCC---------hHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 11111 001111123456889999999999994433
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.5e-18 Score=152.80 Aligned_cols=143 Identities=22% Similarity=0.201 Sum_probs=110.7
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCCh----------------------hhHHHHHHHHHHHhc
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDE----------------------SNVEQFINEVVILSQ 143 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~e~~~l~~ 143 (419)
+......|.+.+.||+|+||.||++...+++.||||....... .....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 3333344788899999999999999988899999997543210 011235678888988
Q ss_pred CCCc--ccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014725 144 INHR--NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKS 221 (419)
Q Consensus 144 l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp 221 (419)
+.|+ .++..++ ....+++|||+++++|...... .....++.+++.++.++|+.+ ++|+||+|
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 8777 4455544 2456899999999998765431 224568889999999999988 99999999
Q ss_pred CcEEECCCCcEEEeecCCceecc
Q 014725 222 SNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 222 ~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-18 Score=152.76 Aligned_cols=130 Identities=22% Similarity=0.324 Sum_probs=106.1
Q ss_pred cccccCcEEEEEEEecCCCEEEEEEcccCC----h----hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 98 ILGQGGQGTVYKGMLADGGIVAVKKSKLVD----E----SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~----~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.||+|+||.||+|.+ ++..+++|...... . .....+.+|++++..++|+++.....++...+..+++|||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999996 56789999754321 1 12356788999999999887665555566667789999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+|++|.+++.... . .++.+++.+|.+||+.+ ++|+|++|+||+++ ++.++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~----~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGN----D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcH----H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 9999998876421 1 68899999999999999 99999999999999 88999999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.9e-18 Score=174.70 Aligned_cols=137 Identities=21% Similarity=0.283 Sum_probs=111.5
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEE-cc-cCC------hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKK-SK-LVD------ESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~-~~-~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
...|...+.||+|+||+||+|.+.+.. +++|+ .. ... ....+.+.+|+++++.++|++++....++.+...
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345567889999999999999975444 33332 21 111 1123568899999999999999988888877778
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++++|.+++. ....++.+++.+|.+||+.+ ++||||||+|||+ .++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999999885 24578999999999999999 9999999999999 57799999999986
Q ss_pred e
Q 014725 242 T 242 (419)
Q Consensus 242 ~ 242 (419)
.
T Consensus 476 ~ 476 (535)
T PRK09605 476 Y 476 (535)
T ss_pred c
Confidence 5
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.5e-19 Score=177.94 Aligned_cols=209 Identities=25% Similarity=0.334 Sum_probs=146.1
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
...+|+.++.|..|+||.||..+++. .+.+|+|.-+. ..+.+. ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq------~lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ------NLILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhccccc------chhhhc--cccccCCccee-----------------
Confidence 45689999999999999999998764 45677743221 111111 22222333332
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc--
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV-- 245 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~-- 245 (419)
|+=...++..+ +++. +++.+++|||+.+ |+|||+||+|.+|+.=|++|++|||+++.-..
T Consensus 136 ----gDc~tllk~~g---~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG---PLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ----chhhhhcccCC---CCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 33333343322 2332 2367899999999 99999999999999999999999999874321
Q ss_pred ------------CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh
Q 014725 246 ------------DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313 (419)
Q Consensus 246 ------------~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 313 (419)
........++||+.|.|||++....|...+|.|++|+++||++-|+.||.+..+++.- -+.+
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------g~vi 271 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------GQVI 271 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------hhhh
Confidence 1112235678999999999999999999999999999999999999999988776531 1111
Q ss_pred cccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCC
Q 014725 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP 354 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP 354 (419)
. +.....+.....+.+.++++.+.|+.+|..|-
T Consensus 272 s--------d~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 272 S--------DDIEWPEEDEALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h--------hhccccccCcCCCHHHHHHHHHHHHhChHhhc
Confidence 1 01111122334456788899999999999995
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.71 E-value=9e-17 Score=140.20 Aligned_cols=136 Identities=25% Similarity=0.276 Sum_probs=97.1
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChh--hHHHH----------------------HHHHHHHhcCCCc--cc
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDES--NVEQF----------------------INEVVILSQINHR--NV 149 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~----------------------~~e~~~l~~l~h~--ni 149 (419)
.+.||+|+||+||+|...+++.||||........ ....+ ..|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4679999999999999888999999986642211 11111 3455555555433 34
Q ss_pred ccEEeEEecCCcceEEEeecCCCCHHHH-hhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEEC
Q 014725 150 VKLLGCCLESEVPLLVYEFIPNGTLYHY-LHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLD 227 (419)
Q Consensus 150 v~l~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~ 227 (419)
++.+++ ...++||||++++++... +.... .. .....++.+++.++.++|. .+ ++|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~ 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE
Confidence 455543 246899999998543221 11111 11 4567889999999999999 87 99999999999999
Q ss_pred CCCcEEEeecCCceecc
Q 014725 228 DKYRAKVSDFGASRTIK 244 (419)
Q Consensus 228 ~~~~~kl~Dfgl~~~~~ 244 (419)
++.++|+|||.+....
T Consensus 150 -~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 -DGKVYIIDVPQAVEID 165 (187)
T ss_pred -CCcEEEEECccccccc
Confidence 8899999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-16 Score=133.91 Aligned_cols=135 Identities=23% Similarity=0.222 Sum_probs=113.5
Q ss_pred ccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC--cccccEEeEEecCCcceEEEeecCCC
Q 014725 95 ANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH--RNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 95 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++++++++....+..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 45789999999999999854 7899998765433 4678899999999976 58999999888888899999999887
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
.+..+ +......++.+++.++.+||.....+++|+|++|+||+++.++.++++|||.++.
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77644 4455677889999999999986544599999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.6e-16 Score=141.21 Aligned_cols=134 Identities=20% Similarity=0.285 Sum_probs=104.1
Q ss_pred Cccc-ccCcEEEEEEEecCCCEEEEEEcccC-------------ChhhHHHHHHHHHHHhcCCCccc--ccEEeEEecCC
Q 014725 97 RILG-QGGQGTVYKGMLADGGIVAVKKSKLV-------------DESNVEQFINEVVILSQINHRNV--VKLLGCCLESE 160 (419)
Q Consensus 97 ~~ig-~G~fg~Vy~~~~~~~~~vavK~~~~~-------------~~~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~~~ 160 (419)
..|| .||.|+||++... +..++||..... +......+.+|+.++..++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4587 8899999998874 677888876421 11223567889999999998775 67777654432
Q ss_pred c----ceEEEeecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 014725 161 V----PLLVYEFIPN-GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235 (419)
Q Consensus 161 ~----~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 235 (419)
. .++|||+++| .+|.+++... +++.. .+.+++.+|.+||+.| |+|+||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 6999888642 24543 3568999999999999 9999999999999998999999
Q ss_pred ecCCcee
Q 014725 236 DFGASRT 242 (419)
Q Consensus 236 Dfgl~~~ 242 (419)
|||.++.
T Consensus 185 Dfg~~~~ 191 (239)
T PRK01723 185 DFDRGEL 191 (239)
T ss_pred ECCCccc
Confidence 9998865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=3.6e-18 Score=172.39 Aligned_cols=256 Identities=23% Similarity=0.299 Sum_probs=188.9
Q ss_pred HhcCccccCcccccCcEEEEEEEecC--CCEEEEEEcccCC--hhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD--GGIVAVKKSKLVD--ESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~ 163 (419)
....|.+.+.||+|+|+.|-...... ...+|+|...... ....+....|..+-..+. |+|++.+++...+.+..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 35568888899999999998877533 3456666655432 233344555777777776 999999999999999999
Q ss_pred EEEeecCCCCHHHHh-hccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeeecCCCCCcEEECCCC-cEEEeecCCc
Q 014725 164 LVYEFIPNGTLYHYL-HDQTEEFPITWEMRLRIAIEVSGAMSYLH-SATSIPIYHRDIKSSNILLDDKY-RAKVSDFGAS 240 (419)
Q Consensus 164 lv~e~~~~g~L~~~l-~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~ 240 (419)
++.+|.+++++.+-+ ..... ..+....-.++.|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~--~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~A 172 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDST--GTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLA 172 (601)
T ss_pred cccCcccccccccccccCCcc--CCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhh
Confidence 999999999999888 33221 2444556678899999999999 777 99999999999999999 9999999999
Q ss_pred eeccc--CCceeeecccc-cCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 241 RTIKV--DQTHLTTRVQG-TFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 241 ~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
..+.. .........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||......... ...|.... .
T Consensus 173 t~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---~ 248 (601)
T KOG0590|consen 173 TAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---G 248 (601)
T ss_pred ccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---c
Confidence 88765 33334455678 9999999998874 5578899999999999999999999765543311 11111000 0
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. ...............+..+++..+|..|.+..++..
T Consensus 249 ~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 R--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred c--------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence 0 001111222334667888889999999999888754
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.3e-15 Score=143.98 Aligned_cols=141 Identities=18% Similarity=0.209 Sum_probs=99.6
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHH----------------------------------------HHH
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVE----------------------------------------QFI 135 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~----------------------------------------~~~ 135 (419)
.+.||+|++|.||+|++.+|+.||||..+........ +|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 3679999999999999999999999987653211100 244
Q ss_pred HHHHHHhcCC----CcccccEEeEEe-cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHH-HHHHHhhc
Q 014725 136 NEVVILSQIN----HRNVVKLLGCCL-ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG-AMSYLHSA 209 (419)
Q Consensus 136 ~e~~~l~~l~----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~-~l~~LH~~ 209 (419)
+|+..+.++. |.+-+.+-..+. ..+..++||||++|++|.++....... .+ +.+++..++. .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~--~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAG--LD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcC--CC---HHHHHHHHHHHHHHHHHhC
Confidence 5555555542 222222222222 234579999999999998876542211 22 3456666665 47888988
Q ss_pred CCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 210 ~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
| ++|+|++|.||+++.++.++++|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 8 9999999999999999999999999997654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=5e-15 Score=143.40 Aligned_cols=249 Identities=21% Similarity=0.247 Sum_probs=180.7
Q ss_pred hcCccccCcccc--cCcEEEEEEEe---cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCc
Q 014725 90 TDNYNANRILGQ--GGQGTVYKGML---ADGGIVAVKKSKL--VDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~--G~fg~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 161 (419)
...+.+.+.+|. |.+|.||.+.. .++..+|+|+-+. ........=.+|+...+.+ .|+|.++.+..+...+.
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCc
Confidence 345677788999 99999999986 3467889997443 2223333445677777777 49999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHH----HHHHHhhcCCCCeeecCCCCCcEEECCC-CcEEEee
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG----AMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSD 236 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~D 236 (419)
.++-.|++ +.+|.++...... .++....+....+... ||.++|..+ ++|.|+||.||+...+ ...+++|
T Consensus 193 lfiqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~d 266 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTD 266 (524)
T ss_pred ceeeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCC
Confidence 99999999 5788888876443 2666777777888888 999999999 9999999999999998 8899999
Q ss_pred cCCceecccCCcee----eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH
Q 014725 237 FGASRTIKVDQTHL----TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 237 fgl~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
||+........... .....|...|++||..+ +-++.++|+|++|.++++..++..+........
T Consensus 267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~----------- 334 (524)
T KOG0601|consen 267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSS----------- 334 (524)
T ss_pred cceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCC-----------
Confidence 99998876543221 12235778899999876 567889999999999999999876654321110
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
|.++-.-.+..+........+...+..|++.+|..|++.+.+..
T Consensus 335 -----W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 335 -----WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred -----ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 00000000111111122233555888999999999998877755
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.3e-14 Score=128.57 Aligned_cols=201 Identities=21% Similarity=0.303 Sum_probs=138.3
Q ss_pred HHhcCCCcccccEEeEEecCC-----cceEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014725 140 ILSQINHRNVVKLLGCCLESE-----VPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIP 213 (419)
Q Consensus 140 ~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 213 (419)
.|-.+-|.||+++..|+.+.. ...++.||+..|++..+|++.. ....+......+|+.||+.||.|||+.. ++
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-Pp 198 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-PP 198 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-Cc
Confidence 444557999999999987543 4578999999999999998743 2345777888899999999999999977 56
Q ss_pred eeecCCCCCcEEECCCCcEEEeecCCcee---cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhC
Q 014725 214 IYHRDIKSSNILLDDKYRAKVSDFGASRT---IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG 290 (419)
Q Consensus 214 iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg 290 (419)
|+|+++.-+-|++..++-+|+.--.-... .............+.++|.+||.-.....+.++|||+||...+||.-+
T Consensus 199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail 278 (458)
T KOG1266|consen 199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL 278 (458)
T ss_pred cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence 99999999999999999888753111100 001111112233467899999987777788899999999999999876
Q ss_pred CCCC-CCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 291 QKPI-RSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 291 ~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..-- ......+ .+..+...+.. .+-..-..++..|++..|..||+|.+++.
T Consensus 279 Eiq~tnseS~~~------------~ee~ia~~i~~--------len~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 279 EIQSTNSESKVE------------VEENIANVIIG--------LENGLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred eeccCCCcceee------------hhhhhhhheee--------ccCccccCcCcccccCCCCCCcchhhhhc
Confidence 5431 1111000 00000000000 00011345788999999999999988754
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.1e-12 Score=128.43 Aligned_cols=167 Identities=20% Similarity=0.220 Sum_probs=128.2
Q ss_pred ecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHH
Q 014725 112 LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEM 191 (419)
Q Consensus 112 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~ 191 (419)
..++.+|.|...+..+....+...+-++.|+.++||||+++++.+...+..|+|.|-+ ..|..++.+. ....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l------~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKEL------GKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHh------HHHH
Confidence 4567888888777655555566788899999999999999999999999999999987 4677777753 3456
Q ss_pred HHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecccccCCccCccccccCCC
Q 014725 192 RLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271 (419)
Q Consensus 192 ~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 271 (419)
....+.||+.||.+||+.+. ++|++|.-+.|+++..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~--lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCN--LVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccCC--eeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 66778899999999986654 99999999999999999999999988865432221 111111223466666554322
Q ss_pred CcccceechhHHHHHHHhCC
Q 014725 272 TEKSDVYSFGVVLVELLTGQ 291 (419)
Q Consensus 272 s~~~Di~slG~~l~el~tg~ 291 (419)
-..|.|.|||+++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3579999999999999983
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.7e-13 Score=135.93 Aligned_cols=147 Identities=16% Similarity=0.170 Sum_probs=93.7
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhh----------------------------------HH--
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESN----------------------------------VE-- 132 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~----------------------------------~~-- 132 (419)
...|+. +.||+|++|.||+|++.+ |+.||||......... .+
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999877 9999999876432110 11
Q ss_pred ----HHHHHHHHHhcCC----CcccccEEeEEec-CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHH-HHH
Q 014725 133 ----QFINEVVILSQIN----HRNVVKLLGCCLE-SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV-SGA 202 (419)
Q Consensus 133 ----~~~~e~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i-~~~ 202 (419)
+|.+|+..+.++. +.+.+.+-.++.+ ....++||||++|+.+.++-.-...+ .+... ++... ..-
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--~d~~~---la~~~v~~~ 272 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--TDMKL---LAERGVEVF 272 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--CCHHH---HHHHHHHHH
Confidence 1334444444442 3333333333332 34568999999999998753211111 22111 22111 112
Q ss_pred HHHHhhcCCCCeeecCCCCCcEEECCCC----cEEEeecCCceeccc
Q 014725 203 MSYLHSATSIPIYHRDIKSSNILLDDKY----RAKVSDFGASRTIKV 245 (419)
Q Consensus 203 l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfgl~~~~~~ 245 (419)
+..+...| ++|+|++|.||+++.++ .+++.|||++..+..
T Consensus 273 ~~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 273 FTQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 33445567 99999999999999888 999999999987643
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.44 E-value=5e-13 Score=114.49 Aligned_cols=131 Identities=21% Similarity=0.165 Sum_probs=96.7
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccc-ccEEeEEecCCcceEEEeecCCCCH
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV-VKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
.+.|+.|.++.||++... ++.+++|....... ....+.+|+..++.+.+.++ ++++.+. ....++||||++|.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 356899999999999875 77899998654322 12346789999998865554 4455443 3345899999999887
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT--SIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
.+. . .. ...++.+++++|..||..+ ...++|+|++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~--~------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTE--D------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccc--c------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 643 0 11 1235678999999999987 22359999999999999 66899999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=2e-11 Score=105.64 Aligned_cols=136 Identities=18% Similarity=0.129 Sum_probs=97.9
Q ss_pred cCcccccCcEEEEEEEecC-------CCEEEEEEcccCC----------------------hhhHHHHH----HHHHHHh
Q 014725 96 NRILGQGGQGTVYKGMLAD-------GGIVAVKKSKLVD----------------------ESNVEQFI----NEVVILS 142 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~-------~~~vavK~~~~~~----------------------~~~~~~~~----~e~~~l~ 142 (419)
...||.|--+.||.|...+ +..+|||..+... ....+.+. +|+..|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3569999999999998643 4789999533210 01122233 7999999
Q ss_pred cCC--CcccccEEeEEecCCcceEEEeecCCCCHHH-HhhccCCCCCCCHHHHHHHHHHHHHHHHHH-hhcCCCCeeecC
Q 014725 143 QIN--HRNVVKLLGCCLESEVPLLVYEFIPNGTLYH-YLHDQTEEFPITWEMRLRIAIEVSGAMSYL-HSATSIPIYHRD 218 (419)
Q Consensus 143 ~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~iiH~D 218 (419)
++. .-++++++++ ...++||||+.+..+.. .+.+. .++......+..+++.+|..| |..+ ++|+|
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGD 150 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKECN---LVHAD 150 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence 985 3567777764 46689999997654422 22221 244556667888999999998 7888 99999
Q ss_pred CCCCcEEECCCCcEEEeecCCceec
Q 014725 219 IKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 219 lkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
|++.||+++ ++.+.|+|||.+...
T Consensus 151 Ls~~NIL~~-~~~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWH-DGKVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEE-CCcEEEEECCCceeC
Confidence 999999997 468999999988653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.8e-11 Score=108.31 Aligned_cols=142 Identities=20% Similarity=0.243 Sum_probs=109.8
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCCh-hhHHHHHHHHHHHhcCCC--cccccEEeEEecCC---cceEEEeecC
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDE-SNVEQFINEVVILSQINH--RNVVKLLGCCLESE---VPLLVYEFIP 170 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~~ 170 (419)
+.|+.|..+.||++...+|..+++|....... .....+.+|+++++.+.+ .++++++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999987768899998654322 134578899999999965 45677888776543 6689999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC----------------------------------------
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT---------------------------------------- 210 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 210 (419)
|.++.+.+.. ..++......++.+++++|..||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9888776532 13677777788888888888888531
Q ss_pred -------------CCCeeecCCCCCcEEECC--CCcEEEeecCCcee
Q 014725 211 -------------SIPIYHRDIKSSNILLDD--KYRAKVSDFGASRT 242 (419)
Q Consensus 211 -------------~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgl~~~ 242 (419)
...++|+|+.|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 134899999999999998 66789999987753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.8e-12 Score=124.49 Aligned_cols=257 Identities=19% Similarity=0.209 Sum_probs=180.3
Q ss_pred ccCHHH-HHHHhcCccccCcccccCcEEEEEEEec--CCCEEEEEEcccCChhhH--HHHHHHHHHHhcC-CCcccccEE
Q 014725 80 LFTKMD-LEKATDNYNANRILGQGGQGTVYKGMLA--DGGIVAVKKSKLVDESNV--EQFINEVVILSQI-NHRNVVKLL 153 (419)
Q Consensus 80 ~~~~~~-~~~~~~~y~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~~~~~~--~~~~~e~~~l~~l-~h~niv~l~ 153 (419)
+|...+ ......+|..+..||.|.|+.|+....+ ++..+++|.....-.... ..-..|+.+...+ .|.+++...
T Consensus 253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~ 332 (524)
T KOG0601|consen 253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN 332 (524)
T ss_pred eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence 344444 4455678999999999999999998743 567899997654322222 2234566666666 589999988
Q ss_pred eEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-CcE
Q 014725 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRA 232 (419)
Q Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~ 232 (419)
..+......|+--|||+++++...+.- ...++...++++..|++.++.++|+.. ++|+|++|.||++..+ +..
T Consensus 333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~ 406 (524)
T KOG0601|consen 333 SSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFS 406 (524)
T ss_pred CCccccccccCchhhhcCcchhhhhHH---HHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhh
Confidence 888888888899999999998877632 224777788999999999999999988 9999999999999876 888
Q ss_pred EEeecCCceecccCCceeeecccccCCcc--CccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH
Q 014725 233 KVSDFGASRTIKVDQTHLTTRVQGTFGYL--DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 310 (419)
++.|||....+... .....+.-+++ +++......+-.+.|+||||..+.+.+++..--....
T Consensus 407 ~~~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------------ 470 (524)
T KOG0601|consen 407 KLGDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------------ 470 (524)
T ss_pred hcccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc------------
Confidence 99999988642211 11112233344 5666667788899999999999999998764321110
Q ss_pred HHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 311 QAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.+..+.... . .........+..+...+..+++..||.+.++....+-+
T Consensus 471 ------~~~~i~~~~-~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~ 518 (524)
T KOG0601|consen 471 ------QSLTIRSGD-T-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY 518 (524)
T ss_pred ------cceeeeccc-c-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence 011110010 0 11112225577788889999999999988876655443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.4e-11 Score=98.64 Aligned_cols=143 Identities=20% Similarity=0.246 Sum_probs=105.9
Q ss_pred ccCcccccCcEEEEEEEecCCCEEEEEEccc--------CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 95 ANRILGQGGQGTVYKGMLADGGIVAVKKSKL--------VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 95 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--------~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
....|-+|+-+.|+++.+. |+...||.-.. ...-...+..+|++.|.++.--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 4678999999999999984 77777774321 11123456788999998886444444444566667778999
Q ss_pred eecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC---cEEEeecCCcee
Q 014725 167 EFIPN-GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY---RAKVSDFGASRT 242 (419)
Q Consensus 167 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfgl~~~ 242 (419)
||++| .++.+++....... ........++..|-+.+.-||..+ ++|+||..+||++.+++ .+.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99976 48888888755432 222333678889999999999999 99999999999996544 358999999864
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.2e-10 Score=97.48 Aligned_cols=131 Identities=24% Similarity=0.287 Sum_probs=98.5
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEccc--C-Ch-----hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKL--V-DE-----SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~-~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..+++|+-..+|.+.+. |.++++|.-.. . .+ -..+.-.+|+.+++.+.--.|.-..=+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45889999999999764 44566664211 1 11 1234567899999988654544444455667777899999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++|..|.+++.... ..++..+-.-+.-||..+ |+|+||.++||++..+. +.++||||+..
T Consensus 81 I~G~~lkd~l~~~~----------~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEAR----------PDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhcc----------hHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 99999999987641 346677778888999999 99999999999998775 99999999874
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.5e-12 Score=128.33 Aligned_cols=252 Identities=23% Similarity=0.285 Sum_probs=170.0
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEecC-CCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
.....+.+.+.+-+-+|.++.++.+.-.. +...++|.... ....+.+....+-.++-..++|-++...--+.....
T Consensus 799 yrsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 799 YRSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred ccCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCC
Confidence 34566778888899999999999877432 22223322111 111122333333333333445655555444455677
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.+|+++|..+++|...++.... .+..........+.++++|||... +.|+|++|.|++...++..+++|||...
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccc
Confidence 8999999999999999887552 344444455667788999999987 8999999999999999999999998433
Q ss_pred ecccC------------------------------CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCC
Q 014725 242 TIKVD------------------------------QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 291 (419)
Q Consensus 242 ~~~~~------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~ 291 (419)
..... .........||+.|.+||...+......+|.|++|++++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 22100 001123356899999999999999999999999999999999999
Q ss_pred CCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHH
Q 014725 292 KPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMK 357 (419)
Q Consensus 292 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 357 (419)
.||........ +....+.+ ......+........+++...+..+|.+|-.+.
T Consensus 1033 pp~na~tpq~~------f~ni~~~~--------~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQI------FENILNRD--------IPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhh------hhccccCC--------CCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 99987665431 10000000 011222344556778888889999999997765
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.17 E-value=1.3e-09 Score=101.67 Aligned_cols=269 Identities=17% Similarity=0.170 Sum_probs=165.1
Q ss_pred cccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeE------Eec-CCcceEE
Q 014725 94 NANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGC------CLE-SEVPLLV 165 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~------~~~-~~~~~lv 165 (419)
...+.||+|+-+.+|-.--- ...+.|+..........+. +..|... .||-+-.-+.+ .-+ +...-+.
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk---~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl 88 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQK---VAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL 88 (637)
T ss_pred CCCccccCCccceeeecchh--hchhheeecCCCchHHHHH---HHHhccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence 34678999999999964321 1234455443333222222 2233333 56644331111 011 2224577
Q ss_pred EeecCCCC-HHHHhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 166 YEFIPNGT-LYHYLHDQ---TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 166 ~e~~~~g~-L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
|..+.+.. +..++.-. ..-.-.+|...++.+..++.+...||..| .+-+|++++|+|+++++.+.|+|-....
T Consensus 89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEccccee
Confidence 88776652 33333221 12234789999999999999999999999 8889999999999999999999855433
Q ss_pred ecccCCceeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhC-CCCCCCCChhhhccHHHHHHHHhcc
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTG-QKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
.. .........+|.+.|.+||... +..-+..+|.|.||+++++++.| +.||.+........-.. ...+..
T Consensus 166 i~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~--E~~Ia~ 241 (637)
T COG4248 166 IN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL--ETDIAH 241 (637)
T ss_pred ec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc--hhhhhc
Confidence 32 1222333456889999999754 34567889999999999999885 99998754322111000 000111
Q ss_pred cchhHHHHHhh-c----cCCC-HHHHHHHHHHHHHHhcc--CCCCCCCHHHHHHHHHhcHHhhCCCC
Q 014725 316 DRLFEVLEARV-L----KEGK-EEEIITVAMLGKRCLNM--IGKKRPSMKEVAFELEGIRASIGSSS 374 (419)
Q Consensus 316 ~~~~~~~~~~~-~----~~~~-~~~~~~l~~li~~cl~~--~p~~RPt~~evl~~L~~i~~~~~~~~ 374 (419)
+......+... . .+.+ .-.+..+..|..+|+.. ++.-|||.+..+..|..+..++..+.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~ 308 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCT 308 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhh
Confidence 11111111110 0 1111 22345677888889875 46789999999999999988876544
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.2e-09 Score=94.33 Aligned_cols=125 Identities=26% Similarity=0.250 Sum_probs=81.6
Q ss_pred EEEEEEecCCCEEEEEEcccCC--------------------------hhhHHHHHHHHHHHhcCCCc--ccccEEeEEe
Q 014725 106 TVYKGMLADGGIVAVKKSKLVD--------------------------ESNVEQFINEVVILSQINHR--NVVKLLGCCL 157 (419)
Q Consensus 106 ~Vy~~~~~~~~~vavK~~~~~~--------------------------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~ 157 (419)
.||.|...++..+|+|..+... ........+|++.|.++..- ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999889999999543210 00123457899999999754 677777553
Q ss_pred cCCcceEEEeecC--CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH-HhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 158 ESEVPLLVYEFIP--NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY-LHSATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 158 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
..++||||++ |..+..+.... ++......++.+++..+.. +|..| ++|+||.+.||+++++ .+.+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 4589999998 55554433221 1122345567777775555 57888 9999999999999988 9999
Q ss_pred eecCCceec
Q 014725 235 SDFGASRTI 243 (419)
Q Consensus 235 ~Dfgl~~~~ 243 (419)
+|||.+...
T Consensus 148 IDf~qav~~ 156 (188)
T PF01163_consen 148 IDFGQAVDS 156 (188)
T ss_dssp --GTTEEET
T ss_pred EecCcceec
Confidence 999988653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=4.5e-09 Score=96.14 Aligned_cols=140 Identities=14% Similarity=0.107 Sum_probs=99.1
Q ss_pred cccccCcEEEEEEEecCCCEEEEEEcccCChh-hH----------HHHHHHHHHHhcCCCc--ccccEEeEEec-----C
Q 014725 98 ILGQGGQGTVYKGMLADGGIVAVKKSKLVDES-NV----------EQFINEVVILSQINHR--NVVKLLGCCLE-----S 159 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~e~~~l~~l~h~--niv~l~~~~~~-----~ 159 (419)
.+-......|.+... +|+.+.||+....... .. ..+.+|...+..+... ..++++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344334445667665 5778999976433211 01 1377899888888433 33455555543 2
Q ss_pred CcceEEEeecCCC-CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-------CCc
Q 014725 160 EVPLLVYEFIPNG-TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-------KYR 231 (419)
Q Consensus 160 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-------~~~ 231 (419)
...++|+|++++. +|.+++..... .+.+...+..++.+++..+..||..| |+|+|+++.|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3468999999886 89999864321 23556677789999999999999999 999999999999975 468
Q ss_pred EEEeecCCcee
Q 014725 232 AKVSDFGASRT 242 (419)
Q Consensus 232 ~kl~Dfgl~~~ 242 (419)
+.++||+.++.
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.05 E-value=5.8e-09 Score=99.81 Aligned_cols=169 Identities=23% Similarity=0.351 Sum_probs=125.7
Q ss_pred cEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEe----cCCcceEEEeecCC-CCHHHH
Q 014725 104 QGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL----ESEVPLLVYEFIPN-GTLYHY 177 (419)
Q Consensus 104 fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-g~L~~~ 177 (419)
-.+.|++.. .||..|++|+++............-++.++++.|+|+|++.+++. .+...++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356799984 578899999984433222223344577899999999999998886 34567899999975 577665
Q ss_pred hhccC------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 178 LHDQT------------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 178 l~~~~------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
..... .....++..+|.++.|+..||.++|+.| +.-+-|.|.+||++.+.+++|+.-|.......
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54321 1224678899999999999999999999 88899999999999999999988887665443
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCC
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p 293 (419)
+.. |-+.. -.+-|.=.||.+++.|.||..-
T Consensus 446 d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 220 11111 2256888999999999999654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=6.9e-09 Score=92.20 Aligned_cols=134 Identities=22% Similarity=0.189 Sum_probs=97.3
Q ss_pred ccccCcccccCcEEEEEEEecCCCEEEEEEcccCC----------------------hhhHHHHHHHHHHHhcCCCc--c
Q 014725 93 YNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD----------------------ESNVEQFINEVVILSQINHR--N 148 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--n 148 (419)
+.+...||-|--+.||.|...+|.++|||.-+... .-......+|.+.|..|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 56678999999999999999999999999422110 01123457899999999654 6
Q ss_pred cccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC
Q 014725 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD 228 (419)
Q Consensus 149 iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~ 228 (419)
+++.++ .+...+||||++|-.|...- ++....-.++..|+.-+.-+-..| +||+|+.+-||++++
T Consensus 173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 777764 45668999999986664321 122223345555555555555677 999999999999999
Q ss_pred CCcEEEeecCCce
Q 014725 229 KYRAKVSDFGASR 241 (419)
Q Consensus 229 ~~~~kl~Dfgl~~ 241 (419)
||.+.++||--+.
T Consensus 238 dg~~~vIDwPQ~v 250 (304)
T COG0478 238 DGDIVVIDWPQAV 250 (304)
T ss_pred CCCEEEEeCcccc
Confidence 9999999996553
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=8.3e-08 Score=83.40 Aligned_cols=139 Identities=19% Similarity=0.131 Sum_probs=102.4
Q ss_pred ccccCcEEEEEEEecCCCEEEEEEcccCC------hhhHHHHHHHHHHHhcCCC--cccccEEeEEecC----CcceEEE
Q 014725 99 LGQGGQGTVYKGMLADGGIVAVKKSKLVD------ESNVEQFINEVVILSQINH--RNVVKLLGCCLES----EVPLLVY 166 (419)
Q Consensus 99 ig~G~fg~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~ 166 (419)
-|+||.+-|+..... |..+-+|+....- +.....|.+|+..+..+.. -.+++...+.... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 467899999997764 4478899765211 2245679999999998853 2355555222211 2347999
Q ss_pred eecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc--EEEeecCCcee
Q 014725 167 EFIPN-GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR--AKVSDFGASRT 242 (419)
Q Consensus 167 e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Dfgl~~~ 242 (419)
|-+++ -+|.+++.+.... +.+...+..+..+++..+.-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 105 e~L~g~~~L~~~l~~~~~~-~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVS-PYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EeCCCCccHHHHHhcCCcC-CcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 97753 5898888664322 4677778899999999999999999 999999999999986667 99999986653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.81 E-value=6.2e-08 Score=85.64 Aligned_cols=106 Identities=22% Similarity=0.255 Sum_probs=83.5
Q ss_pred HHHHHHHHHHHhcCCC--cccccEEeEEecCC----cceEEEeecCCC-CHHHHhhccCCCCCCCHHHHHHHHHHHHHHH
Q 014725 131 VEQFINEVVILSQINH--RNVVKLLGCCLESE----VPLLVYEFIPNG-TLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203 (419)
Q Consensus 131 ~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l 203 (419)
.....+|...+..+.. =..++.+++..... ..++|+|++++. +|.+++..... .+......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 3467788888877743 34566677665532 347999999874 89999886332 45566778999999999
Q ss_pred HHHhhcCCCCeeecCCCCCcEEECCCC---cEEEeecCCcee
Q 014725 204 SYLHSATSIPIYHRDIKSSNILLDDKY---RAKVSDFGASRT 242 (419)
Q Consensus 204 ~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfgl~~~ 242 (419)
.-||+.| |+|+|+++.|||++.+. .+.++||+.++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999 99999999999998877 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.75 E-value=3.2e-09 Score=104.98 Aligned_cols=151 Identities=19% Similarity=0.220 Sum_probs=102.9
Q ss_pred HHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee--------eecccccCCccCccccc
Q 014725 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL--------TTRVQGTFGYLDPEYFR 267 (419)
Q Consensus 196 ~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 267 (419)
+.+++.|+.|+|..-. +||++|.|++|.++.++..||+.|+.+.......... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~sAk--~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAK--VVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcc--eeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 3456699999998653 9999999999999999999999999876543311111 11122345799999999
Q ss_pred cCCCCcccceechhHHHHHHHhCCCC-CCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHh
Q 014725 268 SSQFTEKSDVYSFGVVLVELLTGQKP-IRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCL 346 (419)
Q Consensus 268 ~~~~s~~~Di~slG~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl 346 (419)
....+.++|+||+||++|.+..|..+ +......... . .....+.........+.+.++.+=+.+++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~------~-------~~~~~~~~~~~~~s~~~p~el~~~l~k~l 249 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY------S-------FSRNLLNAGAFGYSNNLPSELRESLKKLL 249 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchh------h-------hhhcccccccccccccCcHHHHHHHHHHh
Confidence 88889999999999999999954444 3322111100 0 00111111112233555667888888899
Q ss_pred ccCCCCCCCHHHHHH
Q 014725 347 NMIGKKRPSMKEVAF 361 (419)
Q Consensus 347 ~~~p~~RPt~~evl~ 361 (419)
..++.-||++.++..
T Consensus 250 ~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 250 NGDSAVRPTLDLLLS 264 (700)
T ss_pred cCCcccCcchhhhhc
Confidence 999999998777644
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=7.8e-08 Score=95.27 Aligned_cols=144 Identities=18% Similarity=0.219 Sum_probs=94.9
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhh------------------------------HH--------
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESN------------------------------VE-------- 132 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~------------------------------~~-------- 132 (419)
..|+ .+.|+.++-|.||+|++.+|+.||||..+..-... .+
T Consensus 126 ~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ 204 (517)
T COG0661 126 SEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLRE 204 (517)
T ss_pred HHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHH
Confidence 3444 26799999999999999999999999765432211 01
Q ss_pred --HHHHHHHHHhcCC-----CcccccEEeEEe-cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHH-H
Q 014725 133 --QFINEVVILSQIN-----HRNVVKLLGCCL-ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA-M 203 (419)
Q Consensus 133 --~~~~e~~~l~~l~-----h~niv~l~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~-l 203 (419)
++.+|...+.++. .|++ .+=.++. -.+...++|||++|-.+.+...-...+ .+... ++..++++ +
T Consensus 205 ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~---ia~~~~~~f~ 278 (517)
T COG0661 205 ELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKE---LAELLVRAFL 278 (517)
T ss_pred HhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHH---HHHHHHHHHH
Confidence 1234555554442 2332 2222333 346678999999999998874332221 44333 33333322 3
Q ss_pred HHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 204 ~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
..+-..| +.|.|..|.||+++.++.+.+.|||+.....
T Consensus 279 ~q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 279 RQLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 4444456 9999999999999999999999999987664
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.64 E-value=5.7e-07 Score=80.55 Aligned_cols=138 Identities=17% Similarity=0.191 Sum_probs=84.5
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCc--ccccEEeEEecCCcceEEEeecCCCC-
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHR--NVVKLLGCCLESEVPLLVYEFIPNGT- 173 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~~g~- 173 (419)
..||+|..+.||+. .+..+++|...... ......+|.++++.+..- .+++.+++....+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 56899999999984 24467788876432 234568899999988643 35778888877777889999999863
Q ss_pred HHHHh---------------------hccCCCCCCCHHHHH-HHHH----------HHHH-HHHHHhhc-CCCCeeecCC
Q 014725 174 LYHYL---------------------HDQTEEFPITWEMRL-RIAI----------EVSG-AMSYLHSA-TSIPIYHRDI 219 (419)
Q Consensus 174 L~~~l---------------------~~~~~~~~l~~~~~~-~i~~----------~i~~-~l~~LH~~-~~~~iiH~Dl 219 (419)
+...+ +..... ........ .+.. .+.. ...+|... ....++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~-~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCD-TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC-CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 21111 110000 01111100 0000 0111 11222211 1234789999
Q ss_pred CCCcEEECCCCcEEEeecCCce
Q 014725 220 KSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 220 kp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.|.||++++++ +.++||+.+.
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcC
Confidence 99999999888 9999998764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-06 Score=75.93 Aligned_cols=139 Identities=17% Similarity=0.204 Sum_probs=91.0
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHH---------HHHHHHHhcCC---CcccccEEeE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQF---------INEVVILSQIN---HRNVVKLLGC 155 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~---------~~e~~~l~~l~---h~niv~l~~~ 155 (419)
....+|...+.+-......|.+-.. +++.+++|..........+.| .+.+..+.+++ --....++-+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~ 106 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA 106 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence 3467788888888777777777666 578899997665333222222 23333333332 2222332322
Q ss_pred Ee-----cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC
Q 014725 156 CL-----ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY 230 (419)
Q Consensus 156 ~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 230 (419)
.. -....+++|||++|..|.++.. +++ .++..+.+++.-||+.| +.|+|..|.|++++.+
T Consensus 107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~- 171 (229)
T PF06176_consen 107 AEKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN- 171 (229)
T ss_pred eeeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-
Confidence 22 1234468999999988876542 222 24556778899999999 9999999999999965
Q ss_pred cEEEeecCCcee
Q 014725 231 RAKVSDFGASRT 242 (419)
Q Consensus 231 ~~kl~Dfgl~~~ 242 (419)
.++++||+..+.
T Consensus 172 ~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 GIRIIDTQGKRM 183 (229)
T ss_pred cEEEEECccccc
Confidence 499999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.47 E-value=2.4e-06 Score=75.52 Aligned_cols=148 Identities=22% Similarity=0.190 Sum_probs=97.1
Q ss_pred HHHHHHHhcCccccC---cccccCcEEEEEEEecCCCEEEEEEcccCChhh-------------------H-----HHHH
Q 014725 83 KMDLEKATDNYNANR---ILGQGGQGTVYKGMLADGGIVAVKKSKLVDESN-------------------V-----EQFI 135 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~---~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------~-----~~~~ 135 (419)
...+.....+..+.. .|++|--..||+|...++..+|+|+.+.....- . .-..
T Consensus 37 ~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~ 116 (268)
T COG1718 37 LETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWAR 116 (268)
T ss_pred HHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHH
Confidence 344444455554444 466777888999998889999999765432111 0 1123
Q ss_pred HHHHHHhcCC--CcccccEEeEEecCCcceEEEeecCCCC-HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCC
Q 014725 136 NEVVILSQIN--HRNVVKLLGCCLESEVPLLVYEFIPNGT-LYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATS 211 (419)
Q Consensus 136 ~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~-L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~ 211 (419)
+|+..|.++. +=.+++.+++. ...|||||+.... -.-.|.+ .++.......+..++++.+.-|-. .+
T Consensus 117 kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a~- 187 (268)
T COG1718 117 KEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEAG- 187 (268)
T ss_pred HHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhcC-
Confidence 5777777763 44555555544 3479999995431 1111111 123333456677788888888877 56
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 212 ~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+||+||+.-|||+. ++.+.++|||-+..
T Consensus 188 --LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 188 --LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred --cccccchhhheEEE-CCeEEEEECccccc
Confidence 99999999999999 88999999998754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.47 E-value=3e-08 Score=97.27 Aligned_cols=190 Identities=17% Similarity=0.119 Sum_probs=134.0
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcc-cccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN-VVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e 167 (419)
.+.-+...+-.++|+++.++|.+..-.+....+.+... ....-++++|.+++||| .+..++-+..++..++.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34445555668999999999988544444444433321 44556889999999999 6666766777788899999
Q ss_pred ecCCC-CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 168 FIPNG-TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 168 ~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
++.++ +-...... ....+..-+...+...-++++++||+.. =+|+| ||+..+ +..+..||+....+...
T Consensus 315 i~s~~rs~~~~~~~--se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEMTV--SEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccCCh--hhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99876 22211111 1112333344455666678899999865 47888 777766 58999999988766543
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCC
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 295 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~ 295 (419)
. ......+|+.++|||+...+.+....|.|++|+--.++.-|-.|-.
T Consensus 385 ~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 385 M--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred c--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 2 3455678999999999999999999999999987777777766643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.6e-06 Score=76.58 Aligned_cols=143 Identities=23% Similarity=0.254 Sum_probs=84.6
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCc--ccccEEeEEecC---CcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHR--NVVKLLGCCLES---EVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~---~~~~lv~e~~~~ 171 (419)
+.|+.|..+.||+....+ +.+++|..... .....+.+|..+++.+... .+++++.+.... ...+++|++++|
T Consensus 3 ~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred ccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 568999999999999876 68999986543 4456778898888888532 456777654332 345899999999
Q ss_pred CCHHH----------------Hhh---cc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHhhc
Q 014725 172 GTLYH----------------YLH---DQ-TEEFPITWEM---------RLRI------------AIEVSG-AMSYLHSA 209 (419)
Q Consensus 172 g~L~~----------------~l~---~~-~~~~~l~~~~---------~~~i------------~~~i~~-~l~~LH~~ 209 (419)
..+.. .+. .. ....+..+.. .... ...+.. .+..++..
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (239)
T PF01636_consen 80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL 159 (239)
T ss_dssp EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence 88877 111 11 0101111110 0000 111222 33333321
Q ss_pred ----CCCCeeecCCCCCcEEEC-CCCcEEEeecCCcee
Q 014725 210 ----TSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRT 242 (419)
Q Consensus 210 ----~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~ 242 (419)
....++|+|+.|.||+++ +++.+-|+||+.+..
T Consensus 160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 334599999999999999 666668999987653
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.1e-06 Score=76.91 Aligned_cols=139 Identities=17% Similarity=0.130 Sum_probs=85.0
Q ss_pred ccccCc-EEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEeecCCCCHHH
Q 014725 99 LGQGGQ-GTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYEFIPNGTLYH 176 (419)
Q Consensus 99 ig~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~ 176 (419)
|..|.. ..||+.... +..+.+|...... .....+|+++++.+. +--+++++++....+..++|||+++|.+|..
T Consensus 6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 445555 788998764 4678888876433 245677888888873 4446678887776677899999999987764
Q ss_pred Hh-------------------hccCC-CCCCCHH--HHHHHHH--------------------HHHHHHHHHhh----cC
Q 014725 177 YL-------------------HDQTE-EFPITWE--MRLRIAI--------------------EVSGAMSYLHS----AT 210 (419)
Q Consensus 177 ~l-------------------~~~~~-~~~l~~~--~~~~i~~--------------------~i~~~l~~LH~----~~ 210 (419)
.. +.... ..++... ....... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100 0011100 0000000 01111222211 11
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 211 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2449999999999999998778999998764
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.9e-06 Score=74.68 Aligned_cols=104 Identities=25% Similarity=0.380 Sum_probs=81.8
Q ss_pred HHHHHHHhcCCC-cccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014725 135 INEVVILSQINH-RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIP 213 (419)
Q Consensus 135 ~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 213 (419)
.+|.-+++.+++ +++++++|+|- .+++.||...+++...-.....-...+|..+.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 358888888976 79999999993 4789999987766422100001113689999999999999999999865455
Q ss_pred eeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 214 IYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 214 iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+.-.|++|+|+-+++++++|++|...+..
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcch
Confidence 88999999999999999999999986644
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=3.5e-06 Score=83.47 Aligned_cols=140 Identities=19% Similarity=0.155 Sum_probs=89.6
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhh-------------------------------HH------HHHHHH
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESN-------------------------------VE------QFINEV 138 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~-------------------------------~~------~~~~e~ 138 (419)
.+.||.-+.|.||+|++++|+.||||..+..-+.. .+ +|.+|+
T Consensus 166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 36799999999999999999999999765432111 00 134455
Q ss_pred HHHhcC----CCcc------cccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh
Q 014725 139 VILSQI----NHRN------VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208 (419)
Q Consensus 139 ~~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 208 (419)
+...+. .|-+ |++++- .-.....|+||||+|..+.+.-.-... .++...+..-+.+.. +.-+-.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~--~~st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYW--DLSTKRVLTMEYVDGIKINDLDAIDKR--GISPHDILNKLVEAY--LEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehh--hcCcceEEEEEecCCccCCCHHHHHHc--CCCHHHHHHHHHHHH--HHHHHh
Confidence 444333 3444 333322 223567899999999877665332222 155544433333321 223334
Q ss_pred cCCCCeeecCCCCCcEEECC----CCcEEEeecCCceecc
Q 014725 209 ATSIPIYHRDIKSSNILLDD----KYRAKVSDFGASRTIK 244 (419)
Q Consensus 209 ~~~~~iiH~Dlkp~Nill~~----~~~~kl~Dfgl~~~~~ 244 (419)
.| ++|.|=.|.||+++. ++.+.+-|||+.....
T Consensus 320 ~G---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TG---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cC---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 45 999999999999983 6789999999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.8e-05 Score=68.97 Aligned_cols=128 Identities=23% Similarity=0.274 Sum_probs=90.1
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCC----------------hhhHHHHHHHHHHHhcCC------CcccccEE
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVD----------------ESNVEQFINEVVILSQIN------HRNVVKLL 153 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~l~ 153 (419)
...||+|+.=.||. +.++....||...... .....+..+|+.....+. +.+|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 46799999999996 4455567788766544 122455666666555554 78999999
Q ss_pred eEEecCCcceEEEeecCC------CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC
Q 014725 154 GCCLESEVPLLVYEFIPN------GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD 227 (419)
Q Consensus 154 ~~~~~~~~~~lv~e~~~~------g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 227 (419)
|+...+...-+|+|.+.+ .+|.+++.+.. ++. ... ..+-.-..||-+.+ |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~---~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELR---QALDEFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHH---HHHHHHHHHHHHcC---CeecCCCcccEEEE
Confidence 999999999999998743 36888885432 554 333 33334556777777 99999999999994
Q ss_pred CC--C--cEEEee
Q 014725 228 DK--Y--RAKVSD 236 (419)
Q Consensus 228 ~~--~--~~kl~D 236 (419)
.+ + .+.|+|
T Consensus 153 ~~~~~~~~lvlID 165 (199)
T PF10707_consen 153 RRDSGEFRLVLID 165 (199)
T ss_pred ecCCCceEEEEEe
Confidence 32 2 577777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.31 E-value=7e-06 Score=68.68 Aligned_cols=129 Identities=19% Similarity=0.201 Sum_probs=89.4
Q ss_pred cccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccc-cEEeEEecCCcceEEEeecCCC
Q 014725 94 NANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV-KLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 172 (419)
...+.|++|++|.||+|.+. +..+|+|.....+ ....+..|+++|..+.-.++. +++.|..+ ++.|||++|-
T Consensus 25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~ 97 (201)
T COG2112 25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGR 97 (201)
T ss_pred hhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCc
Confidence 44678999999999999996 5588998866533 346788999999998866654 44544332 3559999998
Q ss_pred CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC-CCcEEECCCCcEEEeecCCcee
Q 014725 173 TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK-SSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 173 ~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk-p~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+|.+.-... +...+ ..++..---|...| |-|+.|. |...++..++.+.|+||.-|+.
T Consensus 98 ~L~~~~~~~------~rk~l----~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 98 PLGKLEIGG------DRKHL----LRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred chhhhhhcc------cHHHH----HHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 887765421 22222 33444434455556 8899886 5555555555999999998863
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.22 E-value=2.2e-05 Score=83.74 Aligned_cols=79 Identities=14% Similarity=0.278 Sum_probs=57.6
Q ss_pred cCcccccCcEEEEEEEecCC---CEEEEEEcccCC-hhhHHHHHHHHHHHhcCC-Cccc--ccEEeEEecC---CcceEE
Q 014725 96 NRILGQGGQGTVYKGMLADG---GIVAVKKSKLVD-ESNVEQFINEVVILSQIN-HRNV--VKLLGCCLES---EVPLLV 165 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv 165 (419)
.+.++.|.++.+|+....++ ..+++|+..... ......+.+|+++++.+. |+++ ++++.+|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999886554 367777754322 122356889999999995 6665 7888888764 467899
Q ss_pred EeecCCCCH
Q 014725 166 YEFIPNGTL 174 (419)
Q Consensus 166 ~e~~~~g~L 174 (419)
|||++|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.3e-05 Score=69.74 Aligned_cols=74 Identities=19% Similarity=0.226 Sum_probs=46.8
Q ss_pred cCcccccCcE-EEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCc---ccccEEeEEecC---CcceEEEee
Q 014725 96 NRILGQGGQG-TVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHR---NVVKLLGCCLES---EVPLLVYEF 168 (419)
Q Consensus 96 ~~~ig~G~fg-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~ 168 (419)
++.|+.|+.. .||+. +..+++|..... .....+.+|.++++.+... .++++++..... ...+++|++
T Consensus 2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 3567877776 48875 234677765432 2245788899999887532 345555544332 235889999
Q ss_pred cCCCCHH
Q 014725 169 IPNGTLY 175 (419)
Q Consensus 169 ~~~g~L~ 175 (419)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9987663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.9e-05 Score=69.71 Aligned_cols=76 Identities=11% Similarity=0.047 Sum_probs=56.2
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC---cccccEEeEEec---CCcceEEEeec
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH---RNVVKLLGCCLE---SEVPLLVYEFI 169 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~e~~ 169 (419)
.+.||.|..+.||.....++ .+++|..+.. .....+.+|.+.|+.+.- -.++++++++.. .+..++|||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQG-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCC-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 46799999999999876555 4666664331 123578899999988842 468888988754 35689999999
Q ss_pred CCCCH
Q 014725 170 PNGTL 174 (419)
Q Consensus 170 ~~g~L 174 (419)
++.++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.01 E-value=4.5e-05 Score=69.88 Aligned_cols=139 Identities=16% Similarity=0.142 Sum_probs=78.4
Q ss_pred cccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccc-ccEEeEEecCCcceEEEeecCCCCHHH
Q 014725 98 ILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV-VKLLGCCLESEVPLLVYEFIPNGTLYH 176 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~L~~ 176 (419)
.+..|-.+.+|+... ++..+++|..........-...+|..+++.+....+ ++++.... .++||||++|..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356688889998874 566788887543322211234678888888854323 44554432 379999999876542
Q ss_pred H-----------------hhccC-CCCCCCHHHH-HHHHHH---------HHHHHHHHhhc-----CCCCeeecCCCCCc
Q 014725 177 Y-----------------LHDQT-EEFPITWEMR-LRIAIE---------VSGAMSYLHSA-----TSIPIYHRDIKSSN 223 (419)
Q Consensus 177 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------i~~~l~~LH~~-----~~~~iiH~Dlkp~N 223 (419)
. ++... ...+++.... ..+..+ +...+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 1112222211 111111 11112222211 12348999999999
Q ss_pred EEECCCCcEEEeecCCcee
Q 014725 224 ILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~ 242 (419)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999987743
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.00 E-value=7.8e-05 Score=67.27 Aligned_cols=73 Identities=23% Similarity=0.188 Sum_probs=47.6
Q ss_pred CcccccCcEEEEEEEecC--CCEEEEEEcccCChhhHHHHHHHHHHHhcCCC-cccccEEeEEecCCcceEEEeecCCCC
Q 014725 97 RILGQGGQGTVYKGMLAD--GGIVAVKKSKLVDESNVEQFINEVVILSQINH-RNVVKLLGCCLESEVPLLVYEFIPNGT 173 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~g~ 173 (419)
+.|..|-...+|+....+ +..+++|........ .-...+|+.+++.+.. .-.+++++.+. ..++|||++|.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 457778888999998764 678888876543221 1223468888888843 33445554432 248999999876
Q ss_pred H
Q 014725 174 L 174 (419)
Q Consensus 174 L 174 (419)
+
T Consensus 79 l 79 (235)
T cd05157 79 L 79 (235)
T ss_pred C
Confidence 5
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.00 E-value=0.00016 Score=69.80 Aligned_cols=74 Identities=20% Similarity=0.220 Sum_probs=54.2
Q ss_pred CcccccCcEEEEEEEecCC-CEEEEEEcccC-----C--hhhHHHHHHHHHHHhcCC---CcccccEEeEEecCCcceEE
Q 014725 97 RILGQGGQGTVYKGMLADG-GIVAVKKSKLV-----D--ESNVEQFINEVVILSQIN---HRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 165 (419)
+.||.|.+..||++...+| +.++||..... . ....+.+..|.+.|+.+. ..++++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 5799999999999998776 48999984321 1 124566778888888763 2457777766 34567899
Q ss_pred EeecCCC
Q 014725 166 YEFIPNG 172 (419)
Q Consensus 166 ~e~~~~g 172 (419)
|||+++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.91 E-value=0.00013 Score=63.06 Aligned_cols=125 Identities=26% Similarity=0.430 Sum_probs=89.4
Q ss_pred cCccccCcccccCc-EEEEEEEecCCCEEEEEEccc---CCh------------------hhHHHHHHHHHHHhcCC---
Q 014725 91 DNYNANRILGQGGQ-GTVYKGMLADGGIVAVKKSKL---VDE------------------SNVEQFINEVVILSQIN--- 145 (419)
Q Consensus 91 ~~y~~~~~ig~G~f-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~e~~~l~~l~--- 145 (419)
.+++..+.||.|.- |.||++... |..+|+|.... ... .....|..|.+...+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 78899999999999 999999984 77999998221 000 11235778888877774
Q ss_pred Cccc--ccEEeEEecC------------------CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHH
Q 014725 146 HRNV--VKLLGCCLES------------------EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205 (419)
Q Consensus 146 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~ 205 (419)
+.++ |+.+||..-. ....||.||++... .+.. +-+.+|.+-+..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4566 8999987422 01246777775532 1222 234467777888
Q ss_pred HhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 206 LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99999 999999999986 5689999854
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00073 Score=63.98 Aligned_cols=142 Identities=13% Similarity=0.143 Sum_probs=75.5
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC--cccccEEeE------EecCCcceEEEee
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH--RNVVKLLGC------CLESEVPLLVYEF 168 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~------~~~~~~~~lv~e~ 168 (419)
+.|+.|....+|+....++ .+++|....... +....|+..+..|.. -.+++.+.. ....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 5577777789999887555 688887652222 333344455544421 123343321 1224557899999
Q ss_pred cCCCCHH-----------HHh---hccCCC--------CCCCH-HHHHH------------HHHH-HHHHHHHHhhc---
Q 014725 169 IPNGTLY-----------HYL---HDQTEE--------FPITW-EMRLR------------IAIE-VSGAMSYLHSA--- 209 (419)
Q Consensus 169 ~~~g~L~-----------~~l---~~~~~~--------~~l~~-~~~~~------------i~~~-i~~~l~~LH~~--- 209 (419)
++|..+. ..+ +..... ..+.| ..... ...+ +...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 9887431 111 111110 01112 11111 1111 11122333211
Q ss_pred -CCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 210 -TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 210 -~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
-+.+++|+|+.|.||+++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999776568999997743
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00015 Score=76.68 Aligned_cols=195 Identities=18% Similarity=0.182 Sum_probs=133.9
Q ss_pred HHHHHHHhcCCCcccccEEeEEecCCcc----eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC
Q 014725 135 INEVVILSQINHRNVVKLLGCCLESEVP----LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210 (419)
Q Consensus 135 ~~e~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ 210 (419)
.-|...+....|+|++.++.|..+.... .+..+++..-++...+.... .++......+..+...||.|+|+..
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~---~i~~~~~r~~~~~~~~GL~~~h~~~ 306 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG---SIPLETLRILHQKLLEGLAYLHSLS 306 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc---ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence 3466677888999999999998765433 24457888888887777543 4788888889999999999999986
Q ss_pred CCCeeecCCCCC---cEEECCCCcEEEe--ecCCceecccCCceeeecccccCCccCccccccCCCCc--ccceechhHH
Q 014725 211 SIPIYHRDIKSS---NILLDDKYRAKVS--DFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTE--KSDVYSFGVV 283 (419)
Q Consensus 211 ~~~iiH~Dlkp~---Nill~~~~~~kl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--~~Di~slG~~ 283 (419)
..|.-+... +--.+.++.+.++ ||+.++.+...... ....-+..|.+||......+.. ..|+|.+|..
T Consensus 307 ---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll 381 (1351)
T KOG1035|consen 307 ---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL 381 (1351)
T ss_pred ---cceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence 666655555 4445666777777 88887765433222 1222355678888877665554 4799999999
Q ss_pred HHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 284 LVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 284 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
...+..|..+-..... ....++ ......+......|+..++++|+...+++...
T Consensus 382 ~~~~~~~~~i~~~~~~------------------~~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~ 435 (1351)
T KOG1035|consen 382 LLQLSQGEDISEKSAV------------------PVSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTHP 435 (1351)
T ss_pred HhhhhhcCcccccccc------------------hhhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhch
Confidence 9999887654211100 000111 11111467788899999999999999997753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0012 Score=61.80 Aligned_cols=142 Identities=18% Similarity=0.184 Sum_probs=83.7
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCc--ccccEEeE------EecCCcceEEEe
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHR--NVVKLLGC------CLESEVPLLVYE 167 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e 167 (419)
.+.|..|....+|+....+ ..+++|..... .......|+.++..+.+. .+++++.. ....+..+++++
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999987644 46888886642 234566777777777432 24454432 122345689999
Q ss_pred ecCCCCHHH-----------H---hhccCCC--------CCCCHHHHH----------HHHHHHHHHHHHHhh----cCC
Q 014725 168 FIPNGTLYH-----------Y---LHDQTEE--------FPITWEMRL----------RIAIEVSGAMSYLHS----ATS 211 (419)
Q Consensus 168 ~~~~g~L~~-----------~---l~~~~~~--------~~l~~~~~~----------~i~~~i~~~l~~LH~----~~~ 211 (419)
+++|..+.. . ++..... ....|.... .....+..++.++.. ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999876432 0 1110000 011221111 011123334455543 122
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 212 ~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
..++|+|+.|.||++++++.+.|+||+.+.
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 349999999999999998778899998764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.00046 Score=64.83 Aligned_cols=140 Identities=24% Similarity=0.317 Sum_probs=81.7
Q ss_pred CcccccCcEEEEEEEecC-------CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcc-cccEEeEEecCCcceEEEee
Q 014725 97 RILGQGGQGTVYKGMLAD-------GGIVAVKKSKLVDESNVEQFINEVVILSQINHRN-VVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~ 168 (419)
+.+..|-...+|+....+ ++.+++|....... ......+|.+++..+.... .+++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 446667777899988654 47888888654322 2234567888888774322 3455655532 368999
Q ss_pred cCCCCHHHH-----------------hhccCCC--------CCCCHHHHHH--------------------------HHH
Q 014725 169 IPNGTLYHY-----------------LHDQTEE--------FPITWEMRLR--------------------------IAI 197 (419)
Q Consensus 169 ~~~g~L~~~-----------------l~~~~~~--------~~l~~~~~~~--------------------------i~~ 197 (419)
++|..+... +++.... .+.-+..+.. +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 988765431 1111110 0001111111 111
Q ss_pred HHHHHHHHHhh------cCCCCeeecCCCCCcEEECCC----CcEEEeecCCce
Q 014725 198 EVSGAMSYLHS------ATSIPIYHRDIKSSNILLDDK----YRAKVSDFGASR 241 (419)
Q Consensus 198 ~i~~~l~~LH~------~~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfgl~~ 241 (419)
.+...+..|-. ..+..++|+|+.|.||+++++ +.+.++||..+.
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence 22223334432 134459999999999999874 789999998874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.55 E-value=9.8e-05 Score=67.80 Aligned_cols=133 Identities=18% Similarity=0.194 Sum_probs=92.9
Q ss_pred CccccCcccccCcEEEEEEEecCCCEEEEEEcccCC-----------------h-h----hHHHHHHHHHHHhcCC-C-c
Q 014725 92 NYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD-----------------E-S----NVEQFINEVVILSQIN-H-R 147 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~-----------------~-~----~~~~~~~e~~~l~~l~-h-~ 147 (419)
-+++.+.||-|--+.+|.+-+.+|.+.++|.-.... . . ..-...+|...|+.|. | =
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 367889999999999999999999999988422110 0 0 0112356888888774 3 2
Q ss_pred ccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC
Q 014725 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD 227 (419)
Q Consensus 148 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 227 (419)
-+++.++ ....++|||++.+..|...-+- .+.. .+...+..-+.-|-.+| +||+|..--||+++
T Consensus 173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~v------~d~~---~ly~~lm~~Iv~la~~G---lIHgDFNEFNimv~ 236 (465)
T KOG2268|consen 173 PVPKPID----HNRHCVVMELVDGYPLRQVRHV------EDPP---TLYDDLMGLIVRLANHG---LIHGDFNEFNIMVK 236 (465)
T ss_pred CCCCccc----ccceeeHHHhhcccceeeeeec------CChH---HHHHHHHHHHHHHHHcC---ceecccchheeEEe
Confidence 3444554 3456899999988877654321 1222 23444445566777788 99999999999999
Q ss_pred CCCcEEEeecCCc
Q 014725 228 DKYRAKVSDFGAS 240 (419)
Q Consensus 228 ~~~~~kl~Dfgl~ 240 (419)
+++.++++||--.
T Consensus 237 dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 237 DDDKIVVIDFPQM 249 (465)
T ss_pred cCCCEEEeechHh
Confidence 9999999999644
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.47 E-value=0.0029 Score=59.56 Aligned_cols=143 Identities=16% Similarity=0.183 Sum_probs=80.5
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC--cccccEEeEE------ecCCcceEEEe
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH--RNVVKLLGCC------LESEVPLLVYE 167 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~------~~~~~~~lv~e 167 (419)
.+.++.|....+|+....++ .+++|....... ......|.+++..|.. -.+++++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777789999876544 577887654221 2344556666666632 1244444321 12345689999
Q ss_pred ecCCCCHH-----------HH---hhccCCCC---------CCCHHHHHH------------HHHHHHHHHHHHhh----
Q 014725 168 FIPNGTLY-----------HY---LHDQTEEF---------PITWEMRLR------------IAIEVSGAMSYLHS---- 208 (419)
Q Consensus 168 ~~~~g~L~-----------~~---l~~~~~~~---------~l~~~~~~~------------i~~~i~~~l~~LH~---- 208 (419)
|++|..+. .. ++...... .-.|..... ....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 99885432 11 11111110 011111100 01123334555543
Q ss_pred cCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 209 ~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
..+..++|+|+.+.|++++.++.+.|+||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 223459999999999999988777899998764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.0025 Score=60.99 Aligned_cols=141 Identities=19% Similarity=0.206 Sum_probs=80.0
Q ss_pred CcccccCcEEEEEEEecC-----CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccc-ccEEeEEecCCcceEEEeecC
Q 014725 97 RILGQGGQGTVYKGMLAD-----GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV-VKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~ 170 (419)
+.|..|-.-.+|+....+ +..+++|........... -.+|..+++.+..-++ +++++.+..+ .|.+|++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345557778899987532 357888876654332222 2668888888753333 4556665332 5899998
Q ss_pred CCCHHHH-----------------hhccC--C-CCCCCHHHHHHHHHHH-----------------HHHHHHH----hh-
Q 014725 171 NGTLYHY-----------------LHDQT--E-EFPITWEMRLRIAIEV-----------------SGAMSYL----HS- 208 (419)
Q Consensus 171 ~g~L~~~-----------------l~~~~--~-~~~l~~~~~~~i~~~i-----------------~~~l~~L----H~- 208 (419)
+.+|... ++... . ..+..+..+.++..++ ...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 7665421 11111 0 0011233332332111 1112222 21
Q ss_pred cCCCCeeecCCCCCcEEECC-CCcEEEeecCCcee
Q 014725 209 ATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRT 242 (419)
Q Consensus 209 ~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~ 242 (419)
..+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22345999999999999976 46899999987753
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0051 Score=57.52 Aligned_cols=146 Identities=15% Similarity=0.216 Sum_probs=81.8
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcc-cCChhhHHHHHHHHHHHhcCCC--cccccEEeEEecCC--cceEEEeecC
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSK-LVDESNVEQFINEVVILSQINH--RNVVKLLGCCLESE--VPLLVYEFIP 170 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~-~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~ 170 (419)
.+.+..|-.-.+|..... ++++++.+-. ...........+|+.+++.+.- --+...+++|.++. ..+.||+|++
T Consensus 30 v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve 108 (321)
T COG3173 30 VEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE 108 (321)
T ss_pred eeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence 344444444445555443 6677777321 2223345667788888887742 34456677777665 7799999998
Q ss_pred CCCHHHHhhccCC-----------------------------------CCCCCHHHHHHHHH--------HHHHHHHHHh
Q 014725 171 NGTLYHYLHDQTE-----------------------------------EFPITWEMRLRIAI--------EVSGAMSYLH 207 (419)
Q Consensus 171 ~g~L~~~l~~~~~-----------------------------------~~~l~~~~~~~i~~--------~i~~~l~~LH 207 (419)
|..+.+.+..... +.--.|....+.+. ....-..+|+
T Consensus 109 Ge~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~ 188 (321)
T COG3173 109 GEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLE 188 (321)
T ss_pred ceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHH
Confidence 8433221111000 00000111110000 1122234444
Q ss_pred hcC-----CCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 208 SAT-----SIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 208 ~~~-----~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
.+- ...++|+|+.+.|++++.++-+=+.||+++..
T Consensus 189 ~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 189 ANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred hcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 332 23599999999999999988899999999865
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0043 Score=57.48 Aligned_cols=73 Identities=23% Similarity=0.255 Sum_probs=47.6
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC---CcccccEEeEEecCCcceEEEeecCCC
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN---HRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
.+.++.|....+|+.. .+++.+.||.-.. .....|..|.+-|+.|. --.+++++++....+..++++||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4568889999999977 5678899998662 22356778888887773 456888999888777889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.24 E-value=3.3e-05 Score=83.26 Aligned_cols=160 Identities=14% Similarity=0.018 Sum_probs=113.6
Q ss_pred HHHHHHHHhcCCCcccccEEeEEe--cCCcceEEEeecCCCCHHHHhhccCCCC-CCCHHHHHHHHHHHHHHHHHHhhcC
Q 014725 134 FINEVVILSQINHRNVVKLLGCCL--ESEVPLLVYEFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGAMSYLHSAT 210 (419)
Q Consensus 134 ~~~e~~~l~~l~h~niv~l~~~~~--~~~~~~lv~e~~~~g~L~~~l~~~~~~~-~l~~~~~~~i~~~i~~~l~~LH~~~ 210 (419)
...|..-++...|+++.....-.. +....+..++|+.+|.+.+.|.+...+. +++...+.....+......-+|...
T Consensus 1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence 344555566678988877665443 3446689999999999999987654432 3333333333333244455544432
Q ss_pred --CCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHH
Q 014725 211 --SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELL 288 (419)
Q Consensus 211 --~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~ 288 (419)
..-.+|+++|+-|.+|..+.++|+.++|+.+... ..........+++.|+.|+....-.++.++|+|..|+-+|+.-
T Consensus 1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn-p~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN-PVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred cCCccchhhhhhhhccceecCCcccccccccccccC-chHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence 2237899999999999999999999999998322 2223344556788899999988888888899999999999998
Q ss_pred hCCCCC
Q 014725 289 TGQKPI 294 (419)
Q Consensus 289 tg~~p~ 294 (419)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 887765
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0035 Score=57.93 Aligned_cols=30 Identities=23% Similarity=0.520 Sum_probs=25.0
Q ss_pred CeeecCCCCCcEEECCCCc-EEEeecCCcee
Q 014725 213 PIYHRDIKSSNILLDDKYR-AKVSDFGASRT 242 (419)
Q Consensus 213 ~iiH~Dlkp~Nill~~~~~-~kl~Dfgl~~~ 242 (419)
.++|+|+.|.||++++++. .-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997555 56999997754
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.006 Score=57.89 Aligned_cols=73 Identities=18% Similarity=0.189 Sum_probs=48.4
Q ss_pred cccccCcEEEEEEEecCC-CEEEEEEccc----C---ChhhHHHHHHHHHHHhcCC--Cc-ccccEEeEEecCCcceEEE
Q 014725 98 ILGQGGQGTVYKGMLADG-GIVAVKKSKL----V---DESNVEQFINEVVILSQIN--HR-NVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 98 ~ig~G~fg~Vy~~~~~~~-~~vavK~~~~----~---~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~ 166 (419)
.||.|....||++...++ +.++||.-.. . -+-..++..-|.+.|+... .| .+++++. .+.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999998654 5799996331 1 1233455667778887663 35 3445543 3456667999
Q ss_pred eecCCC
Q 014725 167 EFIPNG 172 (419)
Q Consensus 167 e~~~~g 172 (419)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 998543
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.11 E-value=0.0092 Score=57.70 Aligned_cols=73 Identities=16% Similarity=0.207 Sum_probs=50.5
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEccc----CCh---hhHHHHHHHHHHHhcCC---CcccccEEeEEecCCcceEE
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKL----VDE---SNVEQFINEVVILSQIN---HRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv 165 (419)
.+.||.|....||+.... ++.++||+-.. ... ....+-..|+..|+.+. ..++++++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 467899999999998874 56789997541 111 13344455566666653 247888888886 456889
Q ss_pred EeecCC
Q 014725 166 YEFIPN 171 (419)
Q Consensus 166 ~e~~~~ 171 (419)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0051 Score=59.13 Aligned_cols=74 Identities=18% Similarity=0.116 Sum_probs=50.0
Q ss_pred cCcccccCcEEEEEEEecC-CCEEEEEEccc---C---ChhhHHHHHHHHHHHhcCC--Cc-ccccEEeEEecCCcceEE
Q 014725 96 NRILGQGGQGTVYKGMLAD-GGIVAVKKSKL---V---DESNVEQFINEVVILSQIN--HR-NVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~---~---~~~~~~~~~~e~~~l~~l~--h~-niv~l~~~~~~~~~~~lv 165 (419)
.+.||.|.-..||++.+.+ ++.|+||.-.. . -+-..++..-|.+.|+... .| .+++++. .+.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 3578999999999999743 56799996321 1 1234566777888888763 35 4555553 345566789
Q ss_pred EeecCC
Q 014725 166 YEFIPN 171 (419)
Q Consensus 166 ~e~~~~ 171 (419)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 998854
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0062 Score=53.23 Aligned_cols=102 Identities=16% Similarity=0.103 Sum_probs=65.7
Q ss_pred EEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHH
Q 014725 117 IVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI 195 (419)
Q Consensus 117 ~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i 195 (419)
+..+|++...+-. ...-|.++..++++++ .|+++..- +...+-++.|+|..- .....-.|
T Consensus 87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~---------------~i~~~N~i 147 (308)
T PF07387_consen 87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI---------------KINFSNFI 147 (308)
T ss_pred hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc---------------ccchhHHH
Confidence 4556665543333 3456788899988875 46666521 334556889988431 10111112
Q ss_pred HHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 196 ~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
..+ +.+|.-.|+.. ...+|+|-.|+||+-|..|.+||.|-+.
T Consensus 148 ~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 148 TAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 222 35677888544 2399999999999999999999999764
|
The function of this family is unknown. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.0059 Score=54.03 Aligned_cols=30 Identities=27% Similarity=0.429 Sum_probs=21.5
Q ss_pred CeeecCCCCCcEEE-CCCCcEEEeecCCcee
Q 014725 213 PIYHRDIKSSNILL-DDKYRAKVSDFGASRT 242 (419)
Q Consensus 213 ~iiH~Dlkp~Nill-~~~~~~kl~Dfgl~~~ 242 (419)
.++|+|+.|.|||+ +.++.++++||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 38999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.021 Score=53.84 Aligned_cols=141 Identities=18% Similarity=0.187 Sum_probs=91.4
Q ss_pred cccCcccccCcEEEEEEEecCCCEEEEEEcccC-----C--------------------hhhHH-HHHHHHHHHhcCCCc
Q 014725 94 NANRILGQGGQGTVYKGMLADGGIVAVKKSKLV-----D--------------------ESNVE-QFINEVVILSQINHR 147 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~-----~--------------------~~~~~-~~~~e~~~l~~l~h~ 147 (419)
.+...|..|--..||.+...+|..+|||+.+.. + ....+ ....|++.|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 445678999999999999999999999964321 0 01111 123577777777644
Q ss_pred ccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC
Q 014725 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD 227 (419)
Q Consensus 148 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 227 (419)
.|+-.--.. -....|||+|+..... -.-.....+++...+..+-.+++.-+.-|.+.+. +||.||.--|+|+-
T Consensus 227 GIP~PePIl--Lk~hVLVM~FlGrdgw---~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~--LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCPEPIL--LKNHVLVMEFLGRDGW---AAPKLKDASLSTSKARELYQQCVRIMRRLYQKCR--LVHADLSEFNLLYH 299 (520)
T ss_pred CCCCCCcee--eecceEeeeeccCCCC---cCcccccccCChHHHHHHHHHHHHHHHHHHHHhc--eeccchhhhhheEE
Confidence 433111111 1234799999943211 1111122346666677777788888888877664 99999999999886
Q ss_pred CCCcEEEeecCCcee
Q 014725 228 DKYRAKVSDFGASRT 242 (419)
Q Consensus 228 ~~~~~kl~Dfgl~~~ 242 (419)
+|.+.++|.+-+..
T Consensus 300 -dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 300 -DGKLYIIDVSQSVE 313 (520)
T ss_pred -CCEEEEEEcccccc
Confidence 45899999886643
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0027 Score=62.05 Aligned_cols=51 Identities=18% Similarity=0.220 Sum_probs=40.5
Q ss_pred HHHHHHHHHHHhcCCCcccccEEeEEecCC-cceEEEeecCCCCHHHHhhccC
Q 014725 131 VEQFINEVVILSQINHRNVVKLLGCCLESE-VPLLVYEFIPNGTLYHYLHDQT 182 (419)
Q Consensus 131 ~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~ 182 (419)
..+++....+++.+.|+|+...+++..... ...+|||++ +.||.+++....
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~ 77 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN 77 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence 356777888999999999999998876543 457889988 679999887543
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.024 Score=53.45 Aligned_cols=32 Identities=16% Similarity=0.230 Sum_probs=27.9
Q ss_pred CCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 211 ~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+..++|+|+.++|+|+++++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 34599999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.067 Score=50.30 Aligned_cols=29 Identities=34% Similarity=0.399 Sum_probs=24.9
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 212 ~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 45999999999999987 578999998653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.023 Score=54.07 Aligned_cols=140 Identities=19% Similarity=0.228 Sum_probs=77.0
Q ss_pred CcccccCcEEEEEEEecC----CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccc-ccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLAD----GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV-VKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.|..|=...+|+....+ +..|++|........ .-.-.+|..+++.+..-++ +++++++. .+ +|.+|+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence 345557777889887543 237888876543332 1223568888888854444 45666553 22 58899877
Q ss_pred CCHHH--------------H---hhccC---CCCCCCHHHHHHHHHHH----------------------HHHHHHHh--
Q 014725 172 GTLYH--------------Y---LHDQT---EEFPITWEMRLRIAIEV----------------------SGAMSYLH-- 207 (419)
Q Consensus 172 g~L~~--------------~---l~~~~---~~~~l~~~~~~~i~~~i----------------------~~~l~~LH-- 207 (419)
..|.. . ++... ...+..|..+.++..++ ..-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 65421 0 11111 00011233322222221 11111111
Q ss_pred --hc-CCCCeeecCCCCCcEEECC-CCcEEEeecCCce
Q 014725 208 --SA-TSIPIYHRDIKSSNILLDD-KYRAKVSDFGASR 241 (419)
Q Consensus 208 --~~-~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~ 241 (419)
.. .+.-++|+|+.+.|||+++ ++.++++||..+.
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 11 1233899999999999974 5789999998774
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.90 E-value=0.022 Score=53.64 Aligned_cols=72 Identities=21% Similarity=0.220 Sum_probs=54.7
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
...|++|++- |+++.. +. ...+.+...++.+.+..+.-+...- +.-|||+.-.||||+ +|++.|+||-+
T Consensus 299 ~y~yl~~kdh-gt~is~-ik------~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfkl 367 (488)
T COG5072 299 LYLYLHFKDH-GTPISI-IK------ADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKL 367 (488)
T ss_pred eEEEEEEecC-Cceeee-ee------cccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeee
Confidence 3456777765 445432 11 2467888889888877777776654 488999999999999 99999999999
Q ss_pred cee
Q 014725 240 SRT 242 (419)
Q Consensus 240 ~~~ 242 (419)
+|.
T Consensus 368 sRl 370 (488)
T COG5072 368 SRL 370 (488)
T ss_pred eec
Confidence 984
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.1 Score=49.42 Aligned_cols=141 Identities=21% Similarity=0.287 Sum_probs=80.1
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC---Cccccc---EEeEEe--cC--CcceEEE
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN---HRNVVK---LLGCCL--ES--EVPLLVY 166 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~---l~~~~~--~~--~~~~lv~ 166 (419)
..|.+ .-..+|+....+++. ++|..... ....++..|...+..|. .+=.++ +-|-.. -. ...+-++
T Consensus 32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf 107 (331)
T COG2334 32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF 107 (331)
T ss_pred ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence 34555 556789988877776 88877654 23355666777776662 222222 212111 12 3678899
Q ss_pred eecCCCCHHH------------Hh---hccCCC---------CCCCHHH-------------HHHHHHHHHHHHHHHhhc
Q 014725 167 EFIPNGTLYH------------YL---HDQTEE---------FPITWEM-------------RLRIAIEVSGAMSYLHSA 209 (419)
Q Consensus 167 e~~~~g~L~~------------~l---~~~~~~---------~~l~~~~-------------~~~i~~~i~~~l~~LH~~ 209 (419)
+|++|..+.. ++ +....+ ....|.. -.....++...+..+.+.
T Consensus 108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~ 187 (331)
T COG2334 108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR 187 (331)
T ss_pred EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence 9999887762 11 110000 0123320 011233344444444432
Q ss_pred C----CCC---eeecCCCCCcEEECCCCc-EEEeecCCce
Q 014725 210 T----SIP---IYHRDIKSSNILLDDKYR-AKVSDFGASR 241 (419)
Q Consensus 210 ~----~~~---iiH~Dlkp~Nill~~~~~-~kl~Dfgl~~ 241 (419)
- +.. +||+|+.|+||+++.+.. +-++||+-+.
T Consensus 188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 1 222 899999999999999885 8999999775
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.2 Score=44.38 Aligned_cols=75 Identities=20% Similarity=0.249 Sum_probs=52.7
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC---CCcccccEEeEEecCCcceEEEeecCCCC
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI---NHRNVVKLLGCCLESEVPLLVYEFIPNGT 173 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g~ 173 (419)
+.+.-|.--..|...+ +..++.||.-. ......|..|+.-|..+ +.-++.+++....+.+..|+|+||++-+.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3455455445555444 45678888643 44456788888776666 44678899999889999999999998865
Q ss_pred HH
Q 014725 174 LY 175 (419)
Q Consensus 174 L~ 175 (419)
+.
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 54
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.74 E-value=0.2 Score=47.54 Aligned_cols=71 Identities=17% Similarity=0.093 Sum_probs=42.7
Q ss_pred cCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCc--ccccEE---e--EEecCCcceEEEeecCCCC
Q 014725 102 GGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHR--NVVKLL---G--CCLESEVPLLVYEFIPNGT 173 (419)
Q Consensus 102 G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~---~--~~~~~~~~~lv~e~~~~g~ 173 (419)
+.-..||+....++..+++|..... ......+..|.+.+..|... .++... | ...-++..+.++++++|..
T Consensus 36 s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 4557799998877888999976532 12345566777777666311 122211 1 1122455678999998764
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.092 Score=50.33 Aligned_cols=60 Identities=13% Similarity=0.177 Sum_probs=42.3
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD 227 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 227 (419)
..++-+|..|-++..++.... .++....+++.-.++|+-.+--... ++|.|+.|.||++.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~~----~pe~l~kkva~lg~~AllkMl~vDN--FvHaDlHPGNVlir 379 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWKS----QPEALVKKVAKLGVNALLKMLIVDN--FVHADLHPGNVLIR 379 (565)
T ss_pred ceeeeeccccccHHhhhhccc----ChHHHHHHHHHHHHHHHHHHHHhhc--ceecccCCCcEEEE
Confidence 356667888989999987654 3445556666666666654443332 99999999999994
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.64 E-value=0.099 Score=50.66 Aligned_cols=74 Identities=24% Similarity=0.293 Sum_probs=44.0
Q ss_pred CcccccCcEEEEEEEecCC--CE-----EEEEEcccCChhhHHHHHHHHHHHhcCCCccc-ccEEeEEecCCcceEEEee
Q 014725 97 RILGQGGQGTVYKGMLADG--GI-----VAVKKSKLVDESNVEQFINEVVILSQINHRNV-VKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~ 168 (419)
+.|..|-...+|++...++ .. |.++..... ....-.-.+|+.+++.+...++ +++++.+. -++++||
T Consensus 56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~-~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef 130 (383)
T PTZ00384 56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY-NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW 130 (383)
T ss_pred EEeCCcccceEEEEEecCCCCCccccceEEEEeccCC-CceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence 4555688889999875433 12 444432221 1111123568889988865444 45566554 2699999
Q ss_pred cCCCCHH
Q 014725 169 IPNGTLY 175 (419)
Q Consensus 169 ~~~g~L~ 175 (419)
++|..|.
T Consensus 131 IeGr~l~ 137 (383)
T PTZ00384 131 VEGNTMG 137 (383)
T ss_pred eccccCC
Confidence 9987664
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.53 E-value=0.2 Score=54.96 Aligned_cols=31 Identities=32% Similarity=0.512 Sum_probs=25.8
Q ss_pred CCeeecCCCCCcEEECCCC--cEE-EeecCCcee
Q 014725 212 IPIYHRDIKSSNILLDDKY--RAK-VSDFGASRT 242 (419)
Q Consensus 212 ~~iiH~Dlkp~Nill~~~~--~~k-l~Dfgl~~~ 242 (419)
..+||+|+.+.|||++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 4499999999999998875 555 999998754
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 419 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 4e-47 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-47 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-46 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-37 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-37 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-36 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-33 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-30 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 4e-30 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 5e-30 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-29 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-29 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-28 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-26 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-25 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-25 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-25 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-25 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-25 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-25 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-25 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-25 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 5e-25 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 5e-25 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-25 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-25 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-25 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-25 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-25 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-25 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-25 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-24 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-24 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-24 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-24 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-24 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-24 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-24 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-24 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-24 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-24 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-24 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-24 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-24 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-24 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-24 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-24 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-24 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-24 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-24 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-24 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 7e-24 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-24 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-23 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-23 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-23 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-23 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-23 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-23 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-23 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 6e-23 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 6e-23 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-23 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-23 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 6e-23 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-23 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-23 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-23 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-23 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-23 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-23 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-23 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 8e-23 | ||
| 3iok_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-23 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 8e-23 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-23 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 9e-23 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 9e-23 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-22 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-22 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-22 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-22 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-22 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-22 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-22 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-22 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-22 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-22 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-22 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-22 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 6e-22 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-22 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-22 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-22 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-21 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-21 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-21 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-20 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-20 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-20 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-19 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-19 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-19 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-19 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-19 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-19 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-19 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-19 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-19 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-19 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-19 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-19 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 2e-19 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-19 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-19 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-19 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-19 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-19 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-19 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-19 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-19 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-19 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-19 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 3e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-19 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-19 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 4e-19 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-19 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-19 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 4e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-19 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-19 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 5e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-19 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-19 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 5e-19 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 5e-19 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 5e-19 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 6e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 6e-19 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-19 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-19 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-19 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 9e-19 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-19 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-18 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-18 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-18 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-18 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-18 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-18 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-18 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-18 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-18 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-18 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-18 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-18 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-18 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-18 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-18 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-18 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-18 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-18 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 4e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 4e-18 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-18 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-18 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-18 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 6e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-18 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 7e-18 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 8e-18 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-18 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-18 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-18 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 9e-18 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-17 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-17 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-17 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-17 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-17 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-17 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-17 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-17 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-17 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-17 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-17 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-17 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-17 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-17 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-17 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-17 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-17 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-17 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-17 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-17 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-17 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-17 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-17 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-17 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-17 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-17 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-17 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-17 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-17 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-17 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-17 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-17 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-17 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 5e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 5e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-17 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-17 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-17 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-17 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-17 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-17 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-17 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-17 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 6e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-17 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 6e-17 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 6e-17 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-17 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-17 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-17 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-17 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-17 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 7e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-17 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 9e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 9e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-17 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-16 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 1e-16 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-16 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-16 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-16 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-16 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-16 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 2e-16 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-16 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-16 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-16 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-16 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-16 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-16 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 5e-16 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-16 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-16 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-16 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-16 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 9e-16 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 9e-16 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-15 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-15 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-15 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-15 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-15 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-15 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-15 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-15 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-15 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-15 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-15 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-15 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-15 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-15 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-15 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 2e-15 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-15 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-15 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-15 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-15 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-15 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-15 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-15 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-15 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 5e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 5e-15 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 5e-15 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 6e-15 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-15 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-15 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-15 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 6e-15 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-15 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-15 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-15 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 8e-15 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-15 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-15 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-15 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 9e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-15 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-14 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-14 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-14 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-14 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-14 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 2e-14 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-14 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-14 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-14 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-14 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-14 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-14 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-14 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 4e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-14 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-14 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-14 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-14 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-14 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-14 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 7e-14 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 7e-14 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-14 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 8e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 9e-14 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-13 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-13 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-13 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-13 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 2e-13 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-13 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-13 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-13 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-13 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-13 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-13 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-13 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-13 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-13 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-13 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-13 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-13 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-13 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-13 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 5e-13 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 6e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 7e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 7e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 7e-13 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-13 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-13 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-13 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-12 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-12 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 1e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-12 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-12 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-12 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-12 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-12 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-12 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-12 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-12 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-12 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-12 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-12 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-12 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-12 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-12 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-12 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 2e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-12 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-12 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-12 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 2e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-12 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-12 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-12 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-12 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 3e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-12 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-12 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 3e-12 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-12 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-12 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-12 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-12 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-12 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-12 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-12 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-12 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-12 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-12 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 5e-12 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 5e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-12 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-12 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-12 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-12 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-12 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 6e-12 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-12 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-12 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-12 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-12 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-12 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-12 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-12 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-12 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-12 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 8e-12 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 8e-12 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-12 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-12 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-12 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-12 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 8e-12 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 9e-12 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 9e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-12 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 9e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-12 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-11 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-11 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-11 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-11 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-11 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-11 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-11 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-11 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-11 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-11 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-11 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-11 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-11 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-11 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-11 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 1e-11 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-11 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 2e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-11 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-11 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 3e-11 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-11 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 4e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-11 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-11 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-11 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 6e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 8e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 9e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 9e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 9e-11 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 9e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 9e-11 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 9e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 1e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-10 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-10 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-10 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-10 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-10 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-10 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-10 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-10 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 6e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 8e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 8e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 1e-09 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-09 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-09 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-09 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-09 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-09 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-09 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-09 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 1e-09 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-09 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-09 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-09 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-09 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-09 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-09 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-09 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-09 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-09 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-09 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-09 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 2e-09 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-09 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-09 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-09 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 2e-09 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-09 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-09 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-09 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-09 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-09 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-09 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-09 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-09 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-09 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 4e-09 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-09 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-09 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 5e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 5e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 5e-09 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-09 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-09 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-09 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-09 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 7e-09 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-09 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 7e-09 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-09 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 7e-09 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 8e-09 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 8e-09 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-08 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 2e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-08 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-08 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-08 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-08 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 6e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 7e-08 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-08 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 7e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 7e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-08 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 7e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 8e-08 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 9e-08 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-07 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-07 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-07 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-07 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-07 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-07 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-07 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 3e-07 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-07 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-07 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-07 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-07 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-07 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-07 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 5e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 7e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 7e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 8e-07 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 9e-07 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-07 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-06 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-06 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-06 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-06 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 2e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-06 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-06 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-06 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 3e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-06 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 343 bits (882), Expect = e-117
Identities = 110/312 (35%), Positives = 175/312 (56%), Gaps = 5/312 (1%)
Query: 57 KKNGGLLLQQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGG 116
+ LSS+ ++ +DLE+AT+N++ ++G G G VYKG+L DG
Sbjct: 5 YSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA 64
Query: 117 IVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYH 176
VA+K+ +E+F E+ LS H ++V L+G C E +L+Y+++ NG L
Sbjct: 65 KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124
Query: 177 YLHD-QTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235
+L+ ++WE RL I I + + YLH+ I HRD+KS NILLD+ + K++
Sbjct: 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKIT 181
Query: 236 DFGASRTIKV-DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
DFG S+ DQTHL+T V+GT GY+DPEYF + TEKSDVYSFGVVL E+L + I
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241
Query: 295 RSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP 354
+ E +L + +++ N +L ++++ + + + E + +CL + + RP
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP 301
Query: 355 SMKEVAFELEGI 366
SM +V ++LE
Sbjct: 302 SMGDVLWKLEYA 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 328 bits (842), Expect = e-111
Identities = 109/298 (36%), Positives = 177/298 (59%), Gaps = 4/298 (1%)
Query: 72 EGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNV 131
E ++ + K F+ +L+ A+DN++ ILG+GG G VYKG LADG +VAVK+ K
Sbjct: 11 EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGG 70
Query: 132 E-QFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTE-EFPITW 189
E QF EV ++S HRN+++L G C+ LLVY ++ NG++ L ++ E + P+ W
Sbjct: 71 ELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW 130
Query: 190 EMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249
R RIA+ + ++YLH I HRD+K++NILLD+++ A V DFG ++ + TH
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190
Query: 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDA--EEDRSLVG 307
+TT V+GT G++ PEY + + +EK+DV+ +GV+L+EL+TGQ+ ++D L+
Sbjct: 191 VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250
Query: 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365
+ + E +L +++ + K+EE+ + + C +RP M EV LEG
Sbjct: 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 322 bits (829), Expect = e-109
Identities = 100/311 (32%), Positives = 166/311 (53%), Gaps = 18/311 (5%)
Query: 70 SNEGNIEKTKLFTKMDLEKATDN------YNANRILGQGGQGTVYKGMLADGGIVAVKKS 123
S E + + F+ +L+ T+N +G+GG G VYKG + + VAVKK
Sbjct: 4 SLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKL 62
Query: 124 KLVDESNVEQ----FINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLH 179
+ + E+ F E+ ++++ H N+V+LLG + + LVY ++PNG+L L
Sbjct: 63 AAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS 122
Query: 180 DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239
P++W MR +IA + +++LH HRDIKS+NILLD+ + AK+SDFG
Sbjct: 123 CLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGL 179
Query: 240 SRTIKV-DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
+R + QT +T+R+ GT Y+ PE R + T KSD+YSFGVVL+E++TG +
Sbjct: 180 ARASEKFAQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDEH- 237
Query: 299 AEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKE 358
E + L+ + +E++ E + + + + + + +CL+ KRP +K+
Sbjct: 238 -REPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKK 296
Query: 359 VAFELEGIRAS 369
V L+ + AS
Sbjct: 297 VQQLLQEMTAS 307
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 1e-76
Identities = 65/309 (21%), Positives = 116/309 (37%), Gaps = 37/309 (11%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI 144
+L + + +G G V+K L VAVK + D+ + Q EV L +
Sbjct: 18 NLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYSLPGM 75
Query: 145 NHRNVVKLLGCCLESEVP----LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVS 200
H N+++ +G L+ F G+L +L ++W IA ++
Sbjct: 76 KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSWNELCHIAETMA 131
Query: 201 GAMSYLHSATSI-------PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL-TT 252
++YLH I HRDIKS N+LL + A ++DFG + + ++ T
Sbjct: 132 RGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTH 191
Query: 253 RVQGTFGYLDPEYFRSS-----QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307
GT Y+ PE + + D+Y+ G+VL EL + E
Sbjct: 192 GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP--- 248
Query: 308 FFLQAMNEDRLFEVLEARVLKEG----------KEEEIITVAMLGKRCLNMIGKKRPSMK 357
F + + + E ++ V+ + K + + + C + + R S
Sbjct: 249 -FEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307
Query: 358 EVAFELEGI 366
V + +
Sbjct: 308 CVGERITQM 316
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 3e-76
Identities = 90/283 (31%), Positives = 129/283 (45%), Gaps = 30/283 (10%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLG 154
+G G GTV++ G VAVK D V +F+ EV I+ ++ H N+V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
+ +V E++ G+LY LH + RL +A +V+ M+YLH+ PI
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPI 160
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
HR++KS N+L+D KY KV DFG SR +K + GT ++ PE R EK
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 275 SDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334
SDVYSFGV+L EL T Q+P + + Q + A V + K E
Sbjct: 220 SDVYSFGVILWELATLQQPWGNLN----------PAQVV----------AAVGFKCKRLE 259
Query: 335 IIT-----VAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGS 372
I VA + + C KRPS + L + S
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 8e-76
Identities = 84/295 (28%), Positives = 131/295 (44%), Gaps = 36/295 (12%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
++G+G G V K VA+K+ + ES + FI E+ LS++NH N+VKL G C
Sbjct: 14 EVVGRGAFGVVCKAKW-RAKDVAIKQ--IESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 157 LESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
L P+ LV E+ G+LY+ LH T + ++ S ++YLHS +
Sbjct: 71 LN---PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 216 HRDIKSSNILLDDKYR-AKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEK 274
HRD+K N+LL K+ DFG + I QTH+T G+ ++ PE F S ++EK
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK-GSAAWMAPEVFEGSNYSEK 183
Query: 275 SDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEE 334
DV+S+G++L E++T +KP E N R
Sbjct: 184 CDVFSWGIILWEVITRRKPF----DEIGGPAFRIMWAVHNGTRP---------------P 224
Query: 335 IIT-----VAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEIHF 384
+I + L RC + +RPSM+E+ + + + H
Sbjct: 225 LIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHS 279
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 1e-71
Identities = 84/287 (29%), Positives = 128/287 (44%), Gaps = 45/287 (15%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESN----VEQFINEVVILSQINHRNVVKL 152
I+G GG G VY+ G VAVK ++ + + +E E + + + H N++ L
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
G CL+ LV EF G L L + I ++ + A++++ M+YLH +
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 213 PIYHRDIKSSNILLDDKYR--------AKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
PI HRD+KSSNIL+ K K++DFG +R +T + G + ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWMAPE 184
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324
R+S F++ SDV+S+GV+L ELLTG+ P R D L
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGID----------GLAVA----------Y 224
Query: 325 RVLKEGKEEEIIT-----VAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
V I + A L + C N RPS + +L I
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 2e-71
Identities = 85/290 (29%), Positives = 134/290 (46%), Gaps = 47/290 (16%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESN-------VEQFINEVVILSQINHRN 148
+ +G+GG G V+KG + D +VA+K L D ++F EV I+S +NH N
Sbjct: 25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+VKL G P +V EF+P G LYH L D+ PI W ++LR+ ++++ + Y+ +
Sbjct: 85 IVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN 140
Query: 209 ATSIPIYHRDIKSSNILLDDK-----YRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
PI HRD++S NI L AKV+DFG S+ H + + G F ++ P
Sbjct: 141 QNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGLLGNFQWMAP 195
Query: 264 EYF--RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321
E +TEK+D YSF ++L +LTG+ P + +
Sbjct: 196 ETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS----------YGKIK-------- 237
Query: 322 LEARVLKEGKEEEIIT-----VAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+ +EG I + + + C + KKRP + EL +
Sbjct: 238 FINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 3e-68
Identities = 60/283 (21%), Positives = 112/283 (39%), Gaps = 41/283 (14%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLG 154
L + G ++KG G + VK K+ F E L +H NV+ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 155 CCLESEVPLL--VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
C P + ++P G+LY+ LH+ T F + ++ A++++ M++LH+
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEP- 132
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ-- 270
I + S ++++D+ A++S + + + ++ PE +
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQ------SPGRMYAPAWVAPEALQKKPED 186
Query: 271 -FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329
+D++SF V+L EL+T + P ++ +V E
Sbjct: 187 TNRRSADMWSFAVLLWELVTREVPFADLS----------NMEIG----------MKVALE 226
Query: 330 GKEEEIIT-----VAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367
G I V+ L K C+N KRP + LE ++
Sbjct: 227 GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 4e-65
Identities = 66/293 (22%), Positives = 114/293 (38%), Gaps = 38/293 (12%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLG 154
++G+G G VY G G VA++ + +E ++ F EV+ Q H NVV +G
Sbjct: 39 ELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
C+ ++ TLY + D +IA E+ M YLH + I
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLD--VNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKV----DQTHLTTRVQGTFGYLDPEYFRSSQ 270
H+D+KS N+ D+ + ++DFG V + G +L PE R
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 271 ---------FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321
F++ SDV++ G + EL + P ++ AE +G +
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT-------GMKPNL 263
Query: 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSS 374
+ + KE ++ + C ++RP+ ++ LE + S
Sbjct: 264 SQIGMGKE--------ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLS 308
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 5e-64
Identities = 68/296 (22%), Positives = 118/296 (39%), Gaps = 43/296 (14%)
Query: 97 RILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
+LG+G G K G ++ +K+ DE F+ EV ++ + H NV+K +G
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
+ + + E+I GTL + ++P W R+ A +++ M+YLH S+ I
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYP--WSQRVSFAKDIASGMAYLH---SMNII 130
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTI-------------KVDQTHLTTRVQGTFGYLD 262
HRD+ S N L+ + V+DFG +R + K V G ++
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322
PE + EK DV+SFG+VL E++ D
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP-------------DYLPRTMDF----- 232
Query: 323 EARVLKEGKEEEI-----ITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373
++ + + + RC ++ +KRPS ++ LE +R +
Sbjct: 233 -GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGH 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-62
Identities = 77/277 (27%), Positives = 128/277 (46%), Gaps = 27/277 (9%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLG 154
+ +G G GTVYKG G VAVK + ++ F NEV +L + H N++ +G
Sbjct: 30 QRIGSGSFGTVYKGKW--HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 155 CCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIP 213
L +V ++ +LYH+LH +F + + IA + + M YLH+
Sbjct: 88 YSTAP--QLAIVTQWCEGSSLYHHLHASETKFE--MKKLIDIARQTARGMDYLHA---KS 140
Query: 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ-THLTTRVQGTFGYLDPEYFR---SS 269
I HRD+KS+NI L + K+ DFG + +H ++ G+ ++ PE R S+
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 270 QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329
++ +SDVY+FG+VL EL+TGQ P + + + ++ + R
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-----IIEMVGRGSLSPDLSKVR---S 252
Query: 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+ + L CL +RPS + E+E +
Sbjct: 253 NCPKRM---KRLMAECLKKKRDERPSFPRILAEIEEL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-60
Identities = 68/327 (20%), Positives = 124/327 (37%), Gaps = 48/327 (14%)
Query: 81 FTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVI 140
+ DN ++G+G G VYKG L D VAVK + + FINE I
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNI 58
Query: 141 --LSQINHRNVVKLLGCCLESEVP-----LLVYEFIPNGTLYHYLHDQTEEFPITWEMRL 193
+ + H N+ + + LLV E+ PNG+L YL T W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 194 RIAIEVSGAMSYLHSATSI------PIYHRDIKSSNILLDDKYRAKVSDFGASRTI---- 243
R+A V+ ++YLH+ I HRD+ S N+L+ + +SDFG S +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 244 ---KVDQTHLTTRVQGTFGYLDPEYFRSS-------QFTEKSDVYSFGVVLVELLTGQKP 293
++ + GT Y+ PE + ++ D+Y+ G++ E+
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 294 IRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGK-----------EEEIITVAMLG 342
+ ++ + + F + FE ++ V +E + + ++
Sbjct: 235 LFPGESVPEYQMA--FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 343 KRCLNMIGKKRPSMKEVAFELEGIRAS 369
+ C + + R + + + +
Sbjct: 293 EDCWDQDAEARLTAQXAEERMAELMMI 319
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 1e-55
Identities = 61/303 (20%), Positives = 109/303 (35%), Gaps = 43/303 (14%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINE--VVILSQINHRNVVKLLG 154
+ +G+G G V+ G G VAVK +E + E + + H N++ +
Sbjct: 43 KQIGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98
Query: 155 CCLESEVP----LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
++ L+ ++ NG+LY YL T + + L++A + +LH+
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT----LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 211 SI-----PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL---TTRVQGTFGYLD 262
I HRD+KS NIL+ ++D G + D + GT Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 263 PE------YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316
PE Q +D+YSFG++L E+ + + + + D
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQL-----PYHDLVPSD 269
Query: 317 RLFEVLEARVLKEGK----------EEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+E + V + +E + + L C R + V L +
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329
Query: 367 RAS 369
S
Sbjct: 330 SES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-55
Identities = 62/301 (20%), Positives = 111/301 (36%), Gaps = 45/301 (14%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVI--LSQINHRNVVKLLG 154
+G+G G V++G G VAVK + + + E + + H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKI---FSSRDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 155 CCLESEVP----LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+ S L+ + G+LY YL T + LRI + ++ +++LH
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT----LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 211 SI-----PIYHRDIKSSNILLDDKYRAKVSDFGASR----TIKVDQTHLTTRVQGTFGYL 261
I HRD+KS NIL+ + ++D G + + RV GT Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 262 DPE------YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315
PE ++ D+++FG+VL E+ + + F +
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKP-----PFYDVVPN 239
Query: 316 DRLFEVLEARVLKEG----------KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365
D FE + V + + + ++A L K C R + + L
Sbjct: 240 DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299
Query: 366 I 366
I
Sbjct: 300 I 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 3e-53
Identities = 57/304 (18%), Positives = 112/304 (36%), Gaps = 43/304 (14%)
Query: 98 ILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINE--VVILSQINHRNVVKLLGC 155
+G+G G V++G G VAVK + E + + H N++ +
Sbjct: 49 SIGKGRFGEVWRGKW-RGEEVAVKI---FSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 156 CLESEVP----LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
+ LV ++ +G+L+ YL+ T +T E +++A+ + +++LH
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT----VTVEGMIKLALSTASGLAHLHMEIV 160
Query: 212 -----IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT---TRVQGTFGYLDP 263
I HRD+KS NIL+ ++D G + + GT Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 264 EYFRSS------QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317
E S + +++D+Y+ G+V E+ + + + + D
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ-----LPYYDLVPSDP 275
Query: 318 LFEVLEARVLKEGK----------EEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367
E + V ++ E + +A + + C G R + + L +
Sbjct: 276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS 335
Query: 368 ASIG 371
G
Sbjct: 336 QQEG 339
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 7e-45
Identities = 73/299 (24%), Positives = 126/299 (42%), Gaps = 35/299 (11%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKK---SKLVDESNVEQFINEVVILSQINH 146
N+ + +G+G VY+ L DG VA+KK L+D I E+ +L Q+NH
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGAMSY 205
NV+K +E +V E G L + ++ I + +++ A+ +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
+HS + HRDIK +N+ + K+ D G R T + V GT Y+ PE
Sbjct: 152 MHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
+ + KSD++S G +L E+ Q P F+ MN L + +
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP--------------FYGDKMNLYSLCK----K 249
Query: 326 VLKEGKEEEIITVAM------LGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHN 378
+ + + + L C+N +KRP + V +++ + +SSL+H+
Sbjct: 250 IEQ-CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYV-YDVAKRMHACTASSLEHH 306
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-44
Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 97 RILGQGGQGTVYKGMLADGG-----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVV 150
++LG G GTVYKG+ G VA+K+ + ++ ++E +++ +++ +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+LLG CL S V L+ + +P G L Y+ + + + L ++++ M+YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT---FGYLDPEYFR 267
+ HRD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 268 SSQFTEKSDVYSFGVVLVELLT-GQKP 293
+T +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 6e-44
Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 24/288 (8%)
Query: 97 RILGQGGQGTVYKGML-----ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVK 151
+ LG+G G+V G +VAVKK + E ++ F E+ IL + H N+VK
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 152 LLGCCLES-EVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
G C + L L+ E++P G+L YL E I L+ ++ M YL +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTK 164
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFR 267
I HRD+ + NIL++++ R K+ DFG ++ + D+ + + G + PE
Sbjct: 165 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327
S+F+ SDV+SFGVVL EL T + +S AE R + M L E+L+
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK---- 277
Query: 328 KEGKEEEI-----ITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370
+ M+ C N +RPS +++A ++ IR +
Sbjct: 278 -NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 7e-44
Identities = 82/289 (28%), Positives = 132/289 (45%), Gaps = 24/289 (8%)
Query: 97 RILGQGGQGTVYKGMLADGG-----IVAVKKSKLVDESNVEQFINEVVILSQINHRNVVK 151
+ LG+G G+V +VAVKK + E ++ F E+ IL + H N+VK
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 152 LLGCCLES-EVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
G C + L L+ E++P G+L YL E I L+ ++ M YL +
Sbjct: 76 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQICKGMEYLGTK 133
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFR 267
I HRD+ + NIL++++ R K+ DFG ++ + D+ + G + PE
Sbjct: 134 RYI---HRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327
S+F+ SDV+SFGVVL EL T + +S AE R + M L E+L+
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK---- 246
Query: 328 KEGKEEEI-----ITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIG 371
+ M+ C N +RPS +++A ++ IR ++
Sbjct: 247 -NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 3e-43
Identities = 60/219 (27%), Positives = 102/219 (46%), Gaps = 9/219 (4%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHR 147
++Y +G G G K +DG I+ K+ + E+ + ++EV +L ++ H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 148 NVVKLLGCCLESEVPLL--VYEFIPNGTLYHYLHDQTEE-FPITWEMRLRIAIEVSGAMS 204
N+V+ ++ L V E+ G L + T+E + E LR+ +++ A+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 205 YLHS--ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
H + HRD+K +N+ LD K K+ DFG +R + D + T V GT Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMS 184
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
PE + EKSD++S G +L EL P + +E
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE 223
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 72/280 (25%), Positives = 119/280 (42%), Gaps = 35/280 (12%)
Query: 97 RILGQGGQGTVYKGMLADGGI-VAVKKSK-LVDESNVEQFINEVVILSQINHRNVVKLLG 154
+G+G G V+ G L VAVK + + +F+ E IL Q +H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
C + + +V E + G +L + + + L++ + + M YL S I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRV--KTLLQMVGDAAAGMEYLESKCCI-- 235
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFRSSQFT 272
HRD+ + N L+ +K K+SDFG SR D + + PE +++
Sbjct: 236 -HRDLAARNCLVTEKNVLKISDFGMSREEA-DGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 273 EKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLV--GFFLQAMNE--DRLFEVLEARVL 327
+SDV+SFG++L E + G P + ++ R V G L D +F +
Sbjct: 294 SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL------ 347
Query: 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367
M +C +RPS + EL+ IR
Sbjct: 348 ------------ME--QCWAYEPGQRPSFSTIYQELQSIR 373
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-43
Identities = 70/210 (33%), Positives = 108/210 (51%), Gaps = 21/210 (10%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSK-LVDESNVEQFINEVVILSQINHRNVVK 151
++G+G G VY G L D AVK + D V QF+ E +I+ +H NV+
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 152 LLGCCLESEVPLL-VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
LLG CL SE L V ++ +G L +++ + E T + + ++V+ M YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKYLASKK 148
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL------DPE 264
+ HRD+ + N +LD+K+ KV+DFG +R + + + V G E
Sbjct: 149 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMALE 202
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
++ +FT KSDV+SFGV+L EL+T G P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 5e-43
Identities = 80/322 (24%), Positives = 141/322 (43%), Gaps = 52/322 (16%)
Query: 96 NRILGQGGQGTVYKGMLADGG----IVAVK--KSKLVDESNVEQFINEVVILSQINHRNV 149
R+LG+G G+V + L VAVK K+ ++ S++E+F+ E + + +H +V
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 150 VKLLGCCLESE------VPLLVYEFIPNGTLYHYL---HDQTEEFPITWEMRLRIAIEVS 200
KL+G L S +P+++ F+ +G L+ +L F + + +R ++++
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260
M YL S I HRD+ + N +L + V+DFG SR I + QG
Sbjct: 148 CGMEYLSSRNFI---HRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASK 200
Query: 261 L-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLV--GFFLQA 312
L E + +T SDV++FGV + E++T GQ P + E + + G L+
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ 260
Query: 313 MNE--DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370
E + ++++ M +C + K+RPS + ELE I +
Sbjct: 261 PPECMEEVYDL------------------MY--QCWSADPKQRPSFTCLRMELENILGHL 300
Query: 371 GSSSLQHNCEEIHFVGGDNTRH 392
S + I+ + H
Sbjct: 301 SVLSTSQDPLYINIERAHHHHH 322
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 6e-43
Identities = 79/291 (27%), Positives = 130/291 (44%), Gaps = 34/291 (11%)
Query: 97 RILGQGGQGTVYKGMLADGGI-VAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
LG G G VY+G+ + VAVK K D VE+F+ E ++ +I H N+V+LLG
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
C ++ EF+ G L YL + ++ + L +A ++S AM YL I
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKNFI--- 340
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKS 275
HR++ + N L+ + + KV+DFG SR + D + + PE ++F+ KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 276 DVYSFGVVLVELLT-GQKPIRSTDAEEDRSLV--GFFLQAMNE--DRLFEVLEARVLKEG 330
DV++FGV+L E+ T G P D + L+ + ++ ++++E+
Sbjct: 401 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL--------- 451
Query: 331 KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEE 381
M C RPS E+ E + SS+ E+
Sbjct: 452 ---------MR--ACWQWNPSDRPSFAEIHQAFETM---FQESSISDEVEK 488
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-43
Identities = 63/218 (28%), Positives = 103/218 (47%), Gaps = 27/218 (12%)
Query: 96 NRILGQGGQGTVYKGMLADGG----IVAVK--KSKLVDESNVEQFINEVVILSQINHRNV 149
+ILG+G G+V +G L VAVK K + +E+F++E + +H NV
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 150 VKLLGCCLESE-----VPLLVYEFIPNGTLYHYL---HDQTEEFPITWEMRLRIAIEVSG 201
++LLG C+E P+++ F+ G L+ YL +T I + L+ ++++
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
M YL + + HRD+ + N +L D V+DFG S+ I + QG +
Sbjct: 159 GMEYLSNRNFL---HRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKM 211
Query: 262 -----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
E +T KSDV++FGV + E+ T G P
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-42
Identities = 69/209 (33%), Positives = 107/209 (51%), Gaps = 19/209 (9%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSK-LVDESNVEQFINEVVILSQINHRNVVK 151
++G+G G VY G L D AVK + D V QF+ E +I+ +H NV+
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 152 LLGCCLESEVPLL-VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
LLG CL SE L V ++ +G L +++ + E T + + ++V+ M +L S
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI--RNETHNPTVKDLIGFGLQVAKGMKFLASKK 212
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL-----DPEY 265
+ HRD+ + N +LD+K+ KV+DFG +R + + T L E
Sbjct: 213 FV---HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALES 267
Query: 266 FRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
++ +FT KSDV+SFGV+L EL+T G P
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPP 296
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 2e-42
Identities = 76/285 (26%), Positives = 123/285 (43%), Gaps = 27/285 (9%)
Query: 97 RILGQGGQGTVYKGMLADGG-----IVAVKKSKLVDESNVEQFINEVVILSQINHRNVVK 151
LG+G G+V G +VAVK+ + F E+ IL ++ +VK
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 152 LLGCCLES-EVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
G L LV E++P+G L +L + L + ++ M YL S
Sbjct: 89 YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS--RLLLYSSQICKGMEYLGSR 146
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFR 267
+ HRD+ + NIL++ + K++DFG ++ + +D+ + R G + PE
Sbjct: 147 RCV---HRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203
Query: 268 SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326
+ F+ +SDV+SFGVVL EL T K + + E ++G RL E+LE
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLE--- 258
Query: 327 LKEGKEEEI-----ITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
EG+ V L K C + RPS + +L+ +
Sbjct: 259 --EGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-42
Identities = 76/292 (26%), Positives = 119/292 (40%), Gaps = 36/292 (12%)
Query: 97 RILGQGGQGTVYKGMLADGG-----IVAVKKSK-LVDESNVEQFINEVVILSQINHRNVV 150
R LG+G G V +VAVK K + + E+ IL + H +++
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 151 KLLGCCLESEVP--LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
K GCC ++ LV E++P G+L YL + I L A ++ M+YLH+
Sbjct: 97 KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHA 152
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYF 266
I HRD+ + N+LLD+ K+ DFG ++ + + R G + PE
Sbjct: 153 QHYI---HRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209
Query: 267 RSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
+ +F SDV+SFGV L ELLT + + M RL E+LE
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--GQMTVLRLTELLE-- 265
Query: 326 VLKEGKE--------EEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
G+ E+ + M C RP+ + + L+ +
Sbjct: 266 ---RGERLPRPDKCPAEVYHL-MK--NCWETEASFRPTFENLIPILKTVHEK 311
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 4e-42
Identities = 51/206 (24%), Positives = 90/206 (43%), Gaps = 8/206 (3%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHR 147
+ Y + +G+G G DG +K+ + + E+ EV +L+ + H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
N+V+ E+ +V ++ G L+ ++ Q + L +++ A+ ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGV-LFQEDQILDWFVQICLALKHVH 142
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
I HRDIKS NI L ++ DFG +R + + GT YL PE
Sbjct: 143 DRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICE 198
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKP 293
+ + KSD+++ G VL EL T +
Sbjct: 199 NKPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-42
Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 11/200 (5%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
+ LG G G V G VAVK K + ++F E + +++H +VK G C
Sbjct: 14 KELGSGQFGVVKLGKWKGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ +V E+I NG L +YL ++ + L + +V M++L S I H
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFI---H 127
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFRSSQFTEK 274
RD+ + N L+D KVSDFG +R + DQ + V F PE F +++ K
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 275 SDVYSFGVVLVELLT-GQKP 293
SDV++FG+++ E+ + G+ P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-42
Identities = 62/206 (30%), Positives = 108/206 (52%), Gaps = 15/206 (7%)
Query: 96 NRILGQGGQGTVYKGMLADGGI---VAVK--KSKLVDESNVEQFINEVVILSQINHRNVV 150
++ LG G GTV KG + VAVK K++ D + ++ + E ++ Q+++ +V
Sbjct: 22 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+++G C +LV E G L YL + + + + +VS M YL +
Sbjct: 82 RMIGICEAESW-MLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEESN 137
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRS 268
+ HRD+ + N+LL ++ AK+SDFG S+ ++ D+ + + G + + PE
Sbjct: 138 FV---HRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 269 SQFTEKSDVYSFGVVLVELLT-GQKP 293
+F+ KSDV+SFGV++ E + GQKP
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQKP 220
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-42
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 13/205 (6%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVK 151
+I+G G G V G L G VA+K K E F++E I+ Q +H N+++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
L G + ++V E++ NG+L +L +T + T + + V M YL
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFL--RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL--DPEYFRSS 269
+ HRD+ + N+L+D KVSDFG SR ++ D T G PE
Sbjct: 173 V---HRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKP 293
F+ SDV+SFGVV+ E+L G++P
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 6e-42
Identities = 68/200 (34%), Positives = 104/200 (52%), Gaps = 11/200 (5%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
+ +G G G V+ G + VA+K + + E FI E ++ +++H +V+L G C
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
LE LV EF+ +G L YL Q F E L + ++V M+YL A I H
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEEACVI---H 127
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFRSSQFTEK 274
RD+ + N L+ + KVSDFG +R + DQ T+ F PE F S+++ K
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 275 SDVYSFGVVLVELLT-GQKP 293
SDV+SFGV++ E+ + G+ P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 8e-42
Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 97 RILGQGGQGTVYKGMLADGGI----VAVKKSK---LVDESNVEQFINEVVILSQINHRNV 149
LG G G V +G VAVK K L ++ FI EV + ++HRN+
Sbjct: 24 EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
++L G L + +V E P G+L L F + R A++V+ M YL S
Sbjct: 84 IRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLESK 140
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFR 267
I HRD+ + N+LL + K+ DFG R + + H + + PE +
Sbjct: 141 RFI---HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 268 SSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ F+ SD + FGV L E+ T GQ+P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 9e-42
Identities = 76/290 (26%), Positives = 132/290 (45%), Gaps = 43/290 (14%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSK-LVDESNVEQFINEVVILSQINHRNVVK 151
R++G+G G VY G D A+K + + VE F+ E +++ +NH NV+
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86
Query: 152 LLGCCLESE-VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
L+G L E +P ++ ++ +G L ++ ++ + T + + ++V+ M YL
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFI--RSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL-----DPEY 265
+ HRD+ + N +LD+ + KV+DFG +R + + Q L E
Sbjct: 145 FV---HRDLAARNCMLDESFTVKVADFGLAR--DILDREYYSVQQHRHARLPVKWTALES 199
Query: 266 FRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLV--GFFLQAMNE--DRLFE 320
++ +FT KSDV+SFGV+L ELLT G P R D + + G L D L++
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259
Query: 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370
V M +C RP+ + + E+E I +++
Sbjct: 260 V------------------MQ--QCWEADPAVRPTFRVLVGEVEQIVSAL 289
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 69/201 (34%), Positives = 104/201 (51%), Gaps = 11/201 (5%)
Query: 97 RILGQGGQGTVYKGMLADGGI-VAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGC 155
LG G G VY+G+ + VAVK K D VE+F+ E ++ +I H N+V+LLG
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIY 215
C ++ EF+ G L YL + + ++ + L +A ++S AM YL I
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQ-EVSAVVLLYMATQISSAMEYLEKKNFI--- 133
Query: 216 HRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFRSSQFTE 273
HRD+ + N L+ + + KV+DFG SR + D T F PE ++F+
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDT--YTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 274 KSDVYSFGVVLVELLT-GQKP 293
KSDV++FGV+L E+ T G P
Sbjct: 192 KSDVWAFGVLLWEIATYGMSP 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-41
Identities = 55/207 (26%), Positives = 106/207 (51%), Gaps = 18/207 (8%)
Query: 97 RILGQGGQGTVYKGMLADGG-----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVV 150
++LG G GTVYKG+ G VA+K+ + ++ ++E +++ +++ +V
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+LLG CL S V L+ + +P G L Y+ + + + L ++++ M+YL
Sbjct: 81 RLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIGS--QYLLNWCVQIAKGMNYLEDRR 137
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT---FGYLDPEYFR 267
+ HRD+ + N+L+ K++DFG ++ + ++ +G ++ E
Sbjct: 138 LV---HRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA--EGGKVPIKWMALESIL 192
Query: 268 SSQFTEKSDVYSFGVVLVELLT-GQKP 293
+T +SDV+S+GV + EL+T G KP
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 1e-41
Identities = 80/286 (27%), Positives = 126/286 (44%), Gaps = 28/286 (9%)
Query: 97 RILGQGGQGTVYKGMLADGG-----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVV 150
R LG+G G V G VAVK K +++ E+ IL + H N+V
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 151 KLLGCCLESEVP--LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
K G C E L+ EF+P+G+L YL + I + +L+ A+++ M YL S
Sbjct: 87 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYF 266
+ HRD+ + N+L++ +++ K+ DFG ++ I+ D+ + T + + PE
Sbjct: 145 RQYV---HRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECL 201
Query: 267 RSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
S+F SDV+SFGV L ELLT S+ ++G M RL L+
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLTYCDSD--SSPMALFLKMIGPTHGQMTVTRLVNTLK-- 257
Query: 326 VLKEGKEEEI-----ITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
EGK V L ++C R S + + E +
Sbjct: 258 ---EGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
LG G G V+ G VAVK K + + F+ E ++ Q+ H+ +V+L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ + ++ E++ NG+L +L +T L +A +++ M+++ I H
Sbjct: 78 TQEPI-YIITEYMENGSLVDFLKT-PSGIKLTINKLLDMAAQIAEGMAFIEERNYI---H 132
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFRSSQFTEK 274
RD++++NIL+ D K++DFG +R I+ ++ T R F PE FT K
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINYGTFTIK 190
Query: 275 SDVYSFGVVLVELLT-GQKP 293
SDV+SFG++L E++T G+ P
Sbjct: 191 SDVWSFGILLTEIVTHGRIP 210
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 11/200 (5%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
+ LG G G V G VA+K K + ++FI E ++ ++H +V+L G C
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ ++ E++ NG L +YL + + L + +V AM YL S + H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL--REMRHRFQTQQLLEMCKDVCEAMEYLESKQFL---H 143
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFRSSQFTEK 274
RD+ + N L++D+ KVSDFG SR + D+ T+ V F PE S+F+ K
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSKFSSK 201
Query: 275 SDVYSFGVVLVELLT-GQKP 293
SD+++FGV++ E+ + G+ P
Sbjct: 202 SDIWAFGVLMWEIYSLGKMP 221
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-41
Identities = 64/207 (30%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLV-DESNVEQFINEVVILSQINHRN 148
Y LG GG TVY VA+K E +++F EV SQ++H+N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+V ++ E + LV E+I TL Y+ P++ + + ++ + + H
Sbjct: 73 IVSMIDVDEEDDCYYLVMEYIEGPTLSEYIE---SHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT--RVQGTFGYLDPEYF 266
I HRDIK NIL+D K+ DFG ++ + +T LT V GT Y PE
Sbjct: 130 MR---IVHRDIKPQNILIDSNKTLKIFDFGIAKA--LSETSLTQTNHVLGTVQYFSPEQA 184
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ E +D+YS G+VL E+L G+ P
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-41
Identities = 51/207 (24%), Positives = 101/207 (48%), Gaps = 18/207 (8%)
Query: 97 RILGQGGQGTVYKGMLADGG-----IVAVKKSK-LVDESNVEQFINEVVILSQINHRNVV 150
++LG G GTV+KG+ G V +K + + + + ++ + ++H ++V
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+LLG C S + LV +++P G+L ++ ++ L ++++ M YL
Sbjct: 79 RLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGALGP--QLLLNWGVQIAKGMYYLEEHG 135
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT---FGYLDPEYFR 267
+ HR++ + N+LL + +V+DFG + + D L ++ E
Sbjct: 136 MV---HRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY--SEAKTPIKWMALESIH 190
Query: 268 SSQFTEKSDVYSFGVVLVELLT-GQKP 293
++T +SDV+S+GV + EL+T G +P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-41
Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
LGQG G V+ G VA+K K + E F+ E ++ ++ H +V+L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 248
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
E + +V E++ G+L +L +T ++ + + +A +++ M+Y+ + H
Sbjct: 249 SEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---H 303
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 276
RD++++NIL+ + KV+DFG +R I+ ++ + + PE +FT KSD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 277 VYSFGVVLVELLT-GQKP 293
V+SFG++L EL T G+ P
Sbjct: 364 VWSFGILLTELTTKGRVP 381
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 8e-41
Identities = 62/207 (29%), Positives = 108/207 (52%), Gaps = 16/207 (7%)
Query: 97 RILGQGGQGTVYKGMLADGGI-----VAVK--KSKLVDESNVEQFINEVVILSQINHRNV 149
+++G G G VYKGML VA+K K+ ++ V+ F+ E I+ Q +H N+
Sbjct: 50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNI 108
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
++L G + + +++ E++ NG L +L + ++ + + + ++ M YL +
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL--REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFR 267
+ HRD+ + NIL++ KVSDFG SR ++ D T G PE
Sbjct: 167 NYV---HRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223
Query: 268 SSQFTEKSDVYSFGVVLVELLT-GQKP 293
+FT SDV+SFG+V+ E++T G++P
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 8e-41
Identities = 57/198 (28%), Positives = 103/198 (52%), Gaps = 7/198 (3%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
LGQG G V+ G VA+K K + E F+ E ++ ++ H +V+L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 331
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
E + +V E++ G+L +L +T ++ + + +A +++ M+Y+ + H
Sbjct: 332 SEEPI-YIVTEYMSKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVERMNYV---H 386
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSD 276
RD++++NIL+ + KV+DFG +R I+ ++ + + PE +FT KSD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 277 VYSFGVVLVELLT-GQKP 293
V+SFG++L EL T G+ P
Sbjct: 447 VWSFGILLTELTTKGRVP 464
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 9e-41
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 99 LGQGGQGTVYKGMLADGG---IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLG 154
LG G G+V +G+ VA+K K ++++ E+ + E I+ Q+++ +V+L+G
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
C + +LV E G L+ +L + EE + +VS M YL +
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEI--PVSNVAELLHQVSMGMKYLEEKNFV-- 132
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSSQFT 272
HRD+ + N+LL +++ AK+SDFG S+ + D ++ T R G + + PE +F+
Sbjct: 133 -HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 273 EKSDVYSFGVVLVELLT-GQKP 293
+SDV+S+GV + E L+ GQKP
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKP 213
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 2e-40
Identities = 65/226 (28%), Positives = 113/226 (50%), Gaps = 17/226 (7%)
Query: 72 EGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNV 131
G++ F + + +G+G G V G G VAVK K +++
Sbjct: 2 GGSVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD-YRGNKVAVKCIK--NDATA 58
Query: 132 EQFINEVVILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWE 190
+ F+ E +++Q+ H N+V+LLG +E + L +V E++ G+L YL + + +
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGD 117
Query: 191 MRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250
L+ +++V AM YL + HRD+ + N+L+ + AKVSDFG ++
Sbjct: 118 CLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDNVAKVSDFGLTKEAS------ 168
Query: 251 TTRVQGTFGY--LDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+T+ G PE R +F+ KSDV+SFG++L E+ + G+ P
Sbjct: 169 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 2e-40
Identities = 61/205 (29%), Positives = 101/205 (49%), Gaps = 13/205 (6%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVK 151
+++G G G V G L VA+K K+ E F+ E I+ Q +H N+++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
L G +S+ ++V E++ NG+L +L +F T + + ++ M YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQF--TVIQLVGMLRGIASGMKYLSDMGY 168
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL--DPEYFRSS 269
+ HRD+ + NIL++ KVSDFG R ++ D T G PE
Sbjct: 169 V---HRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKP 293
+FT SDV+S+G+VL E+++ G++P
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 62/218 (28%), Positives = 104/218 (47%), Gaps = 27/218 (12%)
Query: 96 NRILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQINHRN 148
+R LGQG G VY+G+ VA+K +F+NE ++ + N +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYL-------HDQTEEFPITWEMRLRIAIEVSG 201
VV+LLG + + L++ E + G L YL + P + +++A E++
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
M+YL++ + HRD+ + N ++ + + K+ DFG +R I + +G G L
Sbjct: 150 GMAYLNANKFV---HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLL 202
Query: 262 -----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
PE + FT SDV+SFGVVL E+ T ++P
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 3e-40
Identities = 67/289 (23%), Positives = 121/289 (41%), Gaps = 54/289 (18%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV 149
++ ++G GG G V+K DG +K+ K N E+ EV L++++H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAEREVKALAKLDHVNI 66
Query: 150 VKLLGCCLESEVPL----------------LVYEFIPNGTLYHYLHDQTEEFPITWEMRL 193
V GC + + EF GTL ++ + E + + L
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE-KLDKVLAL 125
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
+ +++ + Y+HS + +RD+K SNI L D + K+ DFG ++K D T
Sbjct: 126 ELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR-TRS 181
Query: 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313
GT Y+ PE S + ++ D+Y+ G++L ELL A
Sbjct: 182 K-GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------------------AF 222
Query: 314 NEDRLFEVLEARVLKEG---KEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ F L ++ + KE+ ++ ++ L+ + RP+ E+
Sbjct: 223 ETSKFFTDLRDGIISDIFDKKEKTLL------QKLLSKKPEDRPNTSEI 265
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-40
Identities = 67/206 (32%), Positives = 104/206 (50%), Gaps = 18/206 (8%)
Query: 97 RILGQGGQGTVYKGMLADGGI----VAVKKSKL-VDESNVEQFINEVVILSQINHRNVVK 151
RILG+G G VY+G+ + VAVK K N E+F++E VI+ ++H ++VK
Sbjct: 18 RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
L+G E E ++ E P G L HYL + + ++++ AM+YL S
Sbjct: 78 LIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKV--LTLVLYSLQICKAMAYLESINC 134
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT---FGYLDPEYFRS 268
+ HRDI NIL+ K+ DFG SR I+ + + T ++ PE
Sbjct: 135 V---HRDIAVRNILVASPECVKLGDFGLSRYIEDED---YYKASVTRLPIKWMSPESINF 188
Query: 269 SQFTEKSDVYSFGVVLVELLT-GQKP 293
+FT SDV+ F V + E+L+ G++P
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-40
Identities = 67/246 (27%), Positives = 118/246 (47%), Gaps = 19/246 (7%)
Query: 54 MFFKKNGGLLLQQ--QLSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM 111
+ + L + + EG + F + + +G+G G V G
Sbjct: 154 EHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGD 213
Query: 112 LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL-LVYEFIP 170
G VAVK K +++ + F+ E +++Q+ H N+V+LLG +E + L +V E++
Sbjct: 214 Y-RGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 270
Query: 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY 230
G+L YL + + + L+ +++V AM YL + HRD+ + N+L+ +
Sbjct: 271 KGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEGNNFV---HRDLAARNVLVSEDN 326
Query: 231 RAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFRSSQFTEKSDVYSFGVVLVELL 288
AKVSDFG ++ +T+ G PE R +F+ KSDV+SFG++L E+
Sbjct: 327 VAKVSDFGLTKEAS------STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 380
Query: 289 T-GQKP 293
+ G+ P
Sbjct: 381 SFGRVP 386
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 8e-40
Identities = 56/200 (28%), Positives = 97/200 (48%), Gaps = 11/200 (5%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
+ LG G G V+ VAVK K +VE F+ E ++ + H +VKL
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216
+ + ++ EF+ G+L +L + + +++ M+++ I H
Sbjct: 253 TKEPI-YIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFSAQIAEGMAFIEQRNYI---H 307
Query: 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFRSSQFTEK 274
RD++++NIL+ K++DFG +R I+ ++ T R F PE FT K
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 275 SDVYSFGVVLVELLT-GQKP 293
SDV+SFG++L+E++T G+ P
Sbjct: 366 SDVWSFGILLMEIVTYGRIP 385
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-39
Identities = 61/205 (29%), Positives = 102/205 (49%), Gaps = 16/205 (7%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVK 151
R +G+G G V++G+ VA+K K +S E+F+ E + + Q +H ++VK
Sbjct: 21 RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
L+G E+ V ++ E G L +L Q ++ + + A ++S A++YL S
Sbjct: 81 LIGVITENPV-WIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYLESKRF 137
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF--GYLDPEYFRSS 269
+ HRDI + N+L+ K+ DFG SR ++ +G ++ PE
Sbjct: 138 V---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFR 192
Query: 270 QFTEKSDVYSFGVVLVELLT-GQKP 293
+FT SDV+ FGV + E+L G KP
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVKP 217
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 60/230 (26%), Positives = 102/230 (44%), Gaps = 14/230 (6%)
Query: 69 SSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVD 127
S+ EG+ E L + D +LG+G G VY G L++ +A+K+ D
Sbjct: 4 STEEGDCESDLLEYDYEY----DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD 59
Query: 128 ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPI 187
+ E+ + + H+N+V+ LG E+ + E +P G+L L +
Sbjct: 60 SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKD 119
Query: 188 TWEMRLR-IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTIKV 245
E + ++ + YLH I HRDIK N+L++ K+SDFG S+ +
Sbjct: 120 N-EQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 246 DQTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 293
T GT Y+ PE + + +D++S G ++E+ TG+ P
Sbjct: 176 INPCTET-FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-39
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 97 RILGQGGQGTVYKGMLADGGI--------VAVKKSKLVDESNVEQFINEVVILSQINHRN 148
LGQG ++KG+ + G V +K + E F ++S+++H++
Sbjct: 14 ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+V G C+ + +LV EF+ G+L YL I W+ L +A +++ AM +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAAMHFLEE 131
Query: 209 ATSIPIYHRDIKSSNILLDDKYR--------AKVSDFGASRTIKVDQTHLTTRVQGTFGY 260
T I H ++ + NILL + K+SD G S T+ + + L R+
Sbjct: 132 NTLI---HGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV--- 184
Query: 261 LDPE---YFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
PE + +D +SFG L E+ + G KP
Sbjct: 185 -PPECIENPK--NLNLATDKWSFGTTLWEICSGGDKP 218
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 66/221 (29%), Positives = 100/221 (45%), Gaps = 31/221 (14%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
LG+G G V+ + +VAVK K ES + F E +L+ + H+++V
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYL------------HDQTEEFPITWEMRLRIAIE 198
+ G C E L+V+E++ +G L +L + P+ L +A +
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF 258
V+ M YL + HRD+ + N L+ K+ DFG SR I RV G
Sbjct: 167 VAAGMVYLAGLHFV---HRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYRVGGR- 219
Query: 259 GYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
L PE +FT +SDV+SFGVVL E+ T G++P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-39
Identities = 55/207 (26%), Positives = 82/207 (39%), Gaps = 14/207 (6%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLV-DESNVEQFINEVVILSQINHRN 148
Y R++G+GG G VY+ IVA+K L D + E ++ +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
VV + + I L L + P+ + I ++ A+ H+
Sbjct: 96 VVPIHDFGEIDGQLYVDMRLINGVDLAAMLR---RQGPLAPPRAVAIVRQIGSALDAAHA 152
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT--RVQGTFGYLDPEYF 266
A HRD+K NIL+ A + DFG + LT GT Y+ PE F
Sbjct: 153 AG---ATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLYYMAPERF 207
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKP 293
S T ++D+Y+ VL E LTG P
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPP 234
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-39
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 13/202 (6%)
Query: 99 LGQGGQGTVYKGMLADGGI---VAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLG 154
LG G G+V +G+ VA+K K ++++ E+ + E I+ Q+++ +V+L+G
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPI 214
C + +LV E G L+ +L + EE P + +VS M YL +
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQVSMGMKYLEEKNFV-- 458
Query: 215 YHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY--LDPEYFRSSQFT 272
HR++ + N+LL +++ AK+SDFG S+ + D ++ T R G + PE +F+
Sbjct: 459 -HRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 273 EKSDVYSFGVVLVELLT-GQKP 293
+SDV+S+GV + E L+ GQKP
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKP 539
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-39
Identities = 62/222 (27%), Positives = 102/222 (45%), Gaps = 32/222 (14%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
R LG+G G V+ + +VAVK K + + F E +L+ + H ++V
Sbjct: 21 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYL-------------HDQTEEFPITWEMRLRIAI 197
K G C + + ++V+E++ +G L +L + + + L IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT 257
+++ M YL S + HRD+ + N L+ K+ DFG SR + + RV G
Sbjct: 141 QIASGMVYLASQHFV---HRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY---RVGGH 194
Query: 258 FGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
L PE +FT +SDV+SFGV+L E+ T G++P
Sbjct: 195 -TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 6e-39
Identities = 61/294 (20%), Positives = 113/294 (38%), Gaps = 46/294 (15%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRN 148
++ + LG+GG G V++ D A+K+ +L + E E+ + EV L+++ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 149 VVKLLGCCLE---------SEVPLLVY---EFIPNGTLYHYLHDQTEEFPITWEMRLRIA 196
+V+ LE S + +Y + L +++ + + L I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ- 255
++++ A+ +LHS + HRD+K SNI KV DFG + D+ T
Sbjct: 125 LQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 256 ----------GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSL 305
GT Y+ PE + ++ K D++S G++L ELL
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP--------------- 226
Query: 306 VGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
F M R + ++ ++ + L+ +RP +
Sbjct: 227 ---FSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 7e-39
Identities = 68/308 (22%), Positives = 123/308 (39%), Gaps = 69/308 (22%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN 148
++ +LGQG G V K D A+KK + E + ++EV++L+ +NH+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQY 63
Query: 149 VVKLLGCCLESEVPL-------------LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI 195
VV+ LE + + E+ NGTLY +H + + R+
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR--DEYWRL 121
Query: 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK----------- 244
++ A+SY+HS I HRD+K NI +D+ K+ DFG ++ +
Sbjct: 122 FRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 245 ---VDQTHLTTRVQGTFGYLDPEYFR-SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300
+LT+ + GT Y+ E + + EK D+YS G++ E++
Sbjct: 179 NLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP---------- 227
Query: 301 EDRSLVGFFLQAMNEDRLFEVLEARVLKE---------GKEEEIITVAMLGKRCLNMIGK 351
F M + + L + ++ E++II + ++
Sbjct: 228 --------FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKII------RLLIDHDPN 273
Query: 352 KRPSMKEV 359
KRP + +
Sbjct: 274 KRPGARTL 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 69/211 (32%), Positives = 99/211 (46%), Gaps = 16/211 (7%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLV-DESNVEQFINEVVILSQINHRN 148
Y ILG GG V+ L D VAVK ++ L D S +F E + +NH
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 149 VVKLL--GC--CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
+V + G +P +V E++ TL +H E P+T + + + + A++
Sbjct: 74 IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQALN 130
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT--RVQGTFGYLD 262
+ H I HRD+K +NI++ KV DFG +R I +T V GT YL
Sbjct: 131 FSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
PE R +SDVYS G VL E+LTG+ P
Sbjct: 188 PEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 49/206 (23%), Positives = 95/206 (46%), Gaps = 16/206 (7%)
Query: 96 NRILGQGGQGTVYKGM-LADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKL 152
+ +G+G TVYKG+ VA + + +S ++F E +L + H N+V+
Sbjct: 31 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 153 LGCCL---ESEVPLLVY-EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+ + +++ E + +GTL YL + ++ ++ + +LH+
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 209 ATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
+ PI HRD+K NI + K+ D G + + + V GT ++ PE +
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA---TLKRASFAKAVIGTPEFMAPEMYE 203
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKP 293
++ E DVY+FG+ ++E+ T + P
Sbjct: 204 E-KYDESVDVYAFGMCMLEMATSEYP 228
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 4e-38
Identities = 52/219 (23%), Positives = 94/219 (42%), Gaps = 20/219 (9%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
+Y + LG+GG V L DG A+K+ ++ + E+ E + NH N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 151 KLLGCCLESEVP----LLVYEFIPNGTLYHYL-HDQTEEFPITWEMRLRIAIEVSGAMSY 205
+L+ CL L+ F GTL++ + + + +T + L + + + +
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ--------GT 257
+H+ HRD+K +NILL D+ + + D G+ + + T
Sbjct: 150 IHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 258 FGYLDPEYF---RSSQFTEKSDVYSFGVVLVELLTGQKP 293
Y PE F E++DV+S G VL ++ G+ P
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGP 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 6e-38
Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 27/217 (12%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQINHRNV 149
R LG G G VY+G ++ VAVK + E + F+ E +I+S+ NH+N+
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYL----HDQTEEFPITWEMRLRIAIEVSGAMSY 205
V+ +G L+S ++ E + G L +L ++ + L +A +++ Y
Sbjct: 96 VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 206 LHSATSIPIYHRDIKSSNILLD---DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL- 261
L I HRDI + N LL AK+ DFG +R I R G L
Sbjct: 156 LEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---YYRKGGC-AMLP 208
Query: 262 ----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
PE F FT K+D +SFGV+L E+ + G P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQINHRNV 149
+ LG+G G V K VAVK K S + ++E +L Q+NH +V
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYL---------------------HDQTEEFPIT 188
+KL G C + LL+ E+ G+L +L D +E +T
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 189 WEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248
+ A ++S M YL + HRD+ + NIL+ + + K+SDFG SR + + +
Sbjct: 149 MGDLISFAWQISQGMQYLAEMKLV---HRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205
Query: 249 HLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ V+ + G + E +T +SDV+SFGV+L E++T G P
Sbjct: 206 Y----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-37
Identities = 46/209 (22%), Positives = 82/209 (39%), Gaps = 23/209 (11%)
Query: 93 YNANRILGQGGQGTVYKG--MLADGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNV 149
Y + GG G +Y +G V +K D + E L+++ H ++
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSI 141
Query: 150 VKLL-----GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
V++ V +V E++ +L + + +E+ A+S
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALS 196
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
YLHS + + D+K NI+L ++ + K+ D GA I + + GT G+ PE
Sbjct: 197 YLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGY---LYGTPGFQAPE 247
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
R+ T +D+Y+ G L L
Sbjct: 248 IVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 14/209 (6%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
+++ +LG+G VY+ + G VA+K K + V++ NEV I Q+ H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 147 RNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVSGAMS 204
++++L E + LV E NG + YL ++ + F E R + ++ M
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS---ENEARHFMHQIITGML 126
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
YLHS I HRD+ SN+LL K++DFG + +K+ T + GT Y+ PE
Sbjct: 127 YLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPE 182
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
S +SDV+S G + LL G+ P
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 4e-37
Identities = 74/297 (24%), Positives = 117/297 (39%), Gaps = 51/297 (17%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQINHRNV 149
R LG G G VY+G ++ VAVK + E + F+ E +I+S+ NH+N+
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYL----HDQTEEFPITWEMRLRIAIEVSGAMSY 205
V+ +G L+S ++ E + G L +L ++ + L +A +++ Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 206 LHSATSIPIYHRDIKSSNILLD---DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL- 261
L I HRDI + N LL AK+ DFG +R I R G L
Sbjct: 197 LEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---YYRKGGC-AMLP 249
Query: 262 ----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLV--GFFLQAMN 314
PE F FT K+D +SFGV+L E+ + G P S +E V G +
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK 309
Query: 315 E--DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
++ + M +C + RP+ + +E
Sbjct: 310 NCPGPVYRI------------------MT--QCWQHQPEDRPNFAIILERIEYCTQD 346
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-37
Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 12/203 (5%)
Query: 97 RILGQGGQGTVYKGMLADGG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVK 151
R +G+G G V++G+ VA+K K +S E+F+ E + + Q +H ++VK
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS 211
L+G E+ V ++ E G L +L Q +F + + A ++S A++YL S
Sbjct: 456 LIGVITENPV-WIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYLESKRF 512
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
+ HRDI + N+L+ K+ DFG SR ++ + ++ + ++ PE +F
Sbjct: 513 V---HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 272 TEKSDVYSFGVVLVELLT-GQKP 293
T SDV+ FGV + E+L G KP
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKP 592
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 7e-37
Identities = 54/219 (24%), Positives = 90/219 (41%), Gaps = 19/219 (8%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
Y R LG+GG ++ + A K KS L+ E+ E+ I + H
Sbjct: 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 100
Query: 147 RNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSGA 202
++VV G E + +V E +L + TE E R ++
Sbjct: 101 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 153
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
YLH + HRD+K N+ L++ K+ DFG + ++ D + GT Y+
Sbjct: 154 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIA 209
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
PE + + DV+S G ++ LL G+ P ++ +E
Sbjct: 210 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 248
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
+ + ILGQG V++G G + A+K + V+ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 147 RNVVKLLGC--CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
+N+VKL + +L+ EF P G+LY L + + + + L + +V G M+
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 205 YLHSATSIPIYHRDIKSSNILL----DDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260
+L I HR+IK NI+ D + K++DFGA+R ++ D + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEY 181
Query: 261 LDPEYFRSS--------QFTEKSDVYSFGVVLVELLTGQKP 293
L P+ + + ++ D++S GV TG P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 54/219 (24%), Positives = 89/219 (40%), Gaps = 19/219 (8%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
Y R LG+GG ++ + A K KS L+ E+ E+ I + H
Sbjct: 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAH 74
Query: 147 RNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSGA 202
++VV G E + +V E +L + TE E R ++
Sbjct: 75 QHVVGFHGF-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP-----EAR-YYLRQIVLG 127
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
YLH + HRD+K N+ L++ K+ DFG + ++ D GT Y+
Sbjct: 128 CQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC-GTPNYIA 183
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
PE + + DV+S G ++ LL G+ P ++ +E
Sbjct: 184 PEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE 222
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 70/225 (31%), Positives = 100/225 (44%), Gaps = 35/225 (15%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQI-NHRN 148
+ LG+G G V + VAVK K S ++E+ IL I +H N
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92
Query: 149 VVKLLGCCLESEVPLLV-YEFIPNGTLYHYL-------------HDQTEEFPITWEMRLR 194
VV LLG C + PL+V EF G L YL + + +T E +
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 195 IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254
+ +V+ M +L S I HRD+ + NILL +K K+ DFG +R I D + V
Sbjct: 153 YSFQVAKGMEFLASRKCI---HRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----V 205
Query: 255 QGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ L PE +T +SDV+SFGV+L E+ + G P
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 57/223 (25%), Positives = 102/223 (45%), Gaps = 33/223 (14%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQINHRNV 149
LG+ G VYKG L VA+K K + E+F +E ++ +++ H NV
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLH-------------DQTEEFPITWEMRLRIA 196
V LLG + + +++ + +G L+ +L D+T + + + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG 256
+++ M YL S + H+D+ + N+L+ DK K+SD G R + ++ G
Sbjct: 135 AQIAAGMEYLSSHHVV---HKDLATRNVLVYDKLNVKISDLGLFREV---YAADYYKLLG 188
Query: 257 TFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
L PE +F+ SD++S+GVVL E+ + G +P
Sbjct: 189 N-SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-36
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 97 RILGQGGQGTVYKGMLADGG--------IVAVKKSK-LVDESNVEQFINEVVILSQI-NH 146
+ LG+G G V VAVK K E ++ ++E+ ++ I H
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYL-------------HDQTEEFPITWEMRL 193
+N++ LLG C + ++ E+ G L YL ++ E +T++ +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
+++ M YL S I HRD+ + N+L+ + K++DFG +R I +
Sbjct: 161 SCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 213
Query: 254 VQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-36
Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 34/221 (15%)
Query: 97 RILGQGGQGTVYKGMLADGG---IVAVKKSK-LVDESNVEQFINEVVILSQI-NHRNVVK 151
++G+G G V K + G A+K+ K + + F E+ +L ++ +H N++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 152 LLGCCLESEVPLLVYEFIPNGTLYHYL-------------HDQTEEFPITWEMRLRIAIE 198
LLG C L E+ P+G L +L + ++ + L A +
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF 258
V+ M YL I HRD+ + NIL+ + Y AK++DFG SR +V V+ T
Sbjct: 151 VARGMDYLSQKQFI---HRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKTM 200
Query: 259 GYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
G L E S +T SDV+S+GV+L E+++ G P
Sbjct: 201 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-36
Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 36/226 (15%)
Query: 97 RILGQGGQGTVYKGMLADGG--------IVAVKKSK-LVDESNVEQFINEVVILSQI-NH 146
+ LG+G G V VAVK K E ++ ++E+ ++ I H
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYL-------------HDQTEEFPITWEMRL 193
+N++ LLG C + ++ E+ G L YL ++ E +T++ +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
+++ M YL S I HRD+ + N+L+ + K++DFG +R I +
Sbjct: 207 SCTYQLARGMEYLASQKCI---HRDLAARNVLVTENNVMKIADFGLARDINNIDYY---- 259
Query: 254 VQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ T G L PE +T +SDV+SFGV++ E+ T G P
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-36
Identities = 58/231 (25%), Positives = 102/231 (44%), Gaps = 41/231 (17%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQINHRNV 149
R +G+G G V++ +VAVK K F E ++++ ++ N+
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYL---------------------HDQTEEFPIT 188
VKLLG C + L++E++ G L +L P++
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 189 WEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248
+L IA +V+ M+YL + HRD+ + N L+ + K++DFG SR I
Sbjct: 173 CAEQLCIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229
Query: 249 HLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ + G + PE +++T +SDV+++GVVL E+ + G +P
Sbjct: 230 Y---KADGN-DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-36
Identities = 65/313 (20%), Positives = 122/313 (38%), Gaps = 44/313 (14%)
Query: 65 QQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVK--- 121
SS + F M ++ Y+ + +G GG V++ + I A+K
Sbjct: 4 HHHHSSGVDLGTENLYFQSMSVKG--RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVN 61
Query: 122 KSKLVDESNVEQFINEVVILSQINH--RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLH 179
+ D ++ + NE+ L+++ +++L + + +V E N L +L
Sbjct: 62 LEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLK 119
Query: 180 DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239
+ I R + A+ +H I H D+K +N L+ D K+ DFG
Sbjct: 120 KKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGI 172
Query: 240 SRTIKVDQT--HLTTRVQGTFGYLDPE-----------YFRSSQFTEKSDVYSFGVVLVE 286
+ ++ D T ++V GT Y+ PE S+ + KSDV+S G +L
Sbjct: 173 ANQMQPDTTSVVKDSQV-GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYY 231
Query: 287 LLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCL 346
+ G+ P + + + L A+ + K+ ++ + K CL
Sbjct: 232 MTYGKTPFQQIINQISK------LHAIIDPNHEIEFPDIPEKDLQD--------VLKCCL 277
Query: 347 NMIGKKRPSMKEV 359
K+R S+ E+
Sbjct: 278 KRDPKQRISIPEL 290
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-36
Identities = 59/221 (26%), Positives = 101/221 (45%), Gaps = 25/221 (11%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
+ + ILGQG V++G G + A+K + V+ + E +L ++NH
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNH 66
Query: 147 RNVVKLLGC--CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
+N+VKL + +L+ EF P G+LY L + + + + L + +V G M+
Sbjct: 67 KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 205 YLHSATSIPIYHRDIKSSNILL----DDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260
+L I HR+IK NI+ D + K++DFGA+R ++ D + GT Y
Sbjct: 127 HLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLY-GTEEY 181
Query: 261 LDPEYFRSS--------QFTEKSDVYSFGVVLVELLTGQKP 293
L P+ + + ++ D++S GV TG P
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 7e-36
Identities = 52/238 (21%), Positives = 91/238 (38%), Gaps = 20/238 (8%)
Query: 64 LQQQLSSNEGNIEKTKLF-TKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK 121
L + NEG + KL + + +G+G G V++ G AVK
Sbjct: 30 LGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVK 89
Query: 122 KSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ 181
K V E+V + ++ +V L G E + E + G+ L
Sbjct: 90 K---VRLEVFRV--EELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS----LGQL 140
Query: 182 TEEFPITWEMRLR-IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDFGA 239
++ E R + + YLH+ + H D+K+ N+LL RA + DFG
Sbjct: 141 IKQMGCLPEDRALYYLGQALEGLEYLHTRRIL---HGDVKADNVLLSSDGSRAALCDFGH 197
Query: 240 SRTIKVDQTHLTTR----VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ ++ D + + GT ++ PE K D++S +++ +L G P
Sbjct: 198 ALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 9e-36
Identities = 54/274 (19%), Positives = 100/274 (36%), Gaps = 33/274 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQI-NH 146
++ LG G G V+K DG + AVK+S + + + EV ++ H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR-IAIEVSGAMSY 205
V+L E + L E +L + P E ++ + A+++
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLP---EAQVWGYLRDTLLALAH 172
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LHS + H D+K +NI L + R K+ DFG + +G Y+ PE
Sbjct: 173 LHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPEL 227
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325
+ + +DV+S G+ ++E+ + + Q + + L A
Sbjct: 228 LQ-GSYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPPEFTAG 276
Query: 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ E + + L K R + + +
Sbjct: 277 LSSELRS--------VLVMMLEPDPKLRATAEAL 302
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 9e-36
Identities = 68/216 (31%), Positives = 102/216 (47%), Gaps = 15/216 (6%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
+++ R LG+G G VY I+A+K K++L Q EV I S + H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR-IAIEVSGAMSY 205
N+++L G ++ L+ E+ P GT+Y L + +F E R E++ A+SY
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTVYREL-QKLSKFD---EQRTATYITELANALSY 124
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
HS + HRDIK N+LL K++DFG S + + T GT YL PE
Sbjct: 125 CHSKR---VIHRDIKPENLLLGSAGELKIADFGWS--VHAPSSRRTDLC-GTLDYLPPEM 178
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
EK D++S GV+ E L G+ P + +E
Sbjct: 179 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-35
Identities = 60/221 (27%), Positives = 97/221 (43%), Gaps = 16/221 (7%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKK-SKLVDESNVEQFINEVVILSQI 144
+ + LG GG G V + + G VA+K+ + + N E++ E+ I+ ++
Sbjct: 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL 69
Query: 145 NHRNVVKLL------GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIE 198
NH NVV +++PLL E+ G L YL+ + + +
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLD---DKYRAKVSDFGASRTIKVDQTHLTTRVQ 255
+S A+ YLH I HRD+K NI+L + K+ D G ++ + T V
Sbjct: 130 ISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV- 184
Query: 256 GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 296
GT YL PE ++T D +SFG + E +TG +P
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 2e-35
Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 36/227 (15%)
Query: 96 NRILGQGGQGTVYKGMLADGG--------IVAVKKSK-LVDESNVEQFINEVVILSQI-N 145
+ LG+G G V VAVK K E ++ I+E+ ++ I
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYL-------------HDQTEEFPITWEMR 192
H+N++ LLG C + ++ E+ G L YL E ++ +
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT 252
+ A +V+ M YL S I HRD+ + N+L+ + K++DFG +R I +
Sbjct: 194 VSCAYQVARGMEYLASKKCI---HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--- 247
Query: 253 RVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ T G L PE +T +SDV+SFGV+L E+ T G P
Sbjct: 248 -KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-35
Identities = 65/226 (28%), Positives = 99/226 (43%), Gaps = 36/226 (15%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQI-NHRN 148
+ LG G G V + VAVK K + E ++E+ +LS + NH N
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYL---------------HDQTEEFPITWEMRL 193
+V LLG C L++ E+ G L ++L + +E + E L
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
+ +V+ M++L S I HRD+ + NILL K+ DFG +R IK D +
Sbjct: 149 SFSYQVAKGMAFLASKNCI---HRDLAARNILLTHGRITKICDFGLARDIKNDSNY---- 201
Query: 254 VQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
V L PE + +T +SDV+S+G+ L EL + G P
Sbjct: 202 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 62/285 (21%), Positives = 113/285 (39%), Gaps = 40/285 (14%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQINH--R 147
Y+ + +G GG V++ + I A+K L D ++ + NE+ L+++
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
+++L + + +V E N L +L + I R + A+ +H
Sbjct: 70 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH 125
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT--HLTTRVQGTFGYLDPE- 264
I H D+K +N L+ D K+ DFG + ++ D T ++V GT Y+ PE
Sbjct: 126 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GTVNYMPPEA 180
Query: 265 ----------YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314
S+ + KSDV+S G +L + G+ P F
Sbjct: 181 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQ 226
Query: 315 EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+L +++ E + + + K CL K+R S+ E+
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 58/234 (24%), Positives = 92/234 (39%), Gaps = 56/234 (23%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQI-NHRN 148
+ LG G G V + G VAVK K E ++E+ I+S + H N
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD-----------QTEEFPITWEMRLRIAI 197
+V LLG C L++ E+ G L ++L + L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT 257
+V+ M++L S I HRD+ + N+LL + + AK+ DFG +R I
Sbjct: 172 QVAQGMAFLASKNCI---HRDVAARNVLLTNGHVAKIGDFGLARDI-------------- 214
Query: 258 FGYLDPEYFRSSQ-----------------FTEKSDVYSFGVVLVELLT-GQKP 293
D Y +T +SDV+S+G++L E+ + G P
Sbjct: 215 --MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 67/212 (31%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
D+++ R LG+G G VY LA + I+A+K KS+L E Q E+ I S
Sbjct: 14 DDFDIGRPLGKGKFGNVY---LAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSH 70
Query: 144 INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLR-IAIEVSG 201
+ H N++++ + L+ EF P G LY L + F E R E++
Sbjct: 71 LRHPNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQ-KHGRFD---EQRSATFMEELAD 125
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
A+ Y H + HRDIK N+L+ K K++DFG S + T + GT YL
Sbjct: 126 ALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWS--VHAPSLRRRT-MCGTLDYL 179
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
PE EK D++ GV+ E L G P
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-34
Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 26/219 (11%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQINH--R 147
Y+ + +G GG V++ + I A+K L D ++ + NE+ L+++
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
+++L + + +V E N L +L + I R + A+ +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIH 172
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT--HLTTRVQGTFGYLDPE- 264
I H D+K +N L+ D K+ DFG + ++ D T ++V G Y+ PE
Sbjct: 173 QHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV-GAVNYMPPEA 227
Query: 265 ----------YFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
S+ + KSDV+S G +L + G+ P
Sbjct: 228 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-34
Identities = 63/231 (27%), Positives = 102/231 (44%), Gaps = 41/231 (17%)
Query: 97 RILGQGGQGTVYKGMLADGG------IVAVKKSK-LVDESNVEQFINEVVILSQI-NHRN 148
++LG G G V VAVK K D S E ++E+ +++Q+ +H N
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYL--------------------HDQTEEFPIT 188
+V LLG C S L++E+ G L +YL ++ + +T
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 189 WEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248
+E L A +V+ M +L + + HRD+ + N+L+ K+ DFG +R I D
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCV---HRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227
Query: 249 HLTTRVQGTFGYL-----DPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
+ V L PE +T KSDV+S+G++L E+ + G P
Sbjct: 228 Y----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-33
Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 31/289 (10%)
Query: 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKG-MLADGGIVAVK---KSKLVDESNVEQF 134
+F + +D Y R+LG+G G V G AVK K ++ +++ E
Sbjct: 14 GMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESL 73
Query: 135 INEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR 194
+ EV +L Q++H N++KL + LV E G L+ + + R
Sbjct: 74 LREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI---ISRKRFSEVDAAR 130
Query: 195 IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSDFGASRTIKVDQTHLT 251
I +V ++Y+H I HRD+K N+LL+ K ++ DFG S + + +
Sbjct: 131 IIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK-MK 186
Query: 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQ 311
++ GT Y+ PE + + EK DV+S GV+L LL+G P + +
Sbjct: 187 DKI-GTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFN------GANEYDILKK 238
Query: 312 AMNEDRLFEVLE-ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
FE+ + +V + K+ L ++ L + R S ++
Sbjct: 239 VEKGKYTFELPQWKKVSESAKD--------LIRKMLTYVPSMRISARDA 279
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 1e-32
Identities = 64/281 (22%), Positives = 114/281 (40%), Gaps = 37/281 (13%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVV 150
++ +LG G +GT+ + D VAVK+ + EV +L + + H NV+
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKR---ILPECFSFADREVQLLRESDEHPNVI 81
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+ + + + E TL Y+ + ++F + + + + +++LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYV--EQKDFAHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 211 SIPIYHRDIKSSNILLDDK-----YRAKVSDFGASRTIKVDQTHLTTR--VQGTFGYLDP 263
I HRD+K NIL+ +A +SDFG + + V + + R V GT G++ P
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 264 EYFRSSQF---TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320
E T D++S G V +++ F + +
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--------------PF-GKSLQRQANI 240
Query: 321 VLEARVLKEGKEEEIITVAM--LGKRCLNMIGKKRPSMKEV 359
+L A L E+ V L ++ + M +KRPS K V
Sbjct: 241 LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 2e-32
Identities = 44/255 (17%), Positives = 84/255 (32%), Gaps = 29/255 (11%)
Query: 64 LQQQLSSNEGNIEKT----KLFTKMDLEKATDNYNANRILGQGGQGTVYKGM------LA 113
L + +SS E + K + + + + +LG+G VY+
Sbjct: 34 LSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAK 93
Query: 114 DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGT 173
+ +K K + + L +K L +LV E GT
Sbjct: 94 NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153
Query: 174 LYHYLHD--QTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR 231
L + ++ T E + + + A+ + + +H I H DIK N +L + +
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFL 210
Query: 232 A-----------KVSDFGASRTIKV--DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVY 278
+ D G S +K+ T T + T G+ E + + + D +
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC-ETSGFQCVEMLSNKPWNYQIDYF 269
Query: 279 SFGVVLVELLTGQKP 293
+ +L G
Sbjct: 270 GVAATVYCMLFGTYM 284
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 124 bits (311), Expect = 5e-32
Identities = 36/298 (12%), Positives = 70/298 (23%), Gaps = 50/298 (16%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKL 152
L G + V+ + A+K S +E+ +++ + +
Sbjct: 68 EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127
Query: 153 LGCCLESEVP--------------------------LLVYEFIP--NGTLYHYLHD-QTE 183
LL+ L+ L
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187
Query: 184 EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243
+ ++ + L S + H N+ + R + D A +
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244
Query: 244 KVDQTHLTTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
Y E+ +S FT + + G+ + + P
Sbjct: 245 ----GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300
Query: 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
S L+ D L + K +I R LN ++R E
Sbjct: 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVK--TLI------GRFLNFDRRRRLLPLEA 350
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 9e-32
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 9/205 (4%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN 148
++ +G+G G V G VAVK L + E NEVVI+ H N
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
VV++ L E ++ EF+ G L D + + E + V A++YLH+
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHA 159
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS 268
I HRDIKS +ILL R K+SDFG I D + V GT ++ PE
Sbjct: 160 QGVI---HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISR 215
Query: 269 SQFTEKSDVYSFGVVLVELLTGQKP 293
S + + D++S G++++E++ G+ P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 9/205 (4%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN 148
Y +GQG GTVY M +A G VA+++ L + E INE++++ + + N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+V L L + +V E++ G+L D E + + E A+ +LHS
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHS 134
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS 268
I HRDIKS NILL K++DFG I +Q+ +T V GT ++ PE
Sbjct: 135 NQVI---HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTR 190
Query: 269 SQFTEKSDVYSFGVVLVELLTGQKP 293
+ K D++S G++ +E++ G+ P
Sbjct: 191 KAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-31
Identities = 48/229 (20%), Positives = 91/229 (39%), Gaps = 33/229 (14%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQI-N 145
T ++ +G G G+V+K + DG I A+K+SK + + + EV + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLR-IAIEVSGAMS 204
H +VV+ E + L+ E+ G+L + + E L+ + ++V +
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLR 129
Query: 205 YLHSATSIPIYHRDIKSSNILLD-------------------DKYRAKVSDFGASRTIKV 245
Y+HS + + H DIK SNI + +K K+ D G I
Sbjct: 130 YIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186
Query: 246 DQTHLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKP 293
Q +G +L E + + K+D+++ + +V +
Sbjct: 187 PQV-----EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 72/315 (22%), Positives = 120/315 (38%), Gaps = 49/315 (15%)
Query: 65 QQQLSSNEGNIEKTK-------LFTKMDLEKATDNYNANRILGQGGQGTVYKG-MLADGG 116
SS N+ +F ++ Y + LG G G V
Sbjct: 4 HHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHV 63
Query: 117 IVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGT 173
A+K K+ + + + + EV +L ++H N++KL + LV E G
Sbjct: 64 ERAIKIIRKTSVSTS-SNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGE 122
Query: 174 LYHYLHDQ---TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK- 229
L+ + + E I +V ++YLH I HRD+K N+LL+ K
Sbjct: 123 LFDEIIHRMKFNE------VDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKE 173
Query: 230 --YRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVEL 287
K+ DFG S + + + R+ GT Y+ PE R + EK DV+S GV+L L
Sbjct: 174 KDALIKIVDFGLSAVFENQKK-MKERL-GTAYYIAPEVLRKK-YDEKCDVWSIGVILFIL 230
Query: 288 LTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE-VLEARVLKEGKEEEIITVA--MLGKR 344
L G P F + + V + + + E + ++ L K+
Sbjct: 231 LAGYPP--------------FG--GQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 345 CLNMIGKKRPSMKEV 359
L ++R S ++
Sbjct: 275 MLQFDSQRRISAQQA 289
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 62/256 (24%), Positives = 110/256 (42%), Gaps = 37/256 (14%)
Query: 65 QQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLA--DGGIVAVK- 121
+ + SN N+ + K + +K ++Y R L QG + L D A+K
Sbjct: 6 MKDILSNYSNLIYLNKYVK-EKDKYINDYRIIRTLNQGKFNKII---LCEKDNKFYALKK 61
Query: 122 --KSKLV--------------DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL-L 164
KS L +S + F NE+ I++ I + + G + + + +
Sbjct: 62 YEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI-ITNYDEVYI 120
Query: 165 VYEFIPNGTLYHYLH-----DQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDI 219
+YE++ N ++ + D+ I ++ I V + SY+H+ +I HRD+
Sbjct: 121 IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNI--CHRDV 178
Query: 220 KSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT--EKSDV 277
K SNIL+D R K+SDFG S + + GT+ ++ PE+F + K D+
Sbjct: 179 KPSNILMDKNGRVKLSDFGESEY--MVDKKIKGSR-GTYEFMPPEFFSNESSYNGAKVDI 235
Query: 278 YSFGVVLVELLTGQKP 293
+S G+ L + P
Sbjct: 236 WSLGICLYVMFYNVVP 251
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 64/298 (21%), Positives = 117/298 (39%), Gaps = 48/298 (16%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNV 149
+ + +ILG G GTV G VAVK+ + + + E+ +L++ +H NV
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKR---MLIDFCDIALMEIKLLTESDDHPNV 71
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYL---HDQTEEFPITWEMRLRIAI-EVSGAMSY 205
++ + E N L + + E + E + +++ +++
Sbjct: 72 IRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 206 LHSATSIPIYHRDIKSSNILLDDK-------------YRAKVSDFGASRTIKVDQTHLTT 252
LH S+ I HRD+K NIL+ R +SDFG + + Q+ T
Sbjct: 131 LH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 253 RVQ---GTFGYLDPEYFRSSQF-------TEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301
+ GT G+ PE S T D++S G V +L+ G+ P + E
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ G F + D + + + ++ E + L + ++ KRP+ +V
Sbjct: 248 SNIIRGIF----SLDEMKCLHDRSLIAEATD--------LISQMIDHDPLKRPTAMKV 293
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 77/303 (25%), Positives = 122/303 (40%), Gaps = 51/303 (16%)
Query: 80 LFTKMDLEKATDNYNANRILGQGGQGTVYKG-MLADGGIVAVK---KSKLVD-------- 127
++ + K ++Y R LG G G V A+K KS+
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 128 --ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---T 182
E E+ NE+ +L ++H N++KL + + LV EF G L+ + ++
Sbjct: 85 NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 183 EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSDFGA 239
E + I ++ + YLH I HRDIK NILL++K K+ DFG
Sbjct: 145 EC-----DAA-NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGL 195
Query: 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
S D L R+ GT Y+ PE + + EK DV+S GV++ LL G P
Sbjct: 196 SSFFSKDYK-LRDRL-GTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPP------ 246
Query: 300 EEDRSLVGFFLQAMNEDRLFE-VLEARVLKEGKEEEIITVAM--LGKRCLNMIGKKRPSM 356
F N+ + + V + + + + + I+ L K L KR +
Sbjct: 247 --------FG--GQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTA 296
Query: 357 KEV 359
+E
Sbjct: 297 EEA 299
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-30
Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 15/208 (7%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN 148
+ ++ LG+G G+VYK + G IVA+K+ + ES++++ I E+ I+ Q + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPV--ESDLQEIIKEISIMQQCDSPH 85
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGT---LYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
VVK G ++ +V E+ G+ + + E I ++ + Y
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQ-----STLKGLEY 140
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LH I HRDIK+ NILL+ + AK++DFG + + T + GT ++ PE
Sbjct: 141 LHFMRKI---HRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPEV 196
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ + +D++S G+ +E+ G+ P
Sbjct: 197 IQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-30
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 12/207 (5%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL-VDESNVEQFINEVVILSQINHR 147
+ + +G+G G V+KG+ +VA+K L E +E E+ +LSQ +
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYL 206
V K G L+ ++ E++ G+ L +E I +R E+ + YL
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILR-----EILKGLDYL 135
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
HS I HRDIK++N+LL + K++DFG + + Q T V GT ++ PE
Sbjct: 136 HSEKKI---HRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ S + K+D++S G+ +EL G+ P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-30
Identities = 52/225 (23%), Positives = 90/225 (40%), Gaps = 24/225 (10%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNV 149
R+L +GG VY+ + G A+K+ +E I EV + ++ H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 150 VKLLGCCLESEVP-------LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA 202
V+ + L+ + G L +L P++ + L+I + A
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ------- 255
+ ++H PI HRD+K N+LL ++ K+ DFG++ TI + + +
Sbjct: 149 VQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207
Query: 256 ----GTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVELLTGQKP 293
T Y PE EK D+++ G +L L Q P
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-30
Identities = 76/308 (24%), Positives = 125/308 (40%), Gaps = 50/308 (16%)
Query: 65 QQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKG-MLADGGIVAVK-- 121
SS N+ F + YN +LG+G G V K AVK
Sbjct: 4 HHHHSSGRENLYFQGTFA--------ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVI 55
Query: 122 -KSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD 180
K+ ++ + + EV +L +++H N++KL +S +V E G L+ +
Sbjct: 56 NKASAKNK-DTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIK 114
Query: 181 Q---TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKV 234
+ +E RI +V ++Y+H I HRD+K NILL+ K K+
Sbjct: 115 RKRFSE------HDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKI 165
Query: 235 SDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
DFG S + + + R+ GT Y+ PE R + + EK DV+S GV+L LL+G P
Sbjct: 166 IDFGLSTCFQQNTK-MKDRI-GTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPP- 221
Query: 295 RSTDAEEDRSLVGFFLQAMNEDRLFE-VLEARVLKEGKEEEIITVA--MLGKRCLNMIGK 351
F+ NE + + V + + + I+ L ++ L
Sbjct: 222 -------------FY--GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPS 266
Query: 352 KRPSMKEV 359
R + +
Sbjct: 267 LRITATQC 274
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-29
Identities = 41/293 (13%), Positives = 84/293 (28%), Gaps = 59/293 (20%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQ--------- 143
+LGQ + G V ++ + ++Q EV+ L
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 144 -------------INHRNVVKLLGCCLESEVPLLVYEFIP-------NGTLYHYLHDQ-T 182
+ K++ L+ ++ F T L +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 183 EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242
+ RL++ ++V ++ LH + H ++ +I+LD + ++ F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQ-----FTEKSDVYSFGVVLVELLTGQKPIRST 297
R Q T D ++ G+ + + P
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD 320
Query: 298 DAEED---------------RSLVGFFLQAMNEDRL--FEVLEARVLKEGKEE 333
A R+L+ FL+ EDRL + +E ++ + E
Sbjct: 321 AALGGSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE 373
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN 148
+ + LG G G VYK G + A K + E +E +I E+ IL+ +H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGT---LYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
+VKLLG ++ EF P G + L E I R ++ A+++
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCR-----QMLEALNF 132
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE- 264
LHS I HRD+K+ N+L+ + +++DFG S + + GT ++ PE
Sbjct: 133 LHSKRII---HRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188
Query: 265 ----YFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ + + K+D++S G+ L+E+ + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 1e-28
Identities = 72/296 (24%), Positives = 123/296 (41%), Gaps = 23/296 (7%)
Query: 65 QQQLSSNEGNI---EKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGG-IVAV 120
+QQ E + +K D EK LG G G V+K G ++A
Sbjct: 11 EQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLVMAR 63
Query: 121 KKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLH 179
K L + + Q I E+ +L + N +V G + E + G+L L
Sbjct: 64 KLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 123
Query: 180 DQTEEFPITWEMRL-RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238
+ P E L +++I V ++YL I HRD+K SNIL++ + K+ DFG
Sbjct: 124 -KAGRIP---EQILGKVSIAVIKGLTYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFG 177
Query: 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298
S ++ + + V GT Y+ PE + + ++ +SD++S G+ LVE+ G+ PI D
Sbjct: 178 VSG--QLIDSMANSFV-GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234
Query: 299 AEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP 354
A+E + G ++ + + + + L+ I + P
Sbjct: 235 AKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL-LDYIVNEPP 289
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-28
Identities = 45/221 (20%), Positives = 81/221 (36%), Gaps = 25/221 (11%)
Query: 90 TDNYNANRILGQGGQ--GTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQI 144
Y ++G+G + TV G V V++ L V E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYH----YLHDQTEEFPITWEMRLRIAIEVS 200
NH N+V + +V F+ G+ + D E I + ++ V
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ-----GVL 138
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ----- 255
A+ Y+H + HR +K+S+IL+ + +S ++ ++
Sbjct: 139 KALDYIHHMGYV---HRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYS 195
Query: 256 -GTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 293
+L PE + + + KSD+YS G+ EL G P
Sbjct: 196 VKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-28
Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 15/215 (6%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL-VDESNVEQFINEVVILSQINHRN 148
D+Y ++G G V VA+K+ L ++++++ + E+ +SQ +H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYH-YLHDQTEEFPITWEMR-LRIAI---EVSGAM 203
+V + + LV + + G++ H + + + IA EV +
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF-G--- 259
YLH I HRD+K+ NILL + +++DFG S + +V+ TF G
Sbjct: 135 EYLHKNGQI---HRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191
Query: 260 YLDPEYF-RSSQFTEKSDVYSFGVVLVELLTGQKP 293
++ PE + + K+D++SFG+ +EL TG P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-27
Identities = 56/232 (24%), Positives = 93/232 (40%), Gaps = 16/232 (6%)
Query: 80 LFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDES--NVEQ 133
L D D Y ++G+G V + + G AVK +K + E
Sbjct: 13 LDMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTED 72
Query: 134 FINEVVILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMR 192
E I + H ++V+LL S+ L +V+EF+ L + + + + E
Sbjct: 73 LKREASICHMLKHPHIVELLETY-SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAV 131
Query: 193 LRIAI-EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIKVDQT 248
+ ++ A+ Y H I HRD+K +LL K + K+ FG + +
Sbjct: 132 ASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL 188
Query: 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300
RV GT ++ PE + + + DV+ GV+L LL+G P T
Sbjct: 189 VAGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER 239
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-27
Identities = 56/213 (26%), Positives = 88/213 (41%), Gaps = 22/213 (10%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDES---NVEQFINEVVILSQIN 145
++ R +G G G VY + + +VA+KK + + I EV L ++
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNG--TLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
H N ++ GC L LV E+ L +E I +
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH-----GALQGL 167
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
+YLHS I HRD+K+ NILL + K+ DFG++ + + V GT ++ P
Sbjct: 168 AYLHSHNMI---HRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFV-GTPYWMAP 219
Query: 264 E---YFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
E Q+ K DV+S G+ +EL + P
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-27
Identities = 30/242 (12%), Positives = 72/242 (29%), Gaps = 53/242 (21%)
Query: 97 RILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQI-------- 144
+LGQ + G V ++ + ++Q EV+ L +
Sbjct: 79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 145 -----------------NHRNVVKLLGCCLESEVPLLVYEF-IPNGTLYHYL----HDQT 182
+ ++++ + V + + L + +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 183 EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242
+ RL++ ++V ++ LH + H ++ +I+LD + ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 243 IKVDQTHLTTRVQGTFGYLDPEYF-----------RSSQFTEKSDVYSFGVVLVELLTGQ 291
+ G+ PE R + T D ++ G+V+ +
Sbjct: 256 DGARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
Query: 292 KP 293
P
Sbjct: 311 LP 312
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-27
Identities = 66/217 (30%), Positives = 107/217 (49%), Gaps = 20/217 (9%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVI 140
D + NY + +G+G V + G VA+K K++L + +++++ EV I
Sbjct: 9 DEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRI 67
Query: 141 LSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYL--HDQTEEFPITWEMRLRIAI 197
+ +NH N+VKL +E+E L L+ E+ G ++ YL H + +E E R
Sbjct: 68 MKILNHPNIVKLFEV-IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK----EAR-SKFR 121
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT 257
++ A+ Y H I HRD+K+ N+LLD K++DFG S V L G
Sbjct: 122 QIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-KLDAFC-GA 176
Query: 258 FGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKP 293
Y PE F+ ++ + DV+S GV+L L++G P
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 36/277 (12%), Positives = 78/277 (28%), Gaps = 55/277 (19%)
Query: 99 LGQGGQGTVYKGMLAD---GGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKL 152
G ++ + D VA+ ++ + +++ ++ + LS+I+ V ++
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSI 212
L L+V E+I G+L + +R ++ A H A
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVADT-----SPSPVGAIRAMQSLAAAADAAHRA--- 148
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT 272
+ S + + + +
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVL---------------------AYPATMPDA-------N 180
Query: 273 EKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332
+ D+ G L LL + P+ L D + +E +
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSG-------LAPAERDTAGQPIEPADIDRDIP 233
Query: 333 EEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
+I VA R + G R + + ++ A
Sbjct: 234 FQISAVAA---RSVQGDGGIRSAS-TLLNLMQQATAV 266
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-27
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 19/209 (9%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVKKSKL-VDESNVEQFINEV-VILSQINHRNVVKLLGC 155
LG+G G V K G I+AVK+ + V+ ++ + ++ + + ++ V G
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 156 CL-ESEVPLLVYEFIPNGT--LYHYLHDQTEEFPITWEMRL-RIAIEVSGAMSYLHSATS 211
E +V + E + Y + D+ + P E L +IA+ + A+ +LHS S
Sbjct: 75 LFREGDV-WICMELMDTSLDKFYKQVIDKGQTIP---EDILGKIAVSIVKALEHLHSKLS 130
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE----YFR 267
+ I HRD+K SN+L++ + K+ DFG S + VD G Y+ PE
Sbjct: 131 V-I-HRDVKPSNVLINALGQVKMCDFGISGYL-VDDVAKDIDA-GCKPYMAPERINPELN 186
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRS 296
++ KSD++S G+ ++EL + P S
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYDS 215
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 55/222 (24%), Positives = 88/222 (39%), Gaps = 30/222 (13%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLV-----DESNVEQFINEVVI 140
D Y ++ LG G G V VA++ K K + E+ I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 141 LSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAI 197
L ++NH ++K+ + +V E + G L+ + E +
Sbjct: 194 LKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEA-----TCK-LYFY 246
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSDFGASRTIKVDQTHLTTRV 254
++ A+ YLH I HRD+K N+LL + K++DFG S+ + + + + T
Sbjct: 247 QMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMRTLC 302
Query: 255 QGTFGYLDPEYFRSSQF---TEKSDVYSFGVVLVELLTGQKP 293
GT YL PE S D +S GV+L L+G P
Sbjct: 303 -GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 2e-26
Identities = 71/280 (25%), Positives = 120/280 (42%), Gaps = 36/280 (12%)
Query: 90 TDNYNANRILGQGGQGTVYKG-MLADGGIVAVK---KSKLVDESNVEQFINEVVILSQIN 145
+ YN +LG+G G V K AVK K+ ++ + + EV +L +++
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNK-DTSTILREVELLKKLD 79
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
H N++KL +S +V E G L+ + + + RI +V ++Y
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGELFDEI---IKRKRFSEHDAARIIKQVFSGITY 136
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
+H I HRD+K NILL+ K + K+ DFG S + + + R+ GT Y+
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK-MKDRI-GTAYYIA 191
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE-V 321
PE R + + EK DV+S GV+L LL+G P F+ NE + + V
Sbjct: 192 PEVLRGT-YDEKCDVWSAGVILYILLSGTPP--------------FY--GKNEYDILKRV 234
Query: 322 LEARVLKEGKEEEIITVA--MLGKRCLNMIGKKRPSMKEV 359
+ + + I+ L ++ L R + +
Sbjct: 235 ETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 55/214 (25%), Positives = 96/214 (44%), Gaps = 22/214 (10%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQIN 145
+DNY+ LG+G V + + G A K KL + ++ E I ++
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQ 63
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSGA 202
H N+V+L E LV++ + G L+ + + +E + ++ +
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEA-----DAS-HCIQQILES 117
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIKVDQTHLTTRVQGTFG 259
++Y HS I HR++K N+LL K + K++DFG + + D GT G
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN-DSEAWHGFA-GTPG 172
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
YL PE + +++ D+++ GV+L LL G P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-26
Identities = 61/237 (25%), Positives = 95/237 (40%), Gaps = 24/237 (10%)
Query: 65 QQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKG-MLADGGIVAVK-- 121
SS N+ D + R LG G G V+ + G +K
Sbjct: 4 HHHHSSGRENLYFQGTID--------DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTI 55
Query: 122 -KSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD 180
K + + +EQ E+ +L ++H N++K+ + +V E G L +
Sbjct: 56 NKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS 113
Query: 181 QTEEFPITWEMR-LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSD 236
E + ++ A++Y HS + H+D+K NIL D K+ D
Sbjct: 114 AQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIID 170
Query: 237 FGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
FG + K D+ T GT Y+ PE F+ T K D++S GVV+ LLTG P
Sbjct: 171 FGLAELFKSDEH-STNAA-GTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-26
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 19/214 (8%)
Query: 97 RILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNV 149
+ILG+G TV +LA A+K K ++ E+ V E ++S+++H
Sbjct: 36 KILGEGSFSTV---VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 92
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHS 208
VKL + E + NG L Y+ + F E R E+ A+ YLH
Sbjct: 93 VKLYFTFQDDEKLYFGLSYAKNGELLKYIR-KIGSFD---ETCTRFYTAEIVSALEYLHG 148
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFG-ASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
I HRD+K NILL++ +++DFG A + GT Y+ PE
Sbjct: 149 KG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ SD+++ G ++ +L+ G P R+ +
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-26
Identities = 57/219 (26%), Positives = 104/219 (47%), Gaps = 11/219 (5%)
Query: 91 DNYNANRILGQGGQGTVYKGMLAD-GGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
D + R+LG+GG G V+ + G + A K K +L + + E IL++++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 147 RNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMS 204
R +V L E++ L LV + G + +++++ E+ P E R ++ +
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
+LH I +RD+K N+LLDD ++SD G + +K QT GT G++ PE
Sbjct: 304 HLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
++ D ++ GV L E++ + P R+ + +
Sbjct: 360 LLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 7e-26
Identities = 61/286 (21%), Positives = 107/286 (37%), Gaps = 44/286 (15%)
Query: 87 EKATDNYNANRILGQGGQGTVYKG-MLADGGIVAVK---KSKLVDESNVEQFINEVVILS 142
Y +G+G G V A K K + +V++F E+ I+
Sbjct: 5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMK 61
Query: 143 QINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEV 199
++H N+++L ++ LV E G L+ + + E + RI +V
Sbjct: 62 SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES-----DAA-RIMKDV 115
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSDFGASRTIKVDQTHLTTRVQG 256
A++Y H + HRD+K N L K+ DFG + K + + T+V G
Sbjct: 116 LSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM-MRTKV-G 170
Query: 257 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316
T Y+ P+ + + D +S GV++ LL G P F A +
Sbjct: 171 TPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP--------------FS--APTDS 213
Query: 317 RLFE-VLEARVLKEGKEEEIITVA--MLGKRCLNMIGKKRPSMKEV 359
+ + E K+ ++ L +R L K+R + +
Sbjct: 214 EVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-25
Identities = 49/215 (22%), Positives = 94/215 (43%), Gaps = 20/215 (9%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILS 142
D Y+ LG G G V++ + A G + K +D+ V+ NE+ I++
Sbjct: 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMN 103
Query: 143 QINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVS 200
Q++H ++ L E + + L+ EF+ G L+ + + + E + + +
Sbjct: 104 QLHHPKLINLHDAF-EDKYEMVLILEFLSGGELFDRIAAEDYKMS---EAEVINYMRQAC 159
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRA--KVSDFGASRTIKVDQTHLTTRVQGTF 258
+ ++H + I H DIK NI+ + K + K+ DFG + + D+ + T
Sbjct: 160 EGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI-VKVTT-ATA 214
Query: 259 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ PE +D+++ GV+ LL+G P
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 27/223 (12%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQIN 145
+ +LG G V+ G + A+K KS +S++E NE+ +L +I
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIK 64
Query: 146 HRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSG 201
H N+V L ES LV + + G L+ + ++ TE+ + + +V
Sbjct: 65 HENIVTLEDIY-ESTTHYYLVMQLVSGGELFDRILERGVYTEK-----DAS-LVIQQVLS 117
Query: 202 AMSYLHSATSIPIYHRDIKSSNILL---DDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF 258
A+ YLH I HRD+K N+L ++ + ++DFG S+ + ++T GT
Sbjct: 118 AVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--NGIMSTAC-GTP 171
Query: 259 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
GY+ PE +++ D +S GV+ LL G P +
Sbjct: 172 GYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 47/244 (19%), Positives = 88/244 (36%), Gaps = 32/244 (13%)
Query: 127 DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP 186
S ++ ++ + + +N V L + + L +++ +
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 187 ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246
+ L I I+++ A+ +LHS + HRD+K SNI KV DFG + D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 247 QTHLT-----------TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 295
+ T T GT Y+ PE + ++ K D++S G++L ELL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS----- 272
Query: 296 STDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS 355
F M R+ + ++ M+ + L+ +RP
Sbjct: 273 -------------FSTQMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPE 319
Query: 356 MKEV 359
++
Sbjct: 320 ATDI 323
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-25
Identities = 70/345 (20%), Positives = 122/345 (35%), Gaps = 74/345 (21%)
Query: 69 SSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSK 124
+ + + F L + Y+ +GQG G V + I A+K K+K
Sbjct: 4 HHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNK 63
Query: 125 L--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQT 182
+ ++ +VE+ EV ++ +++H N+ +L + + LV E G L L+
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 183 EEFPITWEMRL-------------------------------------RIAIEVSGAMSY 205
++ M + I ++ A+ Y
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 206 LHSATSIPIYHRDIKSSNILLDDK--YRAKVSDFGASRTIKV----DQTHLTTRVQGTFG 259
LH+ I HRDIK N L + K+ DFG S+ + +TT+ GT
Sbjct: 184 LHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPY 239
Query: 260 YLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317
++ PE ++ + K D +S GV+L LL G P F +N+
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP--------------FP--GVNDAD 283
Query: 318 LFE-VLEARVLKEGKEEEIITVAM--LGKRCLNMIGKKRPSMKEV 359
VL ++ E +++ L LN +R
Sbjct: 284 TISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 65/241 (26%), Positives = 111/241 (46%), Gaps = 29/241 (12%)
Query: 69 SSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSK 124
+ ++ TKL + E Y +LG GG G+VY G+ ++D VA+K K +
Sbjct: 21 MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDR 80
Query: 125 LVDESNVEQFIN---EVVILSQINHR--NVVKLLGCCLESEVPL-LVYEFI-PNGTLYHY 177
+ D + EVV+L +++ V++LL E L+ E P L+ +
Sbjct: 81 ISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW-FERPDSFVLILERPEPVQDLFDF 139
Query: 178 LHDQ---TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAK 233
+ ++ EE R +V A+ + H+ + HRDIK NIL+D ++ K
Sbjct: 140 ITERGALQEE-----LAR-SFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELK 190
Query: 234 VSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQK 292
+ DFG+ +K T T GT Y PE+ R ++ + V+S G++L +++ G
Sbjct: 191 LIDFGSGALLK--DTVYTDFD-GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 247
Query: 293 P 293
P
Sbjct: 248 P 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-25
Identities = 64/229 (27%), Positives = 105/229 (45%), Gaps = 31/229 (13%)
Query: 83 KMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFIN-- 136
D E Y +LG+GG GTV+ G L D VA+K +++++ S + +
Sbjct: 23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP 82
Query: 137 -EVVILSQIN----HRNVVKLLGCCLESEVPL-LVYEF-IPNGTLYHYLHDQ---TEEFP 186
EV +L ++ H V++LL E++ LV E +P L+ Y+ ++ E
Sbjct: 83 LEVALLWKVGAGGGHPGVIRLLDW-FETQEGFMLVLERPLPAQDLFDYITEKGPLGEG-- 139
Query: 187 ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTIKV 245
R +V A+ + HS + HRDIK NIL+D + AK+ DFG+ +
Sbjct: 140 ---PSR-CFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH- 191
Query: 246 DQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKP 293
T GT Y PE+ Q+ + V+S G++L +++ G P
Sbjct: 192 -DEPYTDFD-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 23/220 (10%)
Query: 84 MDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVV 139
M + ++++ + LG+G G V + VAVK + VD E E+
Sbjct: 1 MAVPF-VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIC 57
Query: 140 ILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYL--HDQTEEFPITWEMRLRIA 196
I +NH NVVK G L E+ G L+ + E + + R
Sbjct: 58 INKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFF 111
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT--HLTTRV 254
++ + YLH I I HRDIK N+LLD++ K+SDFG + + + L
Sbjct: 112 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 255 QGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKP 293
GT Y+ PE + +F E DV+S G+VL +L G+ P
Sbjct: 169 -GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-25
Identities = 62/240 (25%), Positives = 101/240 (42%), Gaps = 30/240 (12%)
Query: 74 NIEKTKLFTKMDLEKATD---NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDES 129
+ + ++DL D + ++G G G VYKG + G + A+K +
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDV-TGD 62
Query: 130 NVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPL------LVYEFIPNGT---LYHYLH 179
E+ E+ +L + +HRN+ G ++ P LV EF G+ L
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122
Query: 180 DQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238
T +E I + R E+ +S+LH I HRDIK N+LL + K+ DFG
Sbjct: 123 GNTLKEEWIAYICR-----EILRGLSHLHQHKVI---HRDIKGQNVLLTENAEVKLVDFG 174
Query: 239 ASRTIKVDQTHLTTRVQGTFGYLDPE-----YFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
S + T + GT ++ PE + + KSD++S G+ +E+ G P
Sbjct: 175 VSAQLDRTVGRRNTFI-GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-25
Identities = 50/214 (23%), Positives = 88/214 (41%), Gaps = 18/214 (8%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILS 142
+ D+Y+ + LG G G V++ A G A K D+ V E+ +S
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMS 209
Query: 143 QINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI-EVSG 201
+ H +V L + +++YEF+ G L+ + D+ + E + +V
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS---EDEAVEYMRQVCK 266
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDK--YRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
+ ++H H D+K NI+ K K+ DFG + + Q+ + GT
Sbjct: 267 GLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS-VKVTT-GTAE 321
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ PE +D++S GV+ LL+G P
Sbjct: 322 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-25
Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINHR 147
+Y LG G G V G G VAVK + K+ V + E+ L H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 148 NVVKLLGCCLESEVPL-LVYEFIPNGTLYHYL--HDQTEEFPITWEMRLRIAIEVSGAMS 204
+++KL + + +V E++ G L+ Y+ H + EE E R R+ ++ A+
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGELFDYICKHGRVEEM----EAR-RLFQQILSAVD 125
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
Y H + HRD+K N+LLD AK++DFG S + + L T G+ Y PE
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPE 180
Query: 265 YFRSSQFT-EKSDVYSFGVVLVELLTGQKP 293
+ + D++S GV+L LL G P
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLP 210
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 68/220 (30%), Positives = 104/220 (47%), Gaps = 16/220 (7%)
Query: 91 DNYNANRILGQGGQGTVYKGMLAD-GGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
+ + R+LG+GG G V + G + A K K ++ +NE IL ++N
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 147 RNVVKLLGCCLESEVPL-LVYEFIPNGTL-YHYLHDQTEEFPITWEMRLRI-AIEVSGAM 203
R VV L E++ L LV + G L +H H FP E R A E+ +
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP---EARAVFYAAEICCGL 299
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
LH I +RD+K NILLDD ++SD G + + QT + RV GT GY+ P
Sbjct: 300 EDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAP 354
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303
E ++ ++T D ++ G +L E++ GQ P + + R
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR 394
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 6e-25
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 31/224 (13%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNV------EQFINEVV 139
+NY ILG+G V + + AVK + S E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 140 ILSQIN-HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRI 195
IL +++ H N+++L + LV++ + G L+ YL ++ +E+ E R +I
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK-----ETR-KI 129
Query: 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ 255
+ + LH I HRD+K NILLDD K++DFG S + + L
Sbjct: 130 MRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK-LREVC- 184
Query: 256 GTFGYLDPEYFRSSQF------TEKSDVYSFGVVLVELLTGQKP 293
GT YL PE S ++ D++S GV++ LL G P
Sbjct: 185 GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 7e-25
Identities = 52/222 (23%), Positives = 93/222 (41%), Gaps = 21/222 (9%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQIN 145
T+ Y LG+G V + + + G A KL + ++ E I +
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLK 68
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSGA 202
H N+V+L E L+++ + G L+ + + +E + ++ A
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEA-----DAS-HCIQQILEA 122
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIKVDQTHLTTRVQGTFG 259
+ + H + HR++K N+LL K + K++DFG + ++ +Q GT G
Sbjct: 123 VLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPG 178
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
YL PE R + + D+++ GV+L LL G P D
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 7e-25
Identities = 64/220 (29%), Positives = 102/220 (46%), Gaps = 30/220 (13%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKL-----VDESNVEQFINEVVI 140
Y+ ++G+G V + + A G AVK + E E E I
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 141 LSQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIA 196
L Q+ H +++ L+ S LV++ + G L+ YL ++ +E+ E R I
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEK-----ETR-SIM 206
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG 256
+ A+S+LH+ I HRD+K NILLDD + ++SDFG S ++ + L G
Sbjct: 207 RSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK-LRELC-G 261
Query: 257 TFGYLDPEYFRSSQF------TEKSDVYSFGVVLVELLTG 290
T GYL PE + S ++ D+++ GV+L LL G
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 8e-25
Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 16/211 (7%)
Query: 99 LGQGGQGTVYKGMLADGG-IVAVKKSKL-VDESNVEQFINEV-VILSQINHRNVVKLLGC 155
+G+G G+V K + G I+AVK+ + VDE +Q + ++ V++ + +V+ G
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 156 CL-ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITW-EMRL-RIAIEVSGAMSYLHSATSI 212
E + + E + + + + E L +I + A+++L I
Sbjct: 90 LFREGDC-WICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 213 PIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ-- 270
HRDIK SNILLD K+ DFG S + VD T G Y+ PE S
Sbjct: 148 --IHRDIKPSNILLDRSGNIKLCDFGISGQL-VDSIAKTRDA-GCRPYMAPERIDPSASR 203
Query: 271 --FTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
+ +SDV+S G+ L EL TG+ P ++
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 53/212 (25%), Positives = 97/212 (45%), Gaps = 19/212 (8%)
Query: 99 LGQGGQGTVYKGM-LADGGIVAVKKSKL-VDESNVEQFINEV-VILSQINHRNVVKLLGC 155
+G G G V+K G ++AVK+ + ++ ++ + ++ V+L + +V+ G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 156 CLESEVPLLVYEFIPNGT--LYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIP 213
+ + + E + L + E + ++ + + A+ YL +
Sbjct: 93 FITNTDVFIAMELMGTCAEKLKKRMQGPIPERILG-----KMTVAIVKALYYLKEKHGV- 146
Query: 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE-----YFRS 268
I HRD+K SNILLD++ + K+ DFG S + VD G Y+ PE
Sbjct: 147 I-HRDVKPSNILLDERGQIKLCDFGISGRL-VDDKAKDRSA-GCAAYMAPERIDPPDPTK 203
Query: 269 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300
+ ++DV+S G+ LVEL TGQ P ++ +
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTD 235
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-24
Identities = 57/235 (24%), Positives = 100/235 (42%), Gaps = 22/235 (9%)
Query: 69 SSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSK 124
+ + + F K +DNY+ LG+G V + + G A K K
Sbjct: 7 MTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK 66
Query: 125 LVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ--- 181
L ++ E I ++ H N+V+L E LV++ + G L+ + +
Sbjct: 67 LSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFY 125
Query: 182 TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFG 238
+E + ++ +++Y HS I HR++K N+LL K + K++DFG
Sbjct: 126 SEA-----DAS-HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFG 176
Query: 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
+ + D GT GYL PE + +++ D+++ GV+L LL G P
Sbjct: 177 LAIEVN-DSEAWHGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 43/228 (18%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFIN-EVVILSQ 143
E+ Y +++G G G V++ L + VA+KK D ++F N E+ I+
Sbjct: 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-D----KRFKNRELQIMRI 88
Query: 144 INHRNVVKLLGCCLES-----EVPL-LVYEFIPNGTLYHYLHD---QTEEFPI------T 188
+ H NVV L + EV L LV E++P T+Y + P+
Sbjct: 89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYM 147
Query: 189 WEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQ 247
+++ LR +++Y+HS I HRDIK N+LLD K+ DFG+++ + +
Sbjct: 148 YQL-LR-------SLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE 196
Query: 248 --TH-LTTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQ 291
+ +R Y PE F ++ +T D++S G V+ EL+ GQ
Sbjct: 197 PNVSYICSRY-----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 64/220 (29%), Positives = 97/220 (44%), Gaps = 23/220 (10%)
Query: 84 MDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVV 139
M + ++++ + LG+G G V + VAVK + VD E E+
Sbjct: 1 MAVPF-VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEIC 57
Query: 140 ILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYL--HDQTEEFPITWEMRLRIA 196
I +NH NVVK G L E+ G L+ + E + + R
Sbjct: 58 INKMLNHENVVKFYG-HRREGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQ-RFF 111
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT--HLTTRV 254
++ + YLH I I HRDIK N+LLD++ K+SDFG + + + L
Sbjct: 112 HQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC 168
Query: 255 QGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKP 293
GT Y+ PE + +F E DV+S G+VL +L G+ P
Sbjct: 169 -GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 1e-24
Identities = 57/219 (26%), Positives = 92/219 (42%), Gaps = 21/219 (9%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESN---VEQFINEVV 139
+K D Y+ LG G V K + G A K K + E+ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 140 ILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIE 198
IL Q+ H NV+ L E+ + L+ E + G L+ +L ++ ++ E +
Sbjct: 68 ILRQVLHHNVITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ 123
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILL----DDKYRAKVSDFGASRTIKVDQTHLTTRV 254
+ ++YLH+ I H D+K NI+L K+ DFG + I+ D
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIF 179
Query: 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
GT ++ PE ++D++S GV+ LL+G P
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-24
Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 26/221 (11%)
Query: 97 RILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNV 149
+++G+G V + G + A+K K ++ V F E +L + R +
Sbjct: 67 KVIGRGAFSEV---AVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWI 123
Query: 150 VKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLH 207
+L + E L LV E+ G L L E P R E+ A+ +H
Sbjct: 124 TQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIP---AEMARFYLAEIVMAIDSVH 179
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
+ HRDIK NILLD +++DFG+ ++ D T + GT YL PE +
Sbjct: 180 R---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 268 SSQFTEKSDVY-------SFGVVLVELLTGQKPIRSTDAEE 301
+ + Y + GV E+ GQ P + E
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 59/219 (26%), Positives = 92/219 (42%), Gaps = 27/219 (12%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESN---VEQFINEVVILS 142
D+Y LG G V K G A K K +L E+ EV IL
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 143 QINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIE 198
+I H N++ L E++ + L+ E + G L+ +L ++ TE+ + +
Sbjct: 64 EIRHPNIITLHDIF-ENKTDVVLILELVSGGELFDFLAEKESLTEDEAT------QFLKQ 116
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA----KVSDFGASRTIKVDQTHLTTRV 254
+ + YLHS I H D+K NI+L DK K+ DFG + I+
Sbjct: 117 ILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIF 172
Query: 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
GT ++ PE ++D++S GV+ LL+G P
Sbjct: 173 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 30/225 (13%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLV-----DESNVEQFINE 137
+ D Y ++ LG G G V VA+K K K + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 138 VVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLR 194
+ IL ++NH ++K+ ++E +V E + G L+ + E +
Sbjct: 66 IEILKKLNHPCIIKIKNFF-DAEDYYIVLELMEGGELFDKVVGNKRLKEA-----TCK-L 118
Query: 195 IAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSDFGASRTIKVDQTHLT 251
++ A+ YLH I HRD+K N+LL + K++DFG S+ + + + +
Sbjct: 119 YFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG-ETSLMR 174
Query: 252 TRVQGTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVELLTGQKP 293
T GT YL PE S + D +S GV+L L+G P
Sbjct: 175 TLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 23/216 (10%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFIN-EVVILSQINH 146
Y +LG+G G V + + AVK K KL N E + E+ +L ++ H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 147 RNVVKLLG-CCLESEVPL-LVYEFIPNGT--LYHYL-HDQTEEFPITWEMRLRIAIEVSG 201
+NV++L+ E + + +V E+ G + + + + ++
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV----CQAH-GYFCQLID 120
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK--VDQTHLTTRVQGTFG 259
+ YLHS I H+DIK N+LL K+S G + + T QG+
Sbjct: 121 GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPA 176
Query: 260 YLDPEYFRSSQFTE--KSDVYSFGVVLVELLTGQKP 293
+ PE K D++S GV L + TG P
Sbjct: 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-24
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 17/213 (7%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLVDESNVEQFINEVVILSQ 143
++ + Y LG+G G V++ + + K K K D+ V+ E+ IL+
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNI 57
Query: 144 INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA 202
HRN++ L ES L +++EFI ++ ++ F + + +V A
Sbjct: 58 ARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEA 114
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRA--KVSDFGASRTIKVDQTHLTTRVQGTFGY 260
+ +LHS I H DI+ NI+ + + K+ +FG +R +K Y
Sbjct: 115 LQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPEY 169
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
PE + + +D++S G ++ LL+G P
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-24
Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 20/222 (9%)
Query: 81 FTKMDLEKATDNYNANR--ILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQF 134
Y ++ ILG G G V+K A G +A K + D E+
Sbjct: 77 IVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEV 133
Query: 135 INEVVILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRL 193
NE+ +++Q++H N+++L ES+ + LV E++ G L+ + D++ T +
Sbjct: 134 KNEISVMNQLDHANLIQLYD-AFESKNDIVLVMEYVDGGELFDRIIDESYNL--TELDTI 190
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA--KVSDFGASRTIKVDQTHLT 251
++ + ++H I H D+K NIL ++ K+ DFG +R K + L
Sbjct: 191 LFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LK 246
Query: 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
GT +L PE + +D++S GV+ LL+G P
Sbjct: 247 VNF-GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 25/216 (11%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKL-----VDESNVEQFINEVVILS 142
Y+ LG G G V+ + V VK K K+ +++ + + E+ ILS
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 143 QINHRNVVKLLGCCLESEVPL-LVYEFIPNGT-LYHYL--HDQTEEFPITWEMRLRIAIE 198
++ H N++K+L E++ LV E +G L+ ++ H + +E I +
Sbjct: 85 RVEHANIIKVLDI-FENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP----LAS-YIFRQ 138
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF 258
+ A+ YL I HRDIK NI++ + + K+ DFG++ ++ + T GT
Sbjct: 139 LVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-LFYTFC-GTI 193
Query: 259 GYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKP 293
Y PE + + + +++S GV L L+ + P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-24
Identities = 76/297 (25%), Positives = 118/297 (39%), Gaps = 41/297 (13%)
Query: 90 TDNYNANR-ILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQI 144
D Y +LG+G V + L AVK K S V EV +L Q
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQC 67
Query: 145 -NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVS 200
HRNV++L+ E + LV+E + G++ ++H + E E + +V+
Sbjct: 68 QGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNEL-----EAS-VVVQDVA 121
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIK-------VDQTHL 250
A+ +LH+ I HRD+K NIL + + K+ DF IK + L
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 251 TTRVQGTFGYLDPEYFRSSQFTEKS-----DVYSFGVVLVELLTGQKPIRSTDAEEDRSL 305
T G+ Y+ PE + D++S GV+L LL+G P D
Sbjct: 179 LTPC-GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVG-RCGSDCGW 236
Query: 306 VGFFLQAMNEDRLFE-VLEARVLKEGKEEEIITVA--MLGKRCLNMIGKKRPSMKEV 359
++ LFE + E + K+ I+ A L + L K+R S +V
Sbjct: 237 DRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 7e-24
Identities = 61/226 (26%), Positives = 91/226 (40%), Gaps = 35/226 (15%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDE---SNVEQFINEVV 139
E D Y+ LG G V K + G A K K + + E EV
Sbjct: 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 140 ILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRI 195
IL +I H NV+ L E++ + L+ E + G L+ +L ++ TE
Sbjct: 67 ILKEIQHPNVITLHEVY-ENKTDVILILELVAGGELFDFLAEKESLTE----------EE 115
Query: 196 AIE----VSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA----KVSDFGASRTIKVDQ 247
A E + + YLHS I H D+K NI+L D+ K+ DFG + I
Sbjct: 116 ATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172
Query: 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
GT ++ PE ++D++S GV+ LL+G P
Sbjct: 173 E-FKNIF-GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 21/219 (9%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDE---SNVEQFINEVV 139
+K D Y+ LG G V K + G A K K + E+ EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 140 ILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIE 198
IL Q+ H N++ L E+ + L+ E + G L+ +L ++ ++ E +
Sbjct: 68 ILRQVLHPNIITLHDVY-ENRTDVVLILELVSGGELFDFL---AQKESLSEEEATSFIKQ 123
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLDDK----YRAKVSDFGASRTIKVDQTHLTTRV 254
+ ++YLH+ I H D+K NI+L DK K+ DFG + I+ D
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIF 179
Query: 255 QGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
GT ++ PE ++D++S GV+ LL+G P
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 61/237 (25%), Positives = 96/237 (40%), Gaps = 46/237 (19%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLV--------------------- 126
Y +G+G G V D A+K K KL+
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 127 --DESNVEQFINEVVILSQINHRNVVKL---LGCCLESEVPLLVYEFIPNGTLYHYLHDQ 181
+EQ E+ IL +++H NVVKL L E + +V+E + G + +
Sbjct: 74 IQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHL-YMVFELVNQGPVMEVPTLK 132
Query: 182 --TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239
+E+ + R ++ + YLH I HRDIK SN+L+ + K++DFG
Sbjct: 133 PLSED-----QAR-FYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGV 183
Query: 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFT---EKSDVYSFGVVLVELLTGQKP 293
S K L+ V GT ++ PE ++ + DV++ GV L + GQ P
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 69/227 (30%), Positives = 111/227 (48%), Gaps = 45/227 (19%)
Query: 90 TDNYNANRILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQFIN-EVVILSQINHR 147
+Y +++G G G VY+ L D G +VA+KK ++F N E+ I+ +++H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 148 NVVKLLGCCLES-----EVPL-LVYEFIPNGTLYHYLHD---QTEEFPI------TWEMR 192
N+V+L S EV L LV +++P T+Y + P+ +++
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL- 165
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQ--TH 249
R +++Y+HS I HRDIK N+LLD D K+ DFG+++ + +
Sbjct: 166 FR-------SLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS 215
Query: 250 -LTTRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
+ +R Y PE F ++ +T DV+S G VL ELL GQ PI
Sbjct: 216 YICSRY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-23
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 24/215 (11%)
Query: 90 TDNYN---ANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQI- 144
+Y+ ++ LG+G K + AVK ++ + E+ L
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVK---IISKRMEANTQKEITALKLCE 63
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSG 201
H N+VKL + LV E + G L+ + + +E E I ++
Sbjct: 64 GHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSET-----EAS-YIMRKLVS 117
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIKVDQTHLTTRVQGTF 258
A+S++H + HRD+K N+L D+ K+ DFG +R D L T T
Sbjct: 118 AVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTL 173
Query: 259 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
Y PE + + E D++S GV+L +L+GQ P
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 98.4 bits (246), Expect = 3e-23
Identities = 61/211 (28%), Positives = 92/211 (43%), Gaps = 23/211 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFIN--EVVILSQINHR 147
+ Y +G+G G V+K G IVA+KK ++ V + I E+ +L Q+ H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP------ITWEMRLRIAIEVSG 201
N+V LL LV+E+ + T+ H L P ITW L+
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITW-QTLQ------- 113
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
A+++ H HRD+K NIL+ K+ DFG +R + + V T Y
Sbjct: 114 AVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYR 169
Query: 262 DPEY-FRSSQFTEKSDVYSFGVVLVELLTGQ 291
PE +Q+ DV++ G V ELL+G
Sbjct: 170 SPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 19/210 (9%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINHR 147
+Y LG G G V G G VAVK + K+ V + E+ L H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 148 NVVKLLGCCLESEVPL-LVYEFIPNGTLYHYL--HDQTEEFPITWEMRLRIAIEVSGAMS 204
+++KL + + + +V E++ G L+ Y+ + + +E E R R+ ++ +
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGELFDYICKNGRLDEK----ESR-RLFQQILSGVD 130
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
Y H + HRD+K N+LLD AK++DFG S + + L T G+ Y PE
Sbjct: 131 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-FLRTSC-GSPNYAAPE 185
Query: 265 YFRSSQFT-EKSDVYSFGVVLVELLTGQKP 293
+ + D++S GV+L LL G P
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 4e-23
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 97 RILGQGGQGTVYK-GMLADGGIVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKL 152
+++G+G G V + + A+K K +++ S+ F E I++ N VV+L
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134
Query: 153 LGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSAT 210
+ + L +V E++P G L + + + P E R EV A+ +HS
Sbjct: 135 F-YAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVP---EKWARFYTAEVVLALDAIHS-- 186
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-- 268
+ HRD+K N+LLD K++DFG + + GT Y+ PE +S
Sbjct: 187 -MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQG 245
Query: 269 --SQFTEKSDVYSFGVVLVELLTGQKP 293
+ + D +S GV L E+L G P
Sbjct: 246 GDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 97.2 bits (243), Expect = 6e-23
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 25/222 (11%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQF----INEVVILSQINH 146
+ Y +G+G G VYK + G IVA+K+ +L ++ E I E+ +L +++H
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRL--DAEDEGIPSTAIREISLLKELHH 78
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITW-----EMRLRIAIEVSG 201
N+V L+ LV+EF+ L L + + LR
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFMEKD-LKKVLDENKTGLQDSQIKIYLYQLLR------- 130
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
+++ H I HRD+K N+L++ K++DFG +R + T V T Y
Sbjct: 131 GVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYR 186
Query: 262 DPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
P+ S +++ D++S G + E++TG KP+ ++D
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIFAEMITG-KPLFPGVTDDD 227
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 96.8 bits (242), Expect = 7e-23
Identities = 50/224 (22%), Positives = 97/224 (43%), Gaps = 27/224 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF----INEVVILSQIN 145
Y +G+G GTV+K IVA+K+ +L + + E + E+ +L ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRL--DDDDEGVPSSALREICLLKELK 59
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP------ITWEMRLRIAIEV 199
H+N+V+L + LV+EF L Y + +++ L+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL-LK----- 112
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
+ + HS + HRD+K N+L++ K+++FG +R + + V T
Sbjct: 113 --GLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLW 166
Query: 260 YLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
Y P+ F + ++ D++S G + EL +P+ + +D
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 8e-23
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 30/225 (13%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKK-SKLVDESNVEQFINEVVILSQINHR 147
+D + LG+G VY+ A+K K VD+ V E+ +L +++H
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR---TEIGVLLRLSHP 108
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLY-------HYLHDQTEEFPITWEMRLRIAIEVS 200
N++KL LV E + G L+ +Y +E ++
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYY----SER------DAADAVKQIL 158
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIKVDQTHLTTRVQGT 257
A++YLH I HRD+K N+L K++DFG S+ ++ Q + T GT
Sbjct: 159 EAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-HQVLMKTVC-GT 213
Query: 258 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
GY PE R + + D++S G++ LL G +P ++
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 51/225 (22%), Positives = 96/225 (42%), Gaps = 24/225 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
+++ +++G+G G V + + A+K K +++ + F E +L
Sbjct: 74 EDFEILKVIGRGAFGEV---AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN 130
Query: 144 INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSG 201
+ + + L + + L LV ++ G L L + P E R E+
Sbjct: 131 GDSKWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLP---EEMARFYLAEMVI 186
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
A+ +H + HRDIK NIL+D +++DFG+ + D T ++ GT Y+
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243
Query: 262 DPEYFRSSQFTEKS-----DVYSFGVVLVELLTGQKPIRSTDAEE 301
PE ++ + + D +S GV + E+L G+ P + E
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 1e-22
Identities = 59/285 (20%), Positives = 109/285 (38%), Gaps = 45/285 (15%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQ-I 144
TD Y +G G + + A AVK KSK + + E+ IL +
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTE---EIEILLRYG 73
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSG 201
H N++ L + + +V E + G L + Q +E E + ++
Sbjct: 74 QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSER-----EAS-AVLFTITK 127
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRA----KVSDFGASRTIKVDQTHLTTRVQGT 257
+ YLH+ + HRD+K SNIL D+ ++ DFG ++ ++ + L T T
Sbjct: 128 TVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC-YT 183
Query: 258 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317
++ PE + D++S GV+L +LTG P + + +
Sbjct: 184 ANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD-------------TPEE 230
Query: 318 LFE-VLEARVLKEGKEEEIITVA--MLGKRCLNMIGKKRPSMKEV 359
+ + + G ++ L + L++ +R + V
Sbjct: 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALV 275
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-22
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 21/207 (10%)
Query: 97 RILGQGGQGTVYKGMLAD-GGIVAVK---KSKLVDESNVEQFINEVVILSQIN---HRNV 149
RI+G+GG G VY AD G + A+K K ++ + +NE ++LS ++ +
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 150 VKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLH 207
V + + L + + + G L+++L Q F E +R A E+ + ++H
Sbjct: 255 VCM-SYAFHTPDKLSFILDLMNGGDLHYHLS-QHGVFS---EADMRFYAAEIILGLEHMH 309
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
+ + +RD+K +NILLD+ ++SD G + + H V GT GY+ PE +
Sbjct: 310 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHGYMAPEVLQ 363
Query: 268 SSQFTEKS-DVYSFGVVLVELLTGQKP 293
+ S D +S G +L +LL G P
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 96.5 bits (241), Expect = 2e-22
Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 24/222 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFIN--EVVILSQINHR 147
+ Y ++G+G G V K G IVA+KK D+ + + I E+ +L Q+ H
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP------ITWEMRLRIAIEVSG 201
N+V LL C + + LV+EF+ + T+ L +++ +
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI-IN------- 135
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
+ + HS I HRDIK NIL+ K+ DFG +RT+ V T Y
Sbjct: 136 GIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYR 191
Query: 262 DPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
PE ++ + DV++ G ++ E+ G +P+ D++ D
Sbjct: 192 APELLVGDVKYGKAVDVWAIGCLVTEMFMG-EPLFPGDSDID 232
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 53/225 (23%), Positives = 93/225 (41%), Gaps = 14/225 (6%)
Query: 77 KTKLFTKMDLEKATDNYN-ANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLVDESNVE 132
T+ +E + Y ++ LG+G V + + + G A K K + +
Sbjct: 14 GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRA 73
Query: 133 QFINEVVILSQINHR-NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEM 191
+ ++E+ +L V+ L + +L+ E+ G ++ + E ++
Sbjct: 74 EILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM-VSEND 132
Query: 192 RLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY---RAKVSDFGASRTIKVDQT 248
+R+ ++ + YLH I H D+K NILL Y K+ DFG SR I
Sbjct: 133 VIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG-HAC 188
Query: 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
L + GT YL PE T +D+++ G++ LLT P
Sbjct: 189 ELREIM-GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 61/224 (27%), Positives = 99/224 (44%), Gaps = 17/224 (7%)
Query: 97 RILGQGGQGTVYKGMLADGG-IVAVK---KSKLVDESNVEQFINEVVILSQINHRNVVKL 152
R +G+G G V D + A+K K K V+ + V E+ I+ + H +V L
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYLHSATS 211
+ E +V + + G L ++L Q F E +++ E+ A+ YL +
Sbjct: 81 WYSFQDEEDMFMVVDLLLGGDLRYHL-QQNVHFK---EETVKLFICELVMALDYLQNQR- 135
Query: 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF 271
I HRD+K NILLD+ ++DF + + + T + GT Y+ PE F S +
Sbjct: 136 --IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSSRKG 191
Query: 272 TEKS---DVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312
S D +S GV ELL G++P + + +V F
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT 235
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 3e-22
Identities = 55/223 (24%), Positives = 95/223 (42%), Gaps = 27/223 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQF----INEVVILSQINH 146
+ Y+ +G+G G VYK G A+KK +L E E I E+ IL ++ H
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRL--EKEDEGIPSTTIREISILKELKH 59
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP------ITWEMRLRIAIEVS 200
N+VKL + +LV+E + L L ++ L
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQD-LKKLLDVCEGGLESVTAKSFLLQL-LN------ 111
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260
++Y H + HRD+K N+L++ + K++DFG +R + T + T Y
Sbjct: 112 -GIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWY 166
Query: 261 LDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
P+ S +++ D++S G + E++ G P+ +E D
Sbjct: 167 RAPDVLMGSKKYSTTIDIWSVGCIFAEMVNG-TPLFPGVSEAD 208
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-22
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 27/223 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF----INEVVILSQIN 145
+ Y LG+G TVYKG +VA+K+ +L E E I EV +L +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE---EGAPCTAIREVSLLKDLK 58
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITW-----EMRLRIAIEVS 200
H N+V L + LV+E++ L YL D + LR
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLR------ 111
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260
++Y H + HRD+K N+L++++ K++DFG +R + V T Y
Sbjct: 112 -GLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWY 166
Query: 261 LDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
P+ S+ ++ + D++ G + E+ TG +P+ E+
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATG-RPLFPGSTVEE 208
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-22
Identities = 61/242 (25%), Positives = 105/242 (43%), Gaps = 21/242 (8%)
Query: 70 SNEGNIEKTKLFTKMDLEKAT-DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK--- 121
S+ E+ ++ + T + + ++LG+G G V +L G A+K
Sbjct: 126 SDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKV---ILVKEKATGRYYAMKILK 182
Query: 122 KSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHD 180
K +V + V + E +L H + L ++ L V E+ G L+ +L
Sbjct: 183 KEVIVAKDEVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHLS- 240
Query: 181 QTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239
+ F E R R E+ A+ YLHS ++ +Y RD+K N++LD K++DFG
Sbjct: 241 RERVFS---EDRARFYGAEIVSALDYLHSEKNV-VY-RDLKLENLMLDKDGHIKITDFGL 295
Query: 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
+ + GT YL PE + + D + GVV+ E++ G+ P + D
Sbjct: 296 CKE-GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354
Query: 300 EE 301
E+
Sbjct: 355 EK 356
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 20/210 (9%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINHR 147
Y LG+G G V VA+K + L + E+ L + H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 148 NVVKLLGCCLESEVPL-LVYEFIPNGTLYHYL--HDQTEEFPITWEMRLRIAIEVSGAMS 204
+++KL + + + +V E+ G L+ Y+ + E E R R ++ A+
Sbjct: 70 HIIKLYDV-ITTPTDIVMVIEYA-GGELFDYIVEKKRMTED----EGR-RFFQQIICAIE 122
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
Y H I HRD+K N+LLDD K++DFG S + L T G+ Y PE
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-FLKTSC-GSPNYAAPE 177
Query: 265 YFRSSQFT-EKSDVYSFGVVLVELLTGQKP 293
+ + DV+S G+VL +L G+ P
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 2e-21
Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 22/219 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
D ++ + LG G G V ML G A+K K K+V +E +NE IL
Sbjct: 41 DQFDRIKTLGTGSFGRV---MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGA 202
+N +VKL ++ +V E++ G ++ +L F E R A ++
Sbjct: 98 VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-GRFS---EPHARFYAAQIVLT 153
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
YLHS + +RD+K N+L+D + +V+DFG ++ +K T + GT L
Sbjct: 154 FEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK----GRTWTLCGTPEALA 206
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
PE S + + D ++ GV++ E+ G P + +
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 2e-21
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 83 KMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEV 138
M + +D Y+ + +G G G +VAVK + +DE NV++ E+
Sbjct: 12 DMPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE-NVQR---EI 67
Query: 139 VILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRI 195
+ + H N+V+ L ++ E+ G LY + + +E+ E R
Sbjct: 68 INHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSED-----EAR-FF 121
Query: 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY--RAKVSDFGASRTIKVDQTHLTTR 253
++ +SY HS I HRD+K N LLD R K+ DFG S++ + +
Sbjct: 122 FQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 177
Query: 254 VQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKP 293
V GT Y+ PE ++ + +DV+S GV L +L G P
Sbjct: 178 V-GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 3e-21
Identities = 64/232 (27%), Positives = 102/232 (43%), Gaps = 27/232 (11%)
Query: 84 MDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFIN-----E 137
+D++ Y LG+G TVYK IVA+KK KL S + IN E
Sbjct: 3 LDVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALRE 62
Query: 138 VVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP------ITWEM 191
+ +L +++H N++ LL LV++F+ L + D + M
Sbjct: 63 IKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYML-M 120
Query: 192 RLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251
L+ + YLH I HRD+K +N+LLD+ K++DFG +++ T
Sbjct: 121 TLQ-------GLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170
Query: 252 TRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
+V T Y PE F + + D+++ G +L ELL P D++ D
Sbjct: 171 HQVV-TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLR-VPFLPGDSDLD 220
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 3e-21
Identities = 58/223 (26%), Positives = 104/223 (46%), Gaps = 18/223 (8%)
Query: 89 ATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF----INEVVILSQ 143
++ + LG G TVYKG+ G VA+K+ KL E E I E+ ++ +
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE---EGTPSTAIREISLMKE 59
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF---PITWEMRLRIAIEVS 200
+ H N+V+L LV+EF+ N L Y+ +T + + ++
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260
+++ H I HRD+K N+L++ + + K+ DFG +R + ++ V T Y
Sbjct: 119 QGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174
Query: 261 LDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
P+ S ++ D++S G +L E++TG KP+ +E+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPLFPGTNDEE 216
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 61/230 (26%), Positives = 99/230 (43%), Gaps = 28/230 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF----INEVVILSQIN 145
Y +GQG G V+K G VA+KK + +E E F + E+ IL +
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLK 74
Query: 146 HRNVVKLLGCCLESEVPL--------LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI 197
H NVV L+ C P LV++F + L L + +F ++ E++ R+
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS-EIK-RVMQ 131
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT----IKVDQTHLTTR 253
+ + Y+H I HRD+K++N+L+ K++DFG +R T R
Sbjct: 132 MLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 188
Query: 254 VQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
V T Y PE + D++ G ++ E+ T PI + E+
Sbjct: 189 VV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTR-SPIMQGNTEQH 236
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 56/223 (25%), Positives = 95/223 (42%), Gaps = 22/223 (9%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQF----INEVVILSQIN 145
D Y LG+G G VYK + VA+K+ +L E E I EV +L ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRL--EHEEEGVPGTAIREVSLLKELQ 91
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
HRN+++L + L++E+ N L Y+ ++ + ++ +++
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNP---DVSMRVIKSFLYQLINGVNF 147
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRA-----KVSDFGASRTIKVDQTHLTTRVQGTFGY 260
HS HRD+K N+LL + K+ DFG +R + T + T Y
Sbjct: 148 CHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWY 203
Query: 261 LDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
PE S ++ D++S + E+L P+ D+E D
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMK-TPLFPGDSEID 245
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 2e-20
Identities = 52/213 (24%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHR 147
D+Y R LG+G V++ + + + V VK K V + ++ E+ IL +
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGP 91
Query: 148 NVVKLLGCCL--ESEVPLLVYEFIPNGTLYHYLHDQTEEFP--ITWEMRLRIAIEVSGAM 203
N++ L S P LV+E + N T+ +E+ L+ A+
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEI-LK-------AL 143
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRA-KVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
Y HS I HRD+K N+++D ++R ++ D+G + Q RV + +
Sbjct: 144 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE-YNVRV-ASRYFKG 198
Query: 263 PEYFRSSQFTEKS-DVYSFGVVLVELLTGQKPI 294
PE Q + S D++S G +L ++ ++P
Sbjct: 199 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 2e-20
Identities = 56/229 (24%), Positives = 103/229 (44%), Gaps = 37/229 (16%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQFINEVVILSQIN 145
K D + R+ GQG GTV G G VA+KK + D + + + L+ ++
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV-IQDPRFRNRELQIMQDLAVLH 77
Query: 146 HRNVVKLL------GCCLESEVPL-LVYEFIPNGTLYHYL-HDQTEEFPITWEMR----- 192
H N+V+L G ++ L +V E++P+ TL+ + + +
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLF 136
Query: 193 --LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTH 249
+R ++ LH S+ + HRDIK N+L++ K+ DFG+++ + + +
Sbjct: 137 QLIR-------SIGCLHL-PSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 250 ---LTTRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
+ +R Y PE F + +T D++S G + E++ G+ PI
Sbjct: 189 VAYICSRY-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PI 231
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 3e-20
Identities = 62/229 (27%), Positives = 94/229 (41%), Gaps = 22/229 (9%)
Query: 88 KATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFIN-----EVVIL 141
AT Y +G G GTVYK G VA+K ++ + + EV +L
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 142 SQIN---HRNVVKLLGCCLESEVPL-----LVYEFIPNGTLYHYLHDQTEEFPITWEMRL 193
++ H NVV+L+ C S LV+E + L YL + E
Sbjct: 66 RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPG-LPAETIK 123
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
+ + + +LH+ I HRD+K NIL+ K++DFG +R LT
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA-LTPV 179
Query: 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
V T Y PE S + D++S G + E+ KP+ ++E D
Sbjct: 180 VV-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR-KPLFCGNSEAD 226
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 58/258 (22%), Positives = 106/258 (41%), Gaps = 30/258 (11%)
Query: 85 DLEKATDNYN-ANRILGQGGQGTVYKGM---LADGGIVAVKKSKLVDESNVEQFINEVVI 140
+ E+ D + +G+G G VYK D A+K+ + E+ +
Sbjct: 14 ERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIE--GTGISMSACREIAL 71
Query: 141 LSQINHRNVVKLLGCCLESEVPL--LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIE 198
L ++ H NV+ L L L++++ + L+H + ++L +
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 199 VS------GAMSYLHSATSIPIYHRDIKSSNILLDDKYRA----KVSDFGASRTIKV--- 245
S + YLH+ + HRD+K +NIL+ + K++D G +R
Sbjct: 131 KSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 246 DQTHLTTRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRS 304
L V TF Y PE + +T+ D+++ G + ELLT +PI E+ ++
Sbjct: 188 PLADLDPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS-EPIFHCRQEDIKT 245
Query: 305 LVGFFLQAMNEDRLFEVL 322
+ + DR+F V+
Sbjct: 246 SNPYHHDQL--DRIFNVM 261
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 1e-19
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 23/221 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
++++ ++LG+G G V +L G A+K K ++ + V + E +L
Sbjct: 5 NDFDYLKLLGKGTFGKV---ILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 144 INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSG 201
H + L ++ L V E+ G L+ +L + F E R R E+
Sbjct: 62 TRHPFLTALK-YAFQTHDRLCFVMEYANGGELFFHLS-RERVFT---EERARFYGAEIVS 116
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR-TIKVDQTHLTTRVQGTFGY 260
A+ YLHS + +RDIK N++LD K++DFG + I T GT Y
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEY 171
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
L PE + + D + GVV+ E++ G+ P + D E
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 1e-19
Identities = 63/272 (23%), Positives = 92/272 (33%), Gaps = 79/272 (29%)
Query: 97 RILGQGGQGTVYKGML------ADGGIVAVKKSK-LVDESNVEQFINEVVILSQI-NHRN 148
+ LG+G G V + A VAVK K S ++E+ IL I +H N
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87
Query: 149 VVKLLGCCLESEVPLLV-YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVS------- 200
VV LLG C + PL+V EF G L YL + EF R
Sbjct: 88 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147
Query: 201 -----------------------GAMSYLHSATSIPIYHRDIKSSNILL----------- 226
++S + + ++D + L+
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207
Query: 227 -------------------DDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD----- 262
+K K+ DFG +R I D + V+ L
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMA 263
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLT-GQKP 293
PE +T +SDV+SFGV+L E+ + G P
Sbjct: 264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 2e-19
Identities = 57/218 (26%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 97 RILGQGGQGTVYKGMLA-------DGGIVAVK---KSKLVDESN-VEQFINEVVILSQIN 145
R+LG+GG G V G I A+K K+ +V + E IL ++
Sbjct: 23 RVLGKGGYGKV---FQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 146 HRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAM 203
H +V L+ ++ L L+ E++ G L+ L + F E E+S A+
Sbjct: 80 HPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLE-REGIFM---EDTACFYLAEISMAL 134
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
+LH I +RD+K NI+L+ + K++DFG + + +T GT Y+ P
Sbjct: 135 GHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHTFCGTIEYMAP 190
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
E S D +S G ++ ++LTG P + ++
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK 228
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 86.8 bits (216), Expect = 3e-19
Identities = 73/242 (30%), Positives = 117/242 (48%), Gaps = 22/242 (9%)
Query: 72 EGNIEKTKL--FTKMDLEKAT-DNYNANRILGQGGQGTVY----KGMLADGGIVAVK--- 121
EG+I++ + K EKA + ++LGQG G V+ + A+K
Sbjct: 2 EGSIKEIAITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLK 61
Query: 122 KSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHD 180
K+ L V E IL ++NH +VKL ++E L L+ +F+ G L+ L
Sbjct: 62 KATLKVRDRVRT-KMERDILVEVNHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLS- 118
Query: 181 QTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239
+ F E ++ E++ A+ +LHS I +RD+K NILLD++ K++DFG
Sbjct: 119 KEVMFT---EEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299
S+ +D GT Y+ PE T+ +D +SFGV++ E+LTG P + D
Sbjct: 173 SK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDR 231
Query: 300 EE 301
+E
Sbjct: 232 KE 233
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 4e-19
Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 24/229 (10%)
Query: 88 KATDNYNANRILGQGGQGTVYKG--MLADGGIVAVKKSKLVDESNVEQF----INEVVIL 141
+A Y +G+G G V+K + G VA+K+ ++ ++ E I EV +L
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRV--QTGEEGMPLSTIREVAVL 65
Query: 142 SQIN---HRNVVKLLGCCLESEVPL-----LVYEFIPNGTLYHYLHDQTEEFPITWEMRL 193
+ H NVV+L C S LV+E + L YL E + E
Sbjct: 66 RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPG-VPTETIK 123
Query: 194 RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR 253
+ ++ + +LHS + HRD+K NIL+ + K++DFG +R LT+
Sbjct: 124 DMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-LTSV 179
Query: 254 VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
V T Y PE S + D++S G + E+ KP+ ++ D
Sbjct: 180 VV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-KPLFRGSSDVD 226
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 5e-19
Identities = 60/290 (20%), Positives = 112/290 (38%), Gaps = 51/290 (17%)
Query: 90 TDNYNANR-ILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQI 144
TD+Y ++ +LG G G V + G A+K S + EV Q
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQA 78
Query: 145 -NHRNVVKLLGCCLESEVP----LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
++V +L L++ E + G L+ + ++ ++ T I ++
Sbjct: 79 SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA-FTEREAAEIMRDI 137
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIKVDQTHLTTRVQG 256
A+ +LHS I HRD+K N+L K + K++DFG ++ + Q L T
Sbjct: 138 GTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPC-Y 191
Query: 257 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316
T Y+ PE ++ + D++S GV++ LL G P F+ +
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP--------------FY--SNTGQ 235
Query: 317 RLFEVLEARVLK-----EGKEEEIITVA--MLGKRCLNMIGKKRPSMKEV 359
+ ++ R+ E ++ L + L +R ++ +
Sbjct: 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQF 285
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 86.0 bits (214), Expect = 6e-19
Identities = 61/223 (27%), Positives = 107/223 (47%), Gaps = 30/223 (13%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
++ R LG G G V L +G A+K K +V VE +E ++LS
Sbjct: 6 QDFQILRTLGTGSFGRV---HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGA 202
+ H ++++ G +++ ++ ++I G L+ L +++ FP + A EV A
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLR-KSQRFP---NPVAKFYAAEVCLA 118
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTF-G-- 259
+ YLHS I +RD+K NILLD K++DFG ++ + D T+ T G
Sbjct: 119 LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY-------TLCGTP 167
Query: 260 -YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
Y+ PE + + + D +SFG+++ E+L G P ++ +
Sbjct: 168 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 6e-19
Identities = 62/242 (25%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
+++ R++G+G V +L I A+K K + D+ +++ E + Q
Sbjct: 9 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 144 I-NHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVS 200
NH +V L C ++E L V E++ G L ++ + + P E R + E+S
Sbjct: 66 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 120
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR-TIKVDQTHLTTRVQGTFG 259
A++YLH I +RD+K N+LLD + K++D+G + ++ T T+ GT
Sbjct: 121 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPN 175
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319
Y+ PE R + D ++ GV++ E++ G+ P + ++ ED LF
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLF 228
Query: 320 EV 321
+V
Sbjct: 229 QV 230
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 8e-19
Identities = 55/228 (24%), Positives = 90/228 (39%), Gaps = 38/228 (16%)
Query: 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKK--SKLVDESNVEQFIN---------EV 138
Y R + G G V G+ ++G VA+K+ + + D V + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 139 VILSQINHRNVVKLLGCCLESEVPL-----LVYEFIPNGTLYHYLHDQ----TEEF--PI 187
+L+ +H N++ L + E P LV E + L +HDQ + +
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYF 139
Query: 188 TWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247
+ + L + LH A + HRD+ NILL D + DF +R D
Sbjct: 140 MYHI-LL-------GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
Query: 248 THLTTRVQGTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
+ T V Y PE + FT+ D++S G V+ E+ K +
Sbjct: 189 -NKTHYVT-HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNR-KAL 233
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 87.8 bits (217), Expect = 8e-19
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
++N +LG+G G V ML+ + AVK K ++ + +VE + E +L+
Sbjct: 341 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 144 INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSG 201
+ L C ++ L V E++ G L +++ Q F E A E++
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIAI 453
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR-TIKVDQTHLTTRVQGTFGY 260
+ +L S I +RD+K N++LD + K++DFG + I T T GT Y
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPDY 508
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ PE + + D ++FGV+L E+L GQ P D +E
Sbjct: 509 IAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 54/259 (20%), Positives = 99/259 (38%), Gaps = 74/259 (28%)
Query: 86 LEKATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFIN-EVVILSQ 143
LE ++ Y+ + LG G G V + + G A+KK ++ N E+ I+
Sbjct: 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVL-----QDPRYKNRELDIMKV 56
Query: 144 INHRNVVKLLGC-------------------------------------CLESEVPL-LV 165
++H N++KL+ L ++
Sbjct: 57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116
Query: 166 YEFIPNGTLYHYL-HDQTEEFPITWEMR-------LRIAIEVSGAMSYLHSATSIPIYHR 217
E++P+ TL+ L I + R A+ ++HS I HR
Sbjct: 117 MEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFR-------AVGFIHSLG---ICHR 165
Query: 218 DIKSSNILLD-DKYRAKVSDFGASRTIKVDQTH---LTTRVQGTFGYLDPE-YFRSSQFT 272
DIK N+L++ K+ DFG+++ + + + +R Y PE ++++T
Sbjct: 166 DIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYT 220
Query: 273 EKSDVYSFGVVLVELLTGQ 291
D++S G V EL+ G+
Sbjct: 221 PSIDLWSIGCVFGELILGK 239
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 61/242 (25%), Positives = 113/242 (46%), Gaps = 31/242 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
+++ R++G+G V +L I A++ K + D+ +++ E + Q
Sbjct: 52 QDFDLLRVIGRGSYAKV---LLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 144 I-NHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVS 200
NH +V L C ++E L V E++ G L ++ + + P E R + E+S
Sbjct: 109 ASNHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQ-RQRKLP---EEHARFYSAEIS 163
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR-TIKVDQTHLTTRVQGTFG 259
A++YLH I +RD+K N+LLD + K++D+G + ++ T T+ GT
Sbjct: 164 LALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPN 218
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319
Y+ PE R + D ++ GV++ E++ G+ P + ++ ED LF
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNP-------DQNTEDYLF 271
Query: 320 EV 321
+V
Sbjct: 272 QV 273
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 2e-18
Identities = 63/216 (29%), Positives = 102/216 (47%), Gaps = 24/216 (11%)
Query: 97 RILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ-INHRN 148
+++G+G G V +LA + AVK K ++ + + ++E +L + + H
Sbjct: 44 KVIGKGSFGKV---LLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPF 100
Query: 149 VVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVSGAMSYL 206
+V L ++ L V ++I G L+++L + F E R R A E++ A+ YL
Sbjct: 101 LVGLH-FSFQTADKLYFVLDYINGGELFYHLQ-RERCFL---EPRARFYAAEIASALGYL 155
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS-RTIKVDQTHLTTRVQGTFGYLDPEY 265
HS I +RD+K NILLD + ++DFG I+ + T T+ GT YL PE
Sbjct: 156 HSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEV 210
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ D + G VL E+L G P S + E
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 3e-18
Identities = 75/244 (30%), Positives = 117/244 (47%), Gaps = 28/244 (11%)
Query: 69 SSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLA----DGGIVAVK--- 121
SS EGN ++ + DN+ R+LG+G G V MLA G + AVK
Sbjct: 5 SSKEGNGIGVNSSNRLGI----DNFEFIRVLGKGSFGKV---MLARVKETGDLYAVKVLK 57
Query: 122 KSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLH 179
K ++ + +VE + E ILS NH + +L CC ++ L V EF+ G L ++
Sbjct: 58 KDVILQDDDVECTMTEKRILSLARNHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQ 116
Query: 180 DQTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238
++ F E R R A E+ A+ +LH I +RD+K N+LLD + K++DFG
Sbjct: 117 -KSRRFD---EARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFG 169
Query: 239 ASRT-IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRST 297
+ I T T GT Y+ PE + + D ++ GV+L E+L G P +
Sbjct: 170 MCKEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE 227
Query: 298 DAEE 301
+ ++
Sbjct: 228 NEDD 231
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 5e-18
Identities = 69/247 (27%), Positives = 108/247 (43%), Gaps = 22/247 (8%)
Query: 72 EGNIEKTKLFTKMDLEKAT-DNYNANRILGQGGQGTVY---KGMLADGG-IVAVK---KS 123
E EK +N+ ++LG G G V+ K D G + A+K K+
Sbjct: 34 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 93
Query: 124 KLVDESN-VEQFINEVVILSQINHRN-VVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHD 180
+V ++ E E +L I +V L ++E L L+ ++I G L+ +L
Sbjct: 94 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLS- 151
Query: 181 QTEEFPITWEMRLRI-AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239
Q E F E ++I E+ A+ +LH I +RDIK NILLD ++DFG
Sbjct: 152 QRERFT---EHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGL 205
Query: 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRST 297
S+ D+T GT Y+ P+ R + D +S GV++ ELLTG P
Sbjct: 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 265
Query: 298 DAEEDRS 304
+ ++
Sbjct: 266 GEKNSQA 272
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 1e-17
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
++N +LG+G G V ML+ + AVK K ++ + +VE + E +L+
Sbjct: 20 TDFNFLMVLGKGSFGKV---MLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 144 I-NHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVS 200
+ +L C ++ L V E++ G L +++ Q F E A E++
Sbjct: 77 PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQ-QVGRFK---EPHAVFYAAEIA 131
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT-IKVDQTHLTTRVQGTFG 259
+ +L S I +RD+K N++LD + K++DFG + I T T GT
Sbjct: 132 IGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKTFCGTPD 186
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
Y+ PE + + D ++FGV+L E+L GQ P D +E
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 63/222 (28%), Positives = 103/222 (46%), Gaps = 24/222 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
+++ +++LG+G G V LA A+K K ++ + +VE + E +LS
Sbjct: 17 EDFILHKMLGKGSFGKV---FLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 144 -INHRNVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRI-AIEVS 200
H + + C +++ L V E++ G L +++ +F R A E+
Sbjct: 74 AWEHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFD---LSRATFYAAEII 128
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT-IKVDQTHLTTRVQGTFG 259
+ +LHS I +RD+K NILLD K++DFG + + D T GT
Sbjct: 129 LGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNTFCGTPD 183
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
Y+ PE ++ D +SFGV+L E+L GQ P D EE
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 60/286 (20%), Positives = 106/286 (37%), Gaps = 42/286 (14%)
Query: 90 TDNYN-ANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQI 144
D+Y +++LG G G V + A+K EV + +
Sbjct: 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRA 111
Query: 145 -NHRNVVKLLGCCLESEVP----LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
++V+++ L+V E + G L+ + D+ ++ T I +
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSI 170
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIKVDQTHLTTRVQG 256
A+ YLHS I I HRD+K N+L K K++DFG ++ + LTT
Sbjct: 171 GEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS-LTTPC-Y 225
Query: 257 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316
T Y+ PE ++ + D++S GV++ LL G P S
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI------------SP 273
Query: 317 RLFE-VLEARVLKEGKEEEIITVA--MLGKRCLNMIGKKRPSMKEV 359
+ + + E ++ ML + L +R ++ E
Sbjct: 274 GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 319
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 3e-17
Identities = 54/218 (24%), Positives = 91/218 (41%), Gaps = 29/218 (13%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE--QFINEVVILSQINH 146
Y + +G G QG V VA+KK ++ + E+V++ +NH
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 147 RNVVKLLGCCLESEVPL-------LVYEFIPNGTLYHYLH-DQTEEF--PITWEMRLRIA 196
+N++ LL + L +V E + L + + E + ++M L
Sbjct: 84 KNIIGLLNV-FTPQKSLEEFQDVYIVMELMDA-NLCQVIQMELDHERMSYLLYQM-LC-- 138
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG 256
+ +LHSA I HRD+K SNI++ K+ DFG +RT +T V
Sbjct: 139 -----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMTPYV-V 188
Query: 257 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
T Y PE + E D++S G ++ E++ G +
Sbjct: 189 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG-GVL 225
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 60/254 (23%), Positives = 101/254 (39%), Gaps = 50/254 (19%)
Query: 65 QQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKS 123
+++ + D+ Y +G+G G V + VA+KK
Sbjct: 4 HHHMAAAAAAGPEMVRGQVFDV---GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK- 59
Query: 124 KLVDESNVEQFIN---------EVVILSQINHRNVVKLLGCCLESEVPL-----LVYEFI 169
+ F + E+ IL + H N++ + + +V + +
Sbjct: 60 -------ISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM 112
Query: 170 PNGT-LYHYLHDQ--TEEFP--ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224
T LY L Q + + +++ LR + Y+HSA + HRD+K SN+
Sbjct: 113 --ETDLYKLLKTQHLSNDHICYFLYQI-LR-------GLKYIHSAN---VLHRDLKPSNL 159
Query: 225 LLDDKYRAKVSDFGASRTIKVDQTH---LTTRVQGTFGYLDPEY-FRSSQFTEKSDVYSF 280
LL+ K+ DFG +R D H LT V T Y PE S +T+ D++S
Sbjct: 160 LLNTTCDLKICDFGLARVADPDHDHTGFLTEYV-ATRWYRAPEIMLNSKGYTKSIDIWSV 218
Query: 281 GVVLVELLTGQKPI 294
G +L E+L+ +PI
Sbjct: 219 GCILAEMLSN-RPI 231
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 27/217 (12%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE--QFINEVVILSQINH 146
Y + +G G QG V VA+KK ++ + E+V++ +NH
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 120
Query: 147 RNVVKLL-----GCCLESEVPL-LVYEFIP---NGTLYHYLHDQTEEFPITWEMRLRIAI 197
+N++ LL LE + LV E + + L + + + ++M L
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY-LLYQM-LC--- 175
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT 257
+ +LHSA I HRD+K SNI++ K+ DFG +RT +T V T
Sbjct: 176 ----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV-VT 226
Query: 258 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
Y PE + E D++S G ++ E++ K +
Sbjct: 227 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH-KIL 262
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 1e-16
Identities = 54/220 (24%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE--QFINEVVILSQINH 146
Y + +G G G V + G VA+KK +S + + E+ +L + H
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 83
Query: 147 RNVVKLLGCCLESEVPL------LVYEFIPNGTLYHYLHDQ--TEEF--PITWEMRLRIA 196
NV+ LL E LV F+ L + + E+ + ++M L+
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEKLGEDRIQFLVYQM-LK-- 139
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQ 255
+ Y+H+A I HRD+K N+ +++ K+ DFG +R + T ++ TR
Sbjct: 140 -----GLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW- 190
Query: 256 GTFGYLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
Y PE ++T+ D++S G ++ E++TG K +
Sbjct: 191 ----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-KTL 225
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 32/219 (14%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE--QFINEVVILSQINH 146
Y + +G G G+V + G VA+KK +S + + E+++L + H
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH 82
Query: 147 RNVVKLLGCCLESEVPL-------LVYEFIPNGTLYHYLHDQTEEFPITWEM--RLRIAI 197
NV+ LL L LV F+ L + + E I + + L+
Sbjct: 83 ENVIGLLDV-FTPASSLRNFYDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLK--- 137
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQG 256
+ Y+HSA + HRD+K N+ +++ K+ DFG +R + T + TR
Sbjct: 138 ----GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-- 188
Query: 257 TFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
Y PE + + D++S G ++ E+LTG K +
Sbjct: 189 ---YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG-KTL 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 33/220 (15%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE--QFINEVVILSQINH 146
+ Y +G G G+V G VAVKK +S + + E+ +L + H
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 87
Query: 147 RNVVKLLGCCLESEVPL------LVYEFIPNGTLYHYLHDQ--TEEF--PITWEMRLRIA 196
NV+ LL + LV + L + + Q T++ + +++ LR
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQI-LR-- 143
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQ 255
+ Y+HSA I HRD+K SN+ +++ K+ DFG +R + T ++ TR
Sbjct: 144 -----GLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW- 194
Query: 256 GTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
Y PE + + D++S G ++ ELLTG + +
Sbjct: 195 ----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG-RTL 229
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 58/230 (25%), Positives = 104/230 (45%), Gaps = 40/230 (17%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN 148
Y + LG GG G V+ + VA+KK L D +V+ + E+ I+ +++H N
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69
Query: 149 VVKLL----------GCCLESEVPL----LVYEFIPNGT-LYHYLHDQ--TEEFP--ITW 189
+VK+ + S L +V E++ T L + L EE +
Sbjct: 70 IVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQGPLLEEHARLFMY 127
Query: 190 EMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDFGASRTIKVDQT 248
++ LR + Y+HSA + HRD+K +N+ ++ + K+ DFG +R + +
Sbjct: 128 QL-LR-------GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS 176
Query: 249 H---LTTRVQGTFGYLDPE-YFRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
H L+ + T Y P + +T+ D+++ G + E+LTG K +
Sbjct: 177 HKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG-KTL 224
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 4e-15
Identities = 55/235 (23%), Positives = 92/235 (39%), Gaps = 52/235 (22%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFIN---------EVV 139
+ ++ +LG+G G V G IVA+KK +E F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK--------IEPFDKPLFALRTLREIK 61
Query: 140 ILSQINHRNVVKLLGCCLESEVPL-----LVYEFIPNGT-LYHYLHDQ--TEEFP--ITW 189
IL H N++ + ++ E + T L+ + Q +++ +
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVISTQMLSDDHIQYFIY 119
Query: 190 EMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249
+ LR A+ LH + + HRD+K SN+L++ KV DFG +R I
Sbjct: 120 QT-LR-------AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD 168
Query: 250 LTTRVQGTFG---------YLDPEY-FRSSQFTEKSDVYSFGVVLVELLTGQKPI 294
+ G Y PE S++++ DV+S G +L EL +PI
Sbjct: 169 NSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLR-RPI 222
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 50/246 (20%), Positives = 91/246 (36%), Gaps = 49/246 (19%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVE--QFINEVVILSQINH 146
DNY ++G+G G VY VA+KK + E ++ + + E+ IL+++
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKS 84
Query: 147 RNVVKLLGCCL-ESEVPL----LVYEFIPNGT-LYHYLHDQ---TEEF--PITWEMRLRI 195
+++L + + + +V E + L TEE I + + L
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPIFLTEEHIKTILYNL-LL- 140
Query: 196 AIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQ 255
+++H + I HRD+K +N LL+ KV DFG +RTI ++
Sbjct: 141 ------GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDL 191
Query: 256 GTFGYLDP----------EY------------FRSSQFTEKSDVYSFGVVLVELLTGQKP 293
P + +T+ D++S G + ELL +
Sbjct: 192 EENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251
Query: 294 IRSTDA 299
+
Sbjct: 252 HINDPT 257
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 62/237 (26%), Positives = 104/237 (43%), Gaps = 42/237 (17%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLVDESNVEQFINEVVILSQ 143
EK D Y + ++G+G G V K + VA+K K+K ++ + Q EV +L
Sbjct: 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLEL 106
Query: 144 INHR------NVVKLLGC-------CLESEVPLL---VYEFIPNGTLYHYLHDQTEEFPI 187
+N +V L CL E +L +Y+ + T +
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFE--MLSYNLYDLL----------RNTNFRGV 154
Query: 188 TWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA--KVSDFGASRTIKV 245
+ + + A ++ A+ +L + + I H D+K NILL + R+ K+ DFG+S ++
Sbjct: 155 SLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--CQL 211
Query: 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
Q +Q F Y PE + D++S G +LVE+ TG +P+ S E D
Sbjct: 212 GQRI-YQYIQSRF-YRSPEVLLGMPYDLAIDMWSLGCILVEMHTG-EPLFSGANEVD 265
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 1e-13
Identities = 61/233 (26%), Positives = 95/233 (40%), Gaps = 48/233 (20%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLVDESNVEQFINEVVILSQINHR-- 147
Y +++G+G G V K VA+K +++ + Q E+ IL + +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDK 155
Query: 148 ----NVVKLLGC-------CLESEVPLL---VYEFIPNGTLYHYLHDQTEEFPITWEMRL 193
NV+ +L C+ E LL +YE I + + L
Sbjct: 156 DNTMNVIHMLENFTFRNHICMTFE--LLSMNLYELIKKNK-FQGFS-----------LPL 201
Query: 194 --RIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA--KVSDFGASRTIKVDQTH 249
+ A + + LH I H D+K NILL + R+ KV DFG+S Q
Sbjct: 202 VRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRV 256
Query: 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
T +Q F Y PE +++ D++S G +L ELLTG P+ + E D
Sbjct: 257 -YTYIQSRF-YRAPEVILGARYGMPIDMWSLGCILAELLTG-YPLLPGEDEGD 306
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 1e-13
Identities = 48/233 (20%), Positives = 91/233 (39%), Gaps = 55/233 (23%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLVDESNVEQFINEVVILSQIN---- 145
Y R LG G TV+ + + VA+K + + E +E+ +L ++N
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADN 77
Query: 146 -------HRNVVKLLGC-----------CLESEVPLL---VYEFIPNGTLYHYLHDQTEE 184
+++KLL + E +L + I Y +
Sbjct: 78 TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE--VLGENLLALI---KKYEH-----RG 127
Query: 185 FPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA------KVSDFG 238
P+ + ++ +I+ ++ + Y+H I I H DIK N+L++ K++D G
Sbjct: 128 IPLIY-VK-QISKQLLLGLDYMHRRCGI-I-HTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 291
+ H T +Q Y PE + + +D++S ++ EL+TG
Sbjct: 184 NACWYD---EHYTNSIQTRE-YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 1e-13
Identities = 58/281 (20%), Positives = 105/281 (37%), Gaps = 65/281 (23%)
Query: 65 QQQLSSNEGNIEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKS 123
++Q S++ + + + D Y ++G G G V + + +VA+KK
Sbjct: 30 RKQHHSSKPTASMPRPHSDWQI---PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI 86
Query: 124 KLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL-----LVYEFIPNGT-LY 175
V D + ++ + E+ IL+++NH +VVK+L + +V +V E +
Sbjct: 87 LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFK 144
Query: 176 HYL---------HDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL 226
H +T + + + L + Y+HSA I HRD+K +N L+
Sbjct: 145 KLFRTPVYLTELHIKT----LLYNL-LV-------GVKYVHSAG---ILHRDLKPANCLV 189
Query: 227 DDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP---------------EY------ 265
+ KV DFG +RT+ + + +
Sbjct: 190 NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWY 249
Query: 266 ------FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300
+TE DV+S G + ELL K + A+
Sbjct: 250 RAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHAD 290
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 60/246 (24%), Positives = 104/246 (42%), Gaps = 64/246 (26%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKK-----SKLVDESNVEQFINEVVILSQ 143
Y + LG+G G V+K + G +VAVKK D ++ E++IL++
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTD---AQRTFREIMILTE 64
Query: 144 IN-HRNVVKLLGCCLESEVPL--------LVYEFIPNGT-LYHYLHDQ--TEEF--PITW 189
++ H N+V LL V LV++++ T L+ + + +
Sbjct: 65 LSGHENIVNLL------NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVY 116
Query: 190 EMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249
++ ++ + YLHS + HRD+K SNILL+ + KV+DFG SR+ +
Sbjct: 117 QL-IK-------VIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165
Query: 250 LTTRVQGTFGYLDP---------EY------------FRSSQFTEKSDVYSFGVVLVELL 288
+ +Y S+++T+ D++S G +L E+L
Sbjct: 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 289 TGQKPI 294
G KPI
Sbjct: 226 CG-KPI 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 50/238 (21%), Positives = 98/238 (41%), Gaps = 36/238 (15%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRN 148
+ + R +G G G +Y G + VA+K + ++ Q + E I +
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV--KTKHPQLLYESKIYRILQGGTG 64
Query: 149 VVKLLGCCLESEVPLLVYEFI-PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
+ + +E + +LV + + P+ L + + + + + L +A ++ + ++H
Sbjct: 65 IPNVRWFGVEGDYNVLVMDLLGPS--LEDLFNFCSRKLSL--KTVLMLADQMINRVEFVH 120
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAK---VSDFGASRTIKVDQT--HLTTR----VQGTF 258
S + + HRDIK N L+ RA + DFG ++ + T H+ R + GT
Sbjct: 121 SKSFL---HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 259 GY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IRSTDAEEDRSLVG 307
Y L E R + D+ S G VL+ L G P +++ ++ +
Sbjct: 178 RYASVNTHLGIEQSR------RDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKIS 229
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 6e-11
Identities = 76/375 (20%), Positives = 114/375 (30%), Gaps = 126/375 (33%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLVDESNVEQFINEVVILSQI-- 144
Y+ R LG G TV+ + VA+K KS E E ++E+ +L +
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS---AEHYTETALDEIRLLKSVRN 92
Query: 145 ------NHRNVVKLLGC-----------CLESEVPLLVYEFIPNG-TLYHYLHDQTEEFP 186
N VV+LL C+ V+E G L ++
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICM-------VFE--VLGHHLLKWIIKS-NYQG 142
Query: 187 ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL-------------------- 226
+ +I +V + YLH+ I H DIK NILL
Sbjct: 143 LPLPCVKKIIQQVLQGLDYLHTKCRII--HTDIKPENILLSVNEQYIRRLAAEATEWQRS 200
Query: 227 -----------------------------DDKYRAKVSDFGASRTIKVDQTHLTTRVQGT 257
+K + K++D G + H T +Q T
Sbjct: 201 GAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACW---VHKHFTEDIQ-T 256
Query: 258 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRS----------LVG 307
Y E S + +D++S + EL TG EE L+G
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
Query: 308 ---------------FF--------LQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKR 344
FF + + LFEVL + E +EE
Sbjct: 317 KVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY--EWSQEEAAGFTDFLLP 374
Query: 345 CLNMIGKKRPSMKEV 359
L +I +KR + E
Sbjct: 375 MLELIPEKRATAAEC 389
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 1e-10
Identities = 53/238 (22%), Positives = 96/238 (40%), Gaps = 36/238 (15%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINH-RN 148
+ Y R +G G G +Y G +A G VA+K + ++ Q E I +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYKMMQGGVG 66
Query: 149 VVKLLGCCLESEVPLLVYEFI-PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
+ + C E + ++V E + P+ L + + +F + + L +A ++ + Y+H
Sbjct: 67 IPTIRWCGAEGDYNVMVMELLGPS--LEDLFNFCSRKFSL--KTVLLLADQMISRIEYIH 122
Query: 208 SATSIPIYHRDIKSSNILL---DDKYRAKVSDFGASRTIKVDQT--HLTTR----VQGTF 258
S I HRD+K N L+ + DFG ++ + +T H+ R + GT
Sbjct: 123 SKNFI---HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 259 GY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IRSTDAEEDRSLVG 307
Y L E R + D+ S G VL+ G P +++ + +
Sbjct: 180 RYASINTHLGIEQSR------RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 231
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 60.3 bits (145), Expect = 3e-10
Identities = 30/213 (14%), Positives = 65/213 (30%), Gaps = 54/213 (25%)
Query: 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNV--------EQFINEVVI 140
T+ +G+G G V++ + AD VA+K + V E+ + E++I
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 141 LSQI---------NHRNVVKLLGCCL----------------------ESEVPL------ 163
++ + L ++ P
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 164 --LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKS 221
+V EF G + + + I +++ +++ S+ HRD+
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHW 190
Query: 222 SNILLDDKYRAKVSDFGASRTIKVDQTHLTTRV 254
N+LL K+ ++ + L +
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 6e-10
Identities = 48/240 (20%), Positives = 90/240 (37%), Gaps = 38/240 (15%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRN 148
+Y R +G+G G +++G L + VA+K S+ Q +E +
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 67
Query: 149 VVKLLGCCLESEVPLLVYEFI-PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
+ + E +LV + + P+ L L +F + + A ++ + +H
Sbjct: 68 IPNVYYFGQEGLHNVLVIDLLGPS--LEDLLDLCGRKFSV--KTVAMAAKQMLARVQSIH 123
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAK-----VSDFGASRTIKVDQT--HLTTR----VQG 256
+ + +RDIK N L+ V DFG + + T H+ R + G
Sbjct: 124 EKSLV---YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 257 TFGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IRSTDAEEDRSLVG 307
T Y L E R + D+ + G V + L G P +++ ++ +G
Sbjct: 181 TARYMSINTHLGREQSR------RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 234
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-09
Identities = 45/213 (21%), Positives = 77/213 (36%), Gaps = 47/213 (22%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQI-NHR 147
+++LG G G V + A+K EV + +
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR--------EVELHWRASQCP 71
Query: 148 NVVKLLGCCLESEVP----LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
++V+++ L+V E + G L+ + D+ ++ T I + A+
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA-FTEREASEIMKSIGEAI 130
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRA---KVSDFGASRTIKVDQTHLTTRVQGTFGY 260
YLHS I I HRD+K N+L K K++DFG
Sbjct: 131 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFG---------------------- 165
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
E ++ + D++S GV++ LL G P
Sbjct: 166 FAKE-TTGEKYDKSCDMWSLGVIMYILLCGYPP 197
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 51/254 (20%), Positives = 86/254 (33%), Gaps = 66/254 (25%)
Query: 90 TDNYNANRILGQGGQGTVYKGM--LADGGIVAVKKSKLVDESNVEQFIN----EVVILSQ 143
+ Y LG+G G V + + VA+K + NV ++ E+ +L +
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIR-----NVGKYREAARLEINVLKK 72
Query: 144 INHR------NVVKLLGC-------CLESEVPLL---VYEFIPNGTLYHYLHDQTEEFPI 187
I + V + C+ E LL +EF+ + P
Sbjct: 73 IKEKDKENKFLCVLMSDWFNFHGHMCIAFE--LLGKNTFEFL----------KENNFQPY 120
Query: 188 TWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA--------------- 232
+A ++ A+ +LH H D+K NIL +
Sbjct: 121 PLPHVRHMAYQLCHALRFLHENQLT---HTDLKPENILFVNSEFETLYNEHKSCEEKSVK 177
Query: 233 ----KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELL 288
+V+DFG++ + H TT V Y PE + + DV+S G +L E
Sbjct: 178 NTSIRVADFGSA--TFDHEHH-TTIVATRH-YRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 289 TGQKPIRSTDAEED 302
G + T +
Sbjct: 234 RG-FTLFQTHENRE 246
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-09
Identities = 59/244 (24%), Positives = 86/244 (35%), Gaps = 69/244 (28%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFIN----EVVILSQINHR 147
+ R +G G G V + + AVK + N++++ E IL +I +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVR-----NIKKYTRSAKIEADILKKIQND 91
Query: 148 -----NVVKLLGC-------CLESEVPLL---VYEFIPNGTLYHYLHDQTEEFPITWEMR 192
N+VK G CL E L +YE I + E
Sbjct: 92 DINNNNIVKYHGKFMYYDHMCLIFE--PLGPSLYEII----------TRNNYNGFHIEDI 139
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA-------------------- 232
IE+ A++YL + H D+K NILLDD Y
Sbjct: 140 KLYCIEILKALNYLRKMSLT---HTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRT 196
Query: 233 -----KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVEL 287
K+ DFG + H + + Y PE + + SD++SFG VL EL
Sbjct: 197 KSTGIKLIDFGCA--TFKSDYH-GSIINTRQ-YRAPEVILNLGWDVSSDMWSFGCVLAEL 252
Query: 288 LTGQ 291
TG
Sbjct: 253 YTGS 256
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 36/183 (19%), Positives = 61/183 (33%), Gaps = 36/183 (19%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSK--------LVDESNVEQFINEVVILS 142
+ + +G GG G +Y A K L E Q + + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIK 97
Query: 143 QINHRNVVKLLGCCLESEVPLLVY--EFIPNGTLYHY------------LHDQTEEFPIT 188
+ R + LG +PL G Y + + Q F
Sbjct: 98 KWIERKQLDYLG------IPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKK- 150
Query: 189 WEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV--SDFGASRTIKVD 246
L++ I + + Y+H + H DIK++N+LL K +V +D+G S +
Sbjct: 151 -STVLQLGIRMLDVLEYIHENEYV---HGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206
Query: 247 QTH 249
H
Sbjct: 207 GNH 209
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 50/239 (20%), Positives = 89/239 (37%), Gaps = 38/239 (15%)
Query: 92 NYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNV 149
N+ + +G G G + G L VA+K + +S Q E Q+ + +
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPM--KSRAPQLHLEYRFYKQLGSGDGI 67
Query: 150 VKLLGCCLESEVPLLVYEFI-PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
++ + +V E + P+ L F + + L IAI++ M Y+HS
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGPS--LEDLFDLCDRTFSL--KTVLMIAIQLISRMEYVHS 123
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVS-----DFGASRTIKVDQT--HLTTR----VQGT 257
I +RD+K N L+ DF ++ +T H+ R + GT
Sbjct: 124 KNLI---YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGT 180
Query: 258 FGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP---IRSTDAEEDRSLVG 307
Y L E R + D+ + G + + L G P +++ +E +G
Sbjct: 181 ARYMSINTHLGKEQSR------RDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIG 233
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 3e-08
Identities = 58/240 (24%), Positives = 92/240 (38%), Gaps = 65/240 (27%)
Query: 93 YNANRILGQGGQGTVYKG--MLADGGIVAVKKSKLVDESNVEQFIN----EVVILSQINH 146
Y LG+G G V + A G VAVK K NV+++ E+ +L +N
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-----NVDRYCEAARSEIQVLEHLNT 70
Query: 147 R------NVVKLLGC-------CLESEVPLL---VYEFIPNGTLYHYLHDQTEEFPITWE 190
V++L C+ E LL Y+FI + P +
Sbjct: 71 TDPNSTFRCVQMLEWFEHHGHICIVFE--LLGLSTYDFI----------KENGFLPFRLD 118
Query: 191 MRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL-DDKYRA----------------- 232
++A ++ ++++LHS H D+K NIL Y
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLT---HTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175
Query: 233 -KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ 291
KV DFG++ D+ H +T V Y PE + +++ DV+S G +L+E G
Sbjct: 176 IKVVDFGSA--TYDDEHH-STLVSTRH-YRAPEVILALGWSQPCDVWSIGCILIEYYLGF 231
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 1e-07
Identities = 43/238 (18%), Positives = 77/238 (32%), Gaps = 49/238 (20%)
Query: 92 NYNANRILGQGGQGTVYKGM------LADGGIVAVKKSK-----LVDESNVEQFINEVVI 140
+ +GQGG G +Y + VK L E Q +
Sbjct: 36 AWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95
Query: 141 LSQINHRNVVKLLG-----CCLESEVPLLVYEFI------PNGTLYHYLHDQTEEFPITW 189
+ + +K LG + Y F+ + L + F
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSD--LQKIYEANAKRFSR-- 151
Query: 190 EMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV--SDFGASRTIKVDQ 247
+ L++++ + + Y+H + H DIK+SN+LL+ K +V D+G + +
Sbjct: 152 KTVLQLSLRILDILEYIHEHEYV---HGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 248 THL------TTRVQGTFGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293
H GT + R + D+ G +++ LTG P
Sbjct: 209 VHKAYAADPKRCHDGTIEFTSIDAHNGVAPSR------RGDLEILGYCMIQWLTGHLP 260
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 35/241 (14%), Positives = 80/241 (33%), Gaps = 55/241 (22%)
Query: 92 NYNANRILGQGGQGTVYKGMLADGGI---------VAVK----KSKLVDESNVEQFINEV 138
+ + QG +Y+ ++K +L +E N Q +
Sbjct: 43 QWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKP 102
Query: 139 VILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHY------------LHDQTEEFP 186
+ +++ LL +P + F + Y + D + +
Sbjct: 103 LQVNKWKKLYSTPLLA------IPTCMG-FGVHQDKYRFLVLPSLGRSLQSALDVSPKHV 155
Query: 187 ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV--SDFGASRTIK 244
++ L++A + A+ +LH + H ++ + NI +D + +++V + +G +
Sbjct: 156 LSERSVLQVACRLLDALEFLHENEYV---HGNVTAENIFVDPEDQSQVTLAGYGFAFRYC 212
Query: 245 VDQTHLTTRVQ------GTFGY------LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQK 292
H+ G + R +SD+ S G +++ L G
Sbjct: 213 PSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSR------RSDLQSLGYCMLKWLYGFL 266
Query: 293 P 293
P
Sbjct: 267 P 267
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 49.9 bits (118), Expect = 1e-06
Identities = 66/462 (14%), Positives = 141/462 (30%), Gaps = 150/462 (32%)
Query: 30 FILLIGMWGLRKFV---KRRREIKLKRMFF-----------KKNGGLLLQQQLSSNEGNI 75
+L+ G+ G K K++ +L Q
Sbjct: 152 NVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ-------- 203
Query: 76 EKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFI 135
KL ++D N+ + + + K + + + +L+ + +
Sbjct: 204 ---KLLYQIDP-----NWTS-----RSDHSSNIKLRIHS---IQAELRRLLKS---KPYE 244
Query: 136 NEVVILSQINHRNVVKL--LGCCLESEVPLL-------VYEFIPNGTLYH---------Y 177
N +++L + + L C +L V +F+ T H
Sbjct: 245 NCLLVLLNVQNAKAWNAFNLSC------KILLTTRFKQVTDFLSAATTTHISLDHHSMTL 298
Query: 178 LHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF 237
D+ + + + L + +P R++ ++N +S
Sbjct: 299 TPDEVKSLLLKY---LDCRPQ------------DLP---REVLTTNPRR-------LSII 333
Query: 238 GAS-----------RTIKVDQTHLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFG 281
S + + D+ LTT ++ + L+P +R S F + + +
Sbjct: 334 AESIRDGLATWDNWKHVNCDK--LTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPT-- 389
Query: 282 VVLVEL---LTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITV 338
++L + + + + SL ++ ++ + + + K E
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSL----VEKQPKESTISIPSIYLELKVKLENEYA- 444
Query: 339 AMLGKRCLN--MIGKKRPSMKEVAFELEG-IRASIGSSSLQH--NCEEIH---------- 383
L + ++ I K S + L+ + IG H N E
Sbjct: 445 --LHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG----HHLKNIEHPERMTLFRMVFL 498
Query: 384 ---FVGGDNTRHSGTDYSSTGSILNSVA-------YSTDADP 415
F+ RH T ++++GSILN++ Y D DP
Sbjct: 499 DFRFLEQ-KIRHDSTAWNASGSILNTLQQLKFYKPYICDNDP 539
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 419 | |||
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.45 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.31 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.19 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.1 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.85 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.7 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.65 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.63 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.53 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.5 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.29 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.25 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.13 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.98 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.96 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.72 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.61 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.58 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.45 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.38 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.26 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.16 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.98 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.92 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 96.27 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.98 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 95.94 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 95.43 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 94.54 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.98 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 90.37 | |
| 2knc_B | 79 | Integrin beta-3; transmembrane signaling, protein | 89.62 | |
| 1iij_A | 35 | ERBB-2 receptor protein-tyrosine kinase; alpha-hel | 88.5 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.26 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.64 |
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-61 Score=446.14 Aligned_cols=260 Identities=27% Similarity=0.416 Sum_probs=220.5
Q ss_pred cCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
++|.+.+.||+|+||+||+|++. ++..||||+++.......++|.+|+++|++++|||||+++|+|.+.+..++
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56888899999999999999864 367899999987777777899999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccC----------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 165 VYEFIPNGTLYHYLHDQT----------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
|||||++|+|.++|+... ....++|.+++.++.||+.||.|||+++ |+||||||+|||+++++.+||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 999999999999997642 2346999999999999999999999998 999999999999999999999
Q ss_pred eecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHH
Q 014725 235 SDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
+|||+|+......... .....||+.|||||++.+..|+.++|||||||++|||+| |+.||......+.
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---------- 239 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---------- 239 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH----------
T ss_pred CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH----------
Confidence 9999998765433322 234568999999999999999999999999999999999 9999987654331
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
...+........+..++..+.+|+.+||+.||++|||+.+|.+.|+++.+.
T Consensus 240 ------~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~ 290 (299)
T 4asz_A 240 ------IECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA 290 (299)
T ss_dssp ------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ------HHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 111222222344556677899999999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-60 Score=446.77 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=214.5
Q ss_pred hcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.++|.+.+.||+|+||+||+|++. ++..||||+++..+....+.|.+|+++|++++|||||+++|+|.+.+..+
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~ 119 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL 119 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 356778899999999999999864 36789999998777777889999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCC------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc
Q 014725 164 LVYEFIPNGTLYHYLHDQTE------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR 231 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 231 (419)
+|||||++|+|.++++.... ..+++|.+++.|+.||+.||.|||+++ |+||||||+|||+++++.
T Consensus 120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTE
T ss_pred EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCc
Confidence 99999999999999976432 246999999999999999999999998 999999999999999999
Q ss_pred EEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHH
Q 014725 232 AKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFF 309 (419)
Q Consensus 232 ~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~ 309 (419)
+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||......+.
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~------- 269 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA------- 269 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH-------
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH-------
Confidence 99999999987654332 23345679999999999999999999999999999999999 9999987654331
Q ss_pred HHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 310 LQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
...+......+.+..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus 270 ---------~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 270 ---------IDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp ---------HHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred ---------HHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 11111222234455667789999999999999999999999999998865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-60 Score=441.91 Aligned_cols=257 Identities=25% Similarity=0.393 Sum_probs=216.1
Q ss_pred cCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.++++.+.||+|+||+||+|.+. +++.||||+++.. .....+.|.+|+.++++++|||||+++|+|.+.+..+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~ 105 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS 105 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence 44677889999999999999863 4578999998753 3344678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC
Q 014725 164 LVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY 230 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 230 (419)
+|||||++|+|.++|..... ...++|..+++++.|||.||.|||+++ ||||||||+||||++++
T Consensus 106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~ 182 (308)
T 4gt4_A 106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL 182 (308)
T ss_dssp EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence 99999999999999975321 235899999999999999999999998 99999999999999999
Q ss_pred cEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHH
Q 014725 231 RAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGF 308 (419)
Q Consensus 231 ~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~ 308 (419)
.+||+|||+++....... .......||+.|||||++.++.++.++|||||||++|||+| |..||.+....+.
T Consensus 183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~------ 256 (308)
T 4gt4_A 183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------ 256 (308)
T ss_dssp CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH------
T ss_pred CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH------
Confidence 999999999987654332 23345679999999999999999999999999999999999 8999987665331
Q ss_pred HHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.+.+......+.+..++..+.+|+.+||+.||.+|||+.||++.|+.+
T Consensus 257 ----------~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~ 304 (308)
T 4gt4_A 257 ----------VEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW 304 (308)
T ss_dssp ----------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred ----------HHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 112222223345666778899999999999999999999999999864
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-59 Score=434.84 Aligned_cols=265 Identities=28% Similarity=0.433 Sum_probs=210.7
Q ss_pred HHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
+...+++.+.+.||+|+||+||+|++.+ .||||.++.. +....+.|.+|+.++++++|||||+++|++.+ +..++
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i 108 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI 108 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence 4456778889999999999999998753 5999987643 34566789999999999999999999999865 56899
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
|||||++|+|.++|..... .++|.+++.|+.||+.||.|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 109 VmEy~~gGsL~~~l~~~~~--~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~ 183 (307)
T 3omv_A 109 VTQWCEGSSLYKHLHVQET--KFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKS 183 (307)
T ss_dssp EEECCSSCBHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred EEEcCCCCCHHHHHhhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence 9999999999999976543 5999999999999999999999998 9999999999999999999999999998764
Q ss_pred cCC-ceeeecccccCCccCcccccc---CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 245 VDQ-THLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 245 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
... .......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||........ .......+..
T Consensus 184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~------~~~~~~~~~~-- 255 (307)
T 3omv_A 184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ------IIFMVGRGYA-- 255 (307)
T ss_dssp ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH------HHHHHHTTCC--
T ss_pred cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcCCC--
Confidence 322 233455689999999999864 4689999999999999999999999986543321 1111111000
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.......+.+++..+.+|+.+||+.||++|||+.||++.|+.++.++
T Consensus 256 ---~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 256 ---SPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp ---CCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred ---CCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 00011234456678999999999999999999999999999887544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-58 Score=433.18 Aligned_cols=250 Identities=23% Similarity=0.350 Sum_probs=205.7
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999996 46889999987643 44556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
||+||+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 104 y~~gg~L~~~i~~~~~-~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQKG-VLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 9999999999976543 35789999999999999999999999 9999999999999999999999999998764321
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+. +.. +... ..
T Consensus 180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~---------i~~~-~~ 242 (350)
T 4b9d_A 180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL------VLK---------IISG-SF 242 (350)
T ss_dssp -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHH---------HHHT-CC
T ss_pred -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHH---------HHcC-CC
Confidence 123456799999999999999999999999999999999999999987654321 111 1111 11
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 243 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 243 PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1223345567899999999999999999999976
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-58 Score=434.63 Aligned_cols=271 Identities=27% Similarity=0.388 Sum_probs=225.6
Q ss_pred cCHHHHHHHhcCccccCcccccCcEEEEEEEecC------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCC-cccccE
Q 014725 81 FTKMDLEKATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLV-DESNVEQFINEVVILSQINH-RNVVKL 152 (419)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l 152 (419)
+....++...++|++.+.||+|+||+||+|.+.. ++.||||++... .....+.|.+|+.+|++++| ||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 4566777888999999999999999999999643 247999998754 34456789999999999965 999999
Q ss_pred EeEEecC-CcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 014725 153 LGCCLES-EVPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRD 218 (419)
Q Consensus 153 ~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D 218 (419)
+|+|.+. +..++|||||++|+|.++|+.... ...+++..++.++.|||.||.|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999764 568999999999999999976321 235899999999999999999999999 99999
Q ss_pred CCCCcEEECCCCcEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCC
Q 014725 219 IKSSNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRS 296 (419)
Q Consensus 219 lkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~ 296 (419)
|||+|||+++++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |+.||.+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 999999999999999999999997654433 33455679999999999999999999999999999999998 9999987
Q ss_pred CChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 297 TDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
....+. +...+........+..++..+.+++.+||+.||.+|||+.||++.|+.+.++
T Consensus 291 ~~~~~~---------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDEE---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSHH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHH---------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 543221 1222223333444556677899999999999999999999999999988654
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-57 Score=427.54 Aligned_cols=249 Identities=25% Similarity=0.366 Sum_probs=210.1
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
..|++.+.||+|+||+||+|++. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..|+|||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 56999999999999999999974 68899999987554455567899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
+||+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 154 ~gg~L~~~l~~~----~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~ 225 (346)
T 4fih_A 154 EGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-P 225 (346)
T ss_dssp TTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-C
T ss_pred CCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-C
Confidence 999999999753 3899999999999999999999999 9999999999999999999999999998765432 2
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
.....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+. ...+..... ....
T Consensus 226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~~~-----------~~~~ 291 (346)
T 4fih_A 226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNLP-----------PRLK 291 (346)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSSC-----------CCCS
T ss_pred cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcCCC-----------CCCC
Confidence 34557899999999999999999999999999999999999999987654321 111110000 0111
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+..+.+|+.+||+.||++|||+.|+++
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~ 323 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 323 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 12334567899999999999999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=422.20 Aligned_cols=257 Identities=21% Similarity=0.218 Sum_probs=210.4
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.+.|.+.+.||+|+||+||+|++. +|+.||||+++.... ..+|+.+++.++|||||++++++.+++..|+||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 456888899999999999999974 588999999864321 24799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCceecccCC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~~~~ 247 (419)
|+||+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+|+......
T Consensus 132 ~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQMG---CLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999998654 5999999999999999999999999 99999999999999987 69999999999765432
Q ss_pred ce----eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 248 TH----LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 248 ~~----~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.. .....+||+.|||||++.+..|+.++|||||||++|||+||+.||......+. ...+.. ..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~i~~---~~------- 272 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLKIAS---EP------- 272 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHHHHH---SC-------
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHHc---CC-------
Confidence 21 22346799999999999999999999999999999999999999976543321 111111 00
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhC
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIG 371 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~ 371 (419)
......+...+..+.+++.+||+.||.+|||+.|+++.|.......+
T Consensus 273 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~ 319 (336)
T 4g3f_A 273 -PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG 319 (336)
T ss_dssp -CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred -CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence 00112344556779999999999999999999999999887765443
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-57 Score=418.79 Aligned_cols=248 Identities=23% Similarity=0.350 Sum_probs=210.8
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||+||+|+. .+++.||||.+... .....+.+.+|+++|++++|||||++++++.+.+..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 5699999999999999999996 46889999987532 2334578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
|||+||+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 9999999999998654 4999999999999999999999999 999999999999999999999999999987543
Q ss_pred C-ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 Q-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. .......+||+.|||||++.+..|+.++|||||||++|||+||+.||...+..+. ...+ ...
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i--------~~~- 249 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI-------FAKI--------IKL- 249 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH--------HHT-
T ss_pred CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHH--------HcC-
Confidence 3 2334567899999999999999999999999999999999999999987654321 1111 111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+|+.+||+.||.+|||+.|++.
T Consensus 250 -~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~ 284 (311)
T 4aw0_A 250 -EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 284 (311)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred -CCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence 11223344567899999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-56 Score=412.87 Aligned_cols=246 Identities=24% Similarity=0.387 Sum_probs=198.6
Q ss_pred cccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEec----CCcceEEE
Q 014725 94 NANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLE----SEVPLLVY 166 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 166 (419)
++.+.||+|+||+||+|.+. ++..||+|++.. ......+.|.+|+.+|++++|||||++++++.+ ....|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 66778999999999999974 578999998753 345556789999999999999999999999865 34579999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~ 245 (419)
|||++|+|.+++.+.. .+++..+..++.||+.||.|||+++. +|+||||||+|||++. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 9999999999998654 58999999999999999999999863 4999999999999974 79999999999975432
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
......+||+.|||||++.+ .|+.++|||||||++|||+||+.||........ ..........
T Consensus 185 ---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~------~~~~i~~~~~------- 247 (290)
T 3fpq_A 185 ---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVK------- 247 (290)
T ss_dssp ---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCC-------
T ss_pred ---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH------HHHHHHcCCC-------
Confidence 23345689999999999875 699999999999999999999999975443211 1111111100
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...++.+.+|+.+||+.||++|||+.|+++
T Consensus 248 -~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~ 282 (290)
T 3fpq_A 248 -PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00111222346889999999999999999999975
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-56 Score=428.90 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=211.2
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.+.|++.+.||+|+||.||+|++. +|+.||||++........+.+.+|+.+|+.++|||||++++++.+.+..|+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy 229 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 229 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence 357999999999999999999974 5889999998766555567799999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
|+||+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 230 ~~gG~L~~~i~~~----~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~- 301 (423)
T 4fie_A 230 LEGGALTDIVTHT----RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV- 301 (423)
T ss_dssp CTTEEHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred CCCCcHHHHHhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence 9999999999753 3899999999999999999999999 9999999999999999999999999998765432
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+. ...+.... ....
T Consensus 302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~-------~~~i~~~~-------~~~~ 367 (423)
T 4fie_A 302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------MKMIRDNL-------PPRL 367 (423)
T ss_dssp CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHSC-------CCCC
T ss_pred ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHcCC-------CCCC
Confidence 234556899999999999999999999999999999999999999987654331 11111000 0011
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+.+|+.+||+.||++|||+.|+++
T Consensus 368 ~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~ 400 (423)
T 4fie_A 368 KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 400 (423)
T ss_dssp SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 122334567899999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-56 Score=419.40 Aligned_cols=269 Identities=21% Similarity=0.296 Sum_probs=201.2
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC----cceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE----VPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lv~ 166 (419)
++|.+.+.||+|+||+||+|++ +|+.||||++...... ...+..|+..+.+++|||||+++++|.+.+ ..++||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~ 80 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS 80 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence 4578889999999999999998 5889999998643221 122334555667889999999999998654 468999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT-----SIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
|||++|+|.++++.. .++|..+.+++.|++.||.|||++. .++|+||||||+|||++.++++||+|||+++
T Consensus 81 Ey~~~gsL~~~l~~~----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 81 DYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp ECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCCCCCcHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999864 3899999999999999999999871 2349999999999999999999999999998
Q ss_pred ecccCCcee---eecccccCCccCccccccC------CCCcccceechhHHHHHHHhCCCCCCCCChhhh--------cc
Q 014725 242 TIKVDQTHL---TTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED--------RS 304 (419)
Q Consensus 242 ~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~--------~~ 304 (419)
......... ....+||+.|||||++.+. .++.++|||||||++|||+||..||......+. ..
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~ 236 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence 765443322 2345799999999998754 478899999999999999999887754322110 00
Q ss_pred HHHHHHHHhcccchhHHHHHhhc-cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 305 LVGFFLQAMNEDRLFEVLEARVL-KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 305 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
...........+.+ ++.+. ...+.+.+..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 237 ~~~~~~~~~~~~~~----rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~ 298 (303)
T 3hmm_A 237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp CHHHHHHHHTTSCC----CCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hHHHHHHHHhcccC----CCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence 01111111111100 00000 111235667899999999999999999999999999998753
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-55 Score=403.89 Aligned_cols=245 Identities=24% Similarity=0.345 Sum_probs=193.0
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||+||+|+. .+++.||||.+... .....+.+.+|+.++++++|||||++++++.+.+..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 6899999999999999999996 46889999987532 2334567999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+ +|+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQRD---KMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHHSC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 689999998654 5999999999999999999999999 999999999999999999999999999875432
Q ss_pred CceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
......+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+..+. .+.+...
T Consensus 166 --~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~-------~~~i~~~--------- 227 (275)
T 3hyh_A 166 --NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL-------FKNISNG--------- 227 (275)
T ss_dssp -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHT---------
T ss_pred --CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcC---------
Confidence 23345679999999999998876 5799999999999999999999986543321 1111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 228 -~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 228 -VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 11223344567889999999999999999999976
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=410.06 Aligned_cols=242 Identities=27% Similarity=0.323 Sum_probs=196.3
Q ss_pred cCccccCcccccCcEEEEEEEec----CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
++|++.+.||+|+||+||+|+.. .++.||||.+... .......+.+|+++|++++|||||++++++.+.+..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999852 3678999987542 12233468899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
|||||+||+|.+++.+.. .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEV---MFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 999999999999998754 4999999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
... ......+||+.|||||++.+..|+.++|||||||++|||+||+.||.+.+..+. ... +...
T Consensus 178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~--------i~~~ 241 (304)
T 3ubd_A 178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET-------MTM--------ILKA 241 (304)
T ss_dssp ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHH--------HHHC
T ss_pred CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHH-------HHH--------HHcC
Confidence 322 233456899999999999999999999999999999999999999987654331 111 1111
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
....+...+..+.+|+.+||+.||++|||+
T Consensus 242 --~~~~p~~~s~~~~~li~~~L~~dP~~R~ta 271 (304)
T 3ubd_A 242 --KLGMPQFLSPEAQSLLRMLFKRNPANRLGA 271 (304)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred --CCCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence 112334455678999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=404.64 Aligned_cols=250 Identities=24% Similarity=0.376 Sum_probs=190.1
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc-------
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV------- 161 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------- 161 (419)
++|++.+.||+|+||+||+|++. +++.||||++... .....+.+.+|+.+|++++|||||++++++.+.+.
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45899999999999999999964 6889999998653 34455789999999999999999999999875442
Q ss_pred -----ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 014725 162 -----PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSD 236 (419)
Q Consensus 162 -----~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 236 (419)
.|+|||||++|+|.+++.........++..++.++.||+.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 5899999999999999987654445677788899999999999999999 99999999999999999999999
Q ss_pred cCCceecccCCce-----------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccH
Q 014725 237 FGASRTIKVDQTH-----------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSL 305 (419)
Q Consensus 237 fgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~ 305 (419)
||+|+........ .....+||+.|||||++.+..|+.++|||||||++|||++ ||..... .
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~--- 233 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--R--- 233 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--H---
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--H---
Confidence 9999876533211 1234579999999999999999999999999999999996 7753211 0
Q ss_pred HHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 306 VGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. .......... +.......+...+++.+||+.||.+|||+.|+++
T Consensus 234 ~~-~~~~~~~~~~---------p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 VR-TLTDVRNLKF---------PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp HH-HHHHHHTTCC---------CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HH-HHHHHhcCCC---------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0111111110 0011223345678999999999999999999976
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-51 Score=397.65 Aligned_cols=265 Identities=22% Similarity=0.302 Sum_probs=203.9
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEec------CC
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLE------SE 160 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~ 160 (419)
.++|++.+.||+|+||+||+|++ .+|+.||||++... .....+.+.+|+.+|+.++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 36799999999999999999997 46889999998643 33455778999999999999999999999764 35
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..|+|||||+ |+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~~~---~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla 205 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHSSQ---PLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMA 205 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTSSS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEeCCC-CCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeeccee
Confidence 6799999995 68999997643 5999999999999999999999999 999999999999999999999999999
Q ss_pred eecccCC---ceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 241 RTIKVDQ---THLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 241 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
+.+.... .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+...............
T Consensus 206 ~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~ 285 (398)
T 4b99_A 206 RGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPA 285 (398)
T ss_dssp BCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGG
T ss_pred eecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChH
Confidence 8764321 2234567899999999998775 56999999999999999999999998876544221111111110000
Q ss_pred ch--------hHHHHHhhc-cCCC-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 317 RL--------FEVLEARVL-KEGK-----EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 317 ~~--------~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+ ...+..... ...+ ......+.+|+.+||+.||.+|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 344 (398)
T 4b99_A 286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR 344 (398)
T ss_dssp GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 000000000 0000 112356789999999999999999999876
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-51 Score=386.02 Aligned_cols=287 Identities=37% Similarity=0.619 Sum_probs=243.5
Q ss_pred cccCHHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEec
Q 014725 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE 158 (419)
Q Consensus 79 ~~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 158 (419)
..++..++...+++|.+.+.||+|+||.||+|.+.++..||+|+.........+.+.+|+.+++.++||||+++++++.+
T Consensus 27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 106 (321)
T 2qkw_B 27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE 106 (321)
T ss_dssp ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC
T ss_pred eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC
Confidence 34556667778899999999999999999999988899999999887666677889999999999999999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTE-EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF 237 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 237 (419)
.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+||
T Consensus 107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCC
T ss_pred CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeec
Confidence 9999999999999999999976432 235899999999999999999999998 999999999999999999999999
Q ss_pred CCceecccCC-ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 238 GASRTIKVDQ-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 238 gl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
|+++...... ........||+.|+|||++.+..++.++||||||+++|||+||+.||......+......+........
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 9998754322 222344568999999999998999999999999999999999999998766655555555544444444
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.+...+++......+...+..+.+++.+||+.||++|||+.+|++.|+.+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~ 315 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR 315 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence 4555555555556677888999999999999999999999999999998764
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=386.46 Aligned_cols=201 Identities=19% Similarity=0.350 Sum_probs=171.8
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec----CCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCc
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEV 161 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 161 (419)
....++|++.+.||+|+||+||+|+.+ .++.||+|++.... ...++.+|+++|+.+ +||||+++++++.+.+.
T Consensus 17 p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~ 94 (361)
T 4f9c_A 17 PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH 94 (361)
T ss_dssp GGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred CCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence 345688999999999999999999853 35689999876533 345688999999998 69999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCc
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDFGAS 240 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfgl~ 240 (419)
.|+||||+++|+|.+++. .+++.++..++.||+.||+|||+++ |+||||||+|||++.+ +.+||+|||+|
T Consensus 95 ~~lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla 165 (361)
T 4f9c_A 95 VVIAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence 999999999999999984 3889999999999999999999999 9999999999999876 79999999999
Q ss_pred eecccCCc---------------------------eeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCC
Q 014725 241 RTIKVDQT---------------------------HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQK 292 (419)
Q Consensus 241 ~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~ 292 (419)
+....... ......+||+.|+|||++.+. .|+.++||||+||++|||+||+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 86542211 112345799999999998775 58999999999999999999999
Q ss_pred CCCCCC
Q 014725 293 PIRSTD 298 (419)
Q Consensus 293 p~~~~~ 298 (419)
||....
T Consensus 246 Pf~~~~ 251 (361)
T 4f9c_A 246 PFYKAS 251 (361)
T ss_dssp SSSCCS
T ss_pred CCCCCC
Confidence 996543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=380.38 Aligned_cols=291 Identities=37% Similarity=0.635 Sum_probs=243.4
Q ss_pred ccccccCHHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCcccccEEe
Q 014725 76 EKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDE-SNVEQFINEVVILSQINHRNVVKLLG 154 (419)
Q Consensus 76 ~~~~~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~ 154 (419)
.....++..++....++|++.+.||+|+||.||+|...++..||||++..... .....+.+|+.+++.++||||+++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~ 94 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence 34567889999999999999999999999999999988899999999875332 22236899999999999999999999
Q ss_pred EEecCCcceEEEeecCCCCHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEE
Q 014725 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTE-EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAK 233 (419)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~k 233 (419)
++.+.+..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+....+|+||||||+|||++.++.+|
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k 174 (326)
T 3uim_A 95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV 174 (326)
T ss_dssp EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence 99999999999999999999999987542 34599999999999999999999999222299999999999999999999
Q ss_pred EeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCCh--hhhccHHHHHHH
Q 014725 234 VSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDA--EEDRSLVGFFLQ 311 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~--~~~~~~~~~~~~ 311 (419)
|+|||+++..............||+.|+|||++.+..++.++|||||||++|||+||+.||..... ........+...
T Consensus 175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (326)
T 3uim_A 175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254 (326)
T ss_dssp ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence 999999988765555555566799999999999988999999999999999999999999963211 112233344444
Q ss_pred HhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
......+....+.......+...+..+.+++.+||+.||.+|||+.+|++.|++.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 4445555555566666677788889999999999999999999999999999863
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=403.51 Aligned_cols=252 Identities=21% Similarity=0.297 Sum_probs=211.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|++.+.||+|+||+||+|... +|+.||+|.+........+.+.+|+.+|+.++|||||++++++.+.+..|+||||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~ 235 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 235 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence 468999999999999999999974 6889999998776666678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC--CcEEEeecCCceecccC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK--YRAKVSDFGASRTIKVD 246 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~--~~~kl~Dfgl~~~~~~~ 246 (419)
|+||+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus 236 ~~gg~L~~~i~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~ 310 (573)
T 3uto_A 236 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 310 (573)
T ss_dssp CCCCBHHHHHTCTTS--CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred cCCCcHHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence 999999999975432 4899999999999999999999999 9999999999999854 89999999999986543
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. .....+||+.|||||++.+..|+.++|||||||++|||++|..||.+....+. ...+..... ..
T Consensus 311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~-------~~~i~~~~~------~~ 375 (573)
T 3uto_A 311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-------LRNVKSCDW------NM 375 (573)
T ss_dssp S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTCC------CC
T ss_pred C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH-------HHHHHhCCC------CC
Confidence 2 33456799999999999999999999999999999999999999987665431 111111000 00
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...........+.+|+.+||+.||.+|||+.|+++
T Consensus 376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~ 410 (573)
T 3uto_A 376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 410 (573)
T ss_dssp CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111223456889999999999999999999976
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=399.56 Aligned_cols=249 Identities=21% Similarity=0.292 Sum_probs=200.4
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHH---HHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQF---INEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~---~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
.++|++.+.||+|+||.||+|+.. +|+.||+|.+... .......+ ..++.+++.++|||||++++++.+.+..
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 467999999999999999999974 5889999987531 11112223 3446777888999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
|+|||||+||+|.++|.+.. .+++..+..++.||+.||.|||+++ ||||||||+||||+.+|++||+|||+|+.
T Consensus 268 ylVmEy~~GGdL~~~l~~~~---~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~ 341 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 341 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred EEEEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeee
Confidence 99999999999999998754 4999999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
..... ....+||+.|||||++.. ..|+.++|||||||++|||++|..||......+...+. .. +
T Consensus 342 ~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~----~~--------i 406 (689)
T 3v5w_A 342 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RM--------T 406 (689)
T ss_dssp CSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH----HH--------H
T ss_pred cCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----Hh--------h
Confidence 64332 345689999999999964 57999999999999999999999999754322111010 10 0
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
.. .....+...+..+.+|+.+||+.||.+|++ +.||++
T Consensus 407 ~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 407 LT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp HH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred cC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 00 112234445667899999999999999998 566643
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=368.82 Aligned_cols=264 Identities=25% Similarity=0.403 Sum_probs=219.6
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|.+.+.||+|+||+||+|.+. ++..||+|++...+....+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 88 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY 88 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence 467899999999999999999974 5889999998777777788999999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 89 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 163 (310)
T 3s95_A 89 IKGGTLRGIIKSMDS--QYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163 (310)
T ss_dssp CTTCBHHHHHHHCCT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred cCCCcHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence 999999999987443 4899999999999999999999999 99999999999999999999999999987643322
Q ss_pred ee-------------eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 249 HL-------------TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 249 ~~-------------~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
.. .....||+.|+|||++.+..++.++||||||+++|||++|..|+...........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~---------- 233 (310)
T 3s95_A 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG---------- 233 (310)
T ss_dssp ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS----------
T ss_pred cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh----------
Confidence 11 1145799999999999999999999999999999999999999876443221100
Q ss_pred cchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCC
Q 014725 316 DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGS 372 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~ 372 (419)
........ ...+..++..+.+++.+||+.||.+|||+.++++.|+.++..+..
T Consensus 234 ~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~ 286 (310)
T 3s95_A 234 LNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG 286 (310)
T ss_dssp BCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred hhhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence 00111111 122334445689999999999999999999999999999877644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=368.73 Aligned_cols=269 Identities=32% Similarity=0.422 Sum_probs=211.8
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 160 (419)
..++....++|++.+.||+|+||+||+|.+ ++..||+|.+... .....+.+.+|+.++++++||||+++++++.+.+
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP 107 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence 344455677899999999999999999987 5788999997653 3445678999999999999999999999999999
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..++||||+++|+|.+++........+++..++.++.|++.||.|||+.+ .+|+||||||+|||++.++.+||+|||++
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a 186 (309)
T 3p86_A 108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186 (309)
T ss_dssp CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC--
T ss_pred ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCC
Confidence 99999999999999999987543335899999999999999999999986 34999999999999999999999999999
Q ss_pred eecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
+...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.. ..
T Consensus 187 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~-------~~-------- 250 (309)
T 3p86_A 187 RLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV-------AA-------- 250 (309)
T ss_dssp ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHH-------HH--------
T ss_pred ccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HH--------
Confidence 7543221 2233456899999999999999999999999999999999999999876543311 00
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
..........+...+..+.+++.+||+.+|.+|||+.+|++.|+.+.+.
T Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 0001111233445556799999999999999999999999999988654
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=367.11 Aligned_cols=260 Identities=27% Similarity=0.413 Sum_probs=215.5
Q ss_pred HhcCccccCcccccCcEEEEEEEec----CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
..++|.+.+.||+|+||.||+|.+. .+..||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 3467999999999999999999974 3446999998754 4455678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 127 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTHDG--QFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred EEeeCCCCCcHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999976433 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce--eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 244 KVDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 244 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
...... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+. ..
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------~~ 265 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV----------------IS 265 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH----------------HH
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH----------------HH
Confidence 533222 2233446778999999998999999999999999999999 9999977654331 11
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 266 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 266 SVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 1112222333445567899999999999999999999999999998754
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=373.16 Aligned_cols=263 Identities=26% Similarity=0.438 Sum_probs=218.6
Q ss_pred HhcCccccCcccccCcEEEEEEEec--------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEec
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA--------DGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCLE 158 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 158 (419)
..++|.+.+.||+|+||.||+|.+. ++..||||.++.. .....+.+.+|+.+++.+ +||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 4578999999999999999999853 2457999998754 334567899999999999 89999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNIL 225 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil 225 (419)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEE
Confidence 9999999999999999999986532 234899999999999999999999999 999999999999
Q ss_pred ECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhc
Q 014725 226 LDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDR 303 (419)
Q Consensus 226 l~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~ 303 (419)
++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||+| |..||......+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~- 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 999999999999999876533221 2233457889999999999999999999999999999999 9999987654321
Q ss_pred cHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 304 SLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
...+........+..++..+.+++.+||+.+|.+|||+.|+++.|+.+....
T Consensus 315 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~ 366 (370)
T 2psq_A 315 ---------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 366 (370)
T ss_dssp ---------------HHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ---------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1112222223344456678999999999999999999999999999987644
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=359.03 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=216.8
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.++|.+.+.||+|+||.||+|.+.+++.||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 87 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 87 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence 467899999999999999999998888999999875433 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++........
T Consensus 88 ~~~~L~~~l~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 162 (269)
T 4hcu_A 88 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 162 (269)
T ss_dssp TTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHHhcCc--ccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence 99999999976443 5899999999999999999999999 999999999999999999999999999865433333
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......+|+.|+|||++.+..++.++||||||+++++|++ |..||......+. .+.+......
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~----------------~~~~~~~~~~ 226 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV----------------VEDISTGFRL 226 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------HHHHHTTCCC
T ss_pred cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH----------------HHHHhcCccC
Confidence 3334457788999999999999999999999999999999 9999987654321 1111111122
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
..+...+..+.+++.+||+.+|.+|||+.++++.|+++.+
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 227 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 2333445678999999999999999999999999999875
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=356.50 Aligned_cols=284 Identities=33% Similarity=0.574 Sum_probs=230.4
Q ss_pred cccccCHHHHHHHhcCcccc------CcccccCcEEEEEEEecCCCEEEEEEcccC----ChhhHHHHHHHHHHHhcCCC
Q 014725 77 KTKLFTKMDLEKATDNYNAN------RILGQGGQGTVYKGMLADGGIVAVKKSKLV----DESNVEQFINEVVILSQINH 146 (419)
Q Consensus 77 ~~~~~~~~~~~~~~~~y~~~------~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h 146 (419)
....|+..++..++++|... +.||+|+||.||+|.. ++..||+|++... .....+.+.+|+.+++.++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 34678999999999998877 8999999999999987 5789999987542 23456789999999999999
Q ss_pred cccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014725 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL 226 (419)
Q Consensus 147 ~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill 226 (419)
|||+++++++.+.+..++||||+++++|.+++.......++++..++.++.|++.||.|||+.+ ++||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999986544456999999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccH
Q 014725 227 DDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSL 305 (419)
Q Consensus 227 ~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~ 305 (419)
+.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|+|++|..||..........
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~- 244 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLL- 244 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTT-
T ss_pred cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHH-
Confidence 9999999999999987653322 22344568999999998865 58899999999999999999999998654332111
Q ss_pred HHHHHHHhc-ccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 306 VGFFLQAMN-EDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 306 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
........ ...+...++.. ....+...+..+.+++.+||+.+|.+|||+.+|++.|+++.+
T Consensus 245 -~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~ 306 (307)
T 2nru_A 245 -DIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA 306 (307)
T ss_dssp -HHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred -HHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence 11111111 11222222222 234466778889999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-48 Score=356.24 Aligned_cols=258 Identities=26% Similarity=0.378 Sum_probs=218.1
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
..++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEY 84 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEc
Confidence 4578999999999999999999998888999999875433 346789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 85 ~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 85 ISNGCLLNYLRSHGK--GLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp CTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE
T ss_pred cCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhh
Confidence 999999999987532 4899999999999999999999999 99999999999999999999999999987665544
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
.......+|+.|+|||.+.+..++.++||||||+++++|+| |..||......+.. .. +.....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~---------~~~~~~ 223 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV-------LK---------VSQGHR 223 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------HH---------HHTTCC
T ss_pred hcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH-------HH---------HHcCCC
Confidence 44445557788999999999899999999999999999999 99999876554311 00 111111
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
...+...+..+.+++.+||+.+|.+|||+.++++.|+.++.
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 224 LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 12233345578999999999999999999999999998854
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=367.23 Aligned_cols=269 Identities=29% Similarity=0.478 Sum_probs=215.4
Q ss_pred HhcCccccCcccccCcEEEEEEEe-----cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Cc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-----ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES--EV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 161 (419)
..++|++.+.||+|+||.||+|++ .++..||||++........+.+.+|+.+++.++||||+++++++... ..
T Consensus 8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 356799999999999999999984 35778999999877777778899999999999999999999998653 56
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred eEEEEEeCCCCCHHHHHHhccc--ccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 8999999999999999987543 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCce--eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc---
Q 014725 242 TIKVDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED--- 316 (419)
Q Consensus 242 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 316 (419)
........ ......++..|+|||++.+..++.++||||||+++|||+||..|+....... .......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--------~~~~~~~~~~ 234 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF--------MRMIGNDKQG 234 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH--------HHHHCTTCCT
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH--------HhhhcCcccc
Confidence 76433221 2233457778999999999999999999999999999999999986532211 1111110
Q ss_pred -----chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 317 -----RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 317 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.+.+.+........+..++..+.+++.+||+.+|.+|||+.++++.|+++...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l 293 (295)
T 3ugc_A 235 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM 293 (295)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred chhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence 112222222233445566778999999999999999999999999999998755
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=375.71 Aligned_cols=265 Identities=26% Similarity=0.401 Sum_probs=219.6
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
+.+....++|.+.+.||+|+||.||+|.+. ++..||||.++.. .....+.|.+|+.+++.++||||+++++++.+.+.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence 344455678999999999999999999985 6889999998753 33445678999999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++|+|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+|||++.++.+||+|||+++
T Consensus 187 ~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~ 261 (377)
T 3cbl_A 187 IYIVMELVQGGDFLTFLRTEGA--RLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSR 261 (377)
T ss_dssp CEEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred cEEEEEcCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCce
Confidence 9999999999999999986432 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCceee-ecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 242 TIKVDQTHLT-TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 242 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
.......... ....+++.|+|||++.+..++.++|||||||++|||+| |..||......+. .
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~----------------~ 325 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT----------------R 325 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH----------------H
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------H
Confidence 6433221111 12235778999999998999999999999999999998 9999987654331 1
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
+.+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+++.
T Consensus 326 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 326 EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11222222333445667899999999999999999999999999998764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=359.43 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=210.9
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
..++|.+.+.||+|+||+||+|.+ .+++.||+|++........+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 356899999999999999999996 5688999999876555556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++|+|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.......
T Consensus 98 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 98 YLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp CCTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999999864 3899999999999999999999999 9999999999999999999999999998765433
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
. ......||+.|+|||++.+..++.++|||||||++|||++|..||.......... .... .....
T Consensus 171 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------~~~~--------~~~~~ 235 (297)
T 3fxz_A 171 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIAT--------NGTPE 235 (297)
T ss_dssp C-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHH--------HCSCC
T ss_pred c-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh--------CCCCC
Confidence 2 2344579999999999999999999999999999999999999997665432110 0000 00011
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 236 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 1223344567899999999999999999999976
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=372.80 Aligned_cols=260 Identities=25% Similarity=0.420 Sum_probs=205.9
Q ss_pred HhcCccccCcccccCcEEEEEEEec----CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
..++|.+.+.||+|+||.||+|++. ++..||||.++.. .....+.|.+|+.++++++||||+++++++.+.+..+
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 3468999999999999999999964 4667999998754 3455678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|.+++..... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 123 lv~e~~~~~sL~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKHDA--QFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp EEEECCTTCBHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 99999999999999986532 5899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCcee--eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 244 KVDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 244 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+ +.+
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----------------~~~ 261 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----------------VIK 261 (373)
T ss_dssp ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----------------HHH
T ss_pred ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHH
Confidence 5332211 122335778999999999999999999999999999998 999997665432 111
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.+........+..++..+.+++.+||+.+|.+||++.+|++.|+.+...
T Consensus 262 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 2222222333445667899999999999999999999999999998653
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=367.89 Aligned_cols=272 Identities=24% Similarity=0.302 Sum_probs=211.4
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc----ceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEV----PLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~l 164 (419)
..++|++.+.||+|+||.||+|++. ++.||||++..... ....+.+|+.++++++||||+++++++.+... .++
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l 99 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL 99 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred chhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence 4578999999999999999999875 78999999865432 33456678999999999999999999987553 599
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------CCCCeeecCCCCCcEEECCCCcEEE
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA----------TSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~----------~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
||||+++|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+|||++.++.+||
T Consensus 100 v~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL 172 (322)
T 3soc_A 100 ITAFHEKGSLSDFLKAN----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACI 172 (322)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEE
T ss_pred EEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEE
Confidence 99999999999999764 389999999999999999999998 7 999999999999999999999
Q ss_pred eecCCceecccCCce-eeecccccCCccCcccccc-----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH
Q 014725 235 SDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF 308 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 308 (419)
+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..............
T Consensus 173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~ 252 (322)
T 3soc_A 173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252 (322)
T ss_dssp CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence 999999876543322 2334578999999999876 3567789999999999999999999976543322111111
Q ss_pred HHHHhcccchhHHHHHh-hccC-----CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 309 FLQAMNEDRLFEVLEAR-VLKE-----GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.........+....... .... .....+..+.+++.+||+.||.+|||+.+|++.|+++.+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~ 319 (322)
T 3soc_A 253 IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319 (322)
T ss_dssp HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 00000000011111000 0011 1234567799999999999999999999999999998764
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=385.20 Aligned_cols=267 Identities=24% Similarity=0.384 Sum_probs=222.1
Q ss_pred cCHHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC
Q 014725 81 FTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160 (419)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 160 (419)
+...+++...++|.+.+.||+|+||.||+|.+.++..||||.++... ...+.|.+|+.+++.++||||+++++++. .+
T Consensus 178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 33455666778899999999999999999999888899999987543 34678999999999999999999999986 56
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a 331 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA 331 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred ccEEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence 78999999999999999985421 24788999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
+..............+|+.|+|||++....++.++|||||||++|||+| |+.||......+. .
T Consensus 332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~----------------~ 395 (454)
T 1qcf_A 332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV----------------I 395 (454)
T ss_dssp GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----------------H
T ss_pred eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHH----------------H
Confidence 8754322222233446788999999998999999999999999999999 9999987654331 1
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
+.+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 396 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~ 445 (454)
T 1qcf_A 396 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTA 445 (454)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSS
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhc
Confidence 11122222334455667899999999999999999999999999987543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=355.61 Aligned_cols=260 Identities=26% Similarity=0.389 Sum_probs=215.0
Q ss_pred HHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
+...++|++.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 98 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 98 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence 345678999999999999999999998888999999875433 3467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++.....
T Consensus 99 e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 99 EYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp CCCTTCBHHHHHHCGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred eccCCCcHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999986432 4899999999999999999999999 999999999999999999999999999865433
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.........+|+.|+|||++.+..++.++||||||+++|+|+| |+.||......+.. +.+...
T Consensus 174 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~----------------~~~~~~ 237 (283)
T 3gen_A 174 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA----------------EHIAQG 237 (283)
T ss_dssp HHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH----------------HHHHTT
T ss_pred ccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH----------------HHHhcc
Confidence 3223334456788999999998999999999999999999998 99999876543311 111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.....+...+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus 238 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~ 280 (283)
T 3gen_A 238 LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280 (283)
T ss_dssp CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhh
Confidence 1222233345678999999999999999999999999998864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=368.28 Aligned_cols=273 Identities=27% Similarity=0.377 Sum_probs=222.5
Q ss_pred cccCHHHHHHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccc
Q 014725 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVV 150 (419)
Q Consensus 79 ~~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv 150 (419)
..+...+++...++|.+.+.||+|+||.||+|.+. +++.||||.+... .....+.+.+|+++++.+ +||||+
T Consensus 10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv 89 (359)
T 3vhe_A 10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 89 (359)
T ss_dssp SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence 34556777788899999999999999999999842 3468999998753 344557799999999999 799999
Q ss_pred cEEeEEecCCc-ceEEEeecCCCCHHHHhhccCC----------------------------------------------
Q 014725 151 KLLGCCLESEV-PLLVYEFIPNGTLYHYLHDQTE---------------------------------------------- 183 (419)
Q Consensus 151 ~l~~~~~~~~~-~~lv~e~~~~g~L~~~l~~~~~---------------------------------------------- 183 (419)
++++++.+.+. .++||||+++|+|.+++.....
T Consensus 90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (359)
T 3vhe_A 90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169 (359)
T ss_dssp CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence 99999987654 8999999999999999986532
Q ss_pred -----------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 184 -----------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 184 -----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
...+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~ 246 (359)
T 3vhe_A 170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246 (359)
T ss_dssp --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence 112899999999999999999999999 999999999999999999999999999865433
Q ss_pred C-ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 247 Q-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 247 ~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
. ........||+.|+|||++.+..++.++|||||||++|||+| |..||......+. +...+..
T Consensus 247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---------------~~~~~~~ 311 (359)
T 3vhe_A 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---------------FCRRLKE 311 (359)
T ss_dssp TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---------------HHHHHHH
T ss_pred ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH---------------HHHHHHc
Confidence 2 223345568899999999999999999999999999999998 9999976553321 1111122
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
......+...+..+.+++.+||+.+|.+|||+.+|++.|+.+..+
T Consensus 312 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 312 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 222233444556799999999999999999999999999998764
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=359.55 Aligned_cols=248 Identities=25% Similarity=0.371 Sum_probs=209.2
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..++|.+.+.||+|+||.||+|.+ .+++.||||++.. ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 457899999999999999999997 5788999998754 2445567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 93 MEYASGGEVFDYLVAHG---RMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTV 166 (328)
T ss_dssp ECCCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred EECCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence 99999999999997654 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCccCccccccCCCC-cccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFT-EKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......+. ..... ..
T Consensus 167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-------~~~i~--------~~ 229 (328)
T 3fe3_A 167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL-------RERVL--------RG 229 (328)
T ss_dssp SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHH--------HC
T ss_pred CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH-------HHHHH--------hC
Confidence 32 23456799999999999887765 799999999999999999999987654331 11110 00
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 230 --~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 264 (328)
T 3fe3_A 230 --KYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK 264 (328)
T ss_dssp --CCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred --CCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 11223334567889999999999999999999976
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-47 Score=366.47 Aligned_cols=269 Identities=28% Similarity=0.428 Sum_probs=222.5
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec--------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEE
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA--------DGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCC 156 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 156 (419)
+...++|.+.+.||+|+||.||+|.+. .+..||+|++... .....+.+.+|+++++.+ +||||+++++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 144 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC 144 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence 455678999999999999999999953 2347999998653 344567899999999999 899999999999
Q ss_pred ecCCcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 157 LESEVPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 221 (382)
T 3tt0_A 145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARN 221 (382)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGG
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcce
Confidence 999999999999999999999987542 235899999999999999999999998 9999999999
Q ss_pred EEECCCCcEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhh
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~ 301 (419)
||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||+++||++ |..||......+
T Consensus 222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999987643322 22334457889999999999999999999999999999999 999998765433
Q ss_pred hccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCC
Q 014725 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSS 374 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~ 374 (419)
. .+.+........+..++..+.+++.+||+.+|.+|||+.+|++.|+++........
T Consensus 302 ~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~ 358 (382)
T 3tt0_A 302 L----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQE 358 (382)
T ss_dssp H----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC
T ss_pred H----------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCC
Confidence 1 11112222223344556679999999999999999999999999999987654443
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=380.98 Aligned_cols=261 Identities=30% Similarity=0.461 Sum_probs=220.9
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
++....+|.+.+.||+|+||.||+|.+.. +..||||.++.... ..+.|.+|+.+|++++||||++++++|.+.+..++
T Consensus 215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 34456778999999999999999999865 77899999875433 45789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 294 v~E~~~~g~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp EEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EEEccCCCCHHHHHHhcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence 9999999999999986533 35899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
...........+++.|+|||++.+..++.++|||||||++|||+| |..||...+..+ +.+.+.
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~ 433 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE 433 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HHHHHH
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHH
Confidence 443333344456789999999999999999999999999999999 999998765432 112222
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
.......+..++..+.+|+.+||+.+|.+|||+.+|++.|+.+.
T Consensus 434 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 434 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 22233445566678999999999999999999999999998874
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=355.75 Aligned_cols=261 Identities=26% Similarity=0.398 Sum_probs=209.8
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|++.+.||+|+||.||+|.+. ++..||+|.+.. ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 568999999999999999999964 578999998743 2344567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++++|.+++.... ++++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 90 ~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 99999999999998654 4899999999999999999999999 99999999999999999999999999987654
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
..........||+.|+|||++.+..++.++||||||+++|||+||+.||........ ........ ....
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~-~~~~---- 232 (294)
T 4eqm_A 164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDS-VPNV---- 232 (294)
T ss_dssp -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSC-CCCH----
T ss_pred ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhcc-CCCc----
Confidence 443444456799999999999999999999999999999999999999987654321 11111111 0000
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhcHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRP-SMKEVAFELEGIRA 368 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~i~~ 368 (419)
........+..+.+++.+||+.||.+|| ++.++.+.|+.+..
T Consensus 233 -~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~ 275 (294)
T 4eqm_A 233 -TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH 275 (294)
T ss_dssp -HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred -chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence 0112233456789999999999999999 89999999987643
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=354.46 Aligned_cols=261 Identities=26% Similarity=0.345 Sum_probs=215.1
Q ss_pred cccCHHHHHHHhcC----------ccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCc
Q 014725 79 KLFTKMDLEKATDN----------YNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHR 147 (419)
Q Consensus 79 ~~~~~~~~~~~~~~----------y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ 147 (419)
..++..++..+++. |...+.||+|+||.||+|... +++.||||.+........+.+.+|+.+++.++||
T Consensus 23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ 102 (321)
T 2c30_A 23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102 (321)
T ss_dssp --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence 45777777776654 777789999999999999975 6899999998766666678899999999999999
Q ss_pred ccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC
Q 014725 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD 227 (419)
Q Consensus 148 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 227 (419)
||+++++++...+..++||||+++++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~ 175 (321)
T 2c30_A 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT 175 (321)
T ss_dssp TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred CcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence 9999999999999999999999999999998753 4899999999999999999999998 99999999999999
Q ss_pred CCCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHH
Q 014725 228 DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 228 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 307 (419)
.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ ..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~ 251 (321)
T 2c30_A 176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MK 251 (321)
T ss_dssp TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH
T ss_pred CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH
Confidence 999999999999987653322 23445799999999999999999999999999999999999999976554321 11
Q ss_pred HHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...... .. ........+..+.+++.+||+.||.+|||+.++++
T Consensus 252 ~~~~~~-~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 252 RLRDSP-PP----------KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHSS-CC----------CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHhcCC-CC----------CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 110000 00 00111233456889999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=350.38 Aligned_cols=276 Identities=16% Similarity=0.166 Sum_probs=223.1
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 166 (419)
..++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ..+.+.+|+.+++.+ +|+|++++++++.+....++||
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 356799999999999999999996 568899999876432 234678899999999 7999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc-----EEEeecCCce
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR-----AKVSDFGASR 241 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~Dfgl~~ 241 (419)
||+ +++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++
T Consensus 86 e~~-~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~ 159 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159 (298)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred Eec-CCCHHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence 999 9999999987543 4899999999999999999999998 999999999999987776 9999999998
Q ss_pred ecccCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 242 TIKVDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 242 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....................
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T 1csn_A 160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 239 (298)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence 76543221 234566999999999999999999999999999999999999999875543222222111111100
Q ss_pred cchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCccc
Q 014725 316 DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEE 381 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~ 381 (419)
... .......+..+.+++.+||+.+|.+|||+.+|++.|+++...++........|+
T Consensus 240 ~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 296 (298)
T 1csn_A 240 TPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 296 (298)
T ss_dssp SCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred ccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCCCCccccC
Confidence 000 001123346789999999999999999999999999999988877766666665
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=358.13 Aligned_cols=265 Identities=28% Similarity=0.418 Sum_probs=219.7
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEe
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCL 157 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 157 (419)
++....++|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 96 (314)
T 2ivs_A 17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS 96 (314)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence 33445678999999999999999999862 3468999998753 3455678999999999999999999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTE---------------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 216 (419)
+.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+|
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH 173 (314)
T 2ivs_A 97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVH 173 (314)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EEC
T ss_pred cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccc
Confidence 99999999999999999999987542 124899999999999999999999999 999
Q ss_pred cCCCCCcEEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCC
Q 014725 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPI 294 (419)
Q Consensus 217 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~ 294 (419)
|||||+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus 174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999999999999999999876543322 2234457889999999999899999999999999999999 99999
Q ss_pred CCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 295 RSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
........ ...+........+...+..+.+++.+||+.||.+|||+.++++.|+++..
T Consensus 254 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~ 311 (314)
T 2ivs_A 254 PGIPPERL----------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV 311 (314)
T ss_dssp TTCCGGGH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCHHHH----------------HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 87654321 11111222223344556679999999999999999999999999998764
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=349.32 Aligned_cols=257 Identities=28% Similarity=0.427 Sum_probs=215.4
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.++|.+.+.||+|+||.||+|.+.++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence 467899999999999999999998888999999876433 3467999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 86 ~~~~L~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 160 (267)
T 3t9t_A 86 EHGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 160 (267)
T ss_dssp TTCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred CCCcHHHHHhhCcc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence 99999999987543 4899999999999999999999999 999999999999999999999999999865432222
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+. ... +......
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~---------i~~~~~~ 224 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-------VED---------ISTGFRL 224 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHH---------HHTTCCC
T ss_pred ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHH-------HHH---------HhcCCcC
Confidence 2233457788999999998999999999999999999999 8999986554321 111 1111112
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
..+...+..+.+++.+||+.+|.+|||+.++++.|+++.+
T Consensus 225 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 225 YKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 2233345678999999999999999999999999999865
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=351.79 Aligned_cols=261 Identities=26% Similarity=0.392 Sum_probs=203.7
Q ss_pred HHHhcCccccCcccccCcEEEEEEEecC----CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLAD----GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
+...++|++.+.||+|+||.||+|.+.. +..||+|..... .....+.+.+|+.+++.++||||+++++++. ++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~ 89 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 89 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence 3445789999999999999999999643 346999987653 3445678999999999999999999999984 567
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||+++
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 90 VWIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp CEEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-----
T ss_pred cEEEEecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccc
Confidence 8999999999999999986532 5899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
..............+|+.|+|||++.+..++.++||||||+++|||++ |..||......+. . .
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~-------------~ 228 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I-------------G 228 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H-------------H
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---H-------------H
Confidence 765443333344457889999999998999999999999999999997 9999987654321 1 1
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.+........+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 229 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~ 277 (281)
T 1mp8_A 229 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 277 (281)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 1111111223445567799999999999999999999999999988653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=379.02 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=214.1
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
...++...++|.+.+.||+|+||.||+|.+.++..||||.++.... ..+.|.+|+.+++.++||||+++++++.+ +..
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~ 253 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 253 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence 3445566778999999999999999999998888899999875432 35789999999999999999999999876 678
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 254 ~iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~ 329 (452)
T 1fmk_A 254 YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 329 (452)
T ss_dssp EEEECCCTTCBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred EEEehhhcCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCcccee
Confidence 999999999999999975321 24899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.............+++.|+|||++.+..++.++|||||||++|||+| |+.||......+. .+.
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----------------~~~ 393 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQ 393 (452)
T ss_dssp -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------HHH
T ss_pred cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH----------------HHH
Confidence 65433333334457889999999999999999999999999999999 9999987654331 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+........+..++..+.+++.+||+.+|++|||+.+|++.|+.+..
T Consensus 394 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~ 440 (452)
T 1fmk_A 394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 440 (452)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence 11122233445566789999999999999999999999999998754
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-47 Score=361.67 Aligned_cols=266 Identities=26% Similarity=0.409 Sum_probs=217.7
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEecC------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEec
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLE 158 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 158 (419)
+....++|.+.+.||+|+||.||+|.+.+ +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 34567899999999999999999999753 378999998754 34456789999999999999999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTE---------------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~ 217 (419)
.+..++||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999986431 146899999999999999999999999 9999
Q ss_pred CCCCCcEEECCCCcEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCC
Q 014725 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIR 295 (419)
Q Consensus 218 Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~ 295 (419)
||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||+| |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 9999999999999999999999986543221 22234567899999999999999999999999999999999 999998
Q ss_pred CCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 296 STDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.....+. ..... .......+...+..+.+++.+||+.+|.+|||+.+|++.|+++....
T Consensus 279 ~~~~~~~-------~~~~~---------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~ 337 (343)
T 1luf_A 279 GMAHEEV-------IYYVR---------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA 337 (343)
T ss_dssp TSCHHHH-------HHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred CCChHHH-------HHHHh---------CCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence 7654321 11111 11112234455667999999999999999999999999999986543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=351.47 Aligned_cols=264 Identities=25% Similarity=0.407 Sum_probs=218.6
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
+.+...++|++.+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+++++.++||||+++++++. .+..++
T Consensus 7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 84 (279)
T 1qpc_A 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYI 84 (279)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEE
Confidence 3445567899999999999999999998888899999987543 23578999999999999999999999986 456899
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~ 160 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (279)
T ss_dssp EEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred EEecCCCCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCccccccc
Confidence 9999999999999975421 24899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
...........+++.|+|||.+.+..++.++||||||++++||++ |+.||......+. ... +.
T Consensus 161 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~-------~~~---------~~ 224 (279)
T 1qpc_A 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV-------IQN---------LE 224 (279)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-------HHH---------HH
T ss_pred CcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH-------HHH---------Hh
Confidence 444333344557889999999998899999999999999999999 9999987654321 111 11
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.......+...+..+.+++.+||+.+|.+|||+.++++.|+++....
T Consensus 225 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 271 (279)
T 1qpc_A 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (279)
T ss_dssp TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred cccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence 11112233445567999999999999999999999999999987654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=372.20 Aligned_cols=254 Identities=28% Similarity=0.442 Sum_probs=213.4
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-cceEEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE-VPLLVY 166 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 166 (419)
...++|.+.+.||+|+||.||+|.+. +..||||.++... ..+.|.+|+.++++++||||+++++++.+.. ..++||
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred cChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 44578999999999999999999985 7799999987543 4578999999999999999999999987665 789999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ ++||||||+|||++.++.+||+|||+++.....
T Consensus 267 e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 342 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 342 (450)
T ss_dssp ECCTTCBHHHHHHHHCT-TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EecCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc
Confidence 99999999999987543 24789999999999999999999999 999999999999999999999999999864322
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.....+++.|+|||++.+..++.++|||||||++|||+| |..||......+. ...+...
T Consensus 343 ----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----------------~~~i~~~ 402 (450)
T 1k9a_A 343 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------VPRVEKG 402 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH----------------HHHHHTT
T ss_pred ----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHHcC
Confidence 122357889999999999999999999999999999998 9999986654321 1111222
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.....+..++..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 403 ~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 403 YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 2233455667789999999999999999999999999999875
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=359.37 Aligned_cols=257 Identities=26% Similarity=0.490 Sum_probs=207.2
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCC----EEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGG----IVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.++|++.+.||+|+||+||+|.+. ++. +||+|.+... .....+.+.+|+.++++++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 456899999999999999999964 333 4688887542 3345678999999999999999999999998754 78
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+|+||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTT--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 99999999999999987543 4899999999999999999999998 999999999999999999999999999876
Q ss_pred ccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 244 KVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 244 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... ......+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+ +...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~ 231 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI 231 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHH
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----------------HHHH
Confidence 533322 2234456889999999999999999999999999999999 999998765433 1222
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+........+..++..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 22222233344556679999999999999999999999999988754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=355.24 Aligned_cols=274 Identities=16% Similarity=0.153 Sum_probs=220.9
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|.+.+.||+|+||.||+|.. .+++.||||.+..... .+.+.+|+.+++.+ +||||+++++++.+.+..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence 46899999999999999999996 5678999998765332 24588999999999 89999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc-----EEEeecCCcee
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR-----AKVSDFGASRT 242 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~Dfgl~~~ 242 (419)
|+ +++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++. +||+|||+++.
T Consensus 86 ~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~ 159 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDR--TFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE 159 (330)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred eC-CCCHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence 99 9999999987532 5999999999999999999999999 999999999999998887 99999999987
Q ss_pred cccCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 243 IKVDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 243 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~ 239 (330)
T 2izr_A 160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT 239 (330)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS
T ss_pred eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC
Confidence 6433221 1245679999999999999999999999999999999999999998764332211111111100000
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCccc
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEE 381 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~ 381 (419)
.. .. .....+ .+.+++.+||+.+|.+||++.+|++.|+++....+........|+
T Consensus 240 ~~-----~~----~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 240 PI-----EV----LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp CH-----HH----HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred CH-----HH----HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 00 00 011123 799999999999999999999999999999888877766666665
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=347.99 Aligned_cols=254 Identities=31% Similarity=0.501 Sum_probs=200.8
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCCh----hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDE----SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|++.+.||+|+||.||+|.+. +..||+|....... ...+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999985 78899998765322 2356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC--------CCcEEEeec
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD--------KYRAKVSDF 237 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--------~~~~kl~Df 237 (419)
|||+++++|.+++... .+++..++.++.|++.||.|||+++..+++||||||+||+++. ++.+||+||
T Consensus 85 ~e~~~~~~L~~~~~~~----~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df 160 (271)
T 3dtc_A 85 MEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF 160 (271)
T ss_dssp EECCTTEEHHHHHTSS----CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred EEcCCCCCHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence 9999999999998643 4899999999999999999999998556899999999999986 778999999
Q ss_pred CCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 238 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
|+++...... .....||+.|+|||.+.+..++.++||||||+++++|++|+.||......... .
T Consensus 161 g~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~------- 224 (271)
T 3dtc_A 161 GLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------Y------- 224 (271)
T ss_dssp CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------H-------
T ss_pred Cccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H-------
Confidence 9998654322 22346899999999999999999999999999999999999999876543210 0
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
...........+...+..+.+++.+||+.+|.+|||+.|+++.|++|
T Consensus 225 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 225 --GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp --HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred --hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 01111111223344556799999999999999999999999999864
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=353.44 Aligned_cols=264 Identities=30% Similarity=0.455 Sum_probs=223.6
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
+++...++|.+.+.||+|+||.||+|.+.+ +..||+|.+... ....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (288)
T 3kfa_A 7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85 (288)
T ss_dssp TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence 344567789999999999999999999764 778999998753 334678999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++...
T Consensus 86 ~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 86 IITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EEEECCTTEEHHHHHHHCCT-TTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEEEcCCCCcHHHHHHhccc-CCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 99999999999999987543 35899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
............+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.... .+.+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~----------------~~~~ 225 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV----------------YELL 225 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----------------HHHH
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHH
Confidence 6554444455567889999999999999999999999999999999 9999987654331 1222
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
........+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus 226 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 226 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 22222334445567899999999999999999999999999987654
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=365.52 Aligned_cols=262 Identities=27% Similarity=0.384 Sum_probs=215.3
Q ss_pred HhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
..++|.+.+.||+|+||.||+|.+. ++..||||++... .......+.+|+.+++.++||||+++++++.+...
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 3567999999999999999999953 3568999998653 44555679999999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC---cEEE
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTE----EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY---RAKV 234 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl 234 (419)
.++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999986432 235899999999999999999999999 99999999999998554 5999
Q ss_pred eecCCceecccCC-ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHH
Q 014725 235 SDFGASRTIKVDQ-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 235 ~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |..||......+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~---------- 295 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV---------- 295 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH----------
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------
Confidence 9999998653222 222334567899999999999999999999999999999998 9999987654331
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.+.+........+..++..+.+++.+||+.+|.+|||+.+|++.|+.+...
T Consensus 296 ------~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 296 ------LEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp ------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred ------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 111111122233445566799999999999999999999999999988653
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=354.37 Aligned_cols=269 Identities=26% Similarity=0.413 Sum_probs=220.8
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEe------cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcC-CCcccccEEeE
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGML------ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQI-NHRNVVKLLGC 155 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 155 (419)
.+++...++|.+.+.||+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.+++++ +||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 95 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence 33445667899999999999999999985 235689999987543 34567899999999999 89999999999
Q ss_pred EecCCcceEEEeecCCCCHHHHhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 014725 156 CLESEVPLLVYEFIPNGTLYHYLHDQTE---------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220 (419)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk 220 (419)
+.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+++ ++|||||
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlk 172 (313)
T 1t46_A 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLA 172 (313)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred EecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCc
Confidence 9999999999999999999999986542 124899999999999999999999998 9999999
Q ss_pred CCcEEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCC
Q 014725 221 SSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTD 298 (419)
Q Consensus 221 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~ 298 (419)
|+||+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |..||....
T Consensus 173 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 252 (313)
T 1t46_A 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (313)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred cceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence 99999999999999999999876543322 2234457889999999999999999999999999999999 999997654
Q ss_pred hhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 299 AEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.... ....+........+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 253 ~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 309 (313)
T 1t46_A 253 VDSK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES 309 (313)
T ss_dssp SSHH---------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred chhH---------------HHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence 3221 11112222222233445567999999999999999999999999999886643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=358.73 Aligned_cols=267 Identities=28% Similarity=0.440 Sum_probs=202.5
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEecCCC----EEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEec
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGG----IVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLE 158 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~----~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 158 (419)
++....++|.+.+.||+|+||.||+|.+..+. .||+|.+... .....+.+.+|+.+++.++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 34455678999999999999999999965432 7999988653 34556789999999999999999999999987
Q ss_pred CCcc------eEEEeecCCCCHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC
Q 014725 159 SEVP------LLVYEFIPNGTLYHYLHDQT---EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK 229 (419)
Q Consensus 159 ~~~~------~lv~e~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 229 (419)
.... ++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAED 173 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTT
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCC
Confidence 7655 99999999999999997532 1225899999999999999999999999 9999999999999999
Q ss_pred CcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHH
Q 014725 230 YRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 230 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 307 (419)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----- 248 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEI----- 248 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH-----
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHH-----
Confidence 99999999999876433222 2233456789999999999999999999999999999999 9999987654331
Q ss_pred HHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
...+........+...+..+.+++.+||+.||.+|||+.++++.|+++....
T Consensus 249 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~ 300 (323)
T 3qup_A 249 -----------YNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL 300 (323)
T ss_dssp -----------HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred -----------HHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111122334445567999999999999999999999999999986543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=362.32 Aligned_cols=284 Identities=15% Similarity=0.190 Sum_probs=218.4
Q ss_pred HhcCccccCcccccCcEEEEEEEecC------CCEEEEEEcccCChhhH-----------HHHHHHHHHHhcCCCccccc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKLVDESNV-----------EQFINEVVILSQINHRNVVK 151 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~ 151 (419)
..++|.+.+.||+|+||.||+|.+.+ ++.||||.......... ..+..|+..++.++||||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 45689999999999999999999754 36799998765442211 12345666778889999999
Q ss_pred EEeEEecC----CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC
Q 014725 152 LLGCCLES----EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD 227 (419)
Q Consensus 152 l~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 227 (419)
+++++... ...++||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA--KRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99998765 4479999999 999999998753 25999999999999999999999998 99999999999998
Q ss_pred --CCCcEEEeecCCceecccCCcee------eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCCh
Q 014725 228 --DKYRAKVSDFGASRTIKVDQTHL------TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDA 299 (419)
Q Consensus 228 --~~~~~kl~Dfgl~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~ 299 (419)
.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+||+.||.....
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~ 266 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK 266 (364)
T ss_dssp SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 88999999999998765332211 1334599999999999999999999999999999999999999985332
Q ss_pred hhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCc
Q 014725 300 EEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNC 379 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~ 379 (419)
... ........ ....+.+.++.... ....+..+.+++..||+.+|.+||++.+|++.|+++....+........
T Consensus 267 ~~~--~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~d 340 (364)
T 3op5_A 267 DPK--YVRDSKIR-YRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLD 340 (364)
T ss_dssp CHH--HHHHHHHH-HHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCC
T ss_pred CHH--HHHHHHHH-hhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccc
Confidence 211 11111111 11223333333221 1233467899999999999999999999999999999888887777777
Q ss_pred ccccc
Q 014725 380 EEIHF 384 (419)
Q Consensus 380 ~~~~~ 384 (419)
|....
T Consensus 341 w~~~~ 345 (364)
T 3op5_A 341 LSVVE 345 (364)
T ss_dssp C----
T ss_pred eEecc
Confidence 77543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=356.74 Aligned_cols=252 Identities=25% Similarity=0.394 Sum_probs=203.6
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh-hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE-SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 85 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence 468999999999999999999975 688999998764322 234668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 86 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159 (323)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred cCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence 999999999997543 4899999999999999999999999 9999999999999999999999999998764332
Q ss_pred c-eeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 248 T-HLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 248 ~-~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... +...... .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-----~~~~~~~---------~ 225 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDWKEK---------K 225 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-----HHHHHTT---------C
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-----HHHHhcc---------c
Confidence 2 22345679999999999987765 78999999999999999999999765442210 0000000 0
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
............+.+++.+||+.||.+|||+.|+++
T Consensus 226 ~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~ 261 (323)
T 3tki_A 226 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (323)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 001111233456789999999999999999999976
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=360.11 Aligned_cols=267 Identities=27% Similarity=0.428 Sum_probs=216.0
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEE
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCC 156 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 156 (419)
+++...++|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++++ +||||+++++++
T Consensus 39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 34556789999999999999999999962 3457999998643 233457799999999999 899999999999
Q ss_pred ecCCcceEEEeecCCCCHHHHhhccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 014725 157 LESEVPLLVYEFIPNGTLYHYLHDQTEE--------------------FPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216 (419)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 216 (419)
.+.+..++||||+++|+|.+++...... ..+++..++.++.||+.||.|||+++ |+|
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH 195 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVH 195 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence 9999999999999999999999865421 24799999999999999999999999 999
Q ss_pred cCCCCCcEEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCC
Q 014725 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPI 294 (419)
Q Consensus 217 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~ 294 (419)
|||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||+| |..||
T Consensus 196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 275 (344)
T 1rjb_A 196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY 275 (344)
T ss_dssp TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence 999999999999999999999999876543322 2334557889999999999999999999999999999998 99999
Q ss_pred CCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 295 RSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
........ +...+........+...+..+.+++.+||+.||.+|||+.+|++.|+.+...
T Consensus 276 ~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 335 (344)
T 1rjb_A 276 PGIPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLAD 335 (344)
T ss_dssp TTCCCSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred ccCCcHHH---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 77543221 1111112222233444566799999999999999999999999999987553
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=353.07 Aligned_cols=266 Identities=26% Similarity=0.435 Sum_probs=218.7
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec--------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEE
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA--------DGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCC 156 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 156 (419)
....++|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.+ +||||+++++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 345678999999999999999999863 4568999998754 344567899999999999 899999999999
Q ss_pred ecCCcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 157 LESEVPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
.+.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+.+ |+||||||+|
T Consensus 111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~N 187 (334)
T 2pvf_A 111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARN 187 (334)
T ss_dssp CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGG
T ss_pred ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccce
Confidence 999999999999999999999986532 124899999999999999999999999 9999999999
Q ss_pred EEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhh
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~ 301 (419)
|+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~ 267 (334)
T 2pvf_A 188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 267 (334)
T ss_dssp EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence 99999999999999999876543322 2233457889999999998899999999999999999999 999998765432
Q ss_pred hccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhC
Q 014725 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIG 371 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~ 371 (419)
. ...+........+...+..+.+++.+||+.+|.+|||+.++++.|+++.....
T Consensus 268 ~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 L----------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp H----------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred H----------------HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1 11111111222344455679999999999999999999999999999876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=346.08 Aligned_cols=258 Identities=30% Similarity=0.442 Sum_probs=209.6
Q ss_pred HhcCccccCcccccCcEEEEEEEecC----CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD----GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
..++|.+.+.||+|+||.||+|.+.+ +..||+|..... .....+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 45789999999999999999999643 235999998754 34556789999999999999999999999865 4568
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++...
T Consensus 89 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 163 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERNKN--SLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI 163 (281)
T ss_dssp EEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred EEEecCCCCCHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence 99999999999999986543 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
............+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+. ...+
T Consensus 164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~----------------~~~~ 227 (281)
T 3cc6_A 164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV----------------IGVL 227 (281)
T ss_dssp ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH----------------HHHH
T ss_pred ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH----------------HHHH
Confidence 5443333444557889999999998999999999999999999998 9999976554321 1111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
........+...+..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 228 EKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 1111122333455679999999999999999999999999998865
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-46 Score=353.64 Aligned_cols=257 Identities=26% Similarity=0.483 Sum_probs=205.7
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCC----EEEEEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.++|++.+.||+|+||.||+|.+. ++. +||+|.+.. ......+.+.+|+.+++.++||||+++++++.+.. .+
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 467999999999999999999964 333 467887654 23445678999999999999999999999998754 78
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+|+||+++|+|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred EEEEecCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 99999999999999987543 4899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 244 KVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 244 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+. ...
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~----------------~~~ 231 (327)
T 3lzb_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI----------------SSI 231 (327)
T ss_dssp ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH----------------HHH
T ss_pred cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----------------HHH
Confidence 43322 22233456889999999999999999999999999999999 9999987655431 222
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+........+...+..+.+++.+||+.+|.+|||+.++++.|+.+..
T Consensus 232 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 232 LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp HHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred HHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 22222233344456679999999999999999999999999998853
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-46 Score=351.14 Aligned_cols=266 Identities=23% Similarity=0.317 Sum_probs=204.9
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
..++|++.+.||+|+||+||+|.+.+++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 45789999999999999999999988999999987643 2333567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||++ ++|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 99 e~~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 172 (311)
T 3niz_A 99 EFME-KDLKKVLDENKT--GLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP 172 (311)
T ss_dssp ECCS-EEHHHHHHTCTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred cCCC-CCHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence 9997 488888876443 4899999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH--
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE-- 323 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 323 (419)
.. ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+................+....+
T Consensus 173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 251 (311)
T 3niz_A 173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP 251 (311)
T ss_dssp CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence 22 2334568999999999876 5689999999999999999999999987655432111111111111111110000
Q ss_pred ---Hhh---cc-----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ---ARV---LK-----EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ---~~~---~~-----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... .. .........+.+++.+||+.||.+|||+.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 300 (311)
T 3niz_A 252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN 300 (311)
T ss_dssp HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 000 00 001122356889999999999999999999976
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=353.17 Aligned_cols=248 Identities=25% Similarity=0.304 Sum_probs=207.2
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 467999999999999999999975 5889999987642 233456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 157 (337)
T 1o6l_A 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence 99999999999998653 4899999999999999999999999 99999999999999999999999999986432
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+.... ...+ ...
T Consensus 158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i--------~~~- 220 (337)
T 1o6l_A 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELI--------LME- 220 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH--------HHC-
T ss_pred CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHH-------HHHH--------HcC-
Confidence 22 223456799999999999999999999999999999999999999976554321 1110 000
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+|| ++.+|++
T Consensus 221 -~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 221 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1122334456789999999999999999 8888865
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=349.39 Aligned_cols=272 Identities=25% Similarity=0.374 Sum_probs=214.8
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCC--cceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESE--VPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 165 (419)
.++|.+.+.||+|+||+||+|.+. +++.||||.+.... ....+.+.+|+++++.++||||+++++++.+.. ..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 467999999999999999999975 48899999986432 334577889999999999999999999998665 67999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----CCCCcEEEeecCCce
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL----DDKYRAKVSDFGASR 241 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfgl~~ 241 (419)
|||+++++|.+++........+++..++.++.|++.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 999999999999987655445999999999999999999999999 9999999999999 788889999999998
Q ss_pred ecccCCceeeecccccCCccCccccc--------cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhc-cHHHHHHHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFR--------SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR-SLVGFFLQA 312 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~ 312 (419)
...... ......||+.|+|||++. +..++.++|||||||++|||+||+.||......... .........
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 765432 223456899999999986 578899999999999999999999999765432221 111111111
Q ss_pred hcccchhHHH-----------HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 313 MNEDRLFEVL-----------EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 313 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.....+.... ........+......+.+++.+||+.||.+|||+.|+++...+.
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 1110000000 00011234567788899999999999999999999999988764
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=357.97 Aligned_cols=270 Identities=26% Similarity=0.412 Sum_probs=220.9
Q ss_pred cccCHHHHHHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCccccc
Q 014725 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVK 151 (419)
Q Consensus 79 ~~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~ 151 (419)
..+...+++...++|.+.+.||+|+||.||+|.+. .+..||+|.+... .......+.+|+.+++.++||||++
T Consensus 13 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 92 (322)
T 1p4o_A 13 DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 92 (322)
T ss_dssp SCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCC
T ss_pred cccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEee
Confidence 44556667778899999999999999999999864 3678999998753 3344567999999999999999999
Q ss_pred EEeEEecCCcceEEEeecCCCCHHHHhhccC-------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014725 152 LLGCCLESEVPLLVYEFIPNGTLYHYLHDQT-------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224 (419)
Q Consensus 152 l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~-------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni 224 (419)
+++++.+.+..++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+++ |+||||||+||
T Consensus 93 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NI 169 (322)
T 1p4o_A 93 LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNC 169 (322)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGE
T ss_pred eEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceE
Confidence 9999999999999999999999999997532 1135789999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhh
Q 014725 225 LLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEED 302 (419)
Q Consensus 225 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 302 (419)
+++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 170 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 249 (322)
T 1p4o_A 170 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV 249 (322)
T ss_dssp EECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH
T ss_pred EEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHH
Confidence 9999999999999999865433222 2233457889999999999999999999999999999999 8999987654321
Q ss_pred ccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 303 RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
.... ........+...+..+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 250 -------~~~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~ 298 (322)
T 1p4o_A 250 -------LRFV---------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 298 (322)
T ss_dssp -------HHHH---------HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred -------HHHH---------HcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence 1111 111112233445567999999999999999999999999998763
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=348.74 Aligned_cols=262 Identities=22% Similarity=0.333 Sum_probs=203.2
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhc--CCCcccccEEeEEecC----Ccc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQ--INHRNVVKLLGCCLES----EVP 162 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~ 162 (419)
..++|.+.+.||+|+||+||+|.+ +++.||||++... ....+.+|.+++.. ++||||+++++++.+. ...
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 356899999999999999999998 6889999998643 34556667777766 7999999999997643 457
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH--------SATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+|||++.++.+||
T Consensus 82 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp EEEECCCTTCBHHHHHTTC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEE
T ss_pred EEehhhccCCCHHHHHhhc----ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEE
Confidence 8999999999999999643 4899999999999999999999 777 999999999999999999999
Q ss_pred eecCCceecccCCcee---eecccccCCccCccccccC------CCCcccceechhHHHHHHHhC----------CCCCC
Q 014725 235 SDFGASRTIKVDQTHL---TTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTG----------QKPIR 295 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~~~Di~slG~~l~el~tg----------~~p~~ 295 (419)
+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||+|| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 9999998765433322 2334799999999999876 566899999999999999999 78876
Q ss_pred CCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 296 STDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
........ ............... .......+...+..+.+++.+||+.||.+|||+.+|++.|++|
T Consensus 235 ~~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 235 DVVPNDPS--FEDMRKVVCVDQQRP---NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp TTSCSSCC--HHHHHHHHTTSCCCC---CCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccCCCCcc--hhhhhHHHhccCCCC---CCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 54332211 011111110000000 0000112235677899999999999999999999999999876
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-47 Score=370.51 Aligned_cols=259 Identities=20% Similarity=0.291 Sum_probs=211.9
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEec
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLE 158 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 158 (419)
..++....++|++.+.||+|+||+||+|++.+ ++.||+|++.... ......+.+|..++..++||||+++++++.+
T Consensus 66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD 145 (437)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence 44556677899999999999999999999765 6789999875311 1122348899999999999999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
.+..++||||+++|+|.+++..... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 146 ~~~~~lV~Ey~~gg~L~~~l~~~~~--~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFG 220 (437)
T 4aw2_A 146 DNNLYLVMDYYVGGDLLTLLSKFED--RLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFG 220 (437)
T ss_dssp SSEEEEEECCCTTCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEecCCCCcHHHHHHHccC--CCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchh
Confidence 9999999999999999999986432 4899999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 313 (419)
+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+.. .
T Consensus 221 la~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~------~--- 291 (437)
T 4aw2_A 221 SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------G--- 291 (437)
T ss_dssp TCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H---
T ss_pred hhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH------H---
Confidence 99877655555555678999999999987 467899999999999999999999999876543321 1
Q ss_pred cccchhHHHHHhh---ccCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHH
Q 014725 314 NEDRLFEVLEARV---LKEGKEEEIITVAMLGKRCLNMIGKK--RPSMKEVAF 361 (419)
Q Consensus 314 ~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~ 361 (419)
.++.... ...........+.+|+.+||..+|++ ||++.|+++
T Consensus 292 ------~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 ------KIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp ------HHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred ------hhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 1111110 11111234567889999999888888 999999876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=358.82 Aligned_cols=256 Identities=25% Similarity=0.420 Sum_probs=205.9
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CC----EEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GG----IVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~----~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.++|++.+.||+|+||.||+|.+.. +. +||+|...... ......+.+|+.+++.++||||+++++++. .+..+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 4578999999999999999999643 33 37888765422 233456788999999999999999999986 45688
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 91 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHR--GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLL 165 (325)
T ss_dssp EEEECCTTCBSHHHHHSSG--GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGS
T ss_pred EEEEeCCCCCHHHHHHHcc--ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCccccc
Confidence 9999999999999998643 25888999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 244 KVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 244 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||......+. .+.
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~----------------~~~ 229 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV----------------PDL 229 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH----------------HHH
T ss_pred CcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH----------------HHH
Confidence 543322 2344567889999999999999999999999999999999 9999987654331 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
+........+..++..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~ 275 (325)
T 3kex_A 230 LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA 275 (325)
T ss_dssp HHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred HHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 1111122223334456889999999999999999999999998874
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=344.65 Aligned_cols=263 Identities=28% Similarity=0.415 Sum_probs=216.3
Q ss_pred hcCccccC-cccccCcEEEEEEEec---CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANR-ILGQGGQGTVYKGMLA---DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~-~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
.++|.+.+ .||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++ +.+..++
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 45666666 8999999999999853 5678999998764 345667899999999999999999999999 5567899
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~ 161 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALG 161 (287)
T ss_dssp EEECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEeCCCCCHHHHHHhCCc--cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeec
Confidence 9999999999999975433 5899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCcee--eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 245 VDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 245 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... .....+|+.|+|||++.+..++.++||||||+++|||+| |+.||......+. ...
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~----------------~~~ 225 (287)
T 1u59_A 162 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV----------------MAF 225 (287)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH----------------HHH
T ss_pred cCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH----------------HHH
Confidence 433222 223446889999999998899999999999999999999 9999987654321 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCC
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSS 374 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~ 374 (419)
+........+...+..+.+++.+||+.+|.+||++.++++.|+.+..+.....
T Consensus 226 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~~ 278 (287)
T 1u59_A 226 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKV 278 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTTC
T ss_pred HhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCcc
Confidence 11111223344556789999999999999999999999999999987664443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=349.92 Aligned_cols=261 Identities=30% Similarity=0.455 Sum_probs=205.5
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
.++|++.+.||+|+||.||+|.+. ++.||+|.+.. ....+.+.+|+.++++++||||+++++++. +..++||||+
T Consensus 7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~ 81 (307)
T 2eva_A 7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA 81 (307)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence 457889999999999999999985 78899999864 334578999999999999999999999887 3479999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc-EEEeecCCceecccCCc
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR-AKVSDFGASRTIKVDQT 248 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-~kl~Dfgl~~~~~~~~~ 248 (419)
++++|.+++........+++..++.++.|++.||.|||+.+..+|+||||||+||+++.++. +||+|||+++.....
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-- 159 (307)
T 2eva_A 82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-- 159 (307)
T ss_dssp TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence 99999999987654445789999999999999999999943223999999999999988886 799999999764322
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ... . .......
T Consensus 160 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~-~---------~~~~~~~ 223 (307)
T 2eva_A 160 --MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR----IMW-A---------VHNGTRP 223 (307)
T ss_dssp -------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH----HHH-H---------HHTTCCC
T ss_pred --cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH----HHH-H---------HhcCCCC
Confidence 22345899999999999999999999999999999999999999754332211 000 0 0111112
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCC
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~ 373 (419)
..+...+..+.+++.+||+.+|.+|||+.++++.|+.+...+...
T Consensus 224 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~ 268 (307)
T 2eva_A 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA 268 (307)
T ss_dssp CCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred CcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence 223344567899999999999999999999999999987765443
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-46 Score=342.93 Aligned_cols=254 Identities=24% Similarity=0.356 Sum_probs=210.0
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC--CcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES--EVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|++. +..||+|.+... .....+.+.+|+.+++.++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 467999999999999999999985 888999997653 345567899999999999999999999999877 778999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+. +++||||||+||+++.++.++|+|||++.....
T Consensus 88 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~ 165 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEGTN-FVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQS 165 (271)
T ss_dssp EECCTTCBHHHHHHSCSS-CCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred ecccCCCcHHHHHhhccc-CCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence 999999999999986542 358999999999999999999999763 499999999999999999999999988754322
Q ss_pred CCceeeecccccCCccCccccccCCCCc---ccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTE---KSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~---~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
....||+.|+|||++.+..++. ++||||||+++|||++|+.||......+. . ....
T Consensus 166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~---------~~~~ 224 (271)
T 3kmu_A 166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------G---------MKVA 224 (271)
T ss_dssp ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------H---------HHHH
T ss_pred ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------H---------HHHH
Confidence 2245899999999998765544 79999999999999999999986654331 0 1111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
........+...+..+.+++.+||+.||.+|||+.++++.|+++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~ 269 (271)
T 3kmu_A 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269 (271)
T ss_dssp HSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence 111222334455667999999999999999999999999999875
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=353.92 Aligned_cols=275 Identities=28% Similarity=0.411 Sum_probs=217.2
Q ss_pred cCc-cccCcccccCcEEEEEEEec-----CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Cc
Q 014725 91 DNY-NANRILGQGGQGTVYKGMLA-----DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLES--EV 161 (419)
Q Consensus 91 ~~y-~~~~~ig~G~fg~Vy~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 161 (419)
++| ++.+.||+|+||.||++.+. +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS 109 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence 344 89999999999999998742 5778999998754 344567899999999999999999999999874 56
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++++|.+++.... +++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 110 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 110 LQLVMEYVPLGSLRDYLPRHS----IGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEEEECCCTTCBHHHHGGGSC----CCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEEEecccCCcHHHHHhhCC----CCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccc
Confidence 789999999999999997643 899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCce--eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 242 TIKVDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 242 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
........ ......+|+.|+|||++.+..++.++||||||+++|+|+||..||......... .............+.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLRLT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHHHH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHHHH
Confidence 76543322 233455788899999999999999999999999999999999998653221100 000000000111122
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCC
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~ 373 (419)
+.+........+...+..+.+++.+||+.||.+|||+.++++.|+.+...+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~ 315 (318)
T 3lxp_A 262 ELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ 315 (318)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred HHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence 333333334445566778999999999999999999999999999998776443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-46 Score=352.58 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=200.7
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc------
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV------ 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------ 161 (419)
.++|++.+.||+|+||.||+|++. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 467999999999999999999975 6889999998643 33456789999999999999999999999865432
Q ss_pred ---------------------------------------------------ceEEEeecCCCCHHHHhhccCCCCCCCHH
Q 014725 162 ---------------------------------------------------PLLVYEFIPNGTLYHYLHDQTEEFPITWE 190 (419)
Q Consensus 162 ---------------------------------------------------~~lv~e~~~~g~L~~~l~~~~~~~~l~~~ 190 (419)
.++||||+++++|.+++.........++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 68999999999999999887665567788
Q ss_pred HHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc-----------eeeecccccCC
Q 014725 191 MRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT-----------HLTTRVQGTFG 259 (419)
Q Consensus 191 ~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-----------~~~~~~~gt~~ 259 (419)
.++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....... .......||+.
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 89999999999999999999 99999999999999999999999999987654321 12234569999
Q ss_pred ccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHH
Q 014725 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVA 339 (419)
Q Consensus 260 y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 339 (419)
|+|||++.+..++.++|||||||++|||++|..|+.. ... ......... ...........+.
T Consensus 242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~----~~~~~~~~~---------~~~~~~~~~~~~~ 303 (332)
T 3qd2_B 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVR----IITDVRNLK---------FPLLFTQKYPQEH 303 (332)
T ss_dssp GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHH----HHHHHHTTC---------CCHHHHHHCHHHH
T ss_pred ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHH----HHHHhhccC---------CCcccccCChhHH
Confidence 9999999999999999999999999999998766321 000 000000000 0111123345678
Q ss_pred HHHHHHhccCCCCCCCHHHHHH
Q 014725 340 MLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 340 ~li~~cl~~~p~~RPt~~evl~ 361 (419)
+++.+||+.||.+|||+.|+++
T Consensus 304 ~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 304 MMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HHHHHHHCSSGGGSCCHHHHHH
T ss_pred HHHHHHccCCCCcCCCHHHHhh
Confidence 9999999999999999999986
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-46 Score=355.02 Aligned_cols=248 Identities=25% Similarity=0.320 Sum_probs=206.2
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh------hhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE------SNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
..++|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 4578999999999999999999975 588999998764322 135789999999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC----cEEEeec
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY----RAKVSDF 237 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Df 237 (419)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp EEEEEECCCSCBHHHHHTTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 999999999999999997643 5899999999999999999999999 99999999999998776 7999999
Q ss_pred CCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 238 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
|+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+. ...+....
T Consensus 164 G~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~-------~~~i~~~~ 234 (361)
T 2yab_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITAVS 234 (361)
T ss_dssp SSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTC
T ss_pred CCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhcC
Confidence 9998765322 23445799999999999999999999999999999999999999987654321 11111000
Q ss_pred hhHHHHHhhccCCC----HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 LFEVLEARVLKEGK----EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 ~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+ ...+..+.+++.+||..||.+|||+.|+++
T Consensus 235 ----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~ 272 (361)
T 2yab_A 235 ----------YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR 272 (361)
T ss_dssp ----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ----------CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0111 122356889999999999999999999975
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=356.74 Aligned_cols=269 Identities=30% Similarity=0.485 Sum_probs=217.9
Q ss_pred HhcCccccCcccccCcEEEEEEEe-----cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC--c
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-----ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESE--V 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~ 161 (419)
..++|++.+.||+|+||.||+|.+ .++..||+|++........+.+.+|+.+++.++||||+++++++...+ .
T Consensus 39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 346789999999999999999984 357889999988776677788999999999999999999999987654 7
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKE--RIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTT--SSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eEEEEECCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchh
Confidence 8999999999999999987543 4899999999999999999999998 9999999999999999999999999998
Q ss_pred ecccCCcee--eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc---
Q 014725 242 TIKVDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED--- 316 (419)
Q Consensus 242 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 316 (419)
......... .....++..|+|||.+.+..++.++||||||++++||+||..||...... +.......
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~--------~~~~~~~~~~~ 265 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE--------FMRMIGNDKQG 265 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH--------HHHHHCTTCCT
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH--------HHHhhccccch
Confidence 765433221 22345677899999999888999999999999999999999997642111 01111000
Q ss_pred -----chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 317 -----RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 317 -----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.+.+.+........+..++..+.+++.+||+.+|.+|||+.+|++.|++++..+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 266 QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 112222222223334556678999999999999999999999999999998765
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=343.59 Aligned_cols=256 Identities=33% Similarity=0.547 Sum_probs=206.8
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChh---h----HHHHHHHHHHHhcCCCcccccEEeEEecCC
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDES---N----VEQFINEVVILSQINHRNVVKLLGCCLESE 160 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~---~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 160 (419)
..++|++.+.||+|+||.||+|.+ .+++.||+|.+...... . .+.+.+|+.+++.++||||+++++++.+..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 96 (287)
T 4f0f_A 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP 96 (287)
T ss_dssp CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence 347899999999999999999997 46889999987643221 1 167899999999999999999999986554
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc-----EEEe
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR-----AKVS 235 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~-----~kl~ 235 (419)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ .+++||||||+|||++.++. +||+
T Consensus 97 --~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~ 171 (287)
T 4f0f_A 97 --RMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVA 171 (287)
T ss_dssp --EEEEECCTTCBHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEEC
T ss_pred --eEEEEecCCCCHHHHHhcccC--CccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeC
Confidence 799999999999999876543 5899999999999999999999986 34999999999999988776 9999
Q ss_pred ecCCceecccCCceeeecccccCCccCccccc--cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh
Q 014725 236 DFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR--SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 313 (419)
|||+++.... ......||+.|+|||++. ...++.++|||||||++|||++|+.||...........
T Consensus 172 Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-------- 239 (287)
T 4f0f_A 172 DFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-------- 239 (287)
T ss_dssp CCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH--------
T ss_pred CCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH--------
Confidence 9999975332 234456899999999984 45678999999999999999999999976544321100
Q ss_pred cccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
............+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus 240 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 240 -----NMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp -----HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred -----HHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 011111122233445567899999999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=381.48 Aligned_cols=264 Identities=26% Similarity=0.373 Sum_probs=218.6
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
...++...++|.+.+.||+|+||.||+|.+.++..||||+++.... ..+.|.+|+.+|+.++||||+++++++.+ +..
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 4445566778999999999999999999998888899999875432 35789999999999999999999999876 678
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~ 412 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARL 412 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred eEeeehhcCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEccccccee
Confidence 999999999999999975321 24899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.............++..|+|||++.+..++.++|||||||++|||+| |+.||......+. .+.
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~----------------~~~ 476 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV----------------LDQ 476 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHH----------------HHH
T ss_pred cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHH
Confidence 54322222233456788999999999999999999999999999999 9999987654321 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 477 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~ 523 (535)
T 2h8h_A 477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 523 (535)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence 11112223344566789999999999999999999999999998754
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=355.87 Aligned_cols=275 Identities=27% Similarity=0.350 Sum_probs=217.3
Q ss_pred hcCccccCcccccCcEEEEEEEe-----cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEe--cCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-----ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL--ESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~~ 162 (419)
.++|++.+.||+|+||.||+|.+ .++..||+|++........+.+.+|+++++.++||||+++++++. +....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 101 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL 101 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence 36789999999999999999984 357789999998777777788999999999999999999999987 44567
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 102 RLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred EEEEeecCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence 899999999999999986432 4899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCce--eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 243 IKVDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 243 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||............ ..........+.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~ 255 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRLLE 255 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHHHH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHHHH
Confidence 6543322 223445788899999999999999999999999999999999998653322100000 0000000011222
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.+........+...+..+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus 256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 22333333445566778999999999999999999999999999986544
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=343.39 Aligned_cols=277 Identities=19% Similarity=0.229 Sum_probs=216.5
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEE-ecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC-LESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 166 (419)
..++|.+.+.||+|+||.||+|.+ .+++.||+|....... ...+.+|+.+++.++|+|++..++.+ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 457899999999999999999996 5678899998654322 24578899999999988777666655 5667789999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCceec
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL---DDKYRAKVSDFGASRTI 243 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~~~ 243 (419)
||+ +++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999986433 4899999999999999999999999 9999999999999 78899999999999876
Q ss_pred ccCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 244 KVDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 244 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 4hgt_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence 543321 22345789999999999999999999999999999999999999987654433222221111100000
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCcccc
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEI 382 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~ 382 (419)
. . ......+..+.+++.+||+.+|.+|||+.+|++.|+++....+........|+.
T Consensus 239 ~-----~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 239 I-----E----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp H-----H----HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred h-----h----hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCCccCccchhh
Confidence 0 0 001122457999999999999999999999999999999888877766666764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-46 Score=350.17 Aligned_cols=273 Identities=27% Similarity=0.392 Sum_probs=221.0
Q ss_pred ccCHHHHHHHhcCccccCcccccCcEEEEEEEe------cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCccccc
Q 014725 80 LFTKMDLEKATDNYNANRILGQGGQGTVYKGML------ADGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVK 151 (419)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~ 151 (419)
.+....+....++|.+.+.||+|+||.||+|.+ .+++.||+|.+... .....+.+.+|+.+++.+ +||||++
T Consensus 16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence 344556667788999999999999999999984 23578999998753 334556799999999999 7999999
Q ss_pred EEeEEecCC-cceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeec
Q 014725 152 LLGCCLESE-VPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHR 217 (419)
Q Consensus 152 l~~~~~~~~-~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~ 217 (419)
+++++.+.+ ..++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccc
Confidence 999987654 58999999999999999987543 123789999999999999999999998 9999
Q ss_pred CCCCCcEEECCCCcEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCC
Q 014725 218 DIKSSNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIR 295 (419)
Q Consensus 218 Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~ 295 (419)
||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||+| |..||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 9999999999999999999999987643322 22344567899999999999999999999999999999998 999997
Q ss_pred CCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 296 STDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
....... . ...+........+...+..+.+++.+||+.+|.+|||+.+|++.|+.+....
T Consensus 253 ~~~~~~~------~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 312 (316)
T 2xir_A 253 GVKIDEE------F---------CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 312 (316)
T ss_dssp TCCCSHH------H---------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred ccchhHH------H---------HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 6543221 1 1111111112233344567899999999999999999999999999987654
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=354.64 Aligned_cols=268 Identities=24% Similarity=0.393 Sum_probs=218.8
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecC-C-----CEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeE
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLAD-G-----GIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGC 155 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~ 155 (419)
.+++...++|.+.+.||+|+||.||+|.... + ..||+|.+... .....+.+.+|+.+++.+ +||||++++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 118 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA 118 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence 3456667899999999999999999999643 2 37999998754 334567899999999999 89999999999
Q ss_pred EecCCcceEEEeecCCCCHHHHhhccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014725 156 CLESEVPLLVYEFIPNGTLYHYLHDQTE-----------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224 (419)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni 224 (419)
+.+.+..++||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||
T Consensus 119 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NI 195 (333)
T 2i1m_A 119 CTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 195 (333)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGC
T ss_pred EecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceE
Confidence 9999999999999999999999975321 235799999999999999999999998 99999999999
Q ss_pred EECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhh
Q 014725 225 LLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEED 302 (419)
Q Consensus 225 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 302 (419)
|++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++||||||+++|||+| |..||........
T Consensus 196 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 275 (333)
T 2i1m_A 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275 (333)
T ss_dssp EEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred EECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence 9999999999999999876433322 2334457889999999999999999999999999999999 9999976543221
Q ss_pred ccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 303 RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
+...+........+...+..+.+++.+||+.+|.+|||+.+|++.|+++...
T Consensus 276 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 276 ---------------FYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp ---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1111222222223334456789999999999999999999999999987653
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=364.59 Aligned_cols=256 Identities=23% Similarity=0.328 Sum_probs=210.6
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLES 159 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 159 (419)
.++....++|.+.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 345566789999999999999999999975 4788999987531 112234578999999999999999999999999
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
+..++||||+++|+|.+++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~----~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~ 214 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT 214 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence 9999999999999999999754 3899999999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCC----CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ----FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||...+..+. +
T Consensus 215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~------ 282 (410)
T 3v8s_A 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------Y------ 282 (410)
T ss_dssp CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------H------
T ss_pred eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------H------
Confidence 9877655444455678999999999997655 88999999999999999999999987654321 1
Q ss_pred cchhHHHHHh--hccCCCHHHHHHHHHHHHHHhccCCCC--CCCHHHHHH
Q 014725 316 DRLFEVLEAR--VLKEGKEEEIITVAMLGKRCLNMIGKK--RPSMKEVAF 361 (419)
Q Consensus 316 ~~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~~p~~--RPt~~evl~ 361 (419)
..++... ...+........+.+|+.+||..+|.+ ||++.||++
T Consensus 283 ---~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 283 ---SKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp ---HHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred ---HHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 1111111 111111234567899999999999988 999999976
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=349.83 Aligned_cols=260 Identities=26% Similarity=0.424 Sum_probs=207.9
Q ss_pred HhcCccccCcccccCcEEEEEEEecCC-----CEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADG-----GIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
...+|.+.+.||+|+||.||+|.+... ..||+|.+... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 346788889999999999999986432 35999998753 344556799999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.
T Consensus 122 ~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred EEEEeCCCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence 999999999999999986533 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCce--eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 243 IKVDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 243 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
....... ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. .
T Consensus 197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~--------- 260 (333)
T 1mqb_A 197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-------M--------- 260 (333)
T ss_dssp --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------H---------
T ss_pred hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH-------H---------
Confidence 6433211 1223346788999999999999999999999999999999 9999976654321 1
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
+.+........+...+..+.+++.+||+.+|.+||++.++++.|+++...
T Consensus 261 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 261 KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11111112223344566799999999999999999999999999988653
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=346.94 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=197.5
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh--------------------------hhHHHHHHHHHHHh
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE--------------------------SNVEQFINEVVILS 142 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~ 142 (419)
.++|.+.+.||+|+||.||+|.+. +++.||||.+..... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999964 577899998754321 12356889999999
Q ss_pred cCCCcccccEEeEEec--CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCC
Q 014725 143 QINHRNVVKLLGCCLE--SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIK 220 (419)
Q Consensus 143 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlk 220 (419)
.++||||+++++++.+ .+..++||||+++++|.+++.. ..+++..++.++.|++.||.|||+++ |+|||||
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk 164 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL----KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK 164 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence 9999999999999986 5678999999999999886543 25899999999999999999999999 9999999
Q ss_pred CCcEEECCCCcEEEeecCCceecccCCceeeecccccCCccCccccccCC---CCcccceechhHHHHHHHhCCCCCCCC
Q 014725 221 SSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVELLTGQKPIRST 297 (419)
Q Consensus 221 p~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~~~Di~slG~~l~el~tg~~p~~~~ 297 (419)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||...
T Consensus 165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 243 (298)
T 2zv2_A 165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243 (298)
T ss_dssp GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999987654332 233457999999999997655 478899999999999999999999765
Q ss_pred ChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 298 DAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..... ..... ............+..+.+++.+||+.||.+|||+.|+++
T Consensus 244 ~~~~~-------~~~~~--------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 244 RIMCL-------HSKIK--------SQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SHHHH-------HHHHH--------HCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cHHHH-------HHHHh--------cccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 43221 01110 011111112234467899999999999999999999865
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=340.75 Aligned_cols=277 Identities=19% Similarity=0.222 Sum_probs=219.3
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEE-ecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC-LESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lv~ 166 (419)
..++|.+.+.||+|+||.||+|.+ .+++.||+|.+..... .+.+.+|+.+++.++|++++..+.++ .+.+..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 357899999999999999999996 5688999998765332 24688999999999988766666555 5667779999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCceec
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL---DDKYRAKVSDFGASRTI 243 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~~~ 243 (419)
||+ +++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||+ +.++.+||+|||+++..
T Consensus 85 e~~-~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~ 158 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Eec-CCCHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence 999 9999999975433 4899999999999999999999999 9999999999999 48889999999999876
Q ss_pred ccCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 244 KVDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 244 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......................
T Consensus 159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 238 (296)
T 3uzp_A 159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 238 (296)
T ss_dssp BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence 543321 12445799999999999999999999999999999999999999987554332222222111100000
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCcccc
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEI 382 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~ 382 (419)
.+. .....+..+.+++.+||+.||.+|||+.+|++.|+++....+........|+.
T Consensus 239 -----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 3uzp_A 239 -----IEV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp -----HHH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCCSSCCCGGGG
T ss_pred -----hHH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCcccccccccc
Confidence 000 11223457899999999999999999999999999998888776666666654
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=344.09 Aligned_cols=262 Identities=30% Similarity=0.455 Sum_probs=208.8
Q ss_pred hcCccccCcccccCcEEEEEEEecCC----CEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEe-cCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADG----GIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCL-ESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~ 163 (419)
..+|.+.+.||+|+||.||+|.+.++ ..+|+|..... .....+.+.+|+.++++++||||+++++++. .++..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 45688999999999999999996432 25899987653 3455678999999999999999999999865 456789
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||+++..
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~ 178 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDM 178 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred EEEeCCCCCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccc
Confidence 99999999999999976433 4899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCc---eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 244 KVDQT---HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 244 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
..... .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||......+. .
T Consensus 179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~---~------------- 242 (298)
T 3f66_A 179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---T------------- 242 (298)
T ss_dssp SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTH---H-------------
T ss_pred cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHH---H-------------
Confidence 43221 12234557889999999999999999999999999999999 5666665443221 1
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCC
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGS 372 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~ 372 (419)
..+........+...+..+.+++.+||+.+|.+|||+.++++.|+++...+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 243 VYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 11111111222333456799999999999999999999999999998876543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=344.48 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=202.0
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|.+.+.||+|+||.||+|...+++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999998899999999865332 2346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++ +|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 154 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV- 154 (288)
T ss_dssp CSE-EHHHHHHTSTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred cCC-CHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence 975 99999876433 4899999999999999999999999 9999999999999999999999999997654322
Q ss_pred eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc---ccchhHHH--
Q 014725 249 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN---EDRLFEVL-- 322 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~-- 322 (419)
.......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+... ....... ...+....
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 231 (288)
T 1ob3_A 155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM---RIFRILGTPNSKNWPNVTEL 231 (288)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCTTTSTTGGGS
T ss_pred cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHHCCCChhhchhhhcc
Confidence 12234468999999999876 458999999999999999999999998765433211 1111110 00000000
Q ss_pred ---HHhh-------ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 ---EARV-------LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ---~~~~-------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
++.. ........+..+.+++.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 0000 00111223467889999999999999999999975
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=357.49 Aligned_cols=262 Identities=29% Similarity=0.448 Sum_probs=202.4
Q ss_pred cCccccCcccccCcEEEEEEEecC--C--CEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEec-CCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLAD--G--GIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLE-SEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~--~--~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~l 164 (419)
..|.+.+.||+|+||.||+|.+.+ + ..||+|.+... .....+.+.+|+.++++++||||+++++++.+ .+..++
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 347778999999999999999642 2 35899987643 34566889999999999999999999998764 467899
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 169 v~e~~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~ 243 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 243 (373)
T ss_dssp EEECCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEECCCCCCHHHHHhhccc--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeecccccccc
Confidence 9999999999999976443 4889999999999999999999999 9999999999999999999999999998654
Q ss_pred cCCce---eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 245 VDQTH---LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 245 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
..... ......+|+.|+|||++.+..++.++|||||||++|||+| |..||......+. ..
T Consensus 244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~------------- 307 (373)
T 3c1x_A 244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV------------- 307 (373)
T ss_dssp --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HH-------------
T ss_pred ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HH-------------
Confidence 32211 1233457789999999999999999999999999999999 7788876543221 11
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCC
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~ 373 (419)
.+........+..++..+.+++.+||+.+|.+|||+.++++.|+.+...+...
T Consensus 308 ~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~ 360 (373)
T 3c1x_A 308 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360 (373)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence 11111112223445567999999999999999999999999999998766443
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=341.73 Aligned_cols=261 Identities=27% Similarity=0.420 Sum_probs=210.5
Q ss_pred CccccCcccccCcEEEEEEEecC-CC---EEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc-eEE
Q 014725 92 NYNANRILGQGGQGTVYKGMLAD-GG---IVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP-LLV 165 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~-~~---~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lv 165 (419)
.|...+.||+|+||.||+|.+.+ +. .+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 46667899999999999998533 22 6999988753 345567899999999999999999999999876655 999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+.+++|.+++..... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++....
T Consensus 102 ~e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRSPQR--NPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999986433 5899999999999999999999999 99999999999999999999999999986543
Q ss_pred CC---ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCC-CCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 246 DQ---THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP-IRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 246 ~~---~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.. ........+|+.|+|||.+.+..++.++||||||+++|+|++|..| |......+ +...
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~~~~ 240 (298)
T 3pls_A 177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------LTHF 240 (298)
T ss_dssp GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------HHHH
T ss_pred CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------HHHH
Confidence 22 1222345678999999999999999999999999999999995555 44433322 1111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCC
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~ 373 (419)
+........+...+..+.+++.+||+.+|.+|||+.++++.|+++...+...
T Consensus 241 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~ 292 (298)
T 3pls_A 241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292 (298)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence 1111222233445567999999999999999999999999999998876544
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.38 Aligned_cols=263 Identities=29% Similarity=0.477 Sum_probs=201.0
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.+...++|.+.+.||+|+||.||+|.+.+ .+|+|.++.. .....+.+.+|+.+++.++||||+++++++ .....+
T Consensus 19 ~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~ 95 (289)
T 3og7_A 19 WEIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLA 95 (289)
T ss_dssp CBCCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCE
T ss_pred CccCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccE
Confidence 34557789999999999999999998643 5999987643 345567899999999999999999999965 456689
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++..
T Consensus 96 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 170 (289)
T 3og7_A 96 IVTQWCEGSSLYHHLHASET--KFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEK 170 (289)
T ss_dssp EEEECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred EEEEecCCCcHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccc
Confidence 99999999999999976443 5899999999999999999999999 999999999999999999999999999765
Q ss_pred ccC-CceeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 244 KVD-QTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 244 ~~~-~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
... .........||+.|+|||++. +..++.++||||||+++|+|++|+.||......+. ...........
T Consensus 171 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~~~~ 244 (289)
T 3og7_A 171 SRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIEMVGRGSLS 244 (289)
T ss_dssp -------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH------HHHHHHHTSCC
T ss_pred ccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH------HHHHhcccccC
Confidence 432 222234456899999999986 56788999999999999999999999976544321 11111111000
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
. ........++..+.+++.+||+.+|.+|||+.++++.|+++.
T Consensus 245 ~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~ 287 (289)
T 3og7_A 245 P-----DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287 (289)
T ss_dssp C-----CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred c-----chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence 0 001122345567999999999999999999999999999874
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=350.64 Aligned_cols=265 Identities=29% Similarity=0.418 Sum_probs=211.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-----cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC--Cc
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-----ADGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLES--EV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-----~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~ 161 (419)
.++|++.+.||+|+||.||+|++ .+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 35589999999999999999983 35778999998743 334457899999999999999999999999876 56
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+||+++.++.+||+|||+++
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKN--KINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTT--TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHhccc--cCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence 7999999999999999976543 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCce--eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh------
Q 014725 242 TIKVDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM------ 313 (419)
Q Consensus 242 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~------ 313 (419)
........ ......||..|+|||++.+..++.++||||||+++|+|+||..|+...... .....
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--------~~~~~~~~~~~ 246 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL--------FLKMIGPTHGQ 246 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH--------HHHHHCSCCGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH--------HhhccCCcccc
Confidence 76544322 233456888899999999999999999999999999999999986432111 00000
Q ss_pred -cccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 314 -NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 314 -~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
....+...+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 247 MTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp GHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 001111222222233344556678999999999999999999999999998764
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=376.73 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=211.4
Q ss_pred hcCccccC-cccccCcEEEEEEEec---CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANR-ILGQGGQGTVYKGMLA---DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~-~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
.+++.+.+ .||+|+||.||+|.+. ++..||||.++.. .....+.+.+|+.+|+.++||||+++++++.+ +..++
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~l 412 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 412 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEE
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEE
Confidence 34444444 7999999999999864 3557999998754 33456889999999999999999999999976 56899
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++|+|.+++.... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 413 v~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 413 VMEMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp EEECCTTCBHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred EEEeCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 999999999999997643 35899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCcee--eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 245 VDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 245 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... .....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+. .+.
T Consensus 488 ~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~----------------~~~ 551 (613)
T 2ozo_A 488 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV----------------MAF 551 (613)
T ss_dssp --------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH----------------HHH
T ss_pred CCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH----------------HHH
Confidence 332221 122345689999999999999999999999999999998 9999987654331 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCC
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~ 373 (419)
+........+..++..+.+++.+||+.+|.+||++.+|++.|+.+.......
T Consensus 552 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~ 603 (613)
T 2ozo_A 552 IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603 (613)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence 2222223445566778999999999999999999999999999987766544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=353.31 Aligned_cols=252 Identities=23% Similarity=0.331 Sum_probs=206.1
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..++|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4578999999999999999999974 5789999987643 344567899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC---CcEEEeecCCcee
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSDFGASRT 242 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfgl~~~ 242 (419)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+++.
T Consensus 107 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 99999999999997643 5899999999999999999999999 9999999999999765 4599999999987
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+. . ..+......
T Consensus 181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~---~----~~i~~~~~~--- 248 (362)
T 2bdw_A 181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---Y----AQIKAGAYD--- 248 (362)
T ss_dssp CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H----HHHHHTCCC---
T ss_pred ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---H----HHHHhCCCC---
Confidence 65322 23345799999999999998999999999999999999999999986554321 1 111000000
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+..+.+++.+||+.||.+|||+.++++
T Consensus 249 ---~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 249 ---YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp ---CCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 000001223457889999999999999999999875
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=348.32 Aligned_cols=251 Identities=26% Similarity=0.332 Sum_probs=205.4
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh------hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE------SNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
.++|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 466999999999999999999975 578999998764322 1357899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC----cEEEeecC
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY----RAKVSDFG 238 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg 238 (419)
++||||+++++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 90 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp EEEEECCCSCBHHHHHTTSS---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCCCHHHHHHhcC---CcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 99999999999999997543 5899999999999999999999999 99999999999998887 89999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+.. ...... . ...
T Consensus 164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~~~~~-~-~~~ 236 (326)
T 2y0a_A 164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL---ANVSAV-N-YEF 236 (326)
T ss_dssp TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH---HHHHHT-C-CCC
T ss_pred CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH---HHHHhc-C-CCc
Confidence 998764322 223456999999999999899999999999999999999999999765543211 000000 0 000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. .. ....+..+.+++.+||+.||.+|||+.++++
T Consensus 237 ~~----~~----~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 271 (326)
T 2y0a_A 237 ED----EY----FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 271 (326)
T ss_dssp CH----HH----HTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred Cc----cc----cccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 00 00 0122356889999999999999999999986
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=345.21 Aligned_cols=251 Identities=21% Similarity=0.295 Sum_probs=206.7
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|.+.+.||+|+||.||+|... ++..+|+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 578999999999999999999975 47789999887543 3456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC--CCcEEEeecCCceecccC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD--KYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~ 246 (419)
+++++|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.....
T Consensus 83 ~~g~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 99999999997643 25899999999999999999999999 999999999999987 789999999999876543
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. ......||+.|+|||++.+..++.++|||||||++|+|++|..||......+. ...+.. ..... ....
T Consensus 158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~i~~----~~~~~--~~~~ 226 (321)
T 1tki_A 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI---IENIMN----AEYTF--DEEA 226 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHH----TCCCC--CHHH
T ss_pred C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH---HHHHHc----CCCCC--Chhh
Confidence 2 23445689999999999988899999999999999999999999987654321 111110 00000 0000
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 ----~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 227 ----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp ----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ----hccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0122456889999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=346.98 Aligned_cols=255 Identities=25% Similarity=0.405 Sum_probs=206.3
Q ss_pred hcCccccCcccccCcEEEEEEEecC-C-------CEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-G-------GIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~-------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
.++|.+.+.||+|+||.||+|.+.. + ..||+|.+........+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE 86 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence 4679999999999999999999643 2 4699999876666667889999999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc--------EE
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR--------AK 233 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--------~k 233 (419)
.++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++. +|
T Consensus 87 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 87 NILVQEFVKFGSLDTYLKKNKN--CINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred CEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999987542 4899999999999999999999999 999999999999988887 99
Q ss_pred EeecCCceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhC-CCCCCCCChhhhccHHHHHHH
Q 014725 234 VSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTG-QKPIRSTDAEEDRSLVGFFLQ 311 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~ 311 (419)
|+|||++..... .....||+.|+|||++.+ ..++.++||||||+++|||++| ..||......... .
T Consensus 162 l~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~-------~ 229 (289)
T 4fvq_A 162 LSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL-------Q 229 (289)
T ss_dssp ECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH-------H
T ss_pred eccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH-------H
Confidence 999999865432 123457899999999987 7789999999999999999995 4555443332210 0
Q ss_pred HhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCC
Q 014725 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGS 372 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~ 372 (419)
.. .. ....+...+..+.+++.+||+.||.+|||+.++++.|+++..+.+.
T Consensus 230 ~~---------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~ 279 (289)
T 4fvq_A 230 FY---------ED--RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV 279 (289)
T ss_dssp HH---------HT--TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred Hh---------hc--cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence 00 00 1111222234588999999999999999999999999998764433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=360.66 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=206.3
Q ss_pred HHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
...++|++.+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 3467899999999999999999996 467889999876432 3445678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCce
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD---DKYRAKVSDFGASR 241 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfgl~~ 241 (419)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++
T Consensus 88 v~E~~~gg~L~~~i~~~~---~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 88 IFDLVTGGELFEDIVARE---YYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI 161 (444)
T ss_dssp EECCCBCCBHHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred EEEeCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence 999999999999998654 4899999999999999999999999 99999999999998 56789999999998
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+. ...+.....
T Consensus 162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~~~--- 230 (444)
T 3soa_A 162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL-------YQQIKAGAY--- 230 (444)
T ss_dssp CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHTCC---
T ss_pred EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHH-------HHHHHhCCC---
Confidence 7653322 23346799999999999999999999999999999999999999976554321 111111000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 231 ---~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 231 ---DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp ---CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ---CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 0000111233567889999999999999999999976
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-46 Score=354.71 Aligned_cols=250 Identities=25% Similarity=0.344 Sum_probs=202.2
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcc
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 162 (419)
...++|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|..+++.+ +||||+++++++.+.+..
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 34578999999999999999999975 5789999987642 233456788999999988 799999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSR---RFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999998654 4899999999999999999999999 99999999999999999999999999975
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. ... +.
T Consensus 174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------~~~--------i~ 237 (353)
T 3txo_A 174 GICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL-------FEA--------IL 237 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHH--------HH
T ss_pred cccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHH-------HHH--------HH
Confidence 3322 2233456799999999999998999999999999999999999999987654331 111 11
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCH------HHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM------KEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~------~evl~ 361 (419)
.. ....+......+.+++.+||+.||.+||++ .++++
T Consensus 238 ~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 238 ND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 11 112233345678899999999999999998 56654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=355.13 Aligned_cols=253 Identities=20% Similarity=0.287 Sum_probs=209.4
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
..++|.+.+.||+|+||.||+|... ++..+|+|.+..........+.+|+.+++.++||||+++++++.+....++|||
T Consensus 49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 3578999999999999999999974 578899999876655566789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC--CCcEEEeecCCceeccc
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD--KYRAKVSDFGASRTIKV 245 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~~~ 245 (419)
|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++....
T Consensus 129 ~~~gg~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 129 FLSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp CCCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred cCCCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 999999999997643 24899999999999999999999999 999999999999974 57799999999987654
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
... .....||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...+....+ .
T Consensus 204 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~-------~~~i~~~~~------~ 268 (387)
T 1kob_A 204 DEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCDW------E 268 (387)
T ss_dssp TSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHCCC------C
T ss_pred Ccc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCC------C
Confidence 322 2334689999999999999999999999999999999999999987654321 111100000 0
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+..+.+++.+||+.||.+|||+.++++
T Consensus 269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 304 (387)
T 1kob_A 269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 304 (387)
T ss_dssp CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 011112234567899999999999999999999976
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=345.19 Aligned_cols=245 Identities=26% Similarity=0.362 Sum_probs=205.6
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|++.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|..+++.++||||+++++++.+....++|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 467999999999999999999974 6889999987642 123456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 85 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp ECCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred EeCCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999998643 4899999999999999999999999 99999999999999999999999999987542
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. ....+||+.|+|||++.+..++.++|||||||++|||++|..||...+.... +. .++...
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~------~~---------~i~~~~ 219 (318)
T 1fot_A 159 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YE---------KILNAE 219 (318)
T ss_dssp C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HH---------HHHHCC
T ss_pred c----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HH---------HHHhCC
Confidence 2 2345799999999999999999999999999999999999999976554321 11 111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
...+......+.+++.+||+.||.+|| ++.++++
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 122334456789999999999999999 7888764
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=345.79 Aligned_cols=268 Identities=27% Similarity=0.420 Sum_probs=206.5
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecC----CCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEe
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLAD----GGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCL 157 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 157 (419)
.++....++|.+.+.||+|+||.||+|.... +..||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 3444566789999999999999999998642 347999997643 3445678999999999999999999999998
Q ss_pred cCCc-----ceEEEeecCCCCHHHHhhcc---CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC
Q 014725 158 ESEV-----PLLVYEFIPNGTLYHYLHDQ---TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK 229 (419)
Q Consensus 158 ~~~~-----~~lv~e~~~~g~L~~~l~~~---~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~ 229 (419)
+.+. .++||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ |+||||||+||+++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~ 183 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDD 183 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTT
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCC
Confidence 7553 49999999999999998542 12346999999999999999999999998 9999999999999999
Q ss_pred CcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHH
Q 014725 230 YRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 230 ~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~ 307 (419)
+.+||+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+. .
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~- 259 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM---Y- 259 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---H-
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH---H-
Confidence 99999999999876433221 2233457889999999999999999999999999999999 9999987654331 1
Q ss_pred HHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
..+........+...+..+.+++.+||+.+|.+|||+.++++.|+.+...+
T Consensus 260 ------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l 310 (313)
T 3brb_A 260 ------------DYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL 310 (313)
T ss_dssp ------------HHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred ------------HHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence 111111112233445567999999999999999999999999999987654
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=340.79 Aligned_cols=260 Identities=28% Similarity=0.396 Sum_probs=212.1
Q ss_pred HHhcCccccC-cccccCcEEEEEEEec---CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 88 KATDNYNANR-ILGQGGQGTVYKGMLA---DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 88 ~~~~~y~~~~-~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
...++|.+.+ .||+|+||.||+|.+. .+..||||.+.... ....+.+.+|+.+++.++||||+++++++ +.+.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~ 91 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAES 91 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSS
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCC
Confidence 3456788887 9999999999999642 35789999986532 33467899999999999999999999999 5677
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 92 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 92 WMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEEEECCTTEEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred cEEEEEeCCCCCHHHHHHhCc---CCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 899999999999999998753 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCceee--ecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 242 TIKVDQTHLT--TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 242 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
.......... ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---------------- 229 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---------------- 229 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH----------------
Confidence 7654433222 23346788999999998889999999999999999999 9999987654331
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.+.+........+...+..+.+++.+||+.||.+||++.+|++.|+++....
T Consensus 230 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 230 TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 1111111122334455678999999999999999999999999999986554
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=361.68 Aligned_cols=261 Identities=23% Similarity=0.282 Sum_probs=209.4
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEec
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLE 158 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 158 (419)
..+.....++|++.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|..++..++||||+++++++.+
T Consensus 53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD 132 (412)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 4455566789999999999999999999974 6889999987632 12233458899999999999999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
.+..|+||||+++|+|.+++.+... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||
T Consensus 133 ~~~~~lVmE~~~gg~L~~~l~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFG 207 (412)
T 2vd5_A 133 ENYLYLVMEYYVGGDLLTLLSKFGE--RIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFG 207 (412)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHHSS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEcCCCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeech
Confidence 9999999999999999999986532 4899999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccc-------cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHH
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFR-------SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQ 311 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 311 (419)
+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+.. ..
T Consensus 208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~ 281 (412)
T 2vd5_A 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY------GK 281 (412)
T ss_dssp TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HH
T ss_pred hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH------HH
Confidence 99887654444445568999999999987 357899999999999999999999999876543311 10
Q ss_pred HhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCC---CCHHHHHH
Q 014725 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKR---PSMKEVAF 361 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R---Pt~~evl~ 361 (419)
... ..........+...+..+.+++.+||. +|.+| |++.|+++
T Consensus 282 i~~------~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 282 IVH------YKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHT------HHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHh------cccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 000 000000011112345678999999999 99998 58888865
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=351.95 Aligned_cols=252 Identities=23% Similarity=0.339 Sum_probs=200.7
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCC--cccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQINH--RNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~l 164 (419)
..++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.+++.++| |||+++++++.+....++
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 86 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 86 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEE
Confidence 35679999999999999999999988999999987643 34456789999999999976 999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++...
T Consensus 87 v~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~ 158 (343)
T 3dbq_A 87 VME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 158 (343)
T ss_dssp EEC-CCSEEHHHHHHHSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC-
T ss_pred EEe-CCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccC
Confidence 999 55889999998754 4899999999999999999999999 99999999999997 5789999999998765
Q ss_pred cCCce-eeecccccCCccCcccccc-----------CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH
Q 014725 245 VDQTH-LTTRVQGTFGYLDPEYFRS-----------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 245 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 159 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~---- 229 (343)
T 3dbq_A 159 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----K---- 229 (343)
T ss_dssp -----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----H----
T ss_pred cccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----H----
Confidence 33222 2345579999999999865 6789999999999999999999999975432210 0
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
+...++.......+......+.+++.+||+.||.+|||+.++++.
T Consensus 230 -----~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h 274 (343)
T 3dbq_A 230 -----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 274 (343)
T ss_dssp -----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -----HHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence 111222222223333344578899999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=350.65 Aligned_cols=255 Identities=22% Similarity=0.314 Sum_probs=204.1
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-----DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
..++|++.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 101 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML 101 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 3467999999999999999999974 5889999987531 122457799999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc---EEEeecC
Q 014725 163 LLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR---AKVSDFG 238 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg 238 (419)
++||||+++++|.+++.... ....+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||
T Consensus 102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCc
Confidence 99999999999998886532 2335899999999999999999999999 999999999999986654 9999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...... ....+.. ...
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~~i~~----~~~ 249 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER----LFEGIIK----GKY 249 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH----HHHHHHH----TCC
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH----HHHHHHc----CCC
Confidence 9987654322 233456999999999999999999999999999999999999999764221 1111110 000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. .+... ...+..+.+++.+||+.||.+|||+.++++
T Consensus 250 ~~--~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 250 KM--NPRQW----SHISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CC--CHHHH----TTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CC--Ccccc----ccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 00 00000 112356889999999999999999999986
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=355.19 Aligned_cols=251 Identities=24% Similarity=0.371 Sum_probs=200.9
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 163 (419)
..++|++.+.||+|+||.||+|+.. +++.||+|.++.. .....+.+.+|..++.++ +||||+++++++.+.+..+
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 129 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 129 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence 4568999999999999999999975 4678999987642 233345688899999877 8999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 130 lV~E~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~ 203 (396)
T 4dc2_A 130 FVIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 203 (396)
T ss_dssp EEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEEcCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeec
Confidence 9999999999999998654 4899999999999999999999999 999999999999999999999999999853
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhh--ccHHHHHHHHhcccchhHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED--RSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 321 (419)
... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ........+..
T Consensus 204 ~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i-------- 274 (396)
T 4dc2_A 204 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------- 274 (396)
T ss_dssp CCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHH--------
T ss_pred ccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHH--------
Confidence 222 2234456799999999999999999999999999999999999999975432211 00011111111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
.. .....+......+.+++.+||+.||.+||++
T Consensus 275 ~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 275 LE--KQIRIPRSLSVKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp HH--CCCCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred hc--cccCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence 11 1122344455678999999999999999996
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=346.65 Aligned_cols=259 Identities=27% Similarity=0.426 Sum_probs=209.1
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCE--EEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGI--VAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 165 (419)
++|.+.+.||+|+||.||+|.+. ++.. +|+|.+... .....+.+.+|+.+++++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 67999999999999999999964 4444 489987642 334456789999999999 899999999999999999999
Q ss_pred EeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcE
Q 014725 166 YEFIPNGTLYHYLHDQT-------------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA 232 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 232 (419)
|||+++++|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997643 1235899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHH
Q 014725 233 KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQ 311 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~ 311 (419)
||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||+| |..||......+. ..
T Consensus 182 kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-------~~ 252 (327)
T 1fvr_A 182 KIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-------YE 252 (327)
T ss_dssp EECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HH
T ss_pred EEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-------HH
Confidence 99999998743221 11233456889999999998889999999999999999998 9999987654321 11
Q ss_pred HhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.. ........+...+..+.+++.+||+.+|.+|||+.++++.|+.+....
T Consensus 253 ~~---------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~ 302 (327)
T 1fvr_A 253 KL---------PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 302 (327)
T ss_dssp HG---------GGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred Hh---------hcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence 11 111122233445567999999999999999999999999999987654
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-46 Score=343.49 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=205.0
Q ss_pred HHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-CcceEEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES-EVPLLVY 166 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 166 (419)
...++|++.+.||+|+||.||+|... +..||+|.+.... ..+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred CChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 34578999999999999999999874 7899999987533 457899999999999999999999997654 4789999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 170 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST 170 (278)
T ss_dssp CCCTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred ecCCCCCHHHHHHhccc-ccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc
Confidence 99999999999976432 23789999999999999999999999 999999999999999999999999998764322
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.....+++.|+|||.+.+..++.++||||||+++|||+| |..||......+. ...+...
T Consensus 171 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~----------------~~~~~~~ 230 (278)
T 1byg_A 171 ----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------VPRVEKG 230 (278)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH----------------HHHHTTT
T ss_pred ----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHHhcC
Confidence 122357889999999999999999999999999999998 9999976554321 1111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.....+...+..+.+++.+||+.||.+|||+.++++.|++++..
T Consensus 231 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 231 YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 12233445567799999999999999999999999999998753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=344.43 Aligned_cols=267 Identities=24% Similarity=0.364 Sum_probs=192.4
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|++.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 467999999999999999999964 58899999886533 3334678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccC---CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 168 FIPNGTLYHYLHDQT---EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
|++ ++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 997 59999987532 1235899999999999999999999998 9999999999999999999999999998764
Q ss_pred cCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH--
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV-- 321 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 321 (419)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+................+...
T Consensus 160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 3221 2234568999999999876 46899999999999999999999999876654322111111000000000000
Q ss_pred ---------------HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 ---------------LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ---------------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+...............+.+++.+||+.||.+|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0000011111123457899999999999999999999875
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=349.34 Aligned_cols=245 Identities=22% Similarity=0.283 Sum_probs=206.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 467999999999999999999975 5889999987532 123456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 120 ~e~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp EECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999998754 4899999999999999999999999 99999999999999999999999999987543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. .....||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...+ ...
T Consensus 194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i--------~~~- 253 (350)
T 1rdq_E 194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------YEKI--------VSG- 253 (350)
T ss_dssp C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH--------HHC-
T ss_pred C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH-------HHHH--------HcC-
Confidence 2 2345799999999999999999999999999999999999999986554321 1111 111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+||+ +.+|++
T Consensus 254 -~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 254 -KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11223344567899999999999999998 777754
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=352.83 Aligned_cols=275 Identities=24% Similarity=0.270 Sum_probs=213.5
Q ss_pred cccccCHHHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-----Ccccc
Q 014725 77 KTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-----HRNVV 150 (419)
Q Consensus 77 ~~~~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv 150 (419)
....++..+.....++|.+.+.||+|+||.||+|.+ .++..||||.+... ......+..|+.+++.++ ||||+
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv 99 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV 99 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence 345566666677789999999999999999999997 46789999998643 344567788999999986 99999
Q ss_pred cEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC--
Q 014725 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-- 228 (419)
Q Consensus 151 ~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-- 228 (419)
++++++...+..++||||+ +++|.+++...... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.
T Consensus 100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~ 174 (360)
T 3llt_A 100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYN-GFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY 174 (360)
T ss_dssp CEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred cccceeeECCeeEEEEcCC-CCCHHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence 9999999999999999999 99999999875432 4899999999999999999999999 999999999999975
Q ss_pred -----------------------CCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHH
Q 014725 229 -----------------------KYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLV 285 (419)
Q Consensus 229 -----------------------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~ 285 (419)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 250 (360)
T 3llt_A 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250 (360)
T ss_dssp CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence 789999999999864322 23456899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH---------H-----------------hhccCCC---HHHHH
Q 014725 286 ELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE---------A-----------------RVLKEGK---EEEII 336 (419)
Q Consensus 286 el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~-----------------~~~~~~~---~~~~~ 336 (419)
||++|+.||......+................+..... . ......+ .....
T Consensus 251 ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (360)
T 3llt_A 251 ELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330 (360)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCH
T ss_pred HHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHH
Confidence 99999999987665432211111100000000000000 0 0000000 00115
Q ss_pred HHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 337 TVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 337 ~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+.+++.+||+.||.+|||+.|+++
T Consensus 331 ~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 331 LFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhc
Confidence 6789999999999999999999974
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=353.18 Aligned_cols=254 Identities=23% Similarity=0.305 Sum_probs=195.2
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
..++|.+.+.||+|+||+||++... +++.||+|.+...... .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 4578999999999999999999975 6889999998654322 3668899999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc--EEEeecCCceeccc
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR--AKVSDFGASRTIKV 245 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Dfgl~~~~~~ 245 (419)
|+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++. +||+|||+++....
T Consensus 97 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~ 170 (361)
T 3uc3_A 97 YASGGELYERICNAG---RFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 170 (361)
T ss_dssp CCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred eCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence 999999999997644 4899999999999999999999999 999999999999987765 99999999975322
Q ss_pred CCceeeecccccCCccCccccccCCCCcc-cceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEK-SDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
. .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ ....... +...
T Consensus 171 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~---------~~~~ 237 (361)
T 3uc3_A 171 H--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQR---------ILSV 237 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHH---------HHTT
T ss_pred c--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHH---------HhcC
Confidence 2 22234569999999999988877655 9999999999999999999976543221 1111111 1111
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..........+..+.+++.+||+.||.+|||+.|+++.
T Consensus 238 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h 275 (361)
T 3uc3_A 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH 275 (361)
T ss_dssp CCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred CCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence 11111111234678899999999999999999999863
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=352.98 Aligned_cols=267 Identities=19% Similarity=0.257 Sum_probs=205.9
Q ss_pred HhcCccccCccccc--CcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 89 ATDNYNANRILGQG--GQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G--~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
..++|++.+.||+| +||.||+|++. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 102 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW 102 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence 45789999999999 99999999975 6889999987643 3455677889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|.+++...... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++...
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 103 VVTSFMAYGSAKDLICTHFMD-GMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEEECCTTCBHHHHHHHTCTT-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEEccCCCCHHHHHhhhccc-CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 999999999999999875322 4899999999999999999999999 999999999999999999999999998764
Q ss_pred ccCCce------eeecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc-
Q 014725 244 KVDQTH------LTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN- 314 (419)
Q Consensus 244 ~~~~~~------~~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 314 (419)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~ 256 (389)
T 3gni_B 179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTVPC 256 (389)
T ss_dssp EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHH--HHC-------
T ss_pred ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHhcCCCCc
Confidence 322111 1223468999999999987 57999999999999999999999999765443211 000000000
Q ss_pred --------ccc-------------hhHHHH---------HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 --------EDR-------------LFEVLE---------ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 --------~~~-------------~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... +..... .......+......+.+|+.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~ 333 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN 333 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 000 000000 00000112233467899999999999999999999985
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=343.87 Aligned_cols=269 Identities=24% Similarity=0.347 Sum_probs=204.5
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|.+.+.||+|+||.||+|.. .++..||+|++.. ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 456799999999999999999996 5688999998764 334556789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 165 VYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++..
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999997521 2235899999999999999999999999 999999999999999999999999999865
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........ . .........
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~-~~~~~~~~~------ 254 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----S-LCKKIEQCD------ 254 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----H-HHHHHHTTC------
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----H-HHHHhhccc------
Confidence 43221 22344689999999999999999999999999999999999999975432110 0 011111000
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCC
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSS 374 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~ 374 (419)
.........+..+.+++.+||+.||.+|||+.+|++.|+++.+....+.
T Consensus 255 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~ 303 (310)
T 2wqm_A 255 --YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303 (310)
T ss_dssp --SCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC---
T ss_pred --CCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhhh
Confidence 0011113345678999999999999999999999999999988765544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=352.98 Aligned_cols=250 Identities=25% Similarity=0.347 Sum_probs=205.3
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 467999999999999999999975 4778999987532 223457789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 94 ~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~ 167 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNV---HFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167 (384)
T ss_dssp ECCCTTEEHHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence 99999999999998643 4899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeecccccCCccCcccccc---CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
. .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..............+
T Consensus 168 ~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~------------- 232 (384)
T 4fr4_A 168 E--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF------------- 232 (384)
T ss_dssp T--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH-------------
T ss_pred C--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH-------------
Confidence 2 23345679999999999864 45899999999999999999999999765433211111111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS-MKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~ 361 (419)
. ......+...+..+.+++.+||+.||.+||+ +.+|++
T Consensus 233 ~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 233 E-TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp H-HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred h-hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 0 1112234445567999999999999999998 666643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=350.52 Aligned_cols=262 Identities=24% Similarity=0.299 Sum_probs=205.0
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC-----ChhhHHHHHHHHHHHhcCCCcccccEEeEEe
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV-----DESNVEQFINEVVILSQINHRNVVKLLGCCL 157 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 157 (419)
.++....++|.+.+.||+|+||.||+|.. .++..||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~ 98 (345)
T 3hko_A 19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE 98 (345)
T ss_dssp BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence 45567788899999999999999999997 45778999987532 3445678999999999999999999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccC-------------------------------------CCCCCCHHHHHHHHHHHH
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQT-------------------------------------EEFPITWEMRLRIAIEVS 200 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~i~ 200 (419)
+.+..++||||+++|+|.+++.... ....+++..++.++.||+
T Consensus 99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 9999999999999999999986310 011246778889999999
Q ss_pred HHHHHHhhcCCCCeeecCCCCCcEEECCCC--cEEEeecCCceecccCCc---eeeecccccCCccCcccccc--CCCCc
Q 014725 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKY--RAKVSDFGASRTIKVDQT---HLTTRVQGTFGYLDPEYFRS--SQFTE 273 (419)
Q Consensus 201 ~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--~~kl~Dfgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~s~ 273 (419)
.||.|||+.+ |+||||||+|||++.++ .+||+|||+++....... .......||+.|+|||++.+ ..++.
T Consensus 179 ~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 255 (345)
T 3hko_A 179 SALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255 (345)
T ss_dssp HHHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred HHHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence 9999999999 99999999999998776 899999999987643221 12345569999999999875 67899
Q ss_pred ccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCC
Q 014725 274 KSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKR 353 (419)
Q Consensus 274 ~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 353 (419)
++|||||||++|||++|+.||......+. ........... ........+..+.+++.+||+.+|.+|
T Consensus 256 ~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLCF-------ENPNYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCT-------TSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhccccc-------CCcccccCCHHHHHHHHHHcCCChhHC
Confidence 99999999999999999999987665432 11111110000 000111234578999999999999999
Q ss_pred CCHHHHHH
Q 014725 354 PSMKEVAF 361 (419)
Q Consensus 354 Pt~~evl~ 361 (419)
||+.++++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999987
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=340.64 Aligned_cols=262 Identities=22% Similarity=0.336 Sum_probs=201.2
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|++.+.||+|+||+||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57999999999999999999975 5789999987643 33445778999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++ +|.+++..... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 155 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSE-EHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred cCCC-CHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence 9975 66666655332 4899999999999999999999999 9999999999999999999999999998764322
Q ss_pred ceeeecccccCCccCccccccCC-CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc---ccchhHHHH
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN---EDRLFEVLE 323 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 323 (419)
.......||+.|+|||++.+.. ++.++|||||||++|||++|..||........ .......... ...+.....
T Consensus 156 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~ 232 (292)
T 3o0g_A 156 -RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp -SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGG
T ss_pred -ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhcc
Confidence 2234456899999999987765 89999999999999999998888543322211 1111111111 111110000
Q ss_pred H------------hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 A------------RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~------------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. .............+.+++.+||+.||.+|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 282 (292)
T 3o0g_A 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence 0 0000111234467889999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=351.38 Aligned_cols=250 Identities=24% Similarity=0.334 Sum_probs=205.5
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCc
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEV 161 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~ 161 (419)
....++|.+.+.||+|+||.||+|+.. +++.||+|.++.. .....+.+..|..++..+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 445688999999999999999999975 5788999987642 123456688899999876 89999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999998643 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. ...+...
T Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~-------~~~i~~~----- 233 (345)
T 1xjd_A 167 ENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-------FHSIRMD----- 233 (345)
T ss_dssp CCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHC-----
T ss_pred hcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHH-------HHHHHhC-----
Confidence 643222 223456799999999999999999999999999999999999999987654321 1111000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHH-HHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMK-EVA 360 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl 360 (419)
....+......+.+++.+||+.||.+||++. +|+
T Consensus 234 -----~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 234 -----NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp -----CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred -----CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1122333456789999999999999999997 664
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=352.41 Aligned_cols=266 Identities=17% Similarity=0.220 Sum_probs=201.1
Q ss_pred hcCccccCcccccCcEEEEEEEec----CCCEEEEEEcccCChh-----------hHHHHHHHHHHHhcCCCcccccEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLVDES-----------NVEQFINEVVILSQINHRNVVKLLG 154 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~niv~l~~ 154 (419)
.++|.+.+.||+|+||.||+|.+. .+..+|+|........ ....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999975 5678999987654321 1123667889999999999999999
Q ss_pred EEec----CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC
Q 014725 155 CCLE----SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY 230 (419)
Q Consensus 155 ~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~ 230 (419)
++.+ ....++||||+ +++|.+++.... .+++..++.++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~ 188 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN 188 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence 9987 67889999999 999999998654 5899999999999999999999998 99999999999998877
Q ss_pred --cEEEeecCCceecccCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhh
Q 014725 231 --RAKVSDFGASRTIKVDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302 (419)
Q Consensus 231 --~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 302 (419)
.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~ 268 (345)
T 2v62_A 189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV 268 (345)
T ss_dssp TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence 9999999999876432211 11345699999999999999999999999999999999999999964222111
Q ss_pred ccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 303 RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
. .......... .+...+... ......+..+.+++.+||+.+|.+|||+.+|++.|+.+..
T Consensus 269 ~--~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~ 328 (345)
T 2v62_A 269 A--VQTAKTNLLD-ELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI 328 (345)
T ss_dssp H--HHHHHHHHHH-TTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred H--HHHHHHhhcc-cccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence 0 0001111000 011111110 0111344579999999999999999999999999987643
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-45 Score=344.31 Aligned_cols=264 Identities=22% Similarity=0.312 Sum_probs=209.4
Q ss_pred HHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEe----cCCcc
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL----ESEVP 162 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~ 162 (419)
...++|.+.+.||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++. .....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 3467899999999999999999997 568899999987766777788999999999999999999999987 33467
Q ss_pred eEEEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 163 LLVYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~ 182 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMN 182 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcch
Confidence 89999999999999997631 2335899999999999999999999998 9999999999999999999999999987
Q ss_pred ecccCCce--------eeecccccCCccCccccccCC---CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH
Q 014725 242 TIKVDQTH--------LTTRVQGTFGYLDPEYFRSSQ---FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 242 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 310 (419)
........ ......||+.|+|||++.+.. ++.++||||||+++|||++|+.||.......
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------- 253 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG--------- 253 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT---------
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc---------
Confidence 64321110 012345799999999987543 6899999999999999999999985321110
Q ss_pred HHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 311 QAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
..+............+...+..+.+++.+||+.||.+|||+.++++.|+.+..
T Consensus 254 -----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 254 -----DSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp -----SCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred -----chhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 01111111111122233445679999999999999999999999999998754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=347.84 Aligned_cols=245 Identities=21% Similarity=0.240 Sum_probs=194.3
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|++.+.||+|+||+||+|.+. +++.||||++... .......+..|+..+..+ +||||+++++++.+.+..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 367999999999999999999975 6889999987543 233344556666666555 899999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+ +++|.+++..... .+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 136 ~e~~-~~~L~~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~ 209 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAWGA--SLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT 209 (311)
T ss_dssp EECC-CCBHHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred Eecc-CCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence 9999 7799999887543 5999999999999999999999998 99999999999999999999999999987543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. .......||+.|+|||++.+ .++.++|||||||++|||++|..|+..... ...........
T Consensus 210 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~~~----- 271 (311)
T 3p1a_A 210 A--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYLPP----- 271 (311)
T ss_dssp -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCCCH-----
T ss_pred C--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCCCc-----
Confidence 2 22334568999999999875 789999999999999999999776543211 01111111100
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+...+..+.+++.+||+.||++|||+.|+++
T Consensus 272 ---~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 272 ---EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp ---HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 011123457899999999999999999999976
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=351.00 Aligned_cols=247 Identities=23% Similarity=0.318 Sum_probs=203.8
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999996 56889999987532 112235788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+ +|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 88 ~E~~-~g~l~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKK---RMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTD 160 (336)
T ss_dssp ECCC-CEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTT
T ss_pred EECC-CCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccC
Confidence 9999 789999987654 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ..+..
T Consensus 161 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------------~~i~~ 222 (336)
T 3h4j_B 161 GN--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------------KKVNS 222 (336)
T ss_dssp SB--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------------CCCCS
T ss_pred Cc--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------------HHHHc
Confidence 22 2344579999999999988776 68999999999999999999999764432210 00000
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.....+...+..+.+++.+||+.||.+|||+.|+++.
T Consensus 223 -~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 259 (336)
T 3h4j_B 223 -CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD 259 (336)
T ss_dssp -SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred -CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence 0112233345678899999999999999999999763
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=342.39 Aligned_cols=266 Identities=22% Similarity=0.332 Sum_probs=206.3
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC--CCcccccEEeEEecC--
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI--NHRNVVKLLGCCLES-- 159 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~-- 159 (419)
.......++|++.+.||+|+||.||+|.+. +..||||.+... ....+..|.+++..+ +||||+++++++.+.
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~ 105 (337)
T 3mdy_A 30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105 (337)
T ss_dssp HHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred ccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence 334455678999999999999999999985 889999998643 234556666666655 899999999999877
Q ss_pred --CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc--------CCCCeeecCCCCCcEEECCC
Q 014725 160 --EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA--------TSIPIYHRDIKSSNILLDDK 229 (419)
Q Consensus 160 --~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~--------~~~~iiH~Dlkp~Nill~~~ 229 (419)
...++||||+++|+|.+++... .+++..++.++.|++.||.|||+. + |+||||||+|||++.+
T Consensus 106 ~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~ 178 (337)
T 3mdy_A 106 SWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKN 178 (337)
T ss_dssp GGCEEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTT
T ss_pred CCCceEEEEeccCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCC
Confidence 6789999999999999999764 389999999999999999999998 6 9999999999999999
Q ss_pred CcEEEeecCCceecccCCcee---eecccccCCccCccccccCCCCcc------cceechhHHHHHHHhC----------
Q 014725 230 YRAKVSDFGASRTIKVDQTHL---TTRVQGTFGYLDPEYFRSSQFTEK------SDVYSFGVVLVELLTG---------- 290 (419)
Q Consensus 230 ~~~kl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~s~~------~Di~slG~~l~el~tg---------- 290 (419)
+.+||+|||+++......... .....||+.|+|||++.+...+.. +|||||||++|||+||
T Consensus 179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~ 258 (337)
T 3mdy_A 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY 258 (337)
T ss_dssp SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence 999999999998764332221 224579999999999987766655 9999999999999999
Q ss_pred CCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHh
Q 014725 291 QKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEG 365 (419)
Q Consensus 291 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~ 365 (419)
..||......... ........... ...... ...++..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus 259 ~~p~~~~~~~~~~--~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 328 (337)
T 3mdy_A 259 QLPYHDLVPSDPS--YEDMREIVCIK--------KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328 (337)
T ss_dssp CCTTTTTSCSSCC--HHHHHHHHTTS--------CCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred cccHhhhcCCCCc--hhhhHHHHhhh--------ccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHH
Confidence 6666543322111 11111111000 011111 23677889999999999999999999999999999
Q ss_pred cHHhh
Q 014725 366 IRASI 370 (419)
Q Consensus 366 i~~~~ 370 (419)
+..+.
T Consensus 329 l~~~~ 333 (337)
T 3mdy_A 329 MSESQ 333 (337)
T ss_dssp HHHTT
T ss_pred HHhhc
Confidence 87643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=344.16 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=196.2
Q ss_pred hcCccccCcccccCcEEEEEEEe----cCCCEEEEEEcccCC----hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 90 TDNYNANRILGQGGQGTVYKGML----ADGGIVAVKKSKLVD----ESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
.++|++.+.||+|+||.||+|+. .+++.||+|.++... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46799999999999999999997 468899999876432 2344568899999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~ 169 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLEREG---IFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK 169 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence 999999999999999998653 4889999999999999999999999 9999999999999999999999999997
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. . . .+
T Consensus 170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~----~--------~i 233 (327)
T 3a62_A 170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT---I----D--------KI 233 (327)
T ss_dssp ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---H----H--------HH
T ss_pred ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHH---H----H--------HH
Confidence 643222 223445799999999999999999999999999999999999999987654321 0 0 11
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
... ....+......+.+++.+||+.||.+|| ++.++++
T Consensus 234 ~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 234 LKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp HHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred HhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 111 1122334456789999999999999999 5666654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-45 Score=349.69 Aligned_cols=247 Identities=24% Similarity=0.384 Sum_probs=202.3
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|...+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35689999999999999999996 568899999986432 23456789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||++ |+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 133 ~e~~~-g~l~~~l~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp EECCS-EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred EecCC-CCHHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 99997 688888865432 5899999999999999999999999 99999999999999999999999999976542
Q ss_pred CCceeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
. ....||+.|+|||++. ...++.++|||||||++|||++|+.||........ .....
T Consensus 207 ~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~--------- 266 (348)
T 1u5q_A 207 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA--------- 266 (348)
T ss_dssp B-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH---------
T ss_pred C-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHH---------
Confidence 2 2356899999999984 56789999999999999999999999976554321 11110
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
........+...+..+.+++.+||+.+|.+|||+.++++.
T Consensus 267 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h 306 (348)
T 1u5q_A 267 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 306 (348)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0001111122344568899999999999999999999763
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=341.20 Aligned_cols=264 Identities=24% Similarity=0.293 Sum_probs=201.2
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.++|++.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 368999999999999999999975 48899999875432 334567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 82 e~~~~~~l~~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 155 (311)
T 4agu_A 82 EYCDHTVLHELDRYQR---GVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGP 155 (311)
T ss_dssp ECCSEEHHHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EeCCCchHHHHHhhhc---CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCc
Confidence 9999999999887543 4899999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. ......||+.|+|||++.+ ..++.++||||||+++|+|++|..||......+............... ........
T Consensus 156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 233 (311)
T 4agu_A 156 SD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPR-HQQVFSTN 233 (311)
T ss_dssp -----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHH-HHHHHHTC
T ss_pred cc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccc-cccccccc
Confidence 22 2234568999999999876 678999999999999999999999998776544322211111000000 00000000
Q ss_pred -----hccC-----C-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 -----VLKE-----G-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 -----~~~~-----~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.... . ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 284 (311)
T 4agu_A 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284 (311)
T ss_dssp GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000 0 0123456889999999999999999999976
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=335.19 Aligned_cols=247 Identities=23% Similarity=0.308 Sum_probs=206.0
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
..++|.+.+.||+|+||.||+|.+.. +..+|+|++........+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 45679999999999999999999754 66899999876545556889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCceecc
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL---DDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~~~~ 244 (419)
|+++++|.+++.... .+++..++.++.|++.||.|||+++ ++||||||+||++ +.++.+||+|||++....
T Consensus 87 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 87 LCTGGELFERVVHKR---VFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp CCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred ccCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 999999999987654 4899999999999999999999999 9999999999999 788999999999998765
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
... ......||+.|+|||++.+. ++.++||||||+++++|++|+.||......+. ........
T Consensus 161 ~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~------- 223 (277)
T 3f3z_A 161 PGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV-------MLKIREGT------- 223 (277)
T ss_dssp TTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCC-------
T ss_pred Ccc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhCC-------
Confidence 332 22345689999999998754 89999999999999999999999987654321 11111000
Q ss_pred hhccCCCH----HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKE----EEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+. ..+..+.+++.+||+.||.+|||+.++++
T Consensus 224 ---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 224 ---FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp ---CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred ---CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 01111 23457899999999999999999999976
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=348.60 Aligned_cols=271 Identities=24% Similarity=0.336 Sum_probs=200.4
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEe-----
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCL----- 157 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~----- 157 (419)
.++....+|++.+.||+|+||.||+|.+. +++.||+|++........+.+.+|+.+++++. ||||+++++++.
T Consensus 22 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~ 101 (337)
T 3ll6_A 22 TVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEE 101 (337)
T ss_dssp EEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTT
T ss_pred eeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccc
Confidence 34455678999999999999999999964 68899999987666667788999999999995 999999999984
Q ss_pred ---cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 158 ---ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
.....++||||++ |+|.+++........+++..++.++.||+.||.|||+.+ .+|+||||||+|||++.++.+||
T Consensus 102 ~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl 179 (337)
T 3ll6_A 102 SDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKL 179 (337)
T ss_dssp STTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEB
T ss_pred cccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEE
Confidence 3345789999995 799999876444446999999999999999999999976 34999999999999999999999
Q ss_pred eecCCceecccCCce-----------eeecccccCCccCcccc---ccCCCCcccceechhHHHHHHHhCCCCCCCCChh
Q 014725 235 SDFGASRTIKVDQTH-----------LTTRVQGTFGYLDPEYF---RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~ 300 (419)
+|||+++........ ......||+.|+|||++ .+..++.++|||||||++|||++|+.||......
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~ 259 (337)
T 3ll6_A 180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL 259 (337)
T ss_dssp CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence 999999876432221 11234589999999998 5677899999999999999999999999653321
Q ss_pred hhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCc
Q 014725 301 EDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQ 376 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~ 376 (419)
. .................+.+++.+||+.||.+|||+.|+++.|+.+..........
T Consensus 260 ~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~~~~ 316 (337)
T 3ll6_A 260 R-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKS 316 (337)
T ss_dssp -------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred H-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCCCCCc
Confidence 1 01111111112222345888999999999999999999999999998766554443
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=354.67 Aligned_cols=251 Identities=23% Similarity=0.336 Sum_probs=200.6
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCC--CcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQIN--HRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|...+++.||||.+... .....+.+.+|+.+++.++ ||||+++++++...+..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999999888999999987643 4455678999999999996 59999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|| +.+++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++ ++.+||+|||+++....
T Consensus 135 ~E-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EE-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred Ee-cCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 99 56889999998754 5889999999999999999999998 99999999999996 57999999999987653
Q ss_pred CCce-eeecccccCCccCcccccc-----------CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh
Q 014725 246 DQTH-LTTRVQGTFGYLDPEYFRS-----------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313 (419)
Q Consensus 246 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 313 (419)
.... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~-----~----- 276 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----K----- 276 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-----H-----
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH-----H-----
Confidence 3222 2345679999999999865 4688999999999999999999999975432210 0
Q ss_pred cccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
+..+++.......+......+.+++.+||+.||.+|||+.|+++.
T Consensus 277 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h 321 (390)
T 2zmd_A 277 ----LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321 (390)
T ss_dssp ----HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred ----HHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence 111222222222233334578899999999999999999999863
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-45 Score=346.50 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=202.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 164 (419)
.++|.+.+.||+|+||.||+|+.. +++.||+|.+... .....+.+.+|..++..+ +||||+++++++.+.+..++
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 357999999999999999999975 5778999987642 344566788999999988 89999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~gg~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~ 161 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQR---KLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 161 (345)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSC
T ss_pred EEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEecccccccc
Confidence 999999999999998653 4899999999999999999999999 9999999999999999999999999998643
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhc--cHHHHHHHHhcccchhHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR--SLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 322 (419)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......... .......+.. .
T Consensus 162 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i--------~ 232 (345)
T 3a8x_A 162 RPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI--------L 232 (345)
T ss_dssp CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH--------H
T ss_pred CCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH--------H
Confidence 222 2234567999999999999999999999999999999999999999753221110 0001111111 1
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
.. ....+......+.+++.+||+.||.+||++
T Consensus 233 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 233 EK--QIRIPRSLSVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred cC--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence 11 112334455678999999999999999996
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=351.69 Aligned_cols=251 Identities=25% Similarity=0.310 Sum_probs=201.0
Q ss_pred cCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 96 NRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
.+.||+|+||.||+|.. .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 56899999999999996 46889999998876666678899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE--CCCCcEEEeecCCceecccCCceeee
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL--DDKYRAKVSDFGASRTIKVDQTHLTT 252 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill--~~~~~~kl~Dfgl~~~~~~~~~~~~~ 252 (419)
.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++....... ..
T Consensus 174 ~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~ 246 (373)
T 2x4f_A 174 FDRIIDES--YNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LK 246 (373)
T ss_dssp HHHHHHTG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CC
T ss_pred HHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--cc
Confidence 99987643 25899999999999999999999999 9999999999999 6778999999999987653322 23
Q ss_pred cccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCH
Q 014725 253 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKE 332 (419)
Q Consensus 253 ~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (419)
...||+.|+|||++.+..++.++|||||||++|||++|..||......+. ...+... .+ ........
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~---~~~i~~~----~~------~~~~~~~~ 313 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET---LNNILAC----RW------DLEDEEFQ 313 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHHHT----CC------CSCSGGGT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHhc----cC------CCChhhhc
Confidence 34699999999999989999999999999999999999999987654321 1111110 00 00000112
Q ss_pred HHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhc
Q 014725 333 EEIITVAMLGKRCLNMIGKKRPSMKEVAF--ELEGI 366 (419)
Q Consensus 333 ~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~i 366 (419)
..+..+.+++.+||+.||.+|||+.|+++ .+...
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 23457899999999999999999999987 44443
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=345.11 Aligned_cols=261 Identities=28% Similarity=0.390 Sum_probs=210.0
Q ss_pred HhcCccccCcccccCcEEEEEEEe------cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML------ADGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
..++|.+.+.||+|+||.||+|.+ .++..||+|.+... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 457899999999999999999984 24668999998643 34556789999999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEE
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTE----EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKV 234 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl 234 (419)
.++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence 9999999999999999987532 135899999999999999999999999 999999999999984 456999
Q ss_pred eecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHH
Q 014725 235 SDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
+|||+++....... .......||+.|+|||++.+..++.++||||||+++|+|+| |..||......+. .
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~-------~-- 255 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV-------L-- 255 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH-------H--
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHH-------H--
Confidence 99999976533222 22234567899999999998999999999999999999998 9999976654321 1
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
+.+........+...+..+.+++.+||+.||.+||++.+|++.|+.+..
T Consensus 256 -------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 256 -------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp -------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -------HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 1111111122334455678999999999999999999999999998754
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-45 Score=341.44 Aligned_cols=259 Identities=22% Similarity=0.258 Sum_probs=201.2
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|.+.+.||+|+||.||+|.+. +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 2h34_A 32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111 (309)
T ss_dssp --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence 4578999999999999999999975 5788999997643 23345778999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 112 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 185 (309)
T 2h34_A 112 DMRLINGVDLAAMLRRQG---PLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATT 185 (309)
T ss_dssp EEECCCCEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred EEEecCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence 999999999999998653 4899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
...........|++.|+|||++.+..++.++||||||+++|||++|+.||....... ......... .
T Consensus 186 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~-~----- 252 (309)
T 2h34_A 186 DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQAI-P----- 252 (309)
T ss_dssp -----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSCC-C-----
T ss_pred ccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccCC-C-----
Confidence 443333345568999999999999999999999999999999999999997654321 111111000 0
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhcH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRP-SMKEVAFELEGIR 367 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~i~ 367 (419)
.....+...+..+.+++.+||+.||.+|| ++.++++.|+...
T Consensus 253 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l 295 (309)
T 2h34_A 253 -RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL 295 (309)
T ss_dssp -CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred -CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence 00112233445789999999999999999 9999999998764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=351.79 Aligned_cols=266 Identities=24% Similarity=0.336 Sum_probs=195.3
Q ss_pred HHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCC--c
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESE--V 161 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~ 161 (419)
...++|.+.+.||+|+||.||+|.+ .+++.||||++.. ......+.+.+|+.+++.+. ||||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 3467899999999999999999996 4688999998753 34455677889999999997 999999999997544 6
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||++ ++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 86 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRAN----ILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHHT----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHcC----CCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 799999997 6999999763 4889999999999999999999999 9999999999999999999999999998
Q ss_pred ecccC--------------------CceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChh
Q 014725 242 TIKVD--------------------QTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300 (419)
Q Consensus 242 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~ 300 (419)
..... .........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 237 (388)
T 3oz6_A 158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM 237 (388)
T ss_dssp ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 65321 1112344579999999999876 67899999999999999999999999877654
Q ss_pred hhccHHHHHHHHhc--------ccchhHHHH---------------------H-hhccCCCHHHHHHHHHHHHHHhccCC
Q 014725 301 EDRSLVGFFLQAMN--------EDRLFEVLE---------------------A-RVLKEGKEEEIITVAMLGKRCLNMIG 350 (419)
Q Consensus 301 ~~~~~~~~~~~~~~--------~~~~~~~~~---------------------~-~~~~~~~~~~~~~l~~li~~cl~~~p 350 (419)
+............. .......+. . .............+.+|+.+||+.||
T Consensus 238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP 317 (388)
T 3oz6_A 238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP 317 (388)
T ss_dssp HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence 32111110000000 000000000 0 00000111234568899999999999
Q ss_pred CCCCCHHHHHH
Q 014725 351 KKRPSMKEVAF 361 (419)
Q Consensus 351 ~~RPt~~evl~ 361 (419)
.+|||+.|+++
T Consensus 318 ~~R~t~~e~l~ 328 (388)
T 3oz6_A 318 NKRISANDALK 328 (388)
T ss_dssp GGSCCHHHHTT
T ss_pred ccCCCHHHHhC
Confidence 99999999975
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=343.37 Aligned_cols=259 Identities=28% Similarity=0.363 Sum_probs=199.8
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc--
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP-- 162 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-- 162 (419)
..++|++.+.||+|+||.||+|.+ .+++.||||.+... .......+.+|+.+++.++||||+++++++......
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 357899999999999999999996 56789999998653 334456789999999999999999999999876554
Q ss_pred --eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 163 --LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 163 --~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred ccEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 99999999999999998654 4899999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCc--eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 241 RTIKVDQT--HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 241 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
+....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+. ..........
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~ 237 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI 237 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCCC
Confidence 87643322 222345689999999999999999999999999999999999999987654331 1111111110
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHH-HHHHHhc
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV-AFELEGI 366 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ev-l~~L~~i 366 (419)
.. . ......+..+.+++.+||+.||.+||+..++ ...+..+
T Consensus 238 ~~---~----~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 238 PP---S----ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CH---H----HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred Cc---c----cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 00 0 0011234568899999999999999976554 4555544
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-45 Score=347.09 Aligned_cols=244 Identities=24% Similarity=0.319 Sum_probs=202.7
Q ss_pred HhcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~ 163 (419)
..++|++.+.||+|+||.||+|+... ++.||+|.+... .....+.+.+|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 45789999999999999999999754 678999987642 223456788999999988 7999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 98 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 9999999999999998654 4899999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+. .+. +..
T Consensus 172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~-------~~~--------i~~ 235 (353)
T 2i0e_A 172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQS--------IME 235 (353)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHH--------HHH
T ss_pred ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH-------HHH--------HHh
Confidence 3222 233456799999999999999999999999999999999999999987654321 111 111
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
. ....+...+..+.+++.+||+.||.+||+.
T Consensus 236 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 266 (353)
T 2i0e_A 236 H--NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 266 (353)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTC
T ss_pred C--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 1 112233455678999999999999999964
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=352.14 Aligned_cols=277 Identities=14% Similarity=0.187 Sum_probs=215.2
Q ss_pred hcCccccCcccccCcEEEEEEEecC---------CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccccc---------
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD---------GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVK--------- 151 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~--------- 151 (419)
.++|.+.+.||+|+||.||+|.+.. ++.||+|..... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 115 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP 115 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence 4689999999999999999999753 778999998643 45789999999999999998
Q ss_pred ------EEeEEec-CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014725 152 ------LLGCCLE-SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224 (419)
Q Consensus 152 ------l~~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni 224 (419)
+++++.. ....++||||+ +++|.+++.... ...+++..++.++.||+.||.|||+++ |+||||||+||
T Consensus 116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI 190 (352)
T 2jii_A 116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP-KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI 190 (352)
T ss_dssp TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence 5677765 67789999999 999999998652 235999999999999999999999998 99999999999
Q ss_pred EECCCC--cEEEeecCCceecccCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCC
Q 014725 225 LLDDKY--RAKVSDFGASRTIKVDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRS 296 (419)
Q Consensus 225 ll~~~~--~~kl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~ 296 (419)
|++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 999998 8999999999876432211 12345799999999999999999999999999999999999999976
Q ss_pred CChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCc
Q 014725 297 TDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQ 376 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~ 376 (419)
....... ..... ...... ....... .......+..+.+++.+||+.||.+|||+.+|++.|+++....+.....
T Consensus 271 ~~~~~~~-~~~~~-~~~~~~-~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~~~~ 344 (352)
T 2jii_A 271 CLPNTED-IMKQK-QKFVDK-PGPFVGP---CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRVSPYD 344 (352)
T ss_dssp GTTCHHH-HHHHH-HHHHHS-CCCEECT---TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCTTS
T ss_pred CCcCHHH-HHHHH-HhccCC-hhhhhhh---ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCCCcCc
Confidence 5422110 11100 000000 0000000 0000123467999999999999999999999999999999888777666
Q ss_pred cCcccc
Q 014725 377 HNCEEI 382 (419)
Q Consensus 377 ~~~~~~ 382 (419)
...|+.
T Consensus 345 ~~dw~~ 350 (352)
T 2jii_A 345 PIGLPM 350 (352)
T ss_dssp CCCCCC
T ss_pred cccCcC
Confidence 666653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=353.55 Aligned_cols=274 Identities=24% Similarity=0.367 Sum_probs=214.6
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCC--cceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESE--VPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lv 165 (419)
.++|.+.+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|+++++.++||||+++++++.+.+ ..++|
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 467999999999999999999975 48899999986432 234577889999999999999999999998765 66999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----CCCCcEEEeecCCce
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL----DDKYRAKVSDFGASR 241 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~kl~Dfgl~~ 241 (419)
|||+++|+|.+++........+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||+++
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 999999999999987654445999999999999999999999999 9999999999999 778889999999998
Q ss_pred ecccCCceeeecccccCCccCcccccc--------CCCCcccceechhHHHHHHHhCCCCCCCCChhhhc-cHHHHHHHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRS--------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR-SLVGFFLQA 312 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~~~~~ 312 (419)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .........
T Consensus 165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 764332 2234568999999999865 56788999999999999999999999754432211 111111111
Q ss_pred hcccchhHHH-----------HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 313 MNEDRLFEVL-----------EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 313 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.....+.... ........+......+.+++.+||+.||++||++.++++.++.+..
T Consensus 243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~ 309 (396)
T 4eut_A 243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309 (396)
T ss_dssp CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence 1100000000 0001123346777889999999999999999999999999987643
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-44 Score=355.60 Aligned_cols=277 Identities=18% Similarity=0.238 Sum_probs=219.8
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC-cccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINH-RNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|.+.+.||+|+||.||+|.+ .++..||||....... ...+.+|+++++.++| +++..+..++.+.+..++|||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 57899999999999999999996 5688999998764332 2457889999999976 566667777778888899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCceecc
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL---DDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~~~~ 244 (419)
|+ +++|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++...
T Consensus 84 ~~-g~sL~~ll~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNFCSR--KLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999986433 4899999999999999999999999 9999999999999 688999999999998765
Q ss_pred cCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 245 VDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 245 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~- 236 (483)
T 3sv0_A 158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS- 236 (483)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC-
T ss_pred CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc-
Confidence 43322 12356799999999999999999999999999999999999999987654332222221111111011
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCccccc
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEIH 383 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~~ 383 (419)
+.. + ...++..+.+++.+||+.+|.+||++.+|++.|+++....+........|+..
T Consensus 237 ---~~~-l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~ 293 (483)
T 3sv0_A 237 ---IEA-L----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTIL 293 (483)
T ss_dssp ---HHH-H----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHH
T ss_pred ---HHH-H----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhh
Confidence 111 0 11224578999999999999999999999999999988777666656666543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=346.15 Aligned_cols=250 Identities=23% Similarity=0.303 Sum_probs=179.9
Q ss_pred cCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEeecCCCC
Q 014725 96 NRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYEFIPNGT 173 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~ 173 (419)
.+.||+|+||.||+|.+. +++.||||.+.. .....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus 16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~ 92 (325)
T 3kn6_A 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92 (325)
T ss_dssp SCCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred CCccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence 378999999999999974 578999999863 33467789999999997 9999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC---cEEEeecCCceecccCCcee
Q 014725 174 LYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY---RAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 174 L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~---~~kl~Dfgl~~~~~~~~~~~ 250 (419)
|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++...... ..
T Consensus 93 L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-~~ 165 (325)
T 3kn6_A 93 LFERIKKKK---HFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN-QP 165 (325)
T ss_dssp HHHHHHHCS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred HHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCC-Cc
Confidence 999998753 5899999999999999999999999 99999999999997665 89999999998654332 22
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (419)
.....||+.|+|||++.+..++.++|||||||++|+|++|..||..................+....... ....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~------~~~~ 239 (325)
T 3kn6_A 166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF------EGEA 239 (325)
T ss_dssp ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCC------CSHH
T ss_pred ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCC------Cccc
Confidence 3345689999999999999999999999999999999999999986543221111111222211111000 0000
Q ss_pred CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 331 KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 331 ~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+..+.+++.+||+.||.+|||+.++++
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 270 (325)
T 3kn6_A 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY 270 (325)
T ss_dssp HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred ccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence 0123467899999999999999999999864
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=373.57 Aligned_cols=251 Identities=29% Similarity=0.421 Sum_probs=205.6
Q ss_pred CcccccCcEEEEEEEec---CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLA---DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||.||+|.+. .+..||||+++.. .....+.+.+|+.+++.++||||+++++++.+ +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 47999999999999753 3568999998753 33446789999999999999999999999964 557899999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce--
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH-- 249 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-- 249 (419)
|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++........
T Consensus 454 g~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~ 527 (635)
T 4fl3_A 454 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527 (635)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred CCHHHHHhhCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence 99999997643 4899999999999999999999999 999999999999999999999999999876533221
Q ss_pred eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+ +.+.+......
T Consensus 528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~~~~~ 591 (635)
T 4fl3_A 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERM 591 (635)
T ss_dssp -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCC
T ss_pred cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCC
Confidence 2233456789999999999999999999999999999998 999998766543 12222222233
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
..+..++..+.+++.+||+.||++||++.+|++.|+++...+
T Consensus 592 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l 633 (635)
T 4fl3_A 592 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 633 (635)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence 445566778999999999999999999999999999886544
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=340.23 Aligned_cols=275 Identities=21% Similarity=0.324 Sum_probs=214.3
Q ss_pred ccCHHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhc--CCCcccccEEeEEe
Q 014725 80 LFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQ--INHRNVVKLLGCCL 157 (419)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~ 157 (419)
..+..-.....++|.+.+.||+|+||.||+|.+ +++.||||.+.. .....+.+|.+++.. ++||||+++++++.
T Consensus 31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred CCceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 334444556678999999999999999999998 488999999864 334677889998887 68999999999998
Q ss_pred cCC----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeeecCCCCCcEE
Q 014725 158 ESE----VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH--------SATSIPIYHRDIKSSNIL 225 (419)
Q Consensus 158 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~iiH~Dlkp~Nil 225 (419)
... ..++||||+++|+|.+++... .+++..++.++.|++.||.||| +.+ |+||||||+|||
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl 179 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL 179 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhcc----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence 775 789999999999999999764 3899999999999999999999 677 999999999999
Q ss_pred ECCCCcEEEeecCCceecccCCce---eeecccccCCccCccccccC------CCCcccceechhHHHHHHHhC------
Q 014725 226 LDDKYRAKVSDFGASRTIKVDQTH---LTTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTG------ 290 (419)
Q Consensus 226 l~~~~~~kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~~Di~slG~~l~el~tg------ 290 (419)
++.++.+||+|||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||
T Consensus 180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 259 (342)
T 1b6c_B 180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI 259 (342)
T ss_dssp ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence 999999999999999876544332 22445689999999998765 344789999999999999999
Q ss_pred ----CCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 291 ----QKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 291 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
..||......... ............+...+.. .......+..+.+++.+||+.||.+|||+.+|++.|+++
T Consensus 260 ~~~~~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i 334 (342)
T 1b6c_B 260 HEDYQLPYYDLVPSDPS--VEEMRKVVCEQKLRPNIPN---RWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 334 (342)
T ss_dssp CCCCCCTTTTTSCSSCC--HHHHHHHHTTSCCCCCCCG---GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCccccCcCccc--HHHHHHHHHHHHhCCCCcc---cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence 7788654322110 1111111111100000000 001236677899999999999999999999999999998
Q ss_pred HHhh
Q 014725 367 RASI 370 (419)
Q Consensus 367 ~~~~ 370 (419)
....
T Consensus 335 ~~~~ 338 (342)
T 1b6c_B 335 SQQE 338 (342)
T ss_dssp HHTT
T ss_pred HHHh
Confidence 7643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=347.72 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=191.8
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
....++|++.+.||+|+||.||+|.+. +++.||||.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 345678999999999999999999975 47789999987532 346788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEEeecCCcee
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKVSDFGASRT 242 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl~~~ 242 (419)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 127 ~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~ 200 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKG---YYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI 200 (349)
T ss_dssp ECCCCSCBHHHHHTTCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC----
T ss_pred EEeCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccc
Confidence 99999999999997643 4899999999999999999999999 999999999999975 88999999999986
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..||........ . ...+.....
T Consensus 201 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~----~~~i~~~~~---- 268 (349)
T 2w4o_A 201 VEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M----FRRILNCEY---- 268 (349)
T ss_dssp --------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H----HHHHHTTCC----
T ss_pred cCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H----HHHHHhCCC----
Confidence 5432 223345689999999999999999999999999999999999999976543221 1 111100000
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+..+.+++.+||+.||++|||+.++++
T Consensus 269 --~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 305 (349)
T 2w4o_A 269 --YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ 305 (349)
T ss_dssp --CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred --ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0001111234567889999999999999999999976
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=343.37 Aligned_cols=264 Identities=25% Similarity=0.318 Sum_probs=199.5
Q ss_pred hcCcccc-CcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEE
Q 014725 90 TDNYNAN-RILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 90 ~~~y~~~-~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.++|.+. +.||+|+||.||+|.. .+++.||||.+........+.+.+|+.++.++ +||||+++++++.+.+..++||
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~ 90 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF 90 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 4678874 7899999999999995 46889999998765555667899999999985 7999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc---EEEeecCCceec
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR---AKVSDFGASRTI 243 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfgl~~~~ 243 (419)
||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++. +||+|||+++..
T Consensus 91 e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~ 164 (316)
T 2ac3_A 91 EKMRGGSILSHIHKRR---HFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGI 164 (316)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--
T ss_pred EcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccc
Confidence 9999999999998753 4899999999999999999999998 999999999999988776 999999999765
Q ss_pred ccCCc------eeeecccccCCccCcccccc-----CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH
Q 014725 244 KVDQT------HLTTRVQGTFGYLDPEYFRS-----SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 244 ~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
..... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 244 (316)
T 2ac3_A 165 KLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244 (316)
T ss_dssp -----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHH
T ss_pred ccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchh
Confidence 42211 11223458999999999875 56889999999999999999999999875432211100000000
Q ss_pred hcccchhHHHHHhhccCCCH----HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 313 MNEDRLFEVLEARVLKEGKE----EEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. ...+.+.+... ....+. ..+..+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~-~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 295 (316)
T 2ac3_A 245 C-QNMLFESIQEG-KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ 295 (316)
T ss_dssp H-HHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred H-HHHHHHHHhcc-CcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 0 00000111100 011111 13457899999999999999999999976
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=360.39 Aligned_cols=249 Identities=24% Similarity=0.296 Sum_probs=197.5
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|++.+.||+|+||.||+|.. .+++.||||.+.. ........+.+|+.+++.++||||+++++++.+.+..++
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 225 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF 225 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence 457799999999999999999996 4578999998764 233445678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
||||+++|+|.+++.... .+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++.+||+|||+++..
T Consensus 226 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 226 VMEYANGGELFFHLSRER---VFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp EECCCSSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EEeeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999997654 48999999999999999999998 78 999999999999999999999999999754
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..... ... ..
T Consensus 300 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~-------~~i--------~~ 363 (446)
T 4ejn_A 300 IKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELI--------LM 363 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-------HHH--------HH
T ss_pred cCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH-------HHH--------Hh
Confidence 3222 2234567999999999999999999999999999999999999999876543211 000 00
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
. ....+...+..+.+++.+||+.||.+|| ++.|+++
T Consensus 364 ~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~ 404 (446)
T 4ejn_A 364 E--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ 404 (446)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence 0 1122334456789999999999999999 9999875
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=332.67 Aligned_cols=252 Identities=23% Similarity=0.347 Sum_probs=206.9
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.. ......+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 3578999999999999999999974 578999998754 3344567889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc---EEEeecCCcee
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR---AKVSDFGASRT 242 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfgl~~~ 242 (419)
|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++. +||+|||++..
T Consensus 84 ~e~~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~ 157 (284)
T 3kk8_A 84 FDLVTGGELFEDIVARE---FYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 157 (284)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEE
Confidence 99999999999887653 4899999999999999999999999 999999999999976655 99999999987
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ .........
T Consensus 158 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-------~~~~~~~~~---- 224 (284)
T 3kk8_A 158 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL-------YAQIKAGAY---- 224 (284)
T ss_dssp CCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCC----
T ss_pred cccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH-------HHHHHhccc----
Confidence 54332 22345689999999999999999999999999999999999999976554321 111100000
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 225 --~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 225 --DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp --CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred --cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 0001111233457899999999999999999999987
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=338.63 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=201.6
Q ss_pred hcCccccCcccccCcEEEEEEEec--CCC--EEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA--DGG--IVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~--~~~--~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
.++|++.+.||+|+||.||+|.+. ++. .||+|.+... .....+.+.+|+.+++.++||||+++++++.+.. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 467999999999999999999853 233 6899987643 3345678999999999999999999999998755 8
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++++|.+++..... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||+++.
T Consensus 96 ~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 170 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 170 (291)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred eeeEecccCCCHHHHHHhccC--CcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence 999999999999999986432 4899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCce--eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 243 IKVDQTH--LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 243 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
....... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+. ....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~-------~~~~------ 237 (291)
T 1u46_A 171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI-------LHKI------ 237 (291)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------HHHH------
T ss_pred ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHH-------HHHH------
Confidence 6543322 1233457888999999998889999999999999999999 9999987654321 1111
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.........+...+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus 238 --~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~ 284 (291)
T 1u46_A 238 --DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284 (291)
T ss_dssp --HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred --HccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence 00111112233455679999999999999999999999999988753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=334.28 Aligned_cols=248 Identities=29% Similarity=0.402 Sum_probs=203.8
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|++.+.||+|+||.||+|.+. ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 86 (279)
T 3fdn_A 7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 86 (279)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence 4567999999999999999999975 46689999875321 2234678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++....
T Consensus 87 v~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 87 ILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp EECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EEecCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999998654 4899999999999999999999998 9999999999999999999999999886543
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.. ......||+.|+|||.+.+..++.++||||||+++|+|++|..||......+.. ... .
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~----------~ 220 (279)
T 3fdn_A 161 SS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------KRI----------S 220 (279)
T ss_dssp ----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH-------HHH----------H
T ss_pred cc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHH-------HHH----------H
Confidence 22 223456899999999999999999999999999999999999999866543211 000 0
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
......+...+..+.+++.+||+.+|.+|||+.|+++.
T Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h 258 (279)
T 3fdn_A 221 RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH 258 (279)
T ss_dssp HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 11122333445678899999999999999999999874
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=346.30 Aligned_cols=264 Identities=23% Similarity=0.341 Sum_probs=198.8
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChh-hHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDES-NVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|.+.+.||+|+||.||+|... +++.||+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57999999999999999999975 6889999988653322 112456799999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
++ |+|.+++..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~- 154 (324)
T 3mtl_A 82 LD-KDLKQYLDDCGN--IINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT- 154 (324)
T ss_dssp CS-EEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred cc-cCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCc-
Confidence 97 599999887543 5899999999999999999999999 9999999999999999999999999998654322
Q ss_pred eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh-
Q 014725 249 HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV- 326 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 326 (419)
.......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+................+........
T Consensus 155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (324)
T 3mtl_A 155 KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 234 (324)
T ss_dssp --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHH
T ss_pred cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhh
Confidence 22234468999999999876 5689999999999999999999999988765543222211111111111111111000
Q ss_pred ---c---------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 ---L---------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ---~---------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. ..........+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 281 (324)
T 3mtl_A 235 KTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK 281 (324)
T ss_dssp HHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 0 0001123456889999999999999999999987
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=332.72 Aligned_cols=253 Identities=25% Similarity=0.398 Sum_probs=205.8
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
..++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 3467999999999999999999975 6889999987643 2344578899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 158 (276)
T 2yex_A 85 EYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYN 158 (276)
T ss_dssp ECCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEET
T ss_pred EecCCCcHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCC
Confidence 9999999999987543 5899999999999999999999999 999999999999999999999999999876433
Q ss_pred Cc-eeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 247 QT-HLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 247 ~~-~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.. .......||+.|+|||.+.+..+ +.++||||||+++|||++|..||......... . ..+....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~-~~~~~~~------- 225 (276)
T 2yex_A 159 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----Y-SDWKEKK------- 225 (276)
T ss_dssp TEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-----H-HHHHTTC-------
T ss_pred cchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-----H-HHhhhcc-------
Confidence 22 22344568999999999987765 78999999999999999999999765432210 0 0010000
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+..+.+++.+||+.||.+|||+.++++
T Consensus 226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 226 -TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp -TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 000111233456889999999999999999999975
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=356.39 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=206.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|.+. +++.||||.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 467999999999999999999975 68899999876421 22356789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 ~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 95 MEYVSGGELFDYICKNG---RLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp EECCSSEEHHHHTTSSS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred EeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 99999999999997543 5899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.. .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ...+...
T Consensus 169 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~-------~~~i~~~-------- 231 (476)
T 2y94_A 169 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL-------FKKICDG-------- 231 (476)
T ss_dssp TC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH-------HHHHHTT--------
T ss_pred cc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH-------HHHHhcC--------
Confidence 22 2344579999999999988765 6899999999999999999999986543221 1111110
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+......+.+++.+||+.||.+|||+.++++
T Consensus 232 --~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 232 --IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp --CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred --CcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 01122334457889999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=336.22 Aligned_cols=250 Identities=25% Similarity=0.393 Sum_probs=209.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.+.|.+.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 46699999999999999999996 458899999876532 3456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++... .+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 101 ~~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~ 173 (303)
T 3a7i_A 101 YLGGGSALDLLEPG----PLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ 173 (303)
T ss_dssp CCTTEEHHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred eCCCCcHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence 99999999999742 4899999999999999999999999 9999999999999999999999999998764332
Q ss_pred ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
.......||+.|+|||++.+..++.++||||||+++|+|++|..||......... . .+.....
T Consensus 174 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~---------~~~~~~~ 236 (303)
T 3a7i_A 174 -IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-------F---------LIPKNNP 236 (303)
T ss_dssp -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-------H---------HHHHSCC
T ss_pred -cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH-------H---------HhhcCCC
Confidence 2233456899999999999999999999999999999999999999765543211 0 0111111
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFEL 363 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L 363 (419)
...+...+..+.+++.+||+.+|.+|||+.++++..
T Consensus 237 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~ 272 (303)
T 3a7i_A 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK 272 (303)
T ss_dssp CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence 222334456789999999999999999999998743
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=341.74 Aligned_cols=266 Identities=25% Similarity=0.308 Sum_probs=200.2
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-----hhhHHHHHHHHHHHhcC---CCcccccEEeEEecC
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-----ESNVEQFINEVVILSQI---NHRNVVKLLGCCLES 159 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~ 159 (419)
..++|++.+.||+|+||+||+|.+ .+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 467899999999999999999996 568899999876322 11224566777777766 499999999999875
Q ss_pred C-----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 160 E-----VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 160 ~-----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
. ..++||||++ ++|.+++...... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPP-GLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTCCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4689999996 6999999875432 4899999999999999999999999 999999999999999999999
Q ss_pred eecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc
Q 014725 235 SDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
+|||+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.............
T Consensus 162 ~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 162 ADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 999999865422 223456789999999999999999999999999999999999999987665432111111110000
Q ss_pred ccchhHHH---HHhhcc-------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 EDRLFEVL---EARVLK-------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 ~~~~~~~~---~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+.... ...... .........+.+++.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 296 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence 00000000 000000 001123457889999999999999999999975
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=339.26 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=205.9
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh------hhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE------SNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
..++|.+.+.||+|+||.||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 3567999999999999999999975 578999998764322 135789999999999999999999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC----cEEEeec
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY----RAKVSDF 237 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Df 237 (419)
.++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+||
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp EEEEECCCCSCBHHHHHHTCS---CEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred EEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccC
Confidence 999999999999999997643 5899999999999999999999999 99999999999999887 7999999
Q ss_pred CCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 238 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
|+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ........
T Consensus 164 g~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~ 234 (321)
T 2a2a_A 164 GLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANITSVS 234 (321)
T ss_dssp TTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHTTC
T ss_pred ccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHhcc
Confidence 9998765332 22345689999999999999999999999999999999999999987554321 11110000
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. . ..... ....+..+.+++.+||+.||.+|||+.++++
T Consensus 235 ~-~-~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~ 272 (321)
T 2a2a_A 235 Y-D-FDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALR 272 (321)
T ss_dssp C-C-CCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred c-c-cChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0 00000 0122356889999999999999999999976
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=354.09 Aligned_cols=259 Identities=23% Similarity=0.314 Sum_probs=197.2
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-----
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESE----- 160 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 160 (419)
..++|++.+.||+|+||+||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 139 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence 3578999999999999999999964 5788999998643 4455678899999999999999999999997554
Q ss_pred -cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 161 -VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 161 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
..++||||+++ +|.+.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 140 ~~~~lv~E~~~~-~l~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~ 210 (464)
T 3ttj_A 140 QDVYLVMELMDA-NLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 210 (464)
T ss_dssp CEEEEEEECCSE-EHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCC
T ss_pred CeEEEEEeCCCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEe
Confidence 45999999975 56666643 3889999999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc---
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED--- 316 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--- 316 (419)
++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+..... .......
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i---~~~lg~p~~~ 285 (464)
T 3ttj_A 211 ARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKV---IEQLGTPCPE 285 (464)
T ss_dssp C-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---HHHHCSCCHH
T ss_pred eeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhcCCCCHH
Confidence 9875432 2234567999999999999999999999999999999999999999877654321111 1110000
Q ss_pred ---ch-------------------hHHHHHhhccCCC---HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 317 ---RL-------------------FEVLEARVLKEGK---EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 317 ---~~-------------------~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+ ............. ......+.+|+.+||+.||.+|||+.|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0000000000000 112567899999999999999999999976
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=347.05 Aligned_cols=263 Identities=26% Similarity=0.402 Sum_probs=208.3
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|.+.+.||+|+||.||+|.+. ++..||+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 467999999999999999999975 5789999987654 44556789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
|+++++|.+++.... .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||++......
T Consensus 112 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp CCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred CCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999998754 489999999999999999999996 7 999999999999999999999999999754322
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH------------------
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF------------------ 308 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~------------------ 308 (419)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.......
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCC
Confidence 22345689999999999999999999999999999999999999987665432111100
Q ss_pred -----HHHHhcccchhHHHHHhhcc----CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 309 -----FLQAMNEDRLFEVLEARVLK----EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 309 -----~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...........+.++..... ......+..+.+++.+||+.||.+|||+.++++
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 324 (360)
T 3eqc_A 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 324 (360)
T ss_dssp -----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred cccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 00000001111222211111 111223567899999999999999999999987
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=343.13 Aligned_cols=270 Identities=24% Similarity=0.380 Sum_probs=200.3
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHH--hcCCCcccccEEeEEec-----CCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVIL--SQINHRNVVKLLGCCLE-----SEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l--~~l~h~niv~l~~~~~~-----~~~ 161 (419)
..++|++.+.||+|+||.||+|.. +++.||||.+.... ...+..|.+++ ..++||||+++++.+.. ...
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 457899999999999999999987 58899999986432 34455555554 45799999999986542 235
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc---------CCCCeeecCCCCCcEEECCCCcE
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA---------TSIPIYHRDIKSSNILLDDKYRA 232 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------~~~~iiH~Dlkp~Nill~~~~~~ 232 (419)
.++||||+++|+|.+++.... .++..++.++.||+.||.|||+. + |+||||||+|||++.++.+
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCC----BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCE
T ss_pred EEEEEecCCCCcHHHHHhhcc----cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcE
Confidence 689999999999999997643 58899999999999999999998 7 9999999999999999999
Q ss_pred EEeecCCceecccCC-------ceeeecccccCCccCcccccc-------CCCCcccceechhHHHHHHHhCCCCCCCCC
Q 014725 233 KVSDFGASRTIKVDQ-------THLTTRVQGTFGYLDPEYFRS-------SQFTEKSDVYSFGVVLVELLTGQKPIRSTD 298 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~s~~~Di~slG~~l~el~tg~~p~~~~~ 298 (419)
||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 999999998764322 112234569999999999876 456789999999999999999977764332
Q ss_pred hhhh-ccHHHHHHHHhcccchh---HHHH-Hhhcc------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 299 AEED-RSLVGFFLQAMNEDRLF---EVLE-ARVLK------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 299 ~~~~-~~~~~~~~~~~~~~~~~---~~~~-~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
.... ...... ......... .... ..... ......+..+.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 240 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll 317 (336)
T 3g2f_A 240 SVPEYQMAFQT--EVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM 317 (336)
T ss_dssp CCCCCCCTTHH--HHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred chhHHHHhhhc--ccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence 2111 000000 000000000 0000 00011 112346678999999999999999999999999999987
Q ss_pred HhhC
Q 014725 368 ASIG 371 (419)
Q Consensus 368 ~~~~ 371 (419)
....
T Consensus 318 ~~~~ 321 (336)
T 3g2f_A 318 MIWE 321 (336)
T ss_dssp HCCC
T ss_pred HHHH
Confidence 6553
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=335.53 Aligned_cols=250 Identities=26% Similarity=0.422 Sum_probs=205.5
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEec---------
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE--------- 158 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 158 (419)
..++|++.+.||+|+||.||+|.+. +++.||+|.+.... +.+.+|+++++.++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 4567999999999999999999975 68899999987543 346789999999999999999998864
Q ss_pred -------CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc
Q 014725 159 -------SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR 231 (419)
Q Consensus 159 -------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~ 231 (419)
....++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG-EKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 3457999999999999999976432 35899999999999999999999998 999999999999999999
Q ss_pred EEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHH
Q 014725 232 AKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQ 311 (419)
Q Consensus 232 ~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 311 (419)
+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+.... . ...
T Consensus 161 ~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~----~~~ 229 (284)
T 2a19_B 161 VKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----K----FFT 229 (284)
T ss_dssp EEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----H----HHH
T ss_pred EEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----H----HHH
Confidence 9999999998765432 2234468999999999999999999999999999999999998863110 0 011
Q ss_pred HhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
... ....+...+..+.+++.+||+.||.+|||+.++++.|+.++..
T Consensus 230 ~~~------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 230 DLR------------DGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHH------------TTCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred Hhh------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 111 0111223345688999999999999999999999999987643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=369.87 Aligned_cols=263 Identities=26% Similarity=0.405 Sum_probs=213.2
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecC----CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEec
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLAD----GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLE 158 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~ 158 (419)
.+.+...++|.+.+.||+|+||.||+|.+.. +..||+|..... .....+.+.+|+.+++.++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT- 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-
Confidence 4455566789999999999999999999643 357999987753 3445578999999999999999999999985
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
.+..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||
T Consensus 462 ~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG 536 (656)
T 2j0j_A 462 ENPVWIIMELCTLGELRSFLQVRK--FSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFG 536 (656)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCC
T ss_pred cCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecC
Confidence 456899999999999999998653 24899999999999999999999998 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
+++..............+|+.|+|||++.+..++.++|||||||++|||++ |..||......+. .
T Consensus 537 ~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~-------~------- 602 (656)
T 2j0j_A 537 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-------I------- 602 (656)
T ss_dssp CCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-------H-------
T ss_pred CCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH-------H-------
Confidence 998765443333344557889999999998999999999999999999997 9999987654331 1
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
..+........+..++..+.+++.+||+.||.+|||+.+|++.|+.+..
T Consensus 603 --~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~ 651 (656)
T 2j0j_A 603 --GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 651 (656)
T ss_dssp --HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --HHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1111111223344556789999999999999999999999999998854
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=335.06 Aligned_cols=253 Identities=24% Similarity=0.379 Sum_probs=202.8
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
+.|.....||+|+||.||+|.+ .++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++||||+
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 101 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV 101 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence 3455556899999999999996 457899999987766666688999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecCCceecccCCc
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfgl~~~~~~~~~ 248 (419)
++++|.+++........+++..+..++.|++.||.|||+.+ ++|+||||+||+++. ++.+||+|||+++.......
T Consensus 102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~ 178 (295)
T 2clq_A 102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP 178 (295)
T ss_dssp SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC
Confidence 99999999987655456789999999999999999999998 999999999999987 89999999999987543221
Q ss_pred eeeecccccCCccCccccccCC--CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~--~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......... .. .......
T Consensus 179 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~---------~~~~~~~ 243 (295)
T 2clq_A 179 -CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-----MF---------KVGMFKV 243 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-----HH---------HHHHHCC
T ss_pred -cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-----HH---------hhccccc
Confidence 223456899999999987653 789999999999999999999999653322110 00 0000111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 244 HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 12233445567899999999999999999999975
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=348.49 Aligned_cols=252 Identities=24% Similarity=0.326 Sum_probs=197.0
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHH-HhcCCCcccccEEeEEecCCcce
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVI-LSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
..++|++.+.||+|+||.||+|+.. ++..||+|.+... .......+.+|..+ ++.++||||+++++++.+.+..|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 3467999999999999999999975 4778999987542 22334556777776 56789999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 116 lv~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~ 189 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 189 (373)
T ss_dssp EEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGG
T ss_pred EEEeCCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCcccccc
Confidence 9999999999999998644 4889999999999999999999999 999999999999999999999999999864
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
... .......+||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. +. .++.
T Consensus 190 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~---------~i~~ 253 (373)
T 2r5t_A 190 IEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM------YD---------NILN 253 (373)
T ss_dssp BCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH------HH---------HHHH
T ss_pred ccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HH---------HHHh
Confidence 322 2233456799999999999999999999999999999999999999976554321 11 1111
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
.. ...+......+.+++.+||+.||.+||++.+.++.+.
T Consensus 254 ~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~ 292 (373)
T 2r5t_A 254 KP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIK 292 (373)
T ss_dssp SC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHH
T ss_pred cc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHh
Confidence 11 1122334567899999999999999999865544443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=335.81 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=204.3
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
..++|.+.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 3567999999999999999999974 688999999876554455678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCceecc
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL---DDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~~~~ 244 (419)
|+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||++ +.++.+||+|||+++...
T Consensus 87 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 87 LVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred cCCCccHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999997654 4899999999999999999999999 9999999999999 788999999999987543
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.. ......||+.|+|||++.+..++.++||||||+++|+|++|..||........ ...+.....
T Consensus 161 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~i~~~~~------ 224 (304)
T 2jam_A 161 NG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL-------FEKIKEGYY------ 224 (304)
T ss_dssp CB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-------HHHHHHCCC------
T ss_pred CC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCC------
Confidence 22 22334689999999999999999999999999999999999999976554321 111111100
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+..+.+++.+||+.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 225 EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 0001112334567899999999999999999999986
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=335.20 Aligned_cols=258 Identities=25% Similarity=0.377 Sum_probs=206.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEec--CCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLE--SEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~l 164 (419)
.++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.+++.++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 468999999999999999999974 6889999987643 34556789999999999999999999998854 567899
Q ss_pred EEeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 165 VYEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSAT--SIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ..+++||||||+||+++.++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999997632 2335899999999999999999999987 2349999999999999999999999999997
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||......+. ...
T Consensus 165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~--------- 227 (279)
T 2w5a_A 165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGK--------- 227 (279)
T ss_dssp HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHH---------
T ss_pred eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH-------HHH---------
Confidence 6543221 12334689999999999988999999999999999999999999987654321 111
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
+........+...+..+.+++.+||+.+|.+|||+.+|++.+.
T Consensus 228 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~ 270 (279)
T 2w5a_A 228 IREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL 270 (279)
T ss_dssp HHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred HhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence 1111112233345567999999999999999999999987653
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=332.19 Aligned_cols=250 Identities=22% Similarity=0.344 Sum_probs=208.4
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|.+.+.||+|+||.||+|.+. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3467999999999999999999975 4778999987542 34456788999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++....
T Consensus 93 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 93 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166 (294)
T ss_dssp EEECCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecc
Confidence 999999999999987643 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+. ... ....
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~-------- 230 (294)
T 2rku_A 167 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IKKN-------- 230 (294)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHTT--------
T ss_pred cCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-Hhhc--------
Confidence 3222 23345689999999999998999999999999999999999999987554321 111 1000
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
....+......+.+++.+||+.||.+|||+.++++.
T Consensus 231 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 266 (294)
T 2rku_A 231 --EYSIPKHINPVAASLIQKMLQTDPTARPTINELLND 266 (294)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred --cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence 111223344578899999999999999999999873
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=333.37 Aligned_cols=249 Identities=27% Similarity=0.366 Sum_probs=185.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999997 568899999875321 12346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++++|.+++.... .++++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 90 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRV--KPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp EECCTTEEHHHHHHTCS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred EecCCCCcHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999998643 35899999999999999999999999 99999999999999999999999999987543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||......+. .......
T Consensus 165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~--------- 227 (278)
T 3cok_A 165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT-------LNKVVLA--------- 227 (278)
T ss_dssp ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------CCSS---------
T ss_pred CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH-------HHHHhhc---------
Confidence 222 12335689999999999988999999999999999999999999976543221 0000000
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 228 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 228 -DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred -ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 01122334457889999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=344.10 Aligned_cols=261 Identities=22% Similarity=0.311 Sum_probs=198.6
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-----
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESE----- 160 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 160 (419)
..++|.+.+.||+|+||.||+|.+ .+++.||||++.. ......+.+.+|+.+++.++||||+++++++....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 357899999999999999999997 4688999999854 23444577899999999999999999999997653
Q ss_pred -cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 161 -VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 161 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
..++||||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecC-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeec
Confidence 459999999 88999999763 4899999999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH--------HH
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF--------FL 310 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~--------~~ 310 (419)
++..... .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.||.+.+..+....... ..
T Consensus 175 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~ 250 (367)
T 1cm8_A 175 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 250 (367)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence 9875432 234568999999999877 6899999999999999999999999987665432111100 00
Q ss_pred HHhcccchhHHHHHhh------ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 311 QAMNEDRLFEVLEARV------LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+........+.... ...........+.+|+.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 251 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 0000000001110000 00111233567889999999999999999999987
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=338.71 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=208.2
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|.+.+.||+|+||.||++.+. +++.+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 4578999999999999999999975 4678999987532 34556789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++.... .+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 119 v~e~~~~~~L~~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 119 VLELCRRRSLLELHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192 (335)
T ss_dssp EECCCTTCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEecCCCCCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecc
Confidence 999999999999987643 4899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+. ... .. ..
T Consensus 193 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-~~--------~~ 256 (335)
T 2owb_A 193 YDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IK--------KN 256 (335)
T ss_dssp STTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HH--------HT
T ss_pred cCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHH-Hh--------cC
Confidence 3222 23345689999999999999999999999999999999999999986554321 110 00 00
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+......+.+++.+||+.||.+|||+.++++
T Consensus 257 --~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 257 --EYSIPKHINPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred --CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122334456889999999999999999999986
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=332.38 Aligned_cols=252 Identities=26% Similarity=0.331 Sum_probs=198.7
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|.+.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++.+....++|||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 467999999999999999999974 5789999987643 23346789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCceec
Q 014725 168 FIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL---DDKYRAKVSDFGASRTI 243 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~~~ 243 (419)
|+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+||++ +.++.+||+|||+++..
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~ 177 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF 177 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence 999999999986531 1235899999999999999999999999 9999999999999 55688999999999865
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.... ......||+.|+|||++. ..++.++||||||+++|||++|+.||......+.... .. ......
T Consensus 178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~---~~--~~~~~~----- 244 (285)
T 3is5_A 178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK---AT--YKEPNY----- 244 (285)
T ss_dssp -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HH--HCCCCC-----
T ss_pred CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh---hc--cCCccc-----
Confidence 4322 233456899999999986 5689999999999999999999999987654331100 00 000000
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+.+++.+||+.||.+|||+.|+++
T Consensus 245 ----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 245 ----AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ----CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred ----ccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000112456889999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=347.73 Aligned_cols=254 Identities=26% Similarity=0.325 Sum_probs=204.8
Q ss_pred hcCccccCcccccCcEEEEEEEe----cCCCEEEEEEcccCC----hhhHHHHHHHHHHHhcC-CCcccccEEeEEecCC
Q 014725 90 TDNYNANRILGQGGQGTVYKGML----ADGGIVAVKKSKLVD----ESNVEQFINEVVILSQI-NHRNVVKLLGCCLESE 160 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~ 160 (419)
.++|.+.+.||+|+||.||+|+. .+++.||||.++... ....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 47899999999999999999997 368899999875421 22345677899999999 6999999999999999
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a 206 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 206 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred eEEEEeecCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence 9999999999999999998654 4899999999999999999999998 999999999999999999999999999
Q ss_pred eecccCCceeeecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
+..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... .. +...
T Consensus 207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~-~~~~------ 277 (355)
T 1vzo_A 207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AE-ISRR------ 277 (355)
T ss_dssp EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HH-HHHH------
T ss_pred eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HH-HHHH------
Confidence 8765444444455679999999999985 35789999999999999999999999754332111 10 1000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAFE 362 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~~ 362 (419)
.. ......+...+..+.+++.+||+.||.+|| ++.++++.
T Consensus 278 --~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h 322 (355)
T 1vzo_A 278 --IL--KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH 322 (355)
T ss_dssp --HH--HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred --Hh--ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence 00 011223444556789999999999999999 88888763
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=343.83 Aligned_cols=260 Identities=17% Similarity=0.203 Sum_probs=209.4
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEE------ecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC---CcccccEEe
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGM------LADGGIVAVKKSKLVDESNVEQFINEVVILSQIN---HRNVVKLLG 154 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~ 154 (419)
.+++...++|.+.+.||+|+||+||+|. ...++.||+|.+.... ...+..|+.+++.++ |+||+++++
T Consensus 58 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~ 134 (365)
T 3e7e_A 58 TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYS 134 (365)
T ss_dssp CEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred eeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence 3445567889999999999999999994 3457889999987543 356777888888776 999999999
Q ss_pred EEecCCcceEEEeecCCCCHHHHhhccC--CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC----
Q 014725 155 CCLESEVPLLVYEFIPNGTLYHYLHDQT--EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---- 228 (419)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---- 228 (419)
++...+..++||||+++|+|.+++.... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.
T Consensus 135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTC
T ss_pred eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccC
Confidence 9999999999999999999999997521 2335999999999999999999999998 999999999999998
Q ss_pred -------CCcEEEeecCCceeccc-CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChh
Q 014725 229 -------KYRAKVSDFGASRTIKV-DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300 (419)
Q Consensus 229 -------~~~~kl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~ 300 (419)
++.+||+|||+++.... ..........||+.|+|||++.+..++.++|||||||++|||+||+.||......
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~ 291 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence 89999999999987542 2333445667999999999999999999999999999999999999998543221
Q ss_pred hhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCC-CCHHHHHHHHHhcHHhh
Q 014725 301 EDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKR-PSMKEVAFELEGIRASI 370 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R-Pt~~evl~~L~~i~~~~ 370 (419)
.. .+... . ... .....+.+++..|++.+|.+| |++.++.+.|+++....
T Consensus 292 ~~--------------~~~~~----~-~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 292 EC--------------KPEGL----F-RRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp EE--------------EECSC----C-TTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ce--------------eechh----c-ccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 10 00000 0 000 113457789999999999998 57888988888876543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=360.33 Aligned_cols=254 Identities=26% Similarity=0.339 Sum_probs=208.0
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|.+.+.||+|+||.||+|... +++.||+|++... .......+.+|+.+|+.++||||+++++++.+.+..++
T Consensus 182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l 261 (576)
T 2acx_A 182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL 261 (576)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence 3467999999999999999999974 6889999987532 12334668899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++|+|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 262 VmEy~~gg~L~~~l~~~~~-~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~ 337 (576)
T 2acx_A 262 VLTLMNGGDLKFHIYHMGQ-AGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337 (576)
T ss_dssp EECCCCSCBHHHHHHSSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEcCCCCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecc
Confidence 9999999999999986542 24899999999999999999999999 9999999999999999999999999998764
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.......... .+ ...+.
T Consensus 338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~---~i---------~~~i~- 402 (576)
T 2acx_A 338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE---EV---------ERLVK- 402 (576)
T ss_dssp TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH---HH---------HHHHH-
T ss_pred cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH---HH---------HHHhh-
Confidence 332 2334579999999999999899999999999999999999999998654321100 01 11111
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
......+......+.+++.+||+.||.+|| ++.||++
T Consensus 403 ~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 403 EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111223344556789999999999999999 6777764
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=352.11 Aligned_cols=250 Identities=16% Similarity=0.174 Sum_probs=195.1
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHH---HHHhcCCCcccccEE-------e
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEV---VILSQINHRNVVKLL-------G 154 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~---~~l~~l~h~niv~l~-------~ 154 (419)
..++|.+.+.||+|+||.||+|.+ .+++.||||.+.. ......+.+.+|+ ..++.++||||++++ +
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~ 150 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 150 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence 357799999999999999999996 5688999999763 3445567899999 455556899999998 6
Q ss_pred EEecCC-----------------cceEEEeecCCCCHHHHhhccCC----CCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014725 155 CCLESE-----------------VPLLVYEFIPNGTLYHYLHDQTE----EFPITWEMRLRIAIEVSGAMSYLHSATSIP 213 (419)
Q Consensus 155 ~~~~~~-----------------~~~lv~e~~~~g~L~~~l~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 213 (419)
++.+.+ ..++||||+ +|+|.+++..... ...+++..++.++.||+.||.|||+++
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 226 (377)
T 3byv_A 151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 226 (377)
T ss_dssp EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 655443 278999999 6899999986421 123446888899999999999999999
Q ss_pred eeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecccccCCccCccccccC-----------CCCcccceechhH
Q 014725 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-----------QFTEKSDVYSFGV 282 (419)
Q Consensus 214 iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~~~Di~slG~ 282 (419)
|+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||
T Consensus 227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~ 301 (377)
T 3byv_A 227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301 (377)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence 99999999999999999999999999986322 2344567 999999999887 8999999999999
Q ss_pred HHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH-
Q 014725 283 VLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF- 361 (419)
Q Consensus 283 ~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~- 361 (419)
++|||++|+.||........ ...+. ......+..+.+++.+||+.||.+|||+.++++
T Consensus 302 il~elltg~~Pf~~~~~~~~---------------~~~~~------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h 360 (377)
T 3byv_A 302 VIYWIWCADLPITKDAALGG---------------SEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET 360 (377)
T ss_dssp HHHHHHHSSCCC------CC---------------SGGGG------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred HHHHHHHCCCCCcccccccc---------------hhhhh------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence 99999999999975443221 00000 011223456889999999999999999999986
Q ss_pred -HHHhcHH
Q 014725 362 -ELEGIRA 368 (419)
Q Consensus 362 -~L~~i~~ 368 (419)
.++++..
T Consensus 361 p~f~~~~~ 368 (377)
T 3byv_A 361 PEYEQLRT 368 (377)
T ss_dssp HHHHHHHH
T ss_pred hHHHHHHH
Confidence 4555543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-44 Score=332.64 Aligned_cols=246 Identities=22% Similarity=0.291 Sum_probs=200.3
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l 164 (419)
..++|++.+.||+|+||.||+|.+. +++.||+|.+... .......+.+|+..+..+ +||||+++++++.+.+..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3567999999999999999999975 6889999987643 334557788999999999 89999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC--------------
Q 014725 165 VYEFIPNGTLYHYLHDQTE-EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-------------- 229 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-------------- 229 (419)
||||+++++|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence 9999999999999986421 135899999999999999999999999 9999999999999844
Q ss_pred -----CcEEEeecCCceecccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhc
Q 014725 230 -----YRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDR 303 (419)
Q Consensus 230 -----~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~ 303 (419)
..+||+|||++....... ...||+.|+|||++.+. .++.++|||||||++++|++|..|+......
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--- 237 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--- 237 (289)
T ss_dssp ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH---
T ss_pred ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH---
Confidence 479999999998764322 23489999999999765 6678999999999999999998776432211
Q ss_pred cHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 304 SLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... ........+...+..+.+++.+||+.||.+|||+.++++
T Consensus 238 -------~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 238 -------HEI---------RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp -------HHH---------HTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -------HHH---------HcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 001 111112223344567899999999999999999999975
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=343.52 Aligned_cols=243 Identities=23% Similarity=0.347 Sum_probs=202.7
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCCh--------hhHHHHHHHHHHHhcCCCcccccEEeEEecC
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDE--------SNVEQFINEVVILSQINHRNVVKLLGCCLES 159 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 159 (419)
..++|.+.+.||+|+||.||+|.+ .++..||||.+..... ...+.+.+|+.+++.++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 457899999999999999999996 4578899998765321 1334678899999999999999999999999
Q ss_pred CcceEEEeecCCC-CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 160 EVPLLVYEFIPNG-TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 160 ~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
+..++||||+.+| +|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHTCC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 9999998654 4899999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
+++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......
T Consensus 176 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------- 237 (335)
T 3dls_A 176 SAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV---------------- 237 (335)
T ss_dssp TCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT----------------
T ss_pred cceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH----------------
Confidence 998765332 2234568999999999988776 889999999999999999999996532110
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.. ....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 238 -----~~--~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h 275 (335)
T 3dls_A 238 -----EA--AIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD 275 (335)
T ss_dssp -----TT--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred -----hh--ccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 011122234568999999999999999999999773
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-44 Score=339.41 Aligned_cols=264 Identities=25% Similarity=0.372 Sum_probs=201.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.++|++.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 467999999999999999999975 4889999987543 3334566889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++.... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++.....
T Consensus 104 e~~~~~~l~~~~~~~~---~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 104 EFVDHTILDDLELFPN---GLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp ECCSEEHHHHHHHSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred ecCCcchHHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999988876543 4899999999999999999999999 999999999999999999999999999865432
Q ss_pred CceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+............. ..........
T Consensus 178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 255 (331)
T 4aaa_A 178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLI-PRHQELFNKN 255 (331)
T ss_dssp -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC-HHHHHHHHHC
T ss_pred cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC-hhhhhHhhhc
Confidence 22 22345689999999998875 789999999999999999999999987665432111110000000 0000000000
Q ss_pred ----------hccCC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 ----------VLKEG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ----------~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..... ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp GGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred cccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000 1123567899999999999999999999976
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=338.11 Aligned_cols=255 Identities=25% Similarity=0.413 Sum_probs=205.4
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh--------hhHHHHHHHHHHHhcC-CCcccccEEeE
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE--------SNVEQFINEVVILSQI-NHRNVVKLLGC 155 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~niv~l~~~ 155 (419)
.....++|.+.+.||+|+||.||+|.+. +|+.||||.+..... ...+.+.+|+.+++.+ +||||++++++
T Consensus 89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 168 (365)
T 2y7j_A 89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS 168 (365)
T ss_dssp HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence 3455678999999999999999999975 688999998764321 1245678999999999 79999999999
Q ss_pred EecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 014725 156 CLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235 (419)
Q Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 235 (419)
+...+..++||||+++++|.+++.... .+++..+..++.||+.||.|||+.+ ++|+||||+|||++.++.+||+
T Consensus 169 ~~~~~~~~lv~e~~~g~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~ 242 (365)
T 2y7j_A 169 YESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLS 242 (365)
T ss_dssp EEBSSEEEEEECCCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEEC
T ss_pred EeeCCEEEEEEEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEE
Confidence 999999999999999999999998643 4899999999999999999999999 9999999999999999999999
Q ss_pred ecCCceecccCCceeeecccccCCccCcccccc------CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHH
Q 014725 236 DFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF 309 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 309 (419)
|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ ...+
T Consensus 243 DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~---~~~i 317 (365)
T 2y7j_A 243 DFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM---LRMI 317 (365)
T ss_dssp CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH
T ss_pred ecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH---HHHH
Confidence 999998765332 2334579999999999863 3588999999999999999999999976543321 1111
Q ss_pred HHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 310 LQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. .... ...+. ....+..+.+++.+||+.||.+|||+.++++
T Consensus 318 ~~----~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 318 ME----GQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp HH----TCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred Hh----CCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 00 0000 00000 0112346889999999999999999999976
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=342.16 Aligned_cols=267 Identities=22% Similarity=0.278 Sum_probs=194.9
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh--hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE--SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
....++|.+.+.||+|+||+||+|.+. +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 445678999999999999999999964 678899999865332 23456789999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE-----CCCCcEEEeecC
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL-----DDKYRAKVSDFG 238 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill-----~~~~~~kl~Dfg 238 (419)
+||||++ |+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~~~---~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDKNP---DVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999997 59999998754 4899999999999999999999999 9999999999999 455569999999
Q ss_pred CceecccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
+++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......+................
T Consensus 183 ~a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 261 (329)
T 3gbz_A 183 LARAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTT 261 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred CccccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhh
Confidence 998654322 223344689999999998874 589999999999999999999999987655432111110000000000
Q ss_pred hhHHHH-------------HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 LFEVLE-------------ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 ~~~~~~-------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+..... ..............+.+++.+||+.||.+|||+.|+++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 318 (329)
T 3gbz_A 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318 (329)
T ss_dssp STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence 000000 00000000112356889999999999999999999975
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=347.08 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=192.6
Q ss_pred hcCcccc-CcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHh-cCCCcccccEEeEEec----CCcc
Q 014725 90 TDNYNAN-RILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILS-QINHRNVVKLLGCCLE----SEVP 162 (419)
Q Consensus 90 ~~~y~~~-~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~----~~~~ 162 (419)
.++|.+. +.||+|+||+||+|.+. ++..||||++... ..+.+|+.++. ..+||||+++++++.. ....
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~ 134 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 134 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence 4567665 78999999999999975 5789999998632 45678888874 4589999999999875 5678
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEEeecCC
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKVSDFGA 239 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl 239 (419)
++||||+++|+|.+++..... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 135 ~lv~E~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~ 210 (400)
T 1nxk_A 135 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 210 (400)
T ss_dssp EEEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEEeCCCCcHHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence 999999999999999986532 35899999999999999999999998 999999999999987 78999999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhcc-HHHHHHHHhcccch
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRS-LVGFFLQAMNEDRL 318 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~ 318 (419)
++..... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.......... ....+.. ...
T Consensus 211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~----~~~ 284 (400)
T 1nxk_A 211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM----GQY 284 (400)
T ss_dssp CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH----TCC
T ss_pred ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc----Ccc
Confidence 9865432 22345678999999999999999999999999999999999999997654332111 1111100 000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
.............+.+|+.+||+.||.+|||+.++++.
T Consensus 285 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h 322 (400)
T 1nxk_A 285 ------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 322 (400)
T ss_dssp ------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred ------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence 00000112345678999999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=330.02 Aligned_cols=246 Identities=27% Similarity=0.342 Sum_probs=205.6
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 467999999999999999999975 46789999875321 22346789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 93 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHG---RFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp ECCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EEeCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999998654 4899999999999999999999998 99999999999999999999999999976543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. ......|++.|+|||++.+..++.++||||||+++|+|++|..||......+. ......
T Consensus 167 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-------~~~~~~---------- 226 (284)
T 2vgo_A 167 L---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET-------HRRIVN---------- 226 (284)
T ss_dssp S---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHT----------
T ss_pred c---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH-------HHHHhc----------
Confidence 2 22345689999999999999999999999999999999999999986554321 011000
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 227 VDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 011223334567889999999999999999999986
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=353.26 Aligned_cols=193 Identities=28% Similarity=0.440 Sum_probs=155.0
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-----Cc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLES-----EV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 161 (419)
.++|.+.+.||+|+||+||+|.+. +++.||||++.. ......+.+.+|+.+|+.++||||+++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 478999999999999999999964 678999998754 3344567899999999999999999999999543 56
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.|+||||+ +++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 132 ~~lv~e~~-~~~L~~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~ 204 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRTPV---YLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR 204 (458)
T ss_dssp EEEEECCC-SEEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEecc-ccchhhhcccCC---CCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence 79999998 579999987643 5899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCc--------------------------eeeecccccCCccCcccc-ccCCCCcccceechhHHHHHHHh
Q 014725 242 TIKVDQT--------------------------HLTTRVQGTFGYLDPEYF-RSSQFTEKSDVYSFGVVLVELLT 289 (419)
Q Consensus 242 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~~~Di~slG~~l~el~t 289 (419)
....... ......+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 7642211 123445789999999986 56679999999999999999999
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=339.77 Aligned_cols=267 Identities=22% Similarity=0.266 Sum_probs=198.8
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChh-----hHHHHHHHHHHHhcCCCcccccEEeEEecC
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDES-----NVEQFINEVVILSQINHRNVVKLLGCCLES 159 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 159 (419)
.....++|.+.+.||+|+||.||+|.+. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK 84 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence 3445678999999999999999999974 5889999998643221 124688999999999999999999999999
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
+..++||||+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 85 ~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 158 (346)
T 1ua2_A 85 SNISLVFDFMET-DLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGL 158 (346)
T ss_dssp TCCEEEEECCSE-EHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred CceEEEEEcCCC-CHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEeccc
Confidence 999999999975 8998887643 24888899999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc---c
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN---E 315 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~ 315 (419)
++...... .......||+.|+|||++.+. .++.++|||||||++|||++|..||......+.. ..+..... .
T Consensus 159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~---~~i~~~~~~~~~ 234 (346)
T 1ua2_A 159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTE 234 (346)
T ss_dssp GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCT
T ss_pred ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHcCCCCh
Confidence 98754322 223345689999999998754 5899999999999999999999999876543321 11111110 0
Q ss_pred cchhHHHH--Hh----hccCC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 316 DRLFEVLE--AR----VLKEG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 316 ~~~~~~~~--~~----~~~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
..+..... .. ..... .......+.+++.+||+.||.+|||+.|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h 292 (346)
T 1ua2_A 235 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 292 (346)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred hhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence 00000000 00 00000 02234678999999999999999999999773
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=340.93 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=202.9
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecC-------
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLES------- 159 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------- 159 (419)
.++|.+.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.+++.++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999997 568899999875432 23345788999999999999999999999863
Q ss_pred -CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 160 -EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 160 -~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
+..++||||+++ +|.+.+..... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg 169 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLV--KFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 169 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCC-CHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence 457899999975 78777766433 4899999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCC---ceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc
Q 014725 239 ASRTIKVDQ---THLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 239 l~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
+++...... ........||+.|+|||++.+ ..++.++|||||||++|||+||..||....................
T Consensus 170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 249 (351)
T 3mi9_A 170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 249 (351)
T ss_dssp TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 998764221 222344568999999999876 4689999999999999999999999988765443222221111111
Q ss_pred ccchhHHHHHhhc-------c-CCC-HH------HHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 EDRLFEVLEARVL-------K-EGK-EE------EIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 ~~~~~~~~~~~~~-------~-~~~-~~------~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+...-..... . ... .. ....+.+|+.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 311 (351)
T 3mi9_A 250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 311 (351)
T ss_dssp TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence 1111000000000 0 000 00 1245889999999999999999999976
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=341.03 Aligned_cols=252 Identities=21% Similarity=0.301 Sum_probs=200.6
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 166 (419)
..++|.+.+.||+|+||.||+|... +++.||+|.+..... ...+|++++.++ +||||+++++++.+.+..++||
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 4567999999999999999999975 577899999865432 245688888887 7999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC----CcEEEeecCCcee
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK----YRAKVSDFGASRT 242 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfgl~~~ 242 (419)
||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||+.++ +.+||+|||+++.
T Consensus 96 E~~~gg~L~~~i~~~~---~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 96 ELMKGGELLDKILRQK---FFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp CCCCSCBHHHHHHTCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred eCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 9999999999997643 4899999999999999999999999 9999999999998433 3599999999987
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
...... ......||+.|+|||++.+..++.++|||||||++|||++|..||............ ..+.....
T Consensus 170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~---- 240 (342)
T 2qr7_A 170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKF---- 240 (342)
T ss_dssp CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCC----
T ss_pred CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCc----
Confidence 654322 233457899999999998888999999999999999999999999764322111111 11111110
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+..+.+++.+||+.||.+|||+.++++
T Consensus 241 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 241 --SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp --CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred --ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 0001112334567899999999999999999999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=331.67 Aligned_cols=257 Identities=25% Similarity=0.340 Sum_probs=205.5
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh------hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE------SNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
.++|.+.+.||+|+||.||+|... +++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999975 588999998764321 1357899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC----cEEEeecC
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY----RAKVSDFG 238 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg 238 (419)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++ .+||+|||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg 157 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAEKE---SLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG 157 (283)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEeecCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence 99999999999999997643 4899999999999999999999998 99999999999998877 89999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
++....... ......||+.|+|||++.+..++.++||||||+++++|++|..||......+. .........
T Consensus 158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~~ 228 (283)
T 3bhy_A 158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET-------LTNISAVNY 228 (283)
T ss_dssp TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTTCC
T ss_pred cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH-------HHHhHhccc
Confidence 998754322 22344689999999999999999999999999999999999999987654321 111100000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH--HHHhcH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF--ELEGIR 367 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~--~L~~i~ 367 (419)
. ..... ....+..+.+++.+||+.||.+|||+.++++ .++.++
T Consensus 229 ~--~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 229 D--FDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp C--CCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred C--Ccchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 0 00000 0122356889999999999999999999987 455554
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=330.34 Aligned_cols=250 Identities=23% Similarity=0.371 Sum_probs=199.7
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEec----CCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLE----SEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 162 (419)
...|.+.+.||+|+||.||+|.+. ++..||+|.+.. ......+.+.+|+.+++.++||||+++++++.. ....
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 345788899999999999999974 567899998764 345566789999999999999999999999875 3457
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCce
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASR 241 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~ 241 (419)
++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ .+++||||||+|||++ .++.+||+|||++.
T Consensus 105 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred EEEEEecCCCCHHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 99999999999999998653 4899999999999999999999986 3499999999999997 78999999999997
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
..... ......||+.|+|||++. +.++.++||||||+++|+|++|+.||........ ..........
T Consensus 181 ~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~~--- 247 (290)
T 1t4h_A 181 LKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVK--- 247 (290)
T ss_dssp GCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCC---
T ss_pred ccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH------HHHHHhccCC---
Confidence 54322 223456899999999887 4589999999999999999999999976443221 1111111100
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 248 -----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 248 -----PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp -----CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -----ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 00111122346899999999999999999999975
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=326.71 Aligned_cols=248 Identities=25% Similarity=0.347 Sum_probs=198.1
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|.+.+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 88 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM 88 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence 3468999999999999999999975 68899999875421 2335678999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++++|.+++.... .+++..++.++.|++.||.|||+++ ++|+||||+||+++.++.+||+|||++....
T Consensus 89 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 89 VMEYVSGGELFDYICKHG---RVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEECCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred EEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999998654 4899999999999999999999999 9999999999999999999999999997654
Q ss_pred cCCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
... ......||+.|+|||.+.+..+ +.++||||||+++++|++|..||........ .......
T Consensus 163 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~------- 226 (276)
T 2h6d_A 163 DGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL-------FKKIRGG------- 226 (276)
T ss_dssp C---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHC-------
T ss_pred CCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH-------HHHhhcC-------
Confidence 322 2234468999999999987765 6899999999999999999999976543221 1111100
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+......+.+++.+||+.||.+|||+.++++
T Consensus 227 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 227 ---VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 01123334457889999999999999999999987
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=343.42 Aligned_cols=268 Identities=24% Similarity=0.358 Sum_probs=205.9
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESE 160 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~ 160 (419)
..+++...++|.+.+.||+|+||.||+|.+.+ .+|+|.+... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 25 ~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 25 LQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp GGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred cccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 44555667899999999999999999999854 4899987643 2233456788999999999999999999999999
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++ ++.+||+|||++
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~ 176 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAK--IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLF 176 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSC--CCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCC
T ss_pred ceEEEeecccCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCc
Confidence 9999999999999999998654 25889999999999999999999999 99999999999998 679999999998
Q ss_pred eecccCC----ceeeecccccCCccCcccccc---------CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHH
Q 014725 241 RTIKVDQ----THLTTRVQGTFGYLDPEYFRS---------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 241 ~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 307 (419)
+...... ........||+.|+|||++.+ ..++.++||||||+++|||++|+.||........
T Consensus 177 ~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----- 251 (319)
T 2y4i_B 177 SISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI----- 251 (319)
T ss_dssp C----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH-----
T ss_pred cccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----
Confidence 7643211 112233458999999999864 4578999999999999999999999987654321
Q ss_pred HHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCC
Q 014725 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~ 373 (419)
....... ..........+..+.+++.+||+.+|.+|||+.++++.|+.+.......
T Consensus 252 --~~~~~~~--------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~~~ 307 (319)
T 2y4i_B 252 --IWQMGTG--------MKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRL 307 (319)
T ss_dssp --HHHHHTT--------CCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-------
T ss_pred --HHHhccC--------CCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhccC
Confidence 1111000 0000111123446889999999999999999999999999997765443
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=335.66 Aligned_cols=253 Identities=24% Similarity=0.352 Sum_probs=201.9
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
..++|++.+.||+|+||.||+|.+. ++..||+|.+........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 4578999999999999999999975 478999999876666667889999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++++|.+++..... .+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++......
T Consensus 97 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDR--GLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp CCTTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred eCCCCcHHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999876433 4899999999999999999999998 999999999999999999999999987643211
Q ss_pred ceeeecccccCCccCcccc-----ccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 248 THLTTRVQGTFGYLDPEYF-----RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~-----~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
........||+.|+|||++ ....++.++||||||+++|+|++|..||........ .........
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~----- 239 (302)
T 2j7t_A 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSDP----- 239 (302)
T ss_dssp HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHSCC-----
T ss_pred ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhccCC-----
Confidence 1112334689999999998 356789999999999999999999999987654321 111110000
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 240 ---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 ---PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp ---CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred ---cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 001112334557899999999999999999999875
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=332.41 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=201.6
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
...++|.+.+.||+|+||.||+|.+. ++..||+|.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 103 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM 103 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence 45678999999999999999999975 48899999987532 3467899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++++|.+++..... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 104 e~~~~~~L~~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 104 EYCGAGSVSDIIRLRNK--TLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp ECCTTEEHHHHHHHHTC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred ecCCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 99999999999975332 4899999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. .......||+.|+|||.+.+..++.++||||||+++|+|++|..||......... ....... ..
T Consensus 179 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~--------~~ 243 (314)
T 3com_A 179 M-AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI------FMIPTNP--------PP 243 (314)
T ss_dssp B-SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSC--------CC
T ss_pred c-cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHhcCC--------Cc
Confidence 2 2233456899999999999999999999999999999999999999865543211 0000000 00
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 244 ~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 244 TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 01112233457899999999999999999999976
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=342.69 Aligned_cols=268 Identities=21% Similarity=0.274 Sum_probs=201.3
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCC-----------hhhHHHHHHHHHHHhcCCCccccc
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD-----------ESNVEQFINEVVILSQINHRNVVK 151 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~niv~ 151 (419)
..++....++|.+.+.||+|+||.||+|...++..||||++.... ....+.+.+|+.+++.++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 457788899999999999999999999998889999999875321 223478999999999999999999
Q ss_pred EEeEEecC-----CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014725 152 LLGCCLES-----EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL 226 (419)
Q Consensus 152 l~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill 226 (419)
+++++... ...++||||++ |+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR--IVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 99998543 35699999997 68888887543 35899999999999999999999999 9999999999999
Q ss_pred CCCCcEEEeecCCceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccH
Q 014725 227 DDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSL 305 (419)
Q Consensus 227 ~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~ 305 (419)
+.++.+||+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+...
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~- 244 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN- 244 (362)
T ss_dssp CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-
T ss_pred cCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence 99999999999999754322 22334568999999999876 678999999999999999999999998765443211
Q ss_pred HHHHHHHhcccchhHH-----------HHHhhcc-------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 306 VGFFLQAMNEDRLFEV-----------LEARVLK-------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 306 ~~~~~~~~~~~~~~~~-----------~~~~~~~-------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.............. +...... .........+.+++.+||+.||.+|||+.|+++
T Consensus 245 --~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 316 (362)
T 3pg1_A 245 --KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR 316 (362)
T ss_dssp --HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence 11111111111000 0000000 001122456889999999999999999999976
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=331.79 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=189.3
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-h-hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-E-SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..++|++.+.||+|+||.||+|.. .+++.||+|++.... . ...+.+.++...++.++||||+++++++.+.+..++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv 84 (290)
T 3fme_A 5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC 84 (290)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence 457899999999999999999997 467889999886532 2 2233445555668888999999999999999999999
Q ss_pred EeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 166 YEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
|||++ |+|.+++... .....+++..++.++.|++.||.|||++ + ++||||||+||+++.++.+||+|||+++..
T Consensus 85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 99997 5888887642 1223599999999999999999999998 8 999999999999999999999999999865
Q ss_pred ccCCceeeecccccCCccCcccc----ccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYF----RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
.... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||......... . .
T Consensus 161 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----~---------~ 224 (290)
T 3fme_A 161 VDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----L---------K 224 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-----H---------H
T ss_pred cccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-----H---------H
Confidence 4322 22334689999999996 5567899999999999999999999999764332110 1 1
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...............+..+.+++.+||+.||.+|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 225 QVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp HHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 111111111122334567899999999999999999999987
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=355.38 Aligned_cols=251 Identities=24% Similarity=0.320 Sum_probs=205.2
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|.+.+.||+|+||.||+|+.. +++.||+|++... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 367999999999999999999974 5889999987532 123356788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCC-CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 166 YEFIPNGTLYHYLHDQTE-EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~-~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
|||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~ 340 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK 340 (543)
T ss_dssp ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence 999999999999976432 335899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
.... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||........ ... ..+. +...
T Consensus 341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~-~~~~--------i~~~ 408 (543)
T 3c4z_A 341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKE-LKQR--------VLEQ 408 (543)
T ss_dssp TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHH-HHHH--------HHHC
T ss_pred CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHH-HHHH--------Hhhc
Confidence 3322 23345799999999999999999999999999999999999999976532111 000 1111 1111
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMK 357 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~ 357 (419)
....+...+..+.+++.+||+.||.+||++.
T Consensus 409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 439 (543)
T 3c4z_A 409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGFR 439 (543)
T ss_dssp --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCB
T ss_pred --ccCCCcccCHHHHHHHHHhccCCHhHCCCCc
Confidence 1123344566789999999999999999763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=352.84 Aligned_cols=251 Identities=25% Similarity=0.341 Sum_probs=200.1
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..++|.+.+.||+|+||+||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 4567999999999999999999975 57889999876432 33357789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEEeecCCcee
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKVSDFGASRT 242 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl~~~ 242 (419)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++. ++.+||+|||+++.
T Consensus 115 ~e~~~~g~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~ 188 (494)
T 3lij_A 115 MECYKGGELFDEIIHRM---KFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV 188 (494)
T ss_dssp EECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence 99999999999887653 4899999999999999999999999 999999999999976 45599999999987
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
..... ......||+.|+|||++. ..++.++|||||||++|+|++|..||......+. ...+......
T Consensus 189 ~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~--- 255 (494)
T 3lij_A 189 FENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI-------LRKVEKGKYT--- 255 (494)
T ss_dssp CBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCC---
T ss_pred CCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC---
Confidence 65332 234456999999999986 5699999999999999999999999987655331 1111111000
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+..+.+++.+||+.+|.+|||+.++++
T Consensus 256 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 256 ---FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp ---CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 000001123456889999999999999999999985
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=338.32 Aligned_cols=260 Identities=22% Similarity=0.367 Sum_probs=201.4
Q ss_pred cCHHHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEec
Q 014725 81 FTKMDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLE 158 (419)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 158 (419)
+...++....++|++.+.||+|+||.||+|.+ .+++.||+|.+..... ..+.+.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 92 (326)
T 2x7f_A 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK 92 (326)
T ss_dssp --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence 33445556788999999999999999999997 4688999999865432 346789999999998 79999999999976
Q ss_pred ------CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcE
Q 014725 159 ------SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA 232 (419)
Q Consensus 159 ------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 232 (419)
.+..++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+ ++|+||||+||+++.++.+
T Consensus 93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~ 168 (326)
T 2x7f_A 93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV 168 (326)
T ss_dssp CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence 457899999999999999998653 235899999999999999999999999 9999999999999999999
Q ss_pred EEeecCCceecccCCceeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHH
Q 014725 233 KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~ 307 (419)
||+|||++....... .......||+.|+|||++. +..++.++|||||||++|+|++|..||.........
T Consensus 169 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---- 243 (326)
T 2x7f_A 169 KLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---- 243 (326)
T ss_dssp EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH----
T ss_pred EEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH----
Confidence 999999998654321 1223456899999999986 567899999999999999999999999765543211
Q ss_pred HHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. +.........+...+..+.+++.+||+.||.+|||+.++++
T Consensus 244 --~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 244 --FL---------IPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp --HH---------HHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred --HH---------hhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00000011112233457899999999999999999999977
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=337.07 Aligned_cols=266 Identities=23% Similarity=0.343 Sum_probs=188.9
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.....++|.+.+.||+|+||.||+|.. .++..||||.+.... ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus 10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 345568899999999999999999996 467899999876432 334567889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhcc-----CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 164 LVYEFIPNGTLYHYLHDQ-----TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
+||||+++++|.+++... .....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg 166 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG 166 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence 999999999999999741 12235899999999999999999999998 9999999999999999999999999
Q ss_pred CceecccCCc----eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh
Q 014725 239 ASRTIKVDQT----HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313 (419)
Q Consensus 239 l~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 313 (419)
++........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||......... ......
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~~~- 242 (303)
T 2vwi_A 167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL---MLTLQN- 242 (303)
T ss_dssp HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH---HHHHTS-
T ss_pred chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH---HHHhcc-
Confidence 9876543211 11234568999999999876 56899999999999999999999999876543311 000000
Q ss_pred cccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
......... .........+..+.+++.+||+.||.+|||+.++++
T Consensus 243 ~~~~~~~~~---~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 243 DPPSLETGV---QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp SCCCTTC--------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCCcccccc---ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 000000000 001112233457889999999999999999999976
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=354.85 Aligned_cols=251 Identities=26% Similarity=0.374 Sum_probs=205.7
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
..++|++.+.||+|+||.||+|... +++.||||.+... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 4567999999999999999999975 6889999987532 23456789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE---CCCCcEEEeecCCce
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL---DDKYRAKVSDFGASR 241 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill---~~~~~~kl~Dfgl~~ 241 (419)
||||+.+|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||+ +.++.+||+|||+++
T Consensus 104 v~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 177 (484)
T 3nyv_A 104 VGEVYTGGELFDEIISRK---RFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLST 177 (484)
T ss_dssp EECCCCSCBHHHHHHTCS---CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHH
T ss_pred EEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeE
Confidence 999999999999997643 4899999999999999999999999 9999999999999 567899999999998
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+. ...+......
T Consensus 178 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~-- 245 (484)
T 3nyv_A 178 HFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI-------LKKVEKGKYT-- 245 (484)
T ss_dssp HBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCC--
T ss_pred Eccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH-------HHHHHcCCCC--
Confidence 654332 2334569999999999875 689999999999999999999999987654331 1111111000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+.....+..+.+++.+||+.+|.+|||+.++++
T Consensus 246 ----~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 246 ----FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp ----CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ----CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 000011233457889999999999999999999986
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=347.50 Aligned_cols=254 Identities=24% Similarity=0.313 Sum_probs=192.0
Q ss_pred HHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--------hhhHHHHHHHHHHHhcCCCcccccEEeEEe
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--------ESNVEQFINEVVILSQINHRNVVKLLGCCL 157 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 157 (419)
....++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 345789999999999999999999964 57899999875321 112235789999999999999999999985
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC---CcEEE
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKV 234 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl 234 (419)
. +..++||||+++|+|.+++.... .+++..+..++.|++.||.|||+++ |+||||||+|||++.+ ..+||
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl 283 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKI 283 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEE
T ss_pred c-CceEEEEEcCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEE
Confidence 4 45799999999999999987643 5899999999999999999999999 9999999999999654 45999
Q ss_pred eecCCceecccCCceeeecccccCCccCcccccc---CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHH
Q 014725 235 SDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQ 311 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 311 (419)
+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........ .....
T Consensus 284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i-- 357 (419)
T 3i6u_A 284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI-- 357 (419)
T ss_dssp CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH--
T ss_pred eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH--
Confidence 999999875432 22345679999999999853 6788999999999999999999999976443211 11111
Q ss_pred HhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....... . +.. ....+..+.+++.+||+.||.+|||+.++++
T Consensus 358 --~~~~~~~-~-~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~ 399 (419)
T 3i6u_A 358 --TSGKYNF-I-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 399 (419)
T ss_dssp --HTTCCCC-C-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred --hcCCCCC-C-chh----hcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 1000000 0 000 0112456889999999999999999999976
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.77 Aligned_cols=259 Identities=22% Similarity=0.277 Sum_probs=206.2
Q ss_pred HHHHHHhcCcccc-CcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcC-CCcccccEEeEEec
Q 014725 84 MDLEKATDNYNAN-RILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQI-NHRNVVKLLGCCLE 158 (419)
Q Consensus 84 ~~~~~~~~~y~~~-~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 158 (419)
...+...++|.+. +.||+|+||.||+|... +++.||+|.+... .......+.+|+.+++.+ +||||+++++++.+
T Consensus 21 ~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 21 QSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp BCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 3345566778887 89999999999999975 5889999987642 233467899999999999 56999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEEe
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKVS 235 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~ 235 (419)
.+..++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELA-EMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEEC
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEe
Confidence 9999999999999999999865432 35899999999999999999999999 999999999999987 7899999
Q ss_pred ecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc
Q 014725 236 DFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE 315 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 315 (419)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+.. ...... .
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~---~~i~~~-~- 249 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETY---LNISQV-N- 249 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHT-C-
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH---HHHHhc-c-
Confidence 999998764322 223456899999999999999999999999999999999999999876543311 000000 0
Q ss_pred cchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 316 DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 316 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...........+..+.+++.+||+.||.+|||+.++++
T Consensus 250 --------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~ 287 (327)
T 3lm5_A 250 --------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS 287 (327)
T ss_dssp --------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred --------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence 00011112334567889999999999999999999975
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=352.07 Aligned_cols=252 Identities=25% Similarity=0.346 Sum_probs=203.2
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..++|.+.+.||+|+||+||+|... +++.||||.+... .......+.+|+.+++.++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 3567999999999999999999975 6889999987531 223457789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCcee
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD---DKYRAKVSDFGASRT 242 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfgl~~~ 242 (419)
|||+++++|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.
T Consensus 100 ~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 173 (486)
T 3mwu_A 100 GELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173 (486)
T ss_dssp ECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred EEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence 99999999999987654 4899999999999999999999999 99999999999995 456799999999986
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
.... .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+. ...+......
T Consensus 174 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~~~i~~~~~~--- 240 (486)
T 3mwu_A 174 FQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKYA--- 240 (486)
T ss_dssp BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHTCCC---
T ss_pred CCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCCCC---
Confidence 5432 22334569999999999875 599999999999999999999999987654331 1111111000
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
...+.....+..+.+++.+||+.+|.+|||+.++++.
T Consensus 241 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h 277 (486)
T 3mwu_A 241 ---FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH 277 (486)
T ss_dssp ---SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred ---CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 0000112234568899999999999999999999873
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-43 Score=349.50 Aligned_cols=252 Identities=27% Similarity=0.356 Sum_probs=202.4
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCCh-------------hhHHHHHHHHHHHhcCCCcccccEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE-------------SNVEQFINEVVILSQINHRNVVKLL 153 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~l~ 153 (419)
...++|.+.+.||+|+||+||+|... ++..||+|.+..... ...+.+.+|+.+++.++||||++++
T Consensus 33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~ 112 (504)
T 3q5i_A 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF 112 (504)
T ss_dssp CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence 35688999999999999999999975 577899998764221 2356789999999999999999999
Q ss_pred eEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC---
Q 014725 154 GCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY--- 230 (419)
Q Consensus 154 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~--- 230 (419)
+++.+....++||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++
T Consensus 113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~ 186 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYEGGELFEQIINRH---KFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLL 186 (504)
T ss_dssp EEEECSSEEEEEEECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCS
T ss_pred EEEEcCCEEEEEEecCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCc
Confidence 99999999999999999999999997653 4899999999999999999999999 99999999999998775
Q ss_pred cEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH
Q 014725 231 RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 231 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 310 (419)
.+||+|||+++...... ......||+.|+|||++. ..++.++|||||||++|+|++|..||......+. .
T Consensus 187 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-------~ 256 (504)
T 3q5i_A 187 NIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI-------I 256 (504)
T ss_dssp SEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------H
T ss_pred cEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-------H
Confidence 69999999998765332 233456999999999987 5689999999999999999999999987655331 1
Q ss_pred HHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 311 QAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+.......... . ....+..+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~i~~~~~~~~~~--~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYFDFN--D----WKNISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCCCHH--H----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCCCcc--c----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 1111111000000 0 0112356899999999999999999999976
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=339.88 Aligned_cols=265 Identities=22% Similarity=0.299 Sum_probs=203.1
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-----Cc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLES-----EV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 161 (419)
..++|.+.+.||+|+||.||+|.+. ++..||+|++... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 3568999999999999999999964 5778999998753 344457899999999999999999999999754 35
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||++ ++|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 105 ~~iv~e~~~-~~L~~~l~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~ 176 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLAR 176 (364)
T ss_dssp EEEEEECCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEcccC-cCHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceE
Confidence 799999996 5999998753 3899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCcee--eecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 242 TIKVDQTHL--TTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 242 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
......... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+................+
T Consensus 177 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 256 (364)
T 3qyz_A 177 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256 (364)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHH
T ss_pred ecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence 765332221 244579999999998654 45899999999999999999999999876654322111100000000000
Q ss_pred --------hHHHHHhhc-cCC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 --------FEVLEARVL-KEG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 --------~~~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
......... ... .......+.+++.+||+.||.+|||+.|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000000 000 0123456889999999999999999999976
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=344.41 Aligned_cols=199 Identities=26% Similarity=0.388 Sum_probs=167.5
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-----C
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLES-----E 160 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~ 160 (419)
..++|.+.+.||+|+||.||+|.+. +++.||||++.. ......+.+.+|+.+|+.++||||+++++++... .
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3578999999999999999999974 467899999864 2344567899999999999999999999999766 5
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..|+||||++ ++|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~L~~~~~~~~---~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla 176 (432)
T 3n9x_A 104 ELYIVLEIAD-SDLKKLFKTPI---FLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLA 176 (432)
T ss_dssp CEEEEEECCS-EEHHHHHHSSC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecCC-cCHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCc
Confidence 6899999996 69999997643 4899999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCce---------------------eeecccccCCccCcccc-ccCCCCcccceechhHHHHHHHhCCCCC
Q 014725 241 RTIKVDQTH---------------------LTTRVQGTFGYLDPEYF-RSSQFTEKSDVYSFGVVLVELLTGQKPI 294 (419)
Q Consensus 241 ~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~s~~~Di~slG~~l~el~tg~~p~ 294 (419)
+........ ......||+.|+|||++ ....++.++|||||||++|||++|..||
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 177 RTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp EEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred ccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 876433211 23556799999999986 5667999999999999999999855444
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=345.15 Aligned_cols=261 Identities=22% Similarity=0.279 Sum_probs=196.3
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc------c
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEV------P 162 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~ 162 (419)
...+|.+.+.||+|+||+||+|.+.++..+|+|++..... ...+|+.+++.++||||+++++++...+. .
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 113 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence 3457999999999999999999988777899998754322 12369999999999999999999965433 7
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCce
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASR 241 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~ 241 (419)
++||||++++.+............+++..+..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+++
T Consensus 114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 899999987544433322222335899999999999999999999999 99999999999998 79999999999998
Q ss_pred ecccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.... +...........
T Consensus 191 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~---i~~~~g~p~~~~ 265 (394)
T 4e7w_A 191 ILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE---IIKVLGTPSREQ 265 (394)
T ss_dssp ECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---HHHHHCCCCHHH
T ss_pred cccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCCHHH
Confidence 764332 22345689999999998764 589999999999999999999999987665432111 111111000000
Q ss_pred H--HHHhh-------------ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 321 V--LEARV-------------LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 321 ~--~~~~~-------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+ ..+.. ....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 321 (394)
T 4e7w_A 266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321 (394)
T ss_dssp HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence 0 00000 00011223457899999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=326.71 Aligned_cols=252 Identities=22% Similarity=0.260 Sum_probs=200.4
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC----hhhHHHHHHHHHHHhcCCCcccccEEeEEe--cCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD----ESNVEQFINEVVILSQINHRNVVKLLGCCL--ESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~--~~~~ 161 (419)
..++|.+.+.||+|+||.||+|.+ .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 357899999999999999999997 457899999876421 234577999999999999999999999984 4567
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||++++ |.+++..... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||+|||++.
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~ 157 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAE 157 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHSTT-CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEehhccCC-HHHHHHhCcc-cccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeecccccc
Confidence 89999999876 7777766433 35899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccC-CceeeecccccCCccCccccccCC--CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 242 TIKVD-QTHLTTRVQGTFGYLDPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 242 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~--~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
..... .........||+.|+|||++.+.. ++.++||||||+++|||++|+.||......+. .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-------~~~i~~~-- 228 (305)
T 2wtk_C 158 ALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL-------FENIGKG-- 228 (305)
T ss_dssp ECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHHHHC--
T ss_pred ccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH-------HHHHhcC--
Confidence 76432 222234456899999999987644 47899999999999999999999986543321 1111100
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 229 --------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 264 (305)
T 2wtk_C 229 --------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH 264 (305)
T ss_dssp --------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred --------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 112233445678899999999999999999999863
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=331.32 Aligned_cols=256 Identities=20% Similarity=0.302 Sum_probs=201.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEec--CCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLE--SEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv 165 (419)
.++|++.+.||+|+||.||+|.. .+++.||+|.+.... .+.+.+|+.+++.++ ||||+++++++.+ ....++|
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv 111 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV 111 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence 46799999999999999999996 568899999987433 467899999999997 9999999999987 5678999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCceecc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTIK 244 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~ 244 (419)
|||+++++|.+++.. +++..+..++.|++.||.|||+++ |+||||||+|||++.++ .+||+|||+++...
T Consensus 112 ~e~~~~~~l~~~~~~------~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 112 FEHVNNTDFKQLYQT------LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EECCCCCCHHHHGGG------CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeccCchhHHHHHHh------CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 999999999999853 788999999999999999999999 99999999999999776 89999999998764
Q ss_pred cCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ............+.+.++
T Consensus 183 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~--l~~~~~~~~~~~~~~~~~ 258 (330)
T 3nsz_A 183 PGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYID 258 (330)
T ss_dssp TTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHH
T ss_pred CCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH--HHHHHHhcCCchhhhHHH
Confidence 3322 234568999999999877 67899999999999999999999999654332111 111111111111111111
Q ss_pred Hhh-----------------------ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARV-----------------------LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~-----------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... ...........+.+++.+||+.||.+|||+.|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~ 319 (330)
T 3nsz_A 259 KYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 319 (330)
T ss_dssp HTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 100 00111124567899999999999999999999986
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=336.78 Aligned_cols=258 Identities=23% Similarity=0.314 Sum_probs=193.9
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC------
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESE------ 160 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------ 160 (419)
.++|.+.+.||+|+||.||+|... +++.||||++.. ......+.+.+|+.+++.++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 478999999999999999999964 578899998764 23445677899999999999999999999997655
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
..++||||++ ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||++
T Consensus 104 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHhh-----ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 5799999997 478888852 3889999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc-----
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE----- 315 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~----- 315 (419)
+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.. .........
T Consensus 175 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~ 249 (371)
T 2xrw_A 175 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGTPCPEF 249 (371)
T ss_dssp -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHC-CCCCCHHH
T ss_pred cccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHH
Confidence 865422 2233456899999999999999999999999999999999999999876543311 000000000
Q ss_pred --------------------cchhHHHHHhhccCC---CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 316 --------------------DRLFEVLEARVLKEG---KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 316 --------------------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+............ .......+.+|+.+||+.||.+|||+.|+++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 000000000000000 1223567899999999999999999999987
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-43 Score=331.40 Aligned_cols=262 Identities=23% Similarity=0.337 Sum_probs=206.9
Q ss_pred hcCccccCcccccCcEEEEEEEe--cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcc------cccEEeEEecCCc
Q 014725 90 TDNYNANRILGQGGQGTVYKGML--ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN------VVKLLGCCLESEV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~ 161 (419)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+... ....+.+.+|+.+++.++|+| ++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 56899999999999999999986 35788999998753 344577889999999987765 9999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-------------
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD------------- 228 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~------------- 228 (419)
.++||||+ +++|.+++..... .++++..+..++.|++.||.|||+++ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKENGF-LPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 8999999987543 35899999999999999999999999 999999999999987
Q ss_pred ------CCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhh
Q 014725 229 ------KYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302 (419)
Q Consensus 229 ------~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 302 (419)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||...+..+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 678999999999864322 2345689999999999999999999999999999999999999987765443
Q ss_pred ccHHHHHHHHhccc--------ch--------------hHHHHHh-----hccCCCHHHHHHHHHHHHHHhccCCCCCCC
Q 014725 303 RSLVGFFLQAMNED--------RL--------------FEVLEAR-----VLKEGKEEEIITVAMLGKRCLNMIGKKRPS 355 (419)
Q Consensus 303 ~~~~~~~~~~~~~~--------~~--------------~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RPt 355 (419)
.............. .. ....... ............+.+++.+||+.||.+|||
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 22221111100000 00 0000000 001223456778999999999999999999
Q ss_pred HHHHHH
Q 014725 356 MKEVAF 361 (419)
Q Consensus 356 ~~evl~ 361 (419)
+.|+++
T Consensus 323 ~~ell~ 328 (339)
T 1z57_A 323 LREALK 328 (339)
T ss_dssp HHHHTT
T ss_pred HHHHhc
Confidence 999975
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=326.32 Aligned_cols=253 Identities=26% Similarity=0.379 Sum_probs=204.9
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---------hhhHHHHHHHHHHHhcCC-CcccccEEeEE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---------ESNVEQFINEVVILSQIN-HRNVVKLLGCC 156 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~ 156 (419)
...++|.+.+.||+|+||.||+|... +++.||+|.+.... ....+.+.+|+.+++++. ||||+++++++
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (298)
T 1phk_A 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY 93 (298)
T ss_dssp -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence 44678999999999999999999975 57889999976532 123466889999999995 99999999999
Q ss_pred ecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEee
Q 014725 157 LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSD 236 (419)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~D 236 (419)
.+.+..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~d 167 (298)
T 1phk_A 94 ETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTD 167 (298)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECC
T ss_pred ccCCeEEEEEeccCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEec
Confidence 99999999999999999999998643 4899999999999999999999999 99999999999999999999999
Q ss_pred cCCceecccCCceeeecccccCCccCccccc------cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH
Q 014725 237 FGASRTIKVDQTHLTTRVQGTFGYLDPEYFR------SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 237 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 310 (419)
||++....... ......||+.|+|||++. ...++.++||||||+++++|++|..||........ .....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~~~ 242 (298)
T 1phk_A 168 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRMIM 242 (298)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHH
T ss_pred ccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHH---HHHHh
Confidence 99998764332 223456899999999985 45688999999999999999999999976554321 10010
Q ss_pred HHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 311 QAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. ... ..........+..+.+++.+||+.||.+|||+.++++
T Consensus 243 ~----~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 243 S----GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp H----TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred c----CCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 0 000 0000111234567999999999999999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=344.18 Aligned_cols=203 Identities=25% Similarity=0.338 Sum_probs=175.6
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcC------CCcccccEEeEEecCCc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQI------NHRNVVKLLGCCLESEV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~ 161 (419)
...+|++.+.||+|+||.||+|.+. +++.||||++... ......+.+|+.+++.+ +|+||+++++++.....
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 4567999999999999999999975 4788999998753 33446778888888776 57799999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc--EEEeecCC
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR--AKVSDFGA 239 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~--~kl~Dfgl 239 (419)
.++||||+. ++|.+++...... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 174 ~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~ 248 (429)
T 3kvw_A 174 ICMTFELLS-MNLYELIKKNKFQ-GFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGS 248 (429)
T ss_dssp EEEEECCCC-CBHHHHHHHTTTC-CCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred EEEEEeccC-CCHHHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeeccc
Confidence 999999995 6999999875432 4899999999999999999999999 999999999999999887 99999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhh
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~ 301 (419)
++..... .....||+.|+|||++.+..++.++|||||||++|||+||..||...+..+
T Consensus 249 a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 249 SCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp CEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred ceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9764322 234568999999999999999999999999999999999999998776543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=339.42 Aligned_cols=260 Identities=25% Similarity=0.304 Sum_probs=204.0
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC--------CcccccEEeEEe---
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQIN--------HRNVVKLLGCCL--- 157 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~--- 157 (419)
.++|.+.+.||+|+||+||+|+. .+++.||||.+... ....+.+.+|+.+++.++ ||||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 57899999999999999999996 45778999998743 344577899999999885 888999999987
Q ss_pred -cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCC-----
Q 014725 158 -ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKY----- 230 (419)
Q Consensus 158 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~----- 230 (419)
+....++||||+ +++|.+++..... ..+++..++.++.||+.||.|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKSNY-QGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred CCCceEEEEEecc-CccHHHHHHhccc-CCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence 556789999999 6677777665432 2589999999999999999999998 8 99999999999998775
Q ss_pred --------------------------------------------cEEEeecCCceecccCCceeeecccccCCccCcccc
Q 014725 231 --------------------------------------------RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266 (419)
Q Consensus 231 --------------------------------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~ 266 (419)
.+||+|||+++..... .....||+.|+|||++
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~ 265 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL 265 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence 7999999999875432 2334689999999999
Q ss_pred ccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhcc---HHHHHHHHhccc---------------------------
Q 014725 267 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRS---LVGFFLQAMNED--------------------------- 316 (419)
Q Consensus 267 ~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~--------------------------- 316 (419)
.+..++.++|||||||++|||+||+.||......+... ............
T Consensus 266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (397)
T 1wak_A 266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL 345 (397)
T ss_dssp HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence 99999999999999999999999999998655332111 111111111000
Q ss_pred ---chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 317 ---RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 317 ---~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+.+.+. .....+......+.+|+.+||+.||.+|||+.|+++
T Consensus 346 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 346 KPWGLFEVLV--EKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCHHHHHH--HTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred CCcchhHhhh--hhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 0001111 112345677788999999999999999999999975
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=362.25 Aligned_cols=245 Identities=24% Similarity=0.309 Sum_probs=204.4
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcc
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~ 162 (419)
...++|++.+.||+|+||.||+|... +++.||||+++.. .....+.+..|..++..+ +||||+++++++.+.+..
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 34578999999999999999999975 5778999987632 223456788999999988 799999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~---~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVG---RFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEEEeCcCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999998754 4899999999999999999999999 99999999999999999999999999986
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
..... .......||+.|+|||++.+..++.++|||||||++|||++|..||...+..+. .+.+...
T Consensus 492 ~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~------ 557 (674)
T 3pfq_A 492 NIWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL-------FQSIMEH------ 557 (674)
T ss_dssp CCCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHSS------
T ss_pred cccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH-------HHHHHhC------
Confidence 43222 234456799999999999999999999999999999999999999987654321 1111111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
....+......+.+|+.+||+.||.+||++
T Consensus 558 ----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 558 ----NVAYPKSMSKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----CCCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----CCCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence 112334455678999999999999999997
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-44 Score=342.62 Aligned_cols=261 Identities=23% Similarity=0.306 Sum_probs=185.8
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC------
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLES------ 159 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------ 159 (419)
..++|.+.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 357899999999999999999996 45789999998642 344567889999999999999999999998654
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
...++|+||+ +++|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp CCCEEEEECC-CEECC-----C----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC---
T ss_pred CeEEEEeccc-CCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5679999999 78999988752 4899999999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH------
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA------ 312 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~------ 312 (419)
++..... .....||+.|+|||++.+ ..++.++|||||||+++||++|+.||.+.+..+...........
T Consensus 179 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~ 254 (367)
T 2fst_X 179 ARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELL 254 (367)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred ccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9864322 234568999999999876 67899999999999999999999999877654321111111000
Q ss_pred --hcccchhHHHHHhhc-cCCC-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 313 --MNEDRLFEVLEARVL-KEGK-----EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 313 --~~~~~~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+........+..... ...+ ......+.+|+.+||+.||.+|||+.++++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000000000000000 0000 112356889999999999999999999976
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=338.40 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=204.6
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChh-----------------hHHHHHHHHHHHhcCCCccccc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDES-----------------NVEQFINEVVILSQINHRNVVK 151 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~-----------------~~~~~~~e~~~l~~l~h~niv~ 151 (419)
..++|.+.+.||+|+||.||+|.. ++..||+|.+...... ..+.+.+|+.+++.++||||++
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 357899999999999999999999 8999999987642111 1278999999999999999999
Q ss_pred EEeEEecCCcceEEEeecCCCCHHHH------hhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcE
Q 014725 152 LLGCCLESEVPLLVYEFIPNGTLYHY------LHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNI 224 (419)
Q Consensus 152 l~~~~~~~~~~~lv~e~~~~g~L~~~------l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Ni 224 (419)
+++++.+.+..++||||+++++|.++ +.... ...+++..++.++.|++.||.|||+ .+ ++||||||+||
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Ni 183 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNI 183 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGE
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhE
Confidence 99999999999999999999999999 55421 3469999999999999999999999 88 99999999999
Q ss_pred EECCCCcEEEeecCCceecccCCceeeecccccCCccCccccccC-CCCc-ccceechhHHHHHHHhCCCCCCCCChhhh
Q 014725 225 LLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTE-KSDVYSFGVVLVELLTGQKPIRSTDAEED 302 (419)
Q Consensus 225 ll~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-~~Di~slG~~l~el~tg~~p~~~~~~~~~ 302 (419)
+++.++.+||+|||++...... ......||+.|+|||++.+. .++. ++||||||++++||++|..||........
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 260 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260 (348)
T ss_dssp EECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH
T ss_pred EEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence 9999999999999999875433 33445689999999999877 6666 99999999999999999999986554211
Q ss_pred ccHHHHHHHHhcccchhHH---------HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 303 RSLVGFFLQAMNEDRLFEV---------LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+........ .............+..+.+++.+||+.||.+|||+.++++
T Consensus 261 ------~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 261 ------LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ------HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ------HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111111100000 0000000001234567899999999999999999999976
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=330.84 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=202.7
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCC--CcccccEEeEEec
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQIN--HRNVVKLLGCCLE 158 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~ 158 (419)
+..+....++|++.+.||+|+||.||++.+.+++.||+|.+.. ......+.+.+|+.+++.++ ||||+++++++.+
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 3444556778999999999999999999988899999998764 33455678999999999997 5999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
.+..++||| +.+++|.+++.... .+++..++.++.|++.||.|||+.+ ++||||||+|||+++ +.+||+|||
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg 171 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKK---SIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFG 171 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCS
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecc
Confidence 999999999 56889999998653 5899999999999999999999998 999999999999964 799999999
Q ss_pred CceecccCCce-eeecccccCCccCcccccc-----------CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHH
Q 014725 239 ASRTIKVDQTH-LTTRVQGTFGYLDPEYFRS-----------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV 306 (419)
Q Consensus 239 l~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 306 (419)
+++........ ......||+.|+|||.+.+ ..++.++||||||+++|||++|+.||........
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---- 247 (313)
T 3cek_A 172 IANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---- 247 (313)
T ss_dssp SSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH----
T ss_pred ccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH----
Confidence 99876433221 2234568999999999875 4688899999999999999999999976433211
Q ss_pred HHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 307 GFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
. +....+.......+...+..+.+++.+||+.||.+||++.++++.
T Consensus 248 -~---------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h 293 (313)
T 3cek_A 248 -K---------LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293 (313)
T ss_dssp -H---------HHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred -H---------HHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence 0 111111212222233334578999999999999999999999863
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=336.45 Aligned_cols=269 Identities=20% Similarity=0.289 Sum_probs=193.0
Q ss_pred HHHHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc
Q 014725 83 KMDLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEV 161 (419)
Q Consensus 83 ~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~ 161 (419)
........++|.+.+.||+|+||.||+|.+. ++..||||++.... .....+.+++..++.++||||+++++++...+.
T Consensus 15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~ 93 (360)
T 3e3p_A 15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE 93 (360)
T ss_dssp SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence 3456677889999999999999999999974 58899999875432 223456788888999999999999999975433
Q ss_pred -------ceEEEeecCCCCHHHHhhc-cCCCCCCCHHHHHHHHHHHHHHHHHHh--hcCCCCeeecCCCCCcEEECC-CC
Q 014725 162 -------PLLVYEFIPNGTLYHYLHD-QTEEFPITWEMRLRIAIEVSGAMSYLH--SATSIPIYHRDIKSSNILLDD-KY 230 (419)
Q Consensus 162 -------~~lv~e~~~~g~L~~~l~~-~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~iiH~Dlkp~Nill~~-~~ 230 (419)
.++||||+++ +|...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++
T Consensus 94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~ 169 (360)
T 3e3p_A 94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG 169 (360)
T ss_dssp SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence 7899999976 55544432 223345899999999999999999999 887 999999999999986 89
Q ss_pred cEEEeecCCceecccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHH
Q 014725 231 RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF 309 (419)
Q Consensus 231 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 309 (419)
.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||........... .
T Consensus 170 ~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~---~ 244 (360)
T 3e3p_A 170 TLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHE---I 244 (360)
T ss_dssp EEEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH---H
T ss_pred cEEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHH---H
Confidence 99999999998765332 22345689999999998664 489999999999999999999999987665432111 1
Q ss_pred HHHhccc--chhHHHH----------------HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 310 LQAMNED--RLFEVLE----------------ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 310 ~~~~~~~--~~~~~~~----------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....... .....+. ..............+.+++.+||+.||.+|||+.|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 314 (360)
T 3e3p_A 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC 314 (360)
T ss_dssp HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111000 0000000 00111122234567999999999999999999999976
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=341.12 Aligned_cols=269 Identities=22% Similarity=0.281 Sum_probs=199.8
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-----
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES----- 159 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----- 159 (419)
++...++|.+.+.||+|+||+||+|.+ .++..||||++..... ...+|+.+++.++||||+++++++...
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 345678999999999999999999996 5688999998764322 234799999999999999999998543
Q ss_pred ---------------------------------CcceEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHH
Q 014725 160 ---------------------------------EVPLLVYEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSY 205 (419)
Q Consensus 160 ---------------------------------~~~~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~ 205 (419)
...++||||++ ++|.+.+... .....+++..+..++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 33789999997 5887777641 122358999999999999999999
Q ss_pred HhhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCceecccCCceeeecccccCCccCccccccC-CCCcccceechhHH
Q 014725 206 LHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVV 283 (419)
Q Consensus 206 LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~ 283 (419)
||+.+ |+||||||+|||++ .++.+||+|||+++...... ......||+.|+|||++.+. .++.++|||||||+
T Consensus 157 LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i 231 (383)
T 3eb0_A 157 IHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCV 231 (383)
T ss_dssp HHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred HHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHH
Confidence 99999 99999999999997 68899999999998764332 23345689999999998764 58999999999999
Q ss_pred HHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH---------------hhccCCCHHHHHHHHHHHHHHhcc
Q 014725 284 LVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA---------------RVLKEGKEEEIITVAMLGKRCLNM 348 (419)
Q Consensus 284 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~l~~li~~cl~~ 348 (419)
+|||++|+.||.+....+... .............+... ......+...+..+.+++.+||+.
T Consensus 232 l~ell~g~~pf~~~~~~~~~~---~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 308 (383)
T 3eb0_A 232 FGELILGKPLFSGETSIDQLV---RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRY 308 (383)
T ss_dssp HHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCS
T ss_pred HHHHHhCCCCCCCCChHHHHH---HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccC
Confidence 999999999998766543211 11111111100000000 000011223455689999999999
Q ss_pred CCCCCCCHHHHHH--HHHhcH
Q 014725 349 IGKKRPSMKEVAF--ELEGIR 367 (419)
Q Consensus 349 ~p~~RPt~~evl~--~L~~i~ 367 (419)
||.+|||+.|+++ .++.++
T Consensus 309 dP~~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 309 EPDLRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp SGGGSCCHHHHHTSGGGHHHH
T ss_pred ChhhCCCHHHHhcCHHHHHHH
Confidence 9999999999985 344443
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=333.49 Aligned_cols=261 Identities=23% Similarity=0.336 Sum_probs=196.9
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEe-----------
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCL----------- 157 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~----------- 157 (419)
.++|.+.+.||+|+||.||+|.... ++.||+|++...+....+.+.+|+.+++.++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 89 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence 4689999999999999999999754 7899999988777777788999999999999999999999874
Q ss_pred ---cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC-CCCcEE
Q 014725 158 ---ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAK 233 (419)
Q Consensus 158 ---~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~k 233 (419)
+....++||||++ |+|.+++... .+++..++.++.|++.||.|||+++ |+||||||+||+++ +++.+|
T Consensus 90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 90 SLTELNSVYIVQEYME-TDLANVLEQG----PLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp -CCSCSEEEEEEECCS-EEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred cccccCceeEEeeccC-CCHHHHhhcC----CccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence 3456789999997 6999998642 4899999999999999999999999 99999999999997 577999
Q ss_pred EeecCCceecccCCc--eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH
Q 014725 234 VSDFGASRTIKVDQT--HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL 310 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~ 310 (419)
|+|||+++....... .......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~ 238 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLIL 238 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHH
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHH
Confidence 999999987543211 12234457899999998865 67899999999999999999999999876643321 1111
Q ss_pred HHhccc---chhH-------HHHHhhc-cCC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 311 QAMNED---RLFE-------VLEARVL-KEG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 311 ~~~~~~---~~~~-------~~~~~~~-~~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...... ...+ .+..... ... ....+..+.+++.+||+.||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 239 ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 111000 0000 0001000 000 1123467899999999999999999999976
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=344.93 Aligned_cols=254 Identities=13% Similarity=0.048 Sum_probs=182.9
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcC--CCcccccEE-------eEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD---ESNVEQFINEVVILSQI--NHRNVVKLL-------GCC 156 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~niv~l~-------~~~ 156 (419)
..+|.+.+.||+|+||.||+|.+. +++.||+|++.... ....+.+.+|+.+++.+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 456999999999999999999964 67899999987643 23456677885444444 699988755 444
Q ss_pred ecC-----------------CcceEEEeecCCCCHHHHhhccCCCCCCCHHHH------HHHHHHHHHHHHHHhhcCCCC
Q 014725 157 LES-----------------EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMR------LRIAIEVSGAMSYLHSATSIP 213 (419)
Q Consensus 157 ~~~-----------------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~~ 213 (419)
... ...++||||++ |+|.+++..... .+++..+ +.++.||+.||.|||+++
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 332 23699999998 899999987432 2455555 778899999999999999
Q ss_pred eeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCC
Q 014725 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQ 291 (419)
Q Consensus 214 iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~ 291 (419)
|+||||||+|||++.++.+||+|||+++.... ......+|+.|+|||++.+ ..++.++|||||||++|||+||+
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~ 290 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCC
Confidence 99999999999999999999999999986532 1223457799999999987 68999999999999999999999
Q ss_pred CCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 292 KPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 292 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.||.......... +.....................+..+.+++.+||+.||++|||+.++++
T Consensus 291 ~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 291 LPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp CSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 9998764332110 0000000000001111112244567999999999999999999999975
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-43 Score=329.69 Aligned_cols=252 Identities=25% Similarity=0.317 Sum_probs=196.1
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC--------hhhHHHHHHHHHHHhcCCCcccccEEeEEecC
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD--------ESNVEQFINEVVILSQINHRNVVKLLGCCLES 159 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~ 159 (419)
..++|.+.+.||+|+||.||+|.+. +++.||||.+.... ......+.+|+.+++.++||||+++++++...
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 87 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE 87 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence 4567999999999999999999974 47789999875421 12234588999999999999999999998765
Q ss_pred CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc---EEEee
Q 014725 160 EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR---AKVSD 236 (419)
Q Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~D 236 (419)
. .++||||+++++|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++. +||+|
T Consensus 88 ~-~~lv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D 160 (322)
T 2ycf_A 88 D-YYIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD 160 (322)
T ss_dssp S-EEEEEECCTTEETHHHHSTTC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred c-eEEEEecCCCCcHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence 5 799999999999999987543 5899999999999999999999999 999999999999987654 99999
Q ss_pred cCCceecccCCceeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHh
Q 014725 237 FGASRTIKVDQTHLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313 (419)
Q Consensus 237 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 313 (419)
||+++..... .......||+.|+|||++. ...++.++|||||||++|+|++|..||....... .+...+..
T Consensus 161 fg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~-- 234 (322)
T 2ycf_A 161 FGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV--SLKDQITS-- 234 (322)
T ss_dssp CTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSS--CHHHHHHH--
T ss_pred Cccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHH--HHHHHHHh--
Confidence 9999875432 1223456899999999974 4678999999999999999999999997654321 11111111
Q ss_pred cccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..... . +.. ....+..+.+++.+||+.||.+|||+.++++
T Consensus 235 --~~~~~-~-~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 235 --GKYNF-I-PEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp --TCCCC-C-HHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred --Ccccc-C-chh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 00000 0 000 0122456889999999999999999999975
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=330.85 Aligned_cols=264 Identities=25% Similarity=0.377 Sum_probs=201.9
Q ss_pred HHhcCccccCcccccCcEEEEEEEe--cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcC---CCcccccEEeEEe---
Q 014725 88 KATDNYNANRILGQGGQGTVYKGML--ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQI---NHRNVVKLLGCCL--- 157 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~--~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~--- 157 (419)
...++|.+.+.||+|+||.||+|.+ .+++.||+|.+.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~ 87 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 87 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence 4567899999999999999999997 457789999875321 22223466777776665 8999999999987
Q ss_pred --cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEe
Q 014725 158 --ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVS 235 (419)
Q Consensus 158 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~ 235 (419)
.....++||||++ |+|.+++...... .+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+
T Consensus 88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~ 162 (326)
T 1blx_A 88 TDRETKLTLVFEHVD-QDLTTYLDKVPEP-GVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLA 162 (326)
T ss_dssp CSSEEEEEEEEECCS-CBHHHHHHHSCTT-CSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred cCCCceEEEEEecCC-CCHHHHHHhcccC-CCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEe
Confidence 5567899999997 6999999875432 4899999999999999999999999 9999999999999999999999
Q ss_pred ecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc-
Q 014725 236 DFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN- 314 (419)
Q Consensus 236 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~- 314 (419)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......... ........
T Consensus 163 Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~ 237 (326)
T 1blx_A 163 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGL 237 (326)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred cCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCC
Confidence 999998654221 233456899999999999999999999999999999999999999876653321 11111110
Q ss_pred --ccchhHHH---H-------HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 --EDRLFEVL---E-------ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 --~~~~~~~~---~-------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...+.... . ...........+..+.+++.+||+.||.+|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 296 (326)
T 1blx_A 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 296 (326)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 00000000 0 00001112234567889999999999999999999975
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-43 Score=334.20 Aligned_cols=265 Identities=22% Similarity=0.285 Sum_probs=201.8
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecC-----Cc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLES-----EV 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~ 161 (419)
..++|.+.+.||+|+||.||+|.+. +++.||||.+... .......+.+|+.+++.++||||+++++++... ..
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 3578999999999999999999975 5788999998643 334456788999999999999999999988754 56
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.++||||++ ++|.+++... .+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++
T Consensus 89 ~~lv~e~~~-~~L~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (353)
T 2b9h_A 89 VYIIQELMQ-TDLHRVISTQ----MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLAR 160 (353)
T ss_dssp EEEEECCCS-EEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEeccC-ccHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccc
Confidence 799999996 6999998763 4899999999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCce---------eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHH
Q 014725 242 TIKVDQTH---------LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQ 311 (419)
Q Consensus 242 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~ 311 (419)
........ ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.............
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 240 (353)
T 2b9h_A 161 IIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIG 240 (353)
T ss_dssp ECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred ccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Confidence 76432111 1223468999999998764 6789999999999999999999999987664332111110000
Q ss_pred Hhccc---------chhHHHHHhhcc------CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 312 AMNED---------RLFEVLEARVLK------EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 312 ~~~~~---------~~~~~~~~~~~~------~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..... ...+........ ......+..+.+++.+||+.||.+|||+.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (353)
T 2b9h_A 241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305 (353)
T ss_dssp CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000 000010000000 001133467889999999999999999999976
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=342.10 Aligned_cols=266 Identities=21% Similarity=0.322 Sum_probs=183.3
Q ss_pred hcCccc-cCcccccCcEEEEEEEec---CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEec--CCcce
Q 014725 90 TDNYNA-NRILGQGGQGTVYKGMLA---DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE--SEVPL 163 (419)
Q Consensus 90 ~~~y~~-~~~ig~G~fg~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~ 163 (419)
.+.|.+ .++||+|+||.||+|... ++..||+|++..... ...+.+|+.+|+.++||||+++++++.. ....+
T Consensus 19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 344665 568999999999999965 467899999875322 3568899999999999999999999954 66789
Q ss_pred EEEeecCCCCHHHHhhccC------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE----CCCCcEE
Q 014725 164 LVYEFIPNGTLYHYLHDQT------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL----DDKYRAK 233 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill----~~~~~~k 233 (419)
+||||++ ++|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||+ +.++.+|
T Consensus 97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence 9999996 58888876321 1224899999999999999999999999 9999999999999 6788999
Q ss_pred EeecCCceecccCCc--eeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhh------cc
Q 014725 234 VSDFGASRTIKVDQT--HLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED------RS 304 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~------~~ 304 (419)
|+|||+++....... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ..
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999987643221 22345678999999999887 4589999999999999999999999976543210 00
Q ss_pred HHHHHHHHhc---ccchhHH---------HHHh---hccC---------CCHHHHHHHHHHHHHHhccCCCCCCCHHHHH
Q 014725 305 LVGFFLQAMN---EDRLFEV---------LEAR---VLKE---------GKEEEIITVAMLGKRCLNMIGKKRPSMKEVA 360 (419)
Q Consensus 305 ~~~~~~~~~~---~~~~~~~---------~~~~---~~~~---------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl 360 (419)
....+...+. ...+..+ .... .... ........+.+|+.+||+.||.+|||+.|++
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0111111110 0000000 0000 0000 0001134678999999999999999999998
Q ss_pred H
Q 014725 361 F 361 (419)
Q Consensus 361 ~ 361 (419)
+
T Consensus 333 ~ 333 (405)
T 3rgf_A 333 Q 333 (405)
T ss_dssp T
T ss_pred c
Confidence 7
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=342.96 Aligned_cols=259 Identities=24% Similarity=0.337 Sum_probs=194.0
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecC------Ccc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES------EVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~ 162 (419)
..+|.+.+.||+|+||.||+|.+. +++.||||++..... .+.+|+++++.++||||+++++++... ...
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 346999999999999999999975 588999998764322 234799999999999999999998542 235
Q ss_pred eEEEeecCCCCHHHHhhcc-CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-CcEEEeecCCc
Q 014725 163 LLVYEFIPNGTLYHYLHDQ-TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-YRAKVSDFGAS 240 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-~~~kl~Dfgl~ 240 (419)
++||||+++ +|.+.+... .....+++..+..++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||++
T Consensus 129 ~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 129 NLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred Eeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhh
Confidence 799999975 666665431 12235899999999999999999999998 9999999999999965 56899999999
Q ss_pred eecccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
+...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.. .. +..........
T Consensus 205 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~-i~~~lg~p~~~ 279 (420)
T 1j1b_A 205 KQLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VE-IIKVLGTPTRE 279 (420)
T ss_dssp EECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCSCCHH
T ss_pred hhcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHHhCCCCHH
Confidence 8754322 22345689999999998764 7999999999999999999999999876543321 11 11111100000
Q ss_pred HHH--HHh--------h-----ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 320 EVL--EAR--------V-----LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 320 ~~~--~~~--------~-----~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+. .+. . ....+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 280 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 000 000 0 00011223467899999999999999999999985
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=321.40 Aligned_cols=252 Identities=26% Similarity=0.344 Sum_probs=203.4
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
...++|++.+.||+|+||.||+|... +++.||+|.+... .....+.+.+|+.++++++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 44578999999999999999999975 6889999987542 23456789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC---CcEEEeecCCce
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK---YRAKVSDFGASR 241 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~---~~~kl~Dfgl~~ 241 (419)
||||+++++|.+++.... .+++..++.++.|++.||.|||+.+ ++|+||||+||+++.+ +.+||+|||++.
T Consensus 99 v~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 999999999999987653 4899999999999999999999999 9999999999999754 469999999997
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
...... ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||......+. ...........
T Consensus 173 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-------~~~~~~~~~~~- 241 (287)
T 2wei_A 173 CFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI-------LKRVETGKYAF- 241 (287)
T ss_dssp TBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHCCCCC-
T ss_pred eecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHcCCCCC-
Confidence 654322 1223458899999999875 489999999999999999999999987654321 11111110000
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
........+..+.+++.+||+.+|.+|||+.++++
T Consensus 242 -----~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 242 -----DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp -----CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 00001223456899999999999999999999987
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=323.88 Aligned_cols=252 Identities=25% Similarity=0.441 Sum_probs=194.1
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEec---------
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE--------- 158 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------- 158 (419)
..++|++.+.||+|+||.||+|.. .+++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 356799999999999999999996 46889999988642 3455789999999999999999999998865
Q ss_pred ----CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 159 ----SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 159 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
....++||||+++++|.+++.... ..+++..++.++.|++.||.|||+++ ++||||||+||+++.++.+||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl 157 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSEN--LNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKI 157 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSC--GGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEE
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccc--cccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEE
Confidence 356789999999999999998643 24788999999999999999999999 999999999999999999999
Q ss_pred eecCCceecccCC-------------ceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChh
Q 014725 235 SDFGASRTIKVDQ-------------THLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAE 300 (419)
Q Consensus 235 ~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~ 300 (419)
+|||+++...... ........||+.|+|||++.+. .++.++|||||||++|||++ ||......
T Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~ 234 (303)
T 1zy4_A 158 GDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER 234 (303)
T ss_dssp CCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH
T ss_pred eeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH
Confidence 9999998654221 1122345689999999998764 78999999999999999998 55421111
Q ss_pred hhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 301 EDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. ........ ........+...+..+.+++.+||+.||.+|||+.++++
T Consensus 235 --~~----~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 283 (303)
T 1zy4_A 235 --VN----ILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN 283 (303)
T ss_dssp --HH----HHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --HH----HHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence 00 11111100 001112233445567899999999999999999999976
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-42 Score=329.98 Aligned_cols=260 Identities=22% Similarity=0.305 Sum_probs=198.6
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc---
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP--- 162 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~--- 162 (419)
..++|.+.+.||+|+||.||+|.+. +++.||+|++... .....+.+.+|+.+++.++||||+++++++...+..
T Consensus 40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 4578999999999999999999964 5789999998653 334467889999999999999999999999877655
Q ss_pred ---eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 163 ---LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 163 ---~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
++||||++ ++|.+++.. .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~ 190 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMGM-----EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGL 190 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTC
T ss_pred eeEEEEEcccc-ccHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCc
Confidence 99999996 688887742 3899999999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH--------
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL-------- 310 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-------- 310 (419)
++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.........
T Consensus 191 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 266 (371)
T 4exu_A 191 ARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFV 266 (371)
T ss_dssp C------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred ccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHH
Confidence 9864322 234568999999999877 788999999999999999999999998766443211110000
Q ss_pred HHhcccchhHHHHHhhccC------CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 311 QAMNEDRLFEVLEARVLKE------GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+................ ........+.+++.+||+.||.+|||+.|+++
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 323 (371)
T 4exu_A 267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 323 (371)
T ss_dssp TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence 0000000000000000000 01123467899999999999999999999976
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=330.61 Aligned_cols=260 Identities=21% Similarity=0.263 Sum_probs=201.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-----------CcccccEEeEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-----------HRNVVKLLGCCL 157 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~ 157 (419)
.++|.+.+.||+|+||.||+|.+ .+++.||||.+.. .....+.+.+|+.++++++ ||||+++++++.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~ 96 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 96 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS-CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC-CccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence 46899999999999999999996 4678899999864 3344567889999998886 899999999988
Q ss_pred cCC----cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEEC-----
Q 014725 158 ESE----VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLD----- 227 (419)
Q Consensus 158 ~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~----- 227 (419)
..+ ..++||||+ +++|.+++...... .+++..+..++.||+.||.|||++ + |+||||||+|||++
T Consensus 97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~-~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~ 171 (373)
T 1q8y_A 97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHR-GIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP 171 (373)
T ss_dssp EEETTEEEEEEEECCC-CEEHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred ccCCCCceEEEEEecC-CCCHHHHHHHhhcc-CCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence 654 679999999 89999999875432 489999999999999999999998 8 99999999999994
Q ss_pred -CCCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHH
Q 014725 228 -DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV 306 (419)
Q Consensus 228 -~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~ 306 (419)
.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||............
T Consensus 172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~ 247 (373)
T 1q8y_A 172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247 (373)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence 4458999999999875432 23346899999999999999999999999999999999999999865432211111
Q ss_pred ---HHHHHHhccc------------------------------chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCC
Q 014725 307 ---GFFLQAMNED------------------------------RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKR 353 (419)
Q Consensus 307 ---~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~R 353 (419)
.......... .+...+. .....+...+..+.+|+.+||+.||.+|
T Consensus 248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT--EKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH--HTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh--hcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1111111000 0001111 1123456778899999999999999999
Q ss_pred CCHHHHHH
Q 014725 354 PSMKEVAF 361 (419)
Q Consensus 354 Pt~~evl~ 361 (419)
||+.|+++
T Consensus 326 pt~~ell~ 333 (373)
T 1q8y_A 326 ADAGGLVN 333 (373)
T ss_dssp BCHHHHHT
T ss_pred CCHHHHhh
Confidence 99999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.54 Aligned_cols=263 Identities=20% Similarity=0.285 Sum_probs=203.7
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CC-CEEEEEEcccCChhhHHHHHHHHHHHhcCCCcc------cccEEeEEecCC
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DG-GIVAVKKSKLVDESNVEQFINEVVILSQINHRN------VVKLLGCCLESE 160 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~ 160 (419)
..++|.+.+.||+|+||.||+|... ++ ..||+|.+... ....+.+.+|+.+++.++|+| ++.+++++...+
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 3578999999999999999999974 34 68999998643 344577889999999998766 899999999999
Q ss_pred cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE--------------
Q 014725 161 VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL-------------- 226 (419)
Q Consensus 161 ~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill-------------- 226 (419)
..++||||+ +++|.+++..... ..+++..++.++.||+.||.|||+++ |+||||||+|||+
T Consensus 96 ~~~lv~e~~-~~~l~~~l~~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~ 170 (355)
T 2eu9_A 96 HMCIAFELL-GKNTFEFLKENNF-QPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKS 170 (355)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTT-CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred eEEEEEecc-CCChHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccc
Confidence 999999999 6778777766432 25899999999999999999999998 9999999999999
Q ss_pred -----CCCCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhh
Q 014725 227 -----DDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301 (419)
Q Consensus 227 -----~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~ 301 (419)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|..||......+
T Consensus 171 ~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 171 CEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp CCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 56789999999999864322 234568999999999999999999999999999999999999998766543
Q ss_pred hccHHHHHHHHhcc--------cch--------------hHHHHHh-----hccCCCHHHHHHHHHHHHHHhccCCCCCC
Q 014725 302 DRSLVGFFLQAMNE--------DRL--------------FEVLEAR-----VLKEGKEEEIITVAMLGKRCLNMIGKKRP 354 (419)
Q Consensus 302 ~~~~~~~~~~~~~~--------~~~--------------~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~~p~~RP 354 (419)
.............. ... ....... ............+.+++.+||+.||.+||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 22111111100000 000 0000000 00112334566899999999999999999
Q ss_pred CHHHHHH
Q 014725 355 SMKEVAF 361 (419)
Q Consensus 355 t~~evl~ 361 (419)
|+.|+++
T Consensus 327 t~~e~l~ 333 (355)
T 2eu9_A 327 TLAEALL 333 (355)
T ss_dssp CHHHHTT
T ss_pred CHHHHhc
Confidence 9999974
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=329.28 Aligned_cols=256 Identities=22% Similarity=0.315 Sum_probs=198.1
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc-----
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV----- 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----- 161 (419)
.++|.+.+.||+|+||.||+|.+. +++.||||++... .....+.+.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 468999999999999999999974 5789999998643 33445778999999999999999999999987654
Q ss_pred -ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 162 -PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 162 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
.++||||++ ++|.+++.. .+++..+..++.||+.||.|||+++ |+||||||+||+++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~-~~l~~~~~~-----~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMGL-----KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp CCEEEEECCS-EEGGGTTTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred eEEEEecccc-CCHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence 499999997 688887742 3899999999999999999999999 999999999999999999999999999
Q ss_pred eecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc-----
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN----- 314 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~----- 314 (419)
+..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+.. ........
T Consensus 174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~ 246 (353)
T 3coi_A 174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVTGVPGTE 246 (353)
T ss_dssp TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHH---HHHHHHHCBCCHH
T ss_pred cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHH
Confidence 764322 234568999999999877 67899999999999999999999999876643321 11111100
Q ss_pred ------ccchhHHHHHhh------ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 ------EDRLFEVLEARV------LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 ------~~~~~~~~~~~~------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.......+.... ........+..+.+++.+||+.||.+|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000 00112234567999999999999999999999975
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-42 Score=331.94 Aligned_cols=207 Identities=26% Similarity=0.371 Sum_probs=175.2
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-Cc-----ccccEEeEEe
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HR-----NVVKLLGCCL 157 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~ 157 (419)
......++|.+.+.||+|+||+||+|.+. +++.||||++... ......+..|+.+++.++ |+ +|+++++++.
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~ 126 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM 126 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence 33455789999999999999999999975 5778999998743 334567788888888874 44 4999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh--cCCCCeeecCCCCCcEEEC--CCCcEE
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS--ATSIPIYHRDIKSSNILLD--DKYRAK 233 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~--~~~~~iiH~Dlkp~Nill~--~~~~~k 233 (419)
..+..++||||++ ++|.+++...... .+++..+..++.|++.||.|||. .+ |+||||||+|||++ .++.+|
T Consensus 127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~k 201 (382)
T 2vx3_A 127 FRNHLCLVFEMLS-YNLYDLLRNTNFR-GVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIK 201 (382)
T ss_dssp ETTEEEEEEECCC-CBHHHHHHHTTTS-CCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEE
T ss_pred cCCceEEEEecCC-CCHHHHHhhcCcC-CCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEE
Confidence 9999999999996 5999999875432 48999999999999999999995 45 99999999999994 578899
Q ss_pred EeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhh
Q 014725 234 VSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301 (419)
Q Consensus 234 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~ 301 (419)
|+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||......+
T Consensus 202 L~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~ 265 (382)
T 2vx3_A 202 IVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD 265 (382)
T ss_dssp ECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999876432 234568999999999999999999999999999999999999998766543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=326.72 Aligned_cols=253 Identities=20% Similarity=0.262 Sum_probs=174.1
Q ss_pred HhcCccccC-cccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEec----CCcc
Q 014725 89 ATDNYNANR-ILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE----SEVP 162 (419)
Q Consensus 89 ~~~~y~~~~-~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~ 162 (419)
..++|.+.+ .||+|+||.||+|.+. +++.||+|.+.... ....+....++.++||||+++++++.. ....
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 457788854 6999999999999975 68899999986421 112223334566799999999999876 4457
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEEeecCC
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKVSDFGA 239 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl 239 (419)
++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~ 177 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGD-QAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF 177 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-C-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEeccCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence 999999999999999987543 35899999999999999999999999 999999999999976 45599999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ .......
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~--- 248 (336)
T 3fhr_A 178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---KRRIRLG--- 248 (336)
T ss_dssp CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---HHhhhcc---
Confidence 9865422 223456899999999998889999999999999999999999999765432210000 0000000
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
............+..+.+++.+||+.||.+|||+.++++
T Consensus 249 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 ---QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp -----CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ---ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 000011111234567899999999999999999999987
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=327.11 Aligned_cols=256 Identities=25% Similarity=0.349 Sum_probs=180.6
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHH-HHhcCCCcccccEEeEEecCCcceEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVV-ILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
..++|.+.+.||+|+||.||+|... +++.||||.+... .......+..|+. +++.++||||+++++++.+.+..++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 4578999999999999999999974 6789999998654 3334455666666 77778999999999999999999999
Q ss_pred EeecCCCCHHHHhhcc--CCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 166 YEFIPNGTLYHYLHDQ--TEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
|||+++ +|.+++... .....+++..+..++.|++.||.|||+. + ++||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999975 888877631 1123589999999999999999999998 8 99999999999999999999999999986
Q ss_pred cccCCceeeecccccCCccCcccc----ccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYF----RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
..... ......||+.|+|||++ .+..++.++||||||+++|+|++|+.||........ ... ......
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~-~~~~~~- 246 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLT-QVVKGD- 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C-CCCCSC-
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHH-HHhcCC-
Confidence 54322 22334689999999998 456789999999999999999999999976432110 000 000000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.+..........+..+.+++.+||+.||.+|||+.++++
T Consensus 247 ----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 ----PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp ----CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred ----CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 000111111234567999999999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=323.79 Aligned_cols=246 Identities=30% Similarity=0.415 Sum_probs=192.0
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCCh------hhHHHHHHHHHHHhcC----CCcccccE
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDE------SNVEQFINEVVILSQI----NHRNVVKL 152 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~niv~l 152 (419)
.+.+...++|.+.+.||+|+||.||+|.+ .+++.||+|.+..... .....+.+|+.++.++ +||||+++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~ 103 (312)
T 2iwi_A 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRL 103 (312)
T ss_dssp ---------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCE
T ss_pred cchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeE
Confidence 34556678899999999999999999986 4678999999865332 1223456789999888 89999999
Q ss_pred EeEEecCCcceEEEee-cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC-CCC
Q 014725 153 LGCCLESEVPLLVYEF-IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKY 230 (419)
Q Consensus 153 ~~~~~~~~~~~lv~e~-~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~ 230 (419)
++++.+.+..++|||+ +.+++|.+++.... .+++..++.++.||+.||.|||+.+ ++||||||+||+++ .++
T Consensus 104 ~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 104 LDWFETQEGFMLVLERPLPAQDLFDYITEKG---PLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EEEC-----CEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTT
T ss_pred EEEEecCCeEEEEEEecCCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCC
Confidence 9999999999999999 78999999998754 4899999999999999999999999 99999999999998 889
Q ss_pred cEEEeecCCceecccCCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHH
Q 014725 231 RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF 309 (419)
Q Consensus 231 ~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 309 (419)
.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~--------- 245 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEI--------- 245 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH---------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHHH---------
Confidence 99999999998765332 234568999999999887666 45899999999999999999999642110
Q ss_pred HHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 310 LQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. .. ....+......+.+++.+||+.+|++|||+.++++
T Consensus 246 ~------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~ 283 (312)
T 2iwi_A 246 L------------EA--ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL 283 (312)
T ss_dssp H------------HT--CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred h------------hh--ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 00 11122334557889999999999999999999986
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=337.16 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=188.7
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEeec
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
+.|...+.||+|+||+||.+...+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.+.+..++||||+
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~ 91 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC 91 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence 445667889999999998777677999999987642 245678999999876 8999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCC----CCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCC-------------CcE
Q 014725 170 PNGTLYHYLHDQTEEF----PITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDK-------------YRA 232 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~----~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~-------------~~~ 232 (419)
+ |+|.+++....... ..++..++.++.||+.||.|||+++ |+||||||+|||++.+ +.+
T Consensus 92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~ 167 (434)
T 2rio_A 92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI 167 (434)
T ss_dssp S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence 5 69999998653211 1123345789999999999999999 9999999999999654 489
Q ss_pred EEeecCCceecccCCce---eeecccccCCccCcccccc-------CCCCcccceechhHHHHHHHh-CCCCCCCCChhh
Q 014725 233 KVSDFGASRTIKVDQTH---LTTRVQGTFGYLDPEYFRS-------SQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEE 301 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~ 301 (419)
||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+| |..||.......
T Consensus 168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 247 (434)
T 2rio_A 168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247 (434)
T ss_dssp EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence 99999999876543221 1234579999999999865 678999999999999999999 999997543322
Q ss_pred hccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 302 DRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. ........ . +..........+..+.+++.+||+.||.+|||+.+|++
T Consensus 248 ~-----~i~~~~~~--~-----~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 248 S-----NIIRGIFS--L-----DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp H-----HHHHTCCC--C-----CCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred H-----HHhcCCCC--c-----ccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 1 01111000 0 00011123456678999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=327.99 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=199.9
Q ss_pred cCHHHHHHHhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCCh------hhHHHHHHHHHHHhcCC--Cccccc
Q 014725 81 FTKMDLEKATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDE------SNVEQFINEVVILSQIN--HRNVVK 151 (419)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~ 151 (419)
....+.+...++|.+.+.||+|+||.||+|.+ .+++.||||.+..... ...+.+.+|+.+++.++ ||||++
T Consensus 33 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~ 112 (320)
T 3a99_A 33 APGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112 (320)
T ss_dssp -------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCC
T ss_pred CcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceE
Confidence 34455566778999999999999999999996 4678899998764321 12245678999999996 599999
Q ss_pred EEeEEecCCcceEEEeecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC-CC
Q 014725 152 LLGCCLESEVPLLVYEFIPN-GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DK 229 (419)
Q Consensus 152 l~~~~~~~~~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~ 229 (419)
+++++.+.+..++|||++.+ ++|.+++.... .+++..++.++.|++.||.|||+.+ |+||||||+|||++ .+
T Consensus 113 ~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~ 186 (320)
T 3a99_A 113 LLDWFERPDSFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNR 186 (320)
T ss_dssp EEEEEECSSEEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTT
T ss_pred EEEEEecCCcEEEEEEcCCCCccHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCC
Confidence 99999999999999999976 89999998643 4899999999999999999999999 99999999999998 78
Q ss_pred CcEEEeecCCceecccCCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH
Q 014725 230 YRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF 308 (419)
Q Consensus 230 ~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~ 308 (419)
+.+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||......
T Consensus 187 ~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-------- 255 (320)
T 3a99_A 187 GELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-------- 255 (320)
T ss_dssp TEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHH--------
T ss_pred CCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhhh--------
Confidence 899999999998764322 234568999999999887665 78899999999999999999999642110
Q ss_pred HHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. . ....+...+..+.+++.+||+.||.+|||+.+|++
T Consensus 256 -~~------------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 256 -IR------------G--QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp -HH------------C--CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -hc------------c--cccccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 0 00112233456889999999999999999999976
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=318.35 Aligned_cols=253 Identities=24% Similarity=0.392 Sum_probs=181.8
Q ss_pred HHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhh-HHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESN-VEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
...++|.+.+.||+|+||.||+|.+. +++.||||.+.... ... .+.+.++..+++.++||||+++++++.+.+..++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~l 101 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFI 101 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEE
Confidence 34577999999999999999999975 68899999986532 222 2334455567888899999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
||||+ ++.+..+..... ..+++..++.++.|++.||.|||+. + ++|+||||+||+++.++.+||+|||++...
T Consensus 102 v~e~~-~~~~~~l~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 102 AMELM-GTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp EECCC-SEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred EEecc-CCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 99999 556666555432 2589999999999999999999995 8 999999999999999999999999999765
Q ss_pred ccCCceeeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
.... ......||+.|+|||++. ...++.++||||||+++|||++|+.||........ . .........
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~~~~~~~- 247 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--V---LTKVLQEEP- 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H---HHHHHHSCC-
T ss_pred cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--H---HHHHhccCC-
Confidence 4322 223446899999999984 45788999999999999999999999976433211 0 111110000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+..+.+++.+||+.||.+|||+.++++
T Consensus 248 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 -------PLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp -------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred -------CCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 000111223457889999999999999999999986
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-42 Score=335.27 Aligned_cols=250 Identities=24% Similarity=0.324 Sum_probs=188.7
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEEe
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 167 (419)
...+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+.+++.+ +||||+++++++.+....++|||
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 4456899999999999997655556789999999864322 2356899999999 79999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-----CCcEEEeecCCcee
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-----KYRAKVSDFGASRT 242 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfgl~~~ 242 (419)
|++ |+|.+++..... ...+..++.++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||+++.
T Consensus 99 ~~~-g~L~~~l~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 99 LCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp CCS-EEHHHHHHSSSC--CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred CCC-CCHHHHHHhcCC--CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 996 699999986543 2444556789999999999999999 999999999999943 34688999999987
Q ss_pred cccCCc--eeeecccccCCccCccccc---cCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 243 IKVDQT--HLTTRVQGTFGYLDPEYFR---SSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 243 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
...... .......||+.|+|||++. ...++.++|||||||++|||+| |..||........ .......
T Consensus 173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~-------~~~~~~~ 245 (432)
T 3p23_A 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA-------NILLGAC 245 (432)
T ss_dssp C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH-------HHHTTCC
T ss_pred ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH-------HHHhccC
Confidence 653321 2234567999999999987 4567889999999999999999 9999965433221 0001000
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. ............+.+++.+||+.||.+|||+.+|++
T Consensus 246 ~~-------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 246 SL-------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp CC-------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred Cc-------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 00 001112344556889999999999999999999984
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=345.21 Aligned_cols=272 Identities=24% Similarity=0.321 Sum_probs=204.3
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEec------CCc
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLE------SEV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~ 161 (419)
.++|.+.+.||+|+||.||+|.+ .++..||||.+... .....+.+.+|+.+++.++||||+++++++.. .+.
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~ 92 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL 92 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence 47899999999999999999997 45889999987653 44556789999999999999999999999765 677
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCc---EEEeecC
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR---AKVSDFG 238 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~---~kl~Dfg 238 (419)
.++||||+++|+|.+++........+++..++.++.|++.||.|||+.+ |+||||||+||+++.++. +||+|||
T Consensus 93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG 169 (676)
T 3qa8_A 93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG 169 (676)
T ss_dssp CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence 8999999999999999987655446889999999999999999999999 999999999999987665 9999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccH--H-HHHHHHhcc
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSL--V-GFFLQAMNE 315 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~--~-~~~~~~~~~ 315 (419)
+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||........... . .........
T Consensus 170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 247 (676)
T 3qa8_A 170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVY 247 (676)
T ss_dssp CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSC
T ss_pred ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhh
Confidence 998764332 23445789999999999999999999999999999999999999976433211000 0 000000000
Q ss_pred cchhHHH--HH--hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHH-----HHHHHHhc
Q 014725 316 DRLFEVL--EA--RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKE-----VAFELEGI 366 (419)
Q Consensus 316 ~~~~~~~--~~--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~e-----vl~~L~~i 366 (419)
....... .. ..........+..+.+++.+||+.||.+|||+.+ ..+.++.+
T Consensus 248 ~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 248 DDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSI 307 (676)
T ss_dssp CCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHH
T ss_pred hhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHH
Confidence 0000000 00 0011233456788999999999999999999987 44555544
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=344.72 Aligned_cols=241 Identities=22% Similarity=0.332 Sum_probs=195.4
Q ss_pred HhcCccccCcccccCcEEEEEEEec--CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc----
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA--DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV---- 161 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 161 (419)
..++|.+.+.||+|+||.||+|.+. +++.||||.+... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 3478999999999999999999975 5789999987643 34555678999999999999999999999987665
Q ss_pred -ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCc
Q 014725 162 -PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGAS 240 (419)
Q Consensus 162 -~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~ 240 (419)
.|+||||+++++|.+++.. .+++..++.++.||+.||.|||+++ |+||||||+|||++.+ .+||+|||++
T Consensus 158 ~~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a 228 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAV 228 (681)
T ss_dssp EEEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTC
T ss_pred eeEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccc
Confidence 6999999999999987754 4899999999999999999999999 9999999999999986 8999999999
Q ss_pred eecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 241 RTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 241 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
+..... ....||+.|+|||++.+.. +.++|||||||++++|++|..||....... +..
T Consensus 229 ~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~~~ 286 (681)
T 2pzi_A 229 SRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------LPE 286 (681)
T ss_dssp EETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------CCT
T ss_pred hhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------ccc
Confidence 875432 3456999999999987654 899999999999999999998876422110 000
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC-HHHHHHHHHhcH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS-MKEVAFELEGIR 367 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-~~evl~~L~~i~ 367 (419)
..........+.+++.+||+.||.+||+ +.++...|..+.
T Consensus 287 -------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 -------DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp -------TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -------cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 0000112346889999999999999995 667777776653
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-40 Score=305.19 Aligned_cols=233 Identities=14% Similarity=0.120 Sum_probs=185.6
Q ss_pred hcCccccCcccccCcEEEEEEEecC-CCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|++.+.||+|+||.||+|.+.. ++.||||.+.... ....+.+.+|+..++.++||||+++++++.+.+..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 4689999999999999999999754 7899999987532 34457899999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++++|.+++... ....+..+++.|++.||.|||+++ |+||||||+|||++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~~-----~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADTS-----PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------- 174 (286)
T ss_dssp EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-------
T ss_pred EEecCCCCHHHHHhcC-----CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-------
Confidence 9999999999999542 355578889999999999999999 9999999999999999999998543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
|++| ++.++|||||||++|||+||+.||......+..... ..... ..... .
T Consensus 175 --------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~-~~~~~---~- 225 (286)
T 3uqc_A 175 --------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTA-GQPIE---P- 225 (286)
T ss_dssp --------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTT-SCBCC---H-
T ss_pred --------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhc-cCCCC---h-
Confidence 3443 688999999999999999999999876543210000 00000 00000 0
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.......+..+.+++.+||+.||.+| |+.|+++.|+++...
T Consensus 226 --~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~ 266 (286)
T 3uqc_A 226 --ADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV 266 (286)
T ss_dssp --HHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred --hhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence 00112234568999999999999999 999999999987643
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-41 Score=326.93 Aligned_cols=243 Identities=15% Similarity=0.178 Sum_probs=182.0
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCCh---hhHHHHHHHHHHHhcCCC-ccccc------------
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDE---SNVEQFINEVVILSQINH-RNVVK------------ 151 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h-~niv~------------ 151 (419)
...+|...+.||+|+||+||+|.+ .+++.||||++..... ...+.+.+|+.+++.++| +|...
T Consensus 76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~ 155 (413)
T 3dzo_A 76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD 155 (413)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence 345578889999999999999995 5688999998774322 235779999999999976 32211
Q ss_pred ---------EEeEEec-----CCcceEEEeecCCCCHHHHhhc----cCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 014725 152 ---------LLGCCLE-----SEVPLLVYEFIPNGTLYHYLHD----QTEEFPITWEMRLRIAIEVSGAMSYLHSATSIP 213 (419)
Q Consensus 152 ---------l~~~~~~-----~~~~~lv~e~~~~g~L~~~l~~----~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 213 (419)
+..++.. ....+++|+++ +++|.+++.. ......+++..++.++.||+.||.|||+++
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--- 231 (413)
T 3dzo_A 156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--- 231 (413)
T ss_dssp EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence 1111111 12346667665 7899998852 112335888899999999999999999999
Q ss_pred eeecCCCCCcEEECCCCcEEEeecCCceecccCCceeeecccccCCccCcccc----------ccCCCCcccceechhHH
Q 014725 214 IYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF----------RSSQFTEKSDVYSFGVV 283 (419)
Q Consensus 214 iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~~~Di~slG~~ 283 (419)
|+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ .+..++.++|||||||+
T Consensus 232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi 306 (413)
T 3dzo_A 232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306 (413)
T ss_dssp EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence 999999999999999999999999998864322 344567 999999998 55668899999999999
Q ss_pred HHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 284 LVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 284 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+|||+||+.||......... ..++. .....+..+.+++.+||+.||.+||++.++++
T Consensus 307 l~elltg~~Pf~~~~~~~~~---------------~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 307 IYWIWCADLPNTDDAALGGS---------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHHSSCCCCTTGGGSCS---------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHHCCCCCCCcchhhhH---------------HHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 99999999999765432210 00100 01122356999999999999999999888754
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=300.58 Aligned_cols=227 Identities=24% Similarity=0.340 Sum_probs=178.7
Q ss_pred hcCcccc-CcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHH-hcCCCcccccEEeEEec----CCcc
Q 014725 90 TDNYNAN-RILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVIL-SQINHRNVVKLLGCCLE----SEVP 162 (419)
Q Consensus 90 ~~~y~~~-~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~ 162 (419)
.++|.+. +.||+|+||.||+|.. .+++.||+|.+... ..+.+|+.++ +.++||||+++++++.. ....
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4567776 7899999999999997 46789999998642 4567888887 55699999999999876 6678
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEEeecCC
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKVSDFGA 239 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl 239 (419)
++||||+++++|.+++..... ..+++..++.++.|++.||.|||+.+ |+||||||+||+++. ++.+||+|||+
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~ 166 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 166 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred EEEEeecCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence 999999999999999987543 25899999999999999999999999 999999999999988 78999999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
+.... +..++.++|||||||++|||++|..||......... .... ..+
T Consensus 167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~-------~~~~-~~~- 214 (299)
T 3m2w_A 167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PGMK-TRI- 214 (299)
T ss_dssp CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC--------------CCSC-CSS-
T ss_pred ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh-------HHHH-HHH-
Confidence 86532 245678999999999999999999999765432110 0000 000
Q ss_pred HHHHHhhccCCC----HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 320 EVLEARVLKEGK----EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 320 ~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. .....+ ...+..+.+++.+||+.||.+|||+.|+++
T Consensus 215 ---~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 215 ---RM-GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp ---CT-TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---hh-ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00 000111 123457899999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=306.23 Aligned_cols=243 Identities=16% Similarity=0.191 Sum_probs=181.7
Q ss_pred HhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCC--------hhhHHHHHHHHHHHhcCC---------Cccccc
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD--------ESNVEQFINEVVILSQIN---------HRNVVK 151 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~ 151 (419)
..++|.+.+.||+|+||+||+|++ +++.||||++.... ....+.+.+|+.+++.++ ||||++
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 356799999999999999999998 67999999876532 233477889999988886 555555
Q ss_pred EEeE-----------------Eec-------------CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHH
Q 014725 152 LLGC-----------------CLE-------------SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201 (419)
Q Consensus 152 l~~~-----------------~~~-------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~ 201 (419)
+.++ +.+ .+..++||||+++|++.+.+.+ ..+++..+..++.||+.
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~ 172 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTA 172 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHH
Confidence 5554 433 6788999999999977666643 24899999999999999
Q ss_pred HHHHHh-hcCCCCeeecCCCCCcEEECCCC--------------------cEEEeecCCceecccCCceeeecccccCCc
Q 014725 202 AMSYLH-SATSIPIYHRDIKSSNILLDDKY--------------------RAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260 (419)
Q Consensus 202 ~l~~LH-~~~~~~iiH~Dlkp~Nill~~~~--------------------~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y 260 (419)
||.||| +.+ |+||||||+|||++.++ .+||+|||+++..... ...||+.|
T Consensus 173 aL~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y 243 (336)
T 2vuw_A 173 SLAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS 243 (336)
T ss_dssp HHHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred HHHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence 999999 899 99999999999999887 8999999999876432 34699999
Q ss_pred cCccccccCCCCcccceechhHH-HHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHH
Q 014725 261 LDPEYFRSSQFTEKSDVYSFGVV-LVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVA 339 (419)
Q Consensus 261 ~aPE~~~~~~~s~~~Di~slG~~-l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 339 (419)
+|||++.+.. +.++||||||++ .+++++|..||...... .............. ...........+..+.
T Consensus 244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~--~~~~~~~~~~~~~~-------~~~~~~~~~~~s~~~~ 313 (336)
T 2vuw_A 244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWL--HYLTDKMLKQMTFK-------TKCNTPAMKQIKRKIQ 313 (336)
T ss_dssp TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHH--HHHHHHHHHTCCCS-------SCCCSHHHHHHHHHHH
T ss_pred cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhh--hHHHHhhhhhhccC-------cccchhhhhhcCHHHH
Confidence 9999998766 899999998777 77788899987321000 00000000000000 0000111235667899
Q ss_pred HHHHHHhccCCCCCCCHHHHH
Q 014725 340 MLGKRCLNMIGKKRPSMKEVA 360 (419)
Q Consensus 340 ~li~~cl~~~p~~RPt~~evl 360 (419)
+|+.+||+.| |+.|++
T Consensus 314 dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 314 EFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHGGGSS-----SHHHHH
T ss_pred HHHHHHhccC-----CHHHHH
Confidence 9999999976 888887
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-33 Score=279.88 Aligned_cols=184 Identities=20% Similarity=0.142 Sum_probs=129.2
Q ss_pred ccccCcEEEEEEE-ecCCCEEEEEEcccC----------ChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEEE
Q 014725 99 LGQGGQGTVYKGM-LADGGIVAVKKSKLV----------DESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 99 ig~G~fg~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 166 (419)
.+.|++|.+..++ .-.|+.+|+|.+... .+...++|.+|+++|+++ +|+||+++++++.+++..||||
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM 321 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM 321 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence 4556666555544 234777999986532 123456799999999999 7999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||++|++|.++|.+.. +++.. +|+.||+.||+|||++| ||||||||+|||++.++.+||+|||+++.....
T Consensus 322 Eyv~G~~L~d~i~~~~---~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~ 392 (569)
T 4azs_A 322 EKLPGRLLSDMLAAGE---EIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD 392 (569)
T ss_dssp ECCCSEEHHHHHHTTC---CCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred ecCCCCcHHHHHHhCC---CCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence 9999999999998654 46654 47899999999999999 999999999999999999999999999876543
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCC
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP 293 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p 293 (419)
. ......+||+.|||||++.+ .+..++|+||+|++++++.++..|
T Consensus 393 ~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 393 C-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp --CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred C-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 2 23345679999999999975 467789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=253.38 Aligned_cols=185 Identities=15% Similarity=0.204 Sum_probs=145.6
Q ss_pred cccCcccccCcEEEEEEEecCCCEEEEEEcccCC---h-----hhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 94 NANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD---E-----SNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~---~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
...+.||+|+||.||+|.. .+..+++|+..... . ...+.+.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 4467899999999999955 57788988754321 1 1235589999999999999999666666677888999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++++|.+++.. +..++.|++.||.|||+++ |+||||||+|||++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999975 3578999999999999999 999999999999998 999999999998654
Q ss_pred CCcee------eecccccCCccCcccccc--CCCCcccceechhHHHHHHHhCCCCCC
Q 014725 246 DQTHL------TTRVQGTFGYLDPEYFRS--SQFTEKSDVYSFGVVLVELLTGQKPIR 295 (419)
Q Consensus 246 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~~~Di~slG~~l~el~tg~~p~~ 295 (419)
..... .....||+.|||||++.. ..|+..+|+||..+-.++-+.++.+|.
T Consensus 482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 32211 235679999999999987 678889999999998888888777653
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=208.22 Aligned_cols=150 Identities=17% Similarity=0.157 Sum_probs=121.5
Q ss_pred HHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCCh------------------hhHHHHHHHHHHHhcCCCc
Q 014725 86 LEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDE------------------SNVEQFINEVVILSQINHR 147 (419)
Q Consensus 86 ~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~ 147 (419)
+......|.+.+.||+|+||.||+|.+.+++.||+|.+..... .....+.+|+.+++.++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3444566778899999999999999997788999998864221 13467899999999999
Q ss_pred ccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC
Q 014725 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD 227 (419)
Q Consensus 148 niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~ 227 (419)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|++.||.|||+.+ |+||||||+|||++
T Consensus 163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 4 56666543 366799999999999988 421 123469999999999999999 99999999999999
Q ss_pred CCCcEEEeecCCceecccCCceeeecccccCCccCccccc
Q 014725 228 DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267 (419)
Q Consensus 228 ~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 267 (419)
++.+||+|||+++. +..|+|||++.
T Consensus 228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~ 252 (282)
T 1zar_A 228 -EEGIWIIDFPQSVE--------------VGEEGWREILE 252 (282)
T ss_dssp -TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred -CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence 99999999999863 45688999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.7e-21 Score=176.37 Aligned_cols=137 Identities=20% Similarity=0.175 Sum_probs=107.1
Q ss_pred CccccCcccccCcEEEEEEEe-cCCCE--EEEEEcccCChh------------------------hHHHHHHHHHHHhcC
Q 014725 92 NYNANRILGQGGQGTVYKGML-ADGGI--VAVKKSKLVDES------------------------NVEQFINEVVILSQI 144 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l 144 (419)
-|.+.+.||+|+||.||+|.+ .+|.. ||||..+..... ....+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 67888 999986432111 123678999999999
Q ss_pred CCccc--ccEEeEEecCCcceEEEeecCC-C----CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHh-hcCCCCeee
Q 014725 145 NHRNV--VKLLGCCLESEVPLLVYEFIPN-G----TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH-SATSIPIYH 216 (419)
Q Consensus 145 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~iiH 216 (419)
+|+++ +.++++ ...++||||+.+ | +|.++... .++.....++.|++.||.||| +.+ |+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH 194 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH 194 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence 88754 444443 367899999942 3 67766542 223456789999999999999 888 999
Q ss_pred cCCCCCcEEECCCCcEEEeecCCceec
Q 014725 217 RDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 217 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
|||||+|||++. .++|+|||++...
T Consensus 195 rDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 195 ADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred CCCCHHHEEEcC--cEEEEECcccccC
Confidence 999999999998 9999999999753
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=8.9e-19 Score=166.33 Aligned_cols=136 Identities=13% Similarity=0.168 Sum_probs=98.1
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCC--------------hhhHHHH--------HHHHHHHhcCCCcc
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD--------------ESNVEQF--------INEVVILSQINHRN 148 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--------------~~~~~~~--------~~e~~~l~~l~h~n 148 (419)
.-|++.+.||+|+||.||+|...+|+.||||..+... ....... .+|...|.++.+.+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3499999999999999999999899999999754210 0011112 23555555554333
Q ss_pred c--ccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEE
Q 014725 149 V--VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILL 226 (419)
Q Consensus 149 i--v~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill 226 (419)
+ ...+++ ...++||||++|++|..+... + ....++.|++.+|.+||+.+ ||||||||.|||+
T Consensus 175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-------~--~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl 238 (397)
T 4gyi_A 175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-------P--DPASLYADLIALILRLAKHG---LIHGDFNEFNILI 238 (397)
T ss_dssp CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-------S--CHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEE
T ss_pred CCCCeeeec----cCceEEEEecCCccHhhhccc-------H--HHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEE
Confidence 2 222221 234799999999888665321 1 23467889999999999999 9999999999999
Q ss_pred CCCC----------cEEEeecCCcee
Q 014725 227 DDKY----------RAKVSDFGASRT 242 (419)
Q Consensus 227 ~~~~----------~~kl~Dfgl~~~ 242 (419)
++++ .+.|+||+-+..
T Consensus 239 ~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 239 REEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred eCCCCcccccccccceEEEEeCCccc
Confidence 8776 389999997754
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2.5e-13 Score=123.71 Aligned_cols=147 Identities=16% Similarity=0.112 Sum_probs=113.8
Q ss_pred HHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEE
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv 165 (419)
....+.|.+...++.|+.+.||++... ++.+++|............+.+|+.+++.+. +.+++++++++.+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344567888888999999999999864 6889999876421122345888999999884 67888999999888889999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----------------------------------
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT----------------------------------- 210 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 210 (419)
|||++|.+|.+.+... .....++.+++.+|..||+..
T Consensus 89 ~e~i~G~~l~~~~~~~--------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCTT--------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCCc--------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 9999999998764211 122467889999999999811
Q ss_pred ---------------------CCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 211 ---------------------SIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 211 ---------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+..++|+|++|.||+++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13399999999999998766677999987743
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.31 E-value=3.1e-12 Score=116.01 Aligned_cols=139 Identities=16% Similarity=0.160 Sum_probs=101.8
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcc--cccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN--VVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e 167 (419)
...|.+....+.|..+.||++...+|..+++|..... ....+.+|+.+++.+.+.+ +++++++..+.+..++|||
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3445554444456679999998777788999986543 2245778999998885434 5668888888778899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT------------------------------------- 210 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------- 210 (419)
|++|.+|. ... .+ ...++.+++..|..||+..
T Consensus 96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 211 11 1256677888888888643
Q ss_pred ------------------CCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 211 ------------------SIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 211 ------------------~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+..++|+|++|.||++++++.+.|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 12299999999999998776677999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.19 E-value=6.8e-11 Score=112.68 Aligned_cols=142 Identities=15% Similarity=0.214 Sum_probs=106.4
Q ss_pred ccCcccccCcEEEEEEEecCCCEEEEEEcc--cCC-hhhHHHHHHHHHHHhcCC--CcccccEEeEEecC---CcceEEE
Q 014725 95 ANRILGQGGQGTVYKGMLADGGIVAVKKSK--LVD-ESNVEQFINEVVILSQIN--HRNVVKLLGCCLES---EVPLLVY 166 (419)
Q Consensus 95 ~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~ 166 (419)
..+.|+.|.++.||+.... +..+++|+.. ... ......+.+|+.+++.+. +..+++++.++.+. +..++||
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm 120 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM 120 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence 3567899999999998875 4678888765 322 122356788999999886 46688999988776 4589999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT------------------------------------ 210 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 210 (419)
||++|..+.+... ..++...+..++.+++..|..||...
T Consensus 121 e~v~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 121 EFVSGRVLWDQSL-----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp ECCCCBCCCCTTC-----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EecCCeecCCCcc-----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 9999987744211 13677888889999999999999731
Q ss_pred -------------------CCCeeecCCCCCcEEECCCCc--EEEeecCCcee
Q 014725 211 -------------------SIPIYHRDIKSSNILLDDKYR--AKVSDFGASRT 242 (419)
Q Consensus 211 -------------------~~~iiH~Dlkp~Nill~~~~~--~kl~Dfgl~~~ 242 (419)
...++|+|++|.|||++.++. +.|+||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 245999999999999987753 68999998865
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.10 E-value=5.5e-11 Score=110.62 Aligned_cols=183 Identities=21% Similarity=0.239 Sum_probs=121.6
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcC-CCcc--cccEEeEEecCC---cceEEEeec
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRN--VVKLLGCCLESE---VPLLVYEFI 169 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~ 169 (419)
.+.++.|....||+.. ..+++|.... ......+.+|+.+++.+ .+.. +++++......+ ..|+||+++
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~--~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKH--SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESS--HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCC--cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 4568999999999853 4588887543 23456788999999887 3332 455665544333 458999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT--------------------------------------- 210 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------------- 210 (419)
+|.+|.+.... .++..++..++.+++..|..||+..
T Consensus 99 ~G~~l~~~~~~-----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 99 KGVPLTPLLLN-----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp CCEECCHHHHH-----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred CCeECCccccc-----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99888653321 2667777888888888888888621
Q ss_pred ----------------CCCeeecCCCCCcEEECC--CCcEEEeecCCceecccCCceeeecccccCCc---cCcccccc-
Q 014725 211 ----------------SIPIYHRDIKSSNILLDD--KYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY---LDPEYFRS- 268 (419)
Q Consensus 211 ----------------~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~- 268 (419)
...++|+|++|.||++++ +..+.|+||+.+...... .... ....+ ..|+....
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~----~~~~~~~~~~~~~~~~~ 248 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFI----SLMEDDEEYGMEFVSKI 248 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHH----TTCCTTTSCCHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHH----HHHhhccccCHHHHHHH
Confidence 134899999999999988 556889999988653211 0000 00011 12222110
Q ss_pred ----CC---------CCcccceechhHHHHHHHhCCCCC
Q 014725 269 ----SQ---------FTEKSDVYSFGVVLVELLTGQKPI 294 (419)
Q Consensus 269 ----~~---------~s~~~Di~slG~~l~el~tg~~p~ 294 (419)
+. .....+.|+++.+++.+.+|..+|
T Consensus 249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 00 112358899999999999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.65 E-value=2.5e-07 Score=85.83 Aligned_cols=136 Identities=15% Similarity=0.184 Sum_probs=94.4
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCc---ccccEEeEEe-cCCcceEEEeecCC
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHR---NVVKLLGCCL-ESEVPLLVYEFIPN 171 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~ 171 (419)
.+.++.|....||+. +..+++|... .......+.+|..+|+.+.+. .+++.+.++. ..+..++|||+++|
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence 356888999999987 5668888743 233456789999999998642 3667777774 45567899999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc------------------------------------------
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA------------------------------------------ 209 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~------------------------------------------ 209 (419)
.++.+.... .++......++.+++..|..||+.
T Consensus 98 ~~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 98 QILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp EECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred eECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 888663211 134444455555555555555542
Q ss_pred ---------------CCCCeeecCCCCCcEEECC---CCc-EEEeecCCcee
Q 014725 210 ---------------TSIPIYHRDIKSSNILLDD---KYR-AKVSDFGASRT 242 (419)
Q Consensus 210 ---------------~~~~iiH~Dlkp~Nill~~---~~~-~kl~Dfgl~~~ 242 (419)
.+..++|+|++|.||+++. ++. +.|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2234799999999999987 455 48999997754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.63 E-value=1.8e-07 Score=85.06 Aligned_cols=135 Identities=19% Similarity=0.194 Sum_probs=96.7
Q ss_pred cccccCcE-EEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEeecCCCCH
Q 014725 98 ILGQGGQG-TVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYEFIPNGTL 174 (419)
Q Consensus 98 ~ig~G~fg-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g~L 174 (419)
.+..|..| .||+.... ++..+++|.... .....+.+|...|+.+. +--+.++++++.+.+..++|||+++|.++
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~ 107 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA 107 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence 34455555 68988754 456788887653 23456788999988874 33478899999988899999999999888
Q ss_pred HHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-------------------------------------------
Q 014725 175 YHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS------------------------------------------- 211 (419)
Q Consensus 175 ~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~------------------------------------------- 211 (419)
.+...... .....++.+++..|..||....
T Consensus 108 ~~~~~~~~-------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 108 FQVLEEYP-------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp HHHHHHCG-------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccCCH-------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 77654321 1223455666677777775320
Q ss_pred ------------CCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 212 ------------IPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 212 ------------~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 1289999999999999887778999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.50 E-value=2.4e-07 Score=87.83 Aligned_cols=81 Identities=4% Similarity=-0.020 Sum_probs=56.1
Q ss_pred cCcc-cccCcEEEEEEEec-------CCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCC-C--cccccEEeEEecC--
Q 014725 96 NRIL-GQGGQGTVYKGMLA-------DGGIVAVKKSKLVD---ESNVEQFINEVVILSQIN-H--RNVVKLLGCCLES-- 159 (419)
Q Consensus 96 ~~~i-g~G~fg~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~-- 159 (419)
.+.| +.|....+|+.... ++..+++|...... ......+.+|+.+++.+. + -.+++++.++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88989999998764 25678888764322 001245678888888874 3 3577888887665
Q ss_pred -CcceEEEeecCCCCHHH
Q 014725 160 -EVPLLVYEFIPNGTLYH 176 (419)
Q Consensus 160 -~~~~lv~e~~~~g~L~~ 176 (419)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.29 E-value=2.9e-06 Score=81.57 Aligned_cols=75 Identities=13% Similarity=0.136 Sum_probs=49.5
Q ss_pred cCcccccCcEEEEEEEec-CCCEEEEEEcccCCh-------hhHHHHHHHHHHHhcCCC--c-ccccEEeEEecCCcceE
Q 014725 96 NRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDE-------SNVEQFINEVVILSQINH--R-NVVKLLGCCLESEVPLL 164 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~-niv~l~~~~~~~~~~~l 164 (419)
.+.||.|.++.||++... +++.+++|....... ...+.+..|.++++.+.. | .+++++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999754 467899997543211 123456778888887732 3 34556644 3456789
Q ss_pred EEeecCCC
Q 014725 165 VYEFIPNG 172 (419)
Q Consensus 165 v~e~~~~g 172 (419)
|||++++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.25 E-value=3.2e-06 Score=79.28 Aligned_cols=141 Identities=16% Similarity=0.187 Sum_probs=78.5
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC--cccccEEe------EEecCCcceEEEee
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH--RNVVKLLG------CCLESEVPLLVYEF 168 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~------~~~~~~~~~lv~e~ 168 (419)
+.|+.|..+.||+....++ .+++|.... .. ..+..|..+++.+.. -.+++++. +....+..+++|+|
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~-~~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHR-PE---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECS-CH---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCC-CH---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4466677899999987544 588998764 22 233345555554421 12333332 12235667899999
Q ss_pred cCCCCHH--------------HHhhccCC----C-------CCCCHHHHH------------------------------
Q 014725 169 IPNGTLY--------------HYLHDQTE----E-------FPITWEMRL------------------------------ 193 (419)
Q Consensus 169 ~~~g~L~--------------~~l~~~~~----~-------~~l~~~~~~------------------------------ 193 (419)
++|..+. ..++.... . ....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986542 11111100 0 011232110
Q ss_pred -HHHHHHHHHHHHHhh----------cCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 194 -RIAIEVSGAMSYLHS----------ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 194 -~i~~~i~~~l~~LH~----------~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
.+...+..++.+|+. ..+..++|+|+++.|||++.++.+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111123445666663 1234599999999999998888999999997643
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=98.13 E-value=1e-05 Score=74.15 Aligned_cols=79 Identities=20% Similarity=0.122 Sum_probs=57.9
Q ss_pred CccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-C--cccccEEeEEecCCcceEEEee
Q 014725 92 NYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-H--RNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.....+.+|.|..+.||+.+..||+.+++|+...........|..|+..|+.+. . --+++++++. ..++||||
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e~ 91 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAMEW 91 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEEC
T ss_pred CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEEe
Confidence 455567899999999999999999999999866443333345788999888874 2 2345566542 35899999
Q ss_pred cCCCCH
Q 014725 169 IPNGTL 174 (419)
Q Consensus 169 ~~~g~L 174 (419)
++++..
T Consensus 92 l~~~~~ 97 (288)
T 3f7w_A 92 VDERPP 97 (288)
T ss_dssp CCCCCC
T ss_pred ecccCC
Confidence 987643
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.98 E-value=5.3e-05 Score=73.36 Aligned_cols=73 Identities=15% Similarity=0.225 Sum_probs=45.6
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccC----Chh-----hHHHHHHHHHHHh-cCCCcccccEEeEEecCCcceEE
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLV----DES-----NVEQFINEVVILS-QINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~----~~~-----~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.+.||.|..+.||++.. +++.++||..... ... ....+..|+..+. ......+++++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46789999999999965 4678999943210 111 2223333433322 12234677777765 5677999
Q ss_pred Eeec-CC
Q 014725 166 YEFI-PN 171 (419)
Q Consensus 166 ~e~~-~~ 171 (419)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.96 E-value=5.5e-05 Score=69.96 Aligned_cols=138 Identities=17% Similarity=0.133 Sum_probs=91.7
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC---CcccccEEeEEecCCcceEEEeecCCC
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN---HRNVVKLLGCCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~g 172 (419)
.+.|+.|....+|+... +++.+++|..... ....+..|+..|+.|. ...+++++.++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 46789999999999886 4678889976532 3467888999888883 367888999888778899999999987
Q ss_pred CHH--------H---HhhccCC--C-----------------CCCCHHHHH---HHHH----------------HHHHH-
Q 014725 173 TLY--------H---YLHDQTE--E-----------------FPITWEMRL---RIAI----------------EVSGA- 202 (419)
Q Consensus 173 ~L~--------~---~l~~~~~--~-----------------~~l~~~~~~---~i~~----------------~i~~~- 202 (419)
.+. . -|+.... . ..-+|.... ++.. .+...
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 542 1 1222211 0 012454322 1111 11111
Q ss_pred HHHHhh-cCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 203 MSYLHS-ATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 203 l~~LH~-~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 123322 2245699999999999999887 8899974
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00034 Score=65.21 Aligned_cols=141 Identities=12% Similarity=0.060 Sum_probs=72.9
Q ss_pred CcccccCcEE-EEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-C-cccccEEeEEecCCcceEEEeecCCCC
Q 014725 97 RILGQGGQGT-VYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-H-RNVVKLLGCCLESEVPLLVYEFIPNGT 173 (419)
Q Consensus 97 ~~ig~G~fg~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~~~g~ 173 (419)
+.|+.|+... +|+....+++.+++|....... ..+..|+.+++.+. + -.+++++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4566665554 6676654467777876543221 22345666666553 2 2356677664333 378999997777
Q ss_pred HHHHhhccC---------------------C--CCCCCHHHHH-------HH-------------HHHHHHHHHHHhh--
Q 014725 174 LYHYLHDQT---------------------E--EFPITWEMRL-------RI-------------AIEVSGAMSYLHS-- 208 (419)
Q Consensus 174 L~~~l~~~~---------------------~--~~~l~~~~~~-------~i-------------~~~i~~~l~~LH~-- 208 (419)
+.+++.... . ...++..... .+ ...+...+..+..
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 655443210 0 0012211100 00 0011122222211
Q ss_pred -cCCCCeeecCCCCCcEEECCC----CcEEEeecCCcee
Q 014725 209 -ATSIPIYHRDIKSSNILLDDK----YRAKVSDFGASRT 242 (419)
Q Consensus 209 -~~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfgl~~~ 242 (419)
.....++|+|+.+.||+++.+ +.+.|+||+.+..
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 123459999999999999874 6799999998865
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00013 Score=70.65 Aligned_cols=73 Identities=19% Similarity=0.249 Sum_probs=49.5
Q ss_pred cCcccccCcEEEEEEEecC--------CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccc-ccEEeEEecCCcceEEE
Q 014725 96 NRILGQGGQGTVYKGMLAD--------GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV-VKLLGCCLESEVPLLVY 166 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~ 166 (419)
.+.|+.|-...+|++...+ +..+++|+..... ..+.+.+|..+++.+...++ +++++.+.+ .+|+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence 4567888889999998653 4688888874311 11455679888888853333 667776543 3899
Q ss_pred eecCCCCH
Q 014725 167 EFIPNGTL 174 (419)
Q Consensus 167 e~~~~g~L 174 (419)
||++|.+|
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99986443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00019 Score=68.18 Aligned_cols=141 Identities=19% Similarity=0.223 Sum_probs=83.1
Q ss_pred CcccccCcEEEEEEEec--------CCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEe
Q 014725 97 RILGQGGQGTVYKGMLA--------DGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 167 (419)
+.|..|-...+|+.... ++..+++|+.... ......+.+|..+++.+. +.-.+++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 45777888889998864 2468899885332 123456678999988874 3334677777654 29999
Q ss_pred ecCCCCHHHH-----------------hhccCC--CCCC--CHHHHHHHHHHHHH-------------------HHHHHh
Q 014725 168 FIPNGTLYHY-----------------LHDQTE--EFPI--TWEMRLRIAIEVSG-------------------AMSYLH 207 (419)
Q Consensus 168 ~~~~g~L~~~-----------------l~~~~~--~~~l--~~~~~~~i~~~i~~-------------------~l~~LH 207 (419)
|++|..|..- |+.... .... -+.++.++..++.. .+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9988654311 111110 1112 24455555544321 223332
Q ss_pred ----hc-CCCCeeecCCCCCcEEECCC----CcEEEeecCCcee
Q 014725 208 ----SA-TSIPIYHRDIKSSNILLDDK----YRAKVSDFGASRT 242 (419)
Q Consensus 208 ----~~-~~~~iiH~Dlkp~Nill~~~----~~~kl~Dfgl~~~ 242 (419)
.. .+..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 21 23359999999999999876 7899999998754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00022 Score=65.59 Aligned_cols=71 Identities=17% Similarity=0.134 Sum_probs=44.0
Q ss_pred cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccc-ccEEeEEecCCcceEEEeec-CCCC
Q 014725 96 NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV-VKLLGCCLESEVPLLVYEFI-PNGT 173 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~g~ 173 (419)
.+.|+.|....+|+. ..+++|........ .....+|+.+++.+...++ +++++++ .+.-++++||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence 577999999999998 45788876542211 1122457777776642222 5666543 33457999999 6654
Q ss_pred H
Q 014725 174 L 174 (419)
Q Consensus 174 L 174 (419)
+
T Consensus 95 l 95 (301)
T 3dxq_A 95 M 95 (301)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00096 Score=61.74 Aligned_cols=159 Identities=13% Similarity=0.151 Sum_probs=85.2
Q ss_pred cCHHHHHHHhcCccc-----cCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcc--cccEE
Q 014725 81 FTKMDLEKATDNYNA-----NRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRN--VVKLL 153 (419)
Q Consensus 81 ~~~~~~~~~~~~y~~-----~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~ 153 (419)
.+..++......|.+ .+.|+.|....+|+....++ .+++|...... ..+.+..|+.+++.+...+ +++++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 344555555455544 34567788899999987655 67888876421 1234556777766653211 33333
Q ss_pred eE------EecCCcceEEEeecCCCCHHH--------------HhhccCCCC------C---CCHHHHHH----------
Q 014725 154 GC------CLESEVPLLVYEFIPNGTLYH--------------YLHDQTEEF------P---ITWEMRLR---------- 194 (419)
Q Consensus 154 ~~------~~~~~~~~lv~e~~~~g~L~~--------------~l~~~~~~~------~---l~~~~~~~---------- 194 (419)
.. ....+..+++|+|++|..+.. -++...... . ..|...+.
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 112345689999998864311 011111000 0 11222110
Q ss_pred --HHHHHHHHHHHHhhc----CCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 195 --IAIEVSGAMSYLHSA----TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 195 --i~~~i~~~l~~LH~~----~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
+...+...+..+... .+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 001134455555532 133499999999999999876668999987753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.45 E-value=0.00042 Score=67.61 Aligned_cols=74 Identities=14% Similarity=0.024 Sum_probs=46.5
Q ss_pred cCcccccCcEEEEEEEecC-CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccc-ccEEeEEecCCcceEEEeecCCCC
Q 014725 96 NRILGQGGQGTVYKGMLAD-GGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV-VKLLGCCLESEVPLLVYEFIPNGT 173 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g~ 173 (419)
.+.|+.|-...+|+....+ +..+++|......... -...+|..+++.|...++ +++++++.+ .+||||++|.+
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I~G~~ 187 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFTN----GRIEEFMDGYA 187 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECCCSEE
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEeeCCcc
Confidence 3567788889999998765 4678888764322111 112478888888864444 567777632 36999998754
Q ss_pred H
Q 014725 174 L 174 (419)
Q Consensus 174 L 174 (419)
|
T Consensus 188 l 188 (458)
T 2qg7_A 188 L 188 (458)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.38 E-value=0.0013 Score=61.11 Aligned_cols=142 Identities=15% Similarity=0.142 Sum_probs=79.3
Q ss_pred CcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCc--ccccEEeE-----EecCCcceEEEeec
Q 014725 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHR--NVVKLLGC-----CLESEVPLLVYEFI 169 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lv~e~~ 169 (419)
..++ |....||+....+|+.+++|...... .....+..|..+++.+... .+++++.. ....+..+++|+++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 3466 78889999887777789999876321 1234566787777776321 23444443 11234557899999
Q ss_pred CCCCHH-----H------H---hhc----cC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHhhc-
Q 014725 170 PNGTLY-----H------Y---LHD----QT--EEFPITWEMR----LRI---------------AIEVSGAMSYLHSA- 209 (419)
Q Consensus 170 ~~g~L~-----~------~---l~~----~~--~~~~l~~~~~----~~i---------------~~~i~~~l~~LH~~- 209 (419)
+|..+. . . ++. .. .....++... ..+ ...+...+..+...
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 875432 1 1 111 00 0111222211 000 01111222333221
Q ss_pred ---CCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 210 ---TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 210 ---~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
.+..++|+|+++.||+++ + .+.|+||+.+..
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 234489999999999999 4 899999987754
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.26 E-value=0.00055 Score=64.82 Aligned_cols=73 Identities=12% Similarity=0.093 Sum_probs=43.7
Q ss_pred CcccccCcEEEEEEEecC---------CCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcc-cccEEeEEecCCcceEEE
Q 014725 97 RILGQGGQGTVYKGMLAD---------GGIVAVKKSKLVDESNVEQFINEVVILSQINHRN-VVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~ 166 (419)
+.|+.|....+|+....+ +..+++|........ ......|..+++.+...+ .+++++.. .-++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF----NGGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec----CCcEEE
Confidence 567788888999998654 267888876542221 112356788877774333 45666554 237899
Q ss_pred eecCCCCH
Q 014725 167 EFIPNGTL 174 (419)
Q Consensus 167 e~~~~g~L 174 (419)
||++|..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.16 E-value=0.0015 Score=56.14 Aligned_cols=99 Identities=17% Similarity=0.139 Sum_probs=65.5
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCceee
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~~ 251 (419)
-+|.+.|..... ++++.++|.++.|.+.+|.-+-.... -..+=+.|..|++..+|.|.+.+ ..+.
T Consensus 33 vSL~eIL~~~~~--PlsEEqaWALc~Qc~~~L~~~~~~~~--~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------- 97 (229)
T 2yle_A 33 LSLEEILRLYNQ--PINEEQAWAVCYQCCGSLRAAARRRQ--PRHRVRSAAQIRVWRDGAVTLAP-AADD---------- 97 (229)
T ss_dssp EEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTC--CCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred ccHHHHHHHcCC--CcCHHHHHHHHHHHHHHHHhhhhccc--CCceecCCcceEEecCCceeccc-cccc----------
Confidence 389999987654 69999999999999998876622111 11333457999999999988764 1110
Q ss_pred ecccccCCccCccccccCCCCcccceechhHHHHHHHh
Q 014725 252 TRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT 289 (419)
Q Consensus 252 ~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t 289 (419)
.....+.|||... ...+.+.=|||||+++|.-+-
T Consensus 98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ------------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 1223466888763 345678899999999999886
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.92 E-value=0.0034 Score=58.63 Aligned_cols=31 Identities=19% Similarity=0.366 Sum_probs=27.3
Q ss_pred CCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 212 IPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 212 ~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
..++|+|+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4599999999999999888899999987654
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=96.27 E-value=0.002 Score=39.52 Aligned_cols=32 Identities=19% Similarity=0.265 Sum_probs=16.1
Q ss_pred hhhHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 014725 17 SHSISCCGSGLGLFILLIGMWGLRKFVKRRRE 48 (419)
Q Consensus 17 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 48 (419)
+....+.++++|++++++++..+..|.+||++
T Consensus 9 ~~~~~Ia~~vVGvll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 9 SPLTSIISAVVGILLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp CSHHHHHHHHHHHHHHHHHHHHHHHHHHHHCS
T ss_pred CcccchHHHHHHHHHHHHHHHHHHhheehhhh
Confidence 33444455555555555555454555555543
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.98 E-value=0.025 Score=54.29 Aligned_cols=141 Identities=13% Similarity=0.118 Sum_probs=83.2
Q ss_pred cCcccccCcEEEEEEEecC--------CCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEE
Q 014725 96 NRILGQGGQGTVYKGMLAD--------GGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 166 (419)
.+.+..|-...+|+....+ +..+++++....... .-...+|..+++.+. +.-.+++++.+. -++||
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~ 149 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE 149 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence 3567778889999998753 577888886443221 112356888877774 333456665442 37899
Q ss_pred eecCCCCHHH--------------Hh---hc--c-----C---CCCCCCHHHHHHHHHHH-------------------H
Q 014725 167 EFIPNGTLYH--------------YL---HD--Q-----T---EEFPITWEMRLRIAIEV-------------------S 200 (419)
Q Consensus 167 e~~~~g~L~~--------------~l---~~--~-----~---~~~~l~~~~~~~i~~~i-------------------~ 200 (419)
||++|..|.. .+ +. . . ...+..+.++.++..++ .
T Consensus 150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~ 229 (424)
T 3mes_A 150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL 229 (424)
T ss_dssp ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence 9999865321 00 10 0 0 11112244444443322 1
Q ss_pred HHHHHHhh---------------------cCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 201 GAMSYLHS---------------------ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 201 ~~l~~LH~---------------------~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
..+.+|.+ ..+..++|+|+.+.||+ +.++.+.++||..+..
T Consensus 230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 22333321 11334999999999999 7788999999998754
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.94 E-value=0.0014 Score=40.42 Aligned_cols=38 Identities=24% Similarity=0.375 Sum_probs=18.0
Q ss_pred CCccccchhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 014725 10 SCDEEYNSHSISCCGSGLGLFILLIGMWGLRKFVKRRR 47 (419)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 47 (419)
.|+.+-+....|+.+++.|++++++++...+.+++||+
T Consensus 2 gCp~~~s~~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~ 39 (44)
T 2ks1_B 2 GCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRH 39 (44)
T ss_dssp CCCCCCSCSSSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred CCCCCCCCcceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence 35554233334445555556655554444444444443
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.43 E-value=0.0052 Score=37.81 Aligned_cols=29 Identities=31% Similarity=0.461 Sum_probs=14.8
Q ss_pred hHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Q 014725 19 SISCCGSGLGLFILLIGMWGLRKFVKRRR 47 (419)
Q Consensus 19 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 47 (419)
..|+.+++.|++++++++...+.+++||+
T Consensus 10 ~aIA~gVVgGv~~v~ii~~~~~~~~RRRr 38 (44)
T 2l2t_A 10 PLIAAGVIGGLFILVIVGLTFAVYVRRKS 38 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ceEEEeehHHHHHHHHHHHHHHHHhhhhh
Confidence 44555555556665555444444444443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=94.54 E-value=0.2 Score=47.74 Aligned_cols=29 Identities=34% Similarity=0.482 Sum_probs=25.1
Q ss_pred eeecCCCCCcEEE------CCCCcEEEeecCCcee
Q 014725 214 IYHRDIKSSNILL------DDKYRAKVSDFGASRT 242 (419)
Q Consensus 214 iiH~Dlkp~Nill------~~~~~~kl~Dfgl~~~ 242 (419)
++|+|+.+.|||+ +++..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6799999999999 4567899999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.98 E-value=0.56 Score=40.26 Aligned_cols=115 Identities=10% Similarity=0.096 Sum_probs=73.9
Q ss_pred CCcccccEEeEEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHH-HHhhcCCCCeeecCCCCCc
Q 014725 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS-YLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 145 ~h~niv~l~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~iiH~Dlkp~N 223 (419)
.||++ -...-.+++...+.++.-+++.=...+. .++...+++++.+|+.... +++. -+|--+.|+|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N 114 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN 114 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence 57777 3334456666666666543332222333 2678899999999887766 5554 4577899999
Q ss_pred EEECCCCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCC
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 295 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~ 295 (419)
+++|.++.+++.-.|+-. -++|.-+ +...=.-++=|++..++.++..|.
T Consensus 115 L~f~~~~~p~i~hRGi~~------------------~lpP~e~-----~ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 115 LMFNRALEPFFLHVGVKE------------------SLPPDEW-----DDERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp EEECTTCCEEESCCEETT------------------TBSSCSC-----CHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred EEEeCCCcEEEEEcCCcc------------------cCCCCCC-----CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999998877532 2333321 111112256678888888877653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=90.37 E-value=0.36 Score=41.30 Aligned_cols=115 Identities=9% Similarity=0.121 Sum_probs=75.0
Q ss_pred CCcccccEEeEEecCCcceEEEeecCCC-CHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCc
Q 014725 145 NHRNVVKLLGCCLESEVPLLVYEFIPNG-TLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSN 223 (419)
Q Consensus 145 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~N 223 (419)
.||+.++. ..-.+.+...+.++.-+.+ ++.. +. ..+...+++++.+|+....+++. -+|--|.|+|
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik------~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~N 109 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK------SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDE 109 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG------GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH------hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecce
Confidence 57888866 4555556555555543322 2222 22 26788999999999887766654 3477899999
Q ss_pred EEECCCCcEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCC
Q 014725 224 ILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 295 (419)
Q Consensus 224 ill~~~~~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~ 295 (419)
++++.++.+++.-.|+-.. ++|.- .+...=.-.+=|++..+++++..|.
T Consensus 110 L~f~~~~~p~i~~RGik~~------------------l~P~~-----~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 110 LFFTRDGLPIAKTRGLQNV------------------VDPLP-----VSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp EEECTTSCEEESCCEETTT------------------BSCCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred EEEcCCCCEEEEEccCccC------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 9999999999987775422 22221 1111223356688888998888864
|
| >2knc_B Integrin beta-3; transmembrane signaling, protein structure, cell A cleavage on PAIR of basic residues, disease mutation, disul bond, glycoprotein; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.62 E-value=1.5 Score=30.85 Aligned_cols=24 Identities=0% Similarity=-0.097 Sum_probs=11.3
Q ss_pred CCccccchhhHHHHHHHHHHHHHHH
Q 014725 10 SCDEEYNSHSISCCGSGLGLFILLI 34 (419)
Q Consensus 10 ~~~~~~~~~~~~~~~~~~~~~~~~l 34 (419)
.|++.-+.. .|+.|+++|++++.+
T Consensus 3 ~Cp~~~n~~-~Iv~gvi~gilliGl 26 (79)
T 2knc_B 3 MGSKGPDIL-VVLLSVMGAILLIGL 26 (79)
T ss_dssp SSCSSSCSH-HHHHHHHHHHHHHHH
T ss_pred CCCCCCCch-hhHHHHHHHHHHHHH
Confidence 477654433 333444444444433
|
| >1iij_A ERBB-2 receptor protein-tyrosine kinase; alpha-helix-PI-bulge-alpha-helix, signaling protein; NMR {Synthetic} SCOP: j.35.1.1 | Back alignment and structure |
|---|
Probab=88.50 E-value=0.13 Score=29.68 Aligned_cols=25 Identities=24% Similarity=0.391 Sum_probs=11.2
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHH
Q 014725 22 CCGSGLGLFILLIGMWGLRKFVKRR 46 (419)
Q Consensus 22 ~~~~~~~~~~~~l~~~~~~~~~~~~ 46 (419)
+++.++|++++++.......+.|||
T Consensus 10 IaagVvglll~vii~l~~~~~iRRr 34 (35)
T 1iij_A 10 IIATVVGVLLFLILVVVVGILIKRR 34 (35)
T ss_dssp HHHHHHHHHHHHHHTTTTTHHHHHC
T ss_pred eHHHHHHHHHHHHHHHHhheEEeec
Confidence 3444445555444444444444443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.26 E-value=0.068 Score=52.01 Aligned_cols=60 Identities=8% Similarity=0.002 Sum_probs=17.5
Q ss_pred ccCcccccCcEEEEEEEecC-CCEEEE------EEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEe
Q 014725 95 ANRILGQGGQGTVYKGMLAD-GGIVAV------KKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCL 157 (419)
Q Consensus 95 ~~~~ig~G~fg~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 157 (419)
+.+.|| ||.||+|.+.. ..+||+ |..+.. .......|.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 345676 99999999754 357888 665432 2334456888999999999999999988754
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.64 E-value=0.4 Score=29.34 Aligned_cols=33 Identities=18% Similarity=-0.043 Sum_probs=20.7
Q ss_pred CccccchhhHHHHHHHHHHHHHHHHHHHHHHHHH
Q 014725 11 CDEEYNSHSISCCGSGLGLFILLIGMWGLRKFVK 44 (419)
Q Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 44 (419)
.+..-++...+++| ++.++++.++..++.+..+
T Consensus 7 ~~~~~~~Ia~~vVG-vll~vi~~l~~~~~~RRR~ 39 (44)
T 2jwa_A 7 RASPLTSIISAVVG-ILLVVVLGVVFGILIKRRQ 39 (44)
T ss_dssp CCCSHHHHHHHHHH-HHHHHHHHHHHHHHHHHHC
T ss_pred CCCcccchHHHHHH-HHHHHHHHHHHHhheehhh
Confidence 34556777888888 5566666665555555544
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 419 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-73 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-69 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 8e-68 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-67 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-66 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-65 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-64 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-63 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-62 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-62 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 8e-62 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-60 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-60 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-60 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-60 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-59 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-59 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-59 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-59 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-58 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-57 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-56 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-56 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 6e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-54 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-53 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-51 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-50 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-48 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 5e-48 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-46 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-45 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-45 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-44 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-43 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-43 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-42 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-41 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-38 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-29 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 4e-73
Identities = 74/290 (25%), Positives = 124/290 (42%), Gaps = 21/290 (7%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQI 144
D E + +G G GTVYKG V + ++ F NEV +L +
Sbjct: 2 DWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 61
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
H N++ +G + +V ++ +LYH+LH E + IA + + M
Sbjct: 62 RHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMD 118
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTHLTTRVQGTFGYLDP 263
YLH+ I HRD+KS+NI L + K+ DFG + + +H ++ G+ ++ P
Sbjct: 119 YLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAP 175
Query: 264 EYFRSSQ---FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320
E R ++ +SDVY+FG+VL EL+TGQ P + + + + + L
Sbjct: 176 EVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ------IIFMVGRGYLSP 229
Query: 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370
L K + L CL +RP ++ +E + S+
Sbjct: 230 DLSKVRSNCPKA-----MKRLMAECLKKKRDERPLFPQILASIELLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (552), Expect = 9e-69
Identities = 62/279 (22%), Positives = 117/279 (41%), Gaps = 21/279 (7%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
+ LG G G V+ G VAVK K + + F+ E ++ Q+ H+ +V
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLV 71
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+L + + ++ E++ NG+L +L +T L +A +++ M+++
Sbjct: 72 RLYAVVTQEPI-YIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEER- 128
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
HRD++++NIL+ D K++DFG +R I+ ++ + + PE
Sbjct: 129 --NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330
FT KSDV+SFG++L E++T + M + + LE
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRI---------------PYPGMTNPEVIQNLERGYRMVR 231
Query: 331 KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
+ + L + C + RP+ + LE +
Sbjct: 232 PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 214 bits (545), Expect = 8e-68
Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 21/279 (7%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
+ +G G G V+ G + VA+K + + E FI E ++ +++H +V
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+L G CLE LV+EF+ +G L YL Q E L + ++V M+YL A
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEA- 120
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
+ HRD+ + N L+ + KVSDFG +R + DQ +T + + PE F S+
Sbjct: 121 --CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330
++ KSDV+SFGV++ E+ + K + + + E +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKI---------------PYENRSNSEVVEDISTGFRLYK 223
Query: 331 KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
V + C + RP+ + +L I S
Sbjct: 224 PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (548), Expect = 2e-67
Identities = 70/303 (23%), Positives = 127/303 (41%), Gaps = 37/303 (12%)
Query: 86 LEKATDNYNANRILGQGGQGTVYKGMLADGG-IVAVKKSKL-VDESNVEQFINEVVILSQ 143
+E D++ LG G G V+K G ++A K L + + Q I E+ +L +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
N +V G + E + G+L L I ++ +++I V +
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
+YL I HRD+K SNIL++ + K+ DFG S + + GT Y+ P
Sbjct: 118 TYLREKHKI--MHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED--------------------- 302
E + + ++ +SD++S G+ LVE+ G+ PI DA+E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232
Query: 303 --RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGK----RCLNMIGKKRPSM 356
R L + + + +FE+L+ V + + ++ + +CL +R +
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
Query: 357 KEV 359
K++
Sbjct: 293 KQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 211 bits (539), Expect = 1e-66
Identities = 78/283 (27%), Positives = 123/283 (43%), Gaps = 21/283 (7%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQFINEVVILSQ 143
E + LG G G VY+G+ VAVK K D VE+F+ E ++ +
Sbjct: 11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKE 69
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
I H N+V+LLG C ++ EF+ G L YL + ++ + L +A ++S AM
Sbjct: 70 IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAM 128
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
YL HRD+ + N L+ + + KV+DFG SR + D + + P
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 185
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323
E ++F+ KSDV++FGV+L E+ T ++ +++E+LE
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMS---------------PYPGIDLSQVYELLE 230
Query: 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
E E V L + C RPS E+ E +
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (535), Expect = 4e-66
Identities = 68/293 (23%), Positives = 127/293 (43%), Gaps = 21/293 (7%)
Query: 77 KTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFIN 136
+T+ K E ++ LGQG G V+ G VA+K K + E F+
Sbjct: 3 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTMSPEAFLQ 61
Query: 137 EVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIA 196
E ++ ++ H +V+L E + +V E++ G+L +L +T ++ + +A
Sbjct: 62 EAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLR-LPQLVDMA 119
Query: 197 IEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQG 256
+++ M+Y+ HRD++++NIL+ + KV+DFG +R I+ ++ +
Sbjct: 120 AQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176
Query: 257 TFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316
+ PE +FT KSDV+SFG++L EL T + M
Sbjct: 177 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRV---------------PYPGMVNR 221
Query: 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
+ + +E E ++ L +C ++RP+ + + LE S
Sbjct: 222 EVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (525), Expect = 9e-65
Identities = 69/278 (24%), Positives = 126/278 (45%), Gaps = 27/278 (9%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
+ +G+G G V G G VAVK + +++ + F+ E +++Q+ H N+V
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLV 63
Query: 151 KLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
+LLG +E + L +V E++ G+L YL + + + L+ +++V AM YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 210 TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSS 269
HRD+ + N+L+ + AKVSDFG ++ Q + + PE R
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT----GKLPVKWTAPEALREK 175
Query: 270 QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329
+F+ KSDV+SFG++L E+ + + + + +E +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRV---------------PYPRIPLKDVVPRVEKGYKMD 220
Query: 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367
+ V + K C ++ RPS ++ +LE I+
Sbjct: 221 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 205 bits (523), Expect = 5e-64
Identities = 69/304 (22%), Positives = 117/304 (38%), Gaps = 38/304 (12%)
Query: 81 FTKMDLEKATDN---------YNANRILGQGGQGTVYKGMLADGG----IVAVKK-SKLV 126
FT D +A +++G G G V G L G VA+K
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 127 DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFP 186
E F++E I+ Q +H NV+ L G +S +++ EF+ NG+L +L
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--Q 124
Query: 187 ITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246
T + + ++ M YL HRD+ + NIL++ KVSDFG SR ++ D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 247 QTHLTTR----VQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED 302
+ T + + PE + +FT SDV+S+G+V+ E+++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGER--------- 232
Query: 303 RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362
M + +E + + L C RP ++
Sbjct: 233 ------PYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286
Query: 363 LEGI 366
L+ +
Sbjct: 287 LDKM 290
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (516), Expect = 3e-63
Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 25/277 (9%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHR 147
++Y +G G G K +DG I+ K+ + E+ + ++EV +L ++ H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 148 NVVKLLGCCLE--SEVPLLVYEFIPNGTLYHYLHDQTEEF-PITWEMRLRIAIEVSGAMS 204
N+V+ ++ + +V E+ G L + T+E + E LR+ +++ A+
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 205 YLH--SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
H S + HRD+K +N+ LD K K+ DFG +R + D + GT Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMS 182
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322
PE + EKSD++S G +L EL P + +E + E + F +
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGK-FRRI 234
Query: 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
R E E + R LN+ RPS++E+
Sbjct: 235 PYRYSDELNE--------IITRMLNLKDYHRPSVEEI 263
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 3e-63
Identities = 65/276 (23%), Positives = 116/276 (42%), Gaps = 21/276 (7%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVV 150
+ + LG G G V G VA+K K + ++FI E ++ ++H +V
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLV 62
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+L G C + ++ E++ NG L +YL + F + L + +V AM YL S
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQ--TQQLLEMCKDVCEAMEYLESK- 119
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
HRD+ + N L++D+ KVSDFG SR + D+ + + + PE S+
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 271 FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEG 330
F+ KSD+++FGV++ E+ + K + E + +
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKM---------------PYERFTNSETAEHIAQGLRLYR 222
Query: 331 KEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
V + C + +RP+ K + + +
Sbjct: 223 PHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (515), Expect = 1e-62
Identities = 85/296 (28%), Positives = 144/296 (48%), Gaps = 30/296 (10%)
Query: 93 YNANRILGQGGQGTVYKGMLADGG----IVAVKK-SKLVDESNVEQFINEVVILSQINHR 147
+ N ++G+G G VY G L D AVK +++ D V QF+ E +I+ +H
Sbjct: 29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHP 88
Query: 148 NVVKLLGCCLESE-VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
NV+ LLG CL SE PL+V ++ +G L +++ ++T T + + ++V+ M +L
Sbjct: 89 NVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP--TVKDLIGFGLQVAKGMKFL 146
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI---KVDQTHLTTRVQGTFGYLDP 263
S HRD+ + N +LD+K+ KV+DFG +R + + D H T + ++
Sbjct: 147 ASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203
Query: 264 EYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323
E ++ +FT KSDV+SFGV+L EL+T P D + + + RL
Sbjct: 204 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP-----YPDVNTFDITVYLLQGRRLL---- 254
Query: 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS-IGSSSLQHN 378
E + + V + +C + + RPS E+ + I ++ IG + N
Sbjct: 255 ---QPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVN 304
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 202 bits (513), Expect = 2e-62
Identities = 66/311 (21%), Positives = 122/311 (39%), Gaps = 47/311 (15%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGML------ADGGIVAVKK-SKLVDESNVEQFINE 137
LE +N R +G+G G V++ +VAVK + F E
Sbjct: 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66
Query: 138 VVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEF------------ 185
++++ ++ N+VKLLG C + L++E++ G L +L +
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 186 ---------PITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSD 236
P++ +L IA +V+ M+YL HRD+ + N L+ + K++D
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD 183
Query: 237 FGASRTI-KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR 295
FG SR I D ++ PE +++T +SDV+++GVVL E+ +
Sbjct: 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ-- 241
Query: 296 STDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS 355
M + + + + E + + L + C + + RPS
Sbjct: 242 -------------PYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPS 288
Query: 356 MKEVAFELEGI 366
+ L+ +
Sbjct: 289 FCSIHRILQRM 299
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (507), Expect = 6e-62
Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 28/301 (9%)
Query: 85 DLEKATDNYN-ANRILGQGGQGTVYKGMLADGG---IVAVKK-SKLVDESNVEQFINEVV 139
L DN A+ LG G G+V +G+ VA+K + ++++ E+ + E
Sbjct: 2 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61
Query: 140 ILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
I+ Q+++ +V+L+G C ++E +LV E G L+ +L + EE P + +V
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIP--VSNVAELLHQV 118
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR--VQGT 257
S M YL HRD+ + N+LL +++ AK+SDFG S+ + D ++ T R +
Sbjct: 119 SMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 258 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317
+ PE +F+ +SDV+S+GV + E L+ + + M
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK---------------PYKKMKGPE 220
Query: 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQH 377
+ +E E E + L C + RP V + S+ S H
Sbjct: 221 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVEGH 280
Query: 378 N 378
+
Sbjct: 281 H 281
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 8e-62
Identities = 72/273 (26%), Positives = 115/273 (42%), Gaps = 30/273 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGG-IVAVK---KSKLVDESNVEQFINEVVILSQINH 146
+++ R LG+G G VY I+A+K K++L Q EV I S + H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
N+++L G ++ L+ E+ P GT+Y L + + E++ A+SY
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYC 122
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
HS + HRDIK N+LL K++DFG S + + GT YL PE
Sbjct: 123 HSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMI 176
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326
EK D++S GV+ E L G+ P + +E + ++ V
Sbjct: 177 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE-------TYKRISRVEF--TFPDFV 227
Query: 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ ++ L R L +RP ++EV
Sbjct: 228 TEGARD--------LISRLLKHNPSQRPMLREV 252
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 3e-61
Identities = 67/291 (23%), Positives = 123/291 (42%), Gaps = 28/291 (9%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGMLADGG-----IVAVKK-SKLVDESNVEQFINEVVI 140
E +++G G G VYKGML VA+K E F+ E I
Sbjct: 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGI 62
Query: 141 LSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVS 200
+ Q +H N+++L G + + +++ E++ NG L +L ++ EF + + ++
Sbjct: 63 MGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFS--VLQLVGMLRGIA 120
Query: 201 GAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ--THLTTRVQGTF 258
M YL + HRD+ + NIL++ KVSDFG SR ++ D T+ T+ +
Sbjct: 121 AGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177
Query: 259 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318
+ PE +FT SDV+SFG+V+ E++T + ++ +
Sbjct: 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER---------------PYWELSNHEV 222
Query: 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369
+ + + + L +C +RP ++ L+ + +
Sbjct: 223 MKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 1e-60
Identities = 59/273 (21%), Positives = 121/273 (44%), Gaps = 32/273 (11%)
Query: 96 NRILGQGGQGTVYKGMLADGG-IVAVKK--SKLVDESNVEQFINEVVILSQINHRNVVKL 152
+ +G+G TVYKG+ + VA + + + +S ++F E +L + H N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 153 LGCCLES----EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+ + +LV E + +GTL YL + ++ ++ + +LH+
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHT 130
Query: 209 ATSIPIYHRDIKSSNILLDDK-YRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
+ PI HRD+K NI + K+ D G + + + V GT ++ PE +
Sbjct: 131 R-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKAVIGTPEFMAPEMYE 186
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327
++ E DVY+FG+ ++E+ T + P + + N +++ + + V
Sbjct: 187 -EKYDESVDVYAFGMCMLEMATSEYP---------------YSECQNAAQIYRRVTSGVK 230
Query: 328 KEGKEEEIIT-VAMLGKRCLNMIGKKRPSMKEV 359
++ I V + + C+ +R S+K++
Sbjct: 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDL 263
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 1e-60
Identities = 68/276 (24%), Positives = 119/276 (43%), Gaps = 29/276 (10%)
Query: 96 NRILGQGGQGTVYKGMLADGG---IVAVK--KSKLVDESNVEQFINEVVILSQINHRNVV 150
++ LG G GTV KG VAVK K++ D + ++ + E ++ Q+++ +V
Sbjct: 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
+++G C E+E +LV E G L YL + + + + +VS M YL +
Sbjct: 72 RMIGIC-EAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES- 126
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTR--VQGTFGYLDPEYFRS 268
HRD+ + N+LL ++ AK+SDFG S+ ++ D+ + + + + PE
Sbjct: 127 --NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 269 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328
+F+ KSDV+SFGV++ E + + + M + +LE
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQK---------------PYRGMKGSEVTAMLEKGERM 229
Query: 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364
+ L C + RP V L
Sbjct: 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 2e-60
Identities = 74/283 (26%), Positives = 128/283 (45%), Gaps = 25/283 (8%)
Query: 79 KLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINE 137
KL + + + Y +GQG GTVY M +A G VA+++ L + E INE
Sbjct: 8 KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINE 67
Query: 138 VVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAI 197
++++ + + N+V L L + +V E++ G+L + + + +
Sbjct: 68 ILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCR 123
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT 257
E A+ +LHS + HRDIKS NILL K++DFG I +Q+ +T V GT
Sbjct: 124 ECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GT 179
Query: 258 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317
++ PE + K D++S G++ +E++ G+ P +L
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP---------------YLNENPLRA 224
Query: 318 LFEVLEARVLKEGKEEEIITVAM-LGKRCLNMIGKKRPSMKEV 359
L+ + + E++ + RCL+M +KR S KE+
Sbjct: 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKEL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 3e-60
Identities = 71/316 (22%), Positives = 128/316 (40%), Gaps = 41/316 (12%)
Query: 75 IEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKK-SKLVD 127
I+ T+L E + + + LG G G V + VAVK
Sbjct: 7 IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66
Query: 128 ESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHD------ 180
+ E ++E+ +LS + NH N+V LLG C L++ E+ G L ++L
Sbjct: 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126
Query: 181 ---------QTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYR 231
+ +E + E L + +V+ M++L S HRD+ + NILL
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRI 183
Query: 232 AKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG 290
K+ DFG +R IK D + + + ++ PE + +T +SDV+S+G+ L EL +
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243
Query: 291 QKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIG 350
+ + + +++++ E + + K C +
Sbjct: 244 GSS--------------PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADP 289
Query: 351 KKRPSMKEVAFELEGI 366
KRP+ K++ +E
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 3e-60
Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 26/276 (9%)
Query: 90 TDNYNANRILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQFINEVVILSQINHRN 148
D + LG G G VYK + + A K E +E ++ E+ IL+ +H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+VKLL ++ EF G + + + E P+T + + A++YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS 268
I HRD+K+ NIL K++DFG S + + GT ++ PE
Sbjct: 129 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 184
Query: 269 SQ-----FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323
+ K+DV+S G+ L+E+ + P + L+ +
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VLLKIAKSEPPTLAQP 238
Query: 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+R K+ K+CL R + ++
Sbjct: 239 SRWSSNFKD--------FLKKCLEKNVDARWTTSQL 266
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-60
Identities = 71/335 (21%), Positives = 134/335 (40%), Gaps = 50/335 (14%)
Query: 63 LLQQQLSSNEGN----IEKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGMLADGG-- 116
L Q++ + N ++ + + E +N ++LG G G V
Sbjct: 5 LQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKT 64
Query: 117 ----IVAVKK-SKLVDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLVYEFIP 170
VAVK + D S E ++E+ +++Q+ +H N+V LLG C S L++E+
Sbjct: 65 GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCC 124
Query: 171 NGTLYHYLHDQTEEF--------------------PITWEMRLRIAIEVSGAMSYLHSAT 210
G L +YL + E+F +T+E L A +V+ M +L
Sbjct: 125 YGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK- 183
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT-TRVQGTFGYLDPEYFRSS 269
HRD+ + N+L+ K+ DFG +R I D ++ + ++ PE
Sbjct: 184 --SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG 241
Query: 270 QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329
+T KSDV+S+G++L E+ + + + +++++ +
Sbjct: 242 IYTIKSDVWSYGILLWEIFSLGVN--------------PYPGIPVDANFYKLIQNGFKMD 287
Query: 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364
+ ++ + C +KRPS + L
Sbjct: 288 QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 194 bits (495), Expect = 1e-59
Identities = 65/291 (22%), Positives = 114/291 (39%), Gaps = 36/291 (12%)
Query: 76 EKTKLFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNV 131
+ +LF K D EK ++ R +G G G VY + + +VA+K S
Sbjct: 3 DVAELFFKDDPEK---LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 132 EQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEM 191
+ I EV L ++ H N ++ GC L LV E+ + P+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVE 116
Query: 192 RLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT 251
+ ++YLHS + HRD+K+ NILL + K+ DFG++ +
Sbjct: 117 IAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----A 168
Query: 252 TRVQGTFGYLDPEYFRSS---QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF 308
GT ++ PE + Q+ K DV+S G+ +EL + P+ + +A
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------ 222
Query: 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
L + ++ + + + CL I + RP+ + +
Sbjct: 223 -LYHIAQNESPALQSGHWSEYFRN--------FVDSCLQKIPQDRPTSEVL 264
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-59
Identities = 57/298 (19%), Positives = 113/298 (37%), Gaps = 29/298 (9%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCC 156
+G+G G V++G G VAVK E E+ + H N++ +
Sbjct: 9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 157 LESE----VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS---- 208
+ LV ++ +G+L+ YL+ + +T E +++A+ + +++LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLN----RYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 209 -ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL---TTRVQGTFGYLDPE 264
I HRD+KS NIL+ ++D G + + GT Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 265 YFRSS------QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE----DRSLVGFFLQAMN 314
S + +++D+Y+ G+V E+ + + D ++ M
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 315 EDRLFEVLEARVLKEGKEEEII-TVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIG 371
+ + L + + E + +A + + C G R + + L + G
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-59
Identities = 71/316 (22%), Positives = 125/316 (39%), Gaps = 38/316 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGG---IVAVKK-SKLVDESNVEQFINEVVILSQI-N 145
++ ++G+G G V K + G A+K+ + + + F E+ +L ++ +
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ-------------TEEFPITWEMR 192
H N++ LLG C L E+ P+G L +L + ++ +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT 252
L A +V+ M YL HRD+ + NIL+ + Y AK++DFG SR +V T
Sbjct: 130 LHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK--KT 184
Query: 253 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312
+ ++ E S +T SDV+S+GV+L E+++
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT---------------PYCG 229
Query: 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGS 372
M L+E L E V L ++C +RPS ++ L + +
Sbjct: 230 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289
Query: 373 SSLQHNCEEIHFVGGD 388
E+ + G D
Sbjct: 290 YVNTTLYEKFTYAGID 305
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (485), Expect = 8e-59
Identities = 65/273 (23%), Positives = 109/273 (39%), Gaps = 24/273 (8%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKK-SKLVDESNVEQFINEVVILSQINHRN 148
++++ + LG+G G V + VAVK E E+ I +NH N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
VVK G E + L E+ G L+ + + R ++ + YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG 121
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD-QTHLTTRVQGTFGYLDPEYFR 267
I HRDIK N+LLD++ K+SDFG + + + + L ++ GT Y+ PE +
Sbjct: 122 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 268 SSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326
+F E DV+S G+VL +L G+ P + S E + + ++
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLNPWKKI 232
Query: 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
L + L R ++ ++
Sbjct: 233 DSAPLA--------LLHKILVENPSARITIPDI 257
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 4e-58
Identities = 63/286 (22%), Positives = 126/286 (44%), Gaps = 29/286 (10%)
Query: 88 KATDNYNANRILGQGGQGTVYKGMLADGG-----IVAVKK-SKLVDESNVEQFINEVVIL 141
K T+ + ++LG G GTVYKG+ G VA+K+ + ++ ++E ++
Sbjct: 7 KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM 65
Query: 142 SQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201
+ +++ +V +LLG CL S V L+ + +P G L Y+ + + + L ++++
Sbjct: 66 ASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAK 122
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGY 260
M+YL + HRD+ + N+L+ K++DFG ++ + ++ + + +
Sbjct: 123 GMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179
Query: 261 LDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320
+ E +T +SDV+S+GV + EL+T + +
Sbjct: 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSK---------------PYDGIPASEISS 224
Query: 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+LE I V M+ +C + RP +E+ E +
Sbjct: 225 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 1e-57
Identities = 67/287 (23%), Positives = 120/287 (41%), Gaps = 26/287 (9%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGG----IVAVKK-SKLVDESNVEQFINEVV 139
D E + R +G+G G V++G+ VA+K +S E+F+ E +
Sbjct: 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEAL 60
Query: 140 ILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
+ Q +H ++VKL+G E+ V ++ E G L +L + + + + A ++
Sbjct: 61 TMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRK--YSLDLASLILYAYQL 117
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
S A++YL S HRDI + N+L+ K+ DFG SR ++ + ++ +
Sbjct: 118 STALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319
++ PE +FT SDV+ FGV + E+L Q + + +
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVK---------------PFQGVKNNDVI 219
Query: 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+E T+ L +C +RP E+ +L I
Sbjct: 220 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 189 bits (480), Expect = 5e-57
Identities = 56/272 (20%), Positives = 109/272 (40%), Gaps = 23/272 (8%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV 149
D+Y+ + LG G G V++ A G A K ES+ E E+ +S + H +
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
V L + +++YEF+ G L+ + D+ ++ + + +V + ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHEN 143
Query: 210 TSIPIYHRDIKSSNILLDDKY--RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
H D+K NI+ K K+ DFG + + Q+ T GT + PE
Sbjct: 144 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAE 198
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327
+D++S GV+ LL+G P + +E + + + + +
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET-----LRNVKSCDWNMDDSAFSGIS 253
Query: 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
++GK+ ++ L R ++ +
Sbjct: 254 EDGKD--------FIRKLLLADPNTRMTIHQA 277
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 2e-56
Identities = 65/286 (22%), Positives = 110/286 (38%), Gaps = 29/286 (10%)
Query: 91 DNYNANRILGQGGQGTVYKGML----ADGGIVAVK---KSKLVDESNVEQFINEVVILSQ 143
+ LG G G V +G VAVK L ++ FI EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
++HRN+++L G L + +V E P G+L L F R A++V+ M
Sbjct: 68 LDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFL--LGTLSRYAVQVAEGM 124
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH--LTTRVQGTFGYL 261
YL S HRD+ + N+LL + K+ DFG R + + H + + F +
Sbjct: 125 GYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321
PE ++ F+ SD + FGV L E+ T + ++ L ++
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQE--------------PWIGLNGSQILHKI 227
Query: 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367
+ E+ + + +C + RP+ + L +
Sbjct: 228 DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 4e-56
Identities = 61/278 (21%), Positives = 115/278 (41%), Gaps = 28/278 (10%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILS 142
+K +++ +ILG+G TV LA A+K K ++ E+ V E ++S
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 143 QINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGA 202
+++H VKL + E + NG L Y+ E+ A
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSA 120
Query: 203 MSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD-QTHLTTRVQGTFGYL 261
+ YLH I HRD+K NILL++ +++DFG ++ + + + GT Y+
Sbjct: 121 LEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 177
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321
PE + SD+++ G ++ +L+ G P R+ + F + + + F
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLEYDF-- 229
Query: 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ + ++ L ++ L + KR +E+
Sbjct: 230 -PEKFFPKARD--------LVEKLLVLDATKRLGCEEM 258
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 181 bits (460), Expect = 6e-55
Identities = 76/289 (26%), Positives = 116/289 (40%), Gaps = 30/289 (10%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQIN 145
+D Y ILG GG V+ L VAVK D S +F E + +N
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 146 HRNVVKLLGCCLESE----VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201
H +V + +P +V E++ TL +H + P+T + + + +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQ 122
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL--TTRVQGTFG 259
A+++ H I HRD+K +NI++ KV DFG +R I + T V GT
Sbjct: 123 ALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 260 YLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319
YL PE R +SDVYS G VL E+LTG+ P S V Q + ED +
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF------TGDSPVSVAYQHVREDPIP 233
Query: 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP-SMKEVAFELEGIR 367
L + + + L + R + E+ +L +
Sbjct: 234 PSARHEGLSADLDAVV-------LKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (456), Expect = 4e-54
Identities = 70/297 (23%), Positives = 129/297 (43%), Gaps = 33/297 (11%)
Query: 85 DLEKATDNYNANRILGQGGQGTVYKGML------ADGGIVAVKK-SKLVDESNVEQFINE 137
+ E A + +R LGQG G VY+G+ VA+K ++ +F+NE
Sbjct: 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 73
Query: 138 VVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLH-------DQTEEFPITWE 190
++ + N +VV+LLG + + L++ E + G L YL + P +
Sbjct: 74 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLS 133
Query: 191 MRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI-KVDQTH 249
+++A E++ M+YL++ HRD+ + N ++ + + K+ DFG +R I + D
Sbjct: 134 KMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190
Query: 250 LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF 309
+ ++ PE + FT SDV+SFGVVL E+ T +
Sbjct: 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ---------------P 235
Query: 310 LQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
Q ++ +++ + L + + + L + C K RPS E+ ++
Sbjct: 236 YQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 2e-53
Identities = 69/302 (22%), Positives = 124/302 (41%), Gaps = 42/302 (13%)
Query: 91 DNYNANRILGQGGQGTVYKGML--------ADGGIVAVKKSKL-VDESNVEQFINEVVIL 141
D + LG+G G V VAVK K E ++ I+E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 142 SQI-NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ-------------TEEFPI 187
I H+N++ LLG C + ++ E+ G L YL + E +
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 188 TWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247
+ + + A +V+ M YL S HRD+ + N+L+ + K++DFG +R I
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 248 THLTTRVQ-GTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV 306
+ T ++ PE +T +SDV+SFGV+L E+ T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------- 236
Query: 307 GFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+ + LF++L+ + + M+ + C + + +RP+ K++ +L+ I
Sbjct: 237 --PYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
Query: 367 RA 368
A
Sbjct: 295 VA 296
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (452), Expect = 6e-53
Identities = 54/272 (19%), Positives = 104/272 (38%), Gaps = 23/272 (8%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV 149
D Y+ LG G G V++ + A G + K + NE+ I++Q++H +
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
+ L + +L+ EF+ G L+ + + ++ ++ + + + ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 210 TSIPIYHRDIKSSNILLD--DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
I H DIK NI+ + K+ DFG + K++ + T + PE
Sbjct: 147 ---SIVHLDIKPENIMCETKKASSVKIIDFGLAT--KLNPDEIVKVTTATAEFAAPEIVD 201
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327
+D+++ GV+ LL+G P D E + E + V
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-----LQNVKRCDWEFDEDAFSSVS 256
Query: 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
E K+ K L +KR ++ +
Sbjct: 257 PEAKD--------FIKNLLQKEPRKRLTVHDA 280
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 5e-52
Identities = 56/273 (20%), Positives = 104/273 (38%), Gaps = 26/273 (9%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV 149
+ Y LG+G G V++ + + K K+ ++ E+ IL+ HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
+ L E ++++EFI ++ ++ F + + +V A+ +LHS
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSH 121
Query: 210 TSIPIYHRDIKSSNILLDDK--YRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
I H DI+ NI+ + K+ +FG +R +K Y PE +
Sbjct: 122 ---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQ 176
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF-EVLEARV 326
+ +D++S G ++ LL+G P + ++ MN + F E +
Sbjct: 177 HDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTFDEEAFKEI 230
Query: 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
E + R L K R + E
Sbjct: 231 SIEAMD--------FVDRLLVKERKSRMTASEA 255
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 7e-52
Identities = 73/299 (24%), Positives = 117/299 (39%), Gaps = 40/299 (13%)
Query: 91 DNYNANRILGQGGQGTVYKGM------LADGGIVAVKK-SKLVDESNVEQFINEVVILSQ 143
D + LG+G G V + A VAVK + S ++E+ IL
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 144 INHR-NVVKLLGCCLESEVPL-LVYEFIPNGTLYHYLHDQTEEF-------------PIT 188
I H NVV LLG C + PL ++ EF G L YL + EF +T
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 189 WEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248
E + + +V+ M +L S HRD+ + NILL +K K+ DFG +R I D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 249 HL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVG 307
++ + ++ PE +T +SDV+SFGV+L E+ +
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-------------- 235
Query: 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366
+ ++ L+ + + C + +RP+ E+ L +
Sbjct: 236 PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (438), Expect = 3e-51
Identities = 58/276 (21%), Positives = 104/276 (37%), Gaps = 22/276 (7%)
Query: 87 EKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKK-SKLVDESNVEQFINEVVILSQI 144
E D Y+ +LG G V +VA+K +K E NE+ +L +I
Sbjct: 5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64
Query: 145 NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMS 204
H N+V L L+ + + G L+ + ++ T R+ +V A+
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVK 121
Query: 205 YLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPE 264
YLH + + LD+ + +SDFG S+ D + + GT GY+ PE
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPE 179
Query: 265 YFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV-LE 323
+++ D +S GV+ LL G P + + F Q + + F+
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYEFDSPYW 233
Query: 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ K+ + + +KR + ++
Sbjct: 234 DDISDSAKD--------FIRHLMEKDPEKRFTCEQA 261
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 169 bits (429), Expect = 2e-50
Identities = 72/286 (25%), Positives = 116/286 (40%), Gaps = 38/286 (13%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKK---------SKLVDESNVEQFINEVVI 140
+NY ILG+G V + + AVK S + E + EV I
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 141 LSQIN-HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
L +++ H N+++L + LV++ + G L+ YL ++ ++ + +I +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRAL 119
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFG 259
+ LH I HRD+K NILLDD K++DFG S ++D V GT
Sbjct: 120 LEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC--QLDPGEKLREVCGTPS 174
Query: 260 YLDPEYFRSSQ------FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAM 313
YL PE S + ++ D++S GV++ LL G P M
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML------MLRMIM 228
Query: 314 NEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ + F E + TV L R L + +KR + +E
Sbjct: 229 SGNYQFGSPEWDDYSD-------TVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 4e-48
Identities = 57/216 (26%), Positives = 94/216 (43%), Gaps = 12/216 (5%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILS-QIN 145
+++ +++LG+G G V+ A+K K ++ + +VE + E +LS
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 146 HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSY 205
H + + E V E++ G L +++ A E+ + +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQF 118
Query: 206 LHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
LHS I +RD+K NILLD K++DFG + + T GT Y+ PE
Sbjct: 119 LHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEI 174
Query: 266 FRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
++ D +SFGV+L E+L GQ P D EE
Sbjct: 175 LLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 210
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (416), Expect = 5e-48
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 14/215 (6%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
++ R LG G G V+ +G A+K K +V VE +E ++LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
++++ G +++ ++ ++I G L+ L + A EV A+ YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYL 120
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
HS I +RD+K NILLD K++DFG ++ + +T + GT Y+ PE
Sbjct: 121 HSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVV 173
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ + + D +SFG+++ E+L G P ++ +
Sbjct: 174 STKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 160 bits (405), Expect = 9e-47
Identities = 55/283 (19%), Positives = 106/283 (37%), Gaps = 20/283 (7%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRN 148
+ Y+ +G+G G VYK G A+KK +L DE I E+ IL ++ H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 149 VVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS 208
+VKL + +LV+E + E + +++ ++Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 209 ATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRS 268
+ HRD+K N+L++ + K++DFG +R + T + + S
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGS 175
Query: 269 SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE------------DRSLVGFFLQAMNED 316
+++ D++S G + E++ G + + + D
Sbjct: 176 KKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
F V E + + + L + L + +R + K+
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 5e-46
Identities = 60/292 (20%), Positives = 102/292 (34%), Gaps = 25/292 (8%)
Query: 88 KATDNYNANRILGQGGQGTVYKG--MLADGGIVAVK--KSKLVDESNVEQFINEVVILSQ 143
+A Y +G+G G V+K + G VA+K + + +E I EV +L
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 144 I---NHRNVVKLLGCCLESEVPLLVYEFIPNGTLYH---YLHDQTEEFPITWEMRLRIAI 197
+ H NVV+L C S + + D+ E + E +
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 198 EVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGT 257
++ + +LHS + HRD+K NIL+ + K++DFG +R T V T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVT 178
Query: 258 FGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317
Y PE S + D++S G + E+ + R + + + + E+
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238
Query: 318 LFEVLEARVLKEGKEEEIITVAM----------LGKRCLNMIGKKRPSMKEV 359
+ + L +CL KR S
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 5e-46
Identities = 57/281 (20%), Positives = 106/281 (37%), Gaps = 25/281 (8%)
Query: 97 RILGQGGQGTVYKGMLADGG-IVAVKKSKL-----VDESNVEQFINEVVILSQINHRNVV 150
LG+G TVYK + IVA+KK KL + + E+ +L +++H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 151 KLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT 210
LL LV++F+ + +T + + YLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQH- 119
Query: 211 SIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQ 270
I HRD+K +N+LLD+ K++DFG +++ T +V T Y PE ++
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGAR 176
Query: 271 -FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329
+ D+++ G +L ELL + + + + L E++ ++
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 330 GKEEEIITVAMLG-----------KRCLNMIGKKRPSMKEV 359
K I + + + R + +
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 7e-46
Identities = 60/284 (21%), Positives = 104/284 (36%), Gaps = 20/284 (7%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHR 147
+N+ +G+G G VYK G +VA+KK +L E I E+ +L ++NH
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
N+VKLL LV+EF+ P + ++ +++ H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP--LPLIKSYLFQLLQGLAFCH 119
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
S + HRD+K N+L++ + K++DFG +R V T V +
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLG 176
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKP------------IRSTDAEEDRSLVGFFLQAMNE 315
++ D++S G + E++T + I T D + +
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 316 DRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
F + + L + L+ KR S K
Sbjct: 237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (403), Expect = 1e-45
Identities = 51/219 (23%), Positives = 101/219 (46%), Gaps = 17/219 (7%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGG-IVAVK---KSKLVDESNVEQFINEVV---ILSQ 143
++++ +RI+G+GG G VY AD G + A+K K ++ + +NE + ++S
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 144 INHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
+ +V + + + + + G L+++L + A E+ +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGL 120
Query: 204 SYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDP 263
++H+ + +RD+K +NILLD+ ++SD G + + H GT GY+ P
Sbjct: 121 EHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAP 174
Query: 264 EYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
E + + +D +S G +L +LL G P R ++
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-45
Identities = 69/291 (23%), Positives = 116/291 (39%), Gaps = 35/291 (12%)
Query: 80 LFTKMDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLV------DESNVE 132
+F + +++ D Y+ LG G V K + G A K K + E
Sbjct: 2 VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58
Query: 133 QFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMR 192
EV IL +I H NV+ L +L+ E + G L+ +L ++ +T E
Sbjct: 59 DIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEA 115
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD----KYRAKVSDFGASRTIKVDQT 248
++ + YLHS I H D+K NI+L D K R K+ DFG + K+D
Sbjct: 116 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH--KIDFG 170
Query: 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF 308
+ + GT ++ PE ++D++S GV+ LL+G P +E + V
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANV-- 228
Query: 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+ + + K+ +R L KKR ++++
Sbjct: 229 ---SAVNYEFEDEYFSNTSALAKD--------FIRRLLVKDPKKRMTIQDS 268
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-45
Identities = 53/289 (18%), Positives = 112/289 (38%), Gaps = 22/289 (7%)
Query: 90 TDNYNANRILGQGGQGTVYKGM-LADGGIVAVKK-SKLVDESNVEQFINEVVILSQINHR 147
Y +G+G G V + VA+KK S ++ ++ + E+ IL + H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
N++ + + + ++ + L+ + ++ + ++ + Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLT--TRVQGTFGYLDPEY 265
SA + HRD+K SN+LL+ K+ DFG +R D H T T Y PE
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183
Query: 266 FRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324
+S+ +T+ D++S G +L E+L+ + + + + L + +++ L ++
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243
Query: 325 RVLKEGKEEEIITVAMLGK--------------RCLNMIGKKRPSMKEV 359
+ + + L KR +++
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 3e-44
Identities = 64/289 (22%), Positives = 115/289 (39%), Gaps = 28/289 (9%)
Query: 91 DNYNANRILGQGGQGTVYKGMLADGG-IVAVKKSKLVDESNVEQFINEVVILSQINHRNV 149
+Y +++G G G VY+ L D G +VA+KK + E+ I+ +++H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNI 75
Query: 150 VKLLGCCLESEVP------LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAM 203
V+L S LV +++P H + + ++ ++
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 204 SYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLD 262
+Y+HS I HRDIK N+LLD D K+ DFG+++ + + + + + +
Sbjct: 136 AYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAP 191
Query: 263 PEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL---- 318
F ++ +T DV+S G VL ELL GQ + + L +++
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 319 -------FEVLEARVLKEGKEEEIITVAM-LGKRCLNMIGKKRPSMKEV 359
F ++A + A+ L R L R + E
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (383), Expect = 1e-43
Identities = 55/285 (19%), Positives = 110/285 (38%), Gaps = 22/285 (7%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHR 147
Y +G+G GTV+K IVA+K+ +L DE + E+ +L ++ H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 148 NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLH 207
N+V+L + LV+EF ++ + E+ ++ + + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH 118
Query: 208 SATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFR 267
S + HRD+K N+L++ K+++FG +R + + V + F
Sbjct: 119 SR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 268 SSQFTEKSDVYSFGVVLVELLTGQKPI-RSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326
+ ++ D++S G + EL +P+ D ++ + L E++ + +
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPD 235
Query: 327 LKEGKEEEIITVAM------------LGKRCLNMIGKKRPSMKEV 359
K T + L + L +R S +E
Sbjct: 236 YKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-43
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 11/215 (5%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
++++ ++LG+G G V A G A+K K ++ + V + E +L H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
+ L + V E+ G L+ +L E T E E+ A+ YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
HS + +RDIK N++LD K++DFG + D + T GT YL PE
Sbjct: 122 HSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVL 177
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
+ + D + GVV+ E++ G+ P + D E
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 2e-43
Identities = 58/273 (21%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 96 NRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQI-NHRNVVKLL 153
+++LG G G V + A+K + + + EV + + ++V+++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQEKFALKMLQ-----DCPKARREVELHWRASQCPHIVRIV 71
Query: 154 GCC----LESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
+ L+V E + G L+ + D+ ++ T I + A+ YLHS
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQ-AFTEREASEIMKSIGEAIQYLHS- 129
Query: 210 TSIPIYHRDIKSSNILLDDKY---RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
I I HRD+K N+L K K++DFG ++ + T T Y+ PE
Sbjct: 130 --INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYYVAPEVL 185
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326
++ + D++S GV++ LL G P S + M + + V
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-KTRIRMGQYEFPNPEWSEV 244
Query: 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
+E K L + L +R ++ E
Sbjct: 245 SEEVKM--------LIRNLLKTEPTQRMTITEF 269
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-42
Identities = 66/280 (23%), Positives = 117/280 (41%), Gaps = 42/280 (15%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKK------SKLVDESNVEQFINEVVILSQ 143
Y +LG GG G+VY G+ ++D VA+K S + N + EVV+L +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 144 IN--HRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201
++ V++LL + +L+ E TE + E+ +V
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLE 121
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGY 260
A+ + H+ + HRDIK NIL+D ++ K+ DFG+ + + + T GT Y
Sbjct: 122 AVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVY 175
Query: 261 LDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319
PE+ R ++ + V+S G++L +++ G P + + + F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRGQVFF 223
Query: 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEV 359
RV E + L + CL + RP+ +E+
Sbjct: 224 ---RQRVSSECQH--------LIRWCLALRPSDRPTFEEI 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (375), Expect = 3e-42
Identities = 58/292 (19%), Positives = 107/292 (36%), Gaps = 29/292 (9%)
Query: 84 MDLEKATDNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILS 142
M+L + + Y R +G G G +Y G +A G VA+K + ++ Q E I
Sbjct: 1 MEL-RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV--KTKHPQLHIESKIYK 57
Query: 143 QINHRNVVKLLG-CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201
+ + + C E + ++V E + + + + L +A ++
Sbjct: 58 MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMIS 114
Query: 202 AMSYLHSATSIPIYHRDIKSSNIL---LDDKYRAKVSDFGASRTIKVDQTH------LTT 252
+ Y+HS HRD+K N L + DFG ++ + +TH
Sbjct: 115 RIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 253 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312
+ GT Y + + + D+ S G VL+ G P + A R +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY----ER 227
Query: 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364
++E ++ +E VL +G E T C ++ +P +
Sbjct: 228 ISEKKMSTPIE--VLCKGYPSEFATYL---NFCRSLRFDDKPDYSYLRQLFR 274
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 5e-41
Identities = 61/299 (20%), Positives = 112/299 (37%), Gaps = 36/299 (12%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHR 147
Y +GQG G V+K G VA+KK + E + E+ IL + H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 148 NVVKLLGCCLESEVP--------LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEV 199
NVV L+ C P LV++F + + T R+ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQML 126
Query: 200 SGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI---KVDQTHLTTRVQG 256
++ L+ I HRD+K++N+L+ K++DFG +R K Q + T
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 257 TFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV--------G 307
T Y PE + + D++ G ++ E+ T ++ + +L+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243
Query: 308 FFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM-------LGKRCLNMIGKKRPSMKEV 359
++ L+E LE ++ K ++ + + L + L + +R +
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 7e-41
Identities = 55/301 (18%), Positives = 114/301 (37%), Gaps = 28/301 (9%)
Query: 81 FTKMDLEKAT----DNYNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLVDESNVEQ 133
F + ++ K Y + +G G G V + G VA+K E ++
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 134 FINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQ-TEEFPITWEMR 192
E+ +L + H NV+ LL E +F + + + +
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123
Query: 193 LRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTT 252
+ ++ + Y+H+A I HRD+K N+ +++ K+ DFG +R + +T
Sbjct: 124 QFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQA---DSEMTG 177
Query: 253 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV------ 306
V + ++T+ D++S G ++ E++TG+ + +D + +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237
Query: 307 --GFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM------LGKRCLNMIGKKRPSMKE 358
F+Q + D ++ E K+ I L ++ L + ++R + E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297
Query: 359 V 359
Sbjct: 298 A 298
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (367), Expect = 1e-40
Identities = 53/215 (24%), Positives = 93/215 (43%), Gaps = 14/215 (6%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVK---KSKLVDESNVEQFINEVVILSQINH 146
D ++ + LG G G V G A+K K K+V +E +NE IL +N
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
+VKL ++ +V E++ G ++ +L + A ++ YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYL 157
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYF 266
HS + +RD+K N+L+D + +V+DFG ++ T + GT L PE
Sbjct: 158 HSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEII 210
Query: 267 RSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEE 301
S + + D ++ GV++ E+ G P + +
Sbjct: 211 LSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 138 bits (348), Expect = 2e-38
Identities = 45/295 (15%), Positives = 97/295 (32%), Gaps = 28/295 (9%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV 149
+Y R +G+G G +++G L + VA+K S+ Q +E +
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR--RSDAPQLRDEYRTYKLLAGCTG 62
Query: 150 VKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA 209
+ + + + ++ + +L L +F + A ++ + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFS--VKTVAMAAKQMLARVQSIHEK 120
Query: 210 TSIPIYHRDIKSSNILLDDKYR-----AKVSDFGASRTIKVDQT------HLTTRVQGTF 258
+ +RDIK N L+ V DFG + + T + GT
Sbjct: 121 ---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
Query: 259 GYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318
Y+ + + + D+ + G V + L G P + A ++ +R+
Sbjct: 178 RYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKY---------ERI 228
Query: 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373
E ++ L+E N+ P + + + ++
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 133 bits (335), Expect = 3e-36
Identities = 51/296 (17%), Positives = 103/296 (34%), Gaps = 41/296 (13%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRN 148
D+Y R LG+G V++ + + + V VK + ++ E+ IL + N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI---LKPVKKKKIKREIKILENLRGGPN 91
Query: 149 VVKLLGCCLE--SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
++ L + S P LV+E + N +T E+ A+ Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYC 145
Query: 207 HSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEY 265
HS I HRD+K N+++D + + ++ D+G + Q + + + PE
Sbjct: 146 HSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPEL 200
Query: 266 FRSSQ-FTEKSDVYSFGVVLVELLTGQKP----------------IRSTDAEEDRSLVGF 308
Q + D++S G +L ++ ++P + T+ D
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260
Query: 309 FLQAMNEDRLFEVLEARVLKEGKEEEIITVAM-----LGKRCLNMIGKKRPSMKEV 359
+ + + + E + + L + R + +E
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 2e-35
Identities = 58/214 (27%), Positives = 91/214 (42%), Gaps = 17/214 (7%)
Query: 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVK---KSKLVDESN-VEQFINEVVILS 142
+N+ ++LG G G V+ G + A+K K+ +V ++ E E +L
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 143 QINHR-NVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201
I +V L L+ ++I G L+ +L + T E+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVL 140
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
A+ +LH I +RDIK NILLD ++DFG S+ D+T GT Y+
Sbjct: 141 ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 197
Query: 262 DPEYFRSSQ--FTEKSDVYSFGVVLVELLTGQKP 293
P+ R + D +S GV++ ELLTG P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 1e-34
Identities = 59/305 (19%), Positives = 115/305 (37%), Gaps = 36/305 (11%)
Query: 81 FTKMDLEKA----TDNYNANRILGQGGQGTVYKGM-LADGGIVAVK--KSKLVDESNVEQ 133
F + +L K + Y +G G G+V G VAVK + ++
Sbjct: 4 FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63
Query: 134 FINEVVILSQINHRNVVKLLGCC-----LESEVPLLVYEFIPNGTLYHYLHDQTEEFPIT 188
E+ +L + H NV+ LL LE + + + L + + Q +T
Sbjct: 64 TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLT 119
Query: 189 WEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248
+ + ++ + Y+HSA I HRD+K SN+ +++ K+ DFG +R
Sbjct: 120 DDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT---DD 173
Query: 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLV-- 306
+T V + + + D++S G ++ ELLTG+ TD + L+
Sbjct: 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR 233
Query: 307 ------GFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAM------LGKRCLNMIGKKRP 354
L+ ++ + +++ + + L ++ L + KR
Sbjct: 234 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI 293
Query: 355 SMKEV 359
+ +
Sbjct: 294 TAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 2e-33
Identities = 62/303 (20%), Positives = 110/303 (36%), Gaps = 45/303 (14%)
Query: 91 DNYNANRILGQGGQGTVYKGM-LADGGIVAVKK--SKLVDESNVEQFINEVVILSQINHR 147
Y + +G G QG V VA+KK ++++ ++ E+V++ +NH+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 148 NVVKLLGCCL------ESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSG 201
N++ LL E + LV E + + E + ++
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLC 130
Query: 202 AMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHLTTRVQGTFGYL 261
+ +LHSA I HRD+K SNI++ K+ DFG +RT + + T T Y
Sbjct: 131 GIKHLHSAGII---HRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 185
Query: 262 DPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL--- 318
PE + E D++S G ++ E++ + D + + V L + +
Sbjct: 186 APEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245
Query: 319 ------------------FEVLEARVLKEGKEEEIITVAMLGK----RCLNMIGKKRPSM 356
F L L E A + + L + KR S+
Sbjct: 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305
Query: 357 KEV 359
+
Sbjct: 306 DDA 308
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 114 bits (286), Expect = 4e-29
Identities = 49/242 (20%), Positives = 89/242 (36%), Gaps = 27/242 (11%)
Query: 93 YNANRILGQGGQGTVYKGM-LADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVK 151
Y R LG G TV+ + + VA+K + D+ E +E+ +L ++N + K
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG-DKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 152 LLGCCLESEVPLLVY--EFIPNGTLYHY-----------LHDQTEEFPITWEMRLRIAIE 198
+ LL + PNG L + E I +I+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133
Query: 199 VSGAMSYLHSATSIPIYHRDIKSSNILLD------DKYRAKVSDFGASRTIKVDQTHLTT 252
+ + Y+H I H DIK N+L++ + + K++D G + T+
Sbjct: 134 LLLGLDYMHRRCGII--HTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--- 188
Query: 253 RVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312
T Y PE + + +D++S ++ EL+TG + Q
Sbjct: 189 -SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 313 MN 314
+
Sbjct: 248 IE 249
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 82.5 bits (203), Expect = 4e-19
Identities = 33/202 (16%), Positives = 68/202 (33%), Gaps = 28/202 (13%)
Query: 97 RILGQGGQGTVYKGMLADGGIVAVK----------KSKLVDESNVEQFINEVVILSQINH 146
+++G+G + V+ G VK K K + F + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 147 RNVVKLLGCCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYL 206
R + KL G + Y + N + L D E + + E + + ++
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNA-VLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119
Query: 207 HSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK--VDQTHLTTRVQGTFGYLDPE 264
+ I H D+ N+L+ + + DF S + + L V+
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNI-----IT 170
Query: 265 YFRSSQFTEKSDVYSFGVVLVE 286
YF + + D+ S +++
Sbjct: 171 YFS-RTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 419 | |||
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.74 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.27 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.43 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.21 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.84 |
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-58 Score=420.01 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=206.9
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
++|++.+.||+|+||+||+|.+.+++.||||+++... ...++|.+|++++++++||||++++|+|.+.+..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 5788999999999999999999888899999987543 334789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++.........
T Consensus 84 ~g~L~~~l~~~~~--~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 84 HGCLSDYLRTQRG--LFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp TCBHHHHHHTTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 9999999876543 5899999999999999999999999 9999999999999999999999999998776544444
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHhC-CCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG-QKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
.....||+.|+|||++.+..++.++|||||||++|||+|+ ..||......+ +.+.+.......
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~----------------~~~~i~~~~~~~ 222 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVEDISTGFRLY 222 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH----------------HHHHHHHTCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHhcCCCC
Confidence 4556789999999999999999999999999999999995 55555443322 111122222233
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.+..++..+.+++.+||+.||++|||+.||++.|++|.++
T Consensus 223 ~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence 3455567899999999999999999999999999998764
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-57 Score=418.60 Aligned_cols=263 Identities=24% Similarity=0.384 Sum_probs=218.4
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
++++...++|++.+.||+|+||.||+|.++++..||||+++... ...+.|.+|+.++++++|||||+++|++.+ +..+
T Consensus 6 ~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred CCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 34455567899999999999999999999888899999987543 335789999999999999999999998864 5679
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+++|+|.+++..... ..+++..+++++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++..
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~ 159 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI 159 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHhhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEc
Confidence 99999999999998865432 24899999999999999999999998 999999999999999999999999999987
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCC-CCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKP-IRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
............||+.|+|||++.++.++.++|||||||++|||+||..| +......+ . .+.+
T Consensus 160 ~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-------~---------~~~i 223 (272)
T d1qpca_ 160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------V---------IQNL 223 (272)
T ss_dssp SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------H---------HHHH
T ss_pred cCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-------H---------HHHH
Confidence 65555555566799999999999999999999999999999999996555 44433321 1 1111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
........+...+..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus 224 ~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 2222233345566789999999999999999999999999998754
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=419.00 Aligned_cols=265 Identities=28% Similarity=0.447 Sum_probs=210.8
Q ss_pred HHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
+...++|.+.+.||+|+||+||+|+++ ..||||+++. .+....+.|.+|+.++++++||||+++++++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence 445678999999999999999999864 3599999764 345567889999999999999999999998864 56799
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++|+|.+++..... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 v~Ey~~~g~L~~~l~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~ 155 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKS 155 (276)
T ss_dssp EEECCCEEEHHHHHHTSCC--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred EEecCCCCCHHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeecc
Confidence 9999999999999976543 4899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCC-ceeeecccccCCccCcccccc---CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhH
Q 014725 245 VDQ-THLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 245 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
... ........||+.|||||++.+ ..++.++|||||||++|||+||+.||........ .............
T Consensus 156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~~~~~~~~~p~--- 230 (276)
T d1uwha_ 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIFMVGRGYLSPD--- 230 (276)
T ss_dssp ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHHHHHTSCCCC---
T ss_pred ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHHHHhcCCCCCc---
Confidence 332 223455679999999999864 3589999999999999999999999987554321 1111111100000
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
....+..++..+.+|+.+||+.||++|||+.||++.|+.+.+++
T Consensus 231 ------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 231 ------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp ------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence 11223445678999999999999999999999999999988653
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.6e-57 Score=420.61 Aligned_cols=263 Identities=30% Similarity=0.427 Sum_probs=222.0
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
++++...++|++.+.||+|+||+||+|++. +++.||||+++... ...++|.+|+.+|++++|||||+++++|.+.+..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence 345556678999999999999999999975 47789999987543 3457899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++|+|.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.
T Consensus 89 ~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~ 164 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL 164 (287)
T ss_dssp EEEEECCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred EEEeecccCcchHHHhhhccc-cchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence 999999999999999976543 35899999999999999999999998 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCC-CCChhhhccHHHHHHHHhcccchhHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR-STDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.............||+.|+|||++.+..++.++|||||||++|||++|..||. ..+... +.+.
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~----------------~~~~ 228 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYEL 228 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------------HHHH
T ss_pred cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH----------------HHHH
Confidence 76555555555668999999999999999999999999999999999766654 333221 1222
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
+........+...+..+.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus 229 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 229 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred HhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 2333334445566778999999999999999999999999998764
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-56 Score=406.78 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=219.0
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecC
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIP 170 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 170 (419)
++|++.+.||+|+||+||+|+++++..||||+++.... ..++|.+|+.++++++||||++++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 67999999999999999999998888999999875433 34789999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee
Q 014725 171 NGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL 250 (419)
Q Consensus 171 ~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~ 250 (419)
+|+|.+++..... .+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 83 ~g~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 83 NGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp TEEHHHHHHSGGG--CCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCcHHHhhhcccc--CCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 9999999876543 4889999999999999999999998 9999999999999999999999999998766555444
Q ss_pred eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhccC
Q 014725 251 TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKE 329 (419)
Q Consensus 251 ~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (419)
.....||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+. . ..+.......
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~-------~---------~~i~~~~~~~ 221 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET-------A---------EHIAQGLRLY 221 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH-------H---------HHHHTTCCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH-------H---------HHHHhCCCCC
Confidence 555678999999999999999999999999999999998 8999987765431 1 1111222233
Q ss_pred CCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 330 GKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 330 ~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.+...+..+.+++.+||+.||++|||+.+|++.|.+|
T Consensus 222 ~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred CcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence 4455567899999999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2e-56 Score=415.65 Aligned_cols=258 Identities=26% Similarity=0.409 Sum_probs=205.8
Q ss_pred hcCccccCcccccCcEEEEEEEecC-C---CEEEEEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD-G---GIVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~-~---~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
.++|++.+.||+|+||+||+|.+.. + ..||||++.. ......+.|.+|+++|++++|||||+++|++.+.+..++
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 3567888999999999999999743 2 2589998765 345566789999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++|+|.+++..... .+++.+++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 105 v~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 179 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDG--QFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179 (299)
T ss_dssp EEECCTTEEHHHHHHTTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred EEEecCCCcceeeeccccC--CCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEcc
Confidence 9999999999999886443 5899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcee----eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 245 VDQTHL----TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 245 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
...... .....||+.|||||.+.+..++.++|||||||++|||+| |+.||......+. .
T Consensus 180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~----------------~ 243 (299)
T d1jpaa_ 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV----------------I 243 (299)
T ss_dssp ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------H
T ss_pred CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH----------------H
Confidence 332211 223457899999999999999999999999999999998 8999987654321 1
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
..+........+..++..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus 244 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 244 NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 1122222233455667789999999999999999999999999998754
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-56 Score=408.66 Aligned_cols=261 Identities=29% Similarity=0.423 Sum_probs=215.9
Q ss_pred cCccccCc-ccccCcEEEEEEEec---CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 91 DNYNANRI-LGQGGQGTVYKGMLA---DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~-ig~G~fg~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
++|.+.+. ||+|+||+||+|.+. ++..||||.++.. .....+.|.+|+++|++++|||||+++|++.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 45666664 999999999999863 3457999998653 44566889999999999999999999999865 567999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++..... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 mE~~~~g~L~~~l~~~~~--~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTTCTT--TSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhcccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999875433 5899999999999999999999998 99999999999999999999999999998754
Q ss_pred CCcee--eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 246 DQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 246 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
..... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||......+. ...+
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~----------------~~~i 225 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV----------------MAFI 225 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH----------------HHHH
T ss_pred cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH----------------HHHH
Confidence 43322 234568999999999999999999999999999999998 9999987654321 1111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCC
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~ 373 (419)
........+..++..+.+|+.+||+.+|++|||+.+|++.|+.+..++.+.
T Consensus 226 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 226 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 222233445566778999999999999999999999999999887665444
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-55 Score=408.40 Aligned_cols=250 Identities=27% Similarity=0.420 Sum_probs=210.5
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|++.+.||+|+||+||+|.+ .+|+.||||++........+.+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence 35799999999999999999996 46889999998765555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++|+|.+++.+. .+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 99 ~~gg~L~~~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~- 170 (293)
T d1yhwa1 99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ- 170 (293)
T ss_dssp CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT-
T ss_pred cCCCcHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccc-
Confidence 9999999988753 3899999999999999999999999 9999999999999999999999999998765433
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||......+. ....... .....
T Consensus 171 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~--------~~~~~ 236 (293)
T d1yhwa1 171 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATN--------GTPEL 236 (293)
T ss_dssp CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHH--------CSCCC
T ss_pred ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhC--------CCCCC
Confidence 233456799999999999999999999999999999999999999976654321 1110000 00111
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 237 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 223344567899999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-56 Score=407.53 Aligned_cols=252 Identities=25% Similarity=0.390 Sum_probs=204.4
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|++.+.||+|+||+||+|++. +++.||||.+.... ....+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 457999999999999999999974 68899999976432 2334678999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++......
T Consensus 84 y~~gg~L~~~l~~~~---~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSBTTT---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ccCCCcHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCC
Confidence 999999999997543 5999999999999999999999999 9999999999999999999999999999875443
Q ss_pred c-eeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 248 T-HLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 248 ~-~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. ......+||+.|||||++.+..+ +.++|||||||++|||+||+.||......... +..... ..
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~~~~~---------~~ 223 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDWKE---------KK 223 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HHHHHT---------TC
T ss_pred ccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-----HHHHhc---------CC
Confidence 2 23455679999999999988776 67899999999999999999999765432210 000000 00
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+..+.+|+.+||+.||++|||+.|+++
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 224 TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 011111233456889999999999999999999864
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-55 Score=401.05 Aligned_cols=245 Identities=29% Similarity=0.393 Sum_probs=208.1
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||+||+|++. +++.||+|.+... +....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 56999999999999999999974 5789999987531 2234567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 9999999999998654 4899999999999999999999999 999999999999999999999999999765432
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
......||+.|||||++.+..++.++|||||||++|||+||+.||...+..+. .......
T Consensus 160 ---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------~~~i~~~---------- 219 (263)
T d2j4za1 160 ---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-------YKRISRV---------- 219 (263)
T ss_dssp ---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHHHHTT----------
T ss_pred ---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH-------HHHHHcC----------
Confidence 23446799999999999999999999999999999999999999987654321 1111111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 220 ~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 220 EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 11223445567899999999999999999999976
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-55 Score=402.64 Aligned_cols=248 Identities=29% Similarity=0.419 Sum_probs=205.3
Q ss_pred CcccccCcEEEEEEEecC---CCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeecCC
Q 014725 97 RILGQGGQGTVYKGMLAD---GGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFIPN 171 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~---~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 171 (419)
+.||+|+||+||+|.+.+ ++.||||+++. .+....+.|.+|+.+|++++|||||+++++|.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 569999999999998643 35799998864 233445789999999999999999999999965 457899999999
Q ss_pred CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCcee-
Q 014725 172 GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTHL- 250 (419)
Q Consensus 172 g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~~- 250 (419)
|+|.+++.... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.........
T Consensus 92 g~L~~~l~~~~---~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHHCT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CcHHHHHhhcc---CCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence 99999998654 4999999999999999999999998 9999999999999999999999999999765443332
Q ss_pred -eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhcc
Q 014725 251 -TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLK 328 (419)
Q Consensus 251 -~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 328 (419)
.....||+.|||||++.+..++.++|||||||++|||+| |+.||......+. ...+......
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~----------------~~~i~~~~~~ 229 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV----------------TAMLEKGERM 229 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH----------------HHHHHTTCCC
T ss_pred cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH----------------HHHHHcCCCC
Confidence 234568999999999999999999999999999999998 8999987654331 1122222233
Q ss_pred CCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 329 EGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 329 ~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
..+..++..+.+|+.+||+.||++|||+.+|++.|+...
T Consensus 230 ~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 230 GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence 445566778999999999999999999999999998764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-55 Score=405.60 Aligned_cols=258 Identities=25% Similarity=0.397 Sum_probs=207.3
Q ss_pred hcCccccCcccccCcEEEEEEEecCC-----CEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcce
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADG-----GIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~ 163 (419)
.+.|+..++||+|+||.||+|.++++ ..||||++... .......|.+|+.++++++|||||+++|++.+.+..+
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 35688899999999999999997543 36999998653 4445567999999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
+||||+.++++.+++..... .+++.++..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTT--CSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEecccCcchhhhhcccc--cccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999998876543 5899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCc--eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCC-CCChhhhccHHHHHHHHhcccchhH
Q 014725 244 KVDQT--HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIR-STDAEEDRSLVGFFLQAMNEDRLFE 320 (419)
Q Consensus 244 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (419)
..... .......||+.|||||++.+..++.++|||||||++|||+||..|+. .....+ +.+
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~----------------~~~ 224 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMK 224 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHH
T ss_pred cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH----------------HHH
Confidence 43322 22334568999999999999999999999999999999999665544 333221 122
Q ss_pred HHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 321 VLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 321 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.+........+..++..+.+|+.+||+.+|++|||+.||++.|+.+.+
T Consensus 225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 223333344555667789999999999999999999999999998765
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-56 Score=405.32 Aligned_cols=254 Identities=25% Similarity=0.386 Sum_probs=197.7
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEec--CCcceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLE--SEVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lv 165 (419)
++|++.+.||+|+||+||+|+. .+|+.||+|.+... ++...+.+.+|++++++++||||+++++++.+ .+..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 5799999999999999999997 45889999987643 44556779999999999999999999999865 4567899
Q ss_pred EeecCCCCHHHHhhccC-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC--CCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 166 YEFIPNGTLYHYLHDQT-EEFPITWEMRLRIAIEVSGAMSYLHSATS--IPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~--~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
|||+++|+|.+++.+.. ....+++..++.++.||+.||.|||+.+. .+|+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999997532 23359999999999999999999998752 3499999999999999999999999999987
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
..... .......||+.|||||++.+..++.++|||||||++|||+||+.||...+..+. ...+
T Consensus 164 ~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~-------~~~i--------- 226 (269)
T d2java1 164 LNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL-------AGKI--------- 226 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-------HHHH---------
T ss_pred cccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH-------HHHH---------
Confidence 65332 223456799999999999999999999999999999999999999987654321 1111
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
........+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 227 ~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 227 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111112233445567999999999999999999999975
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-56 Score=407.43 Aligned_cols=263 Identities=25% Similarity=0.364 Sum_probs=209.7
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
+++...++|++.+.||+|+||+||+|+++++..||||+++... ...+.|.+|+.++++++|||||++++++.+ +..++
T Consensus 11 ~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~l 88 (285)
T d1fmka3 11 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 88 (285)
T ss_dssp CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEE
Confidence 3334457899999999999999999999888899999987543 345789999999999999999999999854 56799
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
||||+++|+|.+++...... .++|.+++.++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++...
T Consensus 89 v~Ey~~~g~l~~~~~~~~~~-~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~ 164 (285)
T d1fmka3 89 VTEYMSKGSLLDFLKGETGK-YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE 164 (285)
T ss_dssp EECCCTTCBHHHHHSHHHHT-TCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred EEEecCCCchhhhhhhcccc-cchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhcc
Confidence 99999999999998764322 4899999999999999999999999 9999999999999999999999999998765
Q ss_pred cCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 245 VDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 245 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
...........||+.|+|||++....++.++|||||||++|||+||..|+........ +...+..
T Consensus 165 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~---------------~~~~i~~ 229 (285)
T d1fmka3 165 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---------------VLDQVER 229 (285)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---------------HHHHHHT
T ss_pred CCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH---------------HHHHHHh
Confidence 5444444556789999999999999999999999999999999997666543332211 1111112
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
....+.+..++..+.+++.+||+.||++|||+.+|+++|+....
T Consensus 230 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 230 GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 22234455566789999999999999999999999999988653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-55 Score=411.69 Aligned_cols=260 Identities=27% Similarity=0.436 Sum_probs=213.2
Q ss_pred HHHhcCccccCcccccCcEEEEEEEecCC------CEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEec
Q 014725 87 EKATDNYNANRILGQGGQGTVYKGMLADG------GIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCLE 158 (419)
Q Consensus 87 ~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~------~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~ 158 (419)
+...++|++.+.||+|+||+||+|++... ..||+|.+... .......+.+|+.++.++ +|||||++++++.+
T Consensus 33 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 33 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee
Confidence 34557899999999999999999996432 26899987543 334456789999999998 89999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTE--------------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRD 218 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~D 218 (419)
.+..++||||+++|+|.+++..... ...+++..++.++.||+.||.|||+++ |+|||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRD 189 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD 189 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecc
Confidence 9999999999999999999976432 135899999999999999999999998 99999
Q ss_pred CCCCcEEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCC
Q 014725 219 IKSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRS 296 (419)
Q Consensus 219 lkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~ 296 (419)
|||+|||++.++.+||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |..||.+
T Consensus 190 lKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~ 269 (325)
T d1rjba_ 190 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 269 (325)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCC
Confidence 9999999999999999999999876544332 3345668999999999999999999999999999999998 8999986
Q ss_pred CChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHH
Q 014725 297 TDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELE 364 (419)
Q Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~ 364 (419)
...... +.+++........+..++..+.+|+.+||+.||++|||+.||++.|.
T Consensus 270 ~~~~~~---------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 270 IPVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CCCSHH---------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCHHHH---------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 554321 11222222333445556678999999999999999999999999885
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-55 Score=404.79 Aligned_cols=251 Identities=24% Similarity=0.310 Sum_probs=208.8
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
+.|++.+.||+|+||+||+|++. ++..||||++........+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 56999999999999999999974 57899999987766666788999999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++|+|.+++.+... ++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 92 ~~g~L~~~~~~~~~--~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~ 165 (288)
T d2jfla1 92 AGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q 165 (288)
T ss_dssp TTEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred CCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence 99999999876433 5999999999999999999999999 9999999999999999999999999998654321 1
Q ss_pred eeecccccCCccCccccc-----cCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH
Q 014725 250 LTTRVQGTFGYLDPEYFR-----SSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA 324 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~-----~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (419)
......||+.|+|||++. +..++.++|||||||++|||+||+.||......+. ...+. ...
T Consensus 166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~---~~~i~---~~~-------- 231 (288)
T d2jfla1 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV---LLKIA---KSE-------- 231 (288)
T ss_dssp HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH---HHHHH---HSC--------
T ss_pred cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHH---HHHHH---cCC--------
Confidence 223467999999999984 45688999999999999999999999987654331 11111 000
Q ss_pred hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
......+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 232 PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0011223344567899999999999999999999865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-55 Score=400.01 Aligned_cols=260 Identities=25% Similarity=0.388 Sum_probs=204.7
Q ss_pred HHhcCccccCcccccCcEEEEEEEecC----CCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLAD----GGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
...++|++.+.||+|+||.||+|++.. +..||||.++.. .....+.|.+|+.++++++||||+++++++. .+..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 345789999999999999999998643 346899988653 3445678999999999999999999999996 4678
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~ 157 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY--SLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRY 157 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT--TSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------
T ss_pred EEEEEeccCCcHHhhhhccCC--CCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhhee
Confidence 999999999999998876543 5899999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
.............||+.|+|||++.+..++.++|||||||++|||+| |..||......+. . +.
T Consensus 158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~---~-------------~~ 221 (273)
T d1mp8a_ 158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---I-------------GR 221 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---H-------------HH
T ss_pred ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH---H-------------HH
Confidence 66544445556678999999999999999999999999999999998 8999987665431 1 11
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
+......+.+..++..+.+|+.+||+.||++|||+.||++.|+.+...
T Consensus 222 i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 222 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 111112234455667899999999999999999999999999988643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=394.18 Aligned_cols=246 Identities=24% Similarity=0.383 Sum_probs=197.8
Q ss_pred cccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEec----CCcceEEE
Q 014725 94 NANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLE----SEVPLLVY 166 (419)
Q Consensus 94 ~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 166 (419)
++.+.||+|+||+||+|.+. ++..||+|++.. ......+.|.+|+++|++++||||+++++++.+ ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 66778999999999999975 577899998754 345556789999999999999999999999865 34578999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC-CCCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD-DKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~-~~~~~kl~Dfgl~~~~~~ 245 (419)
||+++|+|.+++.+.. .+++..+..++.||+.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhccc---cccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 9999999999998654 4899999999999999999999976 3499999999999996 578999999999976432
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. ......||+.|||||++.+ .++.++|||||||++|||++|+.||........ .......+..
T Consensus 168 ~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~~~~------- 230 (270)
T d1t4ha_ 168 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTSGVK------- 230 (270)
T ss_dssp T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTTTCC-------
T ss_pred C---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH------HHHHHHcCCC-------
Confidence 2 2345679999999999875 699999999999999999999999975443221 1111111100
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+....+.+.+++.+||+.||++|||+.|+++
T Consensus 231 -~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 231 -PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp -CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred -CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 00111223346889999999999999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-55 Score=409.35 Aligned_cols=264 Identities=26% Similarity=0.398 Sum_probs=208.2
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
..++|++.+.||+|+||+||+|++. ++..||+|+++.. .....+.+.+|+.+|+.++|||||+++++|.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 4678999999999999999999974 5788999987643 3445578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
||+++|+|.+++.+.. .+++..+..++.|++.||.|||++ + |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EcCCCCcHHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCC
Confidence 9999999999998654 489999999999999999999974 7 99999999999999999999999999987543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHH-HH--------------
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGF-FL-------------- 310 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~-~~-------------- 310 (419)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+....... ..
T Consensus 158 ~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (322)
T d1s9ja_ 158 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 234 (322)
T ss_dssp H---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------------
T ss_pred C---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccc
Confidence 2 22346799999999999999999999999999999999999999987654322110000 00
Q ss_pred --------HHhcccchhHHHHHhhccC---CC-HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 311 --------QAMNEDRLFEVLEARVLKE---GK-EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 311 --------~~~~~~~~~~~~~~~~~~~---~~-~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+......... .+ ......+.+++.+||+.||.+|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~ 297 (322)
T d1s9ja_ 235 RPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297 (322)
T ss_dssp -----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence 0000001111111111110 01 112356889999999999999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-54 Score=401.85 Aligned_cols=264 Identities=26% Similarity=0.400 Sum_probs=217.3
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEe
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCL 157 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~ 157 (419)
+++...++|++.+.||+|+||+||+|++. ++..||||+++.. .....++|.+|+.+++.++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 45556788999999999999999999964 3468999998753 3344678999999999999999999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeee
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTE---------------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYH 216 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~---------------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH 216 (419)
+.+..+++|||+++|+|.+++..... ...+++..++.++.|++.||+|||+++ ++|
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 99999999999999999999975321 224889999999999999999999999 999
Q ss_pred cCCCCCcEEECCCCcEEEeecCCceecccCC-ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCC-CCC
Q 014725 217 RDIKSSNILLDDKYRAKVSDFGASRTIKVDQ-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ-KPI 294 (419)
Q Consensus 217 ~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~-~p~ 294 (419)
|||||+|||++.++.+||+|||+++...... ........||+.|+|||.+.+..++.++|||||||++|||++|. .||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998664332 22334567899999999999999999999999999999999985 577
Q ss_pred CCCChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcH
Q 014725 295 RSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIR 367 (419)
Q Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~ 367 (419)
......+. ...+. .......+..++..+.+|+.+||+.+|++||||.||+++|++|.
T Consensus 244 ~~~~~~e~-------~~~v~---------~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEV-------IYYVR---------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHH-------HHHHH---------TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHH-------HHHHH---------cCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 76655431 11111 11122334556678999999999999999999999999999874
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=398.85 Aligned_cols=249 Identities=23% Similarity=0.335 Sum_probs=206.7
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||+||+|.+ .+++.||||.+... .....+.+.+|++++++++||||+++++++.+.+..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 5699999999999999999997 46889999987531 2334577999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhccC---CCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 9999999999988654 4899999999999999999999999 999999999999999999999999999876533
Q ss_pred C-ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 247 Q-THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 247 ~-~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
. ........||+.|+|||++.+..++.++|||||||++|||+||+.||...+..+. ...+...
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~--------- 225 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-------FQKIIKL--------- 225 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTT---------
T ss_pred CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHH-------HHHHHcC---------
Confidence 2 2233456799999999999999999999999999999999999999987654321 1111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFE 362 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~ 362 (419)
....+...+..+.+|+.+||+.||.+|||+.|++..
T Consensus 226 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~ 261 (288)
T d1uu3a_ 226 -EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 261 (288)
T ss_dssp -CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence 112233445678999999999999999999998653
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.9e-54 Score=400.61 Aligned_cols=245 Identities=24% Similarity=0.369 Sum_probs=203.0
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC---hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD---ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
+.|+..+.||+|+||+||+|++ .+++.||||++.... ....+.+.+|+.+|++++|||||++++++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 4589999999999999999996 457789999876432 334567899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
|||++|+|..++.... ++++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++....
T Consensus 95 E~~~~g~l~~~~~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EecCCCchHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence 9999999987766543 5999999999999999999999999 99999999999999999999999999986533
Q ss_pred CceeeecccccCCccCcccccc---CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRS---SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.....||+.|||||++.+ ..|+.++|||||||++|||++|..||......+. .. .+..
T Consensus 168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~---------~i~~ 228 (309)
T d1u5ra_ 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LY---------HIAQ 228 (309)
T ss_dssp ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH---------HHHH
T ss_pred ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HH---------HHHh
Confidence 234569999999999864 4689999999999999999999999976554321 11 1111
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.......+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 229 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 229 NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp SCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 11111122334567899999999999999999999975
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-54 Score=391.94 Aligned_cols=252 Identities=28% Similarity=0.446 Sum_probs=204.5
Q ss_pred hcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEec-CCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLE-SEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 168 (419)
.++|++.+.||+|+||.||+|.++ |..||||+++.. ...+.|.+|++++++++||||++++|+|.+ .+..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence 456888999999999999999984 778999998653 345789999999999999999999999865 4568999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+++|+|.+++..... ..+++..+++++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred cCCCCHHHHHHhcCC-CCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence 999999999976432 24899999999999999999999998 999999999999999999999999999865432
Q ss_pred eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhhc
Q 014725 249 HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARVL 327 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (419)
.....+|+.|+|||++.+..++.++|||||||++|||+| |+.||......+. ...+.....
T Consensus 157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~----------------~~~i~~~~~ 218 (262)
T d1byga_ 157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------VPRVEKGYK 218 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH----------------HHHHTTTCC
T ss_pred --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH----------------HHHHHcCCC
Confidence 223457899999999999999999999999999999998 7888876544321 111112223
Q ss_pred cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 328 KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 328 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.+.+...+..+.+|+.+||+.||.+|||+.+|++.|++++.
T Consensus 219 ~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 219 MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence 34455566789999999999999999999999999999875
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.7e-53 Score=402.10 Aligned_cols=252 Identities=21% Similarity=0.276 Sum_probs=210.3
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|++.+.||+|+||.||+|++ .+|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46899999999999999999997 46889999998876666778899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC--CCCcEEEeecCCceecccC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD--DKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfgl~~~~~~~ 246 (419)
|++|+|.+++.+... .+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 105 ~~gg~L~~~l~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTTS--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence 999999999975432 4999999999999999999999999 99999999999995 4678999999999876543
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. ......||+.|||||++.+..++.++|||||||++|||+||+.||.+.+..+. ...+.... .. .
T Consensus 180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i~~~~--~~--------~ 244 (350)
T d1koaa2 180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKSCD--WN--------M 244 (350)
T ss_dssp S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHTC--CC--------S
T ss_pred c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHHHhCC--CC--------C
Confidence 2 33456799999999999999999999999999999999999999987654321 11111000 00 0
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
........+..+.+|+.+||+.||++|||+.|+++
T Consensus 245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 01111233456889999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-53 Score=398.58 Aligned_cols=256 Identities=26% Similarity=0.490 Sum_probs=209.5
Q ss_pred cCccccCcccccCcEEEEEEEecC-CC----EEEEEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLAD-GG----IVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~-~~----~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l 164 (419)
.+|++.+.||+|+||+||+|.+.. |+ +||+|+++. ......+.|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 459999999999999999999643 33 589998764 3344567899999999999999999999999865 5678
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecc
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIK 244 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~ 244 (419)
++||+.+|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHHTSS--SCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCccccccccccc--CCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999998887543 5899999999999999999999998 9999999999999999999999999998765
Q ss_pred cCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchhHHH
Q 014725 245 VDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVL 322 (419)
Q Consensus 245 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (419)
...... .....||+.|+|||++.++.++.++|||||||++|||+| |..||......+ +...+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----------------~~~~i 226 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSIL 226 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----------------HHHHH
T ss_pred cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHH
Confidence 433322 334568999999999999999999999999999999999 899998765433 22222
Q ss_pred HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 323 EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 323 ~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
........+..++..+.+|+.+||+.||.+|||+.||++.|+.+..
T Consensus 227 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 227 EKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence 2333334455666789999999999999999999999999988754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-53 Score=397.83 Aligned_cols=252 Identities=22% Similarity=0.309 Sum_probs=192.5
Q ss_pred HhcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCC-hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 89 ATDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVD-ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
..+.|++.+.||+|+||+||+|++. +++.||||.+.... ......+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 3567999999999999999999975 57899999876432 233456889999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCceec
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD---DKYRAKVSDFGASRTI 243 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfgl~~~~ 243 (419)
||++||+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++ +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHHTCS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred eccCCCcHHHhhhccc---CCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 9999999999997643 5999999999999999999999999 99999999999994 5789999999999865
Q ss_pred ccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE 323 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (419)
.... .....+||+.|||||++.+..++.++|||||||++|||++|+.||......+. ...+ .... .
T Consensus 161 ~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~~i---~~~~-~----- 226 (307)
T d1a06a_ 161 DPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---FEQI---LKAE-Y----- 226 (307)
T ss_dssp --------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHH---HTTC-C-----
T ss_pred cCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHH---hccC-C-----
Confidence 4322 23446799999999999999999999999999999999999999987554321 1111 1100 0
Q ss_pred HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..........+..+.+++.+||+.||.+|||+.|+++
T Consensus 227 -~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 227 -EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp -CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred -CCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 0011122344567899999999999999999999976
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=6.6e-53 Score=399.77 Aligned_cols=252 Identities=21% Similarity=0.283 Sum_probs=211.6
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|++.+.||+|+||.||+|.. .+++.||||.+........+.+.+|+.+|++++||||+++++++.+++..|+||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 46799999999999999999997 46889999998766666667889999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC--CCCcEEEeecCCceecccC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD--DKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~--~~~~~kl~Dfgl~~~~~~~ 246 (419)
|++|+|.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.....
T Consensus 108 ~~gg~L~~~~~~~~~--~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTTC--CBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCChHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence 999999998876433 4999999999999999999999999 99999999999997 6789999999999886543
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
. ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+. ...+.... ...
T Consensus 183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-------~~~i~~~~------~~~ 247 (352)
T d1koba_ 183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET-------LQNVKRCD------WEF 247 (352)
T ss_dssp S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH-------HHHHHHCC------CCC
T ss_pred C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-------HHHHHhCC------CCC
Confidence 3 33445789999999999999999999999999999999999999987655431 11110000 001
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
........+..+.+|+.+||+.||.+|||+.|+++
T Consensus 248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11122344567899999999999999999999976
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-53 Score=394.18 Aligned_cols=270 Identities=27% Similarity=0.375 Sum_probs=209.6
Q ss_pred CHHHHHHHhcCccccCcccccCcEEEEEEEecC------CCEEEEEEccc-CChhhHHHHHHHHHHHhcC-CCcccccEE
Q 014725 82 TKMDLEKATDNYNANRILGQGGQGTVYKGMLAD------GGIVAVKKSKL-VDESNVEQFINEVVILSQI-NHRNVVKLL 153 (419)
Q Consensus 82 ~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~------~~~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~ 153 (419)
....++...++|++.+.||+|+||.||+|.+.. ++.||||+++. ......+.+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 344555566789999999999999999999642 35799999864 3344566788888888777 689999999
Q ss_pred eEEecC-CcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCC
Q 014725 154 GCCLES-EVPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDI 219 (419)
Q Consensus 154 ~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dl 219 (419)
+++.+. ...++|||||++|+|.+++..... ...+++..+..++.||+.||.|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence 998764 467999999999999999975421 235899999999999999999999999 999999
Q ss_pred CCCcEEECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHhC-CCCCCCC
Q 014725 220 KSSNILLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG-QKPIRST 297 (419)
Q Consensus 220 kp~Nill~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg-~~p~~~~ 297 (419)
||+|||+++++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+|| ..||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999876543322 33456799999999999999999999999999999999996 5677655
Q ss_pred ChhhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 298 DAEEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
...+. +...+........+...+..+.+++.+||+.||++|||+.||++.|+++.++
T Consensus 241 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~ 297 (299)
T d1ywna1 241 KIDEE---------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297 (299)
T ss_dssp CCSHH---------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CHHHH---------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence 43221 1122222223334455567799999999999999999999999999988653
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-53 Score=389.93 Aligned_cols=256 Identities=26% Similarity=0.395 Sum_probs=201.8
Q ss_pred hcCccccCcccccCcEEEEEEEecC--C--CEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLAD--G--GIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~~--~--~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
.++|++.+.||+|+||.||+|++.. + ..||||+++.. .....+.|.+|+.+|++++||||++++|++.+ +..
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence 3569999999999999999998632 2 36899987642 34456789999999999999999999999975 567
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
++||||+++|++.+++..... .+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~--~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~ 160 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA 160 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG--GSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred heeeeeecCcchhhhhhcccC--CCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhh
Confidence 899999999999998876543 4999999999999999999999998 99999999999999999999999999998
Q ss_pred cccCCcee--eecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 243 IKVDQTHL--TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 243 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
........ .....|+..|+|||++.+..++.++|||||||++|||+| |+.||...+..+. . ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~-~~i------ 227 (273)
T d1u46a_ 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------L-HKI------ 227 (273)
T ss_dssp CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------H-HHH------
T ss_pred cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH------H-HHH------
Confidence 75443322 234567889999999999999999999999999999998 8999987665432 1 111
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
.......+.+...+..+.+|+.+||+.||++|||+.+|++.|++.
T Consensus 228 --~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 228 --DKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp --HTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred --HhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 111112233445566799999999999999999999999988764
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=388.46 Aligned_cols=251 Identities=27% Similarity=0.344 Sum_probs=206.4
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC------ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV------DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
.++|++.+.||+|+||+||+|++ .+|+.||||.+... .....+.+.+|+.+|++++|||||++++++.+.+..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 47899999999999999999997 46889999987532 122467899999999999999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC----cEEEeecC
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY----RAKVSDFG 238 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~----~~kl~Dfg 238 (419)
++|||||++|+|.+++.... .+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEEcCCCccccchhcccc---ccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence 99999999999999998754 4999999999999999999999999 99999999999998776 59999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
+++...... ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+. ...+.....
T Consensus 163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~-------~~~i~~~~~ 233 (293)
T d1jksa_ 163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET-------LANVSAVNY 233 (293)
T ss_dssp TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHTTCC
T ss_pred hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH-------HHHHHhcCC
Confidence 998764332 23445689999999999999999999999999999999999999987654331 111111000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. . .. ..+...+..+.+|+.+||+.||++|||+.|+++
T Consensus 234 ~-~-~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 234 E-F-ED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp C-C-CH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C-C-Cc----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0 00 001122356889999999999999999999975
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-52 Score=389.01 Aligned_cols=258 Identities=29% Similarity=0.446 Sum_probs=208.4
Q ss_pred cCcccccCcEEEEEEEecCC----CEEEEEEccc-CChhhHHHHHHHHHHHhcCCCcccccEEeEEec-CCcceEEEeec
Q 014725 96 NRILGQGGQGTVYKGMLADG----GIVAVKKSKL-VDESNVEQFINEVVILSQINHRNVVKLLGCCLE-SEVPLLVYEFI 169 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~~~----~~vavK~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~~ 169 (419)
.++||+|+||+||+|++.++ ..||||+++. .+....++|.+|+++|++++||||++++|++.+ ++..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997442 2589999864 455667889999999999999999999999875 45789999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
++|+|.+++..... .+++..+++++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~~--~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNETH--NPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTTC--CCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ecCchhhhhccccc--cchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence 99999999886543 4788899999999999999999999 999999999999999999999999999876543222
Q ss_pred ---eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 250 ---LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 250 ---~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
......||+.|+|||.+.+..++.++||||||+++|||+||..||....... ..... +....
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~-------------i~~g~ 251 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVY-------------LLQGR 251 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH-------------HHTTC
T ss_pred cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHH-------------HHcCC
Confidence 2233568999999999999999999999999999999999888876433211 11111 11111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCC
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSS 373 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~ 373 (419)
....+..++..+.+|+.+||+.||++||++.||++.|+++......+
T Consensus 252 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~ 298 (311)
T d1r0pa_ 252 RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 298 (311)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence 22234445667999999999999999999999999999998765443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-52 Score=389.96 Aligned_cols=258 Identities=26% Similarity=0.411 Sum_probs=208.9
Q ss_pred cCccccCcccccCcEEEEEEEecCC-C--EEEEEEccc-CChhhHHHHHHHHHHHhcC-CCcccccEEeEEecCCcceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADG-G--IVAVKKSKL-VDESNVEQFINEVVILSQI-NHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~-~--~vavK~~~~-~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lv 165 (419)
++|++.+.||+|+||+||+|++.++ . .||||++.. ......+.|.+|+++|+++ +||||+++++++.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 6788899999999999999997543 3 478888754 3344567899999999998 799999999999999999999
Q ss_pred EeecCCCCHHHHhhccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcE
Q 014725 166 YEFIPNGTLYHYLHDQT-------------EEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRA 232 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~ 232 (419)
|||+++|+|.++++... ....+++..++.++.||+.||.|||+++ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 99999999999997541 2346999999999999999999999998 9999999999999999999
Q ss_pred EEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCC-CCCCCCChhhhccHHHHHHH
Q 014725 233 KVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQ-KPIRSTDAEEDRSLVGFFLQ 311 (419)
Q Consensus 233 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~-~p~~~~~~~~~~~~~~~~~~ 311 (419)
||+|||+++...... ......||..|+|||.+.+..++.++|||||||++|||++|. .||...+..+ +..
T Consensus 167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~ 237 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 237 (309)
T ss_dssp EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH
T ss_pred EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHH
Confidence 999999998654222 123446899999999999999999999999999999999965 5676655433 111
Q ss_pred HhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHh
Q 014725 312 AMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRAS 369 (419)
Q Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~ 369 (419)
.+........+...+..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus 238 ---------~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 ---------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp ---------HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ---------HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence 1111222334455667899999999999999999999999999998753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-52 Score=390.87 Aligned_cols=248 Identities=25% Similarity=0.301 Sum_probs=209.2
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEE
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv 165 (419)
.++|++.+.||+|+||.||+|+. .+++.||||++... .....+.+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 36799999999999999999996 56889999987532 233457789999999999999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.+|.+||+|||+++....
T Consensus 84 ~ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred eeccCCCchhhhhhccc---CCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeeccccccccc
Confidence 99999999999998754 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...+..+. .......
T Consensus 158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~-------~~~i~~~--------- 220 (337)
T d1o6la_ 158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL-------FELILME--------- 220 (337)
T ss_dssp TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHC---------
T ss_pred CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHH-------HHHHhcC---------
Confidence 22 233456799999999999999999999999999999999999999987665331 1111111
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
....+...+..+.+|+.+||+.||.+||+ +.|+++
T Consensus 221 -~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 221 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 12234445567899999999999999995 677765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=387.75 Aligned_cols=262 Identities=28% Similarity=0.433 Sum_probs=213.4
Q ss_pred HHhcCccccCcccccCcEEEEEEEecC--------CCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEEe
Q 014725 88 KATDNYNANRILGQGGQGTVYKGMLAD--------GGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCCL 157 (419)
Q Consensus 88 ~~~~~y~~~~~ig~G~fg~Vy~~~~~~--------~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~ 157 (419)
...++|.+.+.||+|+||.||+|+... +..||||+++.. ......++.+|...+.++ +||||++++++|.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 445789999999999999999998532 237999998653 344567889999999888 7999999999999
Q ss_pred cCCcceEEEeecCCCCHHHHhhccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcE
Q 014725 158 ESEVPLLVYEFIPNGTLYHYLHDQTE-------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNI 224 (419)
Q Consensus 158 ~~~~~~lv~e~~~~g~L~~~l~~~~~-------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Ni 224 (419)
+++..++||||+++|+|.+++..... ...+++.+++.++.||+.||+|||+++ |+||||||+||
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~Ni 166 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV 166 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccce
Confidence 99999999999999999999976432 235899999999999999999999999 99999999999
Q ss_pred EECCCCcEEEeecCCceecccCCce-eeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCChhhh
Q 014725 225 LLDDKYRAKVSDFGASRTIKVDQTH-LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDAEED 302 (419)
Q Consensus 225 ll~~~~~~kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~~~~ 302 (419)
|++.++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+| |..||........
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 9999999999999999977543322 2345668999999999999999999999999999999998 7889876655321
Q ss_pred ccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 303 RSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.+.+........+...+..+.+|+.+||+.||.+|||+.||++.|++|.+
T Consensus 247 ----------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 247 ----------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp ----------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----------------HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 11222222333444556779999999999999999999999999999854
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=390.25 Aligned_cols=266 Identities=27% Similarity=0.420 Sum_probs=220.1
Q ss_pred HHHHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcC-CCcccccEEeEE
Q 014725 85 DLEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQI-NHRNVVKLLGCC 156 (419)
Q Consensus 85 ~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~ 156 (419)
.++...++|++.+.||+|+||.||+|++. ++..||||+++.. .......|.+|+.+++.+ +|||||+++++|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 34556688999999999999999999853 3458999998753 344566799999999999 699999999999
Q ss_pred ecCCcceEEEeecCCCCHHHHhhccCC---------------CCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCC
Q 014725 157 LESEVPLLVYEFIPNGTLYHYLHDQTE---------------EFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKS 221 (419)
Q Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~---------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp 221 (419)
.+.+..++||||+++|+|.+++..... ...+++..+..++.||+.||+|||+++ ++||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccccc
Confidence 999999999999999999999976431 235899999999999999999999999 99999999
Q ss_pred CcEEECCCCcEEEeecCCceecccCCc-eeeecccccCCccCccccccCCCCcccceechhHHHHHHHh-CCCCCCCCCh
Q 014725 222 SNILLDDKYRAKVSDFGASRTIKVDQT-HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLT-GQKPIRSTDA 299 (419)
Q Consensus 222 ~Nill~~~~~~kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~t-g~~p~~~~~~ 299 (419)
+||+++.++.+|++|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.....
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999997654333 33455679999999999999999999999999999999999 5555654433
Q ss_pred hhhccHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHH
Q 014725 300 EEDRSLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRA 368 (419)
Q Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~ 368 (419)
.+. +.+++........+...+..+.+|+.+||+.||.+|||+.+|+++|+++..
T Consensus 254 ~~~---------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 254 DSK---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp SHH---------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHH---------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 221 222333333344455566789999999999999999999999999987654
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.6e-52 Score=382.74 Aligned_cols=259 Identities=28% Similarity=0.373 Sum_probs=205.6
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCc----
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEV---- 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~---- 161 (419)
.++|++.+.||+|+||+||+|++ .+++.||||.++.. +....+.+.+|+.+++.++||||+++++++...+.
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 47899999999999999999996 46889999998642 34455679999999999999999999999876543
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.|+||||++|++|.+++.... ++++.++..++.||+.||.|||+++ |+||||||+|||++.++..+++|||.++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcccC---CCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 789999999999999987654 4899999999999999999999999 9999999999999999999999999987
Q ss_pred ecccCC--ceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 242 TIKVDQ--THLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 242 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||......+. .......+..
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~~- 232 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDPI- 232 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCCC-
T ss_pred hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCCC-
Confidence 654322 2233456799999999999999999999999999999999999999987654321 1111111110
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCC-CHHHHHHHHHhcH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRP-SMKEVAFELEGIR 367 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~evl~~L~~i~ 367 (419)
.........+..+.+++.+||+.||.+|| |++++++.|.+++
T Consensus 233 ------~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 233 ------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp ------CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ------CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 00111223456789999999999999999 8999999988764
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-52 Score=388.68 Aligned_cols=268 Identities=26% Similarity=0.410 Sum_probs=219.8
Q ss_pred ccCHHHHHHHhcCccccCcccccCcEEEEEEEec------CCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccE
Q 014725 80 LFTKMDLEKATDNYNANRILGQGGQGTVYKGMLA------DGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKL 152 (419)
Q Consensus 80 ~~~~~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l 152 (419)
.+-.++++...++|.+.+.||+|+||.||+|.+. ++..||||+++.. .......|.+|+.++++++||||+++
T Consensus 9 ~~~~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~ 88 (308)
T d1p4oa_ 9 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL 88 (308)
T ss_dssp CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred CcCccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeee
Confidence 3444556666789999999999999999999863 2468999998643 44455679999999999999999999
Q ss_pred EeEEecCCcceEEEeecCCCCHHHHhhcc-------CCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEE
Q 014725 153 LGCCLESEVPLLVYEFIPNGTLYHYLHDQ-------TEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNIL 225 (419)
Q Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nil 225 (419)
++++...+..++||||+++|+|.+++... .....+++..+.+++.|+++||.|||+++ |+||||||+|||
T Consensus 89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiL 165 (308)
T d1p4oa_ 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM 165 (308)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCcee
Confidence 99999999999999999999999998642 12234789999999999999999999998 999999999999
Q ss_pred ECCCCcEEEeecCCceecccCCcee-eecccccCCccCccccccCCCCcccceechhHHHHHHHhC-CCCCCCCChhhhc
Q 014725 226 LDDKYRAKVSDFGASRTIKVDQTHL-TTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTG-QKPIRSTDAEEDR 303 (419)
Q Consensus 226 l~~~~~~kl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg-~~p~~~~~~~~~~ 303 (419)
++.++++||+|||+++......... .....||+.|+|||.+.+..++.++||||||+++|||+|| ..||......+.
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~- 244 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV- 244 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHH-
T ss_pred ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 9999999999999998765433322 3444689999999999999999999999999999999998 477766544321
Q ss_pred cHHHHHHHHhcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhc
Q 014725 304 SLVGFFLQAMNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGI 366 (419)
Q Consensus 304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i 366 (419)
...+........+..++..+.+++.+||+.+|++|||+.+|++.|++.
T Consensus 245 ---------------~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~ 292 (308)
T d1p4oa_ 245 ---------------LRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292 (308)
T ss_dssp ---------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred ---------------HHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence 111111122333445567899999999999999999999999999875
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-51 Score=386.05 Aligned_cols=244 Identities=26% Similarity=0.357 Sum_probs=206.5
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC---ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV---DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||+||+|++ .+|+.||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5699999999999999999997 45889999987532 2334578999999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||++||+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccccc---cccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 9999999999988654 4788899999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
....+||+.|||||++.+..++.++|||||||++|||+||+.||...+..+. ... +...
T Consensus 158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~--------i~~~-- 216 (316)
T d1fota_ 158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT-------YEK--------ILNA-- 216 (316)
T ss_dssp ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH-------HHH--------HHHC--
T ss_pred ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHH-------HHH--------HHcC--
Confidence 2346799999999999999999999999999999999999999987654321 111 1111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+|| |+.++++
T Consensus 217 ~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 217 ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 1122334456789999999999999996 8888875
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.4e-51 Score=375.63 Aligned_cols=251 Identities=26% Similarity=0.388 Sum_probs=205.7
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC---------hhhHHHHHHHHHHHhcCC-CcccccEEeEEec
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD---------ESNVEQFINEVVILSQIN-HRNVVKLLGCCLE 158 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~ 158 (419)
.++|++.+.||+|+||+||+|+. .+++.||||++.... ....+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999997 467899999875432 112346889999999997 9999999999999
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
++..|+||||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CcceEEEEEcCCCchHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccch
Confidence 999999999999999999998654 5999999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCceeeecccccCCccCcccccc------CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHH
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRS------SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQA 312 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~ 312 (419)
+++...... ......||+.|+|||.+.+ ..++.++||||+||++|||+||+.||........ ...+..
T Consensus 156 ~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~---~~~i~~- 229 (277)
T d1phka_ 156 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM---LRMIMS- 229 (277)
T ss_dssp TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHH-
T ss_pred heeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH---HHHHHh-
Confidence 998765432 2344679999999999863 3568899999999999999999999987654331 111110
Q ss_pred hcccchhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 313 MNEDRLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... ..........++.+.+++.+||+.||.+|||+.||++
T Consensus 230 ---~~~------~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 230 ---GNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---TCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---CCC------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000 0011112244567999999999999999999999864
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.4e-51 Score=386.54 Aligned_cols=244 Identities=23% Similarity=0.293 Sum_probs=206.8
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc---CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL---VDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 166 (419)
++|++.+.||+|+||.||+|++ .+|+.||||++.. ......+.+.+|+.+|+.++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999997 4688999998753 12334577899999999999999999999999999999999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccC
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~ 246 (419)
||+.+|+|..++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 9999999999998754 4899999999999999999999999 999999999999999999999999999876432
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHhh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEARV 326 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 326 (419)
.....||+.|||||++.+..++.++|||||||++|||+||+.||.+.+.... ...+ ...
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-------~~~i--------~~~-- 253 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI-------YEKI--------VSG-- 253 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHH--------HHC--
T ss_pred ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH-------HHHH--------hcC--
Confidence 2345799999999999999999999999999999999999999987654321 1111 111
Q ss_pred ccCCCHHHHHHHHHHHHHHhccCCCCCC-----CHHHHHH
Q 014725 327 LKEGKEEEIITVAMLGKRCLNMIGKKRP-----SMKEVAF 361 (419)
Q Consensus 327 ~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~evl~ 361 (419)
....+...+..+.+++.+||+.||.+|+ |+.++++
T Consensus 254 ~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 254 KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence 1122334556789999999999999994 8888875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-51 Score=382.59 Aligned_cols=250 Identities=22% Similarity=0.289 Sum_probs=206.3
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
.++|.+.+.||+|+||+||+|.+. +++.||||.++.... ....+.+|+++|+.++||||+++++++.+.+..|+||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence 578999999999999999999975 577899999876443 345688999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC--CCcEEEeecCCceecccC
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD--KYRAKVSDFGASRTIKVD 246 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~--~~~~kl~Dfgl~~~~~~~ 246 (419)
|+||+|.+++..... .+++.++..++.||+.||.|||+++ |+||||||+|||++. ...+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~~--~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSAF--ELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 999999999976532 4899999999999999999999999 999999999999975 458999999999876433
Q ss_pred CceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc-chhHHHHHh
Q 014725 247 QTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED-RLFEVLEAR 325 (419)
Q Consensus 247 ~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 325 (419)
. ......+|+.|+|||.+.+..++.++|||||||++|+|++|..||......+. +....+.. .....
T Consensus 158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~---- 225 (321)
T d1tkia_ 158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYTFDEE---- 225 (321)
T ss_dssp C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCCCCHH----
T ss_pred C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCCChh----
Confidence 2 23445689999999999999999999999999999999999999987654321 11111100 00000
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
. ....+..+.+|+.+||..||.+|||+.|+++
T Consensus 226 ~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 226 A----FKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp H----HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred h----ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 0112346889999999999999999999987
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-51 Score=383.47 Aligned_cols=268 Identities=21% Similarity=0.299 Sum_probs=200.9
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHH--HHhcCCCcccccEEeEEecCC----cceE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVV--ILSQINHRNVVKLLGCCLESE----VPLL 164 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~--~l~~l~h~niv~l~~~~~~~~----~~~l 164 (419)
+.|.+.+.||+|+||+||+|++ +|+.||||++... ..+.+..|.+ .+..++||||+++++++.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 4577889999999999999997 5789999998643 2344444444 455779999999999998654 4689
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSAT-----SIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
||||+++|+|.+++++. .++|..+++++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 99999999999999864 3899999999999999999999741 23399999999999999999999999999
Q ss_pred ceecccCCce---eeecccccCCccCccccccC------CCCcccceechhHHHHHHHhCCCCCCCCChhhh--------
Q 014725 240 SRTIKVDQTH---LTTRVQGTFGYLDPEYFRSS------QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEED-------- 302 (419)
Q Consensus 240 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~-------- 302 (419)
++........ ......||+.|+|||++.+. .++.++|||||||+||||+||..||........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~ 234 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence 9987544322 22456799999999998754 367899999999999999999988754322110
Q ss_pred ccHHHHHHHHhcccchhHHHHHhh-ccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhh
Q 014725 303 RSLVGFFLQAMNEDRLFEVLEARV-LKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASI 370 (419)
Q Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~ 370 (419)
.............+.. .+.. ....+.+....+.+|+.+||+.||.+|||+.||++.|+++....
T Consensus 235 ~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~ 299 (303)
T d1vjya_ 235 DPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE 299 (303)
T ss_dssp SCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred cchHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhc
Confidence 0001111111111000 0000 01112345667999999999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-50 Score=386.36 Aligned_cols=249 Identities=21% Similarity=0.285 Sum_probs=200.3
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHH---HHHHHHhcCCCcccccEEeEEecCCcc
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFI---NEVVILSQINHRNVVKLLGCCLESEVP 162 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~ 162 (419)
.++|++.+.||+|+||.||+|++. +|+.||||.+... .......+. +|+.+++.++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 367999999999999999999974 5889999987421 111222333 457778888999999999999999999
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
|+||||+++|+|.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+||+|||+++.
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEecCCCcHHHHHHhcc---cccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeee
Confidence 99999999999999998754 4889999999999999999999999 99999999999999999999999999987
Q ss_pred cccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHH
Q 014725 243 IKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEV 321 (419)
Q Consensus 243 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (419)
..... .....||+.|+|||++.. ..++.++|||||||++|||+||+.||......+... .......
T Consensus 157 ~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----~~~~~~~------ 223 (364)
T d1omwa3 157 FSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLT------ 223 (364)
T ss_dssp CSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH----HHHHSSS------
T ss_pred cCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhccc------
Confidence 65432 334579999999999865 568999999999999999999999998654432110 1111100
Q ss_pred HHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 322 LEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 322 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
.....+...+..+.+|+.+||+.||.+||| +.|+++
T Consensus 224 ----~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 224 ----MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 011223345567899999999999999999 577754
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-51 Score=382.58 Aligned_cols=247 Identities=25% Similarity=0.337 Sum_probs=205.2
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEcccC---ChhhHHHHHHHHHHHh-cCCCcccccEEeEEecCCcceEE
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLV---DESNVEQFINEVVILS-QINHRNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lv 165 (419)
++|.+.+.||+|+||+||+|++. +++.||||++... .....+.+..|..++. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 67999999999999999999974 5788999997531 2233456777777665 68999999999999999999999
Q ss_pred EeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceeccc
Q 014725 166 YEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKV 245 (419)
Q Consensus 166 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~ 245 (419)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 99999999999998654 4899999999999999999999999 99999999999999999999999999986543
Q ss_pred CCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHHh
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEAR 325 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (419)
.. .......||+.|+|||++.+..++.++|||||||++|||+||+.||.+.+..+. .......
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~-------~~~i~~~--------- 218 (320)
T d1xjda_ 156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL-------FHSIRMD--------- 218 (320)
T ss_dssp TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-------HHHHHHC---------
T ss_pred cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH-------HHHHHcC---------
Confidence 32 233446799999999999999999999999999999999999999987655431 1111101
Q ss_pred hccCCCHHHHHHHHHHHHHHhccCCCCCCCHH-HHHH
Q 014725 326 VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMK-EVAF 361 (419)
Q Consensus 326 ~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-evl~ 361 (419)
....+...+..+.+|+.+||+.||.+|||+. ++++
T Consensus 219 -~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 219 -NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred -CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 1122334456789999999999999999995 6754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-50 Score=375.29 Aligned_cols=256 Identities=21% Similarity=0.248 Sum_probs=194.7
Q ss_pred cCcccccCcEEEEEEEec-CCCEEEEEEcccCChh-----hHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEeec
Q 014725 96 NRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDES-----NVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEFI 169 (419)
Q Consensus 96 ~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 169 (419)
+++||+|+||+||+|++. +++.||||+++..... ..+.+.+|+.+++.++|||||++++++.+++..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 578999999999999974 5889999987643221 1246889999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCce
Q 014725 170 PNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQTH 249 (419)
Q Consensus 170 ~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~~ 249 (419)
.++++..+.... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred cchHHhhhhhcc---cCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence 888777665433 25888899999999999999999999 99999999999999999999999999987544322
Q ss_pred eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc---ccchhHHHHH-
Q 014725 250 LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN---EDRLFEVLEA- 324 (419)
Q Consensus 250 ~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~- 324 (419)
.....+||+.|+|||++.. ..++.++|||||||++|||+||..||......+.. ..+..... ...+......
T Consensus 156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~ 232 (299)
T d1ua2a_ 156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLP 232 (299)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSST
T ss_pred cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccc
Confidence 2334579999999999865 46799999999999999999999999876654321 11111110 0000000000
Q ss_pred -----hhccCCC-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 -----RVLKEGK-----EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 -----~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
......+ ......+.+|+.+||+.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence 0000000 122356889999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-50 Score=381.20 Aligned_cols=252 Identities=23% Similarity=0.286 Sum_probs=198.1
Q ss_pred hcCccccC-cccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhc-CCCcccccEEeEEec----CCcc
Q 014725 90 TDNYNANR-ILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQ-INHRNVVKLLGCCLE----SEVP 162 (419)
Q Consensus 90 ~~~y~~~~-~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~ 162 (419)
.++|.+.. .||+|+||+||+|++ .+++.||||+++. ...+.+|+.++.+ .+||||+++++++.+ +...
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence 46788764 699999999999996 5688999999863 2457789988655 489999999999865 4567
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC---CCcEEEeecCC
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD---KYRAKVSDFGA 239 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~---~~~~kl~Dfgl 239 (419)
|+|||||+||+|.+++..... ..+++.++..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCcHHHHHHhcCC-CCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence 999999999999999986532 35999999999999999999999999 999999999999975 56799999999
Q ss_pred ceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
++...... ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||.+....... .............
T Consensus 161 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~---~~~~~~i~~~~~~ 235 (335)
T d2ozaa1 161 AKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYE 235 (335)
T ss_dssp CEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSCSSS
T ss_pred eeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHH---HHHHHHHhcCCCC
Confidence 98765432 234567999999999999999999999999999999999999999765432210 0011111111000
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.........+..+.+|+.+||+.||++|||+.|+++
T Consensus 236 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 236 ------FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp ------CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred ------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 000001233467899999999999999999999976
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=372.84 Aligned_cols=263 Identities=24% Similarity=0.336 Sum_probs=200.0
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|++.+.||+|+||+||+|.+ .+++.||||+++... +...+.+.+|+++|++++||||+++++++.+.+..|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999997 568899999986432 2335788999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
|+.+ ++.+++..... ..+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~~~~-~~~~~~~~~~~-~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASAL-TGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSE-EHHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ecCC-chhhhhhhhcc-cCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence 9965 45555543322 25999999999999999999999999 9999999999999999999999999998764332
Q ss_pred ceeeecccccCCccCccccccCC-CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc--chhHHHHH
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED--RLFEVLEA 324 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 324 (419)
.......||+.|+|||.+.... ++.++|||||||++|+|++|+.||...+..+. +........... .+......
T Consensus 157 -~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 -RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp -BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGS
T ss_pred -ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhccccccc
Confidence 2234456999999999877655 58899999999999999999999987654332 111111111100 00000000
Q ss_pred -hhccC------C-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 -RVLKE------G-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 -~~~~~------~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..... . .......+.+++.+||+.||++|||+.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~ 282 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence 00000 0 0122356889999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-50 Score=369.97 Aligned_cols=264 Identities=21% Similarity=0.280 Sum_probs=202.1
Q ss_pred cCccccCcccccCcEEEEEEEecCCCEEEEEEcccCC--hhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEee
Q 014725 91 DNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVD--ESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYEF 168 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 168 (419)
++|++.+.||+|+||+||+|++.+++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 6899999999999999999999889999999986532 33357899999999999999999999999999999999999
Q ss_pred cCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCCc
Q 014725 169 IPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQT 248 (419)
Q Consensus 169 ~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~~ 248 (419)
+.++.+..+..... .+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTSTT---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred ehhhhHHHHHhhcC---CcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence 98777766655432 5999999999999999999999998 99999999999999999999999999987643322
Q ss_pred eeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHHH---
Q 014725 249 HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLEA--- 324 (419)
Q Consensus 249 ~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 324 (419)
......+++.|+|||.+.+. .++.++|||||||++|||++|+.||......+................+......
T Consensus 156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T d1ob3a_ 156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234 (286)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence 23344689999999998754 5689999999999999999999999876543321111111000001111000000
Q ss_pred ---------hhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 325 ---------RVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 325 ---------~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.............+.+++.+||+.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000111223457889999999999999999999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-50 Score=369.85 Aligned_cols=240 Identities=25% Similarity=0.421 Sum_probs=196.6
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCC---h---hhHHHHHHHHHHHhcCC--CcccccEEeEEecCC
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVD---E---SNVEQFINEVVILSQIN--HRNVVKLLGCCLESE 160 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~---~---~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~ 160 (419)
.++|++.+.||+|+||+||+|++ .+++.||||++.... . .....+.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999997 468899999875321 1 11234678999999986 899999999999999
Q ss_pred cceEEEeecCC-CCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-CCcEEEeecC
Q 014725 161 VPLLVYEFIPN-GTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-KYRAKVSDFG 238 (419)
Q Consensus 161 ~~~lv~e~~~~-g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-~~~~kl~Dfg 238 (419)
..++||||+.+ +++.+++.... .+++..+..++.||+.||.|||+++ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITERG---ALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred eEEEEEEeccCcchHHHHHhccC---CCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccc
Confidence 99999999976 68888887654 4899999999999999999999999 999999999999985 4799999999
Q ss_pred CceecccCCceeeecccccCCccCccccccCCC-CcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 239 ASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQF-TEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 239 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
+++..... ......||+.|+|||++.+..+ +.++|||||||++|||+||+.||..... ....
T Consensus 157 ~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~~~----- 219 (273)
T d1xwsa_ 157 SGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------IIRG----- 219 (273)
T ss_dssp TCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HHHC-----
T ss_pred cceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hhhc-----
Confidence 99875432 2345679999999999987765 6779999999999999999999974211 0000
Q ss_pred hhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 LFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
....+...+..+.+++.+||+.||++|||+.|+++
T Consensus 220 ---------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 ---------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 01112233457899999999999999999999975
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.6e-48 Score=360.08 Aligned_cols=275 Identities=16% Similarity=0.164 Sum_probs=217.6
Q ss_pred hcCccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC-cccccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINH-RNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e 167 (419)
.++|++.+.||+|+||+||+|++. +++.||||...... ....+.+|++.++.++| +|++.+++++.+....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence 468999999999999999999964 57899999875432 22457789999999965 899999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECC-----CCcEEEeecCCcee
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDD-----KYRAKVSDFGASRT 242 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~-----~~~~kl~Dfgl~~~ 242 (419)
|+ +++|.+++..... .+++.++..++.|++.||+|||+++ |+||||||+|||++. ++.+||+|||+++.
T Consensus 82 ~~-~~~l~~~~~~~~~--~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCGR--KFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHhhcc--chhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 99 7899999876543 4899999999999999999999999 999999999999964 57899999999998
Q ss_pred cccCCc------eeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc
Q 014725 243 IKVDQT------HLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED 316 (419)
Q Consensus 243 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 316 (419)
...... .......||+.|||||++.+..++.++|||||||++|||+||+.||..............+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence 653321 12345679999999999999999999999999999999999999998655433221111111110000
Q ss_pred chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCccc
Q 014725 317 RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEE 381 (419)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~ 381 (419)
.. .......++.+.+++..|++.+|++||+++.+.+.|+++....+.......+|+
T Consensus 236 ~~---------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~~~~Dw~ 291 (293)
T d1csna_ 236 PL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFDWN 291 (293)
T ss_dssp CH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSCSCCGGG
T ss_pred Ch---------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCCCCCCCCC
Confidence 00 011122345789999999999999999999999999998777766655555554
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-48 Score=361.16 Aligned_cols=276 Identities=19% Similarity=0.219 Sum_probs=209.9
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccc-ccEEeEEecCCcceEEEe
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV-VKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e 167 (419)
.++|++.+.||+|+||.||+|++ .+++.||||....... .+++..|+++++.++|+|+ +.+.+++.+.+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence 35799999999999999999997 4578999998765332 2457889999999987665 555566677788899999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEEC---CCCcEEEeecCCceecc
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLD---DKYRAKVSDFGASRTIK 244 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~---~~~~~kl~Dfgl~~~~~ 244 (419)
|+ +++|.+.+..... .+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+++...
T Consensus 84 ~~-~~~l~~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCSR--KFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred Ec-CCchhhhhhhccC--CCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceecc
Confidence 99 5677777665433 4899999999999999999999999 99999999999985 45579999999999875
Q ss_pred cCCce------eeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccch
Q 014725 245 VDQTH------LTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRL 318 (419)
Q Consensus 245 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (419)
..... ......||+.|||||++.+..++.++|||||||++|||+||+.||....................
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~---- 233 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM---- 233 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH----
T ss_pred ccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC----
Confidence 43322 23456799999999999999999999999999999999999999987655432221111111000
Q ss_pred hHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHHHHHhcHHhhCCCCCccCcccc
Q 014725 319 FEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAFELEGIRASIGSSSLQHNCEEI 382 (419)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~~L~~i~~~~~~~~~~~~~~~~ 382 (419)
...........+..+.+++.+||+.+|++||++.++.+.|+.+....+.......+|+.
T Consensus 234 -----~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~~~~Dw~~ 292 (299)
T d1ckia_ 234 -----STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFDWNM 292 (299)
T ss_dssp -----HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCSCCCHHHH
T ss_pred -----CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCCCCcCchh
Confidence 00000112234467899999999999999999999999999886666555555556654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=369.72 Aligned_cols=265 Identities=23% Similarity=0.301 Sum_probs=197.5
Q ss_pred hcCccccCcccccCcEEEEEEEec-C-CCEEEEEEcccC--ChhhHHHHHHHHHHHhcC---CCcccccEEeEEec----
Q 014725 90 TDNYNANRILGQGGQGTVYKGMLA-D-GGIVAVKKSKLV--DESNVEQFINEVVILSQI---NHRNVVKLLGCCLE---- 158 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~~-~-~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~niv~l~~~~~~---- 158 (419)
.++|++.+.||+|+||+||+|++. + ++.||||+++.. .......+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 578999999999999999999973 4 557999987532 222233466777776655 79999999999853
Q ss_pred -CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeec
Q 014725 159 -SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDF 237 (419)
Q Consensus 159 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Df 237 (419)
....+++|||++++++........ ..+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 346789999998877765544433 24899999999999999999999999 999999999999999999999999
Q ss_pred CCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc
Q 014725 238 GASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR 317 (419)
Q Consensus 238 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 317 (419)
|+++..... .......||+.|+|||++.+..++.++||||+||++|||+||+.||...+..+................
T Consensus 161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 238 (305)
T d1blxa_ 161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238 (305)
T ss_dssp CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence 998864322 233456799999999999999999999999999999999999999987665432111111110000000
Q ss_pred hhHH------H----HHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 LFEV------L----EARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 ~~~~------~----~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+... . ...............+.+|+.+||+.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 0000 0 000001112233456889999999999999999999975
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-48 Score=366.13 Aligned_cols=265 Identities=21% Similarity=0.294 Sum_probs=199.7
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC-ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC----cce
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV-DESNVEQFINEVVILSQINHRNVVKLLGCCLESE----VPL 163 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~ 163 (419)
+++|++.+.||+|+||+||+|++ .+++.||||++... .....+.+.+|+.+|+.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 46799999999999999999996 57889999998643 3445678999999999999999999999997653 235
Q ss_pred EEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceec
Q 014725 164 LVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTI 243 (419)
Q Consensus 164 lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~ 243 (419)
++++|+.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEeecCCchhhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence 666777799999999754 3899999999999999999999999 999999999999999999999999999876
Q ss_pred ccCCce--eeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccc---
Q 014725 244 KVDQTH--LTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDR--- 317 (419)
Q Consensus 244 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~--- 317 (419)
...... ......||+.|+|||++.. ..++.++||||+||+++||++|+.||......+................
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhh
Confidence 433222 2345679999999999854 5678999999999999999999999987665433222211111000000
Q ss_pred -----hhHHHHHhhc-cCCC-----HHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 318 -----LFEVLEARVL-KEGK-----EEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 318 -----~~~~~~~~~~-~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.......... ...+ ......+.+|+.+||+.||.+|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000000000 0000 112246889999999999999999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-47 Score=360.74 Aligned_cols=266 Identities=22% Similarity=0.297 Sum_probs=198.1
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEec--------
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLE-------- 158 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------- 158 (419)
.++|++.+.||+|+||+||+|++ .+++.||||++... .+.....+.+|+.+|+.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999997 56889999987542 33345678999999999999999999999865
Q ss_pred CCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecC
Q 014725 159 SEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFG 238 (419)
Q Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfg 238 (419)
....++||||+.++.+..+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CceEEEEEeccCCCccchhhhcc---cccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecc
Confidence 34578999999877666554432 24889999999999999999999999 9999999999999999999999999
Q ss_pred CceecccCCc---eeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhc
Q 014725 239 ASRTIKVDQT---HLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMN 314 (419)
Q Consensus 239 l~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 314 (419)
+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.............
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~ 242 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT 242 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred eeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 9987653222 223345799999999998764 689999999999999999999999987665443222222211111
Q ss_pred ccc--------hhHHHHHhhccCCCH-------HHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 315 EDR--------LFEVLEARVLKEGKE-------EEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 315 ~~~--------~~~~~~~~~~~~~~~-------~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
... ............... .....+.+|+.+||+.||++|||+.|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence 110 000000000000000 11235678999999999999999999975
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=362.78 Aligned_cols=260 Identities=22% Similarity=0.291 Sum_probs=196.7
Q ss_pred HhcCccccCcccccCcEEEEEEEe-cCCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecCC-----
Q 014725 89 ATDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLESE----- 160 (419)
Q Consensus 89 ~~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----- 160 (419)
..++|++.+.||+|+||+||+|.+ .+++.||||+++. .+....+.+.+|+.+|+.++|||||+++++|...+
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 357899999999999999999997 4588999999864 33445678999999999999999999999998654
Q ss_pred -cceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCC
Q 014725 161 -VPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGA 239 (419)
Q Consensus 161 -~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl 239 (419)
..++||||+ +.+|..++... .+++..+..++.||+.||.|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE----KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ceEEEEEecc-cccHHHHHHhc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccc
Confidence 469999999 66888877643 4999999999999999999999999 99999999999999999999999999
Q ss_pred ceecccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHH--------
Q 014725 240 SRTIKVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFL-------- 310 (419)
Q Consensus 240 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~-------- 310 (419)
++..... .+...||+.|+|||++.+ ..++.++||||+||++|||++|+.||...+............
T Consensus 168 a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 243 (346)
T d1cm8a_ 168 ARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFV 243 (346)
T ss_dssp CEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred eeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHH
Confidence 9875432 234568999999999876 456899999999999999999999998776543211111100
Q ss_pred HHhcccchhHHHHHhhc-------cCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 311 QAMNEDRLFEVLEARVL-------KEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 311 ~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
........... ..... ..........+.+|+.+||..||.+|||+.|+++
T Consensus 244 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 244 QRLQSDEAKNY-MKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HTCSCHHHHHH-HHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred hhhcchhhhhh-hccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00000000000 00000 0111223456789999999999999999999987
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=364.75 Aligned_cols=258 Identities=24% Similarity=0.312 Sum_probs=193.7
Q ss_pred CccccCcccccCcEEEEEEEec-CCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCcccccEEeEEecC------CcceE
Q 014725 92 NYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNVVKLLGCCLES------EVPLL 164 (419)
Q Consensus 92 ~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l 164 (419)
+|...++||+|+||+||+|++. +++.||||++..... .+.+|+.+|++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5888899999999999999974 588999999865332 234799999999999999999998643 24689
Q ss_pred EEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCceec
Q 014725 165 VYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTI 243 (419)
Q Consensus 165 v~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~ 243 (419)
||||++++.+..+.........+++..+..++.||+.||+|||+++ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999986644444332223346999999999999999999999999 99999999999999775 8999999999876
Q ss_pred ccCCceeeecccccCCccCcccccc-CCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc---chh
Q 014725 244 KVDQTHLTTRVQGTFGYLDPEYFRS-SQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED---RLF 319 (419)
Q Consensus 244 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~ 319 (419)
.... ......||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... +....... .+.
T Consensus 174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~---i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE---IIKVLGTPTREQIR 248 (350)
T ss_dssp CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH---HHHHHCCCCHHHHH
T ss_pred cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHH---HHHHhCCChHHhhh
Confidence 4332 2334578999999998765 5789999999999999999999999987665432111 11111000 000
Q ss_pred HHHHHh------------hccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 320 EVLEAR------------VLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 320 ~~~~~~------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
...... ............+.+|+.+||+.||.+|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 000111233456889999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-47 Score=359.65 Aligned_cols=252 Identities=26% Similarity=0.316 Sum_probs=204.4
Q ss_pred cCccccCcccccCcEEEEEEEec----CCCEEEEEEcccC----ChhhHHHHHHHHHHHhcCCC-cccccEEeEEecCCc
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA----DGGIVAVKKSKLV----DESNVEQFINEVVILSQINH-RNVVKLLGCCLESEV 161 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~----~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~ 161 (419)
++|++.+.||+|+||+||+|... +|+.||||.++.. +....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 67999999999999999999852 3789999987532 22334668899999999976 899999999999999
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.+++|||+.+|+|.+++.... .+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 999999999999999998765 3778889999999999999999999 9999999999999999999999999998
Q ss_pred ecccCCceeeecccccCCccCccccccC--CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchh
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSS--QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLF 319 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (419)
.+............|++.|+|||.+.+. .++.++|||||||+||||+||+.||......+.. ..+....
T Consensus 178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~---~~i~~~~------ 248 (322)
T d1vzoa_ 178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ---AEISRRI------ 248 (322)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH---HHHHHHH------
T ss_pred hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhc------
Confidence 7765544445566799999999998764 4688999999999999999999999766443211 1111100
Q ss_pred HHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCC-----HHHHHH
Q 014725 320 EVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPS-----MKEVAF 361 (419)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~evl~ 361 (419)
.......+...+..+.+++.+||++||.+||| ++|+++
T Consensus 249 ----~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 ----LKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp ----HHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred ----ccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence 01112234456678999999999999999995 677764
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=348.15 Aligned_cols=262 Identities=21% Similarity=0.313 Sum_probs=203.7
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEecCCcceEEEe
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 167 (419)
++|++.+.||+|+||+||+|++ .+++.||||+++.. .....+.+.+|+.+|+.++||||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999997 46788999997543 34456789999999999999999999999999999999999
Q ss_pred ecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCceecccCC
Q 014725 168 FIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASRTIKVDQ 247 (419)
Q Consensus 168 ~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~~~~~~ 247 (419)
++.+++|..++.... .+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~~---~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTTT---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ecccccccccccccc---ccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence 999999988876543 4889999999999999999999999 9999999999999999999999999998765433
Q ss_pred ceeeecccccCCccCccccccCC-CCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcc---cchhHHH-
Q 014725 248 THLTTRVQGTFGYLDPEYFRSSQ-FTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNE---DRLFEVL- 322 (419)
Q Consensus 248 ~~~~~~~~gt~~y~aPE~~~~~~-~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~- 322 (419)
. ......+++.|+|||.+.... ++.++|||||||++|||++|+.||......... ...+...... ..+....
T Consensus 156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 232 (292)
T d1unla_ 156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTK 232 (292)
T ss_dssp S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGG
T ss_pred c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhhhh
Confidence 2 223345788899999987654 689999999999999999999997543322211 1111111110 0000000
Q ss_pred --H---------HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 323 --E---------ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 323 --~---------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
+ ..............+.+|+.+||+.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0 00001111233456889999999999999999999975
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=4.2e-46 Score=351.22 Aligned_cols=255 Identities=21% Similarity=0.305 Sum_probs=196.8
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEec--CCcceEEE
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLE--SEVPLLVY 166 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~ 166 (419)
++|++.+.||+|+||+||+|++ .+++.||||+++... .+.+.+|+.+|+.++ ||||+++++++.. ....++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 5799999999999999999997 468889999986533 467889999999995 9999999999874 35688999
Q ss_pred eecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCC-cEEEeecCCceeccc
Q 014725 167 EFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKY-RAKVSDFGASRTIKV 245 (419)
Q Consensus 167 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~-~~kl~Dfgl~~~~~~ 245 (419)
||+++++|..+.. .+++..+..++.||+.||.|||+++ |+||||||+|||++.++ .+||+|||+++....
T Consensus 112 e~~~~~~L~~~~~------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTTT------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHhc------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999977642 4899999999999999999999999 99999999999998654 699999999987653
Q ss_pred CCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhcccchhHHHH-
Q 014725 246 DQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNEDRLFEVLE- 323 (419)
Q Consensus 246 ~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 323 (419)
.. ......+|+.|+|||.+.+. .++.++||||+||+++||++|+.||............ ...............
T Consensus 183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~--i~~~~g~~~~~~~~~~ 258 (328)
T d3bqca1 183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR--IAKVLGTEDLYDYIDK 258 (328)
T ss_dssp TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH--HHHHHCHHHHHHHHHH
T ss_pred CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHH--HHHHHCCchhhhhhhh
Confidence 32 23445689999999998765 5799999999999999999999999765433221110 111000000000000
Q ss_pred ----------------------HhhccCCCHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 324 ----------------------ARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 324 ----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
..............+.+|+.+||+.||.+|||++|+++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 00001111223456889999999999999999999975
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-46 Score=353.52 Aligned_cols=260 Identities=23% Similarity=0.283 Sum_probs=190.5
Q ss_pred cCccccCcccccCcEEEEEEEec-CCCEEEEEEccc--CChhhHHHHHHHHHHHhcCCCcccccEEeEEecC------Cc
Q 014725 91 DNYNANRILGQGGQGTVYKGMLA-DGGIVAVKKSKL--VDESNVEQFINEVVILSQINHRNVVKLLGCCLES------EV 161 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~~-~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~ 161 (419)
++|++.+.||+|+||+||+|.+. +|+.||||++.. .+......+.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 68999999999999999999975 588999999864 3345566789999999999999999999999643 56
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.|+||||+.++.+ +.+.. .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~-~~~~~-----~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLC-QVIQM-----ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHH-HHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHH-Hhhhc-----CCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 7999999976544 44432 3889999999999999999999999 9999999999999999999999999988
Q ss_pred ecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHH-----Hh---
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQ-----AM--- 313 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~--- 313 (419)
..... .......+|+.|+|||++.+..++.++||||+||+++||++|+.||.+.+............. .+
T Consensus 168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (355)
T d2b1pa1 168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 245 (355)
T ss_dssp ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTS
T ss_pred ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHh
Confidence 65432 233455789999999999999999999999999999999999999987654322111100000 00
Q ss_pred --------cc------cchhHHHHHhhccCC---CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 314 --------NE------DRLFEVLEARVLKEG---KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 314 --------~~------~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
.. ............... .......+.+|+.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence 00 000000000110111 1234567889999999999999999999975
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=354.25 Aligned_cols=261 Identities=22% Similarity=0.266 Sum_probs=196.8
Q ss_pred hcCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccC--ChhhHHHHHHHHHHHhcCCCcccccEEeEEec-----CCc
Q 014725 90 TDNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLV--DESNVEQFINEVVILSQINHRNVVKLLGCCLE-----SEV 161 (419)
Q Consensus 90 ~~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~ 161 (419)
.++|++.+.||+|+||+||+|++ .+++.||||++... +....+.+.+|+.+|+.++|||++++++++.. ...
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 57899999999999999999996 46889999998643 33455678999999999999999999999863 334
Q ss_pred ceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEEeecCCce
Q 014725 162 PLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKVSDFGASR 241 (419)
Q Consensus 162 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~ 241 (419)
.+++|+|+.+|+|.+++... .+++..+..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~----~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhcccc----cccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 57778888899999999643 4999999999999999999999999 9999999999999999999999999997
Q ss_pred ecccCCceeeecccccCCccCccccccC-CCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHHHHHhccc----
Q 014725 242 TIKVDQTHLTTRVQGTFGYLDPEYFRSS-QFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFFLQAMNED---- 316 (419)
Q Consensus 242 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---- 316 (419)
.... ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..................
T Consensus 170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 245 (348)
T d2gfsa1 170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245 (348)
T ss_dssp CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 6432 23345689999999987665 56899999999999999999999998766543221111100000000
Q ss_pred ---chhHHHHHhhcc--CC-----CHHHHHHHHHHHHHHhccCCCCCCCHHHHHH
Q 014725 317 ---RLFEVLEARVLK--EG-----KEEEIITVAMLGKRCLNMIGKKRPSMKEVAF 361 (419)
Q Consensus 317 ---~~~~~~~~~~~~--~~-----~~~~~~~l~~li~~cl~~~p~~RPt~~evl~ 361 (419)
............ .. .......+.+|+.+||+.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp CCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence 000000000000 00 0122356789999999999999999999986
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-40 Score=318.39 Aligned_cols=261 Identities=21% Similarity=0.213 Sum_probs=190.5
Q ss_pred cCccccCcccccCcEEEEEEEe-cCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-----------CcccccEEeEEec
Q 014725 91 DNYNANRILGQGGQGTVYKGML-ADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-----------HRNVVKLLGCCLE 158 (419)
Q Consensus 91 ~~y~~~~~ig~G~fg~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~ 158 (419)
++|++.+.||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence 4699999999999999999997 46889999998743 333467788999888775 5789999998865
Q ss_pred C--CcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhh-cCCCCeeecCCCCCcEEECCCC-----
Q 014725 159 S--EVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHS-ATSIPIYHRDIKSSNILLDDKY----- 230 (419)
Q Consensus 159 ~--~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-~~~~~iiH~Dlkp~Nill~~~~----- 230 (419)
. ...+++|+++..+..............+++..+..++.||+.||.|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred ccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCccccc
Confidence 3 4456667766555443333333334468999999999999999999998 67 99999999999997655
Q ss_pred -cEEEeecCCceecccCCceeeecccccCCccCccccccCCCCcccceechhHHHHHHHhCCCCCCCCChhhhccHHHHH
Q 014725 231 -RAKVSDFGASRTIKVDQTHLTTRVQGTFGYLDPEYFRSSQFTEKSDVYSFGVVLVELLTGQKPIRSTDAEEDRSLVGFF 309 (419)
Q Consensus 231 -~~kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~ 309 (419)
.++++|||.+...... .....||+.|+|||++.+..++.++||||+||++++|++|+.||...............
T Consensus 169 ~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~ 244 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244 (362)
T ss_dssp EEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHH
T ss_pred ceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHH
Confidence 3999999999865432 23456999999999999999999999999999999999999999765432211111110
Q ss_pred H---HHhccc------------------------------chhHHHHHhhccCCCHHHHHHHHHHHHHHhccCCCCCCCH
Q 014725 310 L---QAMNED------------------------------RLFEVLEARVLKEGKEEEIITVAMLGKRCLNMIGKKRPSM 356 (419)
Q Consensus 310 ~---~~~~~~------------------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~ 356 (419)
. ...... ...... .............+.+|+.+||+.||.+|||+
T Consensus 245 ~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVL--TEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHH--HHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhc--ccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 0 000000 000000 01123345677889999999999999999999
Q ss_pred HHHHH
Q 014725 357 KEVAF 361 (419)
Q Consensus 357 ~evl~ 361 (419)
.|+++
T Consensus 323 ~e~L~ 327 (362)
T d1q8ya_ 323 GGLVN 327 (362)
T ss_dssp HHHHT
T ss_pred HHHhc
Confidence 99965
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=8.2e-26 Score=194.77 Aligned_cols=165 Identities=18% Similarity=0.201 Sum_probs=120.9
Q ss_pred ccccCcccccCcEEEEEEEecCCCEEEEEEcccCCh------------------hhHHHHHHHHHHHhcCCCcccccEEe
Q 014725 93 YNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDE------------------SNVEQFINEVVILSQINHRNVVKLLG 154 (419)
Q Consensus 93 y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~l~~ 154 (419)
+.+.+.||+|+||+||+|.+.+|+.||||..+.... .......+|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 356789999999999999988899999997543110 11233456888999999999999886
Q ss_pred EEecCCcceEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCCCCeeecCCCCCcEEECCCCcEEE
Q 014725 155 CCLESEVPLLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATSIPIYHRDIKSSNILLDDKYRAKV 234 (419)
Q Consensus 155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iiH~Dlkp~Nill~~~~~~kl 234 (419)
+. ..+++|||+++..+.+ ++......++.|++.+|.|||+++ |+||||||+|||++++ .++|
T Consensus 82 ~~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l 143 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI 143 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred ec----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence 54 3489999998865543 233335678999999999999999 9999999999999965 5899
Q ss_pred eecCCceecccCCceeeecccccCCccCc--c---ccccCCCCcccceechhHHH
Q 014725 235 SDFGASRTIKVDQTHLTTRVQGTFGYLDP--E---YFRSSQFTEKSDVYSFGVVL 284 (419)
Q Consensus 235 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~s~~~Di~slG~~l 284 (419)
+|||++......... .|... + .+-...|+.++|+||+.--+
T Consensus 144 iDFG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 144 IDFPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCCTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EECCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999999765322111 11111 0 01135678899999976544
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.74 E-value=5e-08 Score=86.09 Aligned_cols=150 Identities=17% Similarity=0.123 Sum_probs=103.6
Q ss_pred HHHHHHhcCccccCcccccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcc
Q 014725 84 MDLEKATDNYNANRILGQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVP 162 (419)
Q Consensus 84 ~~~~~~~~~y~~~~~ig~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~ 162 (419)
.++......|+..+..+-++...||+... +++.+++|+...........+.+|...++.+. +--+++++.++.+.+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 45666667787777655555678999865 45667888765443333345677888877663 43467888888888889
Q ss_pred eEEEeecCCCCHHHHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhcCC-------------------------------
Q 014725 163 LLVYEFIPNGTLYHYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSATS------------------------------- 211 (419)
Q Consensus 163 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~------------------------------- 211 (419)
++||++++|.++.+...... . ...++.+++..+..||+...
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN 157 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred EEEEEecccccccccccccc-----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence 99999999988866543211 1 22345556666666665321
Q ss_pred -------------------------CCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 212 -------------------------IPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 212 -------------------------~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1279999999999999876677999987754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.27 E-value=1.9e-06 Score=75.20 Aligned_cols=130 Identities=17% Similarity=0.150 Sum_probs=85.2
Q ss_pred ccccCc-EEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCC--CcccccEEeEEecCCcceEEEeecCCCCHH
Q 014725 99 LGQGGQ-GTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQIN--HRNVVKLLGCCLESEVPLLVYEFIPNGTLY 175 (419)
Q Consensus 99 ig~G~f-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g~L~ 175 (419)
+..|.. +.||+...+++..+++|....... ..+..|...++.+. .-.+++++.+..+.+..++||++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence 444543 689999887787888998665433 33566777777663 234677888888888889999999886553
Q ss_pred HHhhccCCCCCCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 014725 176 HYLHDQTEEFPITWEMRLRIAIEVSGAMSYLHSA---------------------------------------------- 209 (419)
Q Consensus 176 ~~l~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---------------------------------------------- 209 (419)
+.. ... ...+.+++..|..||+.
T Consensus 95 ~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 95 SSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp TSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred ccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 210 111 11122333333333321
Q ss_pred -----C----CCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 210 -----T----SIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 210 -----~----~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
. ...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 11289999999999999877778999987643
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.88 E-value=3.8e-05 Score=71.35 Aligned_cols=75 Identities=16% Similarity=0.201 Sum_probs=48.0
Q ss_pred CcccccCcEEEEEEEecC-CCEEEEEEccc----CC---hhhHHHHHHHHHHHhcCC-C--cccccEEeEEecCCcceEE
Q 014725 97 RILGQGGQGTVYKGMLAD-GGIVAVKKSKL----VD---ESNVEQFINEVVILSQIN-H--RNVVKLLGCCLESEVPLLV 165 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~-~~~vavK~~~~----~~---~~~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 165 (419)
+.||.|....||+....+ ++.++||.... .. .....+...|.+.|+.+. + ..+++++.+ +.+..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEE
Confidence 468999999999998654 56889996432 11 112334556887777662 2 346666654 45567899
Q ss_pred EeecCCCC
Q 014725 166 YEFIPNGT 173 (419)
Q Consensus 166 ~e~~~~g~ 173 (419)
||++++..
T Consensus 110 mE~L~~~~ 117 (392)
T d2pula1 110 MEDLSHLK 117 (392)
T ss_dssp ECCCTTSE
T ss_pred EeccCCcc
Confidence 99997653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.43 E-value=0.00034 Score=62.88 Aligned_cols=68 Identities=15% Similarity=0.079 Sum_probs=44.1
Q ss_pred cEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCCccc--ccEEe-----EEecCCcceEEEeecCCC
Q 014725 104 QGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINHRNV--VKLLG-----CCLESEVPLLVYEFIPNG 172 (419)
Q Consensus 104 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~g 172 (419)
--.||++...+|..+++|...... ...+++..|...+..|...++ +..+. .+...+..+.++++++|.
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 358999999899999999876432 234667788888877742222 11111 123345678899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.21 E-value=0.00052 Score=63.44 Aligned_cols=72 Identities=19% Similarity=0.211 Sum_probs=48.3
Q ss_pred CcccccCcEEEEEEEecCC--------CEEEEEEcccCChhhHHHHHHHHHHHhcCC-CcccccEEeEEecCCcceEEEe
Q 014725 97 RILGQGGQGTVYKGMLADG--------GIVAVKKSKLVDESNVEQFINEVVILSQIN-HRNVVKLLGCCLESEVPLLVYE 167 (419)
Q Consensus 97 ~~ig~G~fg~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 167 (419)
+.|+.|-.-.+|++...++ ..|.++.... ... .....+|..+++.+. +.-.+++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~-~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN-PET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS-CCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCC-cch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5678888899999986543 4566665442 222 234567888888885 4334577877743 68999
Q ss_pred ecCCCCH
Q 014725 168 FIPNGTL 174 (419)
Q Consensus 168 ~~~~g~L 174 (419)
|++|..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.84 E-value=0.0046 Score=54.73 Aligned_cols=159 Identities=9% Similarity=0.022 Sum_probs=80.2
Q ss_pred cCHHHHHHHhcCccccCcc-----cccCcEEEEEEEecCCCEEEEEEcccCChhhHHHHHHHHHHHhcCCC-----cccc
Q 014725 81 FTKMDLEKATDNYNANRIL-----GQGGQGTVYKGMLADGGIVAVKKSKLVDESNVEQFINEVVILSQINH-----RNVV 150 (419)
Q Consensus 81 ~~~~~~~~~~~~y~~~~~i-----g~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv 150 (419)
.+.++++....+|.+.+.. ..|---+.|+...++| .+++|+..... ..+.+..|++++..|.. |..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 4567788888888775543 3555677899887655 48888875421 12334445666655532 2222
Q ss_pred cEE-e--EEecCCcceEEEeecCCCCHHH--------------Hhhcc----CC--CCCCCH------------------
Q 014725 151 KLL-G--CCLESEVPLLVYEFIPNGTLYH--------------YLHDQ----TE--EFPITW------------------ 189 (419)
Q Consensus 151 ~l~-~--~~~~~~~~~lv~e~~~~g~L~~--------------~l~~~----~~--~~~l~~------------------ 189 (419)
... | +..-......++.++.+..... .++.. .. ......
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 110 0 0112334456666665532210 00000 00 000000
Q ss_pred HHHHHHHHHHHHHHHHHhhc-CCCCeeecCCCCCcEEECCCCcEEEeecCCcee
Q 014725 190 EMRLRIAIEVSGAMSYLHSA-TSIPIYHRDIKSSNILLDDKYRAKVSDFGASRT 242 (419)
Q Consensus 190 ~~~~~i~~~i~~~l~~LH~~-~~~~iiH~Dlkp~Nill~~~~~~kl~Dfgl~~~ 242 (419)
......+......+...+.. -+.++||+|+.++|++++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 01111122222222222221 134599999999999999887778999998753
|